prefix	MIM_number	preferred_title	alternative_title	symbols
NULL	100050	AARSKOG SYNDROME, AUTOSOMAL DOMINANT		
Percent	100070	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 1; AAA1	ANEURYSM, ABDOMINAL AORTIC; AAA;; ABDOMINAL AORTIC ANEURYSM	
Number Sign	100100	PRUNE BELLY SYNDROME; PBS	ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY AND CRYPTORCHIDISM;; EAGLE-BARRETT SYNDROME; EGBRS	
NULL	100200	ABDUCENS PALSY		
Number Sign	100300	ADAMS-OLIVER SYNDROME 1; AOS1	AOS;; ABSENCE DEFECT OF LIMBS, SCALP, AND SKULL;; CONGENITAL SCALP DEFECTS WITH DISTAL LIMB REDUCTION ANOMALIES;; APLASIA CUTIS CONGENITA WITH TERMINAL TRANSVERSE LIMB DEFECTS	APLASIA CUTIS CONGENITA, CONGENITAL HEART DEFECT, AND FRONTONASAL CYSTS, INCLUDED
Percent	100600	ACANTHOSIS NIGRICANS		
NULL	100675	ACETAMINOPHEN METABOLISM		
NULL	100700	ACHARD SYNDROME		
Number Sign	100800	ACHONDROPLASIA; ACH		
Percent	100820	ACHOO SYNDROME	AUTOSOMAL DOMINANT COMPELLING HELIOOPHTHALMIC OUTBURST SYNDROME;; PHOTIC SNEEZE REFLEX;; SNEEZING FROM LIGHT EXPOSURE;; PEROUTKA SNEEZE	
Number Sign	101000	NEUROFIBROMATOSIS, TYPE II; NF2	NEUROFIBROMATOSIS, CENTRAL TYPE;; ACOUSTIC SCHWANNOMAS, BILATERAL;; BILATERAL ACOUSTIC NEUROFIBROMATOSIS; BANF;; ACOUSTIC NEURINOMA, BILATERAL; ACN	
NULL	101120	ACROCEPHALOPOLYSYNDACTYLY TYPE III	ACPS III;; ACPS WITH LEG HYPOPLASIA;; SAKATI-NYHAN SYNDROME	
Number Sign	101200	APERT SYNDROME	ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;; ACS I	APERT-CROUZON DISEASE, INCLUDED;; ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;; ACS II, INCLUDED;; VOGT CEPHALODACTYLY, INCLUDED
Number Sign	101400	SAETHRE-CHOTZEN SYNDROME; SCS	ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;; ACS III;; CHOTZEN SYNDROME;; ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLY	SAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;; BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED; BPES3, FORMERLY, INCLUDED
Number Sign	101600	PFEIFFER SYNDROME	ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;; ACS V;; NOACK SYNDROME	CRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED
Number Sign	101800	ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1	ADOHR	
NULL	101805	ACROFACIAL DYSOSTOSIS, CATANIA TYPE	AFD, CATANIA TYPE	
NULL	101840	ACROKERATODERMA, HEREDITARY PAPULOTRANSLUCENT		
Percent	101850	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE III; PPKP3	ACROKERATOELASTOIDOSIS; AKE;; COLLAGENOUS PLAQUES OF HANDS AND FEET	
Number Sign	101900	ACROKERATOSIS VERRUCIFORMIS; AKV	HOPF DISEASE	
NULL	102000	ACROLEUKOPATHY, SYMMETRIC		
Percent	102100	ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	ROSENTHAL-KLOEPFER SYNDROME	
Percent	102150	ACROMEGALOID FACIAL APPEARANCE SYNDROME	AFA SYNDROME;; THICK LIPS AND ORAL MUCOSA	
Number Sign	102200	PITUITARY ADENOMA 1, MULTIPLE TYPES; PITA1	SOMATOTROPINOMA, FAMILIAL ISOLATED; FIS;; ISOLATED FAMILIAL SOMATOTROPINOMA; IFS;; SOMATOTROPHINOMA, FAMILIAL;; ACROMEGALY DUE TO PITUITARY ADENOMA 1;; PAGH1	PITUITARY ADENOMA PREDISPOSITION, INCLUDED; PAP, INCLUDED;; PITUITARY ADENOMA, FAMILIAL ISOLATED, INCLUDED; FIPA, INCLUDED
Percent	102300	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1	ACROMELALGIA, HEREDITARY;; EKBOM SYNDROME	
Percent	102350	ACROMIAL DIMPLES	SUPRASPINOUS FOSSAE, CONGENITAL	
Number Sign	102370	ACROMICRIC DYSPLASIA; ACMICD		
NULL	102400	ACROOSTEOLYSIS		
Number Sign	102500	HAJDU-CHENEY SYNDROME; HJCYS	ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;; CHENEY SYNDROME;; ARTHRODENTOOSTEODYSPLASIA;; SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	
Percent	102510	ACROPECTOROVERTEBRAL DYSPLASIA; ACRPV	F SYNDROME	
NULL	102520	ACRORENAL SYNDROME		
Number Sign	102530	SPERMATOGENIC FAILURE 6; SPGF6	GLOBOZOOSPERMIA;; ROUND-HEADED SPERMATOZOA;; SPERMATOZOA, ROUND-HEADED;; ACROSOME MALFORMATION OF SPERMATOZOA	
NULL	102590	ACYLASE, COBALT-ACTIVATED		
NULL	102650	ADACTYLIA, UNILATERAL	TERMINAL TRANSVERSE DEFECTS OF HAND, UNILATERAL	
NULL	102660	ADAMANTINOMA OF LONG BONES		
NULL	102699	ADENO-ASSOCIATED VIRUS INTEGRATION SITE 1; AAVS1		
Number Sign	102700	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	SCID DUE TO ADA DEFICIENCY;; ADA-SCID;; SCID DUE TO ADA DEFICIENCY, EARLY-ONSET	SCID DUE TO ADA DEFICIENCY, DELAYED ONSET, INCLUDED;; SCID DUE TO ADA DEFICIENCY, LATE-ONSET, INCLUDED;; ADENOSINE DEAMINASE DEFICIENCY, PARTIAL, INCLUDED;; PARTIAL ADA DEFICIENCY, INCLUDED
NULL	102730	ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO		
Percent	102800	ADENOSINE TRIPHOSPHATASE DEFICIENCY, ANEMIA DUE TO		
Number Sign	102900	ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES	PYRUVATE KINASE HYPERACTIVITY	
Number Sign	103050	ADENYLOSUCCINASE DEFICIENCY; ADSLD	ADENYLOSUCCINATE LYASE DEFICIENCY;; ADSL DEFICIENCY	
Number Sign	103100	ADIE PUPIL	ADIE SYNDROME;; POORLY REACTING PUPILS	HOLMES-ADIE SYNDROME, INCLUDED
Percent	103200	ADIPOSIS DOLOROSA	DERCUM DISEASE	
NULL	103230	ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL	ADDISON DISEASE, CONGENITAL	
Number Sign	103285	ADULT SYNDROME	ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME	
Percent	103300	HYPOGLOSSIA-HYPODACTYLIA	PEROMELIA WITH MICROGNATHISM;; OROMANDIBULAR LIMB HYPOPLASIA;; AGLOSSIA-ADACTYLIA	HANHART SYNDROME, INCLUDED
NULL	103400	AINHUM		
Percent	103420	ALACRIMA, CONGENITAL, AUTOSOMAL DOMINANT	ALACRIMIA CONGENITA, AUTOSOMAL DOMINANT	
Number Sign	103470	ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS	WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE; WS2-OA	
Number Sign	103500	TIETZ ALBINISM-DEAFNESS SYNDROME; TADS	TIETZ SYNDROME;; ALBINISM-DEAFNESS OF TIETZ;; HYPOPIGMENTATION/DEAFNESS OF TIETZ	
Number Sign	103580	PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A	PHP IA;; ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	
Number Sign	103780	ALCOHOL DEPENDENCE	ALCOHOLISM	
Number Sign	103900	HYPERALDOSTERONISM, FAMILIAL, TYPE I; HALD1	GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM; GRA;; FH I;; GLUCOCORTICOID-SUPPRESSIBLE HYPERALDOSTERONISM; GSH;; ALDOSTERONISM, SENSITIVE TO DEXAMETHASONE;; ACTH-DEPENDENT HYPERALDOSTERONISM SYNDROME	
NULL	103920	ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS, FAMILIAL		
Percent	104000	ALOPECIA AREATA 1; AA1		ALOPECIA UNIVERSALIS, INCLUDED; AU, INCLUDED
Number Sign	104100	PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1; PPKCA1	PPKCA, STEVANOVIC TYPE;; KERATODERMA-HYPOTRICHOSIS-LEUKONYCHIA TOTALIS SYNDROME	
NULL	104110	ALOPECIA, FAMILIAL FOCAL; ALPF		
Percent	104130	ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY	SHOKEIR SYNDROME	
Number Sign	104200	ALPORT SYNDROME, AUTOSOMAL DOMINANT		
Number Sign	104290	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1		
Number Sign	104300	ALZHEIMER DISEASE; AD	PRESENILE AND SENILE DEMENTIA	ALZHEIMER DISEASE, FAMILIAL, 1, INCLUDED; AD1, INCLUDED;; ALZHEIMER DISEASE, EARLY-ONSET, WITH CEREBRAL AMYLOID ANGIOPATHY, INCLUDED;; ALZHEIMER DISEASE, PROTECTION AGAINST, INCLUDED
Number Sign	104310	ALZHEIMER DISEASE 2; AD2	ALZHEIMER DISEASE 2, LATE-ONSET;; ALZHEIMER DISEASE ASSOCIATED WITH APOE4	
NULL	104350	AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM		
NULL	104400	AMELIA AND TERMINAL TRANSVERSE HEMIMELIA		
Number Sign	104500	AMELOGENESIS IMPERFECTA, TYPE IB; AI1B	AMELOGENESIS IMPERFECTA, HYPOPLASTIC LOCAL, AUTOSOMAL DOMINANT;; AIH2;; ENAMEL HYPOPLASIA, HEREDITARY LOCALIZED	
Number Sign	104510	AMELOGENESIS IMPERFECTA, TYPE IV; AI4	AMELOGENESIS IMPERFECTA, HYPOMATURATION-HYPOPLASTIC TYPE, WITH TAURODONTISM; AIHHT	
Number Sign	104530	AMELOGENESIS IMPERFECTA, TYPE IA; AI1A	AMELOGENESIS IMPERFECTA, HYPOPLASTIC TYPE IA	
Percent	104570	AMELOONYCHOHYPOHIDROTIC SYNDROME		
NULL	104600	AMENORRHEA-GALACTORRHEA SYNDROME		
Number Sign	105120	AMYLOIDOSIS, FINNISH TYPE	AMYLOIDOSIS V;; AMYLOIDOSIS, MERETOJA TYPE;; AMYLOID CRANIAL NEUROPATHY WITH LATTICE CORNEAL DYSTROPHY;; AMYLOIDOSIS DUE TO MUTANT GELSOLIN	CEREBRAL AMYLOID ANGIOPATHY, GSN-RELATED, INCLUDED;; CORNEAL DYSTROPHY, LATTICE TYPE II, INCLUDED; LCD2, INCLUDED;; LATTICE CORNEAL DYSTROPHY, TYPE II, INCLUDED
Number Sign	105150	CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED	AMYLOIDOSIS, CEREBROARTERIAL, ICELANDIC TYPE;; AMYLOIDOSIS VI;; HEREDITARY CEREBRAL HEMORRHAGE WITH AMYLOIDOSIS; HCHWA;; CEREBRAL HEMORRHAGE, HEREDITARY, WITH AMYLOIDOSIS	
Number Sign	105200	AMYLOIDOSIS, FAMILIAL VISCERAL	AMYLOIDOSIS VIII;; OSTERTAG TYPE AMYLOIDOSIS;; GERMAN TYPE AMYLOIDOSIS;; AMYLOIDOSIS, FAMILIAL RENAL;; AMYLOIDOSIS, SYSTEMIC NONNEUROPATHIC	
Number Sign	105210	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	HEREDITARY AMYLOIDOSIS, TRANSTHYRETIN-RELATED;; TRANSTHYRETIN AMYLOIDOSIS;; AMYLOID POLYNEUROPATHY, FAMILIAL; FAP	AMYLOIDOSIS, LEPTOMENINGEAL, TRANSTHYRETIN-RELATED, INCLUDED;; AMYLOID CARDIOMYOPATHY, TRANSTHYRETIN-RELATED, INCLUDED
Number Sign	105250	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1	AMYLOIDOSIS, PRIMARY CUTANEOUS, 1; PCA1;; PCA;; LICHEN AMYLOIDOSIS, FAMILIAL;; AMYLOIDOSIS IX;; AMYLOIDOSIS, FAMILIAL CUTANEOUS LICHEN	
NULL	105300	AMYOTROPHIC DYSTONIC PARAPLEGIA		
Number Sign	105400	AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1	AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS;; AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT	AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE, INCLUDED;; AMYOTROPHIC LATERAL SCLEROSIS, SPORADIC, INCLUDED
Number Sign	105500	AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX OF GUAM;; GUAM DISEASE;; ALS-PDC	
Number Sign	105550	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 1; FTDALS1	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS; FTDALS;; FRONTOTEMPORAL DEMENTIA AND/OR MOTOR NEURON DISEASE; FTDMND;; AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA; ALSFTD	
NULL	105563	ANAL SPHINCTER DYSPLASIA; ASDP		
NULL	105565	ANAL SPHINCTER MYOPATHY, INTERNAL	PROCTALGIA FUGAX DUE TO ANAL SPHINCTER MYOPATHY	
NULL	105570	ANDROSTENONE, ABILITY TO SMELL		
NULL	105580	ANAL CANAL CARCINOMA		CLOACOGENIC CARCINOMA, INCLUDED
Percent	105600	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE III; CDAN3	DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE III;; CDA III;; ANEMIA WITH MULTINUCLEATED ERYTHROBLASTS;; ERYTHRORETICULOSIS, HEREDITARY BENIGN	
Number Sign	105650	DIAMOND-BLACKFAN ANEMIA 1; DBA1	DBA;; BLACKFAN-DIAMOND SYNDROME; BDS;; ANEMIA, CONGENITAL HYPOPLASTIC, OF BLACKFAN AND DIAMOND;; ANEMIA, CONGENITAL ERYTHROID HYPOPLASTIC;; RED CELL APLASIA, PURE, HEREDITARY;; AREGENERATIVE ANEMIA, CHRONIC CONGENITAL;; ERYTHROGENESIS IMPERFECTA;; AASE-SMITH SYNDROME II;; AASE SYNDROME	
Percent	105800	ANEURYSM, INTRACRANIAL BERRY, 1; ANIB1	ANEURYSMAL SUBARACHNOID HEMORRHAGE, FAMILIAL	
NULL	105805	ANEURYSM OF INTERVENTRICULAR SEPTUM		
Number Sign	105830	ANGELMAN SYNDROME; AS	HAPPY PUPPET SYNDROME, FORMERLY	ANGELMAN SYNDROME CHROMOSOME REGION, INCLUDED; ANCR, INCLUDED
NULL	105835	ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA; ASPED		
NULL	106050	ANGIOMA SERPIGINOSUM, AUTOSOMAL DOMINANT		
Percent	106070	ANGIOMA, HEREDITARY NEUROCUTANEOUS		SPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED;; HEMANGIOMATOSIS, DISSEMINATED, INCLUDED
Number Sign	106100	ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	ANGIONEUROTIC EDEMA, HEREDITARY; HANE;; C1 ESTERASE INHIBITOR, DEFICIENCY OF	ANGIOEDEMA, HEREDITARY, TYPE II, INCLUDED; HAE2, INCLUDED
Number Sign	106190	ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS; ANHD	DANN-EPSTEIN-SOHAR SYNDROME	
Number Sign	106210	ANIRIDIA 1; AN1	AN;; ANIRIDIA II, FORMERLY; AN2, FORMERLY	CATARACT, CONGENITAL, WITH LATE-ONSET CORNEAL DYSTROPHY, INCLUDED
NULL	106220	ANIRIDIA AND ABSENT PATELLA		
NULL	106230	ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT		
NULL	106240	ANISOCORIA		
NULL	106250	ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE; AFA		
Number Sign	106260	ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	AEC SYNDROME;; HAY-WELLS SYNDROME	
NULL	106280	ANKYLOGLOSSIA	'TONGUE-TIE'	
Number Sign	106300	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1	ANKYLOSING SPONDYLITIS, SUSCEPTIBILITY TO;; MARIE-STRUMPELL SPONDYLITIS;; BECHTEREW SYNDROME	
NULL	106400	ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS		DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS, INCLUDED; DISH, INCLUDED
NULL	106500	ANNULAR ERYTHEMA		
Number Sign	106600	TOOTH AGENESIS, SELECTIVE, 1; STHAG1	HYPODONTIA/OLIGODONTIA 1; HYD1;; SECOND PREMOLARS AND THIRD MOLARS, ABSENCE OF;; TOOTH AGENESIS, FAMILIAL	TOOTH AGENESIS, SELECTIVE, WITH OROFACIAL CLEFT, INCLUDED;; HYPODONTIA/OLIGODONTIA WITH OROFACIAL CLEFT, INCLUDED
Percent	106700	TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1	ANOMALOUS PULMONARY VENOUS RETURN; APVR;; SCIMITAR SYNDROME;; SCIMITAR ANOMALY	
NULL	106750	ANONYCHIA WITH FLEXURAL PIGMENTATION		
NULL	106900	ANONYCHIA-ECTRODACTYLY		
NULL	106990	ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY		
Percent	106995	ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES	COOKS SYNDROME	
Percent	107000	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6; NDNC6	ANONYCHIA/HYPONYCHIA AND ONYCHODYSTROPHY;; ANONYCHIA, PARTIAL	
Percent	107100	ANORECTAL ANOMALIES		
Percent	107200	ANOSMIA, ISOLATED CONGENITAL; ANIC	ANOSMIA, CONGENITAL	
Number Sign	107250	ANTERIOR SEGMENT DYSGENESIS 1; ASGD1	ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS; ASMD;; ANTERIOR SEGMENT OCULAR DYSGENESIS; ASOD	
Percent	107290	ANTIPYRINE METABOLISM		
NULL	107320	ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	LUPUS ANTICOAGULANT, FAMILIAL	
NULL	107410	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 2, PSEUDOGENE; SERPINA2P	PROTEASE INHIBITOR 1-LIKE; PIL;; ANTITRYPSIN-RELATED PROTEIN; ATR;; ALPHA-1-ANTITRYPSIN-RELATED GENE SEQUENCE; ARGS;; SERPINA2	
NULL	107440	ANTIVIRAL STATE REPRESSOR, REGULATOR OF; AVRR		
Number Sign	107480	TOWNES-BROCKS SYNDROME 1; TBS1	RENAL-EAR-ANAL-RADIAL SYNDROME;; REAR SYNDROME;; ANUS, IMPERFORATE, WITH HAND, FOOT, AND EAR ANOMALIES;; DEAFNESS, SENSORINEURAL, WITH IMPERFORATE ANUS AND THUMB ANOMALIES	TOWNES-BROCKS-BRANCHIOOTORENAL-LIKE SYNDROME, INCLUDED
NULL	107500	AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION		
NULL	107550	AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA		
Number Sign	107600	APLASIA CUTIS CONGENITA, NONSYNDROMIC; ACC	CONGENITAL DEFECT OF SKULL AND SCALP;; SCALP DEFECT, CONGENITAL	
NULL	107640	APNEA, CENTRAL SLEEP		
Percent	107650	APNEA, OBSTRUCTIVE SLEEP	OSA;; OBSTRUCTIVE SLEEP APNEA SYNDROME; OSAS;; SLEEP APNEA/HYPOPNEA SYNDROME; SAHS; OSAHS	
NULL	107700	APPENDICITIS, PRONENESS TO		
Number Sign	107750	ARBITRARY RESTRICTION POLYMORPHISM 1	ANONYMOUS RESTRICTION POLYMORPHISM 1; ARP1;; RESTRICTION FRAGMENT LENGTH POLYMORPHISM 14A;; RFLP-14A;; ARP-14A; D14S1	
NULL	107800	ARCUS CORNEAE	CORNEAL ARCUS;; ARCUS SENILIS	
NULL	107850	ARM FOLDING PREFERENCE		
NULL	107900	ARMS, MALFORMATION OF		
NULL	107920	AROMATIC ALPHA-KETO ACID REDUCTASE	ALPHA-KETO ACID REDUCTASE; KAR	
Number Sign	107970	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1	ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 1; ARVC1	UHL ANOMALY, INCLUDED;; CARDIOMYOPATHY, RIGHT VENTRICULAR DILATED, INCLUDED
NULL	108000	ARTERIES, ANOMALIES OF		
Number Sign	108010	ARTERIOVENOUS MALFORMATIONS OF THE BRAIN	BAVM;; CEREBRAL ARTERIOVENOUS MALFORMATIONS	INTRACRANIAL HEMORRHAGE IN BRAIN ARTERIOVENOUS MALFORMATIONS, SUSCEPTIBILITY TO, INCLUDED
NULL	108050	ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS		
NULL	108100	ARTHRITIS, SACROILIAC		
Number Sign	108120	ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	ARTHROGRYPOSIS, DISTAL, TYPE 1; DA1;; ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE I; AMCD1	
Number Sign	108145	ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5	ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;; OCULOMELIC AMYOPLASIA;; ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	
NULL	108200	ARTHROGRYPOSIS, DISTAL, TYPE 6; DA6	ARTHROGRYPOSIS AND SENSORINEURAL DEAFNESS	
Number Sign	108300	STICKLER SYNDROME, TYPE I; STL1	STICKLER SYNDROME, VITREOUS TYPE 1;; STICKLER SYNDROME, MEMBRANOUS VITREOUS TYPE;; ARTHROOPHTHALMOPATHY, HEREDITARY PROGRESSIVE; AOM	
NULL	108320	ARTICHOKE, MODIFICATION OF TASTE BY		
Percent	108340	ARYL HYDROCARBON HYDROXYLASE INDUCIBILITY	AHH INDUCIBILITY; AHHI	
Percent	108390	ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY		
Percent	108420	SPERMATOGENIC FAILURE 2; SPGF2	ASPERMIOGENESIS FACTOR; ASG	
NULL	108450	ASYMMETRIC SHORT STATURE SYNDROME		
Number Sign	108500	EPISODIC ATAXIA, TYPE 2; EA2	ATAXIA, EPISODIC, WITH NYSTAGMUS;; EPISODIC ATAXIA, NYSTAGMUS-ASSOCIATED;; CEREBELLOPATHY, HEREDITARY PAROXYSMAL;; ATAXIA, FAMILIAL PAROXYSMAL;; ACETAZOLAMIDE-RESPONSIVE HEREDITARY PAROXYSMAL CEREBELLAR ATAXIA; APCA;; CEREBELLAR ATAXIA, PAROXYSMAL, ACETAZOLAMIDE-RESPONSIVE; CAPA	
Number Sign	108600	SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1		
Percent	108650	SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7	SPASTIC ATAXIA WITH CONGENITAL MIOSIS;; MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	
NULL	108700	ATAXIA WITH FASCICULATIONS		
Number Sign	108720	ATELOSTEOGENESIS, TYPE I; AO1	AOI;; GIANT CELL CHONDRODYSPLASIA;; SPONDYLOHUMEROFEMORAL HYPOPLASIA	
Number Sign	108721	ATELOSTEOGENESIS, TYPE III; AO3	AOIII	
Percent	108725	ATHEROSCLEROSIS SUSCEPTIBILITY; ATHS	ATHEROGENIC LIPOPROTEIN PHENOTYPE; ALP	
Percent	108760	ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTIVE DEAFNESS		
Number Sign	108770	ATRIAL STANDSTILL 1; ATRST1	ATRIAL CARDIOMYOPATHY WITH HEART BLOCK;; CARDIOMYOPATHY, FAMILIAL, WITH CONDUCTION DISTURBANCE	
Percent	108800	ATRIAL SEPTAL DEFECT 1; ASD1	ASD	ATRIAL SEPTAL DEFECT, PRIMUM TYPE, INCLUDED;; ASD I, INCLUDED;; ATRIAL SEPTAL DEFECT, SECUNDUM TYPE, INCLUDED;; ASD II, INCLUDED
Number Sign	108900	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS; ASD7	ASD WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	
NULL	108950	ATRIAL TACHYARRHYTHMIA WITH SHORT PR INTERVAL		
Percent	108980	PR INTERVAL, VARIATION IN	ATRIOVENTRICULAR CONDUCTION TIME, VARIATION IN	
Number Sign	108985	SVEINSSON CHORIORETINAL ATROPHY; SCRA	ATROPHIA AREATA; AA;; PERIPAPILLARY CHORIORETINAL DEGENERATION, ICELANDIC TYPE;; HELICOIDAL PERIPAPILLARY CHORIORETINAL DEGENERATION; HPCD	
Percent	109000	AURICULOOSTEODYSPLASIA		
NULL	109050	AUROCEPHALOSYNDACTYLY	AURALCEPHALOSYNDACTYLY	
Number Sign	109100	AUTOIMMUNE DISEASE		
NULL	109120	AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	DE HAUWERE SYNDROME;; IRIS DYSPLASIA WITH OCULAR HYPERTELORISM, PSYCHOMOTOR RETARDATION, AND SENSORINEURAL DEAFNESS	
NULL	109130	AXIAL OSTEOMALACIA		
Number Sign	109150	MACHADO-JOSEPH DISEASE; MJD	SPINOCEREBELLAR ATAXIA 3; SCA3;; SPINOCEREBELLAR ATROPHY III;; AZOREAN NEUROLOGIC DISEASE;; SPINOPONTINE ATROPHY;; NIGROSPINODENTATAL DEGENERATION	
Percent	109160	AZOTEMIA, FAMILIAL		
NULL	109180	BABOON M7 VIRUS INTEGRATION SITE; BEVI		
Percent	109200	ALOPECIA, ANDROGENETIC, 1; AGA1	ANDROGENETIC ALOPECIA; AGA	BALDNESS, MALE PATTERN, INCLUDED; MPB, INCLUDED
NULL	109300	BANKI SYNDROME		
Percent	109350	GASTROESOPHAGEAL REFLUX; GER	GASTROESOPHAGEAL REFLUX DISEASE; GERD;; GASTROESOPHAGEAL REFLUX, PEDIATRIC	
Number Sign	109400	BASAL CELL NEVUS SYNDROME; BCNS	GORLIN SYNDROME;; GORLIN-GOLTZ SYNDROME;; NEVOID BASAL CELL CARCINOMA SYNDROME; NBCCS;; MULTIPLE BASAL CELL NEVI, ODONTOGENIC KERATOCYSTS, AND SKELETAL ANOMALIES	
Percent	109500	BASILAR IMPRESSION, PRIMARY		
NULL	109540	B-CELL GROWTH FACTOR; BCGF	B-CELL GROWTH FACTOR 1; BCGF1	
Percent	109543	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 2	CLLS2;; B-CELL MALIGNANCY, LOW-GRADE;; DISRUPTED IN B-CELL MALIGNANCY; DBM;; LEUKEMIA, CHRONIC LYMPHOCYTIC, B-CELL; BCLL	
NULL	109600	BEETURIA	BETACYANINURIA	
Percent	109650	BEHCET SYNDROME	BEHCET DISEASE; BD	
Percent	109660	BETA-AMINO ACIDS, RENAL TRANSPORT OF; AABT	TAURINE RENAL REABSORPTION	
NULL	109670	BETA-ADRENERGIC STIMULATION, RESPONSE TO; BAS		
Percent	109720	BILIARY CIRRHOSIS, PRIMARY, 1; PBC1	PBC	
Number Sign	109730	AORTIC VALVE DISEASE 1; AOVD1	AORTIC VALVE DISEASE;; BICUSPID AORTIC VALVE; BAV;; AORTIC VALVE, BICUSPID;; AORTIC VALVE, CALCIFICATION OF;; AORTIC STENOSIS, CALCIFIC	
NULL	109740	BIFID NOSE, AUTOSOMAL DOMINANT		
Number Sign	109800	BLADDER CANCER		
NULL	109820	BLADDER DIVERTICULUM		
NULL	109900	BLEPHAROCHALASIS AND DOUBLE LIP	ASCHER SYNDROME	
NULL	110000	BLEPHAROCHALASIS, SUPERIOR		
NULL	110050	BLEPHARONASOFACIAL MALFORMATION SYNDROME	PASHAYAN SYNDROME	
Number Sign	110100	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS; BPES		BPES, TYPE I, INCLUDED;; BPES, TYPE II, INCLUDED;; BPES WITH OVARIAN FAILURE, INCLUDED;; BPES WITHOUT OVARIAN FAILURE, INCLUDED;; BPES WITH DUANE RETRACTION SYNDROME, INCLUDED;; BPES, TYPE I, AUTOSOMAL RECESSIVE, INCLUDED
NULL	110150	BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS		
NULL	110250	BLOOD GROUP--ABO SUPPRESSOR		
NULL	110310	BLOOD GROUP--ABH ANTIGEN, TYPE 2		
Percent	110350	BLOOD GROUP--AHONEN; AN		
Number Sign	110450	BLOOD GROUP--COLTON; CO		
Number Sign	110500	BLOOD GROUP--DIEGO SYSTEM; DI	DIEGO BLOOD GROUP	
Number Sign	110700	BLOOD GROUP, DUFFY SYSTEM; FY	DUFFY BLOOD GROUP SYSTEM	PLASMODIUM VIVAX, RESISTANCE TO, INCLUDED
NULL	110720	BLOOD GROUP--En		
Number Sign	110800	BLOOD GROUP, I SYSTEM; Ii	I BLOOD GROUP SYSTEM;; Ii BLOOD GROUP SYSTEM	ADULT i PHENOTYPE, INCLUDED
Number Sign	110900	BLOOD GROUP--KELL SYSTEM; KEL	BLOOD GROUP--KELL-CELLANO SYSTEM	KELL-NULL, INCLUDED;; K(0), INCLUDED;; Ko, INCLUDED
Number Sign	111000	BLOOD GROUP--KIDD SYSTEM; JK		
Percent	111130	BLOOD GROUP--LKE; LKE	BLOOD GROUP--LUKE, FORMERLY	
Number Sign	111150	BLOOD GROUP--LUTHERAN INHIBITOR; INLU	DOMINANT LU (a-b-) PHENOTYPE	
Number Sign	111200	BLOOD GROUP--LUTHERAN SYSTEM; LU		AUBERGER SYSTEM, INCLUDED; AU, INCLUDED
Number Sign	111250	BLOOD GROUP SYSTEM, LANDSTEINER-WIENER; LW	LANDSTEINER-WIENER BLOOD GROUP SYSTEM	
NULL	111360	BLOOD GROUP--NEWFOUNDLAND; NFLD		
Number Sign	111380	BLOOD GROUP--OK; OK		
Number Sign	111400	BLOOD GROUP, P1PK SYSTEM		P(1) PHENOTYPE, INCLUDED;; P(2) PHENOTYPE, INCLUDED;; P1(k) PHENOTYPE, INCLUDED;; P2(k) PHENOTYPE, INCLUDED;; p PHENOTYPE, INCLUDED;; NOR POLYAGGLUTINATION SYNDROME, INCLUDED
Number Sign	111500	BLOOD GROUP--PRIVATE SYSTEMS	ANTIGENIC DETERMINANTS OF LOW FREQUENCY IN THE POPULATION	
Number Sign	111600	BLOOD GROUP, LANGEREIS SYSTEM; LAN		
Number Sign	111620	RADIN BLOOD GROUP ANTIGEN; RD	BLOOD GROUP--RADIN ANTIGEN	
Number Sign	111690	BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE		
Number Sign	111750	BLOOD GROUP--SCIANNA SYSTEM; SC	SCIANNA BLOOD GROUP	
Percent	111800	BLOOD GROUP--STOLTZFUS SYSTEM; Sf		
Percent	112000	BLOOD GROUP--Ul SYSTEM; UL		
Number Sign	112010	BLOOD GROUP--WALDNER TYPE; WD	WALDNER BLOOD GROUP ANTIGEN	
Number Sign	112050	BLOOD GROUP--WRIGHT ANTIGEN; WR	WRIGHT BLOOD GROUP ANTIGEN	
Number Sign	112100	YT BLOOD GROUP ANTIGEN	CARTWRIGHT ANTIGEN	
Percent	112200	BLUE RUBBER BLEB NEVUS	BEAN SYNDROME	
Number Sign	112240	COLE-CARPENTER SYNDROME 1; CLCRP1	BONE FRAGILITY WITH CRANIOSYNOSTOSIS, OCULAR PROPTOSIS, HYDROCEPHALUS, AND DISTINCTIVE FACIAL FEATURES	
Number Sign	112250	DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	BONE DYSPLASIA WITH MEDULLARY FIBROSARCOMA; BDMF;; BONE DYSPLASIA WITH MALIGNANT FIBROUS HISTIOCYTOMA;; MYOPATHY, LIMB-GIRDLE, WITH BONE FRAGILITY	
NULL	112270	BONE PAIN, PERIODIC		
Percent	112300	BOOK SYNDROME	PHC SYNDROME	
Number Sign	112310	BOOMERANG DYSPLASIA		
Percent	112350	WEISMANN-NETTER SYNDROME; WNS	BOWING OF LEGS, ANTERIOR, WITH DWARFISM;; TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	
NULL	112370	BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUS ADDUCTUS, AND DEVELOPMENTAL DELAY		
Number Sign	112410	HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB	BRACHYDACTYLY WITH HYPERTENSION;; BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;; BILGINTURAN SYNDROME	
NULL	112430	LONG-THUMB BRACHYDACTYLY SYNDROME	BRACHYDACTYLY, LONG-THUMB TYPE	
Percent	112440	BRACHYDACTYLY, COMBINED B AND E TYPES	PITT-WILLIAMS BRACHYDACTYLY;; BRACHYDACTYLY, BALLARD TYPE	
NULL	112450	BRACHYDACTYLY, PREAXIAL, WITH HALLUX VARUS AND THUMB ABDUCTION	CHRISTIAN BRACHYDACTYLY	
Number Sign	112500	BRACHYDACTYLY, TYPE A1; BDA1	FARABEE-TYPE BRACHYDACTYLY	
Number Sign	112600	BRACHYDACTYLY, TYPE A2; BDA2	BRACHYMESOPHALANGY II;; MOHR-WRIEDT TYPE BRACHYDACTYLY	
Percent	112700	BRACHYDACTYLY, TYPE A3; BDA3	BRACHYMESOPHALANGY V;; BRACHYDACTYLY-CLINODACTYLY	
Percent	112800	BRACHYDACTYLY, TYPE A4; BDA4	BRACHYMESOPHALANGY II AND V;; TEMTAMY TYPE BRACHYDACTYLY	
NULL	112910	OSEBOLD-REMONDINI SYNDROME	BRACHYMESOPHALANGY WITH MESOMELIC SHORT LIMBS AND CARPAL AND TARSAL OSSEOUS ABNORMALITIES;; BRACHYDACTYLY, TYPE A6; BDA6	
Number Sign	113000	BRACHYDACTYLY, TYPE B1; BDB1	BRACHYDACTYLY, TYPE B; BDB	
Number Sign	113100	BRACHYDACTYLY, TYPE C; BDC	BRACHYDACTYLY, HAWS TYPE	
Number Sign	113200	BRACHYDACTYLY, TYPE D; BDD	STUB THUMB	
Number Sign	113300	BRACHYDACTYLY, TYPE E1; BDE1	BRACHYDACTYLY, TYPE E; BDE	
NULL	113301	BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II		
NULL	113310	BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA		
NULL	113400	BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA		
NULL	113450	BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME		
NULL	113470	BRACHYMESOMELIA-RENAL SYNDROME		
NULL	113475	BRACHYMETATARSUS IV	METATARSUS IV, SHORT;; TOE, FOURTH, SHORT	
NULL	113477	BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	BOD SYNDROME	
NULL	113480	BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME		
Number Sign	113500	BRACHYOLMIA TYPE 3; BCYM3	BRACHYOLMIA, AUTOSOMAL DOMINANT;; BRACHYRACHIA	
NULL	113600	BRANCHIAL CLEFT ANOMALIES		BRANCHIAL CYSTS, INCLUDED
NULL	113610	BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA		
Number Sign	113620	BRANCHIOOCULOFACIAL SYNDROME; BOFS	BOF SYNDROME;; BRANCHIAL CLEFTS WITH CHARACTERISTIC FACIES, GROWTH RETARDATION, IMPERFORATE NASOLACRIMAL DUCT, AND PREMATURE AGING;; HEMANGIOMATOUS BRANCHIAL CLEFTS-LIP PSEUDOCLEFT SYNDROME;; LIP PSEUDOCLEFT-HEMANGIOMATOUS BRANCHIAL CYST SYNDROME	
Number Sign	113650	BRANCHIOOTORENAL SYNDROME 1; BOR1	BRANCHIOOTORENAL DYSPLASIA;; MELNICK-FRASER SYNDROME	
Percent	113670	HYPERTROPHY OF THE BREAST, JUVENILE; JHB	GIGANTOMASTIA, JUVENILE	
Percent	113700	BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 1; BNAH1	AMASTIA;; ATHELIA;; AMAZIA	
Number Sign	113750	ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6		SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 4, INCLUDED; SHEP4, INCLUDED;; SKIN/HAIR/EYE PIGMENTATION 4, FAIR/DARK SKIN, INCLUDED
Number Sign	113800	EPIDERMOLYTIC HYPERKERATOSIS; EHK	BULLOUS ERYTHRODERMA ICHTHYOSIFORMIS CONGENITA OF BROCQ;; BULLOUS CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; BCIE;; BULLOUS ICHTHYOSIFORM ERYTHRODERMA; BIE;; EPIDERMOLYTIC ICHTHYOSIS	EPIDERMOLYTIC HYPERKERATOSIS, LATE-ONSET, INCLUDED
Number Sign	113900	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A	PFHBIA;; HEART BLOCK, PROGRESSIVE FAMILIAL, TYPE I; PFHBI;; LENEGRE-LEV DISEASE;; CARDIAC CONDUCTION DEFECT, PROGRESSIVE; PCCD;; BUNDLE BRANCH BLOCK;; HEREDITARY BUNDLE BRANCH SYSTEM DEFECT; HBBD	HEART BLOCK, NONPROGRESSIVE, INCLUDED;; CARDIAC CONDUCTION DEFECT, NONPROGRESSIVE, INCLUDED
Percent	113950	BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT		
NULL	113960	BUTYRYLESTERASE 1		
Number Sign	113970	BURKITT LYMPHOMA; BL		
Number Sign	114000	CAFFEY DISEASE	INFANTILE CORTICAL HYPEROSTOSIS	
NULL	114030	CAFE-AU-LAIT SPOTS, MULTIPLE		
NULL	114065	CALCIFIC AORTIC DISEASE WITH IMMUNOLOGIC ABNORMALITIES, FAMILIAL		
Percent	114100	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET	IBGC, CHILDHOOD-ONSET;; STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;; CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	
Percent	114140	CALLOSITIES, HEREDITARY PAINFUL	CALLOSITIES, PAINFUL PLANTAR	
Percent	114150	CAMPTOBRACHYDACTYLY		
Percent	114200	CAMPTODACTYLY 1; CAMPD1	CAMPTODACTYLY AND KNUCKLE PADS	STREBLODACTYLY, INCLUDED
Number Sign	114290	CAMPOMELIC DYSPLASIA	CMPD;; CMD1; CMPD1;; CMPD1/SRA1	CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL, INCLUDED;; ACAMPOMELIC CAMPOMELIC DYSPLASIA, INCLUDED;; ACAMPOMELIC CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL, INCLUDED;; CAMPTOMELIC DYSPLASIA, INCLUDED
Number Sign	114300	ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	GORDON SYNDROME;; ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE IIA;; CAMPTODACTYLY, CLEFT PALATE, AND CLUBFOOT	
NULL	114450	CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE		
Number Sign	114480	BREAST CANCER	BREAST CANCER, FAMILIAL	BREAST CANCER, FAMILIAL MALE, INCLUDED
Number Sign	114500	COLORECTAL CANCER; CRC	COLON CANCER	
Number Sign	114550	HEPATOCELLULAR CARCINOMA	HCC;; CANCER, HEPATOCELLULAR;; LIVER CANCER;; LIVER CELL CARCINOMA; LCC;; HEPATOMA	HEPATOBLASTOMA, INCLUDED;; HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION, INCLUDED
Percent	114580	CANDIDIASIS, FAMILIAL, 1; CANDF1	CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT, WITH OR WITHOUT THYROID DISEASE;; CMCT	
Percent	114600	CANINE TEETH, ABSENCE OF UPPER PERMANENT		
NULL	114620	CRANIOFACIOFRONTODIGITAL SYNDROME	CANTU CRANIOFACIOFRONTODIGITAL SYNDROME	
NULL	114650	CAR FACTOR DEFICIENCY		
NULL	114700	CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH		
Number Sign	114900	CARCINOID TUMORS, INTESTINAL		
NULL	115000	CARDIAC ARRHYTHMIA	EXTRASYSTOLES	
Number Sign	115080	CARDIAC CONDUCTION DEFECT		SUDDEN CARDIAC DEATH, INCLUDED; SCD, INCLUDED;; FAMILIAL SUDDEN DEATH, INCLUDED
Number Sign	115150	CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	CFC SYNDROME;; CFCS	
Number Sign	115195	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2		
Number Sign	115196	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3		
Number Sign	115197	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4		CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4, SUSCEPTIBILITY TO, INCLUDED
Number Sign	115200	CARDIOMYOPATHY, DILATED, 1A; CMD1A	CARDIOMYOPATHY, DILATED, WITH CONDUCTION DEFECT 1; CDCD1;; CARDIOMYOPATHY, IDIOPATHIC DILATED;; CARDIOMYOPATHY, FAMILIAL IDIOPATHIC;; CARDIOMYOPATHY, CONGESTIVE	
Number Sign	115210	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1; RCM1	RCM	
NULL	115250	COLLAGENOMA, FAMILIAL CUTANEOUS		
Number Sign	115300	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT		CAROTENOIDS, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1, INCLUDED
Number Sign	115310	PARAGANGLIOMAS 4; PGL4	CAROTID BODY TUMORS AND MULTIPLE EXTRAADRENAL PHEOCHROMOCYTOMAS;; PHEOCHROMOCYTOMA, EXTRAADRENAL, AND CERVICAL PARAGANGLIOMA;; PARAGANGLIOMAS, HEREDITARY EXTRAADRENAL;; PHEOCHROMOCYTOMA, FAMILIAL EXTRAADRENAL;; PARAGANGLIOMA, FAMILIAL MALIGNANT	
NULL	115400	CARPAL DISPLACEMENT	CARPAL BOSSING	
Number Sign	115430	CARPAL TUNNEL SYNDROME; CTS1	CTS;; AMYOTROPHY, THENAR, OF CARPAL ORIGIN	
Number Sign	115470	CAT EYE SYNDROME; CES	SCHMID-FRACCARO SYNDROME;; CHROMOSOME 22 PARTIAL TETRASOMY;; INV DUP(22)(q11)	
NULL	115645	CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION		
Percent	115650	CATARACT 32, MULTIPLE TYPES; CTRCT32	CATARACT, ANTERIOR POLAR, 1; CTAA1;; CATARACT, ANTERIOR POLAR; CAP;; CATARACT, POSTERIOR POLAR, 5; CTPP5	
Percent	115660	CATARACT 7; CTRCT7	CATARACT 7, CERULEAN TYPE;; CATARACT, CONGENITAL, CERULEAN TYPE, 1; CCA1	
Percent	115665	CATARACT 8, MULTIPLE TYPES; CTRCT8	CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	
Number Sign	115700	CATARACT 4, MULTIPLE TYPES; CTRCT4	CATARACT 4, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;; CATARACT, CRYSTALLINE ACULEIFORM; CACA;; CATARACT, CONGENITAL, CERULEAN TYPE, 3; CCA3;; CATARACT, NONNUCLEAR POLYMORPHIC CONGENITAL; PCC;; CATARACT, PUNCTATE, PROGRESSIVE JUVENILE-ONSET	
Percent	115800	CATARACT 29; CTRCT29	CATARACT 29, CORALLIFORM	
Number Sign	115900	CATARACT 42; CTRCT42		
Number Sign	116100	CATARACT 20, MULTIPLE TYPES; CTRCT20		
Number Sign	116200	CATARACT 1, MULTIPLE TYPES; CTRCT1	CATARACT 1, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;; CATARACT, DUFFY-LINKED;; CATARACT, ZONULAR PULVERULENT, 1; CZP1; CZP; CAE1	
Number Sign	116300	CATARACT 30, MULTIPLE TYPES; CTRCT30		
Number Sign	116400	CATARACT 41; CTRCT41	CATARACT 41, CONGENITAL NUCLEAR TYPE	
Number Sign	116600	CATARACT 6, MULTIPLE TYPES; CTRCT6	CATARACT, POSTERIOR POLAR, 1; CTPP1;; CATARACT, AGE-RELATED CORTICAL, 2; ARCC2	
Number Sign	116700	CATARACT 13 WITH ADULT i PHENOTYPE; CTRCT13		
Number Sign	116800	CATARACT 5, MULTIPLE TYPES; CTRCT5	CATARACT, LAMELLAR;; CATARACT, MARNER TYPE; CAM; CTM	
NULL	116850	CATATRICHY	FORELOCK	
Number Sign	116860	CEREBRAL CAVERNOUS MALFORMATIONS; CCM	CAVERNOUS ANGIOMA, FAMILIAL;; CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;; CEREBRAL CAPILLARY MALFORMATIONS	CEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;; CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;; HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATED WITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED
NULL	116870	CELIAC ARTERY STENOSIS FROM COMPRESSION BY MEDIAN ARCUATE LIGAMENT OF DIAPHRAGM		
Number Sign	116920	LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD	LAD1;; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN 1 IMMUNODEFICIENCY;; LFA1 IMMUNODEFICIENCY	
NULL	116950	TEMPERATURE-SENSITIVE AF8 COMPLEMENT; AF8T	CELL CYCLE CONTROLLER, G1	
Number Sign	117000	CENTRAL CORE DISEASE OF MUSCLE; CCD	CCO	MINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;; MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;; MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;; NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED; CNMDU1, INCLUDED
Percent	117100	CENTRALOPATHIC EPILEPSY	CENTROTEMPORAL EPILEPSY; ECT;; TEMPORAL-CENTRAL FOCAL EPILEPSY;; BENIGN ROLANDIC EPILEPSY;; BENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES; BECTS	
Number Sign	117210	SPINOCEREBELLAR ATAXIA 31; SCA31	SPINOCEREBELLAR ATAXIA, 16q22-LINKED	
Number Sign	117300	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2	DEMENTIA, FAMILIAL DANISH; FDD;; FAMILIAL DANISH DEMENTIA;; CEREBELLAR ATAXIA, CATARACT, DEAFNESS, AND DEMENTIA OR PSYCHOSIS;; HEREDOPATHIA OPHTHALMOOTOENCEPHALICA; HOOE	
Number Sign	117360	SPINOCEREBELLAR ATAXIA 29; SCA29	CEREBELLAR ATAXIA, CONGENITAL NONPROGRESSIVE, AUTOSOMAL DOMINANT; CNPCA;; CEREBELLAR VERMIS APLASIA;; APLASIA OF CEREBELLAR VERMIS; ACV	
Number Sign	117550	SOTOS SYNDROME 1; SOTOS1	SOTOS SYNDROME;; CEREBRAL GIGANTISM;; CHROMOSOME 5q35 DELETION SYNDROME	
NULL	117600	CEREBRAL SARCOMA		
Number Sign	117650	CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	RIB GAP DEFECTS WITH MICROGNATHIA	
Number Sign	117800	APOCRINE GLAND SECRETION, VARIATION IN	EAR WAX, WET/DRY; EWWD;; WET WAX; WW;; CERUMEN, VARIATION IN;; AXILLARY ODOR, VARIATION IN;; COLOSTRUM SECRETION, VARIATION IN	
NULL	117850	CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS	HYPERTRICHOSIS, POSTERIOR CERVICAL, WITH UNDERLYING KYPHOSCOLIOSIS	
NULL	117900	CERVICAL RIB		
NULL	118000	CERVICAL VERTEBRAL BRIDGE		
NULL	118005	CERVICAL VERTEBRAL DYSPLASIA		
Number Sign	118100	KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	KFS;; CERVICAL VERTEBRAL FUSION, AUTOSOMAL DOMINANT	
Number Sign	118200	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	HEREDITARY MOTOR AND SENSORY NEUROPATHY I; HMSN I;; HEREDITARY MOTOR AND SENSORY NEUROPATHY IB; HMSN IB;; HMSN1;; HMSN1B;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 1B;; CHARCOT-MARIE-TOOTH DISEASE, SLOW NERVE CONDUCTION TYPE, LINKED TO DUFFY;; PERONEAL MUSCULAR ATROPHY;; CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL DOMINANT, WITH FOCALLY FOLDED MYELIN SHEATHS, TYPE 1B	
Number Sign	118210	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A1;; CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2A1;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2A1;; HEREDITARY MOTOR AND SENSORY NEUROPATHY IIA1;; HMSN IIA1;; HMSN2A1	
Number Sign	118220	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A; CMT1A	HEREDITARY MOTOR AND SENSORY NEUROPATHY IA; HMSN IA;; HMSN1A;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 1A;; CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL DOMINANT, WITH FOCALLY FOLDED MYELIN SHEATHS, TYPE 1A	
NULL	118230	CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE		
Number Sign	118300	CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS	CHARCOT-MARIE-TOOTH NEUROPATHY AND DEAFNESS, AUTOSOMAL DOMINANT;; CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1E; CMT1E	
NULL	118301	CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM		
NULL	118330	CHEILITIS GLANDULARIS		
NULL	118350	CHEMODECTOMA, INTRAABDOMINAL, WITH CUTANEOUS ANGIOLIPOMAS		
Number Sign	118400	CHERUBISM	CRBM	
Percent	118420	CHIARI MALFORMATION TYPE I	CM1	CHIARI MALFORMATION TYPE I WITH SYRINGOMYELIA, INCLUDED;; CM1 WITH SYRINGOMYELIA, INCLUDED
NULL	118430	CHLORPROPAMIDE-ALCOHOL FLUSHING; CPAF		
Number Sign	118450	ALAGILLE SYNDROME 1; ALGS1	ALAGILLE SYNDROME; ALGS;; ALAGILLE-WATSON SYNDROME; AWS;; CHOLESTASIS WITH PERIPHERAL PULMONARY STENOSIS;; ARTERIOHEPATIC DYSPLASIA; AHD;; HEPATIC DUCTULAR HYPOPLASIA, SYNDROMATIC	
Number Sign	118600	CHONDROCALCINOSIS 2; CCAL2	CHONDROCALCINOSIS, FAMILIAL ARTICULAR;; CALCIUM GOUT;; CALCIUM PYROPHOSPHATE ARTHROPATHY;; CALCIUM PYROPHOSPHATE DIHYDRATE DEPOSITION DISEASE; CPPDD	
NULL	118610	CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION	FAMILIAL APATITE DISEASE	
NULL	118650	CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANT		CHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED;; CHONDRODYSPLASIA PUNCTATA DUE TO WARFARIN TERATOGENICITY, INCLUDED
Percent	118651	CHONDRODYSPLASIA PUNCTATA, TIBIA-METACARPAL TYPE	CHONDRODYSPLASIA PUNCTATA, MT TYPE	
NULL	118670	CHONDRONECTIN		
Number Sign	118700	CHOREA, BENIGN HEREDITARY; BHC	BCH;; HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA	
NULL	118750	CHOREOATHETOSIS, FAMILIAL INVERTED	INFANTILE CHOREOATHETOSIS OF FISHER	
Number Sign	118800	PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1	PAROXYSMAL DYSTONIC CHOREOATHETOSIS; PDC;; CHOREOATHETOSIS, FAMILIAL PAROXYSMAL; FPD1;; MOUNT-REBACK SYNDROME;; CHOREOATHETOSIS, NONKINESIGENIC;; DYSTONIA 8; DYT8	
Percent	118830	CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEIN LIPASE	HYPERLIPOPROTEINEMIA, TYPE IC	
Percent	118840	CHROMATE RESISTANCE; CHR		
NULL	118865	CHOROIDAL OSTEOMA, BILATERAL		
NULL	118900	CIRRHOSIS, FAMILIAL		
NULL	118943	CHYMOSIN PSEUDOGENE; CYMP		PROCHYMOSIN, INCLUDED
NULL	118980	CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL		
Percent	119000	CLEFT CHIN	CHIN DIMPLE	
Percent	119100	SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1; SHFLD1	SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY; SHFLD;; CLEFT HAND AND ABSENT TIBIA;; APLASIA OF TIBIA WITH ECTRODACTYLY;; TIBIAL APLASIA WITH SPLIT-HAND/SPLIT-FOOT DEFORMITY;; ECTRODACTYLY WITH APLASIA OF LONG BONES	
Number Sign	119300	VAN DER WOUDE SYNDROME 1; VWS1	VDWS;; LIP-PIT SYNDROME; LPS; PIT;; CLEFT LIP AND/OR PALATE WITH MUCOUS CYSTS OF LOWER LIP	
Number Sign	119500	POPLITEAL PTERYGIUM SYNDROME; PPS	CLEFT LIP/PALATE, PARAMEDIAN MUCOUS CYSTS OF THE LOWER LIP, POPLITEAL PTERYGIUM, DIGITAL AND GENITAL ANOMALIES;; FACIOGENITOPOPLITEAL SYNDROME	
Percent	119530	OROFACIAL CLEFT 1; OFC1	CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 1;; OROFACIAL CLEFT, NONSYNDROMIC; OFC;; CLEFT LIP/PALATE, NONSYNDROMIC	
Percent	119540	CLEFT PALATE, ISOLATED; CPI	CLEFT PALATE; CP	
Percent	119550	SYNGNATHIA	CLEFT PALATE-LATERAL SYNECHIA SYNDROME;; CPLS SYNDROME	
NULL	119570	CLEFT SOFT PALATE		
Number Sign	119580	BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	BLEPHAROCHEILODONTIC SYNDROME; BCDS;; BCD SYNDROME;; CLEFTING, ECTROPION, AND CONICAL TEETH;; ECTROPION, INFERIOR, WITH CLEFT LIP AND/OR PALATE;; ELSCHNIG SYNDROME;; LAGOPHTHALMIA WITH BILATERAL CLEFT LIP AND PALATE	
Number Sign	119600	CLEIDOCRANIAL DYSPLASIA; CCD	CLEIDOCRANIAL DYSOSTOSIS; CLCD	CLEIDOCRANIAL DYSPLASIA, FORME FRUSTE, WITH BRACHYDACTYLY, INCLUDED;; CLEIDOCRANIAL DYSPLASIA, FORME FRUSTE, DENTAL ANOMALIES ONLY, INCLUDED
NULL	119650	CLEIDORHIZOMELIC SYNDROME		
Number Sign	119800	CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY; CCF		
Number Sign	119900	DIGITAL CLUBBING, ISOLATED CONGENITAL	CLUBBING OF DIGITS;; ACROPACHY, HEREDITARY	
Percent	119915	CLUSTER HEADACHE, FAMILIAL		
NULL	120000	COARCTATION OF AORTA		
NULL	120040	COCHLEOSACCULAR DEGENERATION WITH PROGRESSIVE CATARACTS		
Percent	120050	COXSACKIEVIRUS B3 SUSCEPTIBILITY; CXB3S	CB3S	
Number Sign	120080	COLCHICINE RESISTANCE	COLCHICINE SENSITIVITY; CLCS	
Number Sign	120100	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1; FCAS1	FCAS;; COLD HYPERSENSITIVITY;; COLD-INDUCED AUTOINFLAMMATORY SYNDROME, FAMILIAL;; COLD URTICARIA, FAMILIAL; FCU;; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 1; CAPS1	
Number Sign	120200	COLOBOMA, OCULAR, AUTOSOMAL DOMINANT	COLOBOMA, UVEORETINAL;; COLOBOMA OF IRIS, CHOROID, AND RETINA; COI	
Percent	120300	COLOBOMA OF MACULA	AGENESIS OF MACULA	
Number Sign	120330	PAPILLORENAL SYNDROME; PAPRS	RENAL-COLOBOMA SYNDROME;; OPTIC NERVE COLOBOMA WITH RENAL DISEASE;; COLOBOMA OF OPTIC NERVE WITH RENAL DISEASE;; OPTIC COLOBOMA, VESICOURETERAL REFLUX, AND RENAL ANOMALIES;; RENAL-COLOBOMA SYNDROME WITH MACULAR ABNORMALITIES;; CONGENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT WITH OR WITHOUT OCULAR ABNORMALITIES;; CAKUT WITH OR WITHOUT OCULAR ABNORMALITIES	
NULL	120400	COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY	APICAL DYSTROPHY;; SORSBY SYNDROME	
Number Sign	120430	COLOBOMA OF OPTIC NERVE		OPTIC NERVE HEAD PITS, BILATERAL CONGENITAL, INCLUDED;; MORNING GLORY DISC ANOMALY, INCLUDED
Number Sign	120433	COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1		
Number Sign	120435	LYNCH SYNDROME I	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 1; HNPCC1;; COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 1; FCC1;; COCA1	LYNCH SYNDROME II, INCLUDED
NULL	120440	COLONIC VARICES WITHOUT PORTAL HYPERTENSION		
Percent	120450	COMEDONES, FAMILIAL DYSKERATOTIC		
NULL	120500	COMMISSURAL LIP PITS		
Percent	120502	BRANCHIOOTIC SYNDROME 2	BO SYNDROME 2; BOS2	
Number Sign	120790	COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF		
Number Sign	120970	CONE-ROD DYSTROPHY 2; CORD2	CONE-ROD DYSTROPHY; CORD;; CONE-ROD RETINAL DYSTROPHY; CRD; CRD2;; RETINAL CONE-ROD DYSTROPHY; RCRD2	
Number Sign	121050	ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9	BEALS SYNDROME;; CONTRACTURAL ARACHNODACTYLY, CONGENITAL; CCA	
NULL	121070	ARTHROGRYPOSIS, DISTAL, TYPE 2E	CONTRACTURES OF FINGERS AND JAW	
Number Sign	121200	SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1		EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;; SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED
Number Sign	121201	SEIZURES, BENIGN FAMILIAL NEONATAL, 2; BFNS2	CONVULSIONS, BENIGN FAMILIAL NEONATAL, 2; BFNC2	
Percent	121210	FEBRILE SEIZURES, FAMILIAL, 1; FEB1	CONVULSIONS, FAMILIAL FEBRILE, 1	
NULL	121270	COPPER DEFICIENCY, FAMILIAL BENIGN		
Number Sign	121300	COPROPORPHYRIA, HEREDITARY; HCP	COPROPORPHYRINOGEN OXIDASE DEFICIENCY;; CPOX DEFICIENCY;; CPO DEFICIENCY;; CPX DEFICIENCY	HARDEROPORPHYRIA, INCLUDED
NULL	121350	CORACOCLAVICULAR JOINT, ANOMALOUS		
Percent	121390	CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS		
Percent	121400	CORNEA PLANA 1, AUTOSOMAL DOMINANT; CNA1		
NULL	121450	CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS	BAND KERATOPATHY WITH DEAFNESS	
Number Sign	121800	SCHNYDER CORNEAL DYSTROPHY; SCCD	CORNEAL DYSTROPHY, SCHNYDER;; SCHNYDER CRYSTALLINE CORNEAL DYSTROPHY;; CORNEAL DYSTROPHY, CRYSTALLINE, OF SCHNYDER	
Number Sign	121820	CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE; EBMD	CORNEAL DYSTROPHY, ANTERIOR BASEMENT MEMBRANE;; COGAN CORNEAL DYSTROPHY;; CORNEAL DYSTROPHY, MAP-DOT-FINGERPRINT TYPE;; CORNEAL DYSTROPHY, MICROCYSTIC	
Number Sign	121850	CORNEAL DYSTROPHY, FLECK	CFD;; FLECK CORNEAL DYSTROPHY; FCD;; CORNEAL DYSTROPHY, FRANCOIS-NEETENS SPECKLED OR FLECKED	
Number Sign	121900	CORNEAL DYSTROPHY, GROENOUW TYPE I; CDGG1	GRANULAR CORNEAL DYSTROPHY, TYPE I; GCD1;; CORNEAL DYSTROPHY, PUNCTATE OR NODULAR	
Number Sign	122000	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1; PPCD1	POSTERIOR POLYMORPHOUS CORNEAL DYSTROPHY; PPCD;; CORNEAL DYSTROPHY, HEREDITARY POLYMORPHOUS POSTERIOR;; MAUMENEE CORNEAL DYSTROPHY;; CORNEAL ENDOTHELIAL DYSTROPHY 1, AUTOSOMAL DOMINANT, FORMERLY; CHED1, FORMERLY	
Number Sign	122100	CORNEAL DYSTROPHY, MEESMANN; MECD	CORNEAL DYSTROPHY, MEESMANN EPITHELIAL;; MEESMANN CORNEAL DYSTROPHY;; CORNEAL DYSTROPHY, JUVENILE EPITHELIAL, OF MEESMANN	
Number Sign	122200	CORNEAL DYSTROPHY, LATTICE TYPE I; LCD1	LCD;; LATTICE CORNEAL DYSTROPHY, TYPE I;; CDL1	
Number Sign	122400	EPITHELIAL RECURRENT EROSION DYSTROPHY; ERED	CORNEAL EROSIONS, RECURRING HEREDITARY	
NULL	122430	CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS, UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION	RAMOS-ARROYO SYNDROME	
NULL	122440	CORNEODERMATOOSSEOUS SYNDROME	CDO SYNDROME;; CORNEAL DYSTROPHY, EPITHELIAL, WITH SKIN AND SKELETAL CHANGES	
Percent	122450	CORNEAL HYPESTHESIA, FAMILIAL	TRIGEMINAL ANESTHESIA, FAMILIAL	
NULL	122455	CORONARY ARTERY DISSECTION, SPONTANEOUS		
Percent	122460	HUMAN CORONAVIRUS SENSITIVITY; HCVS	CORONAVIRUS 229E SUSCEPTIBILITY; CVS	
Number Sign	122470	CORNELIA DE LANGE SYNDROME 1; CDLS1	CDL; CDLS;; TYPUS DEGENERATIVUS AMSTELODAMENSIS;; DE LANGE SYNDROME;; BRACHMANN-DE LANGE SYNDROME; BDLS	
NULL	122550	CORTICOSTERONE SIDE-CHAIN ISOMERASE; CSCI		
NULL	122580	COSTOCORACOID LIGAMENT, CONGENITALLY SHORT		
Number Sign	122600	SPONDYLOCOSTAL DYSOSTOSIS 5; SCDO5	SCOLIOSIS, CONGENITAL, WITH OR WITHOUT RIB ANOMALIES;; SPONDYLOCOSTAL DYSPLASIA;; SPONDYLOTHORACIC DYSOSTOSIS;; COSTOVERTEBRAL SEGMENTATION ANOMALIES	
Number Sign	122700	COUMARIN RESISTANCE	COUMARIN, POOR METABOLISM OF;; WARFARIN RESISTANCE	COUMARIN SENSITIVITY, INCLUDED;; WARFARIN SENSITIVITY, INCLUDED
Percent	122750	COXA VARA		
NULL	122780	COXOAURICULAR SYNDROME		
NULL	122850	CRANIOACROFACIAL SYNDROME		
Number Sign	122860	CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD		
Number Sign	122880	CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS		
NULL	122900	CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	OSTEOSCLEROSIS, STANESCU TYPE	
Number Sign	123000	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CMDD	CMD;; CRANIOMETAPHYSEAL DYSPLASIA, JACKSON TYPE; CMDJ	
NULL	123050	CRANIORHINY		
Number Sign	123100	CRANIOSYNOSTOSIS 1; CRS1	CRS;; CRANIOSTENOSIS	
Number Sign	123150	JACKSON-WEISS SYNDROME; JWS	CRANIOSYNOSTOSIS, MIDFACIAL HYPOPLASIA, AND FOOT ABNORMALITIES	
Percent	123155	HYDROCEPHALUS, AUTOSOMAL DOMINANT; HDCPH1		
NULL	123270	CREATINE KINASE, BRAIN TYPE, ECTOPIC EXPRESSION OF; CKBE		
Number Sign	123320	CREATINE PHOSPHOKINASE, ELEVATED SERUM	CPK, ELEVATED SERUM;; HYPERCKEMIA, IDIOPATHIC	
Number Sign	123400	CREUTZFELDT-JAKOB DISEASE; CJD	CREUTZFELDT-JAKOB DISEASE, FAMILIAL	CREUTZFELDT-JAKOB DISEASE, SPORADIC, INCLUDED; sCJD, INCLUDED;; CREUTZFELDT-JAKOB DISEASE, VARIANT, INCLUDED; vCJD, INCLUDED;; CREUTZFELDT-JAKOB DISEASE, HEIDENHAIN VARIANT, INCLUDED
Number Sign	123450	CRI-DU-CHAT SYNDROME	CAT CRY SYNDROME;; CHROMOSOME 5p DELETION SYNDROME	
Number Sign	123500	CROUZON SYNDROME	CRANIOFACIAL DYSOSTOSIS, TYPE I; CFD1;; CROUZON CRANIOFACIAL DYSOSTOSIS	
NULL	123540	CRYOFIBRINOGENEMIA, FAMILIAL PRIMARY		
Percent	123550	CRYOGLOBULINEMIA, FAMILIAL MIXED	MELTZER SYNDROME	
NULL	123557	CRYPTOTIA, FAMILIAL		
NULL	123560	CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME		
Percent	123570	CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED	ANKYLOBLEPHARON, SIMPLE;; CRYPTOPHTHALMOS WITH MICROPHTHALMIA AND PETERS ANOMALY	
Number Sign	123700	CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1		
Number Sign	123790	BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	BEARE-STEVENSON SYNDROME;; CUTIS GYRATA SYNDROME OF BEARE AND STEVENSON	
NULL	123853	CYPRUS FACIAL NEUROMUSCULOSKELETAL SYNDROME		
NULL	123880	CYSTIC ANGIOMATOSIS OF BONE, DIFFUSE	GORHAM-STOUT DISEASE; GSD;; OSTEOLYSIS, MASSIVE	
NULL	123997	CYTOCHROME c OXIDASE, SUBUNIT 7A2, PSEUDOGENE 2; COX7A2P2	CYTOCHROME c OXIDASE, SUBUNIT VIIa, POLYPEPTIDE 3; COX7A3;; CYTOCHROME c OXIDASE, SUBUNIT VIIa, LIVER ISOFORM 2; COX7AL2	
Number Sign	124000	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1; MC3DN1		
NULL	124100	DANUBIAN ENDEMIC FAMILIAL NEPHROPATHY	DEFN;; BALKAN ENDEMIC NEPHROPATHY; BEN;; NEPHROPATHIA EPIDEMICA	
Number Sign	124200	DARIER-WHITE DISEASE; DAR	KERATOSIS FOLLICULARIS;; DARIER DISEASE; DD	DARIER DISEASE, ACRAL HEMORRHAGIC TYPE, INCLUDED;; DARIER DISEASE, SEGMENTAL, INCLUDED
Percent	124300	DARWINIAN TUBERCLE OF PINNA	DARWINIAN POINT OF PINNA	DARWINIAN NOTCH, INCLUDED
NULL	124400	DARWINIAN TUBERCLE OF PINNA		
Number Sign	124480	DEAFNESS, CONGENITAL, WITH ONYCHODYSTROPHY, AUTOSOMAL DOMINANT; DDOD	DDOD SYNDROME	
NULL	124490	DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY		
Number Sign	124500	VOHWINKEL SYNDROME; VOWNKL	DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OF FINGERS AND TOES;; MUTILATING KERATODERMA;; KERATODERMA HEREDITARIUM MUTILANS; KHM	
Percent	124700	DEAFNESS, MID-TONE NEURAL		
Number Sign	124900	DEAFNESS, AUTOSOMAL DOMINANT 1; DFNA1	KONIGSMARK SYNDROME;; DEAFNESS, AUTOSOMAL DOMINANT 1, WITH OR WITHOUT THROMBOCYTOPENIA	
NULL	124950	DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE		
NULL	125000	DEAFNESS, UNILATERAL		
NULL	125050	DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA		
NULL	125230	DEAFNESS-CRANIOFACIAL SYNDROME		
Number Sign	125250	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	DOMINANT OPTIC ATROPHY PLUS SYNDROME; DOA+	
Percent	125260	DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	DIPI, CONTROL OF;; HOMOLOGOUS VIRAL INTERFERENCE;; VESICULAR STOMATITIS VIRUS DEFECTIVE INTERFERING PARTICLE REPRESSOR; VDI	
NULL	125280	DENS EVAGINATUS		
NULL	125300	DENS IN DENTE AND PALATAL INVAGINATIONS		
Number Sign	125310	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1; CADASIL1	CADASIL;; DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;; CASIL	
NULL	125320	DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES		
Number Sign	125350	FAILURE OF TOOTH ERUPTION, PRIMARY; PFE	PRIMARY FAILURE OF ERUPTION, NONSYNDROMIC;; PRIMARY RETENTION OF TEETH;; UNERUPTED SECOND PRIMARY MOLAR;; POSTERIOR OPENBITE MALOCCLUSION, FAMILIAL;; DENTAL NONERUPTION	
Number Sign	125370	DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA	MYOCLONIC EPILEPSY WITH CHOREOATHETOSIS;; NAITO-OYANAGI DISEASE; NOD;; HAW RIVER SYNDROME; HRS;; ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	
Number Sign	125400	DENTIN DYSPLASIA, TYPE I; DTDP1	DENTIN DYSPLASIA, SHIELDS TYPE I;; ROOTLESS TEETH;; RADICULAR DENTIN DYSPLASIA	DENTIN DYSPLASIA, TYPE I, WITH EXTREME MICRODONTIA AND MISSHAPEN TEETH, INCLUDED
Number Sign	125420	DENTIN DYSPLASIA, TYPE II; DTDP2	DENTIN DYSPLASIA, SHIELDS TYPE II;; CORONAL DENTIN DYSPLASIA;; ANOMALOUS DYSPLASIA OF DENTIN;; PULPAL DYSPLASIA;; PULP STONES	
Percent	125440	DENTIN DYSPLASIA WITH SCLEROTIC BONES		
NULL	125460	DEOXYRIBOSE-5-PHOSPHATE ALDOLASE DEFICIENCY		
Percent	125480	MAJOR AFFECTIVE DISORDER 1; MAFD1	MANIC-DEPRESSIVE PSYCHOSIS; MD1;; BIPOLAR AFFECTIVE DISORDER; BPAD;; MANIC-DEPRESSIVE PSYCHOSIS, AUTOSOMAL	
Number Sign	125490	DENTINOGENESIS IMPERFECTA 1; DGI1	OPALESCENT DENTIN;; DENTINOGENESIS IMPERFECTA WITHOUT OSTEOGENESIS IMPERFECTA;; OPALESCENT TEETH WITHOUT OSTEOGENESIS IMPERFECTA;; DENTINOGENESIS IMPERFECTA, SHIELDS TYPE II;; DGI-II;; CAPDEPONT TEETH	
Number Sign	125500	DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III	DGI-III;; BRANDYWINE TYPE DENTINOGENESIS IMPERFECTA	
Percent	125520	CAYLER CARDIOFACIAL SYNDROME	DEPRESSOR ANGULI ORIS MUSCLE, HYPOPLASIA OF;; ASYMMETRIC CRYING FACIES; ACF;; FACIAL PARESIS, PARTIAL, UNILATERAL	
NULL	125530	DERMAL RIDGES, NELSON SYNDROME		
Percent	125540	DERMAL RIDGES, PATTERNLESS		
Percent	125550	DERMAL RIDGES-OFF-THE-END; ROES	RIDGES-OFF-THE-END SYNDROME	
NULL	125570	DERMATOGLYPHICS--ARCH ON ANY DIGIT		
NULL	125580	DERMATOGLYPHICS--FINGER RIDGE COUNT		
Percent	125590	DERMATOGLYPHICS--FINGERPRINT PATTERN		
Number Sign	125595	DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR		
NULL	125600	DERMATOSIS PAPULOSA NIGRA		
Number Sign	125630	VIBRATORY URTICARIA; VBU	DERMODISTORTIVE URTICARIA; DDU;; VIBRATORY ANGIOEDEMA	
NULL	125635	DERMOGRAPHISM, FAMILIAL	DERMATOGRAPHISM, FAMILIAL	
Percent	125640	DERMOODONTODYSPLASIA	ECTODERMAL DYSPLASIA, HAIR-NAIL-TOOTH TYPE	
Number Sign	125700	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	DIABETES INSIPIDUS, PRIMARY CENTRAL; CDI;; DIABETES INSIPIDUS, CRANIAL TYPE	
Number Sign	125800	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	DIABETES INSIPIDUS, NEPHROGENIC, TYPE II	
Number Sign	125850	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1	MODY, TYPE 1;; MILD JUVENILE DIABETES MELLITUS	
Number Sign	125851	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2	MODY, TYPE 2;; MODY, GLUCOKINASE-RELATED	
Number Sign	125852	DIABETES MELLITUS, INSULIN-DEPENDENT, 2	INSULIN-DEPENDENT DIABETES MELLITUS 2; IDDM2	
Number Sign	125853	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM	DIABETES MELLITUS, TYPE II; T2D;; NONINSULIN-DEPENDENT DIABETES MELLITUS;; MATURITY-ONSET DIABETES	INSULIN RESISTANCE, SUSCEPTIBILITY TO, INCLUDED;; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST, INCLUDED
NULL	125890	DIARRHEA, GLUCOSE-STIMULATED SECRETORY, WITH COMMON VARIABLE IMMUNODEFICIENCY		
NULL	125900	DIASTEMA, DENTAL MEDIAL		
Percent	126050	DIGITOTALAR DYSMORPHISM	ULNAR DRIFT, HEREDITARY	
Percent	126070	DILUTION, PIGMENTARY	ALBINOIDISM, OCULOCUTANEOUS, AUTOSOMAL DOMINANT;; ALBINISM, PARTIAL;; HYPOPIGMENTATION	
NULL	126100	DIMPLES, FACIAL	CHEEK DIMPLES;; SMILING DIMPLES	
NULL	126180	DISCRIMINATION, TWO-POINT, REDUCTION IN	SENSORY DISCRIMINATION	
NULL	126190	DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS		
Number Sign	126200	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS	DISSEMINATED SCLEROSIS	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 1, INCLUDED; MS1, INCLUDED
NULL	126250	DISTAL OSTEOSCLEROSIS	OSTEOSCLEROSIS, DISTAL	
Percent	126300	DISTICHIASIS	EYELASHES, TWO ROWS OF	
NULL	126320	DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL VASCULATURE		
NULL	126370	DNA, SATELLITE, III; HS3; D1Z1		
NULL	126390	DNA, LOW-REPETITIVE SEQUENCES OF	REPETITIVE SEQUENCE DNA	
NULL	126410	DNA, SATELLITE, ALPHA TYPE		
NULL	126500	DOUBLE NAIL FOR FIFTH TOE		
Percent	126550	DOUGHNUT LESIONS OF SKULL, FAMILIAL		
Number Sign	126600	DOYNE HONEYCOMB RETINAL DYSTROPHY; DHRD	DOYNE HONEYCOMB DEGENERATION OF RETINA; DHD	MALATTIA LEVENTINESE, INCLUDED; MLVT, INCLUDED;; DRUSEN, RADIAL, AUTOSOMAL DOMINANT, INCLUDED
Number Sign	126700	BASAL LAMINAR DRUSEN	DRUSEN OF BRUCH MEMBRANE;; DRUSEN, CUTICULAR;; DRUSEN, EARLY ADULT-ONSET, GROUPED	
Percent	126800	DUANE RETRACTION SYNDROME 1; DURS1	DRS;; DUANE SYNDROME; DUS;; DUANE ANOMALY;; RETRACTION SYNDROME	
NULL	126840	DUODENAL ULCER DUE TO ANTRAL G-CELL HYPERFUNCTION		
Percent	126850	DUODENAL ULCER, HYPERPEPSINOGENEMIC I		
Percent	126900	DUPUYTREN CONTRACTURE		DUPUYTREN CONTRACTURE 1, INCLUDED; DUPC1, INCLUDED;; PLANTAR FIBROMAS, INCLUDED;; PLANTAR FIBROMATOSIS, FAMILIAL, INCLUDED
NULL	126950	DWARFISM WITH TALL VERTEBRAE		
Number Sign	127000	KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	DWARFISM, CORTICAL THICKENING OF TUBULAR BONES, AND TRANSIENT HYPOCALCEMIA;; KENNY SYNDROME	
NULL	127100	DWARFISM, LEVI TYPE	SNUB-NOSED TYPE OF DWARFISM	
NULL	127200	DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES	MOORE-FEDERMAN SYNDROME	
Number Sign	127300	LERI-WEILL DYSCHONDROSTEOSIS; LWD	DYSCHONDROSTEOSIS; DCO	MADELUNG DEFORMITY, INCLUDED
NULL	127350	DYSCHONDROSTEOSIS AND NEPHRITIS		
Number Sign	127400	DYSCHROMATOSIS SYMMETRICA HEREDITARIA; DSH	DYSCHROMATOSIS SYMMETRICA HEREDITARIA 1; DSH1;; RETICULATE ACROPIGMENTATION OF DOHI; RAD;; SYMMETRIC DYSCHROMATOSIS OF THE EXTREMITIES	
Percent	127500	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1; DUH1		
Number Sign	127550	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 1; DKCA1	DYSKERATOSIS CONGENITA, SCOGGINS TYPE	
Percent	127600	DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	DKBI	
Number Sign	127700	DYSLEXIA, SUSCEPTIBILITY TO, 1; DYX1	WORD-BLINDNESS, CONGENITAL;; READING DISABILITY, SPECIFIC, 1	DYSLEXIA, SUSCEPTIBILITY TO, 4, INCLUDED; DYX4, INCLUDED;; DYSLEXIA, SUSCEPTIBILITY TO, 7, INCLUDED; DYX7, INCLUDED
Number Sign	127750	DEMENTIA, LEWY BODY; DLB	LEWY BODY DEMENTIA;; DIFFUSE LEWY BODY DISEASE	DIFFUSE LEWY BODY DISEASE WITH GAZE PALSY, INCLUDED;; LEWY BODY VARIANT OF ALZHEIMER DISEASE, INCLUDED
NULL	127800	DYSPLASIA EPIPHYSEALIS HEMIMELICA	TREVOR DISEASE	
NULL	127820	DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS	OSTEOCHONDROMATOSIS, DOMINANT CARPOTARSAL	
Percent	128000	DYSTELEPHALANGY	KIRNER DEFORMITY	
Number Sign	128100	DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT; DYT1	DYSTONIA MUSCULORUM DEFORMANS 1;; EARLY-ONSET TORSION DYSTONIA; EOTD	
Number Sign	128101	DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	WHISPERING DYSPHONIA, HEREDITARY;; DYSTONIA MUSCULORUM DEFORMANS 4	
Number Sign	128200	EPISODIC KINESIGENIC DYSKINESIA 1; EKD1	PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;; PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;; DYSTONIA, FAMILIAL PAROXYSMAL;; DYSTONIA 10; DYT10	
Number Sign	128230	DYSTONIA, DOPA-RESPONSIVE; DRD	DYSTONIA 5; DYT5;; DYSTONIA, PROGRESSIVE, WITH DIURNAL VARIATION;; DYSTONIA-PARKINSONISM WITH DIURNAL FLUCTUATION;; SEGAWA SYNDROME, AUTOSOMAL DOMINANT;; DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL DOMINANT;; DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL DOMINANT	
Number Sign	128235	DYSTONIA 12; DYT12	DYSTONIA-PARKINSONISM, RAPID-ONSET; RDP	
NULL	128290	EAR ANTITRAGUS, TAG AT BASE OF		
NULL	128300	EAR EXOSTOSES	EXOSTOSES OF EXTERNAL AUDITORY CANAL	
NULL	128400	EAR FLARE		
NULL	128500	EAR FOLDING		
Percent	128600	EAR MALFORMATION	CUP EAR	
Percent	128700	PREAURICULAR FISTULAE, CONGENITAL	PAFC;; EAR PITS	
NULL	128710	EAR PITS, POSTERIOR HELICAL	POSTERIOR HELICAL EAR PITS; PHEP	EARLOBE INDENTATIONS, POSTERIOR, INCLUDED
NULL	128800	EAR WITHOUT HELIX		
NULL	128900	EARLOBE ATTACHMENT, ATTACHED VS UNATTACHED		
NULL	128950	EARLOBE CREASE		
Percent	128980	EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIAL ABNORMALITIES		
NULL	129000	EARRING HOLES, NATURAL	EARLOBE SINUSES	
NULL	129100	EARS, ABILITY TO MOVE		
Percent	129150	ECHO VIRUS 11 SENSITIVITY; E11S		
Number Sign	129200	BASAN SYNDROME	ADERMATOGLYPHIA WITH CONGENITAL FACIAL MILIA AND ACRAL BLISTERS, DIGITAL CONTRACTURES, AND NAIL ABNORMALITIES;; ECTODERMAL DYSPLASIA, ABSENT DERMATOGLYPHIC PATTERN, CHANGES IN NAILS, AND SIMIAN CREASE	
Number Sign	129400	RAPP-HODGKIN SYNDROME; RHS	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATE	OROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;; CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED
Number Sign	129490	ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT; ECTD10A	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT; HED	
Number Sign	129500	CLOUSTON SYNDROME	ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;; ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;; CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;; ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	
NULL	129510	ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE		
NULL	129540	ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE AND PREAXIAL POLYDACTYLY OF FEET		
NULL	129550	ECTODERMAL DYSPLASIA WITH ADRENAL CYST		
Number Sign	129600	ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT; ECTOL1		
NULL	129750	ECTOPIA PUPILLAE		
NULL	129810	ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE	EEC SYNDROME WITHOUT CLEFT LIP/PALATE	
NULL	129830	ECTRODACTYLY-CLEFT PALATE SYNDROME	ECP SYNDROME	
NULL	129840	EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL		
Number Sign	129850	EDINBURGH MALFORMATION SYNDROME		
Percent	129900	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1; EEC1	EEC;; EEC SYNDROME 1	
NULL	129905	EGASYN	ESTERASE 22; ES22	
Number Sign	130000	EHLERS-DANLOS SYNDROME, CLASSIC TYPE	EHLERS-DANLOS SYNDROME, TYPE I, FORMERLY; EDS1, FORMERLY;; EHLERS-DANLOS SYNDROME, SEVERE CLASSIC TYPE, FORMERLY;; EDS I, FORMERLY;; EHLERS-DANLOS SYNDROME, GRAVIS TYPE, FORMERLY;; EHLERS-DANLOS SYNDROME, TYPE II, FORMERLY; EDS2, FORMERLY;; EHLERS DANLOS SYNDROME, MILD CLASSIC TYPE, FORMERLY;; EDS II, FORMERLY;; EHLERS DANLOS SYNDROME, MITIS TYPE, FORMERLY	
Percent	130020	EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE	EHLERS-DANLOS SYNDROME, TYPE III; EDS3;; EDS III;; BENIGN HYPERMOBILITY SYNDROME	
Number Sign	130050	EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT	EHLERS-DANLOS SYNDROME, VASCULAR TYPE;; EDS IV; EDS4;; EHLERS-DANLOS SYNDROME, ARTERIAL TYPE;; EHLERS-DANLOS SYNDROME, ECCHYMOTIC TYPE;; EHLERS-DANLOS SYNDROME, SACK-BARABAS TYPE	
Number Sign	130060	EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE;; EDS VIIA; EDS7A;; ARTHROCHALASIS MULTIPLEX CONGENITA;; EDS VII, MUTANT PROCOLLAGEN TYPE	EDS VIIB, INCLUDED; EDS7B, INCLUDED
Number Sign	130070	EHLERS-DANLOS SYNDROME WITH SHORT STATURE AND LIMB ANOMALIES; EDSSLA	PROTEODERMATAN SULFATE, DEFECTIVE BIOSYNTHESIS OF;; PDS, DEFECTIVE BIOSYNTHESIS OF;; DERMATAN SULFATE PROTEOGLYCAN;; XYLOSYLPROTEIN 4-BETA-GALACTOSYLTRANSFERASE DEFICIENCY;; XGPT DEFICIENCY;; GALACTOSYLTRANSFERASE I DEFICIENCY;; EHLERS-DANLOS SYNDROME, PROGEROID TYPE, 1; EDSP1	
Number Sign	130080	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	EHLERS-DANLOS SYNDROME, TYPE VIII; EDS8;; EDS VIII;; EHLERS-DANLOS SYNDROME, PERIODONTITIS TYPE;; EHLERS-DANLOS SYNDROME, PERIODONTOSIS TYPE	
NULL	130090	EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	EDS, UNSPECIFIED TYPE;; EHLERS-DANLOS SYNDROME, FRIEDMAN-HARROD TYPE	
NULL	130100	ELASTOSIS PERFORANS SERPIGINOSA; EPS	ELASTOMA INTRAPAPILLARE PERFORANS VERRUCIFORMIS;; MIESCHER ELASTOMA	
Percent	130180	ELECTROENCEPHALOGRAM, LOW-VOLTAGE	EEG, LOW-VOLTAGE; EEGL;; ELECTROENCEPHALOGRAPHIC VARIANT PATTERN 1; EEGV1	
Percent	130190	ELECTROENCEPHALOGRAPHIC PATTERN, BETA FREQUENCY, QUANTITATIVE TRAIT LOCUS; EEGBQTL		
NULL	130200	ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKE PHENOMENON		
NULL	130300	ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS		
NULL	130400	ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES		
Number Sign	130600	ELLIPTOCYTOSIS 2; EL2	ELLIPTOCYTOSIS, RHESUS-UNLINKED TYPE	
Number Sign	130650	BECKWITH-WIEDEMANN SYNDROME; BWS	EXOMPHALOS-MACROGLOSSIA-GIGANTISM SYNDROME;; EMG SYNDROME;; WIEDEMANN-BECKWITH SYNDROME; WBS	BECKWITH-WIEDEMANN SYNDROME CHROMOSOME REGION, INCLUDED; BWCR, INCLUDED
NULL	130700	EMPHYSEMA, HEREDITARY PULMONARY		
NULL	130710	EMPHYSEMA, CONGENITAL LOBAR; CLE		
Number Sign	130720	LATERAL MENINGOCELE SYNDROME; LMNS	LMS;; LEHMAN SYNDROME	
Number Sign	130900	AMELOGENESIS IMPERFECTA, TYPE IIIA; AI3A	AMELOGENESIS IMPERFECTA, TYPE III; AI3;; AMELOGENESIS IMPERFECTA, HYPOCALCIFICATION TYPE, AUTOSOMAL DOMINANT; ADHCAI;; AMELOGENESIS IMPERFECTA, HYPOMINERALIZATION TYPE	
NULL	130950	ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD		
Number Sign	131100	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1	MEN I;; ENDOCRINE ADENOMATOSIS, MULTIPLE;; MEA I;; WERMER SYNDROME	MEN1 SOMATIC MUTATIONS, INCLUDED
Percent	131200	ENDOMETRIOSIS, SUSCEPTIBILITY TO, 1	ENDO1	
Number Sign	131300	CAMURATI-ENGELMANN DISEASE; CAEND	CED;; ENGELMANN DISEASE;; DIAPHYSEAL DYSPLASIA 1, PROGRESSIVE; DPD1;; PROGRESSIVE DIAPHYSEAL DYSPLASIA; PDD	
NULL	131375	ENOLASE, SPERM SPECIFIC; ENO4		
Percent	131400	EOSINOPHILIA, FAMILIAL	EOS	
NULL	131430	EOSINOPHILOPENIA	EOSINOPHIL APLASIA	
Number Sign	131440	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	MPE; EMP;; EOSINOPHILS, MALIGNANT PROLIFERATION OF	
NULL	131450	EPIBLEPHARON OF LOWER LID		
NULL	131460	EPIBLEPHARON OF UPPER LID		
Percent	131500	EPICANTHUS		
NULL	131600	EPIDERMOID CYSTS		
Number Sign	131705	TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN	EPIDERMOLYSIS BULLOSA DYSTROPHICA, NEONATAL FORM;; DYSTROPHIC EPIDERMOLYSIS BULLOSA, NEONATAL	
Number Sign	131750	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB	DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL DOMINANT;; EPIDERMOLYSIS BULLOSA DYSTROPHICA, COCKAYNE-TOURAINE TYPE; EBDCT;; EPIDERMOLYSIS BULLOSA DYSTROPHICA, PASINI TYPE;; ALBOPAPULOID DOMINANT DYSTROPHIC EPIDERMOLYSIS BULLOSA; EBDD	EPIDERMOLYSIS BULLOSA DYSTROPHICA WITH SUBCORNEAL CLEAVAGE, INCLUDED; EBDSC, INCLUDED
Number Sign	131760	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	EPIDERMOLYSIS BULLOSA HERPETIFORMIS, DOWLING-MEARA TYPE;; EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	
Number Sign	131800	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED	EPIDERMOLYSIS BULLOSA SIMPLEX, WEBER-COCKAYNE TYPE;; EPIDERMOLYSIS BULLOSA OF HANDS AND FEET;; EBS, ACRAL FORM	
Number Sign	131850	EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	DYSTROPHIC EPIDERMOLYSIS BULLOSA, PRETIBIAL;; DEB, PRETIBIAL;; EPIDERMOLYSIS BULLOSA, PRETIBIAL	
NULL	131880	EPIDERMOLYSIS BULLOSA WITH DEFICIENCY OF GALACTOSYLHYDROXYLYSYL GLUCOSYLTRANSFERASE		
Number Sign	131900	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED	EBS, GENERALIZED;; EPIDERMOLYSIS BULLOSA SIMPLEX, KOEBNER TYPE	
Number Sign	131950	EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE; EBSOG		
Number Sign	131960	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBSMP	SPECKLED HYPERPIGMENTATION WITH PUNCTATE PALMOPLANTAR KERATOSES AND CHILDHOOD BLISTERING	
Number Sign	132000	EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS	EPIDERMOLYSIS BULLOSA DYSTROPHICA, BART TYPE	
NULL	132090	EPILEPSY, BENIGN OCCIPITAL; BOE		
Percent	132100	PHOTOPAROXYSMAL RESPONSE 1; PPR1	PPR;; PHOTOSENSITIVITY;; PHOTOCONVULSIVE REACTION;; EPILEPSY, PHOTOGENIC	
NULL	132300	EPILEPSY, READING		
Number Sign	132400	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; EDM1	MULTIPLE EPIPHYSEAL DYSPLASIA, COMP-RELATED	EPIPHYSEAL DYSPLASIA, FAIRBANK TYPE, INCLUDED;; EPIPHYSEAL DYSPLASIA, RIBBING TYPE, INCLUDED
Number Sign	132450	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS; EDMMD		
NULL	132500	EPISTAXIS, HEREDITARY		
Number Sign	132600	PILOMATRIXOMA	PILOMATRICOMA; PTR;; EPITHELIOMA CALCIFICANS OF MALHERBE	
Number Sign	132700	CYLINDROMATOSIS, FAMILIAL	ANCELL-SPIEGLER CYLINDROMAS;; 'TURBAN TUMOR' SYNDROME;; CYLINDROMAS, DERMAL ECCRINE	
Number Sign	132800	MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE	FERGUSON-SMITH-TYPE EPITHELIOMA;; ESS1, FORMERLY	
NULL	132850	EPSTEIN-BARR VIRUS INSERTION SITE 1; EBVS1	EPSTEIN-BARR VIRUS INTEGRATION SITE	
Number Sign	132900	AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4	FAA4;; AORTIC ANEURYSM/AORTIC DISSECTION AND PATENT DUCTUS ARTERIOSUS	
NULL	132990	ERYTHEMA NODOSUM, FAMILIAL		
Percent	133000	ERYTHEMA PALMARE HEREDITARIUM		
Number Sign	133020	ERYTHERMALGIA, PRIMARY	ERYTHROMELALGIA, PRIMARY;; ERYTHROMELALGIA, FAMILIAL	NEUROPATHY, SMALL FIBER, INCLUDED; SFNP, INCLUDED
Number Sign	133100	ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1	POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;; ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	
NULL	133180	ERYTHROLEUKEMIA, FAMILIAL	DI GUGLIELMO DISEASE, FAMILIAL;; LEUKEMIA, ACUTE MYELOGENOUS, M6	
Number Sign	133190	SPINOCEREBELLAR ATAXIA 34; SCA34	ERYTHROKERATODERMIA WITH ATAXIA	
Number Sign	133200	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 1; EKVP1	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA; EKVP;; ERYTHROKERATODERMIA VARIABILIS; EKV;; ERYTHROKERATODERMIA, PROGRESSIVE SYMMETRIC; PSEK;; ERYTHROKERATODERMIA FIGURATA, CONGENITAL FAMILIAL, IN PLAQUES;; ERYTHROKERATODERMIA VARIABILIS WITH ERYTHEMA GYRATUM REPENS	GREITHER DISEASE, INCLUDED;; KERATOSIS PALMOPLANTARIS TRANSGREDIENS ET PROGREDIENS, INCLUDED
Number Sign	133239	ESOPHAGEAL CANCER		ESOPHAGEAL SQUAMOUS CELL CARCINOMA, SUSCEPTIBILITY TO, INCLUDED;; ESCC, SUSCEPTIBILITY TO, INCLUDED;; AERODIGESTIVE TRACT CANCER, SUSCEPTIBILITY TO, INCLUDED;; GASTRIC CARDIA ADENOCARCINOMA, SUSCEPTIBILITY TO, INCLUDED
NULL	133240	ESOPHAGEAL RING, LOWER		
NULL	133260	ESTERASE B; ESB		
NULL	133270	ESTERASE C; ESC		
NULL	133300	ESTERASE ES-2, REGULATOR FOR		
Percent	133500	EXCHONDROSIS OF PINNA, POSTERIOR	EAR BUMP	
Number Sign	133540	COCKAYNE SYNDROME B; CSB		
NULL	133600	EXOSTOSES OF HEEL		
NULL	133690	EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E		
Number Sign	133700	EXOSTOSES, MULTIPLE, TYPE I	EXT; EXT1;; MULTIPLE CARTILAGINOUS EXOSTOSES;; DIAPHYSEAL ACLASIS;; MULTIPLE OSTEOCHONDROMAS;; OSTEOCHONDROMATOSIS	
Number Sign	133701	EXOSTOSES, MULTIPLE, TYPE II	EXT2	
NULL	133705	EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICAL TALUS	RASMUSSEN SYNDROME	
NULL	133750	EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATION AND MICROCEPHALY		
Number Sign	133780	EXUDATIVE VITREORETINOPATHY 1; EVR1	EXUDATIVE VITREORETINOPATHY, FAMILIAL, AUTOSOMAL DOMINANT;; FEVR, AUTOSOMAL DOMINANT;; CRISWICK-SCHEPENS SYNDROME	RETINOPATHY OF PREMATURITY, INCLUDED; ROP, INCLUDED
NULL	133800	EYEBROW, WHORL IN		
NULL	133900	HEMIFACIAL HYPERPLASIA	HEMIFACIAL HYPERTROPHY;; FACIAL HEMIHYPERTROPHY;; FACIAL ASYMMETRY	
NULL	134000	FACIAL HYPERTRICHOSIS		
Percent	134200	FACIAL PALSY, FAMILIAL RECURRENT PERIPHERAL		
NULL	134300	FACIAL SPASM		
NULL	134400	FACTOR V EXCESS WITH SPONTANEOUS THROMBOSIS	THROMBOPHILIA WITH ELEVATED FACTOR V;; PROACCELERIN EXCESS	
NULL	134430	FACTOR VII AND FACTOR VIII, COMBINED DEFICIENCY OF	FAMILIAL MULTIPLE COAGULATION FACTOR DEFICIENCY IV; FMFD IV;; MULTIPLE COAGULATION FACTOR DEFICIENCY IV; MCFD4	
NULL	134500	FACTOR VIII DEFICIENCY	AUTOSOMAL HEMOPHILIA A	
NULL	134510	FACTOR VIII AND FACTOR IX, COMBINED DEFICIENCY OF; F8F9D	FAMILIAL MULTIPLE COAGULATION FACTOR DEFICIENCY II; FMFD II	
NULL	134520	FACTORS VIII, IX AND XI, COMBINED DEFICIENCY OF	FAMILIAL MULTIPLE COAGULATION FACTOR DEFICIENCY V; FMFD V;; MULTIPLE COAGULATION FACTOR DEFICIENCY V; MCFD5	
NULL	134540	FACTOR IX AND FACTOR XI, COMBINED DEFICIENCY OF	FAMILIAL MULTIPLE COAGULATION FACTOR DEFICIENCY VI; FMFD VI;; MULTIPLE COAGULATION FACTOR DEFICIENCY VI; MCFD6	
Percent	134600	FANCONI RENOTUBULAR SYNDROME 1; FRTS1	FANCONI RENOTUBULAR SYNDROME; FRTS;; RENAL FANCONI SYNDROME; RFS;; ADULT FANCONI SYNDROME;; FANCONI SYNDROME WITHOUT CYSTINOSIS;; LUDER-SHELDON SYNDROME	
Number Sign	134610	FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	FMF, AUTOSOMAL DOMINANT	
NULL	134700	FAVISM, SUSCEPTIBILITY TO		
NULL	134720	FECUNDITY GENE, BOOROOLA, OF SHEEP, HOMOLOG OF	FECB	
NULL	134750	FELTY SYNDROME		
NULL	134780	FEMORAL-FACIAL SYNDROME; FFS	FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	
NULL	134900	FIBRINOLYTIC DEFECT		
Number Sign	135100	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP		
Number Sign	135150	BIRT-HOGG-DUBE SYNDROME; BHD	HORNSTEIN-KNICKENBERG SYNDROME;; FIBROFOLLICULOMAS WITH TRICHODISCOMAS AND ACROCHORDONS	
Number Sign	135290	DESMOID DISEASE, HEREDITARY	FIBROMATOSIS, FAMILIAL INFILTRATIVE; FIF	DESMOID TUMOR CAUSED BY SOMATIC MUTATION, INCLUDED
Number Sign	135300	FIBROMATOSIS, GINGIVAL, 1; GINGF1	GINGF;; GGF1;; FIBROMATOSIS, GINGIVAL, HEREDITARY; HGF	
Number Sign	135400	HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA; HTC3	FIBROMATOSIS, GINGIVAL, WITH HYPERTRICHOSIS;; CHROMOSOME 17q24.2-q24.3 DELETION SYNDROME;; CHROMOSOME 17q24.2-q24.3 DUPLICATION SYNDROME;; MICRODELETION 17q24.2-q24.3 SYNDROME;; MICRODUPLICATION 17q24.2-q24.3 SYNDROME;; HYPERTRICHOSIS TERMINALIS, GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	
Number Sign	135500	ZIMMERMANN-LABAND SYNDROME 1; ZLS1	LABAND SYNDROME;; FIBROMATOSIS, GINGIVAL, WITH ABNORMAL FINGERS, FINGERNAILS, NOSE, AND EARS, AND SPLENOMEGALY	
Percent	135550	FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	GINGIVAL FIBROMATOSIS WITH SENSORINEURAL HEARING LOSS; GFD;; JONES SYNDROME	
NULL	135580	FIBROMUSCULAR DYSPLASIA; FMDA	FIBROMUSCULAR DYSPLASIA OF ARTERIES;; FMD	
NULL	135610	FIBRONECTIN-LIKE 2; FNL2		
Number Sign	135700	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	OPHTHALMOPLEGIA, CONGENITAL;; BLEPHAROPTOSIS WITH ABSENT EYE MOVEMENTS;; FEOM1 LOCUS	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B, INCLUDED; CFEOM3B, INCLUDED
Number Sign	135750	LAURIN-SANDROW SYNDROME; LSS	SANDROW SYNDROME;; MIRROR HANDS AND FEET WITH NASAL DEFECTS;; TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;; MIRROR-IMAGE POLYDACTYLY; MIP;; FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUS	LAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED
NULL	135800	FIBULA, RECURRENT DISLOCATION OF HEAD OF		
Number Sign	135900	COFFIN-SIRIS SYNDROME 1; CSS1	COFFIN-SIRIS SYNDROME; CSS;; FIFTH DIGIT SYNDROME;; MENTAL RETARDATION, AUTOSOMAL DOMINANT 12; MRD12	
NULL	135950	FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION AND PROPORTIONATE SHORT STATURE		
Number Sign	136000	ADERMATOGLYPHIA; ADERM	FINGERPRINTS, ABSENCE OF	
NULL	136100	FINGERS, RELATIVE LENGTH OF	2D:4D FINGER-LENGTH RATIO	
Number Sign	136120	FISH-EYE DISEASE; FED	DYSLIPOPROTEINEMIC CORNEAL DYSTROPHY;; ALPHA-LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY;; ALPHA-LCAT DEFICIENCY;; LCATA DEFICIENCY	
Number Sign	136140	FLOATING-HARBOR SYNDROME; FLHS		
NULL	136150	FLOOD FACTOR DEFICIENCY		
NULL	136200	FLUSHING OF EARS AND SOMNOLENCE		
Percent	136300	FLYNN-AIRD SYNDROME		
NULL	136400	FOCAL EPITHELIAL HYPERPLASIA OF THE ORAL MUCOSA		
NULL	136480	FOURTH CRANIAL NERVE PALSY, FAMILIAL CONGENITAL	TROCHLEAR NERVE PALSY, FAMILIAL CONGENITAL;; SUPERIOR OBLIQUE OCULOMOTOR PALSY, FAMILIAL CONGENITAL;; STRABISMUS FROM SUPERIOR OBLIQUE PALSY	
Percent	136500	FOCAL FACIAL DERMAL DYSPLASIA 1, BRAUER TYPE; FFDD1	BRAUER SYNDROME;; HEREDITARY SYMMETRICAL APLASTIC NEVI OF TEMPLES;; BITEMPORAL APLASIA CUTIS CONGENITA	
Number Sign	136520	FOVEAL HYPOPLASIA 1; FVH1	FOVEAL HYPOPLASIA 1 WITH OR WITHOUT ANTERIOR SEGMENT ANOMALIES AND/OR CATARACT	
Number Sign	136540	FRAGILE SITE 10q23		
Number Sign	136550	MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE; MCDR1	NORTH CAROLINA MACULAR DYSTROPHY; NCMD;; CENTRAL AREOLAR PIGMENT EPITHELIAL DYSTROPHY; CAPED;; RETINAL PIGMENT EPITHELIAL DYSTROPHY, CENTRAL;; FOVEAL DYSTROPHY, PROGRESSIVE, FORMERLY	
Number Sign	136570	CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KB		FRAGILE SITE, DISTAMYCIN A TYPE, RARE, FRA(16)(p12.1), INCLUDED; FRA16E, INCLUDED;; FRAGILE SITE 16p12, INCLUDED
Number Sign	136580	FRAGILE SITE, DISTAMYCIN A TYPE, RARE, FRA(16)(q22.1); FRA16B	FRAGILE SITE 16q22	
Number Sign	136590	FRAGILE SITE 20p11		
NULL	136600	FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURAL DEAFNESS		
Number Sign	136620	FRAGILE SITE 10q25; FRA10B	BrdU-DEPENDENT FRAGILE SITE	
Number Sign	136630	MENTAL RETARDATION, FRA12A TYPE		
Number Sign	136640	FRAGILE SITE 9q32		
Number Sign	136660	FRAGILE SITE 17p12		
Number Sign	136680	FRASIER SYNDROME		
Number Sign	136760	FRONTONASAL DYSPLASIA 1; FND1	FRONTORHINY;; FRONTONASAL DYSPLASIA; FND;; FRONTONASAL MALFORMATION; FNM;; MEDIAN FACIAL CLEFT SYNDROME	
Number Sign	136800	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1; FECD1	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, EARLY-ONSET	
NULL	136830	FUCOSIDASE REGULATOR	ALPHA-L-FUCOSIDASE REGULATOR; FUCT	
Number Sign	136880	FUNDUS ALBIPUNCTATUS		RETINITIS PUNCTATA ALBESCENS, INCLUDED
Number Sign	136900	SORSBY FUNDUS DYSTROPHY; SFD	FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY;; MACULAR DYSTROPHY, HEMORRHAGIC	
NULL	137000	FUTCHER LINE		
NULL	137040	GALLBLADDER, AGENESIS OF		
NULL	137050	GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF	IMMUNOGLOBULIN A, DEFECT IN ASSEMBLY OF;; IgA, DEFECT IN ASSEMBLY OF	
Percent	137100	IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1	IMMUNOGLOBULIN A, SELECTIVE DEFICIENCY OF;; IgA, SELECTIVE DEFICIENCY OF;; GAMMA-A-GLOBULIN, SELECTIVE DEFICIENCY OF	
NULL	137130	GASTRIC SNEEZING	STOMACH SNEEZE REFLEX	
Number Sign	137200	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE; NMAN	GAMSTORP-WOHLFART SYNDROME;; MYOKYMIA, MYOTONIA, AND MUSCLE WASTING	
NULL	137210	GASTRIC VOLVULUS, INTRATHORACIC		
Number Sign	137215	GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC	GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC;; GASTRIC CANCER, FAMILIAL DIFFUSE	BREAST CANCER, LOBULAR, INCLUDED; LBC, INCLUDED;; GASTRIC CANCER, FAMILIAL DIFFUSE, AND CLEFT LIP WITH OR WITHOUT CLEFT PALATE, INCLUDED
NULL	137220	GASTRIC JUICE PEPTIDES		
Number Sign	137245	LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TYPE	MALT LYMPHOMA;; GASTRIC LYMPHOMA, PRIMARY	
NULL	137270	GASTROCUTANEOUS SYNDROME	PEPTIC ULCER/HIATAL HERNIA, MULTIPLE LENTIGINES/CAFE-AU-LAIT SPOTS, HYPERTELORISM, MYOPIA	
NULL	137280	GASTRITIS, FAMILIAL GIANT HYPERTROPHIC	MENETRIER DISEASE	
Percent	137360	GENOCHONDROMATOSIS		
NULL	137370	GENU VALGUM, ST. HELENA FAMILIAL	GENU VALGUM, HEREDITARY PUBERTAL	
NULL	137400	GEOGRAPHIC AND FISSURED TONGUE		GLOSSITIS, BENIGN MIGRATORY, INCLUDED;; SCROTAL TONGUE, INCLUDED;; LINGUA PLICATA, INCLUDED
Number Sign	137440	GERSTMANN-STRAUSSLER DISEASE; GSD	ENCEPHALOPATHY, SUBACUTE SPONGIFORM, GERSTMANN-STRAUSSLER TYPE;; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GSS;; CEREBELLAR ATAXIA, PROGRESSIVE DEMENTIA, AND AMYLOID DEPOSITS IN CNS;; AMYLOIDOSIS, CEREBRAL, WITH SPONGIFORM ENCEPHALOPATHY;; PRION DEMENTIA	CEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED, INCLUDED
Percent	137500	GIANT NEUTROPHIL LEUKOCYTES		
Number Sign	137550	MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	GIANT PIGMENTED HAIRY NEVUS; GPHN;; GIANT CONGENITAL PIGMENTED NEVUS;; PIGMENTED MOLES	NEVUS SPILUS, INCLUDED;; SPITZ NEVUS, INCLUDED
NULL	137560	GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA		
Percent	137575	GIGANTIFORM CEMENTOMA, FAMILIAL	CEMENTOMAS, FAMILIAL MULTIPLE;; CEMENTAL DYSPLASIA, PERIAPICAL	
Number Sign	137580	GILLES DE LA TOURETTE SYNDROME; GTS	TOURETTE SYNDROME; TS;; TOURETTE DISORDER	CHRONIC MOTOR TICS, INCLUDED
Number Sign	137600	ANTERIOR SEGMENT DYSGENESIS 4; ASGD4	IRIDOGONIODYSGENESIS, TYPE 2; IRID2;; IRIDOGONIODYSGENESIS SYNDROME; IGDS;; IRIS HYPOPLASIA WITH EARLY-ONSET GLAUCOMA, AUTOSOMAL DOMINANT; IHGA	
NULL	137700	GLAUCOMA WITH ELEVATED EPISCLERAL VENOUS PRESSURE		
Number Sign	137750	GLAUCOMA 1, OPEN ANGLE, A; GLC1A	GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET, 1; JOAG1	GLAUCOMA 1, OPEN ANGLE, L, INCLUDED; GLC1L, INCLUDED
Number Sign	137760	GLAUCOMA, PRIMARY OPEN ANGLE; POAG		GLAUCOMA 1, OPEN ANGLE, E, INCLUDED; GLC1E, INCLUDED;; GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET, INCLUDED
NULL	137763	GLAUCOMA AND SLEEP APNEA		
Number Sign	137800	GLIOMA SUSCEPTIBILITY 1; GLM1		GLIOMA OF BRAIN, FAMILIAL, INCLUDED; GLM, INCLUDED;; GLIOBLASTOMA MULTIFORME, INCLUDED; GBM, INCLUDED;; ASTROCYTOMA, INCLUDED;; OLIGODENDROGLIOMA, INCLUDED;; EPENDYMOMA, INCLUDED;; SUBEPENDYMOMA, INCLUDED
NULL	137900	GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN		
Number Sign	137920	RENAL CYSTS AND DIABETES SYNDROME; RCAD	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 5; MODY5;; HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, ATYPICAL;; FJHN, ATYPICAL;; GLOMERULOCYSTIC KIDNEY DISEASE, HYPOPLASTIC TYPE;; GLOMERULOCYSTIC KIDNEY, FAMILIAL HYPOPLASTIC;; CONGENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT WITH DIABETES;; CAKUT WITH DIABETES	
Number Sign	137940	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	GLOMERULONEPHRITIS WITH SPARSE HAIR AND TELANGIECTASES;; TELANGIECTATIC MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS	
Percent	137950	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	GLOMERULOPATHY WITH GIANT FIBRILLAR DEPOSITS;; LOBULAR GLOMERULOPATHY, FAMILIAL	
Number Sign	138000	GLOMUVENOUS MALFORMATIONS; GVM	VENOUS MALFORMATIONS WITH GLOMUS CELLS; VMGLOM;; GLOMUS TUMORS, MULTIPLE;; GLOMANGIOMAS, MULTIPLE	
NULL	138060	GLUCOCORTICOID RECEPTOR-LIKE 1; GRLL1	GCRL;; GLUCOCORTICOID RECEPTOR 2; GCR2	
NULL	138070	GLUCOGLYCINURIA		
NULL	138110	GLUCOSE-6-PHOSPHATE DEHYDROGENASE-LIKE; G6PDL		
NULL	138277	GLUTAMIC ACID DECARBOXYLASE, BRAIN, MEMBRANE FORM		
NULL	138340	GLUTATHIONE TRANSFERASE ACTIVITY TOWARD TRANS-STILBENE OXIDE	TRANS-STILBENE OXIDE GLUTATHIONE TRANSFERASE ACTIVITY	
Number Sign	138500	HYPERGLYCINURIA	GLYCINURIA WITH OR WITHOUT OXALATE UROLITHIASIS;; GLYCINURIA WITH OR WITHOUT OXALATE NEPHROLITHIASIS;; IMINOGLYCINURIA TYPE II	
NULL	138710	GLYCOPROTEIN, RENAL		
NULL	138770	GMS SYNDROME	GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	
NULL	138790	GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES	MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;; MNG/CRD/DA	
Number Sign	138800	GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS; MNG1	GOITER, NONTOXIC, WITH INTRATHYROIDAL CALCIFICATION;; MULTINODULAR GOITER, ADOLESCENT;; EUTHYROID GOITER;; SIMPLE GOITER	
Number Sign	138900	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1	GOUT SUSCEPTIBILITY 1; GOUT1	
NULL	138920	GRANDDAD SYNDROME	GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUS FAT, AUTOSOMAL DOMINANT INHERITANCE	
NULL	138930	GRANT SYNDROME		
NULL	138990	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL DOMINANT TYPE		
NULL	139000	GRANULOSIS RUBRA NASI		
Number Sign	139090	GRAY PLATELET SYNDROME; GPS	BLEEDING DISORDER, PLATELET-TYPE, 4; BDPLT4;; PLATELET ALPHA-GRANULE DEFICIENCY	
Percent	139100	GRAYING OF HAIR, PRECOCIOUS	WHITE HAIR, PREMATURE	
Number Sign	139210	MYHRE SYNDROME; MYHRS	GROWTH-MENTAL DEFICIENCY SYNDROME OF MYHRE;; LARYNGOTRACHEAL STENOSIS, ARTHROPATHY, PROGNATHISM, AND SHORT STATURE; LAPS SYNDROME	
NULL	139280	GUANYLATE KINASE 2; GUK2		
NULL	139290	GUANYLATE KINASE 3; GUK3		
Number Sign	139300	AROMATASE EXCESS SYNDROME; AEXS	AROMATASE ACTIVITY, INCREASED	GYNECOMASTIA, FAMILIAL, DUE TO INCREASED AROMATASE ACTIVITY, INCLUDED;; GYNECOMASTIA, HEREDITARY, INCLUDED
Number Sign	139393	GUILLAIN-BARRE SYNDROME, FAMILIAL; GBS	POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, ACUTE; AIDP	POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC, INCLUDED; CIDP, INCLUDED
NULL	139400	HAIR WHORL	COWLICK; CROWN	DOUBLE HAIR WHORL, INCLUDED
Percent	139450	HAIR MORPHOLOGY 2; HRM2	CURLY HAIR;; HAIR CURVATURE, VARIATION IN	
NULL	139500	HAIRY EARS	HYPERTRICHOSIS PINNAE AURIS	
Percent	139600	HAIRY ELBOWS	HYPERTRICHOSIS CUBITI	
NULL	139630	HAIRY NOSE TIP		
Percent	139650	HAIRY PALMS AND SOLES	CIRCUMSCRIBED HAIRY DYSEMBRYOPLASIA OF PALMS	
NULL	139750	HAND AND FOOT DEFORMITY WITH FLAT FACIES		
NULL	139800	HAND CLASPING PATTERN		
Percent	139900	HAND SKILL, RELATIVE; HSR	HANDEDNESS	
Number Sign	140000	HAND-FOOT-GENITAL SYNDROME; HFG	HAND-FOOT-UTERUS SYNDROME; HFU	
Percent	140300	HASHIMOTO THYROIDITIS	HT;; HASHIMOTO STRUMA;; HYPOTHYROIDISM, AUTOIMMUNE	THYROID AUTOANTIBODIES, INCLUDED
Number Sign	140350	HAWKINSINURIA		
Percent	140400	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE II; PFHB2	PFHBII	
NULL	140450	HEART-HAND SYNDROME, SPANISH TYPE		
NULL	140500	HEART, MALFORMATION OF		
Number Sign	140600	OSTEOARTHRITIS SUSCEPTIBILITY 2; OS2	OSTEOARTHRITIS OF DISTAL INTERPHALANGEAL JOINTS;; OADIP;; DIPOA;; HAND OSTEOARTHRITIS; HOA	HEBERDEN NODES, INCLUDED
Number Sign	140700	HEINZ BODY ANEMIAS		
NULL	140850	HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE	RAPHE, SUPRAUMBILICAL MIDLINE, WITH CAVERNOUS FACIAL HEMANGIOMAS;; STERNAL NONUNION WITH SUPRAUMBILICAL RAPHE	
NULL	140900	HEMANGIOMAS OF SMALL INTESTINE		
NULL	141000	HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	KASABACH-MERRITT SYNDROME; KMS	
Number Sign	141200	HEMATURIA, BENIGN FAMILIAL; BFH	THIN-BASEMENT-MEMBRANE NEPHROPATHY;; THIN MEMBRANE NEPHROPATHY; TMN	
Percent	141300	HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	PARRY-ROMBERG SYNDROME	
Percent	141350	HEMIFACIAL HYPERPLASIA WITH STRABISMUS	BENCZE SYNDROME	
Percent	141400	HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	GOLDENHAR SYNDROME WITH IPSILATERAL RADIAL DEFECT;; OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECT;; OAVS WITH RADIAL DEFECT	
NULL	141405	HEMIFACIAL SPASM, FAMILIAL		
Number Sign	141500	MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1	FHM;; MHP1	MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA, INCLUDED;; MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED
NULL	141700	HEMOLYTIC POIKILOCYTIC ANEMIA DUE TO REDUCED ANKYRIN BINDING SITES		
Number Sign	141749	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1	HEMOGLOBIN F, HEREDITARY PERSISTENCE OF; HPFH;; HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, HB GENE CLUSTER-RELATED	DELTA-BETA THALASSEMIA, INCLUDED
Number Sign	141750	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, DELETION-TYPE;; ATR-16 SYNDROME;; ATR, DELETION-TYPE;; HEMOGLOBIN H-RELATED MENTAL RETARDATION; HBHR;; MENTAL RETARDATION WITH HEMOGLOBIN H;; CHROMOSOME 16p DELETION SYNDROME	
Number Sign	142309	HEMOGLOBIN--VARIANTS FOR WHICH THE CHAIN CARRYING THE MUTATION IS UNKNOWN OR UNCERTAIN		
Number Sign	142330	HEPATIC ADENOMAS, FAMILIAL	LIVER CELL ADENOMAS, FAMILIAL	
Percent	142335	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 5; HBFQTL5		
Percent	142340	DIAPHRAGMATIC HERNIA, CONGENITAL	DIH;; HERNIA, CONGENITAL DIAPHRAGMATIC; HCD; CDH;; DIAPHRAGMATIC DEFECT, CONGENITAL;; DIAPHRAGM, UNILATERAL AGENESIS OF;; HEMIDIAPHRAGM, AGENESIS OF	DIAPHRAGMATIC HERNIA 1, INCLUDED; DIH1, INCLUDED;; DIAPHRAGM, COMPLETE AGENESIS OF, INCLUDED
NULL	142350	HERNIA, DOUBLE INGUINAL		
Number Sign	142395	HEPATITIS B VACCINE, RESPONSE TO	HBV VACCINE, RESPONSE TO	
Percent	142400	HERNIA, HIATUS	HIATAL HERNIA	
Percent	142470	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HBFQTL2		
NULL	142500	HETEROCHROMIA IRIDIS		
Number Sign	142623	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	HIRSCHSPRUNG DISEASE; HSCR;; AGANGLIONIC MEGACOLON;; MEGACOLON, AGANGLIONIC; MGC	
NULL	142625	HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION		
NULL	142630	HISTIOCYTOSIS, PROGRESSIVE MUCINOUS		
NULL	142660	HEXOSAMINIDASE C; HEXC		
Number Sign	142669	BEUKES HIP DYSPLASIA; BHD	HIP DYSPLASIA, BEUKES TYPE;; BEUKES FAMILIAL HIP DYSPLASIA; BFHD;; OSTEOARTHROPATHY, PREMATURE DEGENERATIVE, OF HIP	
Number Sign	142680	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	FPF;; HIBERNIAN FEVER, FAMILIAL; FHF;; FAMILIAL HIBERNIAN FEVER;; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME; TRAPS;; TNF RECEPTOR-ASSOCIATED PERIODIC SYNDROME	
Number Sign	142690	ACNE INVERSA, FAMILIAL, 1; ACNINV1	ACNE INVERSA, FAMILIAL;; HIDRADENITIS SUPPURATIVA, FAMILIAL	
Percent	142700	DEVELOPMENTAL DYSPLASIA OF THE HIP 1; DDH1	HIP DYSPLASIA, DEVELOPMENTAL; DDH;; HIP DYSPLASIA, CONGENITAL; CDH;; ACETABULAR DYSPLASIA	
NULL	142730	HISTIOCYTIC DERMATOARTHRITIS		
NULL	142770	HLA MODIFIER		
Number Sign	142900	HOLT-ORAM SYNDROME; HOS	HOS1;; HEART-HAND SYNDROME;; ATRIODIGITAL DYSPLASIA	
Number Sign	142945	HOLOPROSENCEPHALY 3; HPE3	HLP3	
Number Sign	142946	HOLOPROSENCEPHALY 4; HPE4		
Percent	143000	HORNER SYNDROME, CONGENITAL		
NULL	143020	HPA I RECOGNITION POLYMORPHISM, BETA-GLOBIN-RELATED; HPA1	RESTRICTION FRAGMENT LENGTH POLYMORPHISM, SICKLE CELL ANEMIA-RELATED	
NULL	143050	HUMERORADIAL SYNOSTOSIS		
Number Sign	143095	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS; SEDCJD	HUMEROSPINAL DYSOSTOSIS; HSD;; SPONDYLOEPIPHYSEAL DYSPLASIA, OMANI TYPE;; CHONDRODYSPLASIA WITH MULTIPLE DISLOCATIONS; CDMD	
Number Sign	143100	HUNTINGTON DISEASE; HD	HUNTINGTON CHOREA	
Number Sign	143200	WAGNER VITREORETINOPATHY; WGVRP	EROSIVE VITREORETINOPATHY; ERVR;; WAGNER VITREORETINAL DEGENERATION;; HYALOIDEORETINAL DEGENERATION OF WAGNER;; WAGNER SYNDROME 1; WGN1	
Number Sign	143400	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2; CAKUT2	URETEROPELVIC JUNCTION OBSTRUCTION; UPJO;; PELVIURETERIC JUNCTION OBSTRUCTION; PUJO;; HYDRONEPHROSIS DUE TO PUJO;; MULTICYSTIC RENAL DYSPLASIA, BILATERAL; MCRD	
NULL	143460	5-HYDROXYTRYPTAMINE OXYGENASE REGULATOR; HTOR		
Number Sign	143465	ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD	HYPERACTIVITY OF CHILDHOOD	
Number Sign	143470	HYPERALPHALIPOPROTEINEMIA 1; HALP1	CHOLESTEROL ESTER TRANSFER PROTEIN DEFICIENCY;; CETP DEFICIENCY	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 10, INCLUDED;; HDLCQ10, INCLUDED
Number Sign	143500	GILBERT SYNDROME	HYPERBILIRUBINEMIA, GILBERT TYPE; HBLRG;; HYPERBILIRUBINEMIA, ARIAS TYPE;; HYPERBILIRUBINEMIA I	
Percent	143850	ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE	OHDS;; ORTHOSTATIC HYPOTENSIVE DISORDER;; HYPERBRADYKININISM	
Number Sign	143860	HYPERCHLORHIDROSIS, ISOLATED		
Number Sign	143870	HYPERCALCIURIA, ABSORPTIVE, 2; HCA2	HYPERCALCIURIA, FAMILIAL IDIOPATHIC	
Number Sign	143880	HYPERCALCEMIA, INFANTILE, 1; HCINF1	HYPERCALCEMIA, IDIOPATHIC, OF INFANCY	
Number Sign	143890	HYPERCHOLESTEROLEMIA, FAMILIAL	FHC; FH;; HYPERLIPOPROTEINEMIA, TYPE II;; HYPERLIPOPROTEINEMIA, TYPE IIA;; HYPER-LOW-DENSITY-LIPOPROTEINEMIA;; HYPERCHOLESTEROLEMIC XANTHOMATOSIS, FAMILIAL;; LDL RECEPTOR DISORDER	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2, INCLUDED; LDLCQ2, INCLUDED
Number Sign	144010	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B	APOLIPOPROTEIN B-100, FAMILIAL LIGAND-DEFECTIVE;; HYPERCHOLESTEROLEMIA, FAMILIAL, DUE TO LIGAND-DEFECTIVE APOLIPOPROTEIN B;; APOLIPOPROTEIN B-100, FAMILIAL DEFECTIVE	
NULL	144020	HYPERCHOLESTEROLEMIA SUPPRESSOR		
NULL	144050	HYPERHEPARINEMIA		
NULL	144100	HYPERHIDROSIS, GUSTATORY; HYPRG	GUSTATORY SWEATING;; FREY SYNDROME;; AURICULOTEMPORAL NERVE SYNDROME	
Percent	144110	HYPERHIDROSIS PALMARIS ET PLANTARIS; HYPRPP	HYPERHIDROSIS, PRIMARY PALMAR	
NULL	144120	HYPERIMMUNOGLOBULIN G1(A1) SYNDROME		
Percent	144150	HYPERKERATOSIS LENTICULARIS PERSTANS; HLP	FLEGEL DISEASE	
NULL	144190	HYPERKERATOSIS-HYPERPIGMENTATION SYNDROME		
Number Sign	144200	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC; EPPK	PPKE;; KERATODERMA, EPIDERMOLYTIC PALMOPLANTAR;; PALMOPLANTAR KERATODERMA, VORNER TYPE;; HYPERKERATOSIS, LOCALIZED EPIDERMOLYTIC;; KERATOSIS PALMARIS ET PLANTARIS FAMILIARIS;; TYLOSIS;; KERATOSIS OF GREITHER	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC, WITH KNUCKLE PADS, INCLUDED
Number Sign	144250	HYPERLIPIDEMIA, FAMILIAL COMBINED; FCHL	FAMILIAL COMBINED HYPERLIPIDEMIA	
NULL	144300	HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS		
NULL	144600	HYPERLIPOPROTEINEMIA, TYPE IV	CARBOHYDRATE-INDUCIBLE HYPERLIPEMIA	
Number Sign	144650	HYPERLIPOPROTEINEMIA, TYPE V	HYPERLIPIDEMIA, TYPE V;; HYPERCHYLOMICRONEMIA, LATE-ONSET;; HYPERCHYLOMICRONEMIA WITH HYPERPREBETALIPOPROTEINEMIA, FAMILIAL;; HYPERLIPEMIA, MIXED;; HYPERLIPEMIA, COMBINED FAT AND CARBOHYDRATE-INDUCED	
Number Sign	144700	RENAL CELL CARCINOMA, NONPAPILLARY; RCC	HYPERNEPHROMA;; ADENOCARCINOMA OF KIDNEY	NONPAPILLARY RENAL CARCINOMA 1 LOCUS, INCLUDED; NRC1, INCLUDED
Number Sign	144750	ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	HYPEROSTOSIS CORTICALIS GENERALISATA, BENIGN FORM OF WORTH, WITH TORUS PALATINUS;; OSTEOSCLEROSIS, AUTOSOMAL DOMINANT	
Percent	144755	HYPEROSTOSIS CRANIALIS INTERNA		
NULL	144800	HYPEROSTOSIS FRONTALIS INTERNA	MORGAGNI-STEWART-MOREL SYNDROME	
Number Sign	145000	HYPERPARATHYROIDISM 1; HRPT1	HYPERPARATHYROIDISM, FAMILIAL ISOLATED PRIMARY; FIHP	PARATHYROID ADENOMA, FAMILIAL, INCLUDED
Number Sign	145001	HYPERPARATHYROIDISM 2 WITH JAW TUMORS; HRPT2	HYPERPARATHYROIDISM, FAMILIAL PRIMARY, WITH MULTIPLE OSSIFYING JAW FIBROMAS;; HYPERPARATHYROIDISM-JAW TUMOR SYNDROME, HEREDITARY; HPT-JT	PARATHYROID ADENOMATOSIS, FAMILIAL CYSTIC, INCLUDED
Percent	145100	HYPERPIGMENTATION OF EYELIDS		
NULL	145200	HYPERPIGMENTATION OF FULDAUER AND KUIJPERS		
Number Sign	145250	HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE; FPHH	MELANOSIS UNIVERSALIS HEREDITARIA; MUH;; HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 2, FORMERLY; FPH2, FORMERLY	
Percent	145260	PSEUDOHYPOALDOSTERONISM, TYPE IIA; PHA2A	HYPERPOTASSEMIA AND HYPERTENSION, FAMILIAL;; HYPERTENSIVE HYPERKALEMIA, FAMILIAL;; GORDON HYPERKALEMIA-HYPERTENSION SYNDROME	
NULL	145270	HYPERPROGLUCAGONEMIA	GLUCAGON, LARGE MOLECULAR WEIGHT SPECIES OF	
NULL	145290	HYPERREFLEXIA; HRX		
NULL	145295	HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL		
NULL	145300	HYPERSENSITIVITY PNEUMONITIS, FAMILIAL		
NULL	145350	HYPERTAURINURIC CARDIOMYOPATHY		
Percent	145400	HYPERTELORISM		
Number Sign	145410	OPITZ GBBB SYNDROME, TYPE II; GBBB2	OPITZ GBBB SYNDROME, AUTOSOMAL DOMINANT;; HYPERTELORISM WITH ESOPHAGEAL ABNORMALITY AND HYPOSPADIAS;; G SYNDROME;; HYPOSPADIAS-DYSPHAGIA SYNDROME;; OPITZ-FRIAS SYNDROME;; OPITZ-G SYNDROME, TYPE II; OGS2;; TELECANTHUS WITH ASSOCIATED ABNORMALITIES;; BBB SYNDROME;; HYPERTELORISM-HYPOSPADIAS SYNDROME;; TELECANTHUS-HYPOSPADIAS SYNDROME;; OPITZ BBBG SYNDROME;; GBBB SYNDROME;; OPITZ OCULOGENITOLARYNGEAL SYNDROME, TYPE II;; CHROMOSOME 22q11.2 DELETION SYNDROME, OPITZ PHENOTYPE	
Percent	145420	HYPERTELORISM, TEEBI TYPE	BRACHYCEPHALOFRONTONASAL DYSPLASIA	
Number Sign	145500	HYPERTENSION, ESSENTIAL	EHT	
NULL	145590	HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	FARMER SYNDROME	
Number Sign	145600	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1	MHS;; HYPERTHERMIA OF ANESTHESIA;; HYPERPYREXIA, MALIGNANT; MH	KING SYNDROME, INCLUDED;; KING-DENBOROUGH SYNDROME, INCLUDED
Number Sign	145650	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY; PRTH	HYPERTHYROIDISM, FAMILIAL, DUE TO INAPPROPRIATE THYROTROPIN SECRETION	
Number Sign	145680	HYPERTHYROXINEMIA, DYSTRANSTHYRETINEMIC; DTTRH	HYPERTHYROXINEMIA, DYSPREALBUMINEMIC;; DYSTRANSTHYRETINEMIC EUTHYROIDAL HYPERTHYROXINEMIA;; EUTHRYROIDAL HYPERTHYROXINEMIA 2	
Percent	145700	HYPERTRICHOSIS LANUGINOSA CONGENITA	HYPERTRICHOSIS UNIVERSALIS	
Percent	145701	HYPERTRICHOSIS UNIVERSALIS CONGENITA, AMBRAS TYPE; HTC1	AMBRAS SYNDROME;; HYPERTRICHOSIS, CONGENITAL GENERALIZED	
Number Sign	145750	HYPERTRIGLYCERIDEMIA, FAMILIAL		
Percent	145800	HYPERTROPHIA MUSCULORUM VERA		
Number Sign	145900	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	DEJERINE-SOTTAS SYNDROME; DSS;; CHARCOT-MARIE-TOOTH DISEASE, TYPE 3; CMT3;; HEREDITARY MOTOR AND SENSORY NEUROPATHY TYPE III; HMSN3;; DEJERINE-SOTTAS NEUROPATHY; DSN	
Number Sign	145980	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1	FHH1;; FAMILIAL BENIGN HYPERCALCEMIA 1; FBH1;; HYPERCALCEMIA, FAMILIAL BENIGN	HYPOCALCIURIC HYPERCALCEMIA, ACQUIRED, INCLUDED
Number Sign	145981	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2	FAMILIAL BENIGN HYPERCALCEMIA, TYPE II; FBH2;; HYPERCALCEMIA, FAMILIAL BENIGN, TYPE II	
Number Sign	146000	HYPOCHONDROPLASIA; HCH		
Number Sign	146110	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7	HYPOGONADISM, ISOLATED HYPOGONADOTROPIC;; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; IHH	
NULL	146160	HYPOMELIA WITH MULLERIAN DUCT ANOMALIES	LIMB-UTERUS SYNDROME	
Number Sign	146200	HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	HYPOPARATHYROIDISM, AUTOSOMAL DOMINANT	HYPOPARATHYROIDISM, AUTOSOMAL RECESSIVE, INCLUDED
Number Sign	146255	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE; HDR	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME; HDRS;; BARAKAT SYNDROME;; NEPHROSIS, NERVE DEAFNESS, AND HYPOPARATHYROIDISM	
Number Sign	146300	HYPOPHOSPHATASIA, ADULT	HYPOPHOSPHATASIA, MILD	ODONTOHYPOPHOSPHATASIA, INCLUDED
Percent	146350	HYPOPHOSPHATEMIC BONE DISEASE; HBD		
Number Sign	146390	CHROMOSOME 18p DELETION SYNDROME	18p- SYNDROME	
Percent	146450	HYPOSPADIAS 3, AUTOSOMAL; HYSP3		
Number Sign	146500	MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	MSA1, SUSCEPTIBILITY TO	AUTONOMIC FAILURE, PURE, INCLUDED;; HYPOTENSION, ORTHOSTATIC, INCLUDED
Number Sign	146510	PALLISTER-HALL SYNDROME; PHS	HYPOTHALAMIC HAMARTOBLASTOMA, HYPOPITUITARISM, IMPERFORATE ANUS, AND POSTAXIAL POLYDACTYLY	
Number Sign	146520	HYPOTRICHOSIS 2; HYPT2	HYPOTRICHOSIS SIMPLEX OF THE SCALP 1; HTSS1;; HTSS;; HYPOTRICHOSIS, SPANISH TYPE	
Number Sign	146550	HYPOTRICHOSIS 4; HYPT4	MARIE UNNA HEREDITARY HYPOTRICHOSIS 1; MUHH1;; HYPOTRICHOSIS, MARIE UNNA TYPE, 1	
NULL	146580	HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE SUPPRESSOR		
Number Sign	146590	ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE; IHCM		
NULL	146600	ICHTHYOSIS HYSTRIX GRAVIOR	ICHTHYOSIS, LAMBERT TYPE;; PORCUPINE MAN	
Number Sign	146700	ICHTHYOSIS VULGARIS	ICHTHYOSIS SIMPLEX	
NULL	146720	ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	ICE SYNDROME	
NULL	146750	ICHTHYOSIS, LAMELLAR, AUTOSOMAL DOMINANT	LAMELLAR ICHTHYOSIS, AUTOSOMAL DOMINANT	
Number Sign	146800	ICHTHYOSIS BULLOSA OF SIEMENS; IBS	ICHTHYOSIS, BULLOUS TYPE	ICHTHYOSIS EXFOLIATIVA, INCLUDED
NULL	146810	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRPHEGAL; IPHEG		
NULL	146820	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGAT; IGAT		
NULL	146830	IMMUNE DEFICIENCY, FAMILIAL VARIABLE		
NULL	146840	IMMUNODEFICIENCY WITH DEFECTIVE LEUKOCYTE AND LYMPHOCYTE FUNCTION AND WITH RESPONSE TO HISTAMINE-1 ANTAGONIST		
NULL	146850	IMMUNE SUPPRESSION; IS	STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO; ISSCW;; ISCW	
NULL	146950	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRHGAL; IHG		
NULL	146960	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRTGAL; ITG		
NULL	146990	IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY REGION 2; IGHDY2	IGD2	
Number Sign	147050	IgE RESPONSIVENESS, ATOPIC; IGER	IMMUNOGLOBULIN E, BASIC LEVEL OF, IN SERUM;; IgE, LEVEL OF; IGEL;; IgE RESPONSE UNDERLYING ALLERGIC ASTHMA AND RHINITIS	IgE, ELEVATED LEVEL OF, INCLUDED;; ATOPY, SUSCEPTIBILITY TO, INCLUDED;; ATOPIC HYPERSENSITIVITY, INCLUDED
Number Sign	147060	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	HYPER-IgE SYNDROME, AUTOSOMAL DOMINANT;; HIES, AUTOSOMAL DOMINANT;; JOB SYNDROME	
Percent	147061	IMMUNOGLOBULIN E CONCENTRATION, SERUM; IGES		
NULL	147080	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 1; IGLP1		
NULL	147090	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 2; IGLP2		
Number Sign	147250	SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	INCISORS, FUSED;; FUSED INCISORS;; SINGLE UPPER CENTRAL INCISOR;; SINGLE CENTRAL MAXILLARY INCISOR	SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR SYNDROME, INCLUDED;; SMMCI SYNDROME, INCLUDED
NULL	147251	INCISORS, FUSED MANDIBULAR	'DOUBLE TOOTH'	
NULL	147260	IMMUNOGLOBULIN SWITCH SEQUENCES	S SEQUENCES	IMMUNOGLOBULIN-INDEPENDENT SWITCH SEQUENCES, INCLUDED
NULL	147300	INCISORS, LONG UPPER CENTRAL		
NULL	147320	INSULIN RECEPTORS, FAMILIAL INCREASE IN		
NULL	147330	INCISORS, LOWER CENTRAL, ABSENCE OF		
NULL	147350	INCISORS, ROTATION OF UPPER CENTRAL		
Percent	147400	INCISORS, SHOVEL-SHAPED	SINODONTY	
Percent	147421	INCLUSION BODY MYOSITIS	IBM	
Percent	147430	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL DOMINANT	CONGENITAL ANALGESIA, AUTOSOMAL DOMINANT	
Number Sign	147480	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	CHOLESTASIS, PREGNANCY-RELATED, 1	
NULL	147530	INSENSITIVITY TO PAIN WITH HYPERPLASTIC MYELINOPATHY		
NULL	147540	INSECT STINGS, HYPERSENSITIVITY TO		
NULL	147560	INTERFERON ANTIVIRAL DEPRESSOR		
NULL	147610	IRIS PIGMENT LAYER, CLEAVAGE OF		
NULL	147630	ISLET CELL ADENOMATOSIS		
NULL	147710	INTUSSUSCEPTION		
Number Sign	147750	IVIC SYNDROME	RADIAL RAY DEFECTS, HEARING IMPAIRMENT, EXTERNAL OPHTHALMOPLEGIA, AND THROMBOCYTOPENIA;; OCULOOTORADIAL SYNDROME; OORS	
Percent	147770	JOHNSON NEUROECTODERMAL SYNDROME	JOHNSON-MCMILLIN SYNDROME; JMS;; ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;; AADH SYNDROME	
Number Sign	147791	JACOBSEN SYNDROME; JBS	CHROMOSOME 11q DELETION SYNDROME;; PARTIAL 11q MONOSOMY SYNDROME	
Percent	147800	AASE-SMITH SYNDROME I	AASE-SMITH SYNDROME;; JOINT CONTRACTURES WITH OTHER ABNORMALITIES	
NULL	147820	INTERNAL CAROTID ARTERY, SPONTANEOUS DISSECTION OF		
NULL	147860	INTERFERON, BETA-3; IFNB3		
Number Sign	147891	ISCHIOCOXOPODOPATELLAR SYNDROME; ICPPS	SMALL PATELLA SYNDROME; SPS;; PATELLA APLASIA, COXA VARA, AND TARSAL SYNOSTOSIS;; ISCHIOPATELLAR DYSPLASIA;; COXOPODOPATELLAR SYNDROME;; SCOTT-TAOR SYNDROME	
Percent	147900	JOINT LAXITY, FAMILIAL	FAMILIAL JOINT INSTABILITY SYNDROME;; ARTICULAR HYPERMOBILITY SYNDROME;; EHLERS-DANLOS SYNDROME, TYPE XI, FORMERLY;; EDS XI, FORMERLY;; EDS11, FORMERLY	
Number Sign	147920	KABUKI SYNDROME 1; KABUK1	KABUKI SYNDROME;; KABUKI MAKE-UP SYNDROME; KMS;; NIIKAWA-KUROKI SYNDROME	
Number Sign	147950	HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA; HH2	KALLMANN SYNDROME 2; KAL2	
Number Sign	148000	KAPOSI SARCOMA, SUSCEPTIBILITY TO	MULTIPLE IDIOPATHIC PIGMENTED HEMANGIOSARCOMA, SUSCEPTIBILITY TO	MULTICENTRIC CASTLEMAN DISEASE, SUSCEPTIBILITY TO, INCLUDED; MCD, INCLUDED
Number Sign	148050	KBG SYNDROME; KBGS	MACRODONTIA, MENTAL RETARDATION, CHARACTERISTIC FACIES, SHORT STATURE, AND SKELETAL ANOMALIES	
Percent	148100	KELOID FORMATION		
Number Sign	148190	KERATITIS, HEREDITARY		
Percent	148200	KERATITIS FUGAX HEREDITARIA	KERATOENDOTHELIITIS FUGAX HEREDITARIA	
Number Sign	148210	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT	KID SYNDROME, AUTOSOMAL DOMINANT	
Number Sign	148300	KERATOCONUS 1; KTCN1		
Number Sign	148350	KERATODERMA, PALMOPLANTAR, WITH DEAFNESS		
NULL	148360	KERATODERMA, PALMOPLANTAR, WITH NAIL DYSTROPHY AND HEREDITARY MOTOR-SENSORY NEUROPATHY	AXONAL NEUROPATHY WITH PALMOPLANTAR KERATODERMA;; CHARCOT-MARIE-TOOTH DISEASE WITH PALMOPLANTAR KERATODERMA AND NAIL DYSTROPHY	
Percent	148370	KERATOLYTIC WINTER ERYTHEMA; KWE	OUDTSHOORN SKIN DISEASE	
NULL	148390	KERATOSIS, FAMILIAL ACTINIC		
Number Sign	148500	TYLOSIS WITH ESOPHAGEAL CANCER; TOC	PALMOPLANTAR KERATODERMA WITH ESOPHAGEAL CANCER;; KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER	
NULL	148520	KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY		
Number Sign	148600	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IA; PPKP1A	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE I; PPKP1;; KPPP1;; KERATODERMIA PALMOPLANTARIS PAPULOSA, BUSCHKE-FISCHER-BRAUER TYPE;; KERATOSIS PALMOPLANTARIS PAPULOSA	
Number Sign	148700	PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE; PPKS1	KERATOSIS PALMOPLANTARIS STRIATA I;; STRIATE PALMOPLANTAR KERATODERMA I; SPPK1;; KERATODERMA, PALMOPLANTAR, STRIATE FORM I; KPPS1	
Percent	148730	KERATOSIS, FOCAL PALMOPLANTAR AND GINGIVAL	FOCAL PALMOPLANTAR AND GINGIVAL HYPERKERATOSIS SYNDROME	
NULL	148800	KLEEBLATTSCHAEDEL	CLOVERLEAF SKULL;; KLEEBLATTSCHADEL	
Number Sign	148820	WAARDENBURG SYNDROME, TYPE 3; WS3	WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;; WAARDENBURG SYNDROME, TYPE III;; KLEIN-WAARDENBURG SYNDROME	
Percent	148840	KLEINE-LEVIN HIBERNATION SYNDROME	KLEINE-LEVIN SYNDROME	
Percent	149000	KLIPPEL-TRENAUNAY-WEBER SYNDROME	KTW SYNDROME;; KLIPPEL-TRENAUNAY SYNDROME; KTS;; ANGIOOSTEOHYPERTROPHY SYNDROME	
Number Sign	149100	KNUCKLE PADS		
Number Sign	149200	KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	BART-PUMPHREY SYNDROME	
Percent	149300	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 2; NDNC2	KOILONYCHIA, HEREDITARY;; SPOON NAILS	KOILONYCHIA WITH LEUKONYCHIA, INCLUDED
Number Sign	149400	HYPEREKPLEXIA, HEREDITARY 1; HKPX1	STARTLE DISEASE, FAMILIAL;; STARTLE REACTION, EXAGGERATED;; EXAGGERATED STARTLE REACTION;; STHE;; STIFF-BABY SYNDROME;; STIFF-MAN SYNDROME, CONGENITAL;; STIFF-PERSON SYNDROME, CONGENITAL;; KOK DISEASE	
NULL	149500	KYRLE DISEASE		
NULL	149600	LABIA MINORA, INCOMPLETE ADHESION OF		
Number Sign	149700	LACRIMAL DUCT DEFECT; LCDD	NASOLACRIMAL DUCT OBSTRUCTION;; LACRIMAL PUNCTA, ABSENCE OF	
Number Sign	149730	LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	LEVY-HOLLISTER SYNDROME	
NULL	150170	LACTIC ACIDOSIS, CHRONIC ADULT FORM		
Number Sign	150230	TRICHORHINOPHALANGEAL SYNDROME, TYPE II; TRPS2	LANGER-GIEDION SYNDROME; LGS;; CHROMOSOME 8q24.1 DELETION SYNDROME	
Number Sign	150250	LARSEN SYNDROME; LRS		
Percent	150260	LARYNGEAL ABDUCTOR PARALYSIS	LABD;; GERHARDT SYNDROME;; VOCAL CORD DYSFUNCTION, FAMILIAL	
Percent	150270	LARYNGEAL ADDUCTOR PARALYSIS; LAP	VOCAL CORD DYSFUNCTION, ADDUCTOR TYPE	
NULL	150280	LARYNGOMALACIA		
NULL	150300	LARYNX, CONGENITAL PARTIAL ATRESIA OF		
NULL	150360	LARYNGEAL WEB, FAMILIAL	GLOTTIC WEB, CONGENITAL ANTERIOR;; SUBGLOTTIC WEB;; SUBGLOTTIC BAR	
Number Sign	150400	TOOTH AGENESIS, SELECTIVE, 4; STHAG4	TOOTH AGENESIS, SELECTIVE, 4, WITH OR WITHOUT ECTODERMAL DYSPLASIA;; LATERAL INCISORS, ABSENCE OF;; LATERAL INCISORS, PEGGED OR MISSING;; SUCCEDANEOUS TEETH, AGENESIS OF	
NULL	150500	LATTICE DEGENERATION OF RETINA LEADING TO RETINAL DETACHMENT		
NULL	150550	LAZY LEUKOCYTE SYNDROME		
NULL	150590	LEG ULCERS, FAMILIAL, OF JUVENILE ONSET		
Number Sign	150600	LEGG-CALVE-PERTHES DISEASE; LCPD	LCP;; LEGG-PERTHES DISEASE;; PERTHES DISEASE	
Number Sign	150699	LEIOMYOMA, UTERINE; UL		
NULL	150700	LEIOMYOMA OF VULVA AND ESOPHAGUS	LEIOMYOMATOSIS, ESOPHAGOGASTRIC AND VULVAR	
Number Sign	150800	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC	MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATA 1, WITH OR WITHOUT RENAL CELL CARCINOMA; MCUL1;; LEIOMYOMATOSIS AND RENAL CELL CANCER, HEREDITARY; LRCC;; LEIOMYOMA, MULTIPLE CUTANEOUS; MCL	
NULL	150900	LENTIGINES		
NULL	151000	LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	LENTIGINOSIS, TOURAINE TYPE	
Percent	151001	LENTIGINOSIS, INHERITED PATTERNED	LENTIGINOSIS, GENERALIZED;; LENTIGINOSIS PROFUSA;; LENTIGINOSIS, DIFFUSE	
Number Sign	151050	LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM; LMHD	LENZ-MAJEWSKI SYNDROME	
Number Sign	151100	LEOPARD SYNDROME 1; LPRD1	LENTIGINOSIS, CARDIOMYOPATHIC;; MULTIPLE LENTIGINES SYNDROME	
Number Sign	151200	CHROMOSOME 8q22.1 DUPLICATION SYNDROME	LERI PLEONOSTEOSIS	
Number Sign	151210	PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT	LETHAL SHORT-LIMBED PLATYSPONDYLIC DWARFISM, TORRANCE TYPE;; THANATOPHORIC DYSPLASIA, TORRANCE VARIANT	PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, LUTON TYPE, INCLUDED; PLSDL, INCLUDED;; THANATOPHORIC DYSPLASIA, LUTON VARIANT, INCLUDED
NULL	151380	LEUKEMIA, ACUTE MONOCYTIC		
Number Sign	151400	LEUKEMIA, CHRONIC LYMPHOCYTIC; CLL	LEUKEMIA, CHRONIC LYMPHATIC	
NULL	151500	LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF		
NULL	151590	LICHEN SCLEROSUS ET ATROPHICUS; LSA		
Number Sign	151600	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3; NDNC3	LEUKONYCHIA TOTALIS AND/OR PARTIALIS;; PORCELAIN NAILS	LEUKONYCHIA STRIATUS, INCLUDED;; LEUKONYCHIA PUNCTATA, INCLUDED
NULL	151610	LEVATOR-MEDIAL RECTUS SYNKINESIS	OCULOMOTOR-LEVATOR SYNKINESIS	
NULL	151620	LICHEN PLANUS, FAMILIAL		
Number Sign	151623	LI-FRAUMENI SYNDROME 1; LFS1	SARCOMA FAMILY SYNDROME OF LI AND FRAUMENI;; SBLA SYNDROME	LI-FRAUMENI-LIKE SYNDROME, INCLUDED; LFL, INCLUDED
Percent	151630	LIP, MEDIAN NODULE OF UPPER		
NULL	151640	LIP, HAMARTOMATOUS	ENLARGEMENT OF LOWER LIP	
Number Sign	151660	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2	FPL2;; LIPODYSTROPHY, FAMILIAL PARTIAL, DUNNIGAN TYPE;; LIPODYSTROPHY, FAMILIAL, OF LIMBS AND LOWER TRUNK;; LIPODYSTROPHY, REVERSE PARTIAL;; LIPOATROPHIC DIABETES	
NULL	151700	LIPOMA OF THE CONJUNCTIVA		
NULL	151800	LIPOMATOSIS, MULTIPLE SYMMETRIC; MSL	LIPOMATOSIS, FAMILIAL BENIGN CERVICAL;; LIPODYSTROPHY, CEPHALOTHORACIC	
Percent	151900	LIPOMATOSIS, MULTIPLE	LIPOMATOSIS, FAMILIAL MULTIPLE; FML;; LIPOMA; LIPO	
Percent	152100	LIPOPROTEIN TYPES--Ld SYSTEM		
NULL	152300	LIPOPROTEIN TYPES--Lt SYSTEM		
NULL	152400	LIPOPROTEIN, VARIANT OF BETA	BETA-LIPOPROTEIN, DOUBLE	
NULL	152420	LITHIUM TRANSPORT		
Percent	152430	LONGEVITY 1		
NULL	152450	LOW DENSITY LIPOPROTEIN, VARIATION IN MOLECULAR WEIGHT OF		
NULL	152550	LUMBAR STENOSIS, FAMILIAL		
NULL	152600	LUNULAE OF FINGERNAILS		
Number Sign	152700	SYSTEMIC LUPUS ERYTHEMATOSUS; SLE		EXCESS LYMPHOCYTE LOW MOLECULAR WEIGHT DNA, INCLUDED;; EXCESS LMW-DNA, INCLUDED
Percent	152800	LYMPHANGIECTASIA, INTESTINAL		
NULL	152900	LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY		
Number Sign	152950	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	MICROCEPHALY, LYMPHEDEMA, CHORIORETINAL DYSPLASIA SYNDROME;; MLCRD SYNDROME;; MICROCEPHALY AND CHORIORETINOPATHY WITH OR WITHOUT MENTAL RETARDATION, AUTOSOMAL DOMINANT;; CDMMR SYNDROME;; LYMPHEDEMA, MICROCEPHALY, CHORIORETINOPATHY SYNDROME;; LYMPHEDEMA AND RETINAL FOLDS WITH MICROCEPHALY AND MICROPHTHALMOS	
Number Sign	153100	LYMPHEDEMA, HEREDITARY, IA; LMPH1A	NONNE-MILROY LYMPHEDEMA;; MILROY DISEASE;; LYMPHEDEMA, EARLY-ONSET;; PRIMARY CONGENITAL LYMPHEDEMA; PCL	
Percent	153200	LYMPHEDEMA, HEREDITARY, II; LMPH2	MEIGE DISEASE;; MEIGE LYMPHEDEMA;; LYMPHEDEMA, LATE-ONSET;; LYMPHEDEMA PRAECOX	
NULL	153280	LYMPHOCYTE CYTOSOL POLYPEPTIDE, 40-KD	LC40P;; LCP40	
NULL	153290	LYMPHOCYTE CYTOSOL POLYPEPTIDE, 49-KD	LC49P;; LCP49	
Percent	153300	YELLOW NAIL SYNDROME	YNS;; LYMPHEDEMA AND YELLOW NAILS	
Number Sign	153400	LYMPHEDEMA-DISTICHIASIS SYNDROME	LYMPHEDEMA WITH DISTICHIASIS	LYMPHEDEMA-DISTICHIASIS SYNDROME WITH RENAL DISEASE AND DIABETES MELLITUS, INCLUDED
NULL	153470	MACROCEPHALY, BENIGN FAMILIAL	COLE-HUGHES SYNDROME	
Number Sign	153480	BANNAYAN-RILEY-RUVALCABA SYNDROME; BRRS	BANNAYAN-ZONANA SYNDROME; BZS;; RILEY-SMITH SYNDROME;; RUVALCABA-MYHRE-SMITH SYNDROME; RMSS;; MACROCEPHALY, PSEUDOPAPILLEDEMA, AND MULTIPLE HEMANGIOMATA;; MACROCEPHALY, MULTIPLE LIPOMAS, AND HEMANGIOMATA	
Number Sign	153550	CHROMOSOME 5q DELETION SYNDROME	5q- SYNDROME;; MACROCYTIC ANEMIA, REFRACTORY, DUE TO 5q DELETION; MAR	MEGAKARYOCYTES, UNILOBULAR NUCLEATED, INCLUDED
Percent	153600	MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1; WM1		MACROGLOBULINEMIA, WALDENSTROM, SOMATIC, INCLUDED
Percent	153630	MACROGLOSSIA		
Number Sign	153640	FECHTNER SYNDROME; FTNS	MACROTHROMBOCYTOPENIA, NEPHRITIS, DEAFNESS, AND LEUKOCYTE INCLUSIONS;; ALPORT SYNDROME WITH MACROTHROMBOCYTOPENIA, FORMERLY; APSM, FORMERLY	
Number Sign	153650	EPSTEIN SYNDROME; EPSTNS	MACROTHROMBOCYTOPENIA, NEPHRITIS, AND DEAFNESS	
Number Sign	153670	BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2		
Number Sign	153700	MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	VITELLIFORM MACULAR DYSTROPHY, EARLY-ONSET;; VITELLIFORM MACULAR DYSTROPHY, JUVENILE-ONSET;; BEST MACULAR DYSTROPHY; BMD;; MACULAR DEGENERATION, POLYMORPHIC VITELLINE;; BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL	
Number Sign	153800	MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2	MACULOPATHY, AGE-RELATED, 2;; MACULAR DEGENERATION, SENILE	
Percent	153840	MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1	MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	
Percent	153870	MACULAR DYSTROPHY, CONCENTRIC ANNULAR	MCDCA;; MACULAR DYSTROPHY, BENIGN CONCENTRIC ANNULAR; BCAMD	
Percent	153880	MACULAR DYSTROPHY, DOMINANT CYSTOID; DCMD	CYSTOID MACULAR DYSTROPHY; CYMD;; MACULAR EDEMA, CYSTOID;; MDDC	
NULL	153890	MACULAR DYSTROPHY, FENESTRATED SHEEN TYPE		
Number Sign	154020	HYPOMAGNESEMIA 2, RENAL; HOMG2	MAGNESIUM WASTING, RENAL;; MAGNESIUM LOSS, ISOLATED RENAL	
Number Sign	154230	46,XY SEX REVERSAL 4; SRXY4	46,XY GONADAL DYSGENESIS, PARTIAL OR COMPLETE, WITH 9p24.3 DELETION;; CHROMOSOME 9p24.3 DELETION SYNDROME	
Percent	154275	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	MHS2	
Percent	154276	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	MHS3	
NULL	154300	MALOCCLUSION DUE TO PROTUBERANT UPPER FRONT TEETH		
NULL	154370	MAMMASTATIN		
Number Sign	154400	ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	MANDIBULOFACIAL DYSOSTOSIS, TREACHER COLLINS TYPE, WITH LIMB ANOMALIES;; NAGER ACROFACIAL DYSOSTOSIS;; AFD, NAGER TYPE;; NAGER SYNDROME	
Number Sign	154500	TREACHER COLLINS SYNDROME 1; TCS1	TREACHER COLLINS-FRANCESCHETTI SYNDROME; TCOF;; TREACHER COLLINS SYNDROME; TCS;; MANDIBULOFACIAL DYSOSTOSIS; MFD1	
Percent	154570	MANNOSE 6-PHOSPHATE RECEPTOR RECOGNITION DEFECT, LEBANESE TYPE	PHOSPHODIESTER GLYCOSIDE DEFICIENCY	
NULL	154600	MARCUS GUNN PHENOMENON	JAW-WINKING;; MAXILLOPALPEBRAL SYNKINESIS	
Number Sign	154700	MARFAN SYNDROME; MFS	MARFAN SYNDROME, TYPE I; MFS1	
NULL	154750	MARFANOID HYPERMOBILITY SYNDROME		
Number Sign	154780	MARSHALL SYNDROME; MRSHS		
NULL	154800	MAST CELL DISEASE	MASTOCYTOSIS	URTICARIA PIGMENTOSA, INCLUDED
NULL	154850	MASTICATORY MUSCLES, HYPERTROPHY OF	MASSETER MUSCLE HYPERTROPHY	
Percent	155000	MAXILLOFACIAL DYSOSTOSIS		
Percent	155050	MAXILLONASAL DYSPLASIA, BINDER TYPE	BINDER SYNDROME	
Number Sign	155100	MAY-HEGGLIN ANOMALY; MHA	BLEEDING DISORDER, PLATELET-TYPE, 6; BDPLT6;; DOHLE LEUKOCYTE INCLUSIONS WITH GIANT PLATELETS;; MACROTHROMBOCYTOPENIA WITH LEUKOCYTE INCLUSIONS	
NULL	155140	MECKEL DIVERTICULUM		
Percent	155145	CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	PAI SYNDROME	
NULL	155150	MEDIAN-ULNAR NERVE COMMUNICATIONS	MARTIN-GRUBER MEDIAN-ULNAR ANASTOMOSIS	
NULL	155200	MEDIOSTERNAL DEPIGMENTATION LINE		
Number Sign	155240	THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC	FMTC;; MTC1	
Number Sign	155255	MEDULLOBLASTOMA; MDB		MEDULLOBLASTOMA, DESMOPLASTIC, INCLUDED;; MEDULLOBLASTOMA WITH EXTENSIVE NODULARITY, INCLUDED; MBEN, INCLUDED
Number Sign	155310	VISCERAL MYOPATHY; VSCM	MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME; MMIH;; INFANTILE VISCERAL MYOPATHY;; MEGADUODENUM AND/OR MEGACYSTIS;; BERDON SYNDROME;; PSEUDOOBSTRUCTION, IDIOPATHIC INTESTINAL	
Percent	155350	MEGALENCEPHALY, AUTOSOMAL DOMINANT		
NULL	155500	MEGALODACTYLY	MACRODACTYLY	
Percent	155600	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1; CMM1	MELANOMA, CUTANEOUS MALIGNANT; CMM;; MELANOMA, MALIGNANT;; FAMILIAL ATYPICAL MOLE-MALIGNANT MELANOMA SYNDROME; FAMMM;; MELANOMA, FAMILIAL; MLM;; DYSPLASTIC NEVUS SYNDROME, HEREDITARY; DNS;; B-K MOLE SYNDROME	
Number Sign	155601	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2; CMM2		
NULL	155700	MELANOMA, MALIGNANT FAMILIAL INTRAOCULAR		
Number Sign	155720	MELANOMA, UVEAL		
Number Sign	155755	MELANOMA-ASTROCYTOMA SYNDROME	MELANOMA AND NEURAL SYSTEM TUMOR SYNDROME	
NULL	155770	MELANOMA TUMOR ANTIGEN GP90	CLASS 1 UNIQUE TUMOR ANTIGEN OF MELANOMA; GP90	
Percent	155900	MELKERSSON-ROSENTHAL SYNDROME	MROS; MRS;; MELKERSSON SYNDROME	
Percent	155950	MELORHEOSTOSIS, ISOLATED	MEL	
Percent	155980	MEMBRANOUS CRANIAL OSSIFICATION, DELAYED		
NULL	156000	MENIERE DISEASE		
NULL	156190	MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA		
Number Sign	156200	MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1		CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED
NULL	156220	MERALGIA PARAESTHETICA, FAMILIAL		
Percent	156230	MESOMELIC DWARFISM OF HYPOPLASTIC TIBIA AND RADIUS TYPE		
Percent	156232	MESOMELIC DYSPLASIA, KANTAPUTRA TYPE; MMDK	MDK;; MESOMELIC DYSPLASIA WITH ANKLE, CARPAL, AND TARSAL SYNOSTOSIS;; MESOMELIC DYSPLASIA, THAI TYPE	
Number Sign	156240	MESOTHELIOMA, MALIGNANT; MESOM		
Number Sign	156250	METACHONDROMATOSIS; METCDS		
NULL	156300	METACHROMASIA OF FIBROBLASTS		
NULL	156310	METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASE A		
Number Sign	156400	METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	METAPHYSEAL CHONDRODYSPLASIA, MURK JANSEN TYPE	
Number Sign	156500	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS	SPONDYLOMETAPHYSEAL DYSPLASIA, JAPANESE TYPE	
Number Sign	156510	METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY; MDMHB		
Percent	156520	METATARSUS VARUS, TYPE I		
Number Sign	156530	METATROPIC DYSPLASIA	METATROPIC DWARFISM	
Number Sign	156550	KNIEST DYSPLASIA		
Percent	156580	MICROCEPHALY, AUTOSOMAL DOMINANT		
Number Sign	156600	MICROCORIA, CONGENITAL	CHROMOSOME 13q32 DELETION SYNDROME;; MCOR;; MIOSIS, CONGENITAL	
Number Sign	156610	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	SKIN CREASES, MULTIPLE BENIGN RING-SHAPED, OF LIMBS;; CIRCUMFERENTIAL SKIN CREASES, KUNZE TYPE;; MICHELIN TIRE BABY SYNDROME	
NULL	156620	MICROCEPHALY-DEAFNESS SYNDROME		
NULL	156700	MICROCORNEA, GLAUCOMA, AND ABSENT FRONTAL SINUSES		
NULL	156810	MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD		
NULL	156830	MICROMELIC BONE DYSPLASIA WITH CLOVERLEAF SKULL		
Percent	156850	MICROPHTHALMIA, ISOLATED, WITH CATARACT 1; MCOPCT1	CATARACT, CONGENITAL, WITH MICROPHTHALMIA; CATM	
NULL	156900	MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA; MCOPCR	MICROPHTHALMIA AND CORECTOPIA;; MICROPHTHALMIA WITH MYOPIA AND CORECTOPIA	
NULL	157150	MICROSPHEROPHAKIA WITH HERNIA		
NULL	157151	MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA		
Number Sign	157170	HOLOPROSENCEPHALY 2; HPE2		
NULL	157200	MIDPHALANGEAL HAIR	MIDDIGITAL HAIR	
Percent	157300	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	MGR1;; MGAU; MA;; MIGRAINE	
Percent	157400	MILIA, MULTIPLE ERUPTIVE		
Number Sign	157600	MIRROR MOVEMENTS 1; MRMV1	MIRROR MOVEMENTS 1 AND/OR AGENESIS OF THE CORPUS CALLOSUM;; MIRROR MOVEMENTS, CONGENITAL;; BIMANUAL SYNERGIA	
Number Sign	157640	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 1	
Percent	157700	MITRAL VALVE PROLAPSE 1; MVP1	MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;; MYXOMATOUS MITRAL VALVE PROLAPSE 1;; MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;; MITRAL REGURGITATION, FAMILIAL;; FLOPPY MITRAL VALVE;; BARLOW SYNDROME;; MYXOMATOUS VALVULAR DISEASE, FAMILIAL;; CLICK-MURMUR SYNDROME	
Number Sign	157800	CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	MITRAL REGURGITATION, CONDUCTIVE DEAFNESS, AND FUSION OF CERVICAL VERTEBRAE AND OF CARPAL AND TARSAL BONES	
Percent	157900	MOEBIUS SYNDROME; MBS	MOBIUS SYNDROME; MBS;; MOEBIUS SEQUENCE	
Percent	157950	PERMANENT MOLARS, SECONDARY RETENTION OF	ANKYLOSIS OF TEETH;; DENTAL ANKYLOSIS;; MOLAR I REINCLUSION	
NULL	157960	MOLONEY LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF; MLVI2		
NULL	157980	MOMO SYNDROME	MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	
Number Sign	158000	MONILETHRIX; MNLIX		
NULL	158030	ANTIGEN DEFINED BY MONOCLONAL ANTIBODY AJ9	MSK1	
NULL	158040	ANTIGEN DEFINED BY MONOCLONAL ANTIBODY T87	MSK2	
NULL	158050	MONKEY RED BLOOD CELL RECEPTOR; MRBC	B-CELL RECEPTOR FOR MONKEY RED BLOOD CELLS	
NULL	158100	MONOPHALANGY OF GREAT TOE		
Number Sign	158170	CHROMOSOME 9p DELETION SYNDROME	MONOSOMY 9p SYNDROME	
NULL	158250	NONDISJUNCTION	MOSAICISM, CHROMOSOMAL;; MIXOPLOIDY, FAMILIAL	
NULL	158280	MOTION SICKNESS		
Number Sign	158300	ARTHROGRYPOSIS, DISTAL, TYPE 7; DA7	TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME;; MOUTH, INABILITY TO OPEN COMPLETELY, AND SHORT FINGER-FLEXOR TENDONS;; HECHT SYNDROME	
Percent	158310	MUCOEPITHELIAL DYSPLASIA, HEREDITARY	HMD	
Number Sign	158320	MUIR-TORRE SYNDROME; MRTES	CUTANEOUS SEBACEOUS NEOPLASMS AND KERATOACANTHOMAS, MULTIPLE, WITH GASTROINTESTINAL AND OTHER CARCINOMAS	
Number Sign	158330	MULLERIAN APLASIA AND HYPERANDROGENISM	MULLERIAN DUCT FAILURE AND HYPERANDROGENISM	
NULL	158345	MULTIPLE EXOSTOSES WITH SPASTIC TETRAPARESIS		
Number Sign	158350	COWDEN SYNDROME 1; CWS1	CS; CD;; MULTIPLE HAMARTOMA SYNDROME; MHAM	DYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;; CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;; CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;; LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;; PROTEUS-LIKE SYNDROME, INCLUDED
Percent	158400	MUSCLE CRAMPS, FAMILIAL		
Percent	158500	MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS		
Number Sign	158580	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A	HMN VIIA;; NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA;; DHMN7A;; DHMNVP;; SPINAL MUSCULAR ATROPHY, DISTAL, WITH VOCAL CORD PARALYSIS;; HARPER-YOUNG MYOPATHY	
Number Sign	158590	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A	HMN IIA;; NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; DHMN2A;; SPINAL MUSCULAR ATROPHY, DISTAL, ADULT, AUTOSOMAL DOMINANT, IIA;; CHARCOT-MARIE-TOOTH DISEASE, SPINAL, IIA	
Number Sign	158600	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	SMA-LED;; SPINAL MUSCULAR ATROPHY, CHILDHOOD, PROXIMAL, AUTOSOMAL DOMINANT;; SPINAL MUSCULAR ATROPHY, JUVENILE, PROXIMAL, AUTOSOMAL DOMINANT;; KUGELBERG-WELANDER SYNDROME, AUTOSOMAL DOMINANT	
NULL	158650	MUSCULAR ATROPHY, MALIGNANT NEUROGENIC		
NULL	158800	MUSCULAR DYSTROPHY, BARNES TYPE		
Number Sign	158810	BETHLEM MYOPATHY 1; BTHLM1	BETHLEM MYOPATHY;; MYOPATHY, BENIGN CONGENITAL, WITH CONTRACTURES;; MUSCULAR DYSTROPHY, BENIGN CONGENITAL	
Number Sign	158900	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1	MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;; LANDOUZY-DEJERINE MUSCULAR DYSTROPHY	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;; FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS AND TORTUOSITY OF RETINAL ARTERIOLES, INCLUDED
Number Sign	158901	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC;; FSHD2, DIGENIC;; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 2;; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1B; FSHD1B	
Number Sign	159000	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A; LGMD1A	LGMD1;; MUSCULAR DYSTROPHY, PROXIMAL, TYPE 1A	
Number Sign	159001	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B; LGMD1B	MUSCULAR DYSTROPHY, PROXIMAL, TYPE 1B	
Percent	159050	MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES		
NULL	159100	MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE		
Percent	159300	MUSICAL PERFECT PITCH	ABSOLUTE PITCH; AP	
NULL	159400	MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	MYASTHENIA GRAVIS, LIMB-GIRDLE	
NULL	159410	MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS		
NULL	159420	MYDRIASIS, CONGENITAL		
NULL	159500	MYELINATED OPTIC NERVE FIBERS		
Number Sign	159550	ATAXIA-PANCYTOPENIA SYNDROME; ATXPC	MYELOCEREBELLAR DISORDER	
NULL	159580	MYELOPATHY, HTLV-1-ASSOCIATED; HAM	FAMILIAL SPASTIC PARAPARESIS, HTLV-1-ASSOCIATED	
Percent	159595	MYELOPROLIFERATIVE SYNDROME, TRANSIENT	MST;; LEUKEMIA, TRANSIENT;; TRANSIENT ABNORMAL MYELOPOIESIS; TAM	
Percent	159600	MYOCLONIC EPILEPSY, HARTUNG TYPE		
NULL	159700	MYOCLONUS AND ATAXIA	RAMSAY HUNT SYNDROME	
NULL	159800	MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS		
Number Sign	159900	DYSTONIA 11, MYOCLONIC; DYT11	MYOCLONUS-DYSTONIA SYNDROME;; MYOCLONIC DYSTONIA;; DYSTONIA, ALCOHOL-RESPONSIVE;; MYOCLONUS, HEREDITARY ESSENTIAL	
Number Sign	159950	SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY; SMAPME	MYOCLONUS, HEREDITARY, WITH PROGRESSIVE DISTAL MUSCULAR ATROPHY	
Percent	160010	MYOGLOBINURIA, AUTOSOMAL DOMINANT		
Number Sign	160120	EPISODIC ATAXIA, TYPE 1; EA1	EPISODIC ATAXIA WITH MYOKYMIA; EAM;; ATAXIA, EPISODIC, WITH MYOKYMIA; AEM; AEMK;; PAROXYSMAL ATAXIA WITH NEUROMYOTONIA, HEREDITARY;; MYOKYMIA WITH PERIODIC ATAXIA	MYOKYMIA 1, INCLUDED;; CONTINUOUS MUSCLE FIBER ACTIVITY, HEREDITARY, INCLUDED;; ISAACS-MERTENS SYNDROME, INCLUDED;; MYOKYMIA 1 WITH OR WITHOUT HYPOMAGNESEMIA, INCLUDED
Number Sign	160150	MYOPATHY, CENTRONUCLEAR, 1; CNM1	MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT;; MYOTUBULAR MYOPATHY, AUTOSOMAL DOMINANT	
Percent	160300	MYOPATHY, DISTAL, INFANTILE-ONSET		
Number Sign	160500	MYOPATHY, DISTAL, 1; MPD1	MYOPATHY, LATE DISTAL HEREDITARY;; LAING DISTAL MYOPATHY;; MYOPATHY, DISTAL, EARLY-ONSET, AUTOSOMAL DOMINANT	
Number Sign	160565	MYOPATHY, TUBULAR AGGREGATE, 1; TAM1	MYOPATHY, TUBULAR AGGREGATE; TAM;; TUBULAR AGGREGATE MYOPATHY	
NULL	160570	MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS		
Percent	160700	MYOPIA 2, AUTOSOMAL DOMINANT; MYP2		
Percent	160750	MYOSITIS	MYOPATHY, FAMILIAL IDIOPATHIC INFLAMMATORY; IIM	
Number Sign	160800	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	THOMSEN DISEASE; THD	MYOTONIA LEVIOR, INCLUDED
Number Sign	160900	MYOTONIC DYSTROPHY 1; DM1	DYSTROPHIA MYOTONICA 1;; DYSTROPHIA MYOTONICA; DM;; STEINERT DISEASE	
Number Sign	160980	CARNEY COMPLEX, TYPE 1; CNC1	CARNEY MYXOMA-ENDOCRINE COMPLEX;; CARNEY SYNDROME; CAR;; MYXOMA, SPOTTY PIGMENTATION, AND ENDOCRINE OVERACTIVITY;; NAME SYNDROME;; LAMB SYNDROME	
NULL	160990	MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS		
Number Sign	161000	NAEGELI-FRANCESCHETTI-JADASSOHN SYNDROME; NFJS	NAEGELI SYNDROME;; NFJ SYNDROME	
Percent	161050	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1; NDNC1	TWENTY-NAIL DYSTROPHY;; ONYCHODYSTROPHY TOTALIS, ISOLATED	NAIL GROWTH, INCLUDED
NULL	161070	NAIL HIGH-SULFUR PROTEIN		
NULL	161080	NAIL LOW-SULFUR PROTEIN		
NULL	161100	NAILBEDS, PIGMENTATION OF		
Number Sign	161200	NAIL-PATELLA SYNDROME; NPS	NPS1;; ONYCHOOSTEODYSPLASIA;; TURNER-KIESER SYNDROME;; FONG DISEASE	
Number Sign	161400	NARCOLEPSY 1; NRCLP1	NARCOLEPTIC SYNDROME 1	CATAPLEXY, INCLUDED
NULL	161470	NASAL ALAR COLLAPSE, BILATERAL		
NULL	161480	NASAL BONES, ABSENCE OF		
Percent	161500	NASAL GROOVE, FAMILIAL TRANSVERSE		
NULL	161530	NASAL HYPERPIGMENTATION, FAMILIAL TRANSVERSE		
Percent	161550	NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 2; NPCA2		
NULL	161600	NAVICULAR BONE, ACCESSORY		
NULL	161700	NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	LEIGH SYNDROME, ADULT	
Number Sign	161800	NEMALINE MYOPATHY 3; NEM3		MYOPATHY, ACTIN, CONGENITAL, WITH EXCESS OF THIN MYOFILAMENTS, INCLUDED;; NEMALINE MYOPATHY 3, WITH INTRANUCLEAR RODS, INCLUDED;; MYOPATHY, ACTIN, CONGENITAL, WITH CORES, INCLUDED
Percent	161900	RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1	NEPHROPATHY, FAMILIAL;; NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;; RENAL FAILURE, ADULT-ONSET; AORF	
Percent	161950	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	IGAN;; NEPHRITIS, IgA TYPE;; BERGER DISEASE	
Number Sign	162000	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE; HNFJ;; FAMILIAL JUVENILE HYPERURICEMIC NEPHROPATHY; FJHN;; NEPHROPATHY, FAMILIAL, WITH GOUT;; GOUTY NEPHROPATHY, FAMILIAL JUVENILE	
NULL	162020	NERVE GROWTH FACTOR, ALPHA SUBUNIT; NGFA		
Number Sign	162091	SCHWANNOMATOSIS 1; SWNTS1	NEURILEMMOMATOSIS, CONGENITAL CUTANEOUS	
Number Sign	162100	AMYOTROPHY, HEREDITARY NEURALGIC; HNA	NEURITIS WITH BRACHIAL PREDILECTION; NAPB;; BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;; AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	
Number Sign	162200	NEUROFIBROMATOSIS, TYPE I; NF1	NEUROFIBROMATOSIS, PERIPHERAL TYPE;; VON RECKLINGHAUSEN DISEASE	
Number Sign	162210	NEUROFIBROMATOSIS, FAMILIAL SPINAL	FSNF	
NULL	162240	NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME	NPDC SYNDROME;; DUODENAL CARCINOID SYNDROME	
NULL	162260	NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL; NF3A	NEUROFIBROMATOSIS, TYPE III, OF RICCARDI;; NF III; NF3;; NEUROFIBROMATOSIS, TYPE III, RICCARDI TYPE	NEUROFIBROMAS, PALMAR CUTANEOUS, INCLUDED
NULL	162270	NEUROFIBROMATOSIS, TYPE IV, OF RICCARDI; NF4	NEUROFIBROMATOSIS, VARIANT FORM(S) OF;; NF IV;; NEUROFIBROMATOSIS, ATYPICAL	
Number Sign	162300	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	MEN IIB;; NEUROMATA, MUCOSAL, WITH ENDOCRINE TUMORS;; WAGENMANN-FROBOESE SYNDROME;; MULTIPLE ENDOCRINE NEOPLASIA, TYPE III, FORMERLY; MEN3, FORMERLY	MUCOSAL NEUROMA SYNDROME, INCLUDED
Number Sign	162350	CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	KUFS DISEASE, AUTOSOMAL DOMINANT;; CEROID LIPOFUSCINOSIS, NEURONAL, PARRY TYPE	
Percent	162370	NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX		
NULL	162380	NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE		
Number Sign	162400	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	HSAN IA;; HSAN1;; NEUROPATHY, HEREDITARY SENSORY, TYPE IA; HSN1A;; HSN IA;; NEUROPATHY, HEREDITARY SENSORY RADICULAR, AUTOSOMAL DOMINANT, TYPE 1A	
Number Sign	162500	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP	POLYNEUROPATHY, FAMILIAL RECURRENT;; TOMACULOUS NEUROPATHY	
NULL	162600	NEUROPATHY, WITH PARAPROTEIN IN SERUM, CEREBROSPINAL FLUID AND URINE		
Percent	162700	NEUTROPENIA, CHRONIC FAMILIAL	LEUKOPENIA, BENIGN FAMILIAL	
Number Sign	162800	CYCLIC NEUTROPENIA	CYCLIC HEMATOPOIESIS	
Percent	162820	NEUTROPHIL MIGRATION; NM	NEUTROPHIL CHEMOTACTIC RESPONSE; NCR	
Number Sign	162830	NEUTROPHILIA, HEREDITARY		
Number Sign	162900	NEVUS, EPIDERMAL	NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC	NEVUS SEBACEOUS, INCLUDED;; NEVUS, WOOLLY HAIR, INCLUDED
Number Sign	163000	CAPILLARY MALFORMATIONS, CONGENITAL; CMC	NEVI FLAMMEI, FAMILIAL MULTIPLE;; PORT-WINE STAIN;; CAPILLARY MALFORMATIONS; CMAL	
NULL	163050	NEVUS ANEMICUS		
Percent	163100	NEVUS FLAMMEUS OF NAPE OF NECK	UNNA NEVUS;; ERYTHEMA NUCHAE	
Number Sign	163200	SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	SFM SYNDROME;; LINEAR SEBACEOUS NEVUS SYNDROME;; SEBACEOUS NEVUS SYNDROME, LINEAR;; JADASSOHN NEVUS PHAKOMATOSIS; JNP;; NEVUS SEBACEUS OF JADASSOHN;; ORGANOID NEVUS PHAKOMATOSIS;; EPIDERMAL NEVUS SYNDROME, FORMERLY	
Percent	163400	NIEVERGELT SYNDROME	MESOMELIC DYSPLASIA, NIEVERGELT TYPE	
Number Sign	163500	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2	NIGHT BLINDNESS, CONGENITAL STATIONARY, RAMBUSCH TYPE	
NULL	163600	NIPPLES INVERTED	MAMMILLAE INVERTITAE	
Percent	163700	NIPPLES, SUPERNUMERARY	ACCESSORY NIPPLES;; POLYMASTIA;; POLYTHELIA, FAMILIAL	
Number Sign	163800	SICK SINUS SYNDROME 2; SSS2	SICK SINUS SYNDROME 2 WITH OR WITHOUT CARDIAC NONCOMPACTION AND/OR ASCENDING AORTA DILATION;; ATRIAL FIBRILLATION WITH BRADYARRHYTHMIA;; SINUS NODE DISEASE, FAMILIAL, AUTOSOMAL DOMINANT;; SINUS BRADYCARDIA SYNDROME, FAMILIAL, AUTOSOMAL DOMINANT	
NULL	163850	NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES		
Number Sign	163950	NOONAN SYNDROME 1; NS1	NOONAN SYNDROME;; MALE TURNER SYNDROME;; FEMALE PSEUDO-TURNER SYNDROME;; TURNER PHENOTYPE WITH NORMAL KARYOTYPE	PTERYGIUM COLLI SYNDROME, INCLUDED
NULL	164000	NOSE, ANOMALOUS SHAPE OF	POTATO NOSE	
Percent	164100	NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	NYSTAGMUS, CONGENITAL MOTOR, 2	
Percent	164150	NYSTAGMUS, HEREDITARY VERTICAL		
Percent	164170	NYSTAGMUS, VOLUNTARY		
NULL	164180	OCULOCEREBROCUTANEOUS SYNDROME	OCCS;; ORBITAL CYST WITH CEREBRAL AND FOCAL DERMAL MALFORMATIONS;; DELLEMAN SYNDROME	
NULL	164185	OCULAR CICATRICIAL PEMPHIGOID; OCP		
NULL	164190	OCULAR DOMINANCE		
Number Sign	164200	OCULODENTODIGITAL DYSPLASIA; ODDD	ODD SYNDROME;; OCULODENTOOSSEOUS DYSPLASIA; ODOD	
Percent	164210	HEMIFACIAL MICROSOMIA; HFM	OCULOAURICULOVERTEBRAL SPECTRUM; OAVS;; GOLDENHAR SYNDROME;; OCULOAURICULOVERTEBRAL DYSPLASIA;; OAV DYSPLASIA;; FACIOAURICULOVERTEBRAL SEQUENCE;; FAV SEQUENCE	
Percent	164220	SCHILBACH-ROTT SYNDROME	OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;; CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;; BLEPHAROFACIOSKELETAL SYNDROME; BRSS	
Number Sign	164230	OBSESSIVE-COMPULSIVE DISORDER; OCD		
Number Sign	164280	FEINGOLD SYNDROME 1; FGLDS1	FEINGOLD SYNDROME;; OCULODIGITOESOPHAGODUODENAL SYNDROME; ODED;; ODED SYNDROME;; MICROCEPHALY-OCULO-DIGITO-ESOPHAGEAL-DUODENAL SYNDROME; MODED;; DIGITAL ANOMALIES WITH SHORT PALPEBRAL FISSURES AND ATRESIA OF ESOPHAGUS OR DUODENUM;; MICROCEPHALY, MENTAL RETARDATION, AND TRACHEOESOPHAGEAL FISTULA SYNDROME;; MMT SYNDROME;; MICROCEPHALY AND DIGITAL ABNORMALITIES WITH NORMAL INTELLIGENCE	
Number Sign	164300	OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD	MUSCULAR DYSTROPHY, OCULOPHARYNGEAL	
Percent	164310	OCULOPHARYNGODISTAL MYOPATHY; OPDM	FACIOOCULOLARYNGOPHARYNGEAL MYOPATHY WITH DISTAL AND RESPIRATORY INVOLVEMENT; FOLP-DR	
NULL	164330	ODONTOMA-DYSPHAGIA SYNDROME		
Number Sign	164400	SPINOCEREBELLAR ATAXIA 1; SCA1	SPINOCEREBELLAR ATROPHY I;; OLIVOPONTOCEREBELLAR ATROPHY I; OPCA1;; OPCA I;; CEREBELLOPARENCHYMAL DISORDER I; CPD1;; MENZEL TYPE OPCA;; OLIVOPONTOCEREBELLAR ATROPHY IV; OPCA4;; OPCA IV;; SCHUT-HAYMAKER TYPE OPCA	
Number Sign	164500	SPINOCEREBELLAR ATAXIA 7; SCA7	OLIVOPONTOCEREBELLAR ATROPHY III; OPCA3;; OPCA III;; OPCA WITH RETINAL DEGENERATION;; OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA;; AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II;; ADCA, TYPE II	
NULL	164680	ONYCHOGRYPOSIS, PEDAL, WITH KERATOSIS PLANTARIS AND COARSE HAIR		
NULL	164700	OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V	OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	
Percent	164745	OMODYSPLASIA 2; OMOD2	OMODYSPLASIA, AUTOSOMAL DOMINANT	
Number Sign	164750	OMPHALOCELE, AUTOSOMAL	CHROMOSOME 1p31 DUPLICATION SYNDROME	
Percent	164800	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 5; NDNC5	ONYCHOLYSIS, PARTIAL, WITH SCLERONYCHIA;; ONYCHOLYSIS, HEREDITARY DISTAL	
NULL	164891	ONCOGENE YUASA		
Percent	164900	OPHTHALMOMANDIBULOMELIC DYSPLASIA	OMM SYNDROME	
Percent	165000	OPHTHALMOPLEGIA, FAMILIAL STATIC	EXTERNAL OPHTHALMOPLEGIA, NONPROGRESSIVE, CONGENITAL HEREDITARY	
NULL	165098	OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION		
NULL	165150	OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY		
NULL	165199	OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL DOMINANT		
NULL	165200	OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS		
NULL	165210	ONCOGENE BMYC; BMYC		
NULL	165290	ONCOGENE RMYC; RMYC		
Number Sign	165300	OPTIC ATROPHY 3, AUTOSOMAL DOMINANT; OPA3	OPTIC ATROPHY AND CATARACT, AUTOSOMAL DOMINANT	
Number Sign	165500	OPTIC ATROPHY 1; OPA1	OPTIC ATROPHY, JUVENILE;; KJER-TYPE OPTIC ATROPHY;; OPTIC ATROPHY, KJER TYPE; OAK	
NULL	165510	OPTIC ATROPHY WITH NEGATIVE ELECTRORETINOGRAMS		
Number Sign	165550	OPTIC NERVE HYPOPLASIA, BILATERAL		OPTIC NERVE APLASIA, BILATERAL, INCLUDED
NULL	165590	OROFACIODIGITAL SYNDROME X; OFD10	OFDS X;; ORAL-FACIAL-DIGITAL SYNDROME, TYPE X;; OROFACIODIGITAL SYNDROME WITH FIBULAR APLASIA;; ORAL-FACIAL-DIGITAL SYNDROME WITH FIBULAR APLASIA	
NULL	165600	ORBITAL MARGIN, HYPOPLASIA OF		
Percent	165660	OSLAM SYNDROME	OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;; OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTIC MARROW	
NULL	165670	OSSIFIED EAR CARTILAGES		
NULL	165680	OSSICULAR MALFORMATIONS, FAMILIAL		
Percent	165700	THIEMANN DISEASE	THIEMANN EPIPHYSEAL DISEASE;; OSTEOARTHROPATHY OF FINGERS, FAMILIAL	
Number Sign	165720	OSTEOARTHRITIS SUSCEPTIBILITY 1; OS1	OA;; OSTEOARTHROSIS;; OSTEOARTHRITIS OF HIP, FEMALE-SPECIFIC, SUSCEPTIBILITY TO	
Number Sign	165800	SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	OSTEOCHONDRITIS DISSECANS, SHORT STATURE, AND EARLY-ONSET OSTEOARTHRITIS; OD	
Percent	166000	ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE	OLLIER DISEASE;; OSTEOCHONDROMATOSIS;; DYSCHONDROPLASIA	
Number Sign	166200	OSTEOGENESIS IMPERFECTA, TYPE I; OI1	OI, TYPE I;; OSTEOGENESIS IMPERFECTA TARDA;; OSTEOGENESIS IMPERFECTA WITH BLUE SCLERAE	
Number Sign	166210	OSTEOGENESIS IMPERFECTA, TYPE II; OI2	OI, TYPE II;; OSTEOGENESIS IMPERFECTA CONGENITA, PERINATAL LETHAL FORM;; OSTEOGENESIS IMPERFECTA CONGENITA; OIC;; VROLIK TYPE OF OSTEOGENESIS IMPERFECTA	
Number Sign	166220	OSTEOGENESIS IMPERFECTA, TYPE IV; OI4	OI, TYPE IV;; OSTEOGENESIS IMPERFECTA WITH NORMAL SCLERAE	
NULL	166230	OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES		
Number Sign	166250	OSTEOGLOPHONIC DYSPLASIA; OGD	OSTEOGLOPHONIC DWARFISM	
Number Sign	166260	GNATHODIAPHYSEAL DYSPLASIA; GDD	OSTEOGENESIS IMPERFECTA WITH UNUSUAL SKELETAL LESIONS;; GNATHODIAPHYSEAL SCLEROSIS	
Number Sign	166300	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	OSTEOLYSIS, HEREDITARY, OF CARPAL BONES WITH OR WITHOUT NEPHROPATHY;; MULTICENTRIC OSTEOLYSIS, AUTOSOMAL DOMINANT	
Number Sign	166350	OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	ECTOPIC OSSIFICATION, FAMILIAL;; OSTEOMA CUTIS	
NULL	166400	OSTEOMAS OF MANDIBLE		
NULL	166450	OSTEOMESOPYKNOSIS	AXIAL OSTEOSCLEROSIS	
Number Sign	166600	OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2	OSTEOPETROSIS, AUTOSOMAL DOMINANT, TYPE II;; MARBLE BONES, AUTOSOMAL DOMINANT;; OSTEOSCLEROSIS FRAGILIS GENERALISATA;; ALBERS-SCHONBERG DISEASE, AUTOSOMAL DOMINANT	
Number Sign	166700	BUSCHKE-OLLENDORFF SYNDROME; BOS	DERMATOOSTEOPOIKILOSIS;; DERMATOFIBROSIS, DISSEMINATED, WITH OSTEOPOIKILOSIS;; DERMATOFIBROSIS LENTICULARIS DISSEMINATA WITH OSTEOPOIKILOSIS;; OSTEOPATHIA CONDENSANS DISSEMINATA	OSTEOPOIKILOSIS, ISOLATED, INCLUDED;; DERMATOFIBROSIS LENTICULARIS DISSEMINATA, ISOLATED, INCLUDED;; OSTEOPOIKILOSIS WITH MELORHEOSTOSIS, INCLUDED
NULL	166705	OSTEOPOIKILOSIS AND DACRYOCYSTITIS		
Number Sign	166710	OSTEOPOROSIS	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS; BMND;; OSTEOPOROSIS, POSTMENOPAUSAL;; OSTEOPOROSIS, INVOLUTIONAL	FRACTURE, HIP, SUSCEPTIBILITY TO, INCLUDED
NULL	166740	OSTEOSCLEROSIS WITH ICHTHYOSIS AND FRACTURES	CORTICAL THICKENING OF LONG BONES WITH BOWING AND ICHTHYOSIS	
Number Sign	166750	OTODENTAL DYSPLASIA	CHROMOSOME 11q13 DELETION SYNDROME;; OTODENTAL SYNDROME	OTODENTAL SYNDROME WITH COLOBOMA, INCLUDED;; OCULOOTODENTAL SYNDROME, INCLUDED
Percent	166760	OTITIS MEDIA, SUSCEPTIBILITY TO	OMS;; OTITIS MEDIA, CHRONIC/RECURRENT;; COME/ROM	
Number Sign	166780	OTOFACIOCERVICAL SYNDROME 1; OTFCS	OFC; OFC1	
Percent	166800	OTOSCLEROSIS 1; OTSC1	OTS	
Number Sign	166900	OVALOCYTOSIS, SOUTHEAST ASIAN; SAO	OVALOCYTOSIS, MALAYSIAN-MELANESIAN-FILIPINO TYPE;; ELLIPTOCYTOSIS 4; EL4;; ELLIPTOCYTOSIS, STOMATOCYTIC HEREDITARY;; HE, STOMATOCYTIC	
NULL	166910	OVALOCYTOSIS, HEREDITARY HEMOLYTIC, WITH DEFECTIVE ERYTHROPOIESIS		
NULL	166950	TERATOMA, OVARIAN	DERMOID CYST, OVARIAN	
NULL	166970	OVARIAN FIBROMATA		
NULL	166990	OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA, HYDROCEPHALUS, AND HYPERTENSION		
Number Sign	167000	OVARIAN CANCER		OVARIAN CANCER, EPITHELIAL, INCLUDED
Number Sign	167030	NEPHROLITHIASIS, CALCIUM OXALATE; CAON	KIDNEY STONES;; UROLITHIASIS, CALCIUM OXALATE	
Percent	167100	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT; PHOAD	PHO, AUTOSOMAL DOMINANT;; PACHYDERMOPERIOSTOSIS, AUTOSOMAL DOMINANT;; PDP, AUTOSOMAL DOMINANT	
Number Sign	167200	PACHYONYCHIA CONGENITA 1; PC1	PACHYONYCHIA CONGENITA, JADASSOHN-LEWANDOWSKY TYPE, FORMERLY;; JADASSOHN-LEWANDOWSKY SYNDROME, FORMERLY	
Number Sign	167210	PACHYONYCHIA CONGENITA 2; PC2	PACHYONYCHIA CONGENITA, JACKSON-LAWLER TYPE, FORMERLY	
NULL	167220	PACMAN DYSPLASIA	EPIPHYSEAL STIPPLING WITH OSTEOCLASTIC HYPERPLASIA	
Number Sign	167250	PAGET DISEASE OF BONE 3; PDB3		
NULL	167300	PAGET DISEASE, EXTRAMAMMARY		
Number Sign	167320	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1; IBMPFD1	MULTISYSTEM PROTEINOPATHY 1; MSP1;; MUSCULAR DYSTROPHY, LIMB-GIRDLE, WITH PAGET DISEASE OF BONE;; PAGETOID AMYOTROPHIC LATERAL SCLEROSIS;; PAGETOID NEUROSKELETAL SYNDROME;; LOWER MOTOR NEURON DEGENERATION WITH PAGET-LIKE BONE DISEASE	
Number Sign	167400	PAROXYSMAL EXTREME PAIN DISORDER	PEXPD; PEPD;; PAIN, SUBMANDIBULAR, OCULAR, AND RECTAL, WITH FLUSHING;; RECTAL PAIN, FAMILIAL	
Percent	167500	PALATOPHARYNGEAL INCOMPETENCE	VELOPHARYNGEAL INCOMPETENCE; VPI;; VELOPHARYNGEAL INSUFFICIENCY	
NULL	167600	PALMARIS LONGUS MUSCLE, ABSENCE OF		
NULL	167700	PALMOMENTAL REFLEX		
Percent	167730	NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	PALPEBRAL COLOBOMA-LIPOMA SYNDROME	
NULL	167750	PANCREAS, ANNULAR		
NULL	167755	PANCREAS, DORSAL, AGENESIS OF		
Number Sign	167800	PANCREATITIS, HEREDITARY; PCTT	HPC;; HP;; PANCREATITIS, CHRONIC	PANCREATITIS, CHRONIC, SUSCEPTIBILITY TO, INCLUDED;; PANCREATITIS, CALCIFIC, INCLUDED;; PANCREATITIS, CHRONIC, PROTECTION AGAINST, INCLUDED
NULL	167850	PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE		
Percent	167870	PANIC DISORDER 1; PAND1	PANIC DISORDER SUSCEPTIBILITY LOCUS, CHROMOSOME 13q-RELATED	PANIC DISORDER WITH BLADDER CONDITIONS, INCLUDED;; PANIC DISORDER WITH JOINT LAXITY, INCLUDED
Percent	167900	PAPILLOMATOSIS, CONFLUENT AND RETICULATED; CARP	PAPILLOMATOSIS, RETICULATED AND CONFLUENT, OF GOUGEROT AND CARTEAUD;; PAPILLOMATOSIS, FAMILIAL CUTANEOUS	
NULL	167950	PAPILLOMATOSIS, FLORID, OF NIPPLE		
NULL	167959	HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 1; HPV18I1	PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 1	
NULL	167960	HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 2; HPV18I2	PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 2	
Number Sign	168000	PARAGANGLIOMAS 1; PGL1	PARAGANGLIOMAS, FAMILIAL, 1;; PARAGANGLIOMATA; PGL;; GLOMUS TUMORS, FAMILIAL, 1;; CHEMODECTOMAS;; CAROTID BODY TUMORS; CBT1;; GLOMUS JUGULARE TUMORS;; PARAGANGLIOMA, CAROTID BODY;; PARAGANGLIOMAS, FAMILIAL NONCHROMAFFIN, 1	PARAGANGLIOMAS WITH SENSORINEURAL HEARING LOSS, INCLUDED
NULL	168100	PARALYSIS AGITANS, JUVENILE, OF HUNT	PARKINSON DISEASE, JUVENILE, OF HUNT	
NULL	168200	PARAMOLAR TUBERCLE OF BOLK	BOLK CUSP	
Number Sign	168300	PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC	PARALYSIS PERIODICA PARAMYOTONICA	PARAMYOTONIA CONGENITA WITHOUT COLD PARALYSIS, INCLUDED
Number Sign	168400	PARASTREMMATIC DWARFISM		
Number Sign	168500	PARIETAL FORAMINA 1; PFM1	PFM;; PARIETAL FORAMINA, SYMMETRIC;; FORAMINA PARIETALIA PERMAGNA; FPP;; CATLIN MARKS;; CRANIUM BIFIDUM OCCULTUM;; CRANIUM BIFIDUM, HEREDITARY	
Number Sign	168550	PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA; PFMCCD	CLEIDOCRANIAL DYSPLASIA WITH PARIETAL FORAMINA	
Number Sign	168600	PARKINSON DISEASE, LATE-ONSET; PD	PARK	
Number Sign	168601	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT LEWY BODY	ATYPICAL PARKINSON DISEASE, INCLUDED
Number Sign	168605	PERRY SYNDROME	PARKINSONISM WITH ALVEOLAR HYPOVENTILATION AND MENTAL DEPRESSION	
NULL	168710	PAROTID PROLINE-RICH SALIVARY PROTEIN Pc		
NULL	168800	PAROTIDOMEGALY, HEREDITARY BILATERAL		
NULL	168830	PASSOVOY FACTOR DEFECT		
Percent	168860	PATELLA APLASIA-HYPOPLASIA; PTLAH		
NULL	168885	PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA		
Percent	168900	PATELLA, CHONDROMALACIA OF		
Percent	169000	PATELLA, FAMILIAL RECURRENT DISLOCATION OF		
Number Sign	169100	CHAR SYNDROME; CHAR	PATENT DUCTUS ARTERIOSUS WITH FACIAL DYSMORPHISM AND ABNORMAL FIFTH DIGITS	
Number Sign	169150	MACULAR DYSTROPHY, PATTERNED, 1; MDPT1	PATTERNED DYSTROPHY OF RETINAL PIGMENT EPITHELIUM;; MACULAR DYSTROPHY, BUTTERFLY-SHAPED PIGMENTARY;; BUTTERFLY DYSTROPHY OF RETINAL PIGMENT EPITHELIUM	
NULL	169170	PATTERSON PSEUDOLEPRECHAUNISM SYNDROME		
NULL	169200	PECHET FACTOR DEFICIENCY	DYNIA FACTOR DEFICIENCY	
NULL	169300	PECTUS EXCAVATUM	FUNNEL CHEST	
Number Sign	169400	PELGER-HUET ANOMALY; PHA		
Number Sign	169500	LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	PELIZAEUS-MERZBACHER DISEASE, AUTOSOMAL DOMINANT OR LATE-ONSET TYPE, FORMERLY	
Percent	169545	PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA		
NULL	169550	PELVIS-SHOULDER DYSPLASIA	KOSENOW SYNDROME;; SCAPULOILIAC DYSOSTOSIS	
Number Sign	169600	BENIGN CHRONIC PEMPHIGUS; BCPM	PEMPHIGUS, BENIGN FAMILIAL;; HAILEY-HAILEY DISEASE; HHD	
NULL	169610	PEMPHIGUS VULGARIS, FAMILIAL		
NULL	169710	PEPSINOGEN 3, GROUP I; PGA3	PEPSINOGEN I--SECOND LOCUS	
Number Sign	170100	PROLIDASE DEFICIENCY		
Number Sign	170390	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	ANDERSEN SYNDROME;; LONG QT SYNDROME 7; LQT7;; ANDERSEN-TAWIL SYNDROME; ATS;; PERIODIC PARALYSIS, POTASSIUM-SENSITIVE CARDIODYSRHYTHMIC TYPE	
Number Sign	170400	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1	HYPOKALEMIC PERIODIC PARALYSIS; HOKPP	
Number Sign	170500	HYPERKALEMIC PERIODIC PARALYSIS; HYPP	ADYNAMIA EPISODICA HEREDITARIA WITH OR WITHOUT MYOTONIA;; GAMSTORP DISEASE	NORMOKALEMIC PERIODIC PARALYSIS, POTASSIUM-SENSITIVE, INCLUDED
NULL	170600	NORMOKALEMIC PERIODIC PARALYSIS		
Number Sign	170650	PERIODONTITIS, AGGRESSIVE, 1	PERIODONTITIS, JUVENILE; JPD; JP;; PERIODONTITIS, PREPUBERTAL; PPP	
NULL	170700	PERIPHERAL DYSOSTOSIS		
NULL	170900	PERNICIOUS ANEMIA		
NULL	170980	PERONEAL NERVE, ACCESSORY DEEP		
NULL	170990	PEROXIDASE, SALIVARY; SAPX		
Percent	171000	PEYRONIE DISEASE		
NULL	171100	PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN		
Number Sign	171200	THIOUREA TASTING		PHENYLTHIOCARBAMIDE TASTING, INCLUDED;; PTC TASTING, INCLUDED;; PROPYLTHIOURACIL TASTING, INCLUDED;; PROP TASTING, INCLUDED
Number Sign	171300	PHEOCHROMOCYTOMA	PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO	
Number Sign	171400	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	PHEOCHROMOCYTOMA AND AMYLOID-PRODUCING MEDULLARY THYROID CARCINOMA;; PTC SYNDROME;; SIPPLE SYNDROME	THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED
NULL	171420	PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME		
NULL	171450	PHLEBECTASIA OF LIPS		
NULL	171480	PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	FACIOAURICULORADIAL DYSPLASIA	
NULL	171660	PHOSPHATASE, ACID, OF TISSUES	LYSOSOMAL ACID PHOSPHATASE;; ACP3--ALPHA POLYPEPTIDE	
Percent	171720	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1	ALPQTL1;; ALKALINE PHOSPHATASE, ELEVATED SERUM;; HYPERPHOSPHATASEMIA, BENIGN FAMILIAL	
NULL	172110	PHOSPHOGLUCOMUTASE 4	PGM4;; MILK PGM	
Percent	172150	6-PHOSPHOGLUCONOLACTONASE DEFICIENCY	PGLS DEFICIENCY;; 6PGL DEFICIENCY	
NULL	172290	PHOSPHOGLYCOPROTEIN 1; PGP1		
NULL	172500	PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRAL DYSFUNCTION	HERRMANN SYNDROME	
Number Sign	172700	PICK DISEASE OF BRAIN	LOBAR ATROPHY OF BRAIN;; DEMENTIA WITH LOBAR ATROPHY AND NEURONAL CYTOPLASMIC INCLUSIONS	
Number Sign	172800	PIEBALD TRAIT; PBT	PIEBALDISM	
NULL	172850	PIEBALD TRAIT WITH NEUROLOGIC DEFECTS		
Number Sign	172870	PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY; PPCRA		
NULL	172880	PIERRE ROBIN SYNDROME AND OLIGODACTYLY	ROBIN SEQUENCE AND OLIGODACTYLY	
Percent	172900	PIGMENTED PURPURIC ERUPTION		
NULL	173000	PILONIDAL SINUS		
Number Sign	173100	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2	IGHD II;; GROWTH HORMONE DEFICIENCY, ISOLATED, AUTOSOMAL DOMINANT;; PITUITARY DWARFISM DUE TO ISOLATED GROWTH HORMONE DEFICIENCY, AUTOSOMAL DOMINANT	
Number Sign	173200	PITYRIASIS RUBRA PILARIS; PRP		
NULL	173395	PLATELET ADENYLATE CYCLASE ACTIVITY		
NULL	173400	PLATELET AGGREGATION, SPONTANEOUS		
NULL	173420	PLATELET DISORDER, UNDEFINED		
NULL	173450	PLATELET FACTOR 3 DEFICIENCY		
Percent	173500	PLATELET GROUPS--Ko SYSTEM; HPA-2		SIB(a), INCLUDED
Percent	173540	PLATELET GROUPS--Pl(E) SYSTEM		
NULL	173560	PLATELET MEMBRANE FLUIDITY; PMF		
NULL	173580	PLATELET RESPONSIVENESS TO ADRENALINE, DEPRESSED		
NULL	173590	PLATELET SIGNAL PROCESSING DEFECT		
Number Sign	173600	PNEUMOTHORAX, PRIMARY SPONTANEOUS	PSP	
Number Sign	173650	KINDLER SYNDROME; KNDLRS	POIKILODERMA, HEREDITARY ACROKERATOTIC;; BULLOUS ACROKERATOTIC POIKILODERMA OF KINDLER AND WEARY;; POIKILODERMA, CONGENITAL, WITH BULLAE, WEARY TYPE	
NULL	173700	POIKILODERMA, HEREDITARY SCLEROSING		
Percent	173800	POLAND SYNDROME	POLAND SYNDACTYLY;; POLAND ANOMALY;; POLAND SEQUENCE	PECTORALIS MUSCLE, ABSENCE OF, INCLUDED
Number Sign	173900	POLYCYSTIC KIDNEY DISEASE 1; PKD1	POLYCYSTIC KIDNEY DISEASE, ADULT; ADPKD;; POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE I; APKD1;; POTTER TYPE III POLYCYSTIC KIDNEY DISEASE, FORMERLY	
Number Sign	174000	MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	MCKD;; MEDULLARY CYSTIC KIDNEY DISEASE, AUTOSOMAL DOMINANT; ADMCKD1;; POLYCYSTIC KIDNEYS, MEDULLARY TYPE	
Number Sign	174050	POLYCYSTIC LIVER DISEASE 1; PCLD1		
Number Sign	174200	POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1	POSTAXIAL POLYDACTYLY, TYPE A; PAPA;; POLYDACTYLY, POSTAXIAL	POSTAXIAL POLYDACTYLY, TYPE B, INCLUDED; PAPB, INCLUDED
Number Sign	174300	OROFACIODIGITAL SYNDROME V; OFD5	OFDS V;; ORAL-FACIAL-DIGITAL SYNDROME, TYPE V;; OROFACIODIGITAL SYNDROME, THURSTON TYPE;; THURSTON SYNDROME;; POLYDACTYLY, POSTAXIAL, WITH MEDIAN CLEFT OF UPPER LIP	
NULL	174310	POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	POLYDACTYLY-MYOPIA SYNDROME; PMS	
Percent	174400	POLYDACTYLY, PREAXIAL I	THUMB POLYDACTYLY	THENAR HYPOPLASIA, INCLUDED;; FROMONT ANOMALY, INCLUDED
Number Sign	174500	POLYDACTYLY, PREAXIAL II; PPD2	POLYDACTYLY OF TRIPHALANGEAL THUMB;; TRIPHALANGEAL THUMB-POLYDACTYLY SYNDROME	TRIPHALANGEAL THUMB WITH POLYSYNDACTYLY, INCLUDED;; TRIPHALANGEAL THUMB-POLYSYNDACTYLY SYNDROME, INCLUDED;; TPT-PS SYNDROME, INCLUDED;; TRIPHALANGEAL THUMB, INCLUDED; TPT, INCLUDED
Percent	174600	POLYDACTYLY, PREAXIAL III	INDEX FINGER POLYDACTYLY	
Number Sign	174700	POLYDACTYLY, PREAXIAL IV	POLYSYNDACTYLY, UNCOMPLICATED	CROSSED POLYDACTYLY, TYPE I, INCLUDED; CP1, INCLUDED
NULL	174750	POLYKARYOCYTOSIS INDUCER; FUSE		
Percent	174770	ACTINIC PRURIGO	POLYMORPHIC LIGHT ERUPTION, HEREDITARY; HPLE	JUVENILE SPRING ERUPTION OF EARS, INCLUDED
Number Sign	174800	MCCUNE-ALBRIGHT SYNDROME; MAS	ALBRIGHT SYNDROME	POLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED
Number Sign	174810	FAMILIAL EXPANSILE OSTEOLYSIS; FEO	POLYOSTOTIC OSTEOLYTIC DYSPLASIA, HEREDITARY EXPANSILE; HEPOD;; MCCABE DISEASE;; EXPANSILE OSTEOLYSIS, FAMILIAL; EOF	
Number Sign	174900	JUVENILE POLYPOSIS SYNDROME; JPS	POLYPOSIS, JUVENILE INTESTINAL; PJI;; JUVENILE INTESTINAL POLYPOSIS; JIP;; POLYPOSIS, FAMILIAL, OF ENTIRE GASTROINTESTINAL TRACT	JUVENILE POLYPOSIS OF STOMACH, INCLUDED;; JUVENILE POLYPOSIS COLI, INCLUDED
Percent	175020	POLYPOSIS, GASTRIC		
Number Sign	175050	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	JP/HHT SYNDROME;; JUVENILE POLYPOSIS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA;; JPS/HHT;; TELANGIECTASIA, HEREDITARY HEMORRHAGIC, WITH JUVENILE POLYPOSIS COLI;; POLYPOSIS, GENERALIZED JUVENILE, WITH PULMONARY ARTERIOVENOUS MALFORMATION	
Number Sign	175100	FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	ADENOMATOUS POLYPOSIS OF THE COLON; APC;; FAMILIAL POLYPOSIS OF THE COLON; FPC;; POLYPOSIS, ADENOMATOUS INTESTINAL	GARDNER SYNDROME, INCLUDED; GS, INCLUDED;; BRAIN TUMOR-POLYPOSIS SYNDROME 2, INCLUDED; BTPS2, INCLUDED;; FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED, INCLUDED; AFAP, INCLUDED;; ADENOMATOUS POLYPOSIS COLI, ATTENUATED, INCLUDED; AAPC, INCLUDED
Number Sign	175200	PEUTZ-JEGHERS SYNDROME; PJS	POLYPOSIS, HAMARTOMATOUS INTESTINAL;; POLYPS-AND-SPOTS SYNDROME	
NULL	175400	POLYPOSIS, INTESTINAL, SCATTERED AND DISCRETE	POLYPS, SCATTERED, DISCRETE INTESTINAL	
NULL	175450	POLYPOSIS, INTESTINAL, WITH MULTIPLE EXOSTOSES		
NULL	175500	POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES	CRONKHITE-CANADA SYNDROME	
NULL	175505	POLYPOSIS OF GASTRIC FUNDUS WITHOUT POLYPOSIS COLI	FUNDIC GLAND POLYPOSIS	
NULL	175510	POLYPS, MULTIPLE AND RECURRENT INFLAMMATORY FIBROID, GASTROINTESTINAL		
Percent	175690	POLYSYNDACTYLY, CROSSED		
Number Sign	175700	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS	POLYSYNDACTYLY WITH PECULIAR SKULL SHAPE	
NULL	175750	POPLITEAL CYST	BAKER CYST	
Number Sign	175780	PORENCEPHALY 1; POREN1	HEMIPLEGIA, INFANTILE, WITH PORENCEPHALY PORENCEPHALY, TYPE 1; T1P;; PORENCEPHALY, TYPE 1, AUTOSOMAL DOMINANT; ADT1P	
Number Sign	175800	POROKERATOSIS 1, MULTIPLE TYPES; POROK1	POROKERATOSIS OF MIBELLI	
Percent	175850	POROKERATOSIS 2, PALMAR, PLANTAR, AND DISSEMINATED TYPE; POROK2	POROKERATOSIS, PALMAR, PLANTAR, AND DISSEMINATED; PPPD;; POROKERATOSIS, PALMAR, PLANTAR, AND DISSEMINATED, 1; PPPD1;; POROKERATOSIS PLANTARIS PALMARIS ET DISSEMINATA;; POROKERATOSIS PALMARIS ET PLANTARIS DISSEMINATA	
Percent	175860	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE II; PPKP2	POROKERATOSIS PUNCTATA PALMARIS ET PLANTARIS; PPPP	
Number Sign	175900	POROKERATOSIS 3, MULTIPLE TYPES; POROK3	POROKERATOSIS, DISSEMINATED SUPERFICIAL ACTINIC, 1; DSAP1	
Number Sign	176000	PORPHYRIA, ACUTE INTERMITTENT; AIP	PORPHYRIA, SWEDISH TYPE;; PORPHOBILINOGEN DEAMINASE DEFICIENCY;; PBGD DEFICIENCY;; UROPORPHYRINOGEN SYNTHASE DEFICIENCY;; UPS DEFICIENCY	PORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;; PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED
NULL	176090	PORPHYRIA CUTANEA TARDA, TYPE I	PCT, TYPE I;; PCT, 'SPORADIC' TYPE	
Number Sign	176100	PORPHYRIA CUTANEA TARDA	PCT;; PORPHYRIA CUTANEA TARDA, TYPE II;; PCT, TYPE II;; PCT, 'FAMILIAL' TYPE;; PORPHYRIA, HEPATOCUTANEOUS TYPE;; UROPORPHYRINOGEN DECARBOXYLASE DEFICIENCY;; UROD DEFICIENCY	PORPHYRIA, HEPATOERYTHROPOIETIC, INCLUDED; HEP, INCLUDED
Number Sign	176200	PORPHYRIA VARIEGATA	VARIEGATE PORPHYRIA; VP;; PORPHYRIA, SOUTH AFRICAN TYPE;; PROTOPORPHYRINOGEN OXIDASE DEFICIENCY;; PPOX DEFICIENCY	VARIEGATE PORPHYRIA, HOMOZYGOUS VARIANT, INCLUDED
NULL	176240	POSTAXIAL OLIGODACTYLY, TETRAMELIC		
NULL	176250	POSTERIOR COLUMN ATAXIA	BIEMOND ATAXIA	
Number Sign	176270	PRADER-WILLI SYNDROME; PWS	PRADER-LABHART-WILLI SYNDROME	PRADER-WILLI SYNDROME CHROMOSOME REGION, INCLUDED; PWCR, INCLUDED;; PRADER-WILLI-LIKE SYNDROME ASSOCIATED WITH CHROMOSOME 6, INCLUDED
Number Sign	176305	PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	GUTTMACHER SYNDROME	
Number Sign	176400	PRECOCIOUS PUBERTY, CENTRAL, 1; CPPB1		
Number Sign	176410	PRECOCIOUS PUBERTY, MALE-LIMITED	SEXUAL PRECOCITY, FAMILIAL, GONADOTROPIN-INDEPENDENT;; TESTOTOXICOSIS, FAMILIAL	LEYDIG CELL ADENOMA, SOMATIC, WITH MALE-LIMITED PRECOCIOUS PUBERTY, INCLUDED
Number Sign	176430	PREMATURE CHROMATID SEPARATION TRAIT; PCS	TOTAL PREMATURE CHROMATID SEPARATION TRAIT	
Number Sign	176450	CURRARINO SYNDROME	CURRARINO TRIAD	SACRAL AGENESIS SYNDROME, INCLUDED;; SACRAL AGENESIS, HEREDITARY, WITH PRESACRAL MASS, ANTERIOR MENINGOCELE, AND/OR TERATOMA, AND ANORECTAL MALFORMATION, INCLUDED;; SCRA1, INCLUDED
Number Sign	176500	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1	DEMENTIA, FAMILIAL BRITISH; FBD;; PRESENILE DEMENTIA WITH SPASTIC ATAXIA;; CEREBRAL AMYLOID ANGIOPATHY, BRITISH TYPE	
NULL	176600	PRESENILE DEMENTIA, KRAEPELIN TYPE		
NULL	176620	PRIAPISM, FAMILIAL IDIOPATHIC		
NULL	176630	PRIMARY RELEASE DISORDER OF PLATELETS		
Number Sign	176670	HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS	PROGERIA	PROGERIA SYNDROME, CHILDHOOD-ONSET, INCLUDED
Percent	176690	PROGEROID SHORT STATURE WITH PIGMENTED NEVI	MULVIHILL-SMITH SYNDROME	
Percent	176700	PROGNATHISM, MANDIBULAR	'HABSBURG JAW';; 'HAPSBURG JAW'	
NULL	176770	PROLINE-NEGATIVE AUXOTROPH OF HAMSTER, COMPLEMENTATION OF; PROA		
Percent	176780	PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO	PROLAPSE OF VAGINA AND RECTUM;; RECTAL PROLAPSE;; VAGINAL PROLAPSE	PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO, 1, INCLUDED; PVOP1, INCLUDED
NULL	176800	PRONATION-SUPINATION OF THE FOREARM, IMPAIRMENT OF		
Number Sign	176807	PROSTATE CANCER		
Number Sign	176860	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT; THPH3	PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT;; PROC DEFICIENCY, AUTOSOMAL DOMINANT	PROTEIN C DEFICIENCY, ACQUIRED, INCLUDED
NULL	176900	PROTEOLYTIC CAPACITY OF PLASMA		
Number Sign	176920	PROTEUS SYNDROME	GIGANTISM, PARTIAL, OF HANDS AND FEET, NEVI, HEMIHYPERTROPHY, AND MACROCEPHALY	ELATTOPROTEUS SYNDROME, INCLUDED
Number Sign	177000	PROTOPORPHYRIA, ERYTHROPOIETIC; EPP	ERYTHROHEPATIC PROTOPORPHYRIA;; HEME SYNTHETASE DEFICIENCY;; FERROCHELATASE DEFICIENCY	
Percent	177050	PROTRUSIO ACETABULI		
NULL	177100	PRURITUS, HEREDITARY LOCALIZED		
Number Sign	177170	PSEUDOACHONDROPLASIA; PSACH	PSEUDOACHONDROPLASTIC DYSPLASIA;; SPONDYLOEPIPHYSEAL DYSPLASIA, PSEUDOACHONDROPLASTIC	
Number Sign	177200	LIDDLE SYNDROME; LIDLS	PSEUDOALDOSTERONISM	
NULL	177300	PSEUDOARTHROGRYPOSIS	HEREDITARY CONGENITAL RIGIDITY OF ELBOWS AND KNEES;; ANKYLOSIS AT ELBOW AND KNEE	
NULL	177350	PSEUDOATROPHODERMA COLLI		
NULL	177600	PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF		
Number Sign	177650	EXFOLIATION SYNDROME; XFS	EXFOLIATION GLAUCOMA; XFG;; PSEUDOEXFOLIATION GLAUCOMA; PEXG;; PSEUDOEXFOLIATION OF THE LENS;; PSEUDOEXFOLIATION SYNDROME; PEXS	
Number Sign	177700	GLAUCOMA 1, OPEN ANGLE, P; GLC1P		
Number Sign	177735	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A	PHA I, AUTOSOMAL DOMINANT	
Percent	177750	PSEUDOMONILETHRIX		
NULL	177800	PSEUDOPAPILLEDEMA		
Number Sign	177820	PSEUDO-VON WILLEBRAND DISEASE; VWDP	BLEEDING DISORDER, PLATELET-TYPE, 3; BDPLT3;; VON WILLEBRAND DISEASE, PLATELET-TYPE	
Number Sign	177850	PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE		PSEUDOXANTHOMA ELASTICUM, HETEROZYGOUS, INCLUDED
Number Sign	177900	PSORIASIS 1, SUSCEPTIBILITY TO; PSORS1		
Number Sign	177980	PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES	HASPESLAGH SYNDROME	
NULL	177990	PTERYGIUM COLLI, ISOLATED		
NULL	178000	PTERYGIUM OF CONJUNCTIVA AND CORNEA		
Number Sign	178110	ARTHROGRYPOSIS, DISTAL, TYPE 8; DA8	MULTIPLE PTERYGIUM SYNDROME, AUTOSOMAL DOMINANT;; PTERYGIUM SYNDROME, MULTIPLE, AUTOSOMAL DOMINANT	
Percent	178200	PTERYGIUM, ANTECUBITAL		
Percent	178300	PTOSIS, HEREDITARY CONGENITAL 1; PTOS1		
NULL	178330	PTOSIS, STRABISMUS, AND ECTOPIC PUPILS		
Percent	178350	PUBIC BONE DYSPLASIA		
NULL	178370	PULMONARY ATRESIA WITH VENTRICULAR SEPTAL DEFECT		
NULL	178400	PULMONARY EDEMA OF MOUNTAINEERS, SUSCEPTIBILITY TO	HIGH ALTITUDE PULMONARY HYPERTENSION; HAPH	
Number Sign	178500	PULMONARY FIBROSIS, IDIOPATHIC; IPF	IDIOPATHIC PULMONARY FIBROSIS, FAMILIAL;; FIBROSING ALVEOLITIS, CRYPTOGENIC;; FIBROCYSTIC PULMONARY DYSPLASIA;; INTERSTITIAL PNEUMONITIS, USUAL; UIP	HAMMAN-RICH DISEASE, INCLUDED
NULL	178550	PULMONARY HEMOSIDEROSIS		
Number Sign	178600	PULMONARY HYPERTENSION, PRIMARY, 1; PPH1	PHT;; PULMONARY ARTERIAL HYPERTENSION; PAH	PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED, INCLUDED;; PULMONARY HYPERTENSION, PRIMARY, FENFLURAMINE-ASSOCIATED, INCLUDED;; PULMONARY HYPERTENSION, PRIMARY, 1, WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA, INCLUDED;; PPH1 WITH HHT, INCLUDED
NULL	178610	PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL		
NULL	178650	PULMONIC STENOSIS, ATRIAL SEPTAL DEFECT, AND UNIQUE ELECTROCARDIOGRAPHIC ABNORMALITIES	CIUFFO SYNDROME	
NULL	178651	PULMONIC STENOSIS AND DEAFNESS		
NULL	178800	PUPIL, EGG-SHAPED		
NULL	178900	PUPILLARY MEMBRANE, PERSISTENCE OF		
NULL	178995	PRURITIC URTICARIAL PAPULES AND PLAQUES OF PREGNANCY; PUPPP	POLYMORPHIC ERUPTION OF PREGNANCY	
NULL	179000	PURPURA SIMPLEX		
Percent	179010	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 1; IHPS1	PYLORIC STENOSIS, INFANTILE;; PYLORIC STENOSIS, INFANTILE HYPERTROPHIC; IHPS	
Percent	179200	RADIAL HEADS, POSTERIOR DISLOCATION OF		
NULL	179250	RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARY DIASTEMA		
NULL	179270	RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA		
NULL	179280	RADIAL-RENAL SYNDROME		
NULL	179300	RADIOULNAR SYNOSTOSIS		
NULL	179400	RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE		
NULL	179450	RAGWEED SENSITIVITY		
NULL	179500	RAINDROP HYPOPIGMENTATION		
Percent	179600	RAYNAUD DISEASE	COLD FINGERS, HEREDITARY	
Number Sign	179613	RECOMBINANT CHROMOSOME 8 SYNDROME	REC8 SYNDROME;; CHROMOSOME 8q22.1-qter DUPLICATION AND 8pter-p23.1 DELETION;; SAN LUIS VALLEY SYNDROME	
Number Sign	179620	RAPH BLOOD GROUP SYSTEM	MER2 BLOOD CELL ANTIGEN EXPRESSION; MER2	
Percent	179650	RED CELL PERMEABILITY DEFECT	ELLIPTOCYTOSIS WITH TRANSVERSE SLITLIKE CHANGES	
Percent	179700	RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	HIGH RED CELL PHOSPHATIDYLCHOLINE HEMOLYTIC ANEMIA; HPCHA;; PHOSPHATIDYLCHOLINE RED CELL MEMBRANE DISORDER;; LEAKY RED CELL SYNDROME	
Number Sign	179800	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	RTA, DISTAL TYPE, AUTOSOMAL DOMINANT;; RENAL TUBULAR ACIDOSIS I;; RTA, CLASSIC TYPE;; RTA, GRADIENT TYPE	
NULL	179830	RENAL TUBULAR ACIDOSIS, PROXIMAL	RENAL TUBULAR ACIDOSIS II;; RTA, PROXIMAL TYPE;; RTA, RATE TYPE	
NULL	179840	RETICULAR DYSTROPHY OF RETINAL PIGMENT EPITHELIUM		
Number Sign	179850	DOWLING-DEGOS DISEASE 1; DDD1	DDD;; RETICULAR PIGMENT ANOMALY OF FLEXURES	
Percent	179900	RETINAL APLASIA	AMAUROSIS CONGENITA	
Number Sign	180000	RETINAL ARTERIES, TORTUOSITY OF; RATOR	RETINAL HEMORRHAGE WITH VASCULAR TORTUOSITY	
Percent	180020	RETINAL CONE DYSTROPHY 1; RCD1	RETINAL CONE DEGENERATION;; CONE DYSTROPHY, AUTOSOMAL DOMINANT	
Percent	180050	RETINAL DETACHMENT		
NULL	180080	RETINAL VENOUS BEADING		
Number Sign	180100	RETINITIS PIGMENTOSA 1; RP1		
Number Sign	180104	RETINITIS PIGMENTOSA 9; RP9		
Number Sign	180105	RETINITIS PIGMENTOSA 10; RP10		
Number Sign	180200	RETINOBLASTOMA; RB1	RB	
NULL	180210	RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT		
NULL	180270	RETINOSCHISIS, AUTOSOMAL DOMINANT		
Number Sign	180295	RHABDOMYOSARCOMA, EMBRYONAL, 2; RMSE2		
Number Sign	180300	RHEUMATOID ARTHRITIS; RA	RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO	
NULL	180350	RHEUMATOID NODULOSIS		
NULL	180360	RHINY		
Number Sign	180500	AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	RIEGER SYNDROME, TYPE 1;; RIEG;; RGS	
Number Sign	180550	RING DERMOID OF CORNEA; RDC		
Percent	180600	RINGED HAIR	PILI ANNULATI	
Number Sign	180700	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1; DRS1	ROBINOW DWARFISM;; FETAL FACE SYNDROME;; ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	
NULL	180730	ROMBO SYNDROME		
Number Sign	180750	ROBINOW-SORAUF SYNDROME	CRANIOSYNOSTOSIS-BIFID HALLUX SYNDROME;; ACROCEPHALOSYNDACTYLY, ROBINOW-SORAUF TYPE	
Number Sign	180800	ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	ROUSSY-LEVY SYNDROME	
Number Sign	180849	RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	RUBINSTEIN SYNDROME;; BROAD THUMBS AND GREAT TOES, CHARACTERISTIC FACIES, AND MENTAL RETARDATION;; BROAD THUMB-HALLUX SYNDROME	
Number Sign	180860	SILVER-RUSSELL SYNDROME; SRS	RUSSELL-SILVER SYNDROME; RSS;; SILVER-RUSSELL DWARFISM	
NULL	180870	RUVALCABA SYNDROME		
Percent	180900	RUTHERFURD SYNDROME	CORNEAL DYSTROPHY WITH GUM HYPERTROPHY;; GINGIVAL HYPERTROPHY WITH CORNEAL DYSTROPHY	
Number Sign	180920	APLASIA OF LACRIMAL AND SALIVARY GLANDS; ALSG		SALIVARY GLANDS, ABSENCE OF, INCLUDED;; PAROTID APLASIA OR HYPOPLASIA, INCLUDED
Percent	180950	SALIVARY SUBSTANCE, CLOSTRIDIUM BOTULINUM TYPE		
Number Sign	181000	SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	SARCOIDOSIS;; BOECK SARCOID	
NULL	181010	SALIVARY DUCT CALCULI	PAROTID DUCT CALCULI;; SUBMANDIBULAR DUCT CALCULI	
Number Sign	181030	SALIVARY GLAND ADENOMA, PLEOMORPHIC	SGPA;; PSA	
NULL	181180	SAY SYNDROME	CLEFT PALATE, MICROCEPHALY, LARGE EARS, AND SHORT STATURE	
NULL	181200	SC(1) TRAIT OF SALIVA		
NULL	181250	SCALP DEFECTS AND POSTAXIAL POLYDACTYLY		
Number Sign	181270	SCALP-EAR-NIPPLE SYNDROME; SENS	FINLAY-MARKS SYNDROME;; SEN SYNDROME	
NULL	181300	SCAPULA, CONTOUR OF VERTEBRAL BORDER OF		
Number Sign	181350	EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2	EMD2;; EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT;; SCAPULOILIOPERONEAL ATROPHY WITH CARDIOPATHY;; MUSCULAR DYSTROPHY WITH EARLY CONTRACTURES AND CARDIOMYOPATHY, AUTOSOMAL DOMINANT;; HAUPTMANN-THANNHAUSER MUSCULAR DYSTROPHY	
Number Sign	181400	SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; SCPNK	KAESER SYNDROME;; STARK-KAESER SYNDROME;; SCAPULOPERONEAL SYNDROME, NEUROGENIC TYPE, OF KAESER	
Number Sign	181405	SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	AMYOTROPHY, NEUROGENIC SCAPULOPERONEAL, NEW ENGLAND TYPE	
Number Sign	181430	SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM	SCAPULOPERONEAL MUSCULAR DYSTROPHY; SPMD;; SCAPULOPERONEAL SYNDROME, MYOPATHIC TYPE	
Percent	181440	SCHEUERMANN DISEASE	SCHEUERMANN JUVENILE KYPHOSIS;; SPINAL OSTEOCHONDROSIS	
Number Sign	181450	ULNAR-MAMMARY SYNDROME; UMS	PALLISTER ULNAR-MAMMARY SYNDROME;; SCHINZEL SYNDROME	
Percent	181460	SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	SCHISTOSOMA MANSONI, INTENSITY OF INFECTION BY; SM1	
Number Sign	181500	SCHIZOPHRENIA; SCZD	SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER	
Percent	181510	SCHIZOPHRENIA 1; SCZD1	SCHIZOPHRENIA 1 WITH OR WITHOUT AN AFFECTIVE DISORDER;; SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 5-RELATED	
Percent	181600	SCLEROTYLOSIS	TYS;; SCLEROATROPHIC AND KERATOTIC DERMATOSIS OF LIMBS;; HURIEZ SYNDROME; HRZ	
NULL	181700	SCLEROCORNEA, AUTOSOMAL DOMINANT		
Percent	181750	SCLERODERMA, FAMILIAL PROGRESSIVE	SYSTEMIC SCLEROSIS, SUSCEPTIBILITY TO	CREST SYNDROME, INCLUDED
Percent	181800	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 1; IS1	ADOLESCENT ISOLATED SCOLIOSIS; AIS;; ADOLESCENT IDIOPATHIC SCOLIOSIS	
Number Sign	182000	KERATOSIS, SEBORRHEIC		
NULL	182150	SIMOSA CRANIOFACIAL SYNDROME		
Number Sign	182170	ANEMIA, SIDEROBLASTIC, 4; SIDBA4		
NULL	182190	SINUS NODE DISEASE AND MYOPIA	SICK SINUS SYNDROME AND MYOPIA;; SSS-MYOPIA SYNDROME	
NULL	182200	SELLA TURCICA, BRIDGED		
NULL	182210	SHPRINTZEN OMPHALOCELE SYNDROME	OMPHALOCELE WITH HYPOPLASIA OF PHARYNX AND LARYNX, LEARNING DISABILITY, DYSMORPHIC FACIES, AND SCOLIOSIS;; PHARYNX AND LARYNX HYPOPLASIA WITH OMPHALOCELE	
Number Sign	182212	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	CRANIOSYNOSTOSIS WITH ARACHNODACTYLY AND ABDOMINAL HERNIAS;; MARFANOID DISORDER WITH CRANIOSYNOSTOSIS, TYPE I;; MARFANOID CRANIOSYNOSTOSIS SYNDROME	
NULL	182220	SISTER CHROMATID EXCHANGE, FREQUENCY OF	SCE, FREQUENCY OF	
Number Sign	182230	SEPTOOPTIC DYSPLASIA	DE MORSIER SYNDROME	PITUITARY HORMONE DEFICIENCY, COMBINED, 5, INCLUDED; CPHD5, INCLUDED;; GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES, INCLUDED
Number Sign	182250	SINGLETON-MERTEN SYNDROME 1; SGMRT1		
NULL	182255	SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION		
NULL	182260	SLIPPED FEMORAL CAPITAL EPIPHYSES	EPIPHYSIOLYSIS CAPITIS FEMORIS	
NULL	182269	SMALL PROLINE-RICH PROTEIN 2C, PSEUDOGENE; SPRR2C		
NULL	182270	KETONE COMPOUNDS, ABILITY TO SMELL		
Percent	182280	SMALL CELL CANCER OF THE LUNG	SCLC1;; SCLC; SCCL	
Number Sign	182290	SMITH-MAGENIS SYNDROME; SMS	CHROMOSOME 17p11.2 DELETION SYNDROME	SMITH-MAGENIS SYNDROME CHROMOSOME REGION, INCLUDED; SMCR, INCLUDED
NULL	182400	SOMATOMEDIN, EMBRYONIC		
Number Sign	182410	SNEDDON SYNDROME	LIVEDO RETICULARIS AND CEREBROVASCULAR ACCIDENTS	
Number Sign	182600	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A	SPG3;; STRUMPELL DISEASE;; FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	
Number Sign	182601	SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4	FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 2; FSP2	
NULL	182610	SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR		
NULL	182690	SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND PROGRESSIVE NEPHROPATHY		
NULL	182800	SPASTIC PARAPLEGIA WITH ASSOCIATED EXTRAPYRAMIDAL SIGNS		
NULL	182815	SPASTIC PARAPLEGIA WITH NEUROPATHY AND POIKILODERMA		
NULL	182820	SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	PRECOCIOUS PUBERTY WITH SPASTIC PARAPLEGIA	
NULL	182830	SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA		
NULL	182875	SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, AND TRANSVERSE EARLOBE CREASE		
NULL	182882	SPERM PROTAMINE P4; PRM4		
Number Sign	182900	SPHEROCYTOSIS, TYPE 1; SPH1	SPHEROCYTOSIS, HEREDITARY, 1; HS1;; SPH; HS	
Number Sign	182920	MYOPATHY, SPHEROID BODY		
Number Sign	182940	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD		SPINA BIFIDA, INCLUDED
Percent	182950	SPINAL ARACHNOIDITIS		
Percent	182960	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE I; HMN1	HMN I;; NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE I; DHMN1;; SPINAL MUSCULAR ATROPHY, DISTAL, JUVENILE, AUTOSOMAL DOMINANT, I;; CHARCOT-MARIE-TOOTH DISEASE, SPINAL, I	
Percent	182970	SPINAL MUSCULAR ATROPHY, FACIOSCAPULOHUMERAL TYPE	FSHSMA	
Number Sign	182980	SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE; SMAFK	FINKEL LATE-ADULT TYPE SMA;; SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANT	
NULL	182990	SPINAL INTRADURAL ARACHNOID CYSTS		
NULL	183020	SPINAL MUSCULAR ATROPHY, SEGMENTAL		
Percent	183050	SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY		
Number Sign	183086	SPINOCEREBELLAR ATAXIA 6; SCA6		
Number Sign	183090	SPINOCEREBELLAR ATAXIA 2; SCA2	SPINOCEREBELLAR ATROPHY II;; OLIVOPONTOCEREBELLAR ATROPHY, HOLGUIN TYPE;; OLIVOPONTOCEREBELLAR ATROPHY II; OPCA2;; SPINOCEREBELLAR ATAXIA, CUBAN TYPE;; CEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS;; WADIA-SWAMI SYNDROME;; SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 13, INCLUDED; ALS13, INCLUDED
NULL	183100	SPINOCEREBELLAR ATROPHY WITH PUPILLARY PARALYSIS		
NULL	183300	SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	SPLENOGONADAL FUSION LIMB DEFECT SYNDROME;; SGFLD SYNDROME	
NULL	183350	SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA AND REDUCED CIRCULATING T HELPER CELLS		
NULL	183400	SPLIT LOWER LIP		
NULL	183500	SPLIT-HAND AND SPLIT-FOOT WITH HYPODONTIA		
Number Sign	183600	SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	SPLIT-HAND/FOOT MALFORMATION 1 WITH OR WITHOUT DEAFNESS;; SPLIT-HAND/FOOT DEFORMITY 1; SHFD1; SHSF1;; SPLIT-HAND DEFORMITY;; ECTRODACTYLY; ECD	
NULL	183700	SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	PATTERSON-STEVENSON-FONTAINE SYNDROME	
NULL	183800	SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS	NYSTAGMUS-SPLIT HAND SYNDROME;; KARSCH-NEUGEBAUER SYNDROME; KNS	
NULL	183802	SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATIC DEFECTS		
Percent	183840	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2; SPDA2		
NULL	183849	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS	WHYTE SYNDROME	
NULL	183850	SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY		
Number Sign	183900	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; SEDC	SED CONGENITA;; SPONDYLOEPIPHYSEAL DYSPLASIA, CONGENITAL TYPE	
NULL	184000	SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS		
Number Sign	184095	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE	SED, MAROTEAUX TYPE;; PSEUDO-MORQUIO SYNDROME, TYPE 2	
Percent	184100	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT		
Percent	184200	SPONDYLOLISTHESIS		
Number Sign	184250	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK	SEMD, STRUDWICK TYPE;; SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;; SMED, STRUDWICK TYPE;; SMED, TYPE I;; STRUDWICK SYNDROME;; DAPPLED METAPHYSIS SYNDROME;; SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;; SEMDC	
Number Sign	184252	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK	SMD, KOZLOWSKI TYPE	
NULL	184253	SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE;; SPONDYLOMETAPHYSEAL DYSPLASIA WITH SEVERE GENU VALGUM	
Percent	184255	SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE	SPONDYLOMETAPHYSEAL DYSPLASIA, SUTCLIFFE TYPE	
NULL	184260	SPONDYLOMETAPHYSEAL DYSPLASIA WITH DENTINOGENESIS IMPERFECTA	GOLDBLATT SYNDROME;; ODONTOCHONDRODYSPLASIA; ODCD	
NULL	184300	SPONDYLOSIS, CERVICAL		
Percent	184400	SPRENGEL DEFORMITY	HIGH SCAPULA	
Number Sign	184450	STUTTERING, FAMILIAL PERSISTENT, 1; STUT1	STAMMERING	
Number Sign	184460	STAPES ANKYLOSIS WITH BROAD THUMB AND TOES	ANKYLOSIS OF STAPES, HYPEROPIA, BROAD THUMBS, BROAD FIRST TOES, AND SYNDACTYLY;; TEUNISSEN-CREMERS SYNDROME;; STAPES ANKYLOSIS SYNDROME WITHOUT SYMPHALANGISM	
Number Sign	184500	STEATOCYSTOMA MULTIPLEX	SEBACEOUS CYSTS, MULTIPLE	
NULL	184510	STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH		
Percent	184700	POLYCYSTIC OVARY SYNDROME 1; PCOS1	PCO1; PCO;; PCOS;; STEIN-LEVENTHAL SYNDROME;; HYPERANDROGENEMIA	
NULL	184705	STEINFELD SYNDROME		
NULL	184800	STERNUM, PREMATURE OBLITERATION OF SUTURES OF		
Number Sign	184840	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; OSMEDA	OSMED, HETEROZYGOUS;; WEISSENBACHER-ZWEYMULLER SYNDROME; WZS;; PIERRE ROBIN SYNDROME WITH FETAL CHONDRODYSPLASIA STICKLER SYNDROME, NONOCULAR TYPE, FORMERLY;; STICKLER SYNDROME, TYPE III, FORMERLY; STL3, FORMERLY	
Percent	184850	STIFF-PERSON SYNDROME; SPS	STIFF-MAN SYNDROME;; STIFF-TRUNK SYNDROME	PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY, INCLUDED; PERM, INCLUDED; PER, INCLUDED
Number Sign	184900	STIFF SKIN SYNDROME; SSKS		
Number Sign	185000	OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHST	OHS;; POTASSIUM-SODIUM DISORDER OF ERYTHROCYTE	
Number Sign	185020	CRYOHYDROCYTOSIS; CHC	STOMATOCYTOSIS, COLD-SENSITIVE	
Percent	185050	STORAGE POOL PLATELET DISEASE		
NULL	185069	STORM SYNDROME		
Number Sign	185070	STORMORKEN SYNDROME; STRMK	THROMBOCYTOPATHY, ASPLENIA, AND MIOSIS;; YORK PLATELET SYNDROME; YPS	
Percent	185100	STRABISMUS, SUSCEPTIBILITY TO		STRABISMUS, SUSCEPTIBILITY TO, 1, INCLUDED; STBMS1, INCLUDED
NULL	185120	STRATTON-PARKER SYNDROME	GROWTH HORMONE DEFICIENCY WITH WORMIAN BONES, CARDIAC ANOMALY, AND BRACHYCAMPTODACTYLY	
Percent	185200	STRIAE DISTENSAE, FAMILIAL		
Number Sign	185300	STURGE-WEBER SYNDROME; SWS		
NULL	185460	SULFHEMOGLOBINEMIA, CONGENITAL		
NULL	185480	SUPRABULBAR PARESIS, CONGENITAL	WORSTER-DROUGHT SYNDROME	
Number Sign	185500	SUPRAVALVULAR AORTIC STENOSIS; SVAS	SUPRAVALVAR AORTIC STENOSIS, EISENBERG TYPE	
NULL	185540	SURFACE ANTIGEN, GLYCOPROTEIN 75	SURFACE GLYCOPROTEIN 75; SGP75	
NULL	185600	SYMPHALANGISM OF TOES		
NULL	185610	SURFACE POLYPEPTIDES, ANONYMOUS	SPA2;; SPA5	
NULL	185650	SYMPHALANGISM, C. S. LEWIS TYPE	THUMBS, STIFF	
Percent	185700	SYMPHALANGISM, DISTAL	SYM2	
NULL	185750	SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET		
Number Sign	185800	SYMPHALANGISM, PROXIMAL, 1A; SYM1A	SYM1;; CUSHING SYMPHALANGISM;; HEREDITARY ABSENCE OF THE PROXIMAL INTERPHALANGEAL JOINTS	
Number Sign	185900	CHROMOSOME 2q35 DUPLICATION SYNDROME	SYNDACTYLY, TYPE I; SDTY1;; SD1;; ZYGODACTYLY	CRANIOSYNOSTOSIS, PHILADELPHIA TYPE, INCLUDED
Number Sign	186000	SYNPOLYDACTYLY 1; SPD1	SYNDACTYLY, TYPE II; SDTY2	
Number Sign	186100	SYNDACTYLY, TYPE III	SDTY3;; RING AND LITTLE FINGER SYNDACTYLY;; SYNDACTYLY OF FINGERS IV AND V	
Number Sign	186200	SYNDACTYLY, TYPE IV; SDTY4	HAAS TYPE SYNDACTYLY;; POLYSYNDACTYLY, HAAS TYPE;; SD4	
Number Sign	186300	SYNDACTYLY, TYPE V; SDTY5	SYNDACTYLY WITH METACARPAL AND METATARSAL FUSION	
Percent	186350	SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME	SPEL SYNDROME	
Percent	186400	SYNOSTOSES, TARSAL, CARPAL, AND DIGITAL	CALCANEONAVICULAR COALITION	
Number Sign	186500	MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1	SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;; SYMPHALANGISM-BRACHYDACTYLY SYNDROME;; WL SYNDROME;; DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;; FACIOAUDIOSYMPHALANGISM SYNDROME	
Number Sign	186550	LIEBENBERG SYNDROME; LBNBG	SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY;; BRACHYDACTYLY WITH JOINT DYSPLASIA	
Number Sign	186570	TARSAL-CARPAL COALITION SYNDROME; TCC		SYNOSTOSIS OF TALUS AND CALCANEUS WITH SHORT STATURE, INCLUDED
NULL	186575	SYNOVIAL CHONDROMATOSIS, FAMILIAL, WITH DWARFISM		
Number Sign	186580	BLAU SYNDROME; BLAUS	SARCOIDOSIS, EARLY-ONSET; EOS;; GRANULOMATOSIS, FAMILIAL JUVENILE SYSTEMIC;; ARTHROCUTANEOUVEAL GRANULOMATOSIS; ACUG;; JABS SYNDROME;; GRANULOMATOUS INFLAMMATORY ARTHRITIS, DERMATITIS, AND UVEITIS, FAMILIAL;; GRANULOMATOSIS, FAMILIAL, BLAU TYPE	
NULL	186600	SYRINGOMAS, MULTIPLE		
Percent	186700	SYRINGOMYELIA, NONCOMMUNICATING ISOLATED		
NULL	186750	TALONAVICULAR COALITION		
Percent	186850	TARSAL COALITION	TARSAL FUSION	
Percent	186890	TEAR PROTEIN, ANODAL		
NULL	186950	T-CELL SUBGROUPS, NON-HLA-LINKED		
Percent	187000	TEETH, ODD SHAPES OF		LOBODONTIA, INCLUDED;; CONICAL TEETH, MULTIPLE, INCLUDED
NULL	187030	T-COMPLEX LOCUS TCP10B; TCP10B		
NULL	187050	TEETH PRESENT AT BIRTH	NATAL TEETH	
NULL	187100	TEETH, SUPERNUMERARY		
Percent	187260	TELANGIECTASIA, HEREDITARY BENIGN	HBT;; TELANGIECTASIA, GENERALIZED ESSENTIAL	
NULL	187290	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, H142; H142T		
Number Sign	187300	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER; HHT	OSLER-RENDU-WEBER DISEASE;; ORW DISEASE	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED
NULL	187310	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, K12	ts COMPLEMENTING, K12; K12T	
NULL	187320	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, ts13; TS13		
NULL	187330	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, ts546; TS546		
NULL	187340	TEMPERATURE-SENSITIVE LETHAL MUTATION		
NULL	187350	TELECANTHUS		
NULL	187360	TEMPORAL ARTERITIS	GIANT CELL ARTERITIS; GCA;; CRANIAL ARTERITIS;; POLYMYALGIA RHEUMATICA	
Percent	187370	ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10	CONGENITAL PLANTAR CONTRACTURES;; TENDO CALCANEUS, SHORT	
NULL	187390	TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF		
NULL	187400	TESTICULAR TORSION	TORSION OF TESTICULAR CORD	
Number Sign	187500	TETRALOGY OF FALLOT; TOF		
NULL	187501	TETRALOGY OF FALLOT AND GLAUCOMA		
NULL	187510	TETRAMELIC MONODACTYLY		
NULL	187550	THALASSEMIA, BETA+, SILENT ALLELE		
Number Sign	187600	THANATOPHORIC DYSPLASIA, TYPE I; TD1	THANATOPHORIC DYSPLASIA; TD;; THANATOPHORIC DWARFISM;; PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, SAN DIEGO TYPE;; LETHAL SHORT-LIMBED PLATYSPONDYLIC DWARFISM, SAN DIEGO TYPE	
Number Sign	187601	THANATOPHORIC DYSPLASIA, TYPE II; TD2	THANATOPHORIC DYSPLASIA WITH STRAIGHT FEMURS AND CLOVERLEAF SKULL;; THANATOPHORIC DYSPLASIA WITH KLEEBLATTSCHAEDEL;; CLOVERLEAF SKULL WITH THANATOPHORIC DWARFISM	
Percent	187650	THEOPHYLLINE BIOTRANSFORMATION		
NULL	187750	THORACIC DYSOSTOSIS, ISOLATED		
NULL	187760	THORACOLARYNGOPELVIC DYSPLASIA; TLPD	BARNES SYNDROME	
NULL	187770	THORACOPELVIC DYSOSTOSIS		
Number Sign	187800	BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16	GLANZMANN THROMBASTHENIA, AUTOSOMAL DOMINANT;; THROMBASTHENIA OF GLANZMANN AND NAEGELI, AUTOSOMAL DOMINANT	
Number Sign	187900	BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	THROMBASTHENIA-THROMBOCYTOPENIA, HEREDITARY	
NULL	187940	THROMBOCYTE B; THB		
Number Sign	187950	THROMBOCYTHEMIA 1; THCYT1	THROMBOCYTOSIS 1	
Number Sign	188000	THROMBOCYTOPENIA 2; THC2	THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 2	
NULL	188020	THROMBOCYTOPENIA, CYCLIC		
Number Sign	188025	THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT	CHROMOSOME 11q23 DELETION SYNDROME	
NULL	188030	THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP	IMMUNE THROMBOCYTOPENIC PURPURA; ITP;; IDIOPATHIC THROMBOCYTOPENIC PURPURA	
Number Sign	188050	THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1	THROMBOPHILIA DUE TO FACTOR 2 DEFECT;; VENOUS THROMBOSIS;; VENOUS THROMBOEMBOLISM	THROMBOSIS, PROTECTION AGAINST, INCLUDED
Number Sign	188055	THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE; THPH2	ACTIVATED PROTEIN C RESISTANCE;; APC RESISTANCE;; THROMBOPHILIA DUE TO DEFICIENCY OF ACTIVATED PROTEIN C COFACTOR;; PROC COFACTOR DEFICIENCY;; PCCF DEFICIENCY;; THROMBOPHILIA V	THROMBOPHILIA DUE TO FACTOR V LEIDEN, INCLUDED
NULL	188100	THUMB DEFORMITY		
NULL	188150	THUMB DEFORMITY AND ALOPECIA		
NULL	188201	THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY		
Number Sign	188400	DIGEORGE SYNDROME; DGS	CHROMOSOME 22q11.2 DELETION SYNDROME;; HYPOPLASIA OF THYMUS AND PARATHYROIDS;; THIRD AND FOURTH PHARYNGEAL POUCH SYNDROME	DIGEORGE SYNDROME CHROMOSOME REGION, INCLUDED; DGCR, INCLUDED;; TAKAO VCF SYNDROME, INCLUDED;; CATCH22, INCLUDED
NULL	188455	THYROGLOSSAL DUCT CYST, FAMILIAL		
Number Sign	188470	THYROID CANCER, NONMEDULLARY, 2; NMTC2		
Number Sign	188550	THYROID CANCER, NONMEDULLARY, 1; NMTC1	PAPILLARY CARCINOMA OF THYROID; PACT; PTC; TPC;; FAMILIAL NONMEDULLARY THYROID CANCER, PAPILLARY;; NONMEDULLARY THYROID CARCINOMA, PAPILLARY	
NULL	188560	THYROID HORMONE PLASMA MEMBRANE TRANSPORT DEFECT	HYPERTHYROXINEMIA, EUMETABOLIC, DUE TO T4 PLASMA MEMBRANE TRANSPORT;; DEFECT;; THYROID HORMONE RESISTANCE DUE TO T4 PLASMA MEMBRANE TRANSPORT DEFECT	
Number Sign	188570	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT; GRTH	GTHR;; THYROID HORMONE UNRESPONSIVENESS;; HYPERTHYROXINEMIA, FAMILIAL EUTHYROID, SECONDARY TO PITUITARY AND PERIPHERAL RESISTANCE TO THYROID HORMONES	
Number Sign	188580	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1		
NULL	188700	BLOUNT DISEASE, INFANTILE	OSTEOCHONDROSIS DEFORMANS TIBIAE, INFANTILE;; TIBIA VARA, INFANTILE	
Number Sign	188740	TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY; THYP	TIBIAL HEMIMELIA-POLYDACTYLY-TRIPHALANGEAL THUMBS WITH FIBULAR DIMELIA	
Percent	188800	TIBIAL TORSION, BILATERAL MEDIAL		
NULL	188850	TL ANTIGEN	THYMUS LEUKEMIA ANTIGEN; TLA;; HISTOCOMPATIBILITY 2, T-REGION LOCUS 18; H2-T18	
Number Sign	188890	TOBACCO ADDICTION, SUSCEPTIBILITY TO	CIGARETTE HABITUATION, SUSCEPTIBILITY TO;; SMOKING HABIT, SUSCEPTIBILITY TO;; NICOTINE DEPENDENCE, SUSCEPTIBILITY TO;; NICOTINE ADDICTION, SUSCEPTIBILITY TO	
NULL	189000	TOE, FIFTH, NUMBER OF PHALANGES IN		
NULL	189100	TOE, MISSHAPEN		
NULL	189150	TOE, ROTATED FIFTH		
NULL	189200	TOES, RELATIVE LENGTH OF FIRST AND SECOND		
NULL	189230	TOES, SPACE BETWEEN FIRST AND SECOND		
NULL	189300	TONGUE CURLING, FOLDING, OR ROLLING		CLOVERLEAF TONGUE, INCLUDED;; TREFOIL TONGUE, INCLUDED
NULL	189490	MALPOSITION OF TEETH WITH OR WITHOUT HYPODONTIA/OLIGODONTIA	ECTOPIC ERUPTION OF TEETH	
Number Sign	189500	WITKOP SYNDROME	ECTODERMAL DYSPLASIA 3, WITKOP TYPE; ECTD3;; ECTODERMAL DYSPLASIA 3, TOOTH/NAIL TYPE;; NAIL DYSPLASIA WITH HYPODONTIA;; TOOTH-AND-NAIL SYNDROME; TNS	
NULL	189600	TORTICOLLIS		
Percent	189700	TORUS PALATINUS AND TORUS MANDIBULARIS		
Percent	189800	PREECLAMPSIA/ECLAMPSIA 1; PEE1	PREG1;; PEE;; TOXEMIA OF PREGNANCY	HYPERTENSION, PREGNANCY-INDUCED, INCLUDED;; HEMOLYSIS, ELEVATED LIVER ENZYMES, AND LOW PLATELET COUNT, INCLUDED; HELLP, INCLUDED
NULL	189960	TRACHEOESOPHAGEAL FISTULA WITH OR WITHOUT ESOPHAGEAL ATRESIA	ESOPHAGEAL ATRESIA WITH OR WITHOUT TRACHEOESOPHAGEAL FISTULA	
NULL	189961	TRACHEOPATHIA OSTEOPLASTICA	TRACHEOBRONCHOPATHIA OSTEOCHONDROPLASTICA	
Percent	190100	GENIOSPASM 1; GSM1	TREMBLING CHIN	
NULL	190200	TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS		
Number Sign	190300	TREMOR, HEREDITARY ESSENTIAL, 1; ETM1	TREMOR, FAMILIAL ESSENTIAL, 1; FET1	
Percent	190310	TREMOR, NYSTAGMUS, AND DUODENAL ULCER		
Number Sign	190320	TRICHODENTOOSSEOUS SYNDROME; TDO	TDO SYNDROME	
Number Sign	190330	TRICHOMEGALY; TCMGLY	EYELASHES, LONG	
Percent	190340	DISCOID FIBROMAS, FAMILIAL MULTIPLE; FMDF	TRICHODISCOMAS, FAMILIAL MULTIPLE	
NULL	190345	TRICHOEPITHELIOMAS, MULTIPLE DESMOPLASTIC		
Number Sign	190350	TRICHORHINOPHALANGEAL SYNDROME, TYPE I; TRPS1	TRPS I	
Number Sign	190351	TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	SUGIO-KAJII SYNDROME	
NULL	190360	TRICHODYSPLASIA-XERODERMA		
NULL	190400	TRIGEMINAL NEURALGIA	TIC DOULOUREUX	
NULL	190410	TRIGGER THUMB		
NULL	190420	TRIGLYCERIDE STORAGE DISEASE, TYPE I		
NULL	190430	TRIGLYCERIDE STORAGE DISEASE, TYPE II		
Number Sign	190440	TRIGONOCEPHALY 1; TRIGNO1	CRANIOSYNOSTOSIS, METOPIC	
NULL	190445	TRIIODOTHYRONINE RECEPTOR AUXILIARY PROTEIN; TRAP		
NULL	190500	TRIPHALANGEAL THUMB WITH DOUBLE PHALANGES		
Percent	190600	TRIPHALANGEAL THUMB, NONOPPOSABLE		
NULL	190650	TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA		
Percent	190680	TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY		
Number Sign	190685	DOWN SYNDROME	TRISOMY 21	DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;; DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;; TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;; LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED
NULL	190800	TRISTICHIASIS	EYELASHES, THREE ROWS OF	
Number Sign	190900	TRITANOPIA	COLORBLINDNESS, TRITANOPIC;; BLUE COLORBLINDNESS;; COLORBLINDNESS, TRITAN; CBT	
NULL	191000	TROCHLEA OF THE HUMERUS, APLASIA OF		
Number Sign	191100	TUBEROUS SCLEROSIS 1; TSC1	TUBEROUS SCLEROSIS COMPLEX; TSC;; TUBEROSE SCLEROSIS; TS	
NULL	191150	TUFTSIN DEFICIENCY		
Percent	191181	SUPPRESSOR OF TUMORIGENICITY 3; ST3	TUMOR-SUPPRESSOR GENE, HELA CELL TYPE; TSHL;; CERVICAL CARCINOMA, TUMOR-SUPPRESSOR GENE INVOLVED IN; CCTS	
Percent	191200	TUNE DEAFNESS	DYSMELODIA;; AMUSIA, CONGENITAL;; TONE DEAFNESS	
NULL	191250	TWINNING DUE TO SUPERFETATION	SUPERFETATION TWINNING	
NULL	191270	TYROSINASE-LIKE; TYRL	TYROSINASE-RELATED SEGMENT	
Percent	191390	INFLAMMATORY BOWEL DISEASE 11; IBD11		
NULL	191400	ULNA AND FIBULA, HYPOPLASIA OF	MESOMELIC DWARFISM OF HYPOPLASTIC ULNA AND FIBULA TYPE;; REINHARDT-PFEIFFER MESOMELIC DYSPLASIA	
NULL	191420	ULNA METAPHYSEAL DYSPLASIA SYNDROME	METAPHYSEAL CHONDRODYSPLASIA, ROSENBERG TYPE	
Percent	191440	ULNAR HYPOPLASIA	UPPER LIMB MESOMELIC DYSPLASIA	
Number Sign	191480	UNCOMBABLE HAIR SYNDROME 1; UHS1	UNCOMBABLE HAIR SYNDROME; UHS;; PILI TRIANGULI ET CANALICULI	
NULL	191482	UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, AND BRACHYDACTYLY	BORK SYNDROME	
Percent	191500	UNDRITZ ANOMALY	HYPERSEGMENTATION OF NUCLEI OF POLYMORPHONUCLEAR LEUKOCYTES	
Percent	191520	UPINGTON DISEASE	PERTHES-LIKE HIP DISEASE, ENCHONDROMATA, AND ECCHONDROMATA	
Percent	191530	URATE-BINDING GLOBULIN, DECREASE IN		
NULL	191540	URATE OXIDASE, PSEUDOGENE; UOX	URICASE	
Percent	191550	URETER, BIFID OR DOUBLE		
NULL	191600	URETER, CANCER OF		
NULL	191650	URETEROCELE		
NULL	191700	UROLITHIASIS, URIC ACID, AUTOSOMAL DOMINANT	NEPHROLITHIASIS, URIC ACID, AUTOSOMAL DOMINANT	
NULL	191800	URINARY BLADDER, ATONY OF		
Number Sign	191830	RENAL HYPODYSPLASIA/APLASIA 1; RHDA1	RENAL ADYSPLASIA;; RENAL AGENESIS;; RENAL APLASIA;; HEREDITARY RENAL APLASIA; HRA	
NULL	191850	URTICARIA, AQUAGENIC		
Number Sign	191900	MUCKLE-WELLS SYNDROME; MWS	URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;; UDA SYNDROME;; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	
NULL	191950	URTICARIA, FAMILIAL LOCALIZED HEAT		
NULL	192000	UTERINE ANOMALIES		
NULL	192050	UTERUS BICORNIS BICOLLIS WITH PARTIAL VAGINAL SEPTUM AND UNILATERAL HEMATOCOLPOS WITH IPSILATERAL RENAL AGENESIS		
NULL	192100	UVULA, BIFID	UVULA, CLEFT	
NULL	192200	VARICOSE VEINS		
NULL	192300	VASCULAR HELIX OF UMBILICAL CORD		
NULL	192310	VASCULITIS, LYMPHOCYTIC, NODULAR		
Number Sign	192315	VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	CEREBRORETINAL VASCULOPATHY, HEREDITARY; CRV;; RETINOPATHY, VASCULAR, WITH CEREBRAL AND RENAL INVOLVEMENT AND RAYNAUD AND MIGRAINE PHENOMENA	
Percent	192350	VATER/VACTERL ASSOCIATION		
NULL	192400	VEINS, PATTERN OF, ON ANTERIOR THORAX		
Number Sign	192430	VELOCARDIOFACIAL SYNDROME	CHROMOSOME 22q11.2 DELETION SYNDROME;; VCF SYNDROME; VCFS;; SHPRINTZEN VCF SYNDROME	
NULL	192445	VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE		
Number Sign	192500	LONG QT SYNDROME 1; LQT1	WARD-ROMANO SYNDROME; WRS;; ROMANO-WARD SYNDROME; RWS;; VENTRICULAR FIBRILLATION WITH PROLONGED QT INTERVAL	LONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;; LONG QT SYNDROME 1, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED
Number Sign	192600	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1	CMH;; VENTRICULAR HYPERTROPHY, HEREDITARY;; ASYMMETRIC SEPTAL HYPERTROPHY; ASH;; HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	
Number Sign	192605	VENTRICULAR TACHYCARDIA, FAMILIAL	VENTRICULAR TACHYCARDIA, FAMILIAL POLYMORPHIC	
NULL	192700	VENULAR INSUFFICIENCY, SYSTEMIC		
NULL	192800	VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS		
Percent	192900	VERTEBRAL HYPOPLASIA WITH LUMBAR KYPHOSIS		
Number Sign	192950	VERTICAL TALUS, CONGENITAL; CVT	ROCKER-BOTTOM FOOT;; PES VALGUS, CONGENITAL CONVEX	
Percent	193000	VESICOURETERAL REFLUX 1; VUR1	VUR	
Percent	193003	NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4	VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	
NULL	193005	VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE		
Percent	193007	VERTIGO, BENIGN RECURRENT; BRV	VERTIGO, BENIGN PAROXYSMAL POSITIONAL; BPPV;; VESTIBULOPATHY, FAMILIAL	VERTIGO, BENIGN RECURRENT, 1, INCLUDED; BRV1, INCLUDED
NULL	193070	VIRUS RD114 RNA COMPLEMENTARITY		
Percent	193090	TRANSCOBALAMIN I DEFICIENCY	TCN1 DEFICIENCY;; COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;; COBALAMIN R BINDER PROTEIN DEFICIENCY	TRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;; R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED
Number Sign	193100	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT; ADHR	VITAMIN D-RESISTANT RICKETS, AUTOSOMAL DOMINANT;; HYPOPHOSPHATEMIA, AUTOSOMAL DOMINANT	
Percent	193200	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 6; VAMAS6		
Number Sign	193220	VITREORETINOCHOROIDOPATHY; VRCP	VITREORETINOCHOROIDOPATHY, AUTOSOMAL DOMINANT; ADVIRC;; VITREORETINOCHOROIDOPATHY WITH MICROCORNEA, GLAUCOMA, AND CATARACT;; VITREORETINOCHOROIDOPATHY, AUTOSOMAL DOMINANT, WITH NANOPHTHALMOS	MICROCORNEA, ROD-CONE DYSTROPHY, CATARACT, AND POSTERIOR STAPHYLOMA, INCLUDED; MRCS, INCLUDED
Number Sign	193230	VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD	SNOWFLAKE VITREORETINAL DEGENERATION	
Number Sign	193235	VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY; VRNI	PROLIFERATIVE VITREORETINOPATHY; PVR;; VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY, AUTOSOMAL DOMINANT; ADNIV	
NULL	193240	VOCAL CORD PARALYSIS AND PTOSIS		
Percent	193250	VOLVULUS OF MIDGUT	INTESTINAL MALROTATION, FAMILIAL	
Number Sign	193300	VON HIPPEL-LINDAU SYNDROME; VHL		VON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED
Number Sign	193400	VON WILLEBRAND DISEASE, TYPE 1; VWD1	VON WILLEBRAND DISEASE, TYPE I;; VWD, TYPE 1	
NULL	193450	VULVOVAGINITIS, ALLERGIC SEMINAL		
Number Sign	193500	WAARDENBURG SYNDROME, TYPE 1; WS1	WAARDENBURG SYNDROME WITH DYSTOPIA CANTHORUM	
Number Sign	193510	WAARDENBURG SYNDROME, TYPE 2A; WS2A	WAARDENBURG SYNDROME, TYPE IIA;; WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;; WS2	
Number Sign	193520	WATSON SYNDROME; WTSN	PULMONIC STENOSIS WITH CAFE-AU-LAIT SPOTS;; CAFE-AU-LAIT SPOTS WITH PULMONIC STENOSIS	
Number Sign	193530	WEYERS ACROFACIAL DYSOSTOSIS; WAD	ACRODENTAL DYSOSTOSIS OF WEYERS;; CURRY-HALL SYNDROME	
Number Sign	193670	WHIM SYNDROME; WHIMS	WARTS, HYPOGAMMAGLOBULINEMIA, INFECTIONS, AND MYELOKATHEXIS SYNDROME	
Number Sign	193700	ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A	FREEMAN-SHELDON SYNDROME; FSS;; WHISTLING FACE-WINDMILL VANE HAND SYNDROME;; CRANIOCARPOTARSAL DYSTROPHY;; CRANIOCARPOTARSAL DYSPLASIA	
Number Sign	193900	WHITE SPONGE NEVUS 1; WSN1	WHITE SPONGE NEVUS OF CANNON;; LEUKOKERATOSIS, HEREDITARY MUCOSAL	
NULL	194000	WIDOW'S PEAK		
Number Sign	194050	WILLIAMS-BEUREN SYNDROME; WBS	CHROMOSOME 7q11.23 DELETION SYNDROME, 1.5- TO 1.8-MB;; WILLIAMS SYNDROME; WMS; WS	
Number Sign	194070	WILMS TUMOR 1; WT1	NEPHROBLASTOMA	
Number Sign	194071	WILMS TUMOR 2; WT2		
Number Sign	194072	WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATION SYNDROME; WAGR	WAGR SYNDROME;; CHROMOSOME 11p13 DELETION SYNDROME	
Number Sign	194080	DENYS-DRASH SYNDROME; DDS	DRASH SYNDROME;; WILMS TUMOR AND PSEUDO- OR TRUE HERMAPHRODITISM;; NEPHROPATHY, WILMS TUMOR, AND GENITAL ANOMALIES	
Percent	194090	WILMS TUMOR 3; WT3		
Number Sign	194190	WOLF-HIRSCHHORN SYNDROME; WHS	CHROMOSOME 4p16.3 DELETION SYNDROME;; PITT-ROGERS-DANKS SYNDROME; PRDS;; PITT SYNDROME;; WITTWER SYNDROME	
Number Sign	194200	WOLFF-PARKINSON-WHITE SYNDROME	WPW SYNDROME	PREEXCITATION SYNDROME, INCLUDED;; ACCESSORY ATRIOVENTRICULAR PATHWAYS, INCLUDED
Number Sign	194300	WOOLLY HAIR, AUTOSOMAL DOMINANT; ADWH		
NULL	194320	WORONETS TRAIT		
Percent	194350	WT LIMB-BLOOD SYNDROME		
NULL	194370	X-RAY SENSITIVITY; XRS		
Number Sign	194380	DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	DEHYDRATED HEREDITARY STOMATOCYTOSIS; DHS;; XEROCYTOSIS, HEREDITARY;; DESICCYTOSIS, HEREDITARY;; PSEUDOHYPERKALEMIA, FAMILIAL, 1, DUE TO RED CELL LEAK; PSHK1;; PSEUDOHYPERKALEMIA EDINBURGH	
NULL	194400	XERODERMA PIGMENTOSUM, AUTOSOMAL DOMINANT, MILD		
Percent	194470	ZINC, ELEVATED PLASMA	ALBUMIN BINDING OF ZINC, ELEVATED;; HYPERZINCEMIA, FAMILIAL DYSALBUMINEMIC	HYPERZINCEMIA AND HYPERCALPROTECTINEMIA, INCLUDED
Number Sign	200100	ABETALIPOPROTEINEMIA; ABL	ACANTHOCYTOSIS;; BASSEN-KORNZWEIG SYNDROME;; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN DEFICIENCY;; MTP DEFICIENCY	
Number Sign	200110	ABLEPHARON-MACROSTOMIA SYNDROME; AMS		
NULL	200130	ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	PSEUDOPROGERIA SYNDROME	
Number Sign	200150	CHOREOACANTHOCYTOSIS; CHAC	LEVINE-CRITCHLEY SYNDROME;; ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;; NEUROACANTHOCYTOSIS;; CHOREA-ACANTHOCYTOSIS	
NULL	200170	ACANTHOSIS NIGRICANS WITH MUSCLE CRAMPS AND ACRAL ENLARGEMENT		
NULL	200300	ACETOPHENETIDIN SENSITIVITY		
Percent	200400	ACHALASIA, FAMILIAL ESOPHAGEAL		
NULL	200450	ACHALASIA-MICROCEPHALY SYNDROME		
Number Sign	200500	ACHEIROPODY; ACHP	ACHEIROPODIA;; ACHEIROPODY, BRAZILIAN TYPE	
Number Sign	200600	ACHONDROGENESIS, TYPE IA; ACG1A	ACHONDROGENESIS, HOUSTON-HARRIS TYPE	
Number Sign	200610	ACHONDROGENESIS, TYPE II; ACG2	ACHONDROGENESIS, LANGER-SALDINO TYPE;; CHONDROGENESIS IMPERFECTA;; ACHONDROGENESIS, TYPE IB, FORMERLY	HYPOCHONDROGENESIS, INCLUDED
Number Sign	200700	CHONDRODYSPLASIA, GREBE TYPE	ACHONDROGENESIS, BRAZILIAN;; GREBE CHONDRODYSPLASIA;; GREBE DYSPLASIA;; ACROMESOMELIC DYSPLASIA, GREBE TYPE; AMDG;; ACHONDROGENESIS, TYPE II, FORMERLY	
NULL	200900	SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	SLSD WITH SCID;; ACHONDROPLASIA, SO-CALLED, AND SEVERE COMBINED IMMUNODEFICIENCY	
NULL	200950	ACID PHOSPHATASE DEFICIENCY		
NULL	200970	ACKERMAN SYNDROME	MOLAR ROOTS, PYRAMIDAL, WITH JUVENILE GLAUCOMA AND UNUSUAL UPPER LIP;; GLAUCOMA, JUVENILE, WITH UNUSUAL UPPER LIP AND DENTAL ROOTS	
NULL	200980	ACRORENAL-MANDIBULAR SYNDROME	ACRORENAL-UTERINE-MANDIBULAR SYNDROME; ARUMS;; SPLIT-HAND AND SPLIT-FOOT WITH MANDIBULAR HYPOPLASIA	
Number Sign	200990	ACROCALLOSAL SYNDROME; ACLS	HALLUX DUPLICATION, POSTAXIAL POLYDACTYLY, AND ABSENCE OF CORPUS CALLOSUM;; SCHINZEL ACROCALLOSAL SYNDROME	JOUBERT SYNDROME 12, INCLUDED; JBTS12, INCLUDED;; JOUBERT SYNDROME 12/15, DIGENIC, INCLUDED
NULL	200995	ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	ELEJALDE SYNDROME	
Number Sign	201000	CARPENTER SYNDROME 1; CRPT1	CARPENTER SYNDROME;; ACROCEPHALOPOLYSYNDACTYLY TYPE II;; ACPS II	
NULL	201020	ACROCEPHALOPOLYSYNDACTYLY TYPE IV	ACPS IV;; GOODMAN SYNDROME	
NULL	201050	ACROCRANIOFACIAL DYSOSTOSIS		
Number Sign	201100	ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ		
Percent	201170	ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	RODRIGUEZ LETHAL ACROFACIAL DYSOSTOSIS SYNDROME	
NULL	201180	ACROFRONTOFACIONASAL DYSOSTOSIS 1	AFFN DYSOSTOSIS 1; AFFND1;; POLYSYNDACTYLY, POSTAXIAL, FRONTONASAL DYSOSTOSIS, AND CLEFT LIP/PALATE;; CLEFT LIP/PALATE WITH FRONTONASAL DYSOSTOSIS AND POSTAXIAL POLYSYNDACTYLY	
NULL	201200	ACROGERIA, GOTTRON TYPE	METAGERIA;; ACROMETAGERIA	
Number Sign	201250	ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE; AMDH	ACROMESOMELIC DWARFISM	
Number Sign	201300	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A	HSAN IIA;; NEUROPATHY, HEREDITARY SENSORY, TYPE IIA; HSN2A;; HSN IIA;; ACROOSTEOLYSIS, NEUROGENIC;; ACROOSTEOLYSIS, GIACCAI TYPE;; NEUROPATHY, HEREDITARY SENSORY RADICULAR, AUTOSOMAL RECESSIVE;; MORVAN DISEASE;; NEUROPATHY, PROGRESSIVE SENSORY, OF CHILDREN;; NEUROPATHY, CONGENITAL SENSORY	
NULL	201310	ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE		
Number Sign	201400	ACTH DEFICIENCY, ISOLATED; IAD	ADRENOCORTICOTROPIC HORMONE DEFICIENCY	
Number Sign	201450	ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD	ACADM DEFICIENCY;; MCAD DEFICIENCY;; MCADH DEFICIENCY;; CARNITINE DEFICIENCY SECONDARY TO MEDIUM-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY	
Number Sign	201470	ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD	ACADS DEFICIENCY;; LIPID-STORAGE MYOPATHY SECONDARY TO SHORT-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY;; SCADH DEFICIENCY;; SCAD DEFICIENCY	
Number Sign	201475	ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD	VLCAD DEFICIENCY	
Percent	201550	ADDUCTED THUMBS SYNDROME		
Number Sign	201710	LIPOID CONGENITAL ADRENAL HYPERPLASIA; LCAH	ADRENAL HYPERPLASIA I;; LIPOID HYPERPLASIA, CONGENITAL, OF ADRENAL CORTEX WITH MALE PSEUDOHERMAPHRODITISM	
Number Sign	201750	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1		
Number Sign	201810	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY	ADRENAL HYPERPLASIA II;; 3-BETA-HSD DEFICIENCY; HSDB	
Number Sign	201910	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	ADRENAL HYPERPLASIA III;; 21-HYDROXYLASE DEFICIENCY;; CYP21 DEFICIENCY;; CONGENITAL ADRENAL HYPERPLASIA 1; CAH1	HYPERANDROGENISM, NONCLASSIC TYPE, DUE TO 21-HYDROXYLASE DEFICIENCY, INCLUDED
Number Sign	202010	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	ADRENAL HYPERPLASIA IV;; STEROID 11-BETA-HYDROXYLASE DEFICIENCY;; 11-BETA-HYDROXYLASE DEFICIENCY;; ADRENAL HYPERPLASIA, HYPERTENSIVE FORM;; P450C11B1 DEFICIENCY	
Number Sign	202110	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	ADRENAL HYPERPLASIA V;; 17-ALPHA-HYDROXYLASE DEFICIENCY	17,20-LYASE DEFICIENCY, ISOLATED, INCLUDED;; 17-ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE, INCLUDED;; 17-ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED PARTIAL, INCLUDED
NULL	202150	ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZING HORMONE		
NULL	202155	ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE		
Number Sign	202200	GLUCOCORTICOID DEFICIENCY 1; GCCD1	FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;; ADRENAL UNRESPONSIVENESS TO ACTH;; ACTH RESISTANCE	
Number Sign	202300	ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC		ADRENOCORTICAL CARCINOMA, PEDIATRIC, INCLUDED
NULL	202355	ADRENOCORTICAL UNRESPONSIVENESS TO ACTH WITH POSTRECEPTOR DEFECT	FAMILIAL GLUCOCORTICOID DEFICIENCY DUE TO DEFECT DISTAL TO ACTH RECEPTOR	
Number Sign	202370	PEROXISOME BIOGENESIS DISORDER 2B; PBD2B		
Number Sign	202400	AFIBRINOGENEMIA, CONGENITAL		HYPOFIBRINOGENEMIA, CONGENITAL, INCLUDED
NULL	202550	AGANGLIONOSIS, TOTAL INTESTINAL		
NULL	202600	AGENESIS OF CEREBRAL WHITE MATTER		
Number Sign	202650	AGNATHIA-OTOCEPHALY COMPLEX; AGOTC	DYSGNATHIA COMPLEX AGNATHIA-HOLOPROSENCEPHALY;; HOLOPROSENCEPHALY-AGNATHIA;; OTOCEPHALY	
NULL	202660	PAGOD SYNDROME	AGONADISM WITH MULTIPLE INTERNAL MALFORMATIONS	
Number Sign	202700	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1		
NULL	202900	ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	STIMMLER SYNDROME	
NULL	203000	FRONTONASAL DYSPLASIA WITH ALAR CLEFTS	ALAR-NASAL CARTILAGES, COLOBOMA OF, WITH TELECANTHUS	
Number Sign	203100	ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	OCULOCUTANEOUS ALBINISM, TYPE I; OCA1;; ALBINISM I;; OCULOCUTANEOUS ALBINISM, TYROSINASE-NEGATIVE; ATN	
Number Sign	203200	ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	OCULOCUTANEOUS ALBINISM, TYPE II;; OCULOCUTANEOUS ALBINISM, TYROSINASE-POSITIVE;; ALBINISM II	ALBINISM, BROWN OCULOCUTANEOUS, INCLUDED; BOCA, INCLUDED;; BROWN OCULOCUTANEOUS ALBINISM, INCLUDED
Number Sign	203290	ALBINISM, OCULOCUTANEOUS, TYPE III; OCA3	OCULOCUTANEOUS ALBINISM, TYPE III;; ALBINISM III;; RUFOUS OCULOCUTANEOUS ALBINISM; ROCA;; XANTHISM	
Number Sign	203300	HERMANSKY-PUDLAK SYNDROME 1; HPS1	ALBINISM WITH HEMORRHAGIC DIATHESIS AND PIGMENTED RETICULOENDOTHELIAL CELLS;; DELTA STORAGE POOL DISEASE	
Percent	203330	PSEUDOHYPOPARATHYROIDISM, TYPE II; PHP2	PHP II	
NULL	203340	ALBINISM-MICROCEPHALY-DIGITAL ANOMALIES SYNDROME	MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	
Number Sign	203400	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	CMO I DEFICIENCY;; ALDOSTERONE DEFICIENCY I;; HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;; ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;; 18-HYDROXYLASE DEFICIENCY;; STEROID 18-HYDROXYLASE DEFICIENCY	
Number Sign	203450	ALEXANDER DISEASE; ALXDRD		
Number Sign	203500	ALKAPTONURIA; AKU	HOMOGENTISIC ACID OXIDASE DEFICIENCY	
NULL	203550	ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	ACD MENTAL RETARDATION SYNDROME	
NULL	203600	ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN	MOYNAHAN ALOPECIA SYNDROME	
Percent	203650	ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1	AMR SYNDROME	
Number Sign	203655	ALOPECIA UNIVERSALIS CONGENITA; ALUNC	ATRICHIA, GENERALIZED	
Number Sign	203700	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A	ALPERS DIFFUSE DEGENERATION OF CEREBRAL GRAY MATTER WITH HEPATIC CIRRHOSIS;; ALPERS PROGRESSIVE INFANTILE POLIODYSTROPHY;; ALPERS SYNDROME;; ALPERS-HUTTENLOCHER SYNDROME;; NEURONAL DEGENERATION OF CHILDHOOD WITH LIVER DISEASE, PROGRESSIVE; PNDC	
Percent	203740	ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	ALPHA-KGD DEFICIENCY;; 2-KETOGLUTARATE DEHYDROGENASE DEFICIENCY;; OXOGLUTARIC ACIDURIA	
Number Sign	203750	ALPHA-METHYLACETOACETIC ACIDURIA	2-METHYL-3-HYDROXYBUTYRIC ACIDEMIA;; BETA-KETOTHIOLASE DEFICIENCY;; MITOCHONDRIAL ACETOACETYL-CoA THIOLASE DEFICIENCY;; MAT DEFICIENCY;; T2 DEFICIENCY;; 3-OXOTHIOLASE DEFICIENCY;; 3-KETOTHIOLASE DEFICIENCY;; 3-KTD DEFICIENCY	
NULL	203760	ALPHA-2-DEFICIENT COLLAGEN DISEASE	MEIGEL DISEASE	
Number Sign	203780	ALPORT SYNDROME, AUTOSOMAL RECESSIVE		
Number Sign	203800	ALSTROM SYNDROME; ALMS	ALSS	
Number Sign	204000	LEBER CONGENITAL AMAUROSIS 1; LCA1	AMAUROSIS CONGENITA OF LEBER I;; LCA;; RETINAL BLINDNESS, CONGENITAL; CRB	
Number Sign	204100	LEBER CONGENITAL AMAUROSIS 2; LCA2	AMAUROSIS CONGENITA OF LEBER II	
NULL	204110	AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS		
Number Sign	204200	CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	NEURONAL CEROID LIPOFUSCINOSIS, JUVENILE; JNCL;; BATTEN DISEASE;; VOGT-SPIELMEYER DISEASE;; SPIELMEYER-SJOGREN DISEASE	
Number Sign	204300	CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE; CLN4A		
Number Sign	204500	CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2	CEROID LIPOFUSCINOSIS, NEURONAL, 2, VARIABLE AGE AT ONSET;; JANSKY-BIELSCHOWSKY DISEASE	NEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, INCLUDED; LINCL, INCLUDED
Number Sign	204650	AMELOGENESIS IMPERFECTA, TYPE IC; AI1C	AMELOGENESIS IMPERFECTA, LOCAL HYPOPLASTIC TYPE, AUTOSOMAL RECESSIVE;; AMELOGENESIS IMPERFECTA, HYPOPLASTIC, WITH OR WITHOUT OPENBITE MALOCCLUSION, AUTOSOMAL RECESSIVE	
Number Sign	204690	AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	ENAMEL-RENAL SYNDROME; ERS;; ENAMEL-RENAL-GINGIVAL SYNDROME;; AMELOGENESIS IMPERFECTA, HYPOPLASTIC, WITH NEPHROCALCINOSIS;; AMELOGENESIS IMPERFECTA AND GINGIVAL FIBROMATOSIS SYNDROME; AIGFS	
Number Sign	204700	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1; AI2A1	AMELOGENESIS IMPERFECTA, PIGMENTED HYPOMATURATION TYPE, 1	
NULL	204730	AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY, OSTEOPOROSIS, AND ACIDOSIS		
Number Sign	204750	2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD		
Percent	204800	AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF		
NULL	204850	AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION		
Number Sign	204870	CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE; GDLD	CDGDL;; AMYLOIDOSIS, CORNEAL;; AMYLOID CORNEAL DYSTROPHY, JAPANESE TYPE;; CORNEAL DYSTROPHY, LATTICE TYPE III;; LATTICE CORNEAL DYSTROPHY, TYPE III	
NULL	204900	AMYLOIDOSIS, CUTANEOUS BULLOUS		
NULL	205000	AMYOTONIA CONGENITA	OPPENHEIM DISEASE	
Number Sign	205100	AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	ALS, JUVENILE; ALSJ	
Percent	205200	AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE, WITH DEMENTIA	ALS-DEMENTIA COMPLEX	
NULL	205250	AMYOTROPHIC LATERAL SCLEROSIS WITH POLYGLUCOSAN BODIES		
Number Sign	205400	TANGIER DISEASE; TGD	HIGH DENSITY LIPOPROTEIN DEFICIENCY, TYPE 1; HDLDT1;; HIGH DENSITY LIPOPROTEIN DEFICIENCY, TANGIER TYPE;; ANALPHALIPOPROTEINEMIA	
NULL	205700	ANEMIA, AUTOIMMUNE HEMOLYTIC		
Number Sign	205950	ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY; SIDBA2		
NULL	206000	ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE	ANEMIA, CONGENITAL SIDEROBLASTIC, B6-RESPONSIVE	
Number Sign	206100	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1		
Number Sign	206200	IRON-REFRACTORY IRON DEFICIENCY ANEMIA; IRIDA	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH DEFECT IN IRON METABOLISM;; IRON-HANDLING DISORDER, HEREDITARY;; PSEUDO-IRON-DEFICIENCY ANEMIA	
NULL	206300	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF RED CELL MEMBRANE		
NULL	206400	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRIN METABOLISM		
Number Sign	206500	ANENCEPHALY; ANPH		
NULL	206550	ANGIOLIPOMATOSIS, FAMILIAL	ANGIOLIPOMA MICROTHROMBOTICUM	
Percent	206570	ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	DIVRY-VAN BOGAERT SYNDROME	
NULL	206600	ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS		
Number Sign	206700	GILLESPIE SYNDROME; GLSP	ANIRIDIA, CEREBELLAR ATAXIA, AND MENTAL RETARDATION	
NULL	206750	ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTOR RETARDATION		
Percent	206780	ANODONTIA OF PERMANENT DENTITION	TEETH, PERMANENT, ABSENCE OF	
Number Sign	206800	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4; NDNC4	ANONYCHIA/HYPONYCHIA CONGENITA;; ANONYCHIA TOTALIS	
Number Sign	206900	MICROPHTHALMIA, SYNDROMIC 3; MCOPS3	MICROPHTHALMIA AND ESOPHAGEAL ATRESIA SYNDROME;; ANOPHTHALMIA, CLINICAL, WITH ASSOCIATED ANOMALIES;; ANOPHTHALMIA-ESOPHAGEAL-GENITAL SYNDROME;; AEG SYNDROME	OPTIC NERVE HYPOPLASIA AND ABNORMALITIES OF THE CENTRAL NERVOUS SYSTEM, INCLUDED
Number Sign	206920	MICROPHTHALMIA WITH LIMB ANOMALIES; MLA	WAARDENBURG ANOPHTHALMIA SYNDROME;; ANOPHTHALMIA-SYNDACTYLY;; OPHTHALMOACROMELIC SYNDROME; OAS	
NULL	207000	ANOSMIA FOR ISOBUTYRIC ACID		
NULL	207300	ANTITHROMBIN, FAMILIAL HEMORRHAGIC DIATHESIS DUE TO		
Number Sign	207410	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	TRAPEZOIDOCEPHALY-SYNOSTOSIS SYNDROME;; MULTISYNOSTOTIC OSTEODYSGENESIS WITH LONG BONE FRACTURES;; OSTEODYSGENESIS, MULTISYNOSTOTIC, WITH FRACTURES	
NULL	207500	ANUS, IMPERFORATE		
NULL	207600	TAKAYASU ARTERITIS	AORTIC ARCH SYNDROME;; YOUNG FEMALE ARTERITIS;; PULSELESS DISEASE	
NULL	207620	APHALANGY WITH HEMIVERTEBRAE		
NULL	207720	APNEA, CENTRAL SLEEP	SLEEP APNEA, LETHAL CENTRAL	
NULL	207731	APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA	ACC WITH INTESTINAL LYMPHANGIECTASIA	
NULL	207740	APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZED POLYNEUROPATHY		
Number Sign	207750	APOLIPOPROTEIN C-II DEFICIENCY	HYPERLIPOPROTEINEMIA, TYPE IB;; C-II ANAPOLIPOPROTEINEMIA;; APOC2 DEFICIENCY	
NULL	207770	APROSENCEPHALY SYNDROME	XK SYNDROME;; GARCIA-LURIE SYNDROME	
NULL	207780	AREDYLD	ACRORENAL FIELD DEFECT, ECTODERMAL DYSPLASIA, AND LIPOATROPHIC DIABETES	
NULL	207790	ARACHNOID CYSTS, INTRACRANIAL		
Number Sign	207800	ARGININEMIA	ARGINASE DEFICIENCY;; HYPERARGININEMIA;; ARG1 DEFICIENCY	
Number Sign	207900	ARGININOSUCCINIC ACIDURIA	ARGININOSUCCINASE DEFICIENCY;; ARGININOSUCCINATE LYASE DEFICIENCY;; ASL DEFICIENCY;; ARGININOSUCCINIC ACID LYASE DEFICIENCY	
Percent	207950	CHIARI MALFORMATION TYPE II	CM2;; ARNOLD-CHIARI MALFORMATION	
Number Sign	208000	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	GACI;; IDIOPATHIC INFANTILE ARTERIAL CALCIFICATION; IIAC;; ARTERIAL CALCIFICATION, IDIOPATHIC INFANTILE;; ARTERIOPATHY, OCCLUSIVE INFANTILE	CORONARY SCLEROSIS, MEDIAL, OF INFANCY, INCLUDED
Number Sign	208050	ARTERIAL TORTUOSITY SYNDROME; ATS	ARTERIAL TORTUOSITY	
Percent	208060	ARTERIOSCLEROSIS, SEVERE JUVENILE		
NULL	208080	ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION, AND FACIAL ANOMALIES		
NULL	208081	ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTIC FACIES		
Number Sign	208085	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1; ARCS1	ARC SYNDROME; ARCS	
Percent	208100	ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	AMC, NEUROGENIC TYPE	
Number Sign	208150	FETAL AKINESIA DEFORMATION SEQUENCE; FADS	PENA-SHOKEIR SYNDROME, TYPE I;; FETAL AKINESIA SEQUENCE;; ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH PULMONARY HYPOPLASIA	
NULL	208155	ILLUM SYNDROME	ARTHROGRYPOSIS, WHISTLING FACE, AND DEVELOPMENTAL RETARDATION	
NULL	208158	ARTHROGRYPOSIS WITH HYPERKERATOSIS		
Number Sign	208230	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD; PPAC	PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD;; SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH PROGRESSIVE ARTHROPATHY; SEDT-PA;; PROGRESSIVE PSEUDORHEUMATOID DYSPLASIA; PPD	
Number Sign	208250	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME; CACP	ARTHROPATHY-CAMPTODACTYLY SYNDROME;; HYPERTROPHIC SYNOVITIS, CONGENITAL FAMILIAL;; JACOBS SYNDROME;; FIBROSING SEROSITIS, FAMILIAL;; PERICARDITIS-ARTHROPATHY-CAMPTODACTYLY SYNDROME;; PAC SYNDROME;; CAMPTODACTYLY-ARTHROPATHY-PERICARDITIS SYNDROME;; CAP SYNDROME	
NULL	208300	ASCITES, CHYLOUS		
Number Sign	208400	ASPARTYLGLUCOSAMINURIA; AGU	GLYCOSYLASPARAGINASE DEFICIENCY;; ASPARTYLGLUCOSAMINIDASE DEFICIENCY;; AGA DEFICIENCY;; GLYCOASPARAGINASE;; ASPARTYLGLYCOSAMINURIA	
Percent	208500	SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	ASPHYXIATING THORACIC DYSTROPHY 1; ATD1;; JEUNE SYNDROME;; THORACIC-PELVIC-PHALANGEAL DYSTROPHY	
Number Sign	208530	RIGHT ATRIAL ISOMERISM; RAI	ASPLENIA WITH CARDIOVASCULAR ANOMALIES;; IVEMARK SYNDROME	POLYSPLENIA SYNDROME, INCLUDED;; POLYASPLENIA, INCLUDED;; HETEROTAXY, VISCEROATRIAL, AUTOSOMAL RECESSIVE, INCLUDED;; VAH, AUTOSOMAL RECESSIVE, INCLUDED
Number Sign	208540	RENAL-HEPATIC-PANCREATIC DYSPLASIA 1; RHPD1	RHPD	
Number Sign	208550	ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	ASA TRIAD	ASTHMA, ASPIRIN-INDUCED, SUSCEPTIBILITY TO, INCLUDED;; ASTHMA AND NASAL POLYPS, INCLUDED
NULL	208600	ASTHMA, SHORT STATURE, AND ELEVATED IgA		
NULL	208700	ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA		
Percent	208750	ATAXIA, DEAFNESS, AND CARDIOMYOPATHY		
NULL	208850	ATAXIA-DEAFNESS-RETARDATION SYNDROME	ADR SYNDROME	
NULL	208870	ATAXIA-MICROCEPHALY-CATARACT SYNDROME	AMC SYNDROME	
Number Sign	208900	ATAXIA-TELANGIECTASIA; AT	AT1;; LOUIS-BAR SYNDROME	AT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;; AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;; AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;; AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;; ATAXIA-TELANGIECTASIA VARIANT, INCLUDED
NULL	208910	ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH		
Number Sign	208920	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	ATAXIA-OCULOMOTOR APRAXIA SYNDROME; AOA;; ATAXIA-OCULOMOTOR APRAXIA 1; AOA1;; ATAXIA-TELANGIECTASIA-LIKE SYNDROME;; CEREBELLAR ATAXIA, EARLY-ONSET, WITH HYPOALBUMINEMIA; EOCA-HA	ATAXIA, ADULT-ONSET, WITH OCULOMOTOR APRAXIA, INCLUDED
NULL	209010	ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS, PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE		
NULL	209050	ATHROMBIA, ESSENTIAL		
Percent	209100	ATONIC-ASTATIC SYNDROME OF FOERSTER		
Number Sign	209300	ATRANSFERRINEMIA	HYPOTRANSFERRINEMIA, FAMILIAL	TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1, INCLUDED; TFQTL1, INCLUDED
Number Sign	209500	ATRICHIA WITH PAPULAR LESIONS; APL	PAPULAR ATRICHIA	
NULL	209600	ATRIOVENTRICULAR DISSOCIATION	A-V DISSOCIATION	
Percent	209700	ATROPHODERMA VERMICULATA; AVA	FOLLICULITIS ULERYTHEMATOSA RETICULATA;; ATROPHODERMIA VERMICULATA;; HONEYCOMB ATROPHY;; ATROPHODERMIA RETICULATA SYMMETRICA FACIEI	
NULL	209770	AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION		
NULL	209800	AUSTRALIA ANTIGEN		
Percent	209850	AUTISM	AUTISTIC DISORDER	AUTISM, SUSCEPTIBILITY TO, 1, INCLUDED; AUTS1, INCLUDED;; AUTISM SPECTRUM DISORDER, INCLUDED; ASD, INCLUDED
Number Sign	209880	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	AUTONOMIC CONTROL, CONGENITAL FAILURE OF;; ONDINE CURSE, CONGENITAL	ONDINE-HIRSCHSPRUNG DISEASE, INCLUDED; OHD, INCLUDED;; CCHS WITH HIRSCHSPRUNG DISEASE, INCLUDED;; HADDAD SYNDROME, INCLUDED
Number Sign	209885	BARBER-SAY SYNDROME; BBRSAY	BSS;; HYPERTRICHOSIS, ATROPHIC SKIN, ECTROPION, AND MACROSTOMIA	
Number Sign	209900	BARDET-BIEDL SYNDROME 1; BBS1		
Number Sign	209920	BARE LYMPHOCYTE SYNDROME, TYPE II	BLS, TYPE II;; BARE LYMPHOCYTE SYNDROME; BLS;; SEVERE COMBINED IMMUNODEFICIENCY, HLA CLASS II-NEGATIVE;; SCID, HLA CLASS II-NEGATIVE	BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP A, INCLUDED;; BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP B, INCLUDED;; BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP C, INCLUDED;; BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP D, INCLUDED;; BARE LYMPHOCYTE SYNDROME, TYPE II, COMPLEMENTATION GROUP E, INCLUDED
Number Sign	209950	IMMUNODEFICIENCY 27A; IMD27A	IMMUNODEFICIENCY 27A, MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE;; IFNGR1 DEFICIENCY, AUTOSOMAL RECESSIVE	
NULL	209970	BEEMER LETHAL MALFORMATION SYNDROME	HYDROCEPHALUS, CARDIAC MALFORMATION, DENSE BONES, ETC.	
Number Sign	210000	BEHR SYNDROME; BEHRS	OPTIC ATROPHY, INFANTILE HEREDITARY, WITH NEUROLOGIC ABNORMALITIES	
NULL	210050	BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	CEREBRAL ANEURYSM-CIRRHOSIS SYNDROME	
Number Sign	210100	BETA-AMINOISOBUTYRIC ACIDURIA; BAIBA	BETA-AMINOISOBUTYRIC ACID, URINARY EXCRETION OF;; BAIB URINARY EXCRETION;; HYPER-BETA-AMINOISOBUTYRIC ACIDURIA	
Number Sign	210200	3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	MCCD TYPE 1;; MCC1 DEFICIENCY;; 3-METHYLCROTONYLGLYCINURIA I;; METHYLCROTONYLGLYCINURIA TYPE I	
Number Sign	210210	3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	MCC2 DEFICIENCY;; 3-METHYLCROTONYLGLYCINURIA II;; METHYLCROTONYLGLYCINURIA, TYPE II	
Number Sign	210250	SITOSTEROLEMIA	STSL;; PHYTOSTEROLEMIA	MACROTHROMBOCYTOPENIA/STOMATOCYTOSIS, MEDITERRANEAN, INCLUDED
NULL	210350	BIEMOND SYNDROME II		
Number Sign	210370	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	BIETTI CRYSTALLINE DYSTROPHY;; BIETTI TAPETORETINAL DEGENERATION WITH MARGINAL CORNEAL DYSTROPHY	
NULL	210400	BIFID NOSE, AUTOSOMAL RECESSIVE	MEDIAN FISSURE OF NOSE;; NOSE, MEDIAN CLEFT OF	
Percent	210500	BILIARY ATRESIA, EXTRAHEPATIC; EHBA		
NULL	210550	BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	CHOLESTATIC JAUNDICE AND RENAL TUBULAR INSUFFICIENCY	
Number Sign	210600	SECKEL SYNDROME 1; SCKL1	SCKL;; SECKEL-TYPE DWARFISM;; NANOCEPHALIC DWARFISM;; MICROCEPHALIC PRIMORDIAL DWARFISM I;; BIRD-HEADED DWARFISM	
NULL	210700	MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	BIRD-HEADED DWARFISM, MONTREAL TYPE	
Number Sign	210710	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I; MOPD1	MOPD I; MOPD;; OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I;; BRACHYMELIC PRIMORDIAL DWARFISM;; TAYBI-LINDER SYNDROME; TALS;; CEPHALOSKELETAL DYSPLASIA;; LOW-BIRTH-WEIGHT DWARFISM WITH SKELETAL DYSPLASIA	
Number Sign	210720	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	MOPD II;; OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II	
Percent	210730	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	MOPD III; MOPD3;; OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III;; MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, CAROLINE CRACHAMI TYPE;; MOPD, CAROLINE CRACHAMI TYPE;; MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, SICILIAN FAIRY TYPE;; MOPD, SICILIAN FAIRY TYPE	
NULL	210740	BANGSTAD SYNDROME	BIRD-HEADED DWARFISM WITH PROGRESSIVE ATAXIA, INSULIN-RESISTANT DIABETES, GOITER, AND PRIMARY GONADAL INSUFFICIENCY	
Percent	210745	BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE		
Number Sign	210750	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6; SHEP6	SKIN/HAIR/EYE PIGMENTATION 6, BLOND/BROWN HAIR;; SKIN/HAIR/EYE PIGMENTATION 6, BLUE/GREEN EYES	
Number Sign	210900	BLOOM SYNDROME; BLM	BS; BLS	
NULL	211000	BLUE DIAPER SYNDROME	HYPERCALCEMIA, FAMILIAL, WITH NEPHROCALCINOSIS AND INDICANURIA	
NULL	211120	BONE DYSPLASIA, LETHAL, HOLMGREN TYPE		
Number Sign	211180	BOWEN-CONRADI SYNDROME; BWCNS	BOWEN HUTTERITE SYNDROME, FORMERLY	
NULL	211200	BOWEN SYNDROME OF MULTIPLE MALFORMATIONS		
Percent	211350	KYPHOMELIC DYSPLASIA	BOWING, CONGENITAL, WITH SHORT BONES	
NULL	211355	BOWING OF LONG BONES, ASYMMETRIC AND SYMMETRIC		
NULL	211369	BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY		
NULL	211370	BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	ANODONTIA-HYPOTRICHOSIS SYNDROME;; OCULOOSTEOCUTANEOUS SYNDROME	
NULL	211380	BRACHIOSKELETOGENITAL SYNDROME	BSG SYNDROME	
Percent	211390	SABINAS BRITTLE HAIR SYNDROME	BRITTLE HAIR AND MENTAL DEFICIT	
Number Sign	211400	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1	CYSTIC FIBROSIS-LIKE SYNDROME	
NULL	211450	BRONCHOMALACIA	WILLIAMS-CAMPBELL SYNDROME	
NULL	211480	BUERGER DISEASE	THROMBOANGIITIS OBLITERANS	
Number Sign	211500	FAZIO-LONDE DISEASE	BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	
Number Sign	211530	BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	BULBAR PALSY, PROGRESSIVE, WITH SENSORINEURAL DEAFNESS;; PONTOBULBAR PALSY WITH DEAFNESS	
Number Sign	211600	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1	BYLER DISEASE	
Number Sign	211750	C SYNDROME	OPITZ TRIGONOCEPHALY SYNDROME;; TRIGONOCEPHALY SYNDROME	
NULL	211770	CAHMR SYNDROME	CATARACT, HYPERTRICHOSIS, MENTAL RETARDATION SYNDROME	
Number Sign	211800	CALCIFICATION OF JOINTS AND ARTERIES; CALJA	ARTERIAL CALCIFICATION DUE TO DEFICIENCY OF CD73; ACDC	
Percent	211890	CAMPOMELIA, CUMMING TYPE	CERVICAL LYMPHOCELE WITH BOWED LONG BONES;; CUMMING SYNDROME	
Number Sign	211900	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL; HFTC	CALCINOSIS, TUMORAL, WITH HYPERPHOSPHATEMIA;; TUMORAL CALCINOSIS, PRIMARY HYPERPHOSPHATEMIC; PHPTC;; LIPOCALCINOGRANULOMATOSIS;; TEUTSCHLAENDER DISEASE, FAMILIAL;; MORBUS TEUTSCHLAENDER;; HYPEROSTOSIS-HYPERPHOSPHATEMIA SYNDROME; HHS;; HYPEROSTOSIS WITH HYPERPHOSPHATEMIA;; CORTICAL HYPEROSTOSIS WITH HYPERPHOSPHATEMIA	
NULL	211910	CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1	FACIOTHORACOSKELETAL SYNDROME; FTSS	
NULL	211920	CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II		
NULL	211930	CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA		
Percent	211960	CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMAL PALMAR CREASES	TEL HASHOMER CAMPTODACTYLY SYNDROME	
NULL	211965	CAMPTODACTYLY-ICHTHYOSIS SYNDROME		
Number Sign	211980	LUNG CANCER		ALVEOLAR CELL CARCINOMA, INCLUDED;; ADENOCARCINOMA OF LUNG, INCLUDED;; NONSMALL CELL LUNG CANCER, INCLUDED;; LUNG CANCER, PROTECTION AGAINST, INCLUDED
NULL	211990	CAMPTOMELIC SYNDROME, LONG-LIMB TYPE	CAMPOMELIC SYNDROME, LONG-LIMB TYPE	
Number Sign	212050	CANDIDIASIS, FAMILIAL, 2; CANDF2	CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE;; CARD9 IMMUNODEFICIENCY	
NULL	212060	CARBIMAZOLE SENSITIVITY		
Number Sign	212065	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	CDG Ia; CDGIa;; JAEKEN SYNDROME;; PHOSPHOMANNOMUTASE 2 DEFICIENCY;; CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE Ia, FORMERLY	
Number Sign	212066	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	CDG IIa; CDGIIa;; ALKURAYA SYNDROME;; MENTAL RETARDATION, GROWTH RETARDATION, PROMINENT COLUMELLA, AND OPEN MOUTH;; CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE II, FORMERLY; CDGS2, FORMERLY	
NULL	212067	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx	CDG-x	
Number Sign	212070	CARBOXYPEPTIDASE N DEFICIENCY		
NULL	212080	CARDIAC LIPIDOSIS, FAMILIAL		
NULL	212090	CARDIAC SEPTAL DEFECTS WITH COARCTATION OF THE AORTA		
Number Sign	212093	CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD		
NULL	212100	CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS		
Number Sign	212112	CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	MALOUF SYNDROME;; CARDIOMYOPATHY, CONGESTIVE, WITH HYPERGONADOTROPIC HYPOGONADISM;; CARDIOMYOPATHY, DILATED, WITH PREMATURE OVARIAN FAILURE;; CARDIOMYOPATHY WITH PRIMARY TESTICULAR FAILURE;; NAJJAR SYNDROME;; GENITAL ANOMALY WITH CARDIOMYOPATHY;; CARDIOGENITAL SYNDROME	
Percent	212130	CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH		
NULL	212135	CARDIOSKELETAL SYNDROME, KUWAITI TYPE		
Number Sign	212138	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD	CACT DEFICIENCY	
Number Sign	212140	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP	SYSTEMIC CARNITINE DEFICIENCY; SCD;; CARNITINE DEFICIENCY, SYSTEMIC, DUE TO DEFECT IN RENAL REABSORPTION OF CARNITINE;; CARNITINE DEFICIENCY, PRIMARY;; CARNITINE TRANSPORTER, PLASMA-MEMBRANE, DEFICIENCY OF;; CARNITINE UPTAKE DEFECT; CUD	
Percent	212160	CARNITINE DEFICIENCY, MYOPATHIC		
Percent	212200	CARNOSINEMIA	CARNOSINASE DEFICIENCY	
Number Sign	212350	SENGERS SYNDROME	MITOCHONDRIAL DNA DEPLETION SYNDROME 10 (CARDIOMYOPATHIC TYPE); MTDPS10;; CARDIOMYOPATHY AND CATARACT	
NULL	212360	PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	PPKCA, WALLIS TYPE;; CATARACT-ALOPECIA-SCLERODACTYLY SYNDROME; CASS	
Percent	212400	CATARACT AND CONGENITAL ICHTHYOSIS		
Number Sign	212500	CATARACT 46, JUVENILE-ONSET; CTRCT46	CATARACT, JUVENILE, HUTTERITE TYPE	
NULL	212540	CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME	CAMFAK SYNDROME	CATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;; CAMAK SYNDROME, INCLUDED
Number Sign	212550	OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD		
NULL	212710	CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	POLYNEUROPATHY-CATARACT-DEAFNESS SYNDROME	
Number Sign	212720	MARTSOLF SYNDROME	CATARACT-MENTAL RETARDATION-HYPOGONADISM	
Number Sign	212750	CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	CELIAC SPRUE, SUSCEPTIBILITY TO, 1;; GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 1	
Number Sign	212780	CENANI-LENZ SYNDACTYLY SYNDROME; CLSS	CENANI SYNDACTYLISM;; CENANI-LENZ SYNDACTYLY;; SYNDACTYLY, TYPE VII	
Percent	212790	PREMATURE CENTROMERE DIVISION; PCD	X-CHROMOSOME CENTROMERE PECULIARITY	
NULL	212800	CEPHALIN LIPIDOSIS		
NULL	212835	CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA		
Number Sign	212840	GORDON HOLMES SYNDROME; GDHS	CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;; LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;; LHRH DEFICIENCY AND ATAXIA	
NULL	212850	CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS		
NULL	212890	CEREBELLAR ATAXIA, BENIGN, WITH THERMOANALGESIA	CEREBELLAR ATAXIA WITH LOSS OF PAIN AND TEMPERATURE SENSATION	
Percent	212895	CEREBELLAR ATAXIA, EARLY-ONSET, WITH RETAINED TENDON REFLEXES; EOCA		
Percent	213000	CEREBELLAR HYPOPLASIA		
NULL	213002	CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS		
NULL	213010	CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZ SYNDROME AND MECKEL SYNDROME		
Percent	213100	CEREBELLOPARENCHYMAL DISORDER II; CPD2	CPD, LATE-ONSET RECESSIVE TYPE	
Number Sign	213200	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	CEREBELLAR HYPOPLASIA, NONPROGRESSIVE NORMAN TYPE;; CEREBELLAR GRANULAR CELL HYPOPLASIA AND MENTAL RETARDATION, CONGENITAL;; CEREBELLOPARENCHYMAL DISORDER III; CPD3;; CPD III	
Number Sign	213300	JOUBERT SYNDROME 1; JBTS1	JOUBERT SYNDROME; JBTS;; JOUBERT-BOLTSHAUSER SYNDROME;; CEREBELLOPARENCHYMAL DISORDER IV; CPD4;; CEREBELLOOCULORENAL SYNDROME 1; CORS1	
NULL	213400	CEREBELLOPARENCHYMAL DISORDER V; CPD5	SPINODENTATE ATROPHY;; DYSSYNERGIA CEREBELLARIS MYOCLONICA OF HUNT	
NULL	213500	CEREBRAL ANGIOPATHY, DYSPHORIC		
Number Sign	213600	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	STRIOPALLIDODENTATE CALCINOSIS, BILATERAL; BSPDC;; STRIOPALLIDODENTATE CALCINOSIS, AUTOSOMAL DOMINANT, ADULT-ONSET;; CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, ADULT-ONSET;; FERROCALCINOSIS, CEREBROVASCULAR;; FAHR DISEASE, FAMILIAL, FORMERLY;; BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 3, FORMERLY; IBGC3, FORMERLY	
Number Sign	213700	CEREBROTENDINOUS XANTHOMATOSIS; CTX	CEREBRAL CHOLESTERINOSIS	
NULL	213820	CEREBRAL MALFORMATION, SEIZURES, HYPERTRICHOSIS, AND OVERLAPPING FINGERS		
NULL	213900	CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE		
NULL	213950	CEREBROCORTICAL DEGENERATION OF INFANCY		
Number Sign	213980	CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME; CFSMR	CEREBROFACIOTHORACIC DYSPLASIA	
Number Sign	214100	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER); PBD1A	ZS; ZWS;; CEREBROHEPATORENAL SYNDROME; CHR	PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 1, INCLUDED; CG1, INCLUDED;; PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP E, INCLUDED; CGE, INCLUDED
Number Sign	214110	PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A		PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 2, INCLUDED; CG2, INCLUDED
Number Sign	214150	CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1	COFS SYNDROME; COFS;; PENA-SHOKEIR SYNDROME, TYPE II	
NULL	214200	CEROID STORAGE DISEASE	LIPOFUSCIN STORAGE DISEASE	
NULL	214290	CERVICAL VERTEBRAE, AGENESIS OF		
Number Sign	214300	KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE; KFS2	KFS, AUTOSOMAL RECESSIVE;; CERVICAL VERTEBRAL FUSION, AUTOSOMAL RECESSIVE	
NULL	214350	CHAND SYNDROME; CHANDS	CURLY HAIR-ANKYLOBLEPHARON-NAIL DYSPLASIA SYNDROME	
Percent	214370	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION, AND ABSENT SENSORY LARGE MYELINATED FIBERS	CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS;; DEAFNESS WITH CHARCOT-MARIE-TOOTH DISEASE	
Number Sign	214400	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4A;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4A	
Number Sign	214450	GRISCELLI SYNDROME, TYPE 1; GS1	GRISCELLI SYNDROME WITH NEUROLOGIC IMPAIRMENT;; PARTIAL ALBINISM AND PRIMARY NEUROLOGIC DISEASE WITHOUT HEMOPHAGOCYTIC SYNDROME;; GRISCELLI SYNDROME, CUTANEOUS AND NEUROLOGIC TYPE	
Number Sign	214500	CHEDIAK-HIGASHI SYNDROME; CHS		
Number Sign	214700	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1	CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;; CHLORIDORRHEA, CONGENITAL	
Number Sign	214800	CHARGE SYNDROME	CHARGE ASSOCIATION--COLOBOMA, HEART ANOMALY, CHOANAL ATRESIA, RETARDATION, GENITAL AND EAR ANOMALIES;; HALL-HITTNER SYNDROME; HHS	
Percent	214900	CHOLESTASIS-LYMPHEDEMA SYNDROME	CHLS;; AAGENAES SYNDROME;; LYMPHEDEMA-CHOLESTASIS SYNDROME; LCS; LCS1	
Number Sign	214950	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4; CBAS4	CHOLESTASIS, INTRAHEPATIC, WITH DEFECTIVE CONVERSION OF TRIHYDROXYCOPROSTANIC ACID TO CHOLIC ACID;; TRIHYDROXYCOPROSTANIC ACID IN BILE	
NULL	214980	CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE		
NULL	215030	CHOLESTEROL PNEUMONIA		
Number Sign	215045	CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD		
NULL	215050	CHONDRODYSPLASIA CALCIFICANS METAPHYSEALIS		
Number Sign	215100	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1	PEROXISOME BIOGENESIS DISORDER 9; PBD9;; CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;; CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	
NULL	215105	CHONDRODYSPLASIA PUNCTATA SYNDROME		
Number Sign	215140	GREENBERG DYSPLASIA; GRBGD	HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;; HEM SKELETAL DYSPLASIA;; MOTH-EATEN SKELETAL DYSPLASIA;; CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	
Number Sign	215150	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; OSMEDB	OSMED;; CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;; NANCE-INSLEY SYNDROME;; NANCE-SWEENEY CHONDRODYSPLASIA;; WEISSENBACHER-ZWEYMULLER SYNDROME, FORMERLY; WZS, FORMERLY	
NULL	215250	CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME		
Number Sign	215300	CHONDROSARCOMA		
Number Sign	215400	CHORDOMA, SUSCEPTIBILITY TO; CHDM		
NULL	215450	CHOREA, BENIGN FAMILIAL		
Number Sign	215470	BOUCHER-NEUHAUSER SYNDROME; BNHS	SPINOCEREBELLAR ATAXIA, HYPOGONADOTROPIC HYPOGONADISM, AND CHORIORETINAL DYSTROPHY	
NULL	215480	CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION		
Percent	215500	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 1; CACD1	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR; CACD;; CHOROIDAL SCLEROSIS	
NULL	215510	CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY		
NULL	215518	CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	RUTLAND CILIARY DISORIENTATION SYNDROME	
Percent	215520	CILIARY DYSKINESIA WITH TRANSPOSITION OF CILIARY MICROTUBULES		
NULL	215550	CIRCUMVALLATE PLACENTA SYNDROME		
Number Sign	215600	CIRRHOSIS, FAMILIAL		CIRRHOSIS, FAMILIAL, WITH PULMONARY HYPERTENSION, INCLUDED;; INDIAN CHILDHOOD CIRRHOSIS, INCLUDED; ICC, INCLUDED;; SEN SYNDROME, INCLUDED;; COPPER-OVERLOAD CIRRHOSIS, INCLUDED;; ENDEMIC TYROLEAN INFANTILE CIRRHOSIS, INCLUDED; ETIC, INCLUDED;; COPPER TOXICOSIS, IDIOPATHIC, INCLUDED; ICT, INCLUDED;; CIRRHOSIS, CRYPTOGENIC, INCLUDED;; CIRRHOSIS, NONCRYPTOGENIC, SUSCEPTIBILITY TO, INCLUDED
Number Sign	215700	CITRULLINEMIA, CLASSIC	CITRULLINEMIA, TYPE I; CTLN1;; CITRULLINURIA;; ARGININOSUCCINATE SYNTHETASE DEFICIENCY;; ASS DEFICIENCY	
NULL	215720	CITRULLINE TRANSPORT DEFECT		
NULL	215800	CLEFT LARYNX, POSTERIOR		STRIDOR, CONGENITAL, INCLUDED
NULL	215850	CLEFT-LIMB-HEART MALFORMATION SYNDROME	CLH SYNDROME	
NULL	216100	CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	OROCRANIODIGITAL SYNDROME;; JUBERG-HAYWARD SYNDROME; JHS	
NULL	216300	CLEFT PALATE, DEAFNESS, AND OLIGODONTIA		
NULL	216330	CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM		
Number Sign	216340	YUNIS-VARON SYNDROME; YVS	CLEIDOCRANIAL DYSPLASIA WITH MICROGNATHIA, ABSENT THUMBS, AND DISTAL APHALANGIA	
Number Sign	216360	COACH SYNDROME	CEREBELLAR VERMIS HYPO/APLASIA, OLIGOPHRENIA, CONGENITAL ATAXIA, OCULAR COLOBOMA, AND HEPATIC FIBROSIS;; JOUBERT SYNDROME WITH CONGENITAL HEPATIC FIBROSIS	
Number Sign	216400	COCKAYNE SYNDROME A; CSA		
Number Sign	216550	COHEN SYNDROME; COH1	COH;; HYPOTONIA, OBESITY, AND PROMINENT INCISORS;; PEPPER SYNDROME;; CHS1, FORMERLY	
Percent	216700	COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING; RPC		
NULL	216800	COLOBOMA OF MACULA AND SKELETAL ANOMALIES		
Number Sign	216820	COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE		
Number Sign	216900	ACHROMATOPSIA 2; ACHM2	COLORBLINDNESS, TOTAL;; ROD MONOCHROMATISM 2;; ROD MONOCHROMACY 2; RMCH2	
NULL	216920	COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT		
Percent	216950	COMPLEMENT COMPONENT C1r/C1s DEFICIENCY	C1r/C1s DEFICIENCY	
Number Sign	217000	COMPLEMENT COMPONENT 2 DEFICIENCY; C2D	C2 DEFICIENCY	
Number Sign	217080	JALILI SYNDROME	CONE-ROD DYSTROPHY AND AMELOGENESIS IMPERFECTA	
Number Sign	217085	CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY; CHDTHP		
Number Sign	217090	PLASMINOGEN DEFICIENCY, TYPE I		LIGNEOUS CONJUNCTIVITIS, INCLUDED;; DYSPLASMINOGENEMIA, INCLUDED;; PLASMINOGEN DEFICIENCY, TYPE II, INCLUDED
Number Sign	217095	CONOTRUNCAL HEART MALFORMATIONS; CTHM		TRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;; CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;; DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;; PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;; INTERRUPTED AORTIC ARCH, INCLUDED
Percent	217100	CONSTRICTING BANDS, CONGENITAL	AMNIOTIC BAND SEQUENCE; ABS;; STREETER ANOMALY	ADAM COMPLEX, INCLUDED;; TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;; AMPUTATION, CONGENITAL, INCLUDED
NULL	217150	CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA		
NULL	217200	CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET		
Number Sign	217300	CORNEA PLANA 2, AUTOSOMAL RECESSIVE; CNA2		
Number Sign	217400	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS; CDPD	CDPD1;; CORNEAL DYSTROPHY AND SENSORINEURAL DEAFNESS;; HARBOYAN SYNDROME	
Percent	217500	CORNEAL DYSTROPHY, BAND-SHAPED	BAND KERATOPATHY	
NULL	217520	CORNEAL DEGENERATION, BAND-SHAPED SPHEROID		
NULL	217600	CENTRAL CLOUDY DYSTROPHY OF FRANCOIS; CCDF	CORNEAL DYSTROPHY, CENTRAL TYPE	
Number Sign	217700	CORNEAL ENDOTHELIAL DYSTROPHY; CHED	CORNEAL DYSTROPHY, CONGENITAL HEREDITARY ENDOTHELIAL;; CONGENITAL HEREDITARY ENDOTHELIAL DYSTROPHY OF CORNEA;; CORNEAL ENDOTHELIAL DYSTROPHY 2, AUTOSOMAL RECESSIVE, FORMERLY; CHED2, FORMERLY	
Number Sign	217800	MACULAR DYSTROPHY, CORNEAL; MCD	CORNEAL DYSTROPHY, MACULAR TYPE;; GROENOUW TYPE II CORNEAL DYSTROPHY;; MACULAR CORNEAL DYSTROPHY, TYPE I;; MCDC1, FORMERLY	MACULAR CORNEAL DYSTROPHY, TYPE II, INCLUDED
Percent	217980	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	TORIELLO-CAREY SYNDROME	
Percent	217990	CORPUS CALLOSUM, AGENESIS OF	ACC	
Number Sign	218000	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN	CHARLEVOIX DISEASE;; ANDERMANN SYNDROME;; POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUS CALLOSUM;; CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	
NULL	218010	CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY		
Number Sign	218030	APPARENT MINERALOCORTICOID EXCESS; AME	AME1;; CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY	
Number Sign	218040	COSTELLO SYNDROME; CSTLO	FACIOCUTANEOSKELETAL SYNDROME;; FCS SYNDROME	MYOPATHY, CONGENITAL, WITH EXCESS OF MUSCLE SPINDLES, INCLUDED; CMEMS, INCLUDED
NULL	218050	CRAMPS, FAMILIAL ADOLESCENT		
NULL	218090	CRANE-HEISE SYNDROME	CLEFT LIP/PALATE, AGENESIS OF CLAVICLES AND CERVICAL VERTEBRAE, AND TALIPES EQUINOVARUS	
Percent	218100	CRANIAL NERVES, CONGENITAL PARESIS OF		
NULL	218200	CRANIAL NERVES, RECURRENT PARESIS OF		
NULL	218300	CRANIODIAPHYSEAL DYSPLASIA; CDD		
Number Sign	218330	CRANIOECTODERMAL DYSPLASIA 1; CED1	SENSENBRENNER SYNDROME;; LEVIN SYNDROME I	
Number Sign	218340	TEMTAMY SYNDROME; TEMTYS	MENTAL RETARDATION WITH OR WITHOUT CRANIOFACIAL DYSMORPHISM, OCULAR COLOBOMA, OR ABNORMAL CORPUS CALLOSUM	
NULL	218350	CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	BILATERAL LAMBDOID AND SAGITTAL SYNOSTOSIS; BLSS	
Number Sign	218400	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR		
NULL	218450	CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	PFEIFFER CARDIOCRANIAL SYNDROME	
NULL	218530	CRANIOSYNOSTOSIS WITH ANOMALIES OF THE CRANIAL BASE AND DIGITS		
NULL	218550	CRANIOSYNOSTOSIS WITH FIBULAR APLASIA		
Number Sign	218600	BALLER-GEROLD SYNDROME; BGS	CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;; CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	
NULL	218649	CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG		
NULL	218650	CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME		
NULL	218670	CRANIOTELENCEPHALIC DYSPLASIA		
Number Sign	218700	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2; CHNG2	THYROID DYSGENESIS;; THYROID AGENESIS;; THYROID HYPOPLASIA;; THYROID, ECTOPIC;; HYPOTHYROIDISM, CONGENITAL, DUE TO THYROID DYSGENESIS;; HYPOTHYROIDISM, ATHYREOTIC;; ATHYREOTIC HYPOTHYROIDISM;; RESISTANCE TO THYROTROPIN; RTSH;; THYROTROPIN RESISTANCE	
Number Sign	218800	CRIGLER-NAJJAR SYNDROME, TYPE I	HYPERBILIRUBINEMIA, CRIGLER-NAJJAR TYPE I; HBLRCN1;; CRIGLER-NAJJAR SYNDROME	
Percent	218900	CROME SYNDROME		
Number Sign	219000	FRASER SYNDROME 1; FRASRS1	FRASER SYNDROME;; CRYPTOPHTHALMOS WITH OTHER MALFORMATIONS;; CRYPTOPHTHALMOS-SYNDACTYLY SYNDROME	
Number Sign	219050	CRYPTORCHIDISM, UNILATERAL OR BILATERAL	UNDESCENDED TESTIS	
NULL	219070	CURVED NAIL OF FOURTH TOE	CLAW-LIKE FINGERS AND TOES	
Number Sign	219080	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	ACTH-INDEPENDENT MACRONODULAR ADRENOCORTICAL HYPERPLASIA;; ADRENOCORTICOTROPIC HORMONE-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA;; CORTICOTROPIN-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA;; CUSHING SYNDROME, ADRENAL, DUE TO AIMAH	
Number Sign	219090	PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	CUSHING DISEASE, PITUITARY	
NULL	219095	CUTANEOUS PHOTOSENSITIVITY AND COLITIS, LETHAL		
Number Sign	219100	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A	ARCL1;; CUTIS LAXA, AUTOSOMAL RECESSIVE	
Number Sign	219150	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA; ARCL3A	DE BARSY SYNDROME A;; CUTIS LAXA, CORNEAL CLOUDING, AND MENTAL RETARDATION;; PROGEROID SYNDROME OF DE BARSY	
Number Sign	219200	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	ARCL2;; CUTIS LAXA WITH CONGENITAL DISORDER OF GLYCOSYLATION;; CUTIS LAXA WITH GROWTH AND DEVELOPMENTAL DELAY;; CUTIS LAXA, DEBRE TYPE;; CUTIS LAXA WITH BONE DYSTROPHY;; CUTIS LAXA WITH JOINT LAXITY AND RETARDED DEVELOPMENT	
NULL	219250	CUTIS MARMORATA TELANGIECTATICA CONGENITA; CMTC		
NULL	219300	CUTIS VERTICIS GYRATA AND MENTAL RETARDATION; CVG/MR		
NULL	219400	CYANOSIS AND HEPATIC DISEASE		
Number Sign	219500	CYSTATHIONINURIA	CYSTATHIONASE DEFICIENCY	
NULL	219550	CYSTEINE PEPTIDURIA		
NULL	219600	CYSTIC DISEASE OF LUNG		
Number Sign	219700	CYSTIC FIBROSIS; CF	MUCOVISCIDOSIS	
NULL	219721	CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION		
Number Sign	219730	VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD		
Number Sign	219750	CYSTINOSIS, ADULT NONNEPHROPATHIC	CYSTINOSIS, OCULAR NONNEPHROPATHIC;; CYSTINOSIS, BENIGN NONNEPHROPATHIC	
Number Sign	219800	CYSTINOSIS, NEPHROPATHIC; CTNS	LYSOSOMAL CYSTINE TRANSPORT PROTEIN, DEFECT OF;; CYSTINOSIN, DEFECT OF	CYSTINOSIS, INFANTILE NEPHROPATHIC, INCLUDED;; CYSTINOSIS, ATYPICAL NEPHROPATHIC, INCLUDED
Number Sign	219900	CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE	CYSTINOSIS, INTERMEDIATE	
Number Sign	220100	CYSTINURIA	CSNU;; CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;; CYSTINURIA, TYPE II, FORMERLY;; CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;; CYSTINURIA, TYPE NON-I, FORMERLY	CYSTINURIA, TYPE A, INCLUDED;; CYSTINURIA, TYPE B, INCLUDED;; CYSTINURIA, TYPE A/B, INCLUDED
Number Sign	220110	MITOCHONDRIAL COMPLEX IV DEFICIENCY	CYTOCHROME c OXIDASE DEFICIENCY;; COX DEFICIENCY	
Number Sign	220111	LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	CYTOCHROME c OXIDASE DEFICIENCY, FRENCH CANADIAN TYPE;; COX DEFICIENCY, FRENCH CANADIAN TYPE;; COX DEFICIENCY, SAGUENAY-LAC-SAINT-JEAN TYPE;; LEIGH SYNDROME, SAGUENAY-LAC-SAINT-JEAN TYPE	
Number Sign	220120	D-GLYCERIC ACIDURIA	D-GLYCERIC ACIDEMIA;; GLYCERATE KINASE DEFICIENCY	
Number Sign	220150	HYPOURICEMIA, RENAL, 1; RHUC1	DALMATIAN HYPOURICEMIA;; RENAL HYPOURICEMIA	
Percent	220200	DANDY-WALKER SYNDROME; DWS		DANDY-WALKER MALFORMATION, INCLUDED; DWM, INCLUDED
Number Sign	220210	RITSCHER-SCHINZEL SYNDROME 1; RTSC1	CRANIOCEREBELLOCARDIAC DYSPLASIA;; 3C SYNDROME;; DANDY-WALKER-LIKE MALFORMATION WITH ATRIOVENTRICULAR SEPTAL DEFECT	
NULL	220219	DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY		
NULL	220220	DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	DWM WITH POSTAXIAL POLYDACTYLY;; PIERQUIN SYNDROME	
Number Sign	220290	DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1A		DEAFNESS, DIGENIC, GJB2/GJB6, INCLUDED;; DEAFNESS, DIGENIC, GJB2/GJB3, INCLUDED
NULL	220300	DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY		
Number Sign	220400	JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1	DEAFNESS, CONGENITAL, AND FUNCTIONAL HEART DISEASE;; PROLONGED QT INTERVAL IN EKG AND SUDDEN DEATH;; CARDIOAUDITORY SYNDROME OF JERVELL AND LANGE-NIELSEN;; SURDO-CARDIAC SYNDROME	
Number Sign	220500	DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	DOOR SYNDROME;; DIGITORENOCEREBRAL SYNDROME;; DRC SYNDROME;; BRACHYDACTYLY DUE TO ABSENCE OF DISTAL PHALANGES;; ERONEN SYNDROME	
Number Sign	220600	SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS, AUTOSOMAL RECESSIVE; SHFM1D	DEAFNESS, CONGENITAL, WITH SPLIT HANDS AND FEET	
NULL	220900	DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM		
Number Sign	221200	DEAFNESS AND MYOPIA; DFNMYP		
Percent	221300	DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR		
NULL	221320	DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES		
Percent	221350	DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA		
NULL	221400	DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL AND PROGRESSIVE SENSORY NEUROPATHY	GROLL-HIRSCHOWITZ SYNDROME	
NULL	221500	DEAFNESS, NEURAL, CONGENITAL MODERATE		
NULL	221700	DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS		
NULL	221740	DEAFNESS-OLIGODONTIA SYNDROME		
NULL	221745	DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE		
Number Sign	221750	PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3	PITUITARY HORMONE DEFICIENCY, COMBINED, WITH RIGID CERVICAL SPINE;; DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	
NULL	221760	DERMATOGLYPHICS--PALMAR TRIRADIUS d, ABSENCE OF		
Number Sign	221770	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	NASU-HAKOLA DISEASE; NHD;; PRESENILE DEMENTIA WITH BONE CYSTS;; DEMENTIA, PREFRONTAL, WITH BONE CYSTS;; DEMENTIA, PROGRESSIVE, WITH LIPOMEMBRANOUS POLYCYSTIC OSTEODYSPLASIA;; BRAIN-BONE-FAT DISEASE	
NULL	221780	DERMATOGLYPHICS--HYPOTHENAR RADIAL ARCH		
NULL	221790	DERMATOLEUKODYSTROPHY		
Percent	221800	DERMOCHONDROCORNEAL DYSTROPHY	FRANCOIS SYNDROME	
NULL	221810	DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	KIRGHIZIAN DERMATOOSTEOLYSIS	
Number Sign	221820	LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS; HDLS	LEUKOENCEPHALOPATHY, ADULT-ONSET, WITH AXONAL SPHEROIDS AND PIGMENTED GLIA; ALSP;; LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;; GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;; DEMENTIA, FAMILIAL, NEUMANN TYPE;; SUBCORTICAL GLIOSIS OF NEUMANN	
Number Sign	221900	PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR	RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL; RNANC; NCRNA;; RETINAL NONATTACHMENT AND FALCIFORM DETACHMENT;; PERSISTENT FETAL VASCULATURE	
NULL	221950	DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA		
NULL	221995	DIABETES INSIPIDUS, NEPHROGENIC, WITH MENTAL RETARDATION AND INTRACEREBRAL CALCIFICATION		
Percent	222100	DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	DIABETES MELLITUS, TYPE I;; JUVENILE-ONSET DIABETES; JOD	DIABETES MELLITUS, INSULIN-DEPENDENT, 1, INCLUDED; IDDM1, INCLUDED;; INSULIN-DEPENDENT DIABETES MELLITUS 1, INCLUDED
Number Sign	222300	WOLFRAM SYNDROME 1; WFS1	WFS;; DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	
NULL	222350	DIAMINOPENTANURIA	CYSTINE-LYSINURIA	
Percent	222400	DIAPHRAGMATIC HERNIA 2; DIH2		
Number Sign	222448	DONNAI-BARROW SYNDROME	FACIOOCULOACOUSTICORENAL SYNDROME;; DBS/FOAR SYNDROME;; DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM, MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	
Number Sign	222470	TRICHOHEPATOENTERIC SYNDROME 1; THES1	THE SYNDROME;; DIARRHEA, SYNDROMIC;; DIARRHEA, FATAL INFANTILE, WITH TRICHORRHEXIS NODOSA	
NULL	222500	DIASTEMATOMYELIA		
Number Sign	222600	DIASTROPHIC DYSPLASIA; DTD	DD	DIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED
Percent	222690	DIBASIC AMINO ACIDURIA I		
Number Sign	222700	LYSINURIC PROTEIN INTOLERANCE; LPI	DIBASIC AMINO ACIDURIA II	
Number Sign	222730	DICARBOXYLIC AMINOACIDURIA; DCBXA	GLUTAMATE-ASPARTATE TRANSPORT DEFECT	
Number Sign	222748	DIHYDROPYRIMIDINASE DEFICIENCY; DPYSD	DIHYDROPYRIMIDINURIA;; DPYS DEFICIENCY;; DPH DEFICIENCY	
Number Sign	222765	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2	DIHYDROXYACETONEPHOSPHATE ACYLTRANSFERASE DEFICIENCY;; DHAPAT DEFICIENCY;; GLYCERONEPHOSPHATE O-ACYLTRANSFERASE DEFICIENCY;; GNPAT DEFICIENCY;; PEROXISOMAL DIHYDROXYACETONEPHOSPHATE ACYLTRANSFERASE DEFICIENCY;; CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC, DUE TO DIHYDROXYACETONEPHOSPHATE ACYLTRANSFERASE DEFICIENCY	
Number Sign	222800	BISPHOSPHOGLYCERATE MUTASE DEFICIENCY	BISPHOSPHOGLYCEROMUTASE DEFICIENCY;; BPGM DEFICIENCY;; DIPHOSPHOGLYCERATE MUTASE DEFICIENCY OF ERYTHROCYTE;; DPGM DEFICIENCY	
Number Sign	222900	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL; CSID	DISACCHARIDE INTOLERANCE I;; SUCROSE-ISOMALTOSE MALABSORPTION, CONGENITAL;; SUCROSE INTOLERANCE, CONGENITAL;; SI DEFICIENCY	
Number Sign	223000	LACTASE DEFICIENCY, CONGENITAL	ALACTASIA, CONGENITAL;; DISACCHARIDE INTOLERANCE II	
Number Sign	223100	LACTOSE INTOLERANCE, ADULT TYPE	HYPOLACTASIA, ADULT TYPE;; ADULT LACTASE DEFICIENCY;; DISACCHARIDE INTOLERANCE III	LACTASE PERSISTENCE, INCLUDED
Percent	223200	DISORGANIZATION, MOUSE, HOMOLOG OF	DS	
NULL	223300	DISSEMINATED SCLEROSIS WITH NARCOLEPSY		
NULL	223320	DIVERTICULOSIS, SMALL-INTESTINAL		
NULL	223330	DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT		
NULL	223340	DK PHOCOMELIA SYNDROME	PHOCOMELIA, THROMBOCYTOPENIA, ENCEPHALOCELE, UROGENITAL MALFORMATIONS;; VON VOSS-CHERSTVOY SYNDROME	
NULL	223350	DOHLE BODIES AND LEUKEMIA		
Number Sign	223360	DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL	NOREPINEPHRINE DEFICIENCY;; NORADRENALINE DEFICIENCY	
Percent	223370	DUBOWITZ SYNDROME		
NULL	223380	DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF		
NULL	223400	DUODENAL ATRESIA		
NULL	223500	DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE		
NULL	223540	DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY	MOLLICA SYNDROME	
NULL	223550	DWARFISM, PROPORTIONATE, WITH HIP DISLOCATION		
Number Sign	223800	DYGGVE-MELCHIOR-CLAUSEN DISEASE; DMC		
Number Sign	223900	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3	HSAN III;; DYSAUTONOMIA, FAMILIAL; DYS; FD;; RILEY-DAY SYNDROME	
NULL	224000	DYSAUTONOMIA-LIKE DISORDER		
Number Sign	224050	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	CEREBELLAR HYPOPLASIA, VLDLR-ASSOCIATED;; CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL LOCOMOTION 1;; CEREBELLAR ATAXIA, CONGENITAL, AND MENTAL RETARDATION, AUTOSOMAL RECESSIVE;; DYSEQUILIBRIUM SYNDROME; DES	
Number Sign	224100	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE II; CDAN2	DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE II;; CDA II;; DYSERYTHROPOIETIC ANEMIA, HEMPAS TYPE;; HEREDITARY ERYTHROBLASTIC MULTINUCLEARITY WITH POSITIVE ACIDIFIED-SERUM TEST; HEMPAS	
Number Sign	224120	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A	DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE Ia;; CDA Ia;; ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	
Number Sign	224230	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1		
NULL	224250	DYSMYELINATION WITH JAUNDICE		
Percent	224300	DYSOSTEOSCLEROSIS		
Percent	224400	DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	DDRD;; DYSSEGMENTAL DWARFISM, ROLLAND-DESBUQUOIS TYPE;; ANISOSPONDYLIC CAMPTOMICROMELIC DWARFISM, ROLLAND-DESBUQUOIS TYPE	
Number Sign	224410	DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	DYSSEGMENTAL DWARFISM, SILVERMAN-HANDMAKER TYPE;; ANISOSPONDYLIC CAMPTOMICROMELIC DWARFISM, SILVERMAN-HANDMAKER TYPE	
Number Sign	224500	DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	DYSTONIA MUSCULORUM DEFORMANS 2	
NULL	224550	DYSTONIA WITH RINGBINDEN		
Number Sign	224690	MEIER-GORLIN SYNDROME 1; MGORS1	EAR, PATELLA, SHORT STATURE SYNDROME; EPS;; MICROTIA, ABSENT PATELLAE, MICROGNATHIA SYNDROME;; MEIER-GORLIN SYNDROME	
NULL	224700	EBSTEIN ANOMALY		
Number Sign	224750	SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	KERATOSIS PALMOPLANTARIS WITH CYSTIC EYELIDS, HYPODONTIA, AND HYPOTRICHOSIS;; ECCRINE TUMORS WITH ECTODERMAL DYSPLASIA	
NULL	224800	ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS		
Number Sign	224900	ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	ECTODERMAL DYSPLASIA, HYPOHIDROTIC; HED;; ECTODERMAL DYSPLASIA, ANHIDROTIC; EDA	
Percent	225000	ROSSELLI-GULIENETTI SYNDROME		
NULL	225040	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESIS OF THE CORPUS CALLOSUM		
NULL	225050	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARY DYSKINESIA	HEDH SYNDROME	
Number Sign	225060	CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	ZLOTOGORA-OGUR SYNDROME;; ECTODERMAL DYSPLASIA, MARGARITA ISLAND TYPE;; ECTODERMAL DYSPLASIA, TYPE 4; ED4;; ECTODERMAL DYSPLASIA, CLEFT LIP AND PALATE, MENTAL RETARDATION, AND SYNDACTYLY	OROFACIAL CLEFT 7, INCLUDED; OFC7, INCLUDED;; CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 7, INCLUDED
Number Sign	225100	ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE; ECTOL2		
Number Sign	225200	ECTOPIA LENTIS ET PUPILLAE	ECTOPIA LENTIS WITH ECTOPIA OF PUPIL	
Number Sign	225250	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5		
Number Sign	225280	ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME; EEMS	EEM SYNDROME	
NULL	225290	ECTRODACTYLY-POLYDACTYLY		
Number Sign	225300	SPLIT-HAND/FOOT MALFORMATION 6; SHFM6	ECTRODACTYLY, AUTOSOMAL RECESSIVE	
NULL	225310	EHLERS-DANLOS SYNDROME WITH PLATELET DYSFUNCTION FROM FIBRONECTIN ABNORMALITY	FN ABNORMALITY;; EHLERS-DANLOS SYNDROME, TYPE X;; EDS X; EDS10;; EHLERS-DANLOS SYNDROME, DYSFIBRONECTINEMIC TYPE	
Number Sign	225320	EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM		
Number Sign	225400	EHLERS-DANLOS SYNDROME, TYPE VI; EDS6	EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE;; EDS VI;; EHLERS-DANLOS SYNDROME, OCULAR-SCOLIOTIC TYPE;; NEVO SYNDROME;; EHLERS-DANLOS SYNDROME, TYPE VIA, FORMERLY; EDS6A, FORMERLY	
Number Sign	225410	EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE	EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;; DERMATOSPARAXIS;; EDS VIIC;; EDS7C	
Number Sign	225500	ELLIS-VAN CREVELD SYNDROME; EVC	CHONDROECTODERMAL DYSPLASIA;; MESOECTODERMAL DYSPLASIA	
NULL	225700	ENCEPHALOMALACIA, MULTILOCULAR		
NULL	225740	ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	LYON SYNDROME	
Number Sign	225750	AICARDI-GOUTIERES SYNDROME 1; AGS1	AGS;; ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATION AND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;; CREE ENCEPHALITIS;; PSEUDOTOXOPLASMOSIS SYNDROME	AICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED
Number Sign	225753	PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	ENCEPHALOPATHY, FATAL INFANTILE, WITH OLIVOPONTOCEREBELLAR HYPOPLASIA	
NULL	225755	ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION		
Number Sign	225790	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	HYDRANENCEPHALY, FOWLER TYPE;; HYDROCEPHALY/HYDRANENCEPHALY DUE TO CEREBRAL VASCULOPATHY;; ENCEPHALOCLASTIC PROLIFERATIVE VASCULOPATHY; EPV	
NULL	226000	ENDOCARDIAL FIBROELASTOSIS; EFE		
NULL	226100	ENDOCARDIAL FIBROELASTOSIS AND COARCTATION OF ABDOMINAL AORTA		
NULL	226110	ENDOTHELIAL DYSTROPHY, CONGENITAL HEREDITARY, WITH NAIL HYPOPLASIA		
NULL	226150	ENTEROCOLITIS		
Number Sign	226200	ENTEROKINASE DEFICIENCY	ENTEROPEPTIDASE DEFICIENCY	
Number Sign	226300	COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE		
NULL	226350	EOSINOPHILIC FASCIITIS		
Number Sign	226400	EPIDERMODYSPLASIA VERRUCIFORMIS; EV		
NULL	226440	EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTAL RETARDATION		
Percent	226500	EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA	EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;; EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	
Number Sign	226600	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB	DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;; EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1;; EPIDERMOLYSIS BULLOSA DYSTROPHICA, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATA VARIANT, INCLUDED;; EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED
Number Sign	226650	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	EPIDERMOLYSIS BULLOSA JUNCTIONALIS, NON-HERLITZ TYPE;; EPIDERMOLYSIS BULLOSA JUNCTIONALIS, PROGRESSIVE;; EPIDERMOLYSIS BULLOSA JUNCTIONALIS, SEVERE NONLETHAL;; EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DISENTIS TYPE;; EPIDERMOLYSIS BULLOSA, GENERALIZED ATROPHIC BENIGN; GABEB	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT, INCLUDED;; JUNCTIONAL EPIDERMOLYSIS BULLOSA INVERSA, INCLUDED;; JEB-I, INCLUDED
Number Sign	226670	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY; EBSMD	EPIDERMOLYSIS BULLOSA SIMPLEX AND LIMB-GIRDLE MUSCULAR DYSTROPHY;; MD-EBS; MDEBS	
Number Sign	226700	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	EPIDERMOLYSIS BULLOSA JUNCTIONALIS, HERLITZ TYPE;; JEB-HERLITZ TYPE;; EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ-PEARSON TYPE;; HERLITZ-PEARSON-TYPE EPIDERMOLYSIS BULLOSA;; EPIDERMOLYSIS BULLOSA LETALIS	
Number Sign	226730	EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA;; JUNCTIONAL EPIDERMOLYSIS BULLOSA WITH PYLORIC ATRESIA;; JEB-PA;; EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA AND APLASIA CUTIS CONGENITA;; EB-PA-ACC;; CARMI SYNDROME;; APLASIA CUTIS CONGENITA WITH GASTROINTESTINAL ATRESIA	
NULL	226735	EPIDERMOLYSIS BULLOSA WITH DIAPHRAGMATIC HERNIA		
Number Sign	226750	KOHLSCHUTTER-TONZ SYNDROME; KTZS	EPILEPSY AND YELLOW TEETH;; EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;; KOHLSCHUTTER SYNDROME	
NULL	226800	EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION		
NULL	226810	EPILEPSY WITH BILATERAL OCCIPITAL CALCIFICATIONS		
NULL	226850	EPILEPSY-TELANGIECTASIA		
Number Sign	226900	EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4	MULTIPLE EPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE;; MULTIPLE EPIPHYSEAL DYSPLASIA WITH CLUBFOOT;; MULTIPLE EPIPHYSEAL DYSPLASIA WITH BILAYERED PATELLAE	
NULL	226950	EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS		
Percent	226960	EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	LOWRY-WOOD SYNDROME; LWS	
Number Sign	226980	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	MED-IDDM SYNDROME;; IDDM-MED SYNDROME;; WOLCOTT-RALLISON SYNDROME	
NULL	226985	EPITHELIAL SQUAMOUS DYSPLASIA, KERATINIZING DESQUAMATIVE, OF URINARY TRACT		
NULL	226990	EPSTEIN-BARR VIRUS, SUSCEPTIBILITY TO CHRONIC INFECTION BY		
NULL	227000	ERYTHEMA OF ACRAL REGIONS		
NULL	227010	ERMINE PHENOTYPE	PIGMENTARY DISORDER WITH HEARING LOSS	BLACK LOCKS WITH ALBINISM AND DEAFNESS SYNDROME, INCLUDED; BADS, INCLUDED
Percent	227050	TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD; TEC	ERYTHROBLASTOPENIA, TRANSIENT	
Percent	227090	ERYTHRODERMA, LETHAL CONGENITAL		
Percent	227150	ETHANOLAMINOSIS	ETHANOLAMINE KINASE DEFICIENCY	
NULL	227210	EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY		
Number Sign	227220	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1	SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES;; SKIN/HAIR/EYE PIGMENTATION 1, BLUE/BROWN EYES;; SKIN/HAIR/EYE PIGMENTATION 1, BLOND/BROWN HAIR;; EYE COLOR, BROWN/BLUE;; EYE COLOR, BLUE/NONBLUE;; EYE COLOR 3; EYCL3;; BROWN EYE COLOR 2; BEY2;; HAIR COLOR 3; HCL3	
Number Sign	227240	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5; SHEP5	SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR;; SKIN/HAIR/EYE PIGMENTATION 5, DARK/LIGHT EYES;; SKIN/HAIR/EYE PIGMENTATION 5, DARK/FAIR SKIN	
NULL	227250	FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION		
NULL	227255	FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS		
Number Sign	227260	FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE; FFDD3	SETLEIS SYNDROME;; BITEMPORAL FORCEPS MARKS SYNDROME;; FACIAL ECTODERMAL DYSPLASIA;; FOCAL FACIAL DERMAL DYSPLASIA, TYPE II, FORMERLY	
NULL	227270	FACIOCARDIOMELIC DYSPLASIA, LETHAL		
NULL	227280	FACIOCARDIORENAL SYNDROME	EASTMAN-BIXLER SYNDROME	
Number Sign	227300	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1; F5F8D1	FAMILIAL MULTIPLE COAGULATION FACTOR DEFICIENCY I; FMFD1;; FMFD I;; MULTIPLE COAGULATION FACTOR DEFICIENCY I; MCFD1	
NULL	227310	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, WITH NORMAL PROTEIN C AND PROTEIN C INHIBITOR		
NULL	227320	FACIOTHORACOGENITAL SYNDROME		
Percent	227330	FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	AARSKOG-LIKE SYNDROME;; KUWAIT TYPE FACIODIGITOGENITAL SYNDROME	
Number Sign	227400	FACTOR V DEFICIENCY	PARAHEMOPHILIA;; OWREN PARAHEMOPHILIA;; LABILE FACTOR DEFICIENCY	
Number Sign	227500	FACTOR VII DEFICIENCY	F7 DEFICIENCY;; HYPOPROCONVERTINEMIA	
Number Sign	227600	FACTOR X DEFICIENCY	F10 DEFICIENCY;; STUART-PROWER FACTOR DEFICIENCY	
Number Sign	227645	FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC	FACC; FAC;; FANCONI PANCYTOPENIA, TYPE 3; FA3	
Number Sign	227646	FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2	FAD2;; FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;; FANCONI PANCYTOPENIA, TYPE 4; FA4	
Number Sign	227650	FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA	FANCONI ANEMIA; FA	FANCONI ANEMIA, ESTREN-DAMESHEK VARIANT, INCLUDED;; ESTREN-DAMESHEK VARIANT OF FANCONI ANEMIA, INCLUDED;; ESTREN-DAMESHEK VARIANT OF FANCONI PANCYTOPENIA, INCLUDED
Number Sign	227810	FANCONI-BICKEL SYNDROME; FBS	HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;; HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;; HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;; FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;; PSEUDO-PHLORIZIN DIABETES;; GLYCOGENOSIS, FANCONI TYPE;; GLYCOGEN STORAGE DISEASE XI	
NULL	227850	FANCONI-LIKE SYNDROME		
Number Sign	228000	FARBER LIPOGRANULOMATOSIS; FRBRL	FARBER DISEASE;; CERAMIDASE DEFICIENCY;; ACID CERAMIDASE DEFICIENCY;; AC DEFICIENCY;; N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	
NULL	228020	FASCIAL DYSTROPHY, CONGENITAL		
Percent	228100	VISCERAL STEATOSIS, CONGENITAL	FATTY LIVER DISEASE, CONGENITAL;; FATTY METAMORPHOSIS OF VISCERA;; STEATOSIS OF LIVER;; WHITE LIVER DISEASE	
NULL	228200	FEMUR-FIBULA-ULNA SYNDROME	FFU SYNDROME	
Percent	228250	FEMUR, UNILATERAL BIFID, WITH MONODACTYLOUS ECTRODACTYLY	GOLLOP-WOLFGANG COMPLEX; GWC	
Number Sign	228300	HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	PASQUALINI SYNDROME;; FERTILE EUNUCH SYNDROME	
NULL	228355	FETAL IODINE DEFICIENCY DISORDER; FIDD	ENDEMIC CRETINISM	
NULL	228400	FEVER, FAMILIAL LIFELONG PERSISTENT		
Number Sign	228520	FIBROCHONDROGENESIS 1; FBCG1		
Number Sign	228550	MYOFIBROMATOSIS, INFANTILE, 1; IMF1	MYOFIBROMATOSIS, JUVENILE;; FIBROMATOSIS, CONGENITAL GENERALIZED; CGF	
NULL	228560	FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES		
Number Sign	228600	HYALINE FIBROMATOSIS SYNDROME; HFS	HYALINOSIS, SYSTEMIC	
NULL	228800	FIBROSCLEROSIS, MULTIFOCAL	MEDIASTINAL FIBROSIS, FAMILIAL;; RETROPERITONEAL FIBROSIS, FAMILIAL	
Number Sign	228900	FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY	DU PAN SYNDROME	
Number Sign	228930	FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	FUHRMANN SYNDROME	
NULL	228940	FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES		
Number Sign	228960	HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY	HMWK DEFICIENCY;; KININOGEN DEFICIENCY, HIGH MOLECULAR WEIGHT;; FITZGERALD TRAIT	KININOGEN DEFICIENCY, TOTAL, INCLUDED;; KININOGEN DEFICIENCY, HIGH MOLECULAR WEIGHT AND LOW MOLECULAR WEIGHT, INCLUDED;; FLAUJEAC TRAIT, INCLUDED;; WILLIAMS TRAIT, INCLUDED
Number Sign	228980	FLECK RETINA, FAMILIAL BENIGN; FRFB		
NULL	228990	FLECK RETINA OF KANDORI		
NULL	229045	FOCAL EPITHELIAL HYPERPLASIA, ORAL	FEH, ORAL;; HECK DISEASE	
Number Sign	229050	FOLATE MALABSORPTION, HEREDITARY		
Number Sign	229070	HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	FOLLICLE-STIMULATING HORMONE DEFICIENCY, ISOLATED	
Number Sign	229100	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY	FORMIMINOTRANSFERASE DEFICIENCY;; FORMIMINOGLUTAMIC ACIDURIA;; FIGLU-URIA	
Percent	229120	FOUNTAIN SYNDROME	MENTAL RETARDATION, SENSORINEURAL DEAFNESS, SKELETAL ABNORMALITIES, AND COARSE FACE WITH FULL LIPS	
Number Sign	229200	BRITTLE CORNEA SYNDROME 1; BCS1	FRAGILITAS OCULI WITH JOINT HYPEREXTENSIBILITY;; CORNEAL FRAGILITY, KERATOGLOBUS, BLUE SCLERAE, JOINT HYPEREXTENSIBILITY;; DYSGENESIS MESODERMALIS CORNEAE ET SCLERAE;; EHLERS-DANLOS SYNDROME, TYPE VIB, FORMERLY; EDS6B, FORMERLY	
NULL	229230	FRASER-LIKE SYNDROME	FUSED EYELIDS, AIRWAY ANOMALIES, OVARIAN CYSTS, AND DIGITAL ANOMALIES	
NULL	229250	FREESIA FLOWERS, INABILITY TO SMELL		
Number Sign	229300	FRIEDREICH ATAXIA 1; FRDA	FRDA1;; FA	FRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED; FARR, INCLUDED
NULL	229310	FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA		
Percent	229400	FRONTOFACIONASAL DYSPLASIA	FFND;; FRONTOFACIONASAL DYSOSTOSIS	
Percent	229500	FRUCTOSE AND GALACTOSE INTOLERANCE		
Number Sign	229600	FRUCTOSE INTOLERANCE, HEREDITARY	FRUCTOSEMIA;; FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;; ALDOLASE B DEFICIENCY;; ALDOB DEFICIENCY	
NULL	229650	FRUCTOSE UTILIZATION		
Number Sign	229700	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY; FBP1D		
Number Sign	229800	FRUCTOSURIA, ESSENTIAL	HEPATIC FRUCTOKINASE DEFICIENCY;; KETOHEXOKINASE DEFICIENCY	
Percent	229850	FRYNS SYNDROME; FRNS	DIAPHRAGMATIC HERNIA, ABNORMAL FACE, AND DISTAL LIMB ANOMALIES	
Number Sign	230000	FUCOSIDOSIS	ALPHA-L-FUCOSIDASE DEFICIENCY	
Number Sign	230200	GALACTOKINASE DEFICIENCY	GALK DEFICIENCY;; GALACTOSEMIA II	
NULL	230300	GALACTORRHEA		
Number Sign	230350	GALACTOSE EPIMERASE DEFICIENCY	GALE DEFICIENCY;; GALACTOSEMIA III;; UDP-GALACTOSE-4-EPIMERASE DEFICIENCY	
Number Sign	230400	GALACTOSEMIA	GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE DEFICIENCY;; GALT DEFICIENCY;; GALACTOSEMIA, CLASSIC	GALACTOSEMIA, DUARTE VARIANT, INCLUDED
Number Sign	230450	GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO		
Number Sign	230500	GM1-GANGLIOSIDOSIS, TYPE I	GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;; GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;; GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;; BETA-GALACTOSIDASE-1 DEFICIENCY;; GLB1 DEFICIENCY	GM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;; GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED
Number Sign	230600	GM1-GANGLIOSIDOSIS, TYPE II	GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;; GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;; GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2	GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED
Number Sign	230650	GM1-GANGLIOSIDOSIS, TYPE III	GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;; GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;; GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;; GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	
Number Sign	230740	GAPO SYNDROME	GROWTH RETARDATION, ALOPECIA, PSEUDOANODONTIA, AND OPTIC ATROPHY	
NULL	230750	GASTROSCHISIS		ABDOMINAL WALL DEFECTS, INCLUDED
Number Sign	230800	GAUCHER DISEASE, TYPE I	GD I;; GAUCHER DISEASE, NONCEREBRAL JUVENILE;; GLUCOCEREBROSIDASE DEFICIENCY;; ACID BETA-GLUCOSIDASE DEFICIENCY;; GBA DEFICIENCY	
Number Sign	230900	GAUCHER DISEASE, TYPE II	GD II;; GAUCHER DISEASE, ACUTE NEURONOPATHIC TYPE	
Number Sign	231000	GAUCHER DISEASE, TYPE III	GD III;; GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;; GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;; GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRAL	GAUCHER DISEASE, TYPE IIIA, INCLUDED;; GAUCHER DISEASE, TYPE IIIB, INCLUDED;; GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED
Number Sign	231005	GAUCHER DISEASE, TYPE IIIC		
Number Sign	231050	GELEOPHYSIC DYSPLASIA 1; GPHYSD1		
NULL	231060	GENITOPALATOCARDIAC SYNDROME	GARDNER-SILENGO-WACHTEL SYNDROME;; MALE PSEUDOHERMAPHRODITISM WITH MICROGNATHIA, CLEFT PALATE, AND CONOTRUNCAL CARDIAC DEFECT	
Number Sign	231070	GERODERMA OSTEODYSPLASTICUM; GO	GERODERMIA OSTEODYSPLASTICA;; WALT DISNEY DWARFISM	
NULL	231080	GERMAN SYNDROME		
Number Sign	231090	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	HYDATIDIFORM MOLE; HYDM;; HYDATIDIFORM MOLE, COMPLETE; CHM;; GESTATIONAL TROPHOBLASTIC DISEASE	
Number Sign	231095	GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD	GHOSAL SYNDROME	
NULL	231100	HEMOCHROMATOSIS, NEONATAL	NH;; NHC;; ALLOIMMUNE HEPATITIS, CONGENITAL;; NEONATAL HEPATITIS, FORMERLY;; GIANT CELL HEPATITIS, FORMERLY	
Number Sign	231200	BERNARD-SOULIER SYNDROME; BSS	BLEEDING DISORDER, PLATELET-TYPE, 1; BDPLT1;; PLATELET GLYCOPROTEIN Ib DEFICIENCY;; GLYCOPROTEIN Ib, PLATELET, DEFICIENCY OF;; VON WILLEBRAND FACTOR RECEPTOR DEFICIENCY	BERNARD-SOULIER SYNDROME, TYPE A1, INCLUDED;; BERNARD-SOULIER SYNDROME, TYPE B, INCLUDED;; BERNARD-SOULIER SYNDROME, TYPE C, INCLUDED
Number Sign	231300	GLAUCOMA 3, PRIMARY CONGENITAL, A; GLC3A	GLAUCOMA, CONGENITAL; GLC3;; BUPHTHALMOS	GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET, INCLUDED;; GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET, INCLUDED
Number Sign	231530	3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	HADH DEFICIENCY;; SCHAD DEFICIENCY, FORMERLY	
Number Sign	231550	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS	TRIPLE-A SYNDROME;; ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;; GLUCOCORTICOID DEFICIENCY AND ACHALASIA;; ALLGROVE SYNDROME;; ADDISONIAN-ACHALASIA SYNDROME;; HYPOADRENALISM WITH ACHALASIA;; ALACRIMA-ACHALASIA-ADDISONIANISM;; ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMA	ACHALASIA-ALACRIMA SYNDROME, INCLUDED
NULL	231630	MONOSODIUM GLUTAMATE SENSITIVITY	CHINESE RESTAURANT SYNDROME	
Number Sign	231670	GLUTARIC ACIDEMIA I; GA1	GLUTARIC ACIDURIA I;; GA I;; GLUTARYL-CoA DEHYDROGENASE DEFICIENCY	
Number Sign	231680	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	GLUTARIC ACIDEMIA II;; GLUTARIC ACIDURIA II;; GA II;; ETHYLMALONIC-ADIPICACIDURIA; EMA	GLUTARIC ACIDEMIA IIA, INCLUDED;; ETFA DEFICIENCY, INCLUDED;; GLUTARIC ACIDEMIA IIB, INCLUDED;; ETFB DEFICIENCY, INCLUDED;; GLUTARIC ACIDEMIA IIC, INCLUDED;; ETFDH DEFICIENCY, INCLUDED
Number Sign	231690	GLUTARIC ACIDURIA III; GA3	GA III;; GLUTARYL-CoA OXIDASE DEFICIENCY	
Number Sign	231900	GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO; GSSDE		
NULL	231950	GLUTATHIONURIA	GAMMA-GLUTAMYLTRANSPEPTIDASE DEFICIENCY;; GGT DEFICIENCY;; GTG DEFICIENCY;; GAMMA-GLUTAMYLTRANSFERASE DEFICIENCY	
NULL	231970	GLUTEAL MUSCLES, ABSENCE OF		
Number Sign	232200	GLYCOGEN STORAGE DISEASE Ia; GSD1A	GSD Ia;; GLYCOGEN STORAGE DISEASE I; GSD1;; VON GIERKE DISEASE;; HEPATORENAL FORM OF GLYCOGEN STORAGE DISEASE;; GLUCOSE-6-PHOSPHATASE DEFICIENCY;; HEPATORENAL GLYCOGENOSIS	
Number Sign	232220	GLYCOGEN STORAGE DISEASE Ib; GSD1B	GSD Ib;; GLUCOSE-6-PHOSPHATE TRANSPORT DEFECT	
Number Sign	232240	GLYCOGEN STORAGE DISEASE Ic; GSD1C	GSD Ic	GLYCOGEN STORAGE DISEASE Id, INCLUDED; GSD1D, INCLUDED
Number Sign	232300	GLYCOGEN STORAGE DISEASE II; GSD2	GSD II; ACID ALPHA-GLUCOSIDASE DEFICIENCY;; GAA DEFICIENCY;; POMPE DISEASE;; GLYCOGENOSIS, GENERALIZED, CARDIAC FORM;; CARDIOMEGALIA GLYCOGENICA DIFFUSA;; ACID MALTASE DEFICIENCY; AMD;; ALPHA-1,4-GLUCOSIDASE DEFICIENCY	
Number Sign	232400	GLYCOGEN STORAGE DISEASE III; GSD3	FORBES DISEASE;; CORI DISEASE;; LIMIT DEXTRINOSIS;; AMYLO-1,6-GLUCOSIDASE DEFICIENCY;; AGL DEFICIENCY;; GLYCOGEN DEBRANCHER DEFICIENCY;; GDE DEFICIENCY	GLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;; GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;; GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;; GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED
Number Sign	232500	GLYCOGEN STORAGE DISEASE IV; GSD4	GSD IV;; GLYCOGEN BRANCHING ENZYME DEFICIENCY;; GBE1 DEFICIENCY;; ANDERSEN DISEASE;; BRANCHER DEFICIENCY;; GLYCOGENOSIS IV;; AMYLOPECTINOSIS;; CIRRHOSIS, FAMILIAL, WITH DEPOSITION OF ABNORMAL GLYCOGEN	GSD IV, CLASSIC HEPATIC, INCLUDED;; GSD IV, NONPROGRESSIVE HEPATIC, INCLUDED;; GSD IV, NEUROMUSCULAR FORM, FATAL PERINATAL, INCLUDED;; GSD IV, NEUROMUSCULAR FORM, CONGENITAL, INCLUDED;; GSD IV, NEUROMUSCULAR FORM, CHILDHOOD, INCLUDED;; GSD IV, NEUROMUSCULAR FORM, ADULT, WITH ISOLATED MYOPATHY, INCLUDED
Number Sign	232600	GLYCOGEN STORAGE DISEASE V; GSD5	GSD V;; MCARDLE DISEASE;; MYOPHOSPHORYLASE DEFICIENCY;; MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY;; PYGM DEFICIENCY	
Number Sign	232700	GLYCOGEN STORAGE DISEASE VI; GSD6	GSD VI;; HERS DISEASE;; PHOSPHORYLASE DEFICIENCY GLYCOGEN-STORAGE DISEASE OF LIVER	
Number Sign	232800	GLYCOGEN STORAGE DISEASE VII; GSD7	GSD VII;; MUSCLE PHOSPHOFRUCTOKINASE DEFICIENCY;; PFKM DEFICIENCY;; TARUI DISEASE	
NULL	232900	GLYCOPROTEIN STORAGE DISEASE		
Number Sign	233100	RENAL GLUCOSURIA; GLYS	GLYS1;; GLYCOSURIA, RENAL	
NULL	233270	GOMBO SYNDROME	GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY, AND OLIGOPHRENIA	
Number Sign	233300	OVARIAN DYSGENESIS 1; ODG1	OVARIAN DYSGENESIS, HYPERGONADOTROPIC, AUTOSOMAL RECESSIVE;; OVARIAN DYSGENESIS, HYPERGONADOTROPIC, WITH NORMAL KARYOTYPE;; GONADAL DYSGENESIS, XX TYPE;; XX GONADAL DYSGENESIS; XXGD;; OVARIAN FAILURE, HYPERGONADOTROPIC	
Number Sign	233400	PERRAULT SYNDROME 1; PRLTS1	OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;; GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	
Number Sign	233420	46,XY SEX REVERSAL 7; SRXY7	46,XY SEX REVERSAL, PARTIAL OR COMPLETE, DHH-RELATED;; 46,XY GONADAL DYSGENESIS, PARTIAL OR COMPLETE, DHH-RELATED;; GONADAL DYSGENESIS, XY, MALE-LIMITED; GDXYM	
NULL	233430	GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES		
NULL	233450	GOODPASTURE SYNDROME		
Percent	233500	GORLIN-CHAUDHRY-MOSS SYNDROME; GCMS	CRANIOFACIAL DYSOSTOSIS, HYPERTRICHOSIS, HYPOPLASIA OF LABIA MAJORA, DENTAL AND EYE ANOMALIES, PATENT DUCTUS ARTERIOSUS, AND NORMAL INTELLIGENCE	
NULL	233600	GRANULOCYTOPENIA WITH IMMUNOGLOBULIN ABNORMALITY		
Number Sign	233650	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS; CCHIDG		
NULL	233670	GRANULOMATOUS DISEASE WITH DEFECT IN NEUTROPHIL CHEMOTAXIS		
Number Sign	233690	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	CGD, AUTOSOMAL RECESSIVE CYTOCHROME b-NEGATIVE;; CGD DUE TO DEFICIENCY OF THE ALPHA SUBUNIT OF CYTOCHROME b;; CYBA DEFICIENCY	
Number Sign	233700	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	CGD, AUTOSOMAL RECESSIVE CYTOCHROME b-POSITIVE, TYPE I;; GRANULOMATOUS DISEASE, CHRONIC, DUE TO NCF1 DEFICIENCY;; NEUTROPHIL CYTOSOL FACTOR 1, DEFICIENCY OF;; NCF1, DEFICIENCY OF;; SOLUBLE OXIDASE COMPONENT II, DEFICIENCY OF;; SOC2, DEFICIENCY OF;; p47-PHOX, DEFICIENCY OF	
Number Sign	233710	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	CGD, AUTOSOMAL RECESSIVE CYTOCHROME b-POSITIVE, TYPE II;; GRANULOMATOUS DISEASE, CHRONIC, DUE TO NCF2 DEFICIENCY;; NEUTROPHIL CYTOSOL FACTOR 2, DEFICIENCY OF;; NCF2, DEFICIENCY OF;; p67-PHOX, DEFICIENCY OF	
NULL	233800	GROUPED PIGMENTATION OF THE RETINA	GROUPED PIGMENTATION OF RETINAL PIGMENT EPITHELIUM;; GROUPED PIGMENTATION OF THE MACULA	
NULL	233805	GROWTH FACTORS, COMBINED DEFECT OF	INSULIN, INSULIN-LIKE GROWTH FACTOR I, AND EPIDERMAL GROWTH FACTOR DEFICIENCY;; WERNER-LIKE SYNDROME DUE TO COMBINED GROWTH FACTOR DEFICIENCY	
NULL	233810	GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA		
Number Sign	233910	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	HYPERPHENYLALANINEMIA, TETRAHYDROBIOPTERIN-DEFICIENT, DUE TO GTP CYCLOHYDROLASE I DEFICIENCY;; GTP CYCLOHYDROLASE I DEFICIENCY	DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE, INCLUDED
Number Sign	234000	FACTOR XII DEFICIENCY	F12 DEFICIENCY;; HAGEMAN FACTOR DEFICIENCY;; HAF DEFICIENCY	
NULL	234030	HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION		
Number Sign	234050	TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1; TTDN1;; AMISH BRITTLE HAIR BRAIN SYNDROME; ABHS;; HAIR-BRAIN SYNDROME;; BIDS SYNDROME;; POLLITT SYNDROME;; TRICHOTHIODYSTROPHY-NEUROCUTANEOUS SYNDROME	
Percent	234100	HALLERMANN-STREIFF SYNDROME; HSS	FRANCOIS DYSCEPHALIC SYNDROME	
Number Sign	234200	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; PKAN;; PKAN NEUROAXONAL DYSTROPHY, JUVENILE-ONSET;; HALLERVORDEN-SPATZ DISEASE	
NULL	234250	HALL-RIGGS MENTAL RETARDATION SYNDROME		
NULL	234280	HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY		
NULL	234300	HALO NEVI	LEUKODERMA ACQUISITUM CENTRIFUGUM OF SUTTON	
NULL	234350	HALOTHANE HEPATITIS		
Number Sign	234500	HARTNUP DISORDER; HND	HARTNUP DISEASE	
Number Sign	234580	HEIMLER SYNDROME 1; HMLR1	HEARING LOSS, SENSORINEURAL, WITH ENAMEL HYPOPLASIA AND NAIL DEFECTS;; PEROXISOME BIOGENESIS DISORDER 1C; PBD1C	
NULL	234700	HEART BLOCK, CONGENITAL		
NULL	234750	HEART, MALFORMATION OF		
NULL	234800	HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES		
Number Sign	234810	PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2	HEMANGIOMATOSIS, FAMILIAL PULMONARY CAPILLARY	
NULL	234820	HEMANGIOPERICYTOMA, MALIGNANT		
Percent	235000	HEMIHYPERPLASIA, ISOLATED; IH	HEMIHYPERPLASIA; HHP;; HEMIHYPERTROPHY, ISOLATED	HEMI-3 SYNDROME, INCLUDED
Number Sign	235200	HEMOCHROMATOSIS, TYPE 1; HFE1	HEMOCHROMATOSIS; HFE;; HEMOCHROMATOSIS, HEREDITARY; HH	
Percent	235255	MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	URIOSTE SYNDROME	
NULL	235370	HEMOLYTIC ANEMIA WITH THERMAL SENSITIVITY OF RED CELLS		
Number Sign	235400	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1	AHUS, SUSCEPTIBILITY TO, 1	HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED
NULL	235500	HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN		
Number Sign	235510	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1; HKLLS1	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME;; LYMPHATIC DYSPLASIA, GENERALIZED	
Number Sign	235550	HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY; VODI		
Number Sign	235555	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2	CHOLESTASIS WITH DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE DEFICIENCY	
Number Sign	235700	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY		
Number Sign	235730	MOWAT-WILSON SYNDROME; MOWS	MICROCEPHALY, MENTAL RETARDATION, AND DISTINCT FACIAL FEATURES, WITH OR WITHOUT HIRSCHSPRUNG DISEASE;; HIRSCHSPRUNG DISEASE-MENTAL RETARDATION SYNDROME	
NULL	235740	HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS		
NULL	235750	HIRSCHSPRUNG DISEASE WITH ULNAR POLYDACTYLY, POLYSYNDACTYLY OF BIG TOES, AND VENTRICULAR SEPTAL DEFECT		
NULL	235760	HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIAL FEATURES		
Number Sign	235800	HISTIDINEMIA	HISTIDINE AMMONIA-LYASE DEFICIENCY;; HAL DEFICIENCY;; HISTIDASE DEFICIENCY;; HIS DEFICIENCY	
Percent	235830	HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT		
Percent	235900	HISTIOCYTOSIS, FAMILIAL LIPOCHROME		
Number Sign	236000	LYMPHOMA, HODGKIN, CLASSIC; CHL	HODGKIN DISEASE	
Percent	236100	HOLOPROSENCEPHALY 1; HPE1	HOLOPROSENCEPHALY, FAMILIAL ALOBAR;; HPE, FAMILIAL; HPEC;; ARHINENCEPHALY;; CYCLOPIA;; DEMYER SEQUENCE	
NULL	236110	HOLZGREVE SYNDROME		
NULL	236130	HOMOCARNOSINOSIS	HOMOCARNOSINASE DEFICIENCY	
Number Sign	236200	HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	HOMOCYSTINURIA WITH OR WITHOUT RESPONSE TO PYRIDOXINE;; CYSTATHIONINE BETA-SYNTHASE DEFICIENCY;; CBS DEFICIENCY	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED, INCLUDED
Number Sign	236250	HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY	METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;; MTHFR DEFICIENCY	MTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED
Number Sign	236270	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE; HMAE	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblE COMPLEMENTATION TYPE;; VITAMIN B12-RESPONSIVE HOMOCYSTINURIA, cblE TYPE;; METHYLCOBALAMIN DEFICIENCY, cblE TYPE	
NULL	236300	HOOFT DISEASE		
Percent	236400	HUMERORADIAL SYNOSTOSIS		HUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME, INCLUDED
NULL	236410	HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES		
NULL	236450	HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME	COND;; CEREBROOSTEONEPHOSIS SYNDROME	
Number Sign	236500	MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	HYDRANENCEPHALY WITH RENAL APLASIA-DYSPLASIA	
Number Sign	236600	HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1	HYDROCEPHALY;; VENTRICULOMEGALY	
NULL	236635	HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	AQUEDUCTAL STENOSIS	
NULL	236640	HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS		
NULL	236660	HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS		
Number Sign	236670	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1	WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT1-RELATED;; HYDROCEPHALUS, AGYRIA, AND RETINAL DYSPLASIA;; HARD SYNDROME;; CEREBROOCULAR DYSPLASIA-MUSCULAR DYSTROPHY SYNDROME;; COD-MD SYNDROME	
Number Sign	236680	HYDROLETHALUS SYNDROME 1; HLS1		
NULL	236690	HYDROCEPHALUS, NORMAL-PRESSURE		
Number Sign	236700	MCKUSICK-KAUFMAN SYNDROME; MKKS	HYDROMETROCOLPOS SYNDROME;; HYDROMETROCOLPOS, POSTAXIAL POLYDACTYLY, AND CONGENITAL HEART MALFORMATION; HMCS;; KAUFMAN-MCKUSICK SYNDROME	
Number Sign	236730	UROFACIAL SYNDROME 1; UFS1	UROFACIAL SYNDROME; UFS;; OCHOA SYNDROME;; HYDRONEPHROSIS WITH PECULIAR FACIAL EXPRESSION;; INVERTED SMILE AND OCCULT NEUROPATHIC BLADDER;; FACIAL PALSY, PARTIAL, WITH URINARY ABNORMALITIES	
Number Sign	236750	HYDROPS FETALIS, NONIMMUNE; NIHF		HYDROPS FETALIS, ALPHA-THALASSEMIA-RELATED, INCLUDED;; HEMOGLOBIN H HYDROPS FETALIS SYNDROME, INCLUDED
Number Sign	236792	L-2-HYDROXYGLUTARIC ACIDURIA; L2HGA	L-2-HYDROXYGLUTARIC ACIDEMIA	
Percent	236795	3-HYDROXYISOBUTYRIC ACIDURIA		
Number Sign	236800	HYDROXYKYNURENINURIA	XANTHURENIC ACIDURIA;; KYNURENINASE DEFICIENCY, PARTIAL	
Percent	236900	HYDROXYLYSINURIA		
NULL	237000	HYDROXYPROLINEMIA	4-HYDROXY-L-PROLINE OXIDASE DEFICIENCY	
NULL	237100	HYMEN, IMPERFORATE		
Number Sign	237300	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;; CPS I DEFICIENCY	
Number Sign	237310	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY; NAGSD	HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY;; N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY;; NAGS DEFICIENCY	
NULL	237400	HYPER-BETA-ALANINEMIA	HYPERALANINEMIA	
Number Sign	237450	HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR	ROTOR SYNDROME	
Number Sign	237500	DUBIN-JOHNSON SYNDROME; DJS	HYPERBILIRUBINEMIA, DUBIN-JOHNSON TYPE; HBLRDJ;; HYPERBILIRUBINEMIA II	
NULL	237550	HYPERBILIRUBINEMIA, CONJUGATED, TYPE III		
Percent	237800	HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB		
Number Sign	237900	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN	LUCEY-DRISCOLL SYNDROME	BREAST MILK JAUNDICE, INCLUDED
Number Sign	238320	LEYDIG CELL HYPOPLASIA, TYPE I	LEYDIG CELL HYPOPLASIA WITH MALE PSEUDOHERMAPHRODITISM;; HYPERGONADOTROPIC HYPOGONADISM, MALE, DUE TO LHCGR DEFECT;; LEYDIG CELL HYPOPLASIA, COMPLETE;; LEYDIG CELL AGENESIS	LEYDIG CELL HYPOPLASIA, TYPE II, INCLUDED;; LEYDIG CELL HYPOPLASIA, PARTIAL, INCLUDED;; LUTEINIZING HORMONE RESISTANCE, FEMALE, INCLUDED
NULL	238340	HYPERLEUCINE-ISOLEUCINEMIA		
NULL	238350	HYPERLEXIA	COMPULSIVE READING;; PRECOCIOUS READING	
Number Sign	238600	HYPERLIPOPROTEINEMIA, TYPE I	LIPOPROTEIN LIPASE DEFICIENCY;; LPL DEFICIENCY;; HYPERCHYLOMICRONEMIA, FAMILIAL;; HYPERLIPEMIA, IDIOPATHIC, BURGER-GRUTZ TYPE;; HYPERLIPEMIA, ESSENTIAL FAMILIAL;; LIPASE D DEFICIENCY;; LIPD DEFICIENCY;; HYPERLIPOPROTEINEMIA, TYPE IA;; CHYLOMICRONEMIA, FAMILIAL	
Number Sign	238700	HYPERLYSINEMIA, TYPE I	LYSINE:ALPHA-KETOGLUTARATE REDUCTASE DEFICIENCY;; ALPHA-AMINOADIPIC SEMIALDEHYDE SYNTHASE DEFICIENCY;; LYSINE INTOLERANCE;; L-LYSINE:NAD-OXIDO-REDUCTASE DEFICIENCY	
NULL	238710	HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA		
NULL	238750	HYPERLYSINURIA WITH HYPERAMMONEMIA	HYPERLYSINEMIA, PERIODIC	
NULL	238800	HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA		
NULL	238950	HYPEROPIA, HIGH		
Number Sign	238970	HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	HHH SYNDROME; HHHS; HHH;; ORNITHINE TRANSLOCASE DEFICIENCY	
Number Sign	239000	PAGET DISEASE OF BONE 5, JUVENILE-ONSET; PDB5	JUVENILE PAGET DISEASE; JPD;; HYPEROSTOSIS CORTICALIS DEFORMANS JUVENILIS;; HYPERPHOSPHATASIA, FAMILIAL IDIOPATHIC;; HYPERPHOSPHATASEMIA, CHRONIC CONGENITAL IDIOPATHIC;; OSTEOECTASIA, FAMILIAL	
Number Sign	239100	HYPEROSTOSIS CORTICALIS GENERALISATA	VAN BUCHEM DISEASE; VBCH;; HYPERPHOSPHATASEMIA TARDA;; ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	
NULL	239199	HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA		
Number Sign	239200	HYPERPARATHYROIDISM, NEONATAL SEVERE; NSHPT	NSPH; NHPT;; HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY	
Number Sign	239300	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1; HPMRS1	MABRY SYNDROME;; GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 2; GPIBD2	
NULL	239350	HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES		
Number Sign	239500	HYPERPROLINEMIA, TYPE I; HYRPRO1	HPI;; PROLINE OXIDASE DEFICIENCY	
Number Sign	239510	HYPERPROLINEMIA, TYPE II; HYRPRO2	HPII;; 1-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE DEFICIENCY	
NULL	239710	ACROFRONTOFACIONASAL DYSOSTOSIS 2	AFFN DYSOSTOSIS 2; AFFND2;; ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;; NAGUIB-RICHIERI-COSTA SYNDROME;; HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	
NULL	239711	HYPERTELORISM AND TETRALOGY OF FALLOT		
Percent	239800	HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	HMC SYNDROME	
NULL	239840	HYPERTRICHOSIS, CONGENITAL ANTERIOR CERVICAL, WITH PERIPHERAL SENSORY AND MOTOR NEUROPATHY		
Number Sign	239850	CANTU SYNDROME	HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	
NULL	239900	HYPERTROPHIC NEUROPATHY AND CATARACT		
NULL	240000	HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE		
NULL	240150	HYPERVITAMINOSIS A, SUSCEPTIBILITY TO		
Percent	240200	HYPOADRENOCORTICISM, FAMILIAL	ADRENAL HYPOPLASIA;; ADRENAL APLASIA;; ADDISON DISEASE	
Number Sign	240300	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS1	APS I;; AUTOIMMUNE POLYENDOCRINOPATHY-CANDIDIASIS-ECTODERMAL DYSTROPHY; APECED;; AUTOIMMUNE POLYGLANDULAR SYNDROME, TYPE I;; POLYGLANDULAR AUTOIMMUNE SYNDROME, TYPE I;; PGA I;; HYPOADRENOCORTICISM WITH HYPOPARATHYROIDISM AND SUPERFICIAL MONILIASIS	AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I, AUTOSOMAL DOMINANT, INCLUDED;; POLYGLANDULAR DEFICIENCY SYNDROME, PERSIAN-JEWISH TYPE, INCLUDED
NULL	240400	HYPOASCORBEMIA	SCURVY;; VITAMIN C, INABILITY TO SYNTHESIZE	L-GULONOLACTONE OXIDASE PSEUDOGENE, INCLUDED; GULOP, INCLUDED;; L-GULONOLACTONE OXIDASE, NONFUNCTIONAL, INCLUDED;; GULO, NONFUNCTIONAL, INCLUDED
Number Sign	240500	IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	ANTIBODY DEFICIENCY DUE TO TACI DEFECT;; HYPOGAMMAGLOBULINEMIA DUE TO TACI DEFICIENCY	
Number Sign	240600	GLYCOGEN STORAGE DISEASE 0, LIVER; GSD0A	GSD 0a;; HYPOGLYCEMIA WITH DEFICIENCY OF GLYCOGEN SYNTHETASE IN THE LIVER;; LIVER GLYCOGEN SYNTHASE DEFICIENCY;; LIVER GLYCOGEN STORAGE DISEASE 0	
Number Sign	240800	HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	LEUCINE-SENSITIVE HYPOGLYCEMIA OF INFANCY	
Number Sign	240900	HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH		
NULL	240950	HYPOGONADISM-CATARACT SYNDROME	CATARACTS AND TESTICULAR FAILURE	
NULL	241000	HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY		
Number Sign	241080	WOODHOUSE-SAKATI SYNDROME	HYPOGONADISM, ALOPECIA, DIABETES MELLITUS, MENTAL RETARDATION, DEAFNESS, AND EXTRAPYRAMIDAL SYNDROME;; EXTRAPYRAMIDAL DISORDER, PROGRESSIVE, WITH PRIMARY HYPOGONADISM, MENTAL RETARDATION, AND ALOPECIA	
Percent	241090	HYPERGONADOTROPIC HYPOGONADISM AND PARTIAL ALOPECIA		
NULL	241100	HYPOGONADISM, MALE		HYPOGONADISM AND TESTICULAR ATROPHY, INCLUDED
NULL	241120	HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	SWEAT GLAND HYPOPLASIA	
Percent	241150	HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY	HYPOKALEMIA, FAMILIAL;; GULLNER SYNDROME	
Number Sign	241200	BARTTER SYNDROME, TYPE 2, ANTENATAL; BARTS2	HYPOKALEMIC ALKALOSIS WITH HYPERCALCIURIA 2, ANTENATAL;; HYPERPROSTAGLANDIN E SYNDROME 2	
Percent	241310	HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS		
Number Sign	241410	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRDS	HYPOPARATHYROIDISM WITH SHORT STATURE, MENTAL RETARDATION, AND SEIZURES;; SANJAD-SAKATI SYNDROME;; HYPOPARATHYROIDISM, CONGENITAL, ASSOCIATED WITH DYSMORPHISM, GROWTH RETARDATION, AND DEVELOPMENTAL DELAY	
Number Sign	241500	HYPOPHOSPHATASIA, INFANTILE	HOPS;; PHOSPHOETHANOLAMINURIA	HYPOPHOSPHATASIA, PERINATAL LETHAL, INCLUDED
Number Sign	241510	HYPOPHOSPHATASIA, CHILDHOOD		
NULL	241519	HYPOPHOSPHATEMIA, RENAL, WITH INTRACEREBRAL CALCIFICATIONS		
Number Sign	241520	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1; ARHR1	ARHR;; HYPOPHOSPHATEMIA, AUTOSOMAL RECESSIVE; ARHP	
Number Sign	241530	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY; HHRH	HYPERCALCIURIC RICKETS	
NULL	241540	HYPOPITUITARISM, CONGENITAL, WITH CENTRAL DIABETES INSIPIDUS		
Number Sign	241550	HYPOPLASTIC LEFT HEART SYNDROME 1; HLHS1	HLHS	
Number Sign	241600	IMMUNODEFICIENCY 43; IMD43	BETA-2-MICROGLOBULIN DEFICIENCY;; B2M DEFICIENCY;; HYPOPROTEINEMIA, HYPERCATABOLIC	
NULL	241760	HYPOSPADIAS-MENTAL RETARDATION SYNDROME		
NULL	241800	HYPOTHALAMIC HAMARTOMAS		CONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED
Number Sign	241850	HYPOTHYROIDISM, THYROIDAL OR ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	BAMFORTH-LAZARUS SYNDROME	
NULL	242050	HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY		
Number Sign	242100	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2; ARCI2	COLLODION BABY, SELF-HEALING;; ICHTHYOSIFORM ERYTHRODERMA, NONBULLOUS CONGENITAL, 1, FORMERLY; NCIE1, FORMERLY;; ICHTHYOSIFORM ERYTHRODERMA, BROCQ CONGENITAL, NONBULLOUS FORM, FORMERLY	
NULL	242150	ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE;; KID SYNDROME, AUTOSOMAL RECESSIVE;; DESMONS SYNDROME	
Number Sign	242300	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1, WITH BATHING SUIT DISTRIBUTION;; COLLODION BABY, SELF-HEALING; SHCB;; ICHTHYOSIS CONGENITA;; LAMELLAR EXFOLIATION OF NEWBORN;; DESQUAMATION OF NEWBORN;; COLLODION FETUS;; ICHTHYOSIS CONGENITA II; ICR2;; ICHTHYOSIS, LAMELLAR, 1, FORMERLY; LI1, FORMERLY	
NULL	242400	ICHTHYOSIS CONGENITA WITH BILIARY ATRESIA		
Number Sign	242500	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B	ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;; HARLEQUIN ICHTHYOSIS; HI;; 'HARLEQUIN FETUS'	
NULL	242510	ICHTHYOSIS WITH ALOPECIA, ECLABIUM, ECTROPION, AND MENTAL RETARDATION		
NULL	242520	ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION		
NULL	242530	ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT		
NULL	242550	ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA		
Number Sign	242600	IMINOGLYCINURIA		
Percent	242670	CILIARY DYSKINESIA WITH DEFECTIVE RADIAL SPOKES	IMMOTILE CILIA SYNDROME DUE TO DEFECTIVE RADIAL SPOKES	
NULL	242680	CILIARY DYSKINESIA WITH EXCESSIVELY LONG CILIA	IMMOTILE CILIA SYNDROME DUE TO EXCESSIVELY LONG CILIA	
Percent	242700	IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	T-LYMPHOCYTE DEFICIENCY;; NEZELOF SYNDROME;; THYMIC APLASIA	
Number Sign	242840	VICI SYNDROME; VICIS	IMMUNODEFICIENCY WITH CLEFT LIP/PALATE, CATARACT, HYPOPIGMENTATION, AND ABSENT CORPUS CALLOSUM	
NULL	242850	IMMUNE DEFICIENCY DISEASE		
Number Sign	242860	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1; ICF1	IMMUNE DEFICIENCY, VARIABLE, WITH CENTROMERIC INSTABILITY OF CHROMOSOMES 1, 9, AND 16;; CENTROMERIC INSTABILITY, IMMUNODEFICIENCY SYNDROME; CIID;; IMMUNODEFICIENCY SYNDROME, VARIABLE	
NULL	242870	IMMUNODEFICIENCY, PARTIAL COMBINED, WITH ABSENCE OF HLA DETERMINANTS AND BETA-2-MICROGLOBULIN FROM LYMPHOCYTES		
NULL	242880	IMMUNOERYTHROMYELOID HYPOPLASIA		
NULL	242890	IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW		
Number Sign	242900	SCHIMKE IMMUNOOSSEOUS DYSPLASIA; SIOD	IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	
Number Sign	243000	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	INSENSITIVITY TO PAIN, CHANNELOPATHY-ASSOCIATED;; CONGENITAL ANALGESIA, AUTOSOMAL RECESSIVE;; ASYMBOLIA FOR PAIN	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IID, INCLUDED; HSAN2D, INCLUDED
NULL	243050	INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION		
Number Sign	243060	SPERMATOGENIC FAILURE 5; SPGF5	MALE INFERTILITY WITH LARGE-HEADED, MULTIFLAGELLAR, POLYPLOID SPERMATOZOA;; INFERTILITY ASSOCIATED WITH MULTITAILED SPERMATOZOA AND EXCESSIVE DNA	
NULL	243080	INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO		
NULL	243100	INTERNAL CAROTID ARTERIES, HYPOPLASIA OF		
NULL	243110	IMMUNODEFICIENCY WITH DEFECTIVE T-CELL RESPONSE TO INTERLEUKIN 1	INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	
Number Sign	243150	GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	INTESTINAL ATRESIA, MULTIPLE AND/OR INFLAMMATORY BOWEL DISEASE WITH OR WITHOUT IMMUNODEFICIENCY;; INTESTINAL ATRESIA, MULTIPLE; MINAT;; FAMILIAL INTESTINAL POLYATRESIA SYNDROME; FIPA	
Percent	243180	VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	INTESTINAL PSEUDOOBSTRUCTION DUE TO NEURONAL DISEASE;; ARGYROPHIL MYENTERIC PLEXUS, DEFICIENCY OF;; PSEUDOOBSTRUCTION, CHRONIC IDIOPATHIC INTESTINAL, NEURONAL TYPE	NEURONAL INTESTINAL DYSPLASIA, TYPE A, INCLUDED;; NID A, INCLUDED
NULL	243185	INTESTINAL PSEUDOOBSTRUCTION WITH PATENT DUCTUS ARTERIOSUS AND NATAL TEETH		
NULL	243200	INTRACRANIAL HYPERTENSION, IDIOPATHIC	PSEUDOTUMOR CEREBRI	
Number Sign	243300	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1	SUMMERSKILL SYNDROME	
Number Sign	243310	BARAITSER-WINTER SYNDROME 1; BRWS1	IRIS COLOBOMA WITH PTOSIS, HYPERTELORISM, AND MENTAL RETARDATION;; FRYNS-AFTIMOS SYNDROME;; PACHYGYRIA, MENTAL RETARDATION, EPILEPSY, AND CHARACTERISTIC FACIES;; CEREBROOCULOFACIAL LYMPHATIC SYNDROME; COFLS;; MENTAL RETARDATION WITH EPILEPSY AND CHARACTERISTIC FACIES;; CEREBROFRONTOFACIAL SYNDROME	
NULL	243320	INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF		
Number Sign	243400	ACETYLATION, SLOW	SLOW ACETYLATOR PHENOTYPE;; ISONIAZID INACTIVATION, SLOW;; INH INACTIVATION, SLOW	ACETYLATION, FAST, INCLUDED;; FAST ACETYLATOR PHENOTYPE, INCLUDED;; INH INACTIVATION, FAST, INCLUDED
NULL	243440	ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME	MICROTIA-AORTIC ARCH SYNDROME	
NULL	243450	ISOVALERIC ACID, INABILITY TO SMELL		
Number Sign	243500	ISOVALERIC ACIDEMIA; IVA	ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;; IVD DEFICIENCY	
Percent	243600	JEJUNAL ATRESIA	APPLE PEEL SYNDROME;; APPLE PEEL SMALL BOWEL SYNDROME; APSB	
Number Sign	243605	STROMME SYNDROME; STROMS	JEJUNAL ATRESIA WITH MICROCEPHALY AND OCULAR ANOMALIES;; APPLE PEEL SYNDROME WITH MICROCEPHALY AND OCULAR ANOMALIES;; CILIARY DYSKINESIA, PRIMARY, 31, FORMERLY; CILD31, FORMERLY	
Number Sign	243700	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE	HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;; HIES, AUTOSOMAL RECESSIVE	
Number Sign	243800	JOHANSON-BLIZZARD SYNDROME; JBS	NASAL ALAR HYPOPLASIA, HYPOTHYROIDISM, PANCREATIC ACHYLIA, AND CONGENITAL DEAFNESS	
Percent	243910	ARIMA SYNDROME	DEKABAN-ARIMA SYNDROME;; JOUBERT SYNDROME WITH BILATERAL CHORIORETINAL COLOBOMA;; COLOBOMA, CHORIORETINAL, WITH CEREBELLAR VERMIS APLASIA;; CEREBROOCULOHEPATORENAL SYNDROME	
NULL	244100	JUMPING FRENCHMEN OF MAINE		
Number Sign	244200	HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3		
Percent	244300	KAPUR-TORIELLO SYNDROME	LONG COLUMELLA WITH CLEFT LIP/PALATE AND EYE, HEART, AND INTESTINAL ANOMALIES	
Number Sign	244400	CILIARY DYSKINESIA, PRIMARY, 1; CILD1	PCD;; CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;; IMMOTILE CILIA SYNDROME; ICS;; POLYNESIAN BRONCHIECTASIS	KARTAGENER SYNDROME, INCLUDED;; DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;; SIEWERT SYNDROME, INCLUDED
Number Sign	244450	KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	BLEPHAROPHIMOSIS-PTOSIS-INTELLECTUAL DISABILITY SYNDROME; BPIDS	
Number Sign	244460	KENNY-CAFFEY SYNDROME, TYPE 1; KCS1	KCS;; KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	
NULL	244510	KERATOCONUS AND CONGENITAL HIP DYSPLASIA		
NULL	244600	KERATOCONUS POSTICUS CIRCUMSCRIPTUS; KPC		KPC WITH ASSOCIATED MALFORMATIONS, INCLUDED
NULL	244850	PALMOPLANTAR KERATODERMA, NORRBOTTEN RECESSIVE TYPE; PPKNR		
Number Sign	245000	PAPILLON-LEFEVRE SYNDROME; PALS	PLS;; KERATOSIS PALMOPLANTARIS WITH PERIODONTOPATHIA	
Number Sign	245010	HAIM-MUNK SYNDROME; HMS	KERATOSIS PALMOPLANTARIS WITH PERIODONTOPATHIA AND ONYCHOGRYPOSIS;; COCHIN JEWISH DISORDER	
Number Sign	245050	SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY; SCOTD	SCOT DEFICIENCY;; SUCCINYL-CoA:3-KETOACID CoA-TRANSFERASE DEFICIENCY;; SUCCINYL-CoA:ACETOACETATE TRANSFERASE DEFICIENCY;; KETOACIDOSIS DUE TO SCOT DEFICIENCY	
Percent	245100	RICHARDS-RUNDLE SYNDROME; RRNS	ATAXIA-DEAFNESS-MENTAL RETARDATION SYNDROME	
NULL	245130	KETOADIPICACIDURIA		
Number Sign	245150	KEUTEL SYNDROME; KTLS	PULMONIC STENOSIS, BRACHYTELEPHALANGISM, AND CALCIFICATION OF CARTILAGES	
NULL	245160	KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS	BURTON SYNDROME	
NULL	245180	KIFAFA SEIZURE DISORDER		
NULL	245190	KNIEST-LIKE DYSPLASIA, LETHAL		
Number Sign	245200	KRABBE DISEASE	GLOBOID CELL LEUKODYSTROPHY; GLD; GCL;; GLOBOID CELL LEUKOENCEPHALOPATHY;; GALACTOSYLCERAMIDE BETA-GALACTOSIDASE DEFICIENCY;; GALACTOCEREBROSIDASE DEFICIENCY;; GALC DEFICIENCY	
Number Sign	245300	KURU, SUSCEPTIBILITY TO		
Number Sign	245340	ERYTHROCYTE LACTATE TRANSPORTER DEFECT	LACTATE TRANSPORTER DEFECT, MYOPATHY DUE TO	
Number Sign	245348	PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	LACTIC ACIDEMIA DUE TO DEFECT OF E2 LIPOYL TRANSACETYLASE OF THE PYRUVATE DEHYDROGENASE COMPLEX	
Number Sign	245349	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD	LACTIC ACIDEMIA DUE TO DEFECT IN LIPOYL-CONTAINING COMPONENT X OF THE PYRUVATE DEHYDROGENASE COMPLEX	
Number Sign	245400	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9	LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	
NULL	245450	LACTIC ACIDURIA DUE TO D-LACTIC ACID		
Number Sign	245480	SPECIFIC GRANULE DEFICIENCY 1; SGD1	LACTOFERRIN-DEFICIENT NEUTROPHILS;; NEUTROPHIL LACTOFERRIN DEFICIENCY	
NULL	245550	LAMBERT SYNDROME	BRANCHIAL DYSPLASIA, CLUBFOOT, INGUINAL HERNIA, AND BILIARY ATRESIA	
NULL	245552	LAMBOTTE SYNDROME	MICROCEPHALY, HOLOPROSENCEPHALY, AND INTRAUTERINE GROWTH RETARDATION	
Number Sign	245570	EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION; FESD	APHASIA, ACQUIRED, WITH EPILEPSY	LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED;; CONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLUDED; CSWSS, INCLUDED;; ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED;; BENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED
Number Sign	245590	GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY	LARON SYNDROME DUE TO POSTRECEPTOR DEFECT;; GROWTH HORMONE INSENSITIVITY DUE TO POSTRECEPTOR DEFECT	
Number Sign	245600	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS; JDSCD	LARSEN SYNDROME, AUTOSOMAL RECESSIVE, FORMERLY	
NULL	245650	LARSEN-LIKE SYNDROME, LETHAL TYPE		
Number Sign	245660	LARYNGOONYCHOCUTANEOUS SYNDROME; LOCS	LOGIC SYNDROME	
Number Sign	245800	LAURENCE-MOON SYNDROME; LNMS		
Number Sign	245900	LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	LCAT DEFICIENCY;; NORUM DISEASE	
Percent	246000	LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT		
Number Sign	246200	DONOHUE SYNDROME	LEPRECHAUNISM	INSULIN RECEPTOR, DEFECT IN, INCLUDED
Number Sign	246300	LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3		
Percent	246400	LETTERER-SIWE DISEASE	L-S DISEASE; LESD;; HISTIOCYTOSIS X, ACUTE DISSEMINATED	
Number Sign	246450	3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	HMG-CoA LYASE DEFICIENCY;; HMGCL DEFICIENCY;; HL DEFICIENCY;; HYDROXYMETHYLGLUTARIC ACIDURIA	
NULL	246470	LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER		
NULL	246500	LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS		
NULL	246550	LICHTENSTEIN SYNDROME		
NULL	246555	LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY		
Number Sign	246560	SPLIT-HAND/FOOT MALFORMATION 3; SHFM3	SHSF3;; LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;; CHROMOSOME 10q24 DUPLICATION SYNDROME	
NULL	246570	FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	FATCO SYNDROME	
Number Sign	246650	LIPASE DEFICIENCY, COMBINED	LIPOPROTEIN LIPASE DEFICIENCY WITH HEPATIC TRIGLYCERIDE LIPASE DEFICIENCY;; LPL AND HTGL DEFICIENCY;; LPL AND HL DEFICIENCY	
Number Sign	246700	CHYLOMICRON RETENTION DISEASE; CMRD	ANDERSON DISEASE; ANDD;; LIPID TRANSPORT DEFECT OF INTESTINE;; HYPOBETALIPOPROTEINEMIA WITH ACCUMULATION OF APOLIPOPROTEIN B-LIKE PROTEIN IN INTESTINAL CELLS	
Number Sign	246900	DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY; DLDD	DLD DEFICIENCY;; E3 DEFICIENCY;; LIPOAMIDE DEHYDROGENASE DEFICIENCY, LACTIC ACIDOSIS DUE TO;; MAPLE SYRUP URINE DISEASE, TYPE III	
Number Sign	247100	LIPOID PROTEINOSIS OF URBACH AND WIETHE	LIPOID PROTEINOSIS;; URBACH-WIETHE DISEASE;; HYALINOSIS CUTIS ET MUCOSAE	
NULL	247150	LIP PRINTS		
Number Sign	247200	MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	MDS	CHROMOSOME 17p13.3 DELETION SYNDROME, INCLUDED;; MILLER-DIEKER SYNDROME CHROMOSOME REGION, INCLUDED; MDCR, INCLUDED
NULL	247410	LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	HYPOPARATHYROIDISM-LYMPHEDEMA SYNDROME	
Number Sign	247420	LUTHERAN NULL	RECESSIVE LU (a-b-) PHENOTYPE	
NULL	247430	LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF		
NULL	247440	LYMPHEDEMA, CONGENITAL RECESSIVE		
NULL	247450	LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN		
NULL	247610	LYMPHOID INTERSTITIAL PNEUMONIA; LIP		
NULL	247630	LYMPHOID SYSTEM DETERIORATION, PROGRESSIVE		
NULL	247640	LYMPHOBLASTIC LEUKEMIA, ACUTE, WITH LYMPHOMATOUS FEATURES; LALL	LYMPHOMATOUS ALL	
NULL	247650	LYMPHOKINE DEFICIENCY		
Percent	247800	LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNE HEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS		
NULL	247950	LYSINE MALABSORPTION SYNDROME		
NULL	247990	MACDERMOT-WINTER SYNDROME		
Number Sign	248000	MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE; MGCPH		
NULL	248010	MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE		
NULL	248100	MACROSOMIA ADIPOSA CONGENITA		
NULL	248110	MACROSOMIA WITH MICROPHTHALMIA, LETHAL		
Number Sign	248190	HYPOMAGNESEMIA 5, RENAL, WITH OCULAR INVOLVEMENT; HOMG5	HYPOMAGNESEMIA, RENAL, WITH OCULAR INVOLVEMENT;; HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA, NEPHROCALCINOSIS, AND SEVERE OCULAR INVOLVEMENT;; FHHNC WITH SEVERE OCULAR INVOLVEMENT;; MACULAR COLOBOMA, BILATERAL, WITH HYPERCALCIURIA	
Number Sign	248200	STARGARDT DISEASE 1; STGD1	STGD;; MACULAR DEGENERATION, JUVENILE;; MACULAR DYSTROPHY WITH FLECKS, TYPE 1	FUNDUS FLAVIMACULATUS, INCLUDED; FFM, INCLUDED;; RETINAL DYSTROPHY, EARLY-ONSET SEVERE, INCLUDED
Number Sign	248250	HYPOMAGNESEMIA 3, RENAL; HOMG3	HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORT OF MAGNESIUM;; HYPOMAGNESEMIA, ISOLATED RENAL;; HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	HYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED
NULL	248260	MAGNESIUM, ELEVATED RED CELL		
Number Sign	248300	MAL DE MELEDA; MDM	MELEDA DISEASE;; KERATOSIS PALMOPLANTARIS TRANSGREDIENS OF SIEMENS	
Percent	248310	PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL	PFBI;; PLASMODIUM FALCIPARUM PARASITEMIA	
Number Sign	248340	3MC SYNDROME 3; 3MC3	FACIAL CLEFTING SYNDROME, GYPSY TYPE;; MALPUECH FACIAL CLEFTING SYNDROME, FORMERLY	
NULL	248350	MALOCCLUSION AND SHORT STATURE		
Number Sign	248360	MALONYL-CoA DECARBOXYLASE DEFICIENCY		
Number Sign	248370	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	LIPODYSTROPHY, TYPE A, ASSOCIATED WITH MANDIBULOACRAL DYSPLASIA;; CRANIOMANDIBULAR DERMATODYSOSTOSIS	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY, ATYPICAL, INCLUDED
Number Sign	248390	TREACHER COLLINS SYNDROME 3; TCS3	MANDIBULOFACIAL DYSOSTOSIS, TREACHER COLLINS TYPE, AUTOSOMAL RECESSIVE	
NULL	248400	MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL DEFICIENCY		
Number Sign	248450	MANITOBA OCULOTRICHOANAL SYNDROME; MOTA	MARLES SYNDROME	
Number Sign	248500	MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA	ALPHA-MANNOSIDOSIS;; LYSOSOMAL ALPHA-D-MANNOSIDASE DEFICIENCY;; ALPHA-MANNOSIDASE B DEFICIENCY	
Number Sign	248510	MANNOSIDOSIS, BETA A, LYSOSOMAL; MANSB	BETA-MANNOSIDOSIS;; LYSOSOMAL BETA-MANNOSIDASE DEFICIENCY;; BETA-MANNOSIDASE DEFICIENCY	
Number Sign	248600	MAPLE SYRUP URINE DISEASE; MSUD	BRANCHED-CHAIN KETOACIDURIA;; BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE DEFICIENCY;; BCKD DEFICIENCY;; KETO ACID DECARBOXYLASE DEFICIENCY	MAPLE SYRUP URINE DISEASE, CLASSIC, INCLUDED;; MAPLE SYRUP URINE DISEASE, INTERMEDIATE, INCLUDED;; MAPLE SYRUP URINE DISEASE, INTERMITTENT, INCLUDED;; MAPLE SYRUP URINE DISEASE, THIAMINE-RESPONSIVE, INCLUDED;; MAPLE SYRUP URINE DISEASE, TYPE IA, INCLUDED; MSUD1A, INCLUDED;; MAPLE SYRUP URINE DISEASE, TYPE IB, INCLUDED; MSUD1B, INCLUDED;; MAPLE SYRUP URINE DISEASE, TYPE II, INCLUDED; MSUD2, INCLUDED
Number Sign	248700	MARDEN-WALKER SYNDROME; MWKS	MWS	
NULL	248760	MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS		
NULL	248770	MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL		
Number Sign	248800	MARINESCO-SJOGREN SYNDROME; MSS		
Number Sign	248900	MAST SYNDROME	SPASTIC PARAPLEGIA 21, AUTOSOMAL RECESSIVE; SPG21	
NULL	248910	CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA		
NULL	248950	MCDONOUGH SYNDROME		
Number Sign	249000	MECKEL SYNDROME, TYPE 1; MKS1	MECKEL-GRUBER SYNDROME, TYPE 1;; MECKEL SYNDROME; MKS;; MES;; DYSENCEPHALIA SPLANCHNOCYSTICA;; GRUBER SYNDROME;; MECKEL-GRUBER SYNDROME	
Number Sign	249100	FAMILIAL MEDITERRANEAN FEVER; FMF	FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL RECESSIVE;; POLYSEROSITIS, RECURRENT;; POLYSEROSITIS, FAMILIAL PAROXYSMAL	
NULL	249230	MEGAEPIPHYSEAL DWARFISM		
NULL	249240	MEGALENCEPHALY WITH DYSMYELINATION	MEGALENCEPHALY WITH DIFFUSE WHITE MATTER HYPODENSITY	
Number Sign	249270	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA	THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA, DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;; MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUS AND SENSORINEURAL DEAFNESS;; ROGERS SYNDROME;; THIAMINE-RESPONSIVE ANEMIA SYNDROME;; THIAMINE-RESPONSIVE MYELODYSPLASIA	
NULL	249300	MEGALOCORNEA		
Percent	249310	MEGALOCORNEA-MENTAL RETARDATION SYNDROME	MMR SYNDROME;; NEUHAUSER SYNDROME	
Number Sign	249400	MELANOSIS, NEUROCUTANEOUS; NCMS	NEUROMELANOSIS	
Number Sign	249420	FRANK-TER HAAR SYNDROME; FTHS	TER HAAR SYNDROME;; BORRONE DERMATOCARDIOSKELETAL SYNDROME;; MELNICK-NEEDLES SYNDROME, AUTOSOMAL RECESSIVE, FORMERLY	
Number Sign	249500	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1; MRT1		
NULL	249599	MENTAL RETARDATION SYNDROME, BELGIAN TYPE		
NULL	249600	MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	MIETENS-WEBER SYNDROME	
Percent	249620	OHDO SYNDROME	OHDO BLEPHAROPHIMOSIS SYNDROME;; MENTAL RETARDATION, CONGENITAL HEART DISEASE, BLEPHAROPHIMOSIS, BLEPHAROPTOSIS, AND HYPOPLASTIC TEETH	
NULL	249630	MENTAL RETARDATION, BUENOS AIRES TYPE	MUTCHINICK SYNDROME	
Percent	249650	MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU	DISULFIDURIA, MIXED	
NULL	249660	MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES		
NULL	249670	MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	MEXICAN CARDIOMELIC DYSPLASIA	
Number Sign	249700	LANGER MESOMELIC DYSPLASIA; LMD	DYSCHONDROSTEOSIS, HOMOZYGOUS;; MESOMELIC DWARFISM OF THE HYPOPLASTIC ULNA, FIBULA, AND MANDIBLE TYPE	
NULL	249710	MESOMELIC LIMB SHORTENING AND BOWING		
Number Sign	249900	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	METACHROMATIC LEUKODYSTROPHY DUE TO CEREBROSIDE SULFATASE ACTIVATOR DEFICIENCY;; SAPOSIN B DEFICIENCY	
Number Sign	250100	METACHROMATIC LEUKODYSTROPHY; MLD	METACHROMATIC LEUKOENCEPHALOPATHY;; CEREBRAL SCLEROSIS, DIFFUSE, METACHROMATIC FORM;; SULFATIDE LIPIDOSIS;; ARYLSULFATASE A DEFICIENCY;; ARSA DEFICIENCY;; CEREBROSIDE SULFATASE DEFICIENCY	PSEUDOARYLSULFATASE A DEFICIENCY, INCLUDED;; METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE, INCLUDED;; METACHROMATIC LEUKODYSTROPHY, JUVENILE, INCLUDED;; METACHROMATIC LEUKODYSTROPHY, ADULT, INCLUDED
Percent	250215	METAPHYSEAL ACROSCYPHODYSPLASIA	WEDGE-SHAPED EPIPHYSES OF KNEES;; CUPPED METAPHYSES AND CONE-SHAPED EPIPHYSES OF KNEES WITH BRACHYDACTYLY	
Number Sign	250220	SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	SEDAGHATIAN CHONDRODYSPLASIA;; METAPHYSEAL CHONDRODYSPLASIA, CONGENITAL LETHAL	
NULL	250230	METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE		
Number Sign	250250	CARTILAGE-HAIR HYPOPLASIA; CHH	METAPHYSEAL CHONDRODYSPLASIA, MCKUSICK TYPE	
NULL	250300	METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE		
Number Sign	250400	METAPHYSEAL DYSPLASIA, SPAHR TYPE; MDST	METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	
Number Sign	250410	RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES; RPSKA	METAPHYSEAL CHONDRODYSPLASIA WITH RETINITIS PIGMENTOSA	
NULL	250420	METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS		
NULL	250450	METAPHYSEAL DYSPLASIA, ANETODERMA, AND OPTIC ATROPHY		
Number Sign	250460	METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS; MDWH	CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSIS OR IMMUNODEFICIENCY;; CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	
NULL	250500	METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA		
Number Sign	250620	3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY; HIBCHD	BETA-HYDROXYISOBUTYRYL CoA DEACYLASE DEFICIENCY;; HIBCH DEFICIENCY;; METHACRYLIC ACIDURIA;; METHACRYLIC ACID TOXICITY;; VALINE METABOLIC DEFECT	
NULL	250650	METHANE PRODUCTION		
NULL	250700	METHEMOGLOBIN REDUCTASE DEFICIENCY	NADPH-DEPENDENT METHEMOGLOBIN REDUCTASE DEFICIENCY;; TPNH-METHEMOGLOBIN REDUCTASE DEFICIENCY	
Number Sign	250790	METHEMOGLOBINEMIA TYPE IV	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF CYTOCHROME b5	
Number Sign	250800	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	NADH-DEPENDENT METHEMOGLOBIN REDUCTASE DEFICIENCY;; NADH-CYTOCHROME b5 REDUCTASE DEFICIENCY;; METHEMOGLOBINEMIA, CONGENITAL, AUTOSOMAL RECESSIVE	METHEMOGLOBINEMIA, TYPE I, INCLUDED;; METHEMOGLOBINEMIA, TYPE II, INCLUDED;; NADH-CYTOCHROME b5 REDUCTASE DEFICIENCY, TYPE I, INCLUDED;; NADH-CYTOCHROME b5 REDUCTASE DEFICIENCY, TYPE II, INCLUDED
Number Sign	250850	METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	MAT DEFICIENCY;; MAT I/III DEFICIENCY;; HYPERMETHIONINEMIA, ISOLATED PERSISTENT	
Percent	250900	METHIONINE MALABSORPTION SYNDROME	SMITH-STRANG DISEASE;; OASTHOUSE URINE DISEASE	
Number Sign	250940	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE; HMAG	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblG COMPLEMENTATION TYPE;; METHYLCOBALAMIN DEFICIENCY, cblG TYPE;; METHIONINE SYNTHASE DEFICIENCY	
Number Sign	250950	3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	MGA, TYPE I; MGA1;; 3-METHYLGLUTACONYL-CoA HYDRATASE DEFICIENCY;; 3-MG-CoA-HYDRATASE DEFICIENCY	
NULL	250951	3-METHYLGLUTACONIC ACIDURIA, TYPE IV; MGCA4	MGA, TYPE IV; MGA4	
Number Sign	251000	METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY	METHYLMALONIC ACIDEMIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY MMA DUE TO MCM DEFICIENCY;; METHYLMALONIC ACIDURIA, mut TYPE	METHYLMALONIC ACIDURIA, mut(0) TYPE, INCLUDED;; METHYLMALONIC ACIDURIA, mut(-) TYPE, INCLUDED
Number Sign	251100	METHYLMALONIC ACIDURIA, cblA TYPE	METHYLMALONIC ACIDEMIA, cblA TYPE;; METHYLMALONIC ACIDURIA, VITAMIN B12-RESPONSIVE, DUE TO DEFECT IN SYNTHESIS OF ADENOSYLCOBALAMIN, cblA TYPE	
Number Sign	251110	METHYLMALONIC ACIDURIA, cblB TYPE	METHYLMALONIC ACIDEMIA, cblB TYPE;; METHYLMALONIC ACIDURIA, VITAMIN B12-RESPONSIVE, DUE TO DEFECT IN SYNTHESIS OF ADENOSYLCOBALAMIN, cblB TYPE	
Number Sign	251120	METHYLMALONYL-CoA EPIMERASE DEFICIENCY	METHYLMALONYL-CoA RACEMASE DEFICIENCY;; METHYLMALONIC ACIDURIA III, FORMERLY	METHYLMALONYL-CoA EPIMERASE DEFICIENCY WITH SEPIAPTERIN REDUCTASE DEFICIENCY, INCLUDED
NULL	251190	MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE		
Number Sign	251200	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1	PREMATURE CHROMOSOME CONDENSATION WITH MICROCEPHALY AND MENTAL RETARDATION;; PREMATURE CHROMOSOME CONDENSATION SYNDROME;; PCC SYNDROME	
NULL	251220	MICROCEPHALY-CARDIOMYOPATHY		
Number Sign	251230	MICROCEPHALY-MICROMELIA SYNDROME; MIMIS		
NULL	251240	MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA		
NULL	251250	MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES		
Number Sign	251255	JAWAD SYNDROME; JWDS	KELLY SYNDROME;; MICROCEPHALY WITH MENTAL RETARDATION AND DIGITAL ANOMALIES	
Number Sign	251260	NIJMEGEN BREAKAGE SYNDROME; NBS	ATAXIA-TELANGIECTASIA VARIANT V1; AT-V1;; MICROCEPHALY WITH NORMAL INTELLIGENCE, IMMUNODEFICIENCY, AND LYMPHORETICULAR MALIGNANCIES;; SEEMANOVA SYNDROME II;; NONSYNDROMAL MICROCEPHALY, AUTOSOMAL RECESSIVE, WITH NORMAL INTELLIGENCE;; IMMUNODEFICIENCY, MICROCEPHALY, AND CHROMOSOMAL INSTABILITY	BERLIN BREAKAGE SYNDROME, INCLUDED; BBS, INCLUDED;; ATAXIA-TELANGIECTASIA VARIANT V2, INCLUDED; AT-V2, INCLUDED
Number Sign	251270	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1		
Number Sign	251280	MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC		
Number Sign	251290	PSEUDO-TORCH SYNDROME 1; PTORCH1	PSEUDO-TORCH SYNDROME; BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA; BLCPMG	
Number Sign	251300	GALLOWAY-MOWAT SYNDROME; GAMOS	MICROCEPHALY, HIATAL HERNIA, AND NEPHROTIC SYNDROME;; GALLOWAY SYNDROME;; NEPHROSIS-NEURONAL DYSMIGRATION SYNDROME;; NEPHROSIS-MICROCEPHALY SYNDROME;; CEREBELLAR ATAXIA WITH MENTAL RETARDATION, OPTIC ATROPHY, AND SKIN ABNORMALITIES; CAMOS;; SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 5, FORMERLY; SCAR5, FORMERLY	
NULL	251400	MICROCOLON		
Number Sign	251450	DESBUQUOIS DYSPLASIA 1; DBQD1	DESBUQUOIS SYNDROME;; MICROMELIC DWARFISM WITH VERTEBRAL AND METAPHYSEAL ABNORMALITIES AND ADVANCED CARPOTARSAL OSSIFICATION	DESBUQUOIS DYSPLASIA, KIM VARIANT, INCLUDED
NULL	251505	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 4; MCOPCB4	MICROPHTHALMIA WITH COLOBOMATOUS CYST	
Percent	251600	MICROPHTHALMIA, ISOLATED 1; MCOP1	MCOP;; ANOPHTHALMIA, CLINICAL, ISOLATED;; MICROPHTHALMOS, AUTOSOMAL RECESSIVE	
NULL	251700	MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA, AND DENTAL ANOMALIES		
Number Sign	251750	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA		
Percent	251800	MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS		
Number Sign	251850	DIARRHEA 2, WITH MICROVILLUS ATROPHY; DIAR2	MICROVILLUS INCLUSION DISEASE; MVID;; MICROVILLUS ATROPHY, CONGENITAL;; DAVIDSON DISEASE;; CONGENITAL FAMILIAL PROTRACTED DIARRHEA WITH ENTEROCYTE BRUSH-BORDER ABNORMALITIES;; INTRACTABLE DIARRHEA OF INFANCY	
Number Sign	251880	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE); MTDPS3		
NULL	251900	MITOCHONDRIAL MYOPATHY		
NULL	251945	MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT		
Number Sign	251950	MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA		
Number Sign	252010	MITOCHONDRIAL COMPLEX I DEFICIENCY	NADH:Q(1) OXIDOREDUCTASE DEFICIENCY;; NADH-COENZYME Q REDUCTASE DEFICIENCY;; MITOCHONDRIAL NADH DEHYDROGENASE COMPONENT OF COMPLEX I, DEFICIENCY OF	
Number Sign	252011	MITOCHONDRIAL COMPLEX II DEFICIENCY	SUCCINATE CoQ REDUCTASE DEFICIENCY	
Percent	252100	MOHR SYNDROME	OROFACIODIGITAL SYNDROME II; OFD2;; OFDS II;; ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	
Number Sign	252150	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	SULFITE OXIDASE, XANTHINE DEHYDROGENASE, AND ALDEHYDE OXIDASE, COMBINED DEFICIENCY OF	
Number Sign	252160	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB		
NULL	252250	MONOCYTE CHEMOTACTIC DISORDER		
Number Sign	252270	MONOSOMY 7 OF BONE MARROW	MYELODYSPLASIA AND LEUKEMIA SYNDROME WITH MONOSOMY 7; MLSM7;; CHROMOSOME 7q DELETION	
NULL	252300	MORQUIO SYNDROME C	MORQUIO SYNDROME, NONKERATOSULFATE-EXCRETING TYPE	
NULL	252320	MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA		
Percent	252350	MOYAMOYA DISEASE 1; MYMY1	MOYAMOYA DISEASE; MYMY;; SPONTANEOUS OCCLUSION OF THE CIRCLE OF WILLIS	
Number Sign	252500	MUCOLIPIDOSIS II ALPHA/BETA	MUCOLIPIDOSIS II; ML II;; ML II ALPHA/BETA;; I-CELL DISEASE; ICD	
Number Sign	252600	MUCOLIPIDOSIS III ALPHA/BETA	ML III ALPHA/BETA;; MUCOLIPIDOSIS IIIA; ML IIIA;; MUCOLIPIDOSIS III;; ML III;; PSEUDO-HURLER POLYDYSTROPHY	MUCOLIPIDOSIS III ALPHA/BETA, ATYPICAL, INCLUDED
Number Sign	252605	MUCOLIPIDOSIS III GAMMA	ML III GAMMA;; MUCOLIPIDOSIS III, COMPLEMENTATION GROUP C;; MUCOLIPIDOSIS IIIC;; ML IIIC;; MUCOLIPIDOSIS III, IRANIAN VARIANT FORM;; MUCOLIPIDOSIS III, VARIANT FORM	
Number Sign	252650	MUCOLIPIDOSIS IV; ML4	ML IV;; SIALOLIPIDOSIS	
Number Sign	252700	MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES		
Number Sign	252900	MUCOPOLYSACCHARIDOSIS, TYPE IIIA; MPS3A	MPS IIIA;; SANFILIPPO SYNDROME A;; HEPARAN SULFATE SULFATASE DEFICIENCY;; SULFAMIDASE DEFICIENCY	
Number Sign	252920	MUCOPOLYSACCHARIDOSIS, TYPE IIIB; MPS3B	MPS IIIB;; SANFILIPPO SYNDROME B;; N-ACETYL-ALPHA-D-GLUCOSAMINIDASE DEFICIENCY;; NAGLU DEFICIENCY	
Number Sign	252930	MUCOPOLYSACCHARIDOSIS, TYPE IIIC; MPS3C	MPS IIIC;; SANFILIPPO SYNDROME C;; ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	
Number Sign	252940	MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D	MPS IIID;; SANFILIPPO SYNDROME D;; N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	
Number Sign	253000	MUCOPOLYSACCHARIDOSIS, TYPE IVA; MPS4A	MORQUIO SYNDROME A;; MPS IVA;; MORQUIO A DISEASE;; GALACTOSAMINE-6-SULFATASE DEFICIENCY;; GALNS DEFICIENCY	
Number Sign	253010	MUCOPOLYSACCHARIDOSIS, TYPE IVB; MPS4B	MORQUIO SYNDROME B;; MPS IVB	
Number Sign	253200	MUCOPOLYSACCHARIDOSIS TYPE VI; MPS6	MPS VI;; MAROTEAUX-LAMY SYNDROME;; ARYLSULFATASE B DEFICIENCY;; ARSB DEFICIENCY;; N-ACETYLGALACTOSAMINE-4-SULFATASE DEFICIENCY	
Number Sign	253220	MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	MPS VII;; SLY SYNDROME;; BETA-GLUCURONIDASE DEFICIENCY;; GUSB DEFICIENCY	
Percent	253240	MUCUS INSPISSATION OF RESPIRATORY TRACT		
Number Sign	253250	MULIBREY NANISM	MUSCLE-LIVER-BRAIN-EYE NANISM;; PERICARDIAL CONSTRICTION AND GROWTH FAILURE;; PERHEENTUPA SYNDROME	
Number Sign	253260	BIOTINIDASE DEFICIENCY	BTD DEFICIENCY;; MULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET;; MULTIPLE CARBOXYLASE DEFICIENCY, JUVENILE-ONSET	
Number Sign	253270	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	HLCS DEFICIENCY;; MULTIPLE CARBOXYLASE DEFICIENCY, NEONATAL FORM;; MULTIPLE CARBOXYLASE DEFICIENCY, EARLY ONSET	
Number Sign	253280	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMGNT1-RELATED	
Number Sign	253290	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS	PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	
Number Sign	253300	SPINAL MUSCULAR ATROPHY, TYPE I; SMA1	SMA I;; SMA, INFANTILE ACUTE FORM;; MUSCULAR ATROPHY, INFANTILE;; WERDNIG-HOFFMANN DISEASE	
Number Sign	253310	LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1	LCCS;; MULTIPLE CONTRACTURE SYNDROME, FINNISH TYPE	
NULL	253320	MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPIC HYPOGONADISM	CHUDLEY SYNDROME	
Number Sign	253400	SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	SMA III;; MUSCULAR ATROPHY, JUVENILE;; KUGELBERG-WELANDER SYNDROME; KWS;; SPINAL MUSCULAR ATROPHY, MILD CHILDHOOD AND ADOLESCENT FORM	
Number Sign	253550	SPINAL MUSCULAR ATROPHY, TYPE II; SMA2	SMA II;; MUSCULAR ATROPHY, SPINAL, INTERMEDIATE TYPE;; MUSCULAR ATROPHY, SPINAL, INFANTILE CHRONIC FORM	
NULL	253590	MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY		
Number Sign	253600	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2; LGMD2;; MUSCULAR DYSTROPHY, PELVOFEMORAL;; LEYDEN-MOEBIUS MUSCULAR DYSTROPHY;; CALPAINOPATHY	MYOSITIS, EOSINOPHILIC, INCLUDED
Number Sign	253601	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 3; LGMD3	
Number Sign	253700	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C	MUSCULAR DYSTROPHY, DUCHENNE-LIKE;; DUCHENNE-LIKE MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, TYPE 1; DMDA1;; DMDA;; ADHALIN DEFICIENCY, SECONDARY;; SARCOGLYCAN, GAMMA, DEFICIENCY OF;; SEVERE CHILDHOOD AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, NORTH AFRICAN TYPE; SCARMD;; MAGHREBIAN MYOPATHY	
Number Sign	253800	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; FCMD;; WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, FKTN-RELATED	
Percent	253900	MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS		
NULL	254000	MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM		
Number Sign	254090	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1; UCMD1	ULLRICH CONGENITAL MUSCULAR DYSTROPHY; UCMD;; MUSCULAR DYSTROPHY, SCLEROATONIC;; ULLRICH DISEASE;; ULLRICH SCLEROATONIC MUSCULAR DYSTROPHY	
NULL	254100	MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION		
Number Sign	254110	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H; LGMD2H	MUSCULAR DYSTROPHY, HUTTERITE TYPE;; SARCOTUBULAR MYOPATHY	
NULL	254120	MUSCULAR HYPERTONIA, LETHAL		
Number Sign	254130	MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	MIYOSHI MYOPATHY;; MUSCULAR DYSTROPHY, DISTAL, LATE-ONSET, AUTOSOMAL RECESSIVE	
Percent	254150	MUSK, INABILITY TO SMELL		
NULL	254190	MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS		
NULL	254200	MYASTHENIA GRAVIS; MG		
Number Sign	254210	MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	MYASTHENIC SYNDROME, PRESYNAPTIC, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA; CMSEA;; CONGENITAL MYASTHENIC SYNDROME TYPE Ia2, FORMERLY; CMS1A2, FORMERLY;; CMS Ia2, FORMERLY;; MYASTHENIA, FAMILIAL INFANTILE, FORMERLY; FIM, FORMERLY;; MYASTHENIA GRAVIS, FAMILIAL INFANTILE, 2, FORMERLY; FIMG2, FORMERLY	
Number Sign	254300	MYASTHENIC SYNDROME, CONGENITAL, 10; CMS10	MYASTHENIA, LIMB-GIRDLE, FAMILIAL, FORMERLY; LGM, FORMERLY;; CONGENITAL MYASTHENIC SYNDROME TYPE Ib, FORMERLY; CMS1B, FORMERLY;; CMS Ib, FORMERLY;; MYASTHENIC MYOPATHY, FORMERLY	
NULL	254400	MYCOSIS FUNGOIDES		
Number Sign	254450	MYELOFIBROSIS		MYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED; MMM, INCLUDED
Number Sign	254500	MYELOMA, MULTIPLE		AMYLOIDOSIS, SYSTEMIC, INCLUDED; AL, INCLUDED;; AL AMYLOIDOSIS, INCLUDED
Number Sign	254600	MYELOPEROXIDASE DEFICIENCY; MPOD	MPO DEFICIENCY	
NULL	254700	MYELOPROLIFERATIVE DISEASE, AUTOSOMAL RECESSIVE		
Number Sign	254770	EPILEPSY, MYOCLONIC JUVENILE; EJM	MYOCLONIC EPILEPSY, JUVENILE; JME;; PETIT MAL, IMPULSIVE;; JANZ SYNDROME	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1, INCLUDED
Number Sign	254780	MYOCLONIC EPILEPSY OF LAFORA	MELF;; LAFORA DISEASE;; LAFORA BODY DISEASE; LBD;; EPILEPSY, PROGRESSIVE MYOCLONIC, 2A; EPM2A;; EPM2	EPILEPSY, PROGRESSIVE MYOCLONIC, 2B, INCLUDED; EPM2B, INCLUDED
Number Sign	254800	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	ULD;; EPILEPSY, PROGRESSIVE MYOCLONIC, 1A; EPM1A;; EPILEPSY, PROGRESSIVE MYOCLONIC, 1; EPM1;; PROGRESSIVE MYOCLONIC EPILEPSY; PME;; BALTIC MYOCLONIC EPILEPSY	
Number Sign	254900	EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	ACTION MYOCLONUS-RENAL FAILURE SYNDROME; AMRF;; MYOCLONUS-NEPHROPATHY SYNDROME	
Number Sign	254940	CAREY-FINEMAN-ZITER SYNDROME; CFZS	MYOPATHY, CONGENITAL NONPROGRESSIVE, WITH MOEBIUS SEQUENCE AND ROBIN SEQUENCE	
NULL	254950	MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA		
NULL	254960	MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT		
Number Sign	255100	LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY; LSMFLAD		
Number Sign	255110	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC;; CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ADULT-ONSET;; CPT II DEFICIENCY, MYOPATHIC;; CPT2 DEFICIENCY, LATE-ONSET	
Number Sign	255120	CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY;; CPT I DEFICIENCY;; CPT DEFICIENCY, HEPATIC, TYPE I	
Number Sign	255125	MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY; HML	MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE;; MYOPATHY WITH DEFICIENCY OF SUCCINATE DEHYDROGENASE AND ACONITASE;; MYOGLOBINURIA DUE TO ABNORMAL GLYCOLYSIS	
NULL	255140	MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA		
Number Sign	255160	MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB	MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE	
Number Sign	255200	MYOPATHY, CENTRONUCLEAR, 2; CNM2	MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;; MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	
Percent	255300	MYOPATHY, CONGENITAL	BATTEN-TURNER CONGENITAL MYOPATHY	
Number Sign	255310	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	FIBER-TYPE DISPROPORTION MYOPATHY, CONGENITAL; CFTDM	
Number Sign	255320	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	MINICORE MYOPATHY;; MULTICORE MYOPATHY;; MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;; MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	
Percent	255500	MYOPIA 18, AUTOSOMAL RECESSIVE; MYP18		
Number Sign	255600	MYOSCLEROSIS, AUTOSOMAL RECESSIVE	MYOPATHY, MYOSCLEROTIC;; MYOSCLEROSIS, CONGENITAL, OF LOWENTHAL	
Number Sign	255700	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	BECKER DISEASE;; MYOTONIA, GENERALIZED	
NULL	255710	MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION		
Number Sign	255800	SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	SCHWARTZ-JAMPEL SYNDROME; SJS;; MYOTONIC MYOPATHY, DWARFISM, CHONDRODYSTROPHY, AND OCULAR AND FACIAL ABNORMALITIES;; SCHWARTZ-JAMPEL-ABERFELD SYNDROME;; SJA SYNDROME;; CHONDRODYSTROPHIC MYOTONIA	
NULL	255900	MYXEDEMA		
Number Sign	255960	MYXOMA, INTRACARDIAC	ATRIAL MYXOMA, FAMILIAL	
Percent	255980	NASODIGITOACOUSTIC SYNDROME	KEIPERT SYNDROME	
NULL	255990	NATHALIE SYNDROME		
Number Sign	255995	NATIVE AMERICAN MYOPATHY; NAM	MYOPATHY, CONGENITAL, WITH CLEFT PALATE AND MALIGNANT HYPERTHERMIA	
Number Sign	256000	LEIGH SYNDROME; LS	NECROTIZING ENCEPHALOPATHY, INFANTILE SUBACUTE, OF LEIGH; SNE	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY, INCLUDED;; LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX II DEFICIENCY, INCLUDED;; LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX III DEFICIENCY, INCLUDED;; LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX IV DEFICIENCY, INCLUDED;; LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX V DEFICIENCY, INCLUDED
NULL	256020	NAIL-PATELLA-LIKE RENAL DISEASE	GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	
Number Sign	256030	NEMALINE MYOPATHY 2; NEM2		
Number Sign	256040	AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD	NAKAJO-NISHIMURA SYNDROME; NKJO;; JOINT CONTRACTURES, MUSCULAR ATROPHY, MICROCYTIC ANEMIA, AND PANNICULITIS-INDUCED LIPODYSTROPHY; JMP SYNDROME;; CHRONIC ATYPICAL NEUTROPHILIC DERMATOSIS WITH LIPODYSTROPHY AND ELEVATED TEMPERATURE SYNDROME; CANDLE	
Number Sign	256050	ATELOSTEOGENESIS, TYPE II; AO2	AOII;; NEONATAL OSSEOUS DYSPLASIA I	DE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED
Number Sign	256100	NEPHRONOPHTHISIS 1; NPHP1	NEPHRONOPHTHISIS, FAMILIAL JUVENILE;; NPH1	
NULL	256120	NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM		
NULL	256150	NEPHROSIALIDOSIS		
NULL	256200	NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS		
Number Sign	256300	NEPHROTIC SYNDROME, TYPE 1; NPHS1	FINNISH CONGENITAL NEPHROSIS; CNF;; NEPHROTIC SYNDROME, CONGENITAL	
Number Sign	256370	NEPHROTIC SYNDROME, TYPE 4; NPHS4		
Number Sign	256450	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1	PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;; HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;; HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;; NESIDIOBLASTOSIS OF PANCREAS;; HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;; HYPERINSULINISM, CONGENITAL	
Number Sign	256500	NETHERTON SYNDROME; NETH	ERYTHRODERMA, ICHTHYOSIFORM, WITH HYPOTRICHOSIS AND HYPER-IgE;; NS;; NETHERTON DISEASE;; COMEL-NETHERTON SYNDROME	
Number Sign	256520	NEU-LAXOVA SYNDROME 1; NLS1	NEU-LAXOVA SYNDROME; NLS	
Number Sign	256540	GALACTOSIALIDOSIS; GSL	GOLDBERG SYNDROME;; NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY;; NEURAMINIDASE/BETA-GALACTOSIDASE EXPRESSION; NGBE;; LYSOSOMAL PROTECTIVE PROTEIN DEFICIENCY;; CATHEPSIN A DEFICIENCY;; PROTECTIVE PROTEIN/CATHEPSIN A DEFICIENCY;; PPCA DEFICIENCY	
Number Sign	256550	NEURAMINIDASE DEFICIENCY	SIALIDOSIS, TYPE II;; MUCOLIPIDOSIS I;; ML I;; LIPOMUCOPOLYSACCHARIDOSIS;; SIALIDASE DEFICIENCY;; GLYCOPROTEIN NEURAMINIDASE DEFICIENCY;; NEUG DEFICIENCY;; NEURAMINIDASE 1 DEFICIENCY;; NEU DEFICIENCY;; NEU1 DEFICIENCY	SIALIDOSIS, TYPE I, INCLUDED;; CHERRY RED SPOT--MYOCLONUS SYNDROME, INCLUDED;; MYOCLONUS--CHERRY RED SPOT SYNDROME, INCLUDED
Number Sign	256600	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A	NEURODEGENERATION, PLA2G6-ASSOCIATED; PLAN;; NEUROAXONAL DYSTROPHY, INFANTILE; INAD; INAD1;; SEITELBERGER DISEASE	
NULL	256690	NEUROFACIODIGITORENAL SYNDROME	NFDR SYNDROME	
Number Sign	256700	NEUROBLASTOMA, SUSCEPTIBILITY TO		NEUROBLASTOMA, SUSCEPTIBILITY TO, 1, INCLUDED; NBLST1, INCLUDED
Number Sign	256710	ELEJALDE DISEASE	NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	
NULL	256720	NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY		
Number Sign	256730	CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1	CEROID LIPOFUSCINOSIS, NEURONAL, 1, VARIABLE AGE AT ONSET	NEURONAL CEROID LIPOFUSCINOSIS, INFANTILE, INCLUDED; INCL, INCLUDED;; SANTAVUORI DISEASE, INCLUDED;; SANTAVUORI-HALTIA DISEASE, INCLUDED
Number Sign	256731	CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5	CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSET	NEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;; FINNISH vLINCL, INCLUDED
Number Sign	256800	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	NEUROPATHY, CONGENITAL SENSORY, WITH ANHIDROSIS;; HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY IV; HSAN4;; HSAN IV;; FAMILIAL DYSAUTONOMIA, TYPE II	
Number Sign	256810	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6	NAVAJO NEUROHEPATOPATHY; NNH;; NAVAJO NEUROPATHY; NN	NAVAJO FAMILIAL NEUROGENIC ARTHROPATHY, INCLUDED
Number Sign	256840	NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE		
Number Sign	256850	GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1	GAN	
Percent	256855	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH EXCESSIVE MYELIN FOLDING COMPLEX, AUTOSOMAL RECESSIVE	HMSN WITH EXCESSIVE MYELIN OUTFOLDING, AUTOSOMAL RECESSIVE;; CHARCOT-MARIE-TOOTH DISEASE WITH EXCESSIVE MYELIN FOLDING, AUTOSOMAL RECESSIVE	
NULL	256860	NEUROPATHY, HEREDITARY SENSORY, ATYPICAL		
NULL	256870	NEUROPATHY, PAINFUL		
NULL	257000	NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES		
NULL	257100	NEUTROPENIA, LETHAL CONGENITAL, WITH EOSINOPHILIA		
Percent	257150	NEUTROPHIL ACTIN DYSFUNCTION; NAD		
Number Sign	257200	NIEMANN-PICK DISEASE, TYPE A	SPHINGOMYELIN LIPIDOSIS;; SPHINGOMYELINASE DEFICIENCY	NIEMANN-PICK DISEASE, INTERMEDIATE, PROTRACTED NEUROVISCERAL, INCLUDED
Number Sign	257220	NIEMANN-PICK DISEASE, TYPE C1; NPC1	NIEMANN-PICK DISEASE, TYPE C; NPC;; NIEMANN-PICK DISEASE WITH CHOLESTEROL ESTERIFICATION BLOCK;; NIEMANN-PICK DISEASE, SUBACUTE JUVENILE FORM;; NIEMANN-PICK DISEASE, CHRONIC NEURONOPATHIC FORM;; NIEMANN-PICK DISEASE WITHOUT SPHINGOMYELINASE DEFICIENCY;; NEUROVISCERAL STORAGE DISEASE WITH VERTICAL SUPRANUCLEAR OPHTHALMOPLEGIA	NIEMANN-PICK DISEASE, TYPE D, INCLUDED;; NIEMANN-PICK DISEASE, NOVA SCOTIAN TYPE, INCLUDED
Number Sign	257270	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B	NIGHT BLINDNESS, CONGENITAL STATIONARY, COMPLETE, AUTOSOMAL RECESSIVE;; CSNB, COMPLETE, AUTOSOMAL RECESSIVE	
Number Sign	257300	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1	MVA SYNDROME	
Number Sign	257320	LISSENCEPHALY 2; LIS2	LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE;; NORMAN-ROBERTS SYNDROME	
NULL	257350	NUCHAL BLEB, FAMILIAL	CYSTIC HYGROMA, FETAL; FCH	
NULL	257400	NYSTAGMUS, CONGENITAL, AUTOSOMAL RECESSIVE		
NULL	257500	OBESITY-HYPOVENTILATION SYNDROME	PICKWICKIAN SYNDROME	
Percent	257550	OCULAR MOTOR APRAXIA	OCULOMOTOR APRAXIA, COGAN TYPE; COMA;; SACCADE INITIATION FAILURE, CONGENITAL	
Percent	257600	OCULAR MYOPATHY WITH CURARE SENSITIVITY		
NULL	257790	OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS		
Percent	257800	OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	CROSS SYNDROME;; KRAMER SYNDROME	
Number Sign	257850	OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	ODDD, AUTOSOMAL RECESSIVE;; OCULODENTOOSSEOUS DYSPLASIA, AUTOSOMAL RECESSIVE;; ODOD, AUTOSOMAL RECESSIVE	
Percent	257910	OCULOPALATOCEREBRAL SYNDROME	OCULOPALATOCEREBRAL DWARFISM;; OPC DWARFISM	
Number Sign	257920	3MC SYNDROME 1; 3MC1	OCULOPALATOSKELETAL SYNDROME;; CRANIOSYNOSTOSIS WITH LID ANOMALIES;; MICHELS SYNDROME, FORMERLY	
NULL	257960	OCULOTRICHODYSPLASIA; OTD		
Percent	257970	OCULORENOCEREBELLAR SYNDROME	ORC SYNDROME	
Number Sign	257980	ODONTOONYCHODERMAL DYSPLASIA; OODD		
NULL	258040	OEIS COMPLEX	OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	
Number Sign	258100	OGUCHI DISEASE 1	NIGHT BLINDNESS, CONGENITAL STATIONARY, OGUCHI TYPE 1; CSNBO1	
Percent	258150	SPERMATOGENIC FAILURE 1; SPGF1	OLIGOSYNAPTIC INFERTILITY;; OLIGOCHIASMATIC INFERTILITY	
NULL	258200	OLIVER SYNDROME	POSTAXIAL POLYDACTYLY AND MENTAL RETARDATION	
Percent	258300	OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	OPCA II, FICKLER-WINKLER TYPE	
Number Sign	258315	OMODYSPLASIA 1; OMOD1	OMODYSPLASIA, GENERALIZED FORM;; OMODYSPLASIA, AUTOSOMAL RECESSIVE;; MICROMELIC DYSPLASIA, CONGENITAL, WITH DISLOCATION OF RADIUS	
NULL	258320	OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	CLEFT PALATE-OMPHALOCELE SYNDROME, LETHAL	
Percent	258360	ONYCHOTRICHODYSPLASIA AND NEUTROPENIA		
Percent	258400	OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS		
Number Sign	258450	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1; PEOB1	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE 1	
NULL	258470	OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA		
Number Sign	258480	OPSISMODYSPLASIA; OPSMD		
Percent	258500	OPTIC ATROPHY 6; OPA6	OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	
Number Sign	258501	3-METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3	MGA, TYPE III; MGA3;; OPTIC ATROPHY PLUS SYNDROME;; OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;; IRAQI-JEWISH 'OPTIC ATROPHY PLUS';; COSTEFF SYNDROME;; OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;; OPA3, AUTOSOMAL RECESSIVE	
NULL	258650	OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE		
Number Sign	258660	NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO	NAION, SUSCEPTIBILITY TO;; OPTIC NEUROPATHY, ANTERIOR ISCHEMIC, SUSCEPTIBILITY TO	
Percent	258700	OPTICOCOCHLEODENTATE DEGENERATION		
NULL	258800	ORAL SENSIBILITY, DISTURBANCE OF		
NULL	258840	ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS		
Percent	258850	OROFACIODIGITAL SYNDROME III; OFD3	OFDS III;; ORAL-FACIAL-DIGITAL SYNDROME, TYPE III;; SUGARMAN SYNDROME	
Number Sign	258860	OROFACIODIGITAL SYNDROME IV; OFD4	OFDS IV;; ORAL-FACIAL-DIGITAL SYNDROME, TYPE IV;; OFD SYNDROME WITH TIBIAL DEFECTS;; MOHR-MAJEWSKI SYNDROME;; OFD SYNDROME, BARAITSER-BURN TYPE;; BARAITSER-BURN SYNDROME	
Percent	258865	OROFACIODIGITAL SYNDROME IX; OFD9	OFDS IX;; ORAL-FACIAL-DIGITAL SYNDROME, TYPE IX;; ORAL-FACIAL-DIGITAL SYNDROME WITH RETINAL ABNORMALITIES;; OROFACIODIGITAL SYNDROME WITH RETINAL ABNORMALITIES	
Number Sign	258870	GYRATE ATROPHY OF CHOROID AND RETINA; GACR	HYPERORNITHINEMIA WITH GYRATE ATROPHY OF CHOROID AND RETINA; HOGA;; GYRATE ATROPHY;; ORNITHINE AMINOTRANSFERASE DEFICIENCY;; OAT DEFICIENCY;; ORNITHINE KETO ACID AMINOTRANSFERASE DEFICIENCY;; OKT DEFICIENCY;; ORNITHINE-DELTA-AMINOTRANSFERASE DEFICIENCY	
Number Sign	258900	OROTIC ACIDURIA	OROTIC ACIDURIA I;; OROTATE PHOSPHORIBOSYLTRANSFERASE AND OROTIDYLIC DECARBOXYLASE DEFICIENCY;; OPRT AND ODC DEFICIENCY;; OROTIDYLIC PYROPHOSPHORYLASE AND OROTIDYLIC DECARBOXYLASE DEFICIENCY;; URIDINE MONOPHOSPHATE SYNTHASE DEFICIENCY;; UMP SYNTHASE DEFICIENCY;; UMPS DEFICIENCY	OROTIC ACIDURIA WITHOUT MEGALOBLASTIC ANEMIA, INCLUDED; OAWA, INCLUDED
Number Sign	259050	PRIMROSE SYNDROME; PRIMS	OSSIFIED EAR CARTILAGES WITH MENTAL DEFICIENCY, MUSCLE WASTING, AND BONY CHANGES	
Number Sign	259100	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	PHO, AUTOSOMAL RECESSIVE;; PACHYDERMOPERIOSTOSIS, AUTOSOMAL RECESSIVE;; PDP, AUTOSOMAL RECESSIVE;; TOURAINE-SOLENTE-GOLE SYNDROME	CRANIOOSTEOARTHROPATHY, INCLUDED; COA, INCLUDED;; FAMILIAL IDIOPATHIC OSTEOARTHROPATHY OF CHILDHOOD, INCLUDED;; CURRARINO IDIOPATHIC OSTEOARTHROPATHY, INCLUDED; CIO, INCLUDED
NULL	259200	BLOUNT DISEASE, ADOLESCENT	OSTEOCHONDROSIS DEFORMANS TIBIAE, ADOLESCENT;; TIBIA VARA, ADOLESCENT	
Percent	259250	OSTEODYSPLASIA, FAMILIAL, ANDERSON TYPE		
NULL	259270	OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI		
NULL	259410	OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS		
Number Sign	259420	OSTEOGENESIS IMPERFECTA, TYPE III; OI3	OI, TYPE III;; OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	
Number Sign	259440	OSTEOGENESIS IMPERFECTA, TYPE IX; OI9	OI, TYPE IX	
Number Sign	259450	BRUCK SYNDROME 1; BRKS1	KUSKOKWIM DISEASE;; ARTHROGRYPOSIS-LIKE DISORDER	
Number Sign	259500	OSTEOGENIC SARCOMA	OSTEOSARCOMA; OSRC	
NULL	259550	OSTEOID OSTEOMA		
Number Sign	259600	MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	TORG SYNDROME;; NODULOSIS-ARTHROPATHY-OSTEOLYSIS SYNDROME;; NAO SYNDROME;; AL-AQEEL SEWAIRI SYNDROME;; OSTEOLYSIS, HEREDITARY MULTICENTRIC;; TORG-WINCHESTER SYNDROME, FORMERLY	
NULL	259610	OSTEOLYSIS SYNDROME, RECESSIVE	OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTIC FACIAL APPEARANCE	
NULL	259650	OSTEOMA OF MIDDLE EAR		
NULL	259660	OSTEOMALACIA, SCLEROSING, WITH CEREBRAL CALCIFICATION		
NULL	259680	CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS; CRMO	OSTEOMYELITIS, CHRONIC MULTIFOCAL; CMO	
NULL	259690	OSTEOPENIA AND SPARSE HAIR		
Number Sign	259700	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	OSTEOPETROSIS, INFANTILE MALIGNANT 1;; MARBLE BONES, AUTOSOMAL RECESSIVE;; ALBERS-SCHONBERG DISEASE, AUTOSOMAL RECESSIVE	
Number Sign	259710	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2	OSTEOPETROSIS, OSTEOCLAST-POOR;; OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	
Number Sign	259720	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	OSTEOPETROSIS, INFANTILE MALIGNANT 3	
Number Sign	259730	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS;; CARBONIC ANHYDRASE II DEFICIENCY;; GUIBAUD-VAINSEL SYNDROME;; MARBLE BRAIN DISEASE	
NULL	259750	OSTEOPOROSIS, JUVENILE	IDIOPATHIC JUVENILE OSTEOPOROSIS; IJO	
Number Sign	259770	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG	OPS;; OSTEOGENESIS IMPERFECTA, OCULAR FORM	
Number Sign	259775	RAINE SYNDROME; RNS	OSTEOSCLEROTIC BONE DYSPLASIA, LETHAL	
Percent	259780	OTOONYCHOPERONEAL SYNDROME		
Number Sign	259900	HYPEROXALURIA, PRIMARY, TYPE I; HP1	OXALOSIS I;; GLYCOLIC ACIDURIA;; ALANINE-GLYOXYLATE AMINOTRANSFERASE DEFICIENCY;; PEROXISOMAL ALANINE:GLYOXYLATE AMINOTRANSFERASE DEFICIENCY;; HEPATIC AGT DEFICIENCY;; SERINE:PYRUVATE AMINOTRANSFERASE DEFICIENCY	
Number Sign	260000	HYPEROXALURIA, PRIMARY, TYPE II; HP2	OXALOSIS II;; GLYCERIC ACIDURIA;; GLYOXYLATE REDUCTASE/HYDROXYPYRUVATE REDUCTASE DEFICIENCY;; D-GLYCERATE DEHYDROGENASE DEFICIENCY	
Number Sign	260005	5-OXOPROLINASE DEFICIENCY; OPLAHD	OXOPROLINURIA DUE TO 5-OXOPROLINASE DEFICIENCY	
NULL	260100	PA POLYMORPHISM OF ALPHA-2-GLOBULIN	ALPHA-2-GLOBULIN POLYMORPHISM PA	
NULL	260130	PACHYONYCHIA CONGENITA, AUTOSOMAL RECESSIVE		
NULL	260150	PALANT CLEFT PALATE SYNDROME		
NULL	260200	PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA		
Number Sign	260300	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK15	PARKINSONIAN-PYRAMIDAL SYNDROME; PKPS;; PALLIDOPYRAMIDAL SYNDROME;; PALLIDO-PYRAMIDAL SYNDROME	
Number Sign	260350	PANCREATIC CANCER	PANCREATIC CARCINOMA;; PANCREATIC ACINAR CARCINOMA	
Number Sign	260370	PANCREATIC AGENESIS 1; PAGEN1	PAGEN;; PANCREATIC HYPOPLASIA, CONGENITAL	
Number Sign	260400	SHWACHMAN-DIAMOND SYNDROME; SDS	PANCREATIC INSUFFICIENCY AND BONE MARROW DYSFUNCTION;; SHWACHMAN-BODIAN SYNDROME;; LIPOMATOSIS OF PANCREAS, CONGENITAL	
NULL	260450	PANCREATIC INSUFFICIENCY, COMBINED EXOCRINE		
NULL	260470	PANENCEPHALITIS, SUBACUTE SCLEROSING	SUBACUTE SCLEROSING PANENCEPHALITIS; SSPE	
NULL	260480	PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX		
Number Sign	260500	PAPILLOMA OF CHOROID PLEXUS; CPP	CHOROID PLEXUS PAPILLOMA	CHOROID PLEXUS CARCINOMA, INCLUDED; CPC, INCLUDED
NULL	260530	PARANA HARD-SKIN SYNDROME		
Number Sign	260540	PARKINSON-DEMENTIA SYNDROME		SUPRANUCLEAR PALSY, PROGRESSIVE, 1, ATYPICAL, INCLUDED;; STEELE-RICHARDSON-OLSZEWSKI SYNDROME, ATYPICAL, INCLUDED
NULL	260555	PARTINGTON-ANDERSON SYNDROME		
Number Sign	260565	PEHO SYNDROME; PEHO	PROGRESSIVE ENCEPHALOPATHY WITH EDEMA, HYPSARRHYTHMIA, AND OPTIC ATROPHY;; INFANTILE CEREBELLOOPTIC ATROPHY	
NULL	260570	PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN		
Number Sign	260600	LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3		
NULL	260650	PELLAGRA-LIKE SYNDROME		
Number Sign	260660	COUSIN SYNDROME	CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORT STATURE;; PELVISCAPULAR DYSPLASIA	
Number Sign	260800	PENTOSURIA; PNTSU	L-XYLULOSURIA;; XYLITOL DEHYDROGENASE DEFICIENCY;; L-XYLULOSE REDUCTASE DEFICIENCY	
NULL	260900	PERICARDIAL EFFUSION, CHRONIC	CHOLESTEROL PERICARDITIS	
NULL	260910	PERIFOLLICULITIS CAPITIS ABSCEDENS ET SUFFODIENS, FAMILIAL	DISSECTING CELLULITIS OF THE SCALP	
Number Sign	260920	HYPER-IgD SYNDROME; HIDS	HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME;; PERIODIC FEVER, DUTCH TYPE	
NULL	260950	PERIODONTITIS, CHRONIC	PERIODONTITIS, ADULT	
NULL	260970	PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND SPONGY DEGENERATION OF BRAIN		
Number Sign	261000	INTRINSIC FACTOR DEFICIENCY; IFD	PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	
Number Sign	261100	MEGALOBLASTIC ANEMIA 1	MGA1;; IMERSLUND-GRASBECK SYNDROME; IGS;; PERNICIOUS ANEMIA, JUVENILE, DUE TO SELECTIVE INTESTINAL MALABSORPTION OF VITAMIN B12, WITH PROTEINURIA;; ENTEROCYTE COBALAMIN MALABSORPTION;; ENTEROCYTE INTRINSIC FACTOR RECEPTOR, DEFECT OF	
NULL	261400	PERONEUS TERTIUS MUSCLE, ABSENCE OF		
Number Sign	261500	EOSINOPHIL PEROXIDASE DEFICIENCY; EPXD	EOSINOPHIL PEROXIDASE DEFICIENCY, PARTIAL;; PEROXIDASE AND PHOSPHOLIPID DEFICIENCY IN EOSINOPHILS;; PRESENTEY ANOMALY	
Number Sign	261515	D-BIFUNCTIONAL PROTEIN DEFICIENCY	17-BETA-HYDROXYSTEROID DEHYDROGENASE IV DEFICIENCY;; DBP DEFICIENCY;; PEROXISOMAL BIFUNCTIONAL ENZYME DEFICIENCY;; PBFE DEFICIENCY	
Number Sign	261540	PETERS-PLUS SYNDROME	KRAUSE-KIVLIN SYNDROME;; PETERS ANOMALY WITH SHORT-LIMB DWARFISM	
Number Sign	261550	PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II; PMDS	PSEUDOHERMAPHRODITISM, MALE INTERNAL;; HERNIA UTERI INGUINALE;; PERSISTENT OVIDUCT SYNDROME;; FEMALE GENITAL DUCTS IN OTHERWISE NORMAL MALE	
NULL	261560	PFEIFFER-PALM-TELLER SYNDROME	PPT SYNDROME;; SHORT STATURE, UNIQUE FACIES, ENAMEL HYPOPLASIA, PROGRESSIVE JOINT STIFFNESS, AND HIGH-PITCHED VOICE	
NULL	261575	PHAVER SYNDROME		
NULL	261590	PHENFORMIN 4-HYDROXYLATION		
Number Sign	261600	PHENYLKETONURIA; PKU	PHENYLALANINE HYDROXYLASE DEFICIENCY;; PAH DEFICIENCY;; OLIGOPHRENIA PHENYLPYRUVICA;; FOLLING DISEASE	HYPERPHENYLALANINEMIA, NON-PKU MILD, INCLUDED;; HPA, NON-PKU MILD, INCLUDED;; PHENYLKETONURIA, MATERNAL, INCLUDED
Number Sign	261630	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	HYPERPHENYLALANINEMIA, TETRAHYDROBIOPTERIN-DEFICIENT, DUE TO DHPR DEFICIENCY;; DIHYDROPTERIDINE REDUCTASE DEFICIENCY;; DHPR DEFICIENCY;; QUINOID DIHYDROPTERIDINE REDUCTASE DEFICIENCY;; QDPR DEFICIENCY	
Number Sign	261640	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	HYPERPHENYLALANINEMIA, TETRAHYDROBIOPTERIN-DEFICIENT, DUE TO PTS DEFICIENCY;; 6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY;; PTS DEFICIENCY	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, DUE TO PARTIAL PTS DEFICIENCY, INCLUDED
Percent	261650	PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL; PCKDM	PCK2 DEFICIENCY;; PEPCK2 DEFICIENCY	
Number Sign	261670	GLYCOGEN STORAGE DISEASE X; GSD10	GSD X;; PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF;; MYOPATHY DUE TO PHOSPHOGLYCERATE MUTASE DEFICIENCY;; PGAMM DEFICIENCY	
Number Sign	261680	PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	PCK1 DEFICIENCY, CYTOSOLIC;; PEPCK DEFICIENCY, CYTOSOLIC	
Number Sign	261740	GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	PHOSPHORYLASE KINASE DEFICIENCY OF HEART;; GLYCOGEN STORAGE DISEASE OF HEART	
Number Sign	261750	GLYCOGEN STORAGE DISEASE IXb; GSD9B	GSD IXb;; GLYCOGENOSIS OF LIVER AND MUSCLE, AUTOSOMAL RECESSIVE;; PHOSPHORYLASE KINASE DEFICIENCY OF LIVER AND MUSCLE, AUTOSOMAL RECESSIVE	
Percent	261800	PIERRE ROBIN SYNDROME; PRBNS	GLOSSOPTOSIS, MICROGNATHIA, AND CLEFT PALATE;; PIERRE ROBIN SEQUENCE	
Percent	261900	PILI TORTI, EARLY-ONSET	PILI TORTI, RONCHESE TYPE;; TWISTED HAIR	
NULL	261990	PILI TORTI AND DEVELOPMENTAL DELAY		
Number Sign	262000	BJORNSTAD SYNDROME; BJS	PILI TORTI AND NERVE DEAFNESS;; PTD	
NULL	262020	PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	TRICHODENTAL DYSPLASIA WITH HYPEROPIA	
Number Sign	262190	PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	RABSON-MENDENHALL SYNDROME;; MENDENHALL SYNDROME	
Number Sign	262300	ACHROMATOPSIA 3; ACHM3	PINGELAPESE BLINDNESS;; TOTAL COLORBLINDNESS WITH MYOPIA;; ACHROMATOPSIA WITH MYOPIA;; ACHM1, FORMERLY;; ROD MONOCHROMATISM 1, FORMERLY;; ROD MONOCHROMACY 1, FORMERLY; RMCH1, FORMERLY	
Number Sign	262400	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA; IGHD1A	IGHD IA;; GROWTH HORMONE DEFICIENCY, ISOLATED, AUTOSOMAL RECESSIVE;; ILLIG-TYPE GROWTH HORMONE DEFICIENCY;; PRIMORDIAL DWARFISM;; SEXUAL ATELEIOTIC DWARFISM;; PITUITARY DWARFISM I	
Number Sign	262500	LARON SYNDROME	GROWTH HORMONE INSENSITIVITY SYNDROME;; PITUITARY DWARFISM II;; GROWTH HORMONE RECEPTOR DEFICIENCY	
Number Sign	262600	PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2	PANHYPOPITUITARISM;; ATELIOTIC DWARFISM WITH HYPOGONADISM;; PITUITARY DWARFISM III;; HANHART DWARFISM	
Number Sign	262650	KOWARSKI SYNDROME	BIODEFECTIVE GROWTH HORMONE;; PITUITARY DWARFISM WITH NORMAL IMMUNOREACTIVE GROWTH HORMONE AND LOW SOMATOMEDIN	
Number Sign	262700	PITUITARY HORMONE DEFICIENCY, COMBINED, 4; CPHD4	PITUITARY HORMONE DEFICIENCY, COMBINED, WITH OR WITHOUT CEREBELLAR DEFECTS;; SHORT STATURE, PITUITARY AND CEREBELLAR DEFECTS, AND SMALL SELLA TURCICA	
NULL	262710	PITUITARY DWARFISM WITH LARGE SELLA TURCICA		
NULL	262800	PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF		
Number Sign	262850	ALPHA-2-PLASMIN INHIBITOR DEFICIENCY	ANTIPLASMIN DEFICIENCY;; PLASMIN INHIBITOR DEFICIENCY	
NULL	262875	PLATELET PROSTACYCLIN RECEPTOR DEFECT	VIENNA-HIETZING DEFECT	
Number Sign	262890	SCOTT SYNDROME; SCTS	BLEEDING DISORDER, PLATELET-TYPE, 7; BDPLT7;; BLEEDING ABNORMALITY DUE TO DEFICIENCY OF PLATELET BINDING OF FACTOR X;; PROTHROMBIN CONVERSION DEFECT, FAMILIAL;; PROTHROMBIN CONSUMPTION DEFICIENCY;; PROTHROMBIN CONSUMPTION INHIBITOR, FAMILIAL	
NULL	262900	PLEOCONIAL MYOPATHY WITH SALT CRAVING		
Percent	263000	INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	PNEUMONITIS, DESQUAMATIVE INTERSTITIAL, FAMILIAL;; PNEUMONIA, DESQUAMATIVE INTERSTITIAL, FAMILIAL;; INTERSTITIAL LUNG DISEASE, DESQUAMATIVE;; ILD, DESQUAMATIVE	
NULL	263100	POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS		
Number Sign	263200	POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT HEPATIC DISEASE; PKD4	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE; ARPKD;; POLYCYSTIC KIDNEY AND HEPATIC DISEASE 1; PKHD1;; POLYCYSTIC KIDNEY DISEASE, INFANTILE, TYPE I;; PKD3, FORMERLY	HEPATIC FIBROSIS, CONGENITAL, INCLUDED
Number Sign	263210	GILLESSEN-KAESBACH-NISHIMURA SYNDROME; GIKANIS	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE, WITH MICROBRACHYCEPHALY, HYPERTELORISM, AND BRACHYMELIA	
Number Sign	263300	POLYCYTHEMIA VERA; PV	POLYCYTHEMIA RUBRA VERA; PRV	
Number Sign	263400	ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2	ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;; POLYCYTHEMIA, VHL-DEPENDENT;; POLYCYTHEMIA, CHUVASH TYPE	
Percent	263450	POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5		
Number Sign	263520	SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	SHORT RIB-POLYDACTYLY SYNDROME, TYPE II;; SRPS, TYPE II;; MAJEWSKI SYNDROME;; SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIA; SRPS2A;; POLYDACTYLY WITH NEONATAL CHONDRODYSTROPHY, TYPE II	
NULL	263540	POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES		
NULL	263550	POLYMYOCLONUS, INFANTILE		
Number Sign	263570	POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM; APBN	POLYGLUCOSAN BODY DISEASE, ADULT FORM; APBD	
NULL	263600	POLYSACCHARIDE, STORAGE OF UNUSUAL		
NULL	263610	POLYHYDRAMNIOS, CHRONIC IDIOPATHIC	LACTOGEN RECEPTOR DEFECT OF CHORION	
Percent	263630	POLYSYNDACTYLY WITH CARDIAC MALFORMATION	BONNEAU SYNDROME	
Number Sign	263650	POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE	BARTSOCAS-PAPAS SYNDROME; BPS;; PTERYGIUM, POPLITEAL, LETHAL TYPE;; MULTIPLE PTERYGIUM SYNDROME, ASLAN TYPE	
Number Sign	263700	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	CEP;; GUNTHER DISEASE;; UROPORPHYRINOGEN III SYNTHASE DEFICIENCY;; UROS DEFICIENCY	
Number Sign	263750	POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS	MILLER SYNDROME;; GENEE-WIEDEMANN SYNDROME	
Number Sign	263800	GITELMAN SYNDROME; GTLMNS	HYPOMAGNESEMIA-HYPOKALEMIA, PRIMARY RENOTUBULAR, WITH HYPOCALCIURIA;; POTASSIUM AND MAGNESIUM DEPLETION	
NULL	264010	PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY	URBAN-ROGERS-MEYER SYNDROME	
NULL	264050	PRENATAL BOWING		
NULL	264060	PREPAPILLARY VASCULAR LOOPS	PRERETINAL VASCULAR LOOPS	
Number Sign	264070	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D; HPABH4D	HYPERPHENYLALANINEMIA, TETRAHYDROBIOPTERIN-DEFICIENT, DUE TO PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE DEFICIENCY;; HYPERPHENYLALANINEMIA WITH PRIMAPTERINURIA;; CADH DEFICIENCY;; PCBD DEFICIENCY	
NULL	264080	PROGESTERONE RESISTANCE	PSEUDOCORPUS LUTEUM INSUFFICIENCY	
Percent	264090	PROGEROID SYNDROME, NEONATAL	WIEDEMANN-RAUTENSTRAUCH SYNDROME	
NULL	264110	PROLACTIN DEFICIENCY, ISOLATED		
NULL	264120	PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES	PRL DEFICIENCY WITH OBESITY AND ENLARGED TESTES	
NULL	264140	PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, AND DEAFNESS		
NULL	264180	PSEUDODIASTROPHIC DYSPLASIA		
Percent	264270	PSEUDOHERMAPHRODITISM, FEMALE, WITH SKELETAL ANOMALIES		
Number Sign	264300	17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	17-KETOSTEROID REDUCTASE DEFICIENCY OF TESTIS;; 17-KSR DEFICIENCY;; NEUTRAL 17-BETA-HYDROXYSTEROID OXIDOREDUCTASE DEFICIENCY;; PSEUDOHERMAPHRODITISM, MALE, WITH GYNECOMASTIA	POLYCYSTIC OVARIAN DISEASE DUE TO 17-KETOSTEROID REDUCTASE DEFICIENCY, INCLUDED
Number Sign	264350	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B	PHA I, AUTOSOMAL RECESSIVE	
NULL	264420	FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	PFD, LAVIA TYPE;; PFD, FINNISH TYPE	
Number Sign	264470	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY	STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;; PSEUDONEONATAL ADRENOLEUKODYSTROPHY	
NULL	264475	PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HAND ANOMALIES	ACROOTOOCULAR SYNDROME;; AOO SYNDROME	
NULL	264480	PSEUDOTRISOMY 13 SYNDROME	HOLOPROSENCEPHALY-POLYDACTYLY SYNDROME	
NULL	264500	PSEUDOURIDINURIA AND MENTAL DEFECT		
Number Sign	264600	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	MALE PSEUDOHERMAPHRODITISM DUE TO 5-ALPHA-REDUCTASE DEFICIENCY;; FAMILIAL INCOMPLETE MALE PSEUDOHERMAPHRODITISM, TYPE 2	MICROPENIS, INCLUDED
Number Sign	264700	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A	VITAMIN D-DEPENDENT RICKETS, TYPE 1A;; 1-ALPHA, 25-HYDROXYVITAMIN D3 DEFICIENCY, SELECTIVE;; 25-HYDROXYCHOLECALCIFEROL-1-HYDROXYLASE DEFICIENCY;; 1-ALPHA-HYDROXYLASE DEFICIENCY;; VITAMIN D DEPENDENCY, TYPE 1; VDD1;; PSEUDOVITAMIN D-DEFICIENCY RICKETS, TYPE IA; PDDR1A;; PDDR IA	
Number Sign	264800	PSEUDOXANTHOMA ELASTICUM; PXE	GRONBLAD-STRANDBERG SYNDROME	PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF, INCLUDED;; PXE, MODIFIER OF SEVERITY OF, INCLUDED
Number Sign	265000	MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS	ESCOBAR SYNDROME;; MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;; PTERYGIUM SYNDROME;; MULTIPLE PTERYGIUM SYNDROME;; PTERYGIUM COLLI SYNDROME;; PTERYGIUM UNIVERSALE	
Number Sign	265050	3MC SYNDROME 2; 3MC2	PTOSIS OF EYELIDS WITH DIASTASIS RECTI AND HIP DYSPLASIA;; OCULO-SKELETAL-ABDOMINAL SYNDROME;; OSA SYNDROME;; CARNEVALE SYNDROME, FORMERLY	
Number Sign	265100	PULMONARY ALVEOLAR MICROLITHIASIS		
Number Sign	265120	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	PULMONARY ALVEOLAR PROTEINOSIS, CONGENITAL, 1;; INTERSTITIAL LUNG DISEASE DUE TO SURFACTANT PROTEIN B DEFICIENCY;; INTERSTITIAL LUNG DISEASE, NONSPECIFIC, DUE TO SURFACTANT PROTEIN B DEFICIENCY	
NULL	265140	PULMONARY ARTERIOVENOUS FISTULAS		
NULL	265150	PULMONARY ATRESIA WITH INTACT VENTRICULAR SEPTUM		
NULL	265200	PULMONARY BULLAE CAUSING PNEUMOTHORAX		
Percent	265300	LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL	LYMPHANGIOMATOSIS, PULMONARY;; PULMONARY CYSTIC LYMPHANGIECTASIS	
Number Sign	265380	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS AND OTHER CONGENITAL ANOMALIES	
NULL	265400	PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE		
NULL	265430	LUNG AGENESIS	PULMONARY HYPOPLASIA, PRIMARY	
Number Sign	265450	PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT; PVOD1	PVOD	
NULL	265500	PULMONIC STENOSIS		
NULL	265600	PULMONIC STENOSIS AND CONGENITAL NEPHROSIS		
Number Sign	265800	PYCNODYSOSTOSIS	PYKNODYSOSTOSIS; PKND;; PYCD	
Percent	265850	PYGMY	PYGMY, AFRICAN	
NULL	265880	PYKNOACHONDROGENESIS		
Number Sign	265900	PYLE DISEASE; PYL	METAPHYSEAL DYSPLASIA	
Percent	265950	PYLORIC ATRESIA		
Number Sign	266100	EPILEPSY, PYRIDOXINE-DEPENDENT; EPD	PYRIDOXINE-DEPENDENT EPILEPSY; PDE;; PYRIDOXINE DEPENDENCY WITH SEIZURES;; AASA DEHYDROGENASE DEFICIENCY	
Number Sign	266120	URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	HEMOLYTIC ANEMIA DUE TO UMPH1 DEFICIENCY;; PYRIMIDINE 5-PRIME NUCLEOTIDASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO;; HEMOLYTIC ANEMIA DUE TO P5N DEFICIENCY;; P5N DEFICIENCY;; UMPH1 DEFICIENCY	
Number Sign	266130	GLUTATHIONE SYNTHETASE DEFICIENCY; GSSD	5-OXOPROLINURIA;; PYROGLUTAMIC ACIDURIA	
Number Sign	266140	PYROPOIKILOCYTOSIS, HEREDITARY; HPP		
Number Sign	266150	PYRUVATE CARBOXYLASE DEFICIENCY	PC DEFICIENCY;; ATAXIA WITH LACTIC ACIDOSIS II;; LEIGH NECROTIZING ENCEPHALOPATHY DUE TO PYRUVATE CARBOXYLASE DEFICIENCY;; LEIGH SYNDROME DUE TO PYRUVATE CARBOXYLASE DEFICIENCY	
Number Sign	266200	PYRUVATE KINASE DEFICIENCY OF RED CELLS	PYRUVATE KINASE DEFICIENCY OF ERYTHROCYTE;; PK DEFICIENCY	
Percent	266250	RADICULONEUROPATHY, FATAL NEONATAL		
NULL	266255	RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATION AND HYPOTONIA		
Number Sign	266265	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	CDG IIc; CDGIIc;; LEUKOCYTE ADHESION DEFICIENCY, TYPE II; LAD2;; RAMBAM-HASHARON SYNDROME; RHS	
NULL	266270	RAMON SYNDROME	CHERUBISM, GINGIVAL FIBROMATOSIS, EPILEPSY, MENTAL DEFICIENCY, HYPERTRICHOSIS, AND STUNTED GROWTH	
Number Sign	266280	RAPADILINO SYNDROME		
Number Sign	266300	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2; SHEP2	RED HAIR COLOR; RHC;; BLOND HAIR/FAIR SKIN;; RHA;; HAIR COLOR 2; HCL2	UV-INDUCED SKIN DAMAGE, SUSCEPTIBILITY TO, INCLUDED
Percent	266350	RED SKIN PIGMENT ANOMALY OF NEW GUINEA		
NULL	266400	REESE RETINAL DYSPLASIA		
Number Sign	266500	REFSUM DISEASE, CLASSIC	REFSUM DISEASE, ADULT, 1;; PHYTANIC ACID OXIDASE DEFICIENCY;; HEREDOPATHIA ATACTICA POLYNEURITIFORMIS;; HEREDITARY MOTOR AND SENSORY NEUROPATHY IV; HMSN4;; HMSN IV	
Number Sign	266510	PEROXISOME BIOGENESIS DISORDER 3B; PBD3B		
Number Sign	266600	INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 1; IBD1		REGIONAL ENTERITIS, INCLUDED;; CROHN DISEASE, INCLUDED;; ULCERATIVE COLITIS, INCLUDED;; CROHN DISEASE-ASSOCIATED GROWTH FAILURE, SUSCEPTIBILITY TO, INCLUDED
NULL	266810	RENAL AND MULLERIAN DUCT HYPOPLASIA		
Number Sign	266900	SENIOR-LOKEN SYNDROME 1; SLSN1	SENIOR-LOKEN SYNDROME;; LOKEN-SENIOR SYNDROME;; RENAL-RETINAL SYNDROME;; JUVENILE NEPHRONOPHTHISIS WITH LEBER AMAUROSIS;; RENAL DYSPLASIA AND RETINAL APLASIA	
NULL	266910	RENAL DYSPLASIA-LIMB DEFECTS SYNDROME	RL SYNDROME	
Number Sign	266920	SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	MAINZER-SALDINO SYNDROME; MZSDS;; CONORENAL SYNDROME;; RENAL DYSPLASIA, RETINAL PIGMENTARY DYSTROPHY, CEREBELLAR ATAXIA, AND SKELETAL DYSPLASIA	
Number Sign	267000	PERLMAN SYNDROME; PRLMNS	RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;; NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	
Number Sign	267010	MECKEL SYNDROME, TYPE 7; MKS7	RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;; GOLDSTON SYNDROME	
NULL	267200	RENAL TUBULAR ACIDOSIS III	RTA, DISLOCATION TYPE;; RTA, BICARBONATE-WASTING TYPE	
Number Sign	267300	RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PROGRESSIVE NERVE DEAFNESS;; RENAL TUBULAR ACIDOSIS WITH PROGRESSIVE NERVE DEAFNESS;; RTA WITH PROGRESSIVE NERVE DEAFNESS	
NULL	267400	RENAL, GENITAL, AND MIDDLE EAR ANOMALIES		
Number Sign	267430	RENAL TUBULAR DYSGENESIS; RTD	PRIMITIVE RENAL TUBULE SYNDROME	RENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED
NULL	267450	RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS	RDS OF PREMATURITY;; HYALINE MEMBRANE DISEASE, FORMERLY	
NULL	267480	RESPIRATORY UNDERRESPONSIVENESS TO HYPOXIA AND HYPERCAPNIA		
Number Sign	267500	RETICULAR DYSGENESIS	RETICULAR DYSGENESIA;; CONGENITAL ALEUKIA;; SEVERE COMBINED IMMUNODEFICIENCY WITH LEUKOPENIA;; DE VAAL DISEASE;; HEMATOPOIETIC HYPOPLASIA, GENERALIZED;; ALEUKOCYTOSIS	
Percent	267700	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1; FHL1	HPLH1;; HLH1;; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL; FHL; FHLH; HPLH;; RETICULOSIS, FAMILIAL HISTIOCYTIC;; HEMOPHAGOCYTIC RETICULOSIS, FAMILIAL;; ERYTHROPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL; FEL	
NULL	267730	RETICULUM CELL SARCOMA		
NULL	267740	RETINAL DEGENERATION AND EPILEPSY		
Number Sign	267750	KNOBLOCH SYNDROME 1; KNO1	KNO;; RETINAL DETACHMENT AND OCCIPITAL ENCEPHALOCELE	
NULL	267760	RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION, AND ANGLE CLOSURE GLAUCOMA		
NULL	267800	RETINAL DYSTROPHY, RETICULAR PIGMENTARY, OF POSTERIOR POLE		
NULL	267900	RETINAL TELANGIECTASIA AND HYPOGAMMAGLOBULINEMIA		
Number Sign	268000	RETINITIS PIGMENTOSA; RP		
NULL	268010	RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS		
NULL	268020	RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	INSULIN-RESISTANT DIABETES WITH ACANTHOSIS NIGRICANS, HYPOGONADISM, PIGMENTARY RETINOPATHY, DEAFNESS, AND MENTAL RETARDATION	
NULL	268025	RETINITIS PIGMENTOSA, LATE-ADULT ONSET	RETINITIS PIGMENTOSA, 'SENILE'	
NULL	268040	RETINOHEPATOENDOCRINOLOGIC SYNDROME	RHE SYNDROME	
NULL	268050	RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	MIRHOSSEINI-HOLMES-WALTON SYNDROME	
NULL	268060	RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	RETINITIS PIGMENTOSA, PERICENTRAL	
Percent	268080	RETINOSCHISIS OF FOVEA		
Number Sign	268100	ENHANCED S-CONE SYNDROME; ESCS		GOLDMANN-FAVRE SYNDROME, INCLUDED;; RETINOSCHISIS WITH EARLY HEMERALOPIA, INCLUDED;; FAVRE HYALOIDEORETINAL DEGENERATION, INCLUDED
Number Sign	268130	REVESZ SYNDROME	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 5; DKCA5;; EXUDATIVE RETINOPATHY WITH BONE MARROW FAILURE	
Number Sign	268150	RH-NULL, REGULATOR TYPE; RHN		RH DEFICIENCY SYNDROME, INCLUDED;; RH-NULL DISEASE, INCLUDED
Number Sign	268200	MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE	MYOGLOBINURIA, FAMILIAL PAROXYSMAL PARALYTIC;; RHABDOMYOLYSIS, ACUTE RECURRENT	
Number Sign	268210	RHABDOMYOSARCOMA, EMBRYONAL, 1; RMSE1	RHABDOMYOSARCOMA 1; RMS1;; RHABDOMYOSARCOMA CHROMOSOMAL REGION; RMSCR	
Number Sign	268220	RHABDOMYOSARCOMA 2; RMS2	RHABDOMYOSARCOMA, ALVEOLAR; RMSA	
NULL	268240	RHEUMATIC FEVER-RELATED ANTIGEN		RHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED
NULL	268250	RHIZOMELIC SYNDROME	RHIZOMELIC DYSPLASIA, FAMILIAL	
Number Sign	268300	ROBERTS SYNDROME; RBS	LONG BONE DEFICIENCIES ASSOCIATED WITH CLEFT LIP-PALATE	
Number Sign	268305	ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	RICHIERI-COSTA-PEREIRA SYNDROME; RCPS	
Number Sign	268310	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS	COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;; COVESDEM SYNDROME, FORMERLY	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OF PHALANGES AND METACARPALS/METATARSALS, INCLUDED;; ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY, INCLUDED
NULL	268315	ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL DYSFUNCTION		
NULL	268320	RODRIGUES BLINDNESS	MICROPHTHALMIA, MICROCORNEA, AND SCLEROCORNEA WITH SHORT STATURE AND HAIR AND DENTAL ABNORMALITIES	
Number Sign	268400	ROTHMUND-THOMSON SYNDROME; RTS	POIKILODERMA ATROPHICANS AND CATARACT	
NULL	268500	ROWLEY-ROSENBERG SYNDROME	GROWTH RETARDATION, PULMONARY HYPERTENSION, AND AMINO ACIDURIA	
NULL	268650	RUDIGER SYNDROME		
Percent	268700	SACCHAROPINURIA	HYPERLYSINEMIA, TYPE II;; SACCHAROPINE DEHYDROGENASE DEFICIENCY;; ALPHA-AMINOADIPIC SEMIALDEHYDE SYNTHASE DEFICIENCY	
Number Sign	268800	SANDHOFF DISEASE	GM2-GANGLIOSIDOSIS, TYPE II;; HEXOSAMINIDASES A AND B DEFICIENCY	SANDHOFF DISEASE, ADULT TYPE, INCLUDED;; SANDHOFF DISEASE, JUVENILE TYPE, INCLUDED;; SANDHOFF DISEASE, INFANTILE TYPE, INCLUDED
Percent	268850	RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	SHORT STATURE, MENTAL RETARDATION, EYE ANOMALIES, AND CLEFT LIP/PALATE;; SAO PAULO MCA/MR SYNDROME	
Number Sign	268900	SARCOSINEMIA; SARCOS	HYPERSARCOSINEMIA;; SARCOSINE DEHYDROGENASE COMPLEX DEFICIENCY;; SARDH DEFICIENCY; SARDHD;; SARD DEFICIENCY	
Number Sign	269000	SC PHOCOMELIA SYNDROME	SC PSEUDOTHALIDOMIDE SYNDROME	
Number Sign	269150	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME	SGS	
Number Sign	269160	SCHIZENCEPHALY		
Percent	269200	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II; APS2	SCHMIDT SYNDROME;; DIABETES MELLITUS, ADDISON DISEASE, MYXEDEMA;; POLYGLANDULAR AUTOIMMUNE SYNDROME, TYPE II;; PGA II;; POLYENDOCRINE AUTOIMMUNE SYNDROME, TYPE II;; APS II	
Number Sign	269250	SCHNECKENBECKEN DYSPLASIA	CHONDRODYSPLASIA, LETHAL NEONATAL, WITH SNAIL-LIKE PELVIS	
Percent	269300	CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD		
Number Sign	269400	ANTERIOR SEGMENT DYSGENESIS 7; ASGD7	CORNEAL OPACIFICATION WITH OTHER OCULAR ANOMALIES; COPOA;; SCLEROCORNEA WITH OTHER OCULAR ANOMALIES	
Number Sign	269500	SCLEROSTEOSIS 1; SOST1	SOST;; CORTICAL HYPEROSTOSIS WITH SYNDACTYLY	
Number Sign	269600	SEA-BLUE HISTIOCYTE DISEASE	SEA-BLUE HISTIOCYTOSIS;; HISTIOCYTOSIS, SEA-BLUE	
NULL	269630	SECOND METATARSAL-METACARPAL SYNDROME		
NULL	269650	SECRETORY COMPONENT DEFICIENCY	IgA DEFICIENCY, SECRETORY	
Number Sign	269700	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2	BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY, TYPE 2;; SEIP SYNDROME;; BERARDINELLI SYNDROME;; LIPODYSTROPHY, TOTAL, AND ACROMEGALOID GIGANTISM;; LIPOATROPHIC DIABETES, CONGENITAL;; LIPODYSTROPHY, BERARDINELLI-SEIP CONGENITAL, TYPE 2;; BRUNZELL SYNDROME, BSCL2-RELATED	
NULL	269720	SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	BFNS, AUTOSOMAL RECESSIVE;; CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;; EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	
NULL	269800	SENILE PLAQUE FORMATION		
Number Sign	269840	IMMUNODEFICIENCY 48; IMD48	SELECTIVE T-CELL DEFECT; STCD	
Percent	269860	SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	SHORT RIB-POLYDACTYLY SYNDROME, TYPE IV; SRPS4;; SRPS IV;; BEEMER-LANGER SYNDROME;; SHORT RIB SYNDROME, BEEMER TYPE	
NULL	269870	SHORT STATURE-OBESITY SYNDROME; SSOS		
Number Sign	269880	SHORT SYNDROME	SHORT STATURE, HYPEREXTENSIBILITY, HERNIA, OCULAR DEPRESSION, RIEGER ANOMALY, AND TEETHING DELAY;; LIPODYSTROPHY, PARTIAL, WITH RIEGER ANOMALY AND SHORT STATURE	
Number Sign	269920	INFANTILE SIALIC ACID STORAGE DISEASE; ISSD	SIALURIA, INFANTILE FORM;; N-ACETYLNEURAMINIC ACID STORAGE DISEASE;; NANA STORAGE DISEASE; NSD	
Number Sign	269921	SIALURIA	SIALURIA, FRENCH TYPE	
Number Sign	270100	HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5	SITUS INVERSUS VISCERUM; SIV	
Percent	270150	SJOGREN SYNDROME	SICCA SYNDROME	
Number Sign	270200	SJOGREN-LARSSON SYNDROME; SLS	ICHTHYOSIS, SPASTIC NEUROLOGIC DISORDER, AND OLIGOPHRENIA;; FATTY ALCOHOL:NAD+ OXIDOREDUCTASE DEFICIENCY;; FATTY ALDEHYDE DEHYDROGENASE DEFICIENCY;; FALDH DEFICIENCY	
NULL	270220	SJOGREN-LARSSON-LIKE ICHTHYOSIS WITHOUT CNS OR EYE INVOLVEMENT	ICHTHYOSIS, SJOGREN-LARSSON-LIKE, WITHOUT CNS OR EYE INVOLVEMENT	
Number Sign	270300	PEELING SKIN SYNDROME 1; PSS1	PSS;; SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;; KERATOLYSIS EXFOLIATIVA CONGENITA;; DECIDUOUS SKIN	
NULL	270350	ANOSMIA FOR BUTYL MERCAPTAN	SKUNK N-BUTYL MERCAPTAN, INABILITY TO SMELL	
Number Sign	270400	SMITH-LEMLI-OPITZ SYNDROME; SLOS	SLO SYNDROME;; RSH SYNDROME;; RUTLEDGE LETHAL MULTIPLE CONGENITAL ANOMALY SYNDROME;; POLYDACTYLY, SEX REVERSAL, RENAL HYPOPLASIA, AND UNILOBAR LUNG;; LETHAL ACRODYSGENITAL SYNDROME	
Number Sign	270420	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES; DIAR3	SODIUM DIARRHEA, CONGENITAL; CSD;; DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, SYNDROMIC	
NULL	270425	SODIUM-POTASSIUM-ATPase ACTIVITY OF RED CELL	SODIUM PUMP SITES, NUMBER OF	
Number Sign	270450	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO	SOMATOMEDIN, END-ORGAN INSENSITIVITY TO;; SOMATOMEDIN-C, RESISTANCE TO;; IGF-I RESISTANCE	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO, DUE TO INCREASED BINDING PROTEIN, INCLUDED
NULL	270460	SONODA SYNDROME	ROUND FACE WITH DEPRESSED NASAL BRIDGE AND SMALL MOUTH, CONGENITAL HEART DEFECT, AND RETARDED DEVELOPMENT	
NULL	270500	ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION		
Number Sign	270550	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE; SACS	SPASTIC ATAXIA 6, AUTOSOMAL RECESSIVE; SPAX6;; CHARLEVOIX-SAGUENAY SPASTIC ATAXIA;; AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY; ARSACS	
Percent	270600	SPASTIC DIPLEGIA AND MENTAL RETARDATION	SPASTIC DIPLEGIA, INFANTILE TYPE	
Number Sign	270685	SPASTIC PARAPLEGIA 17, AUTOSOMAL DOMINANT; SPG17	SPASTIC PARAPLEGIA WITH AMYOTROPHY OF HANDS AND FEET;; SILVER SYNDROME;; SILVER SPASTIC PARAPLEGIA SYNDROME	
Number Sign	270700	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15	SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;; KJELLIN SYNDROME	
Number Sign	270750	SPASTIC PARAPLEGIA 23; SPG23	SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;; SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;; LISON SYNDROME	
Number Sign	270800	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A		
NULL	270805	SPASTIC PARAPLEGIA WITH MYOCLONIC EPILEPSY		
NULL	270850	SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION		
NULL	270900	SPASTIC PSEUDOSCLEROSIS	DISSEMINATED ENCEPHALOMYELOPATHY;; CORTICOPALLIDODEGENERATION	
NULL	270950	SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION		
Number Sign	270960	SPERMATOGENIC FAILURE 4; SPGF4	AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;; AZOOSPERMIA WITH MATURATION ARREST;; SPERMATOGENESIS ARREST	PREGNANCY LOSS, RECURRENT, 4, INCLUDED; RPRGL4, INCLUDED
Number Sign	270970	SPHEROCYTOSIS, TYPE 3; SPH3	SPHEROCYTOSIS, HEREDITARY, 3; HS3	
NULL	271109	SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION		
NULL	271110	SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY		
Number Sign	271150	SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4	SPINAL MUSCULAR ATROPHY, ADULT FORM;; SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL RECESSIVE	
NULL	271200	SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE		
NULL	271220	SPINAL MUSCULAR ATROPHY, SCAPULOPERONEAL		
NULL	271225	SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES		
Number Sign	271245	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7	SPINOCEREBELLAR ATAXIA, INFANTILE-ONSET; IOSCA;; OPHTHALMOPLEGIA, HYPOTONIA, ATAXIA, HYPOACUSIS, AND ATHETOSIS;; OHAHA SYNDROME;; SPINOCEREBELLAR ATAXIA, INFANTILE, WITH SENSORY NEUROPATHY;; SPINOCEREBELLAR ATAXIA 8, FORMERLY; SCA8, FORMERLY	
Percent	271250	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3; SCAR3	SPINOCEREBELLAR ATAXIA WITH BLINDNESS AND DEAFNESS; SCABD	
NULL	271270	SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM		
NULL	271310	SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	CORNEAL-CEREBELLAR SYNDROME;; CORNEAL DYSTROPHY WITH SPINOCEREBELLAR DEGENERATION	
NULL	271320	SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITAL CATARACTS, AND MYOPIA	BEDOUIN SPASTIC ATAXIA SYNDROME	
NULL	271322	SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM		
Number Sign	271400	ASPLENIA, ISOLATED CONGENITAL; ICAS	HYPOSPLENIA, ISOLATED CONGENITAL;; SPLENIC HYPOPLASIA;; ASPLENIA, FAMILIAL	
NULL	271500	SPLENOPORTAL VASCULAR ANOMALIES		
Percent	271510	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE	SPONDYLAR AND NASAL ALTERATIONS WITH STRIATED METAPHYSES;; SPONASTRIME DYSPLASIA;; SHORT-LIMB DWARFISM WITH SADDLE NOSE, SPINAL ALTERATIONS, AND METAPHYSEAL STRIATION	
NULL	271520	SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	CASAMASSIMA-MORTON-NANCE SYNDROME;; CMN SYNDROME	
Percent	271530	BRACHYOLMIA TYPE 1, HOBAEK TYPE; BCYM1A	BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;; SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	
Percent	271600	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE		
NULL	271620	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION	SEDT WITH MENTAL RETARDATION	
Percent	271630	BRACHYOLMIA TYPE 1, TOLEDO TYPE; BCYM1B	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;; SED, CHONDROITIN SULFATE TYPE;; PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	
Number Sign	271640	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	SEMDJL	
Percent	271650	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE; SEMDIT		
Number Sign	271665	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	SMED-SL;; SMED, SHORT LIMB-HAND TYPE;; SMED, TYPE II;; SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-ABNORMAL CALCIFICATION TYPE;; SMED, SHORT LIMB-ABNORMAL CALCIFICATION TYPE;; SMED-SL/AC	
Number Sign	271700	SPONDYLOPERIPHERAL DYSPLASIA	SPONDYLOPERIPHERAL DYSPLASIA WITH SHORT ULNA	
Number Sign	271900	CANAVAN DISEASE	CANAVAN-VAN BOGAERT-BERTRAND DISEASE;; SPONGY DEGENERATION OF CENTRAL NERVOUS SYSTEM;; ASPARTOACYLASE DEFICIENCY;; ASPA DEFICIENCY;; ASP DEFICIENCY;; AMINOACYLASE 2 DEFICIENCY;; ACY2 DEFICIENCY	
Number Sign	271930	STRIATONIGRAL DEGENERATION, INFANTILE; SNDI	INFANTILE BILATERAL STRIATAL NECROSIS; IBSN;; BILATERAL STRIATAL NECROSIS, INFANTILE;; STRIATAL DEGENERATION, FAMILIAL	
NULL	271950	SUBAORTIC STENOSIS, MEMBRANOUS		
NULL	271960	SUBAORTIC STENOSIS--SHORT STATURE SYNDROME	ONAT SYNDROME	
Number Sign	271980	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; SSADHD	SSADH DEFICIENCY;; 4-HYDROXYBUTYRIC ACIDURIA;; GABA METABOLIC DEFECT;; GAMMA-HYDROXYBUTYRIC ACIDURIA	
NULL	272000	SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION		
NULL	272100	SUDANOPHILIC CEREBRAL SCLEROSIS	SCHILDER DISEASE	
Number Sign	272120	SUDDEN INFANT DEATH SYNDROME	SIDS	
NULL	272150	SUGARMAN BRACHYDACTYLY	BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	
Number Sign	272200	MULTIPLE SULFATASE DEFICIENCY; MSD	MUCOSULFATIDOSIS;; SULFATIDOSIS, JUVENILE, AUSTIN TYPE	
Number Sign	272300	SULFOCYSTEINURIA	SULFITE OXIDASE DEFICIENCY	
NULL	272350	SUMMITT SYNDROME		
Percent	272370	SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS; EC1	NATURAL KILLER CELL SUSCEPTIBILITY 1; NKS1	
Number Sign	272430	COLD-INDUCED SWEATING SYNDROME 1; CISS1	CRISPONI SYNDROME;; SOHAR-CRISPONI SYNDROME;; MUSCLE CONTRACTIONS, TETANOFORM, WITH CHARACTERISTIC FACE, CAMPTODACTYLY, HYPERTHERMIA, AND SUDDEN DEATH	
Number Sign	272440	FILIPPI SYNDROME; FLPIS	SYNDACTYLY, TYPE I, WITH MICROCEPHALY AND MENTAL RETARDATION;; SCOTT CRANIODIGITAL SYNDROME WITH MENTAL RETARDATION	
NULL	272450	SYNDESMODYSPLASIC DWARFISM		
Number Sign	272460	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	SPONDYLOCARPOTARSAL SYNDROME;; SYNSPONDYLISM, CONGENITAL;; VERTEBRAL FUSION WITH CARPAL COALITION;; SCOLIOSIS, CONGENITAL, WITH UNILATERAL UNSEGMENTED BAR	
NULL	272600	TAPETORETINAL DEGENERATION WITH ATAXIA		
NULL	272620	TARDIVE DYSKINESIA		
Percent	272650	TATSUMI FACTOR DEFICIENCY		
NULL	272700	TAURODONTISM		
Number Sign	272750	GM2-GANGLIOSIDOSIS, AB VARIANT	HEXOSAMINIDASE ACTIVATOR DEFICIENCY;; GM2 ACTIVATOR DEFICIENCY;; AB VARIANT GM2-GANGLIOSIDOSIS;; TAY-SACHS DISEASE, AB VARIANT	
Number Sign	272800	TAY-SACHS DISEASE; TSD	GM2-GANGLIOSIDOSIS, TYPE I;; B VARIANT GM2-GANGLIOSIDOSIS;; HEXOSAMINIDASE A DEFICIENCY;; HEXA DEFICIENCY	TAY-SACHS DISEASE, JUVENILE, INCLUDED;; HEXOSAMINIDASE A DEFICIENCY, ADULT TYPE, INCLUDED;; GM2-GANGLIOSIDOSIS, ADULT CHRONIC TYPE, INCLUDED;; GM2-GANGLIOSIDOSIS, VARIANT B1, INCLUDED;; TAY-SACHS DISEASE, VARIANT B1, INCLUDED;; TAY-SACHS DISEASE, PSEUDO-AB VARIANT, INCLUDED
NULL	272950	TEEBI-SHALTOUT SYNDROME; TBSH	CRANIOFACIAL ANOMALIES, ABNORMAL HAIR, CAMPTODACTYLY, AND CAUDAL APPENDAGE	
NULL	272980	TEETH, CONGENITAL ABSENCE OF, WITH TAURODONTIA AND SPARSE HAIR	TAURODONTIA, ABSENT TEETH, AND SPARSE HAIR	
NULL	273000	TEETH, FUSED		
NULL	273050	TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM		
NULL	273120	TERATOMA, PINEAL		
NULL	273150	TESTES, RUDIMENTARY		
Percent	273250	TESTICULAR REGRESSION SYNDROME; TRS	TESTICULAR REGRESSION, EMBRYONIC;; XY GONADAL AGENESIS SYNDROME;; ANORCHIA, FAMILIAL	
Number Sign	273300	TESTICULAR GERM CELL TUMOR; TGCT	MALE GERM CELL TUMOR; MGCT	SEMINOMA, INCLUDED;; NONSEMINOMATOUS GERM CELL TUMORS, INCLUDED;; TERATOMA, TESTICULAR, INCLUDED;; EMBRYONAL CELL CARCINOMA, INCLUDED;; ENDODERMAL SINUS TUMOR, INCLUDED;; SPERMATOCYTIC SEMINOMA, INCLUDED
NULL	273390	TETRAAMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES		
Number Sign	273395	TETRAAMELIA SYNDROME, AUTOSOMAL RECESSIVE; TETAMS		
NULL	273400	TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, AND OTHER ABNORMALITIES	ODONTOTRICHOMELIC SYNDROME	
NULL	273490	THALAMIC DEGENERATION, SYMMETRIC INFANTILE		
NULL	273600	THALIDOMIDE SUSCEPTIBILITY		
NULL	273680	THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	NEONATALLY LETHAL SHORT-LIMB SKELETAL DYSPLASIA, GLASGOW TYPE	
NULL	273730	THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME		
NULL	273740	THORACOMELIC DYSPLASIA	'THORACO-LIMB' DYSPLASIA	
Number Sign	273750	THREE M SYNDROME 1; 3M1	3M SYNDROME;; LE MERRER SYNDROME;; DOLICHOSPONDYLIC DYSPLASIA;; GLOOMY FACE SYNDROME	YAKUT SHORT STATURE SYNDROME, INCLUDED
NULL	273770	THREONINEMIA	HYPERTHREONINEMIA	
Number Sign	273800	GLANZMANN THROMBASTHENIA; GT	BLEEDING DISORDER, PLATELET-TYPE, 2; BDPLT2;; THROMBASTHENIA OF GLANZMANN AND NAEGELI;; PLATELET GLYCOPROTEIN IIb-IIIa DEFICIENCY;; GP IIb-IIIa COMPLEX, DEFICIENCY OF;; PLATELET FIBRINOGEN RECEPTOR, DEFICIENCY OF;; GLYCOPROTEIN COMPLEX IIb-IIIa, DEFICIENCY OF	
Number Sign	273900	THROMBOCYTOPENIA 3; THC3	THROMBOCYTOPENIA, AUTOSOMAL RECESSIVE, 3	
Number Sign	274000	THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR	TAR SYNDROME;; CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	
Number Sign	274150	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP	MICROANGIOPATHIC HEMOLYTIC ANEMIA;; THROMBOTIC MICROANGIOPATHY, FAMILIAL;; UPSHAW-SCHULMAN SYNDROME; USS;; SCHULMAN-UPSHAW SYNDROME;; UPSHAW FACTOR, DEFICIENCY OF;; MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;; THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	
Percent	274190	THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY		
NULL	274200	THUMB, DISTAL HYPEREXTENSIBILITY OF		
NULL	274205	THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX, AND DEAFNESS		
NULL	274210	THYMIC APLASIA WITH FETAL DEATH		
NULL	274230	THYMOMA, FAMILIAL	THYMIC NEOPLASIA	
NULL	274240	THYROCEREBRORETINAL SYNDROME		
NULL	274265	THYMIC-RENAL-ANAL-LUNG DYSPLASIA		
Number Sign	274270	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	DPD DEFICIENCY;; DPYD DEFICIENCY;; THYMINE-URACILURIA, HEREDITARY;; PYRIMIDINEMIA, FAMILIAL	5-FLUOROURACIL TOXICITY, INCLUDED
Number Sign	274300	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE; GRTH	GTHR;; THYROID HORMONE UNRESPONSIVENESS;; REFETOFF SYNDROME	
Number Sign	274400	THYROID DYSHORMONOGENESIS 1; TDH1	THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1;; HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 1;; IODINE ACCUMULATION, TRANSPORT, OR TRAPPING DEFECT	
Number Sign	274500	THYROID DYSHORMONOGENESIS 2A; TDH2A	THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A;; HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2A;; IODIDE PEROXIDASE DEFICIENCY;; THYROID PEROXIDASE DEFICIENCY	
Number Sign	274600	PENDRED SYNDROME; PDS	DEAFNESS WITH GOITER;; GOITER-DEAFNESS SYNDROME;; THYROID DYSHORMONOGENESIS 2B; TDH2B;; THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2B;; HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 2B	
Number Sign	274700	THYROID DYSHORMONOGENESIS 3; TDH3	THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3;; HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 3	
Number Sign	274800	THYROID DYSHORMONOGENESIS 4; TDH4	THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4;; HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 4;; IODOTYROSINE DEHALOGENASE DEFICIENCY;; DEIODINASE DEFICIENCY	
Number Sign	274900	THYROID DYSHORMONOGENESIS 5; TDH5	THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5;; HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 5	
Percent	275000	GRAVES DISEASE, SUSCEPTIBILITY TO, 1; GRD1	GRD;; THYROTOXICOSIS;; HYPERTHYROIDISM, AUTOIMMUNE	
Number Sign	275100	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4; CHNG4	THYROTROPIN DEFICIENCY, ISOLATED;; THYROID-STIMULATING HORMONE DEFICIENCY;; TSH DEFICIENCY;; PITUITARY CRETINISM	THYROTROPIN, BIOLOGICALLY INACTIVE, INCLUDED
Percent	275120	THYROTROPIN-RELEASING HORMONE DEFICIENCY	TRH DEFICIENCY;; HYPOTHALAMIC HYPOTHYROIDISM	
NULL	275190	TIGLIC ACIDEMIA		
Number Sign	275200	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1	THYROTROPIN RESISTANCE;; THYROID-STIMULATING HORMONE, RESISTANCE TO; RTSH;; TSH RESISTANCE;; HYPOTHYROIDISM, NONAUTOIMMUNE;; HYPOTHYROIDISM, CONGENITAL, DUE TO TSH RESISTANCE;; HYPOTHYROIDISM DUE TO UNRESPONSIVENESS TO THYROTROPIN	
Number Sign	275210	RESTRICTIVE DERMOPATHY, LETHAL	TIGHT SKIN CONTRACTURE SYNDROME, LETHAL;; HYPERKERATOSIS-CONTRACTURE SYNDROME;; FETAL HYPOKINESIA SEQUENCE DUE TO RESTRICTIVE DERMOPATHY	
NULL	275220	TIBIAL HEMIMELIA	THM;; TIBIA, ABSENCE OF	
NULL	275230	TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS		
NULL	275240	TINEA IMBRICATA, SUSCEPTIBILITY TO		
Percent	275250	TONGUE, PIGMENTED FUNGIFORM PAPILLAE OF		
NULL	275300	TRACHEOBRONCHOMEGALY		
Number Sign	275350	TRANSCOBALAMIN II DEFICIENCY	TC II DEFICIENCY;; TCN2 DEFICIENCY	
Number Sign	275355	SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC		
Percent	275370	TRICARBOXYLIC ACID CYCLE, DEFECT OF		
Number Sign	275400	OLIVER-MCFARLANE SYNDROME; OMCS	TRICHOMEGALY WITH MENTAL RETARDATION, DWARFISM, AND PIGMENTARY DEGENERATION OF RETINA;; EYELASHES, LONG, WITH MENTAL RETARDATION	
NULL	275450	TRICHOODONTOONYCHIAL DYSPLASIA WITH BONE DEFICIENCY		
NULL	275595	TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIES OF THE HANDS AND FEET		
Number Sign	275630	CHANARIN-DORFMAN SYNDROME; CDS	NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS; NLSDI;; TRIGLYCERIDE STORAGE DISEASE WITH IMPAIRED LONG-CHAIN FATTY ACID OXIDATION;; ICHTHYOTIC NEUTRAL LIPID STORAGE DISEASE;; DORFMAN-CHANARIN SYNDROME; DCS;; CHANARIN-DORFMAN DISEASE;; ICHTHYOSIFORM ERYTHRODERMA WITH LEUKOCYTE VACUOLATION	
Number Sign	275900	SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20	TROYER SYNDROME;; SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;; SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	
Percent	276100	TRYPTOPHANURIA WITH DWARFISM		
NULL	276200	T-SUBSTANCE ANOMALY		
Number Sign	276300	MISMATCH REPAIR CANCER SYNDROME; MMRCS	CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME; CMMRDS;; MISMATCH REPAIR DEFICIENCY;; MMR DEFICIENCY;; CHILDHOOD CANCER SYNDROME;; BRAIN TUMOR-POLYPOSIS SYNDROME 1; BTPS1;; BTP1 SYNDROME;; TURCOT SYNDROME	
Percent	276400	TWINNING, DIZYGOTIC		OVARIAN RESPONSE TO FSH STIMULATION, INCLUDED
NULL	276410	TWINNING, MONOZYGOTIC		
Number Sign	276600	TYROSINEMIA, TYPE II; TYRSN2	RICHNER-HANHART SYNDROME;; TYROSINE AMINOTRANSFERASE DEFICIENCY;; TAT DEFICIENCY;; TYROSINE TRANSAMINASE DEFICIENCY;; KERATOSIS PALMOPLANTARIS WITH CORNEAL DYSTROPHY;; OREGON TYPE TYROSINEMIA;; TYROSINOSIS, OCULOCUTANEOUS TYPE	
Number Sign	276700	TYROSINEMIA, TYPE I; TYRSN1	HEPATORENAL TYROSINEMIA;; FUMARYLACETOACETASE DEFICIENCY;; FAH DEFICIENCY	
Number Sign	276710	TYROSINEMIA, TYPE III; TYRSN3	4-HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	
NULL	276800	TYROSINOSIS		
Number Sign	276820	ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY	LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;; AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;; SCHINZEL PHOCOMELIA SYNDROME	
NULL	276821	ULNAR HYPOPLASIA WITH MENTAL RETARDATION	MESOMELIA OF THE UPPER LIMBS, ANONYCHIA CONGENITA, CLUBFEET, AND MENTAL RETARDATION	
NULL	276822	ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS		
Number Sign	276880	UROCANASE DEFICIENCY; UROCD		
Number Sign	276900	USHER SYNDROME, TYPE I; USH1	US1;; RETINITIS PIGMENTOSA AND CONGENITAL DEAFNESS	USHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED;; USHER SYNDROME, TYPE IA, FORMERLY, INCLUDED; USH1A, FORMERLY, INCLUDED;; USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY, INCLUDED
Number Sign	276901	USHER SYNDROME, TYPE IIA; USH2A		
Number Sign	276902	USHER SYNDROME, TYPE IIIA; USH3A	USHER SYNDROME, TYPE III; USH3	
Number Sign	276904	USHER SYNDROME, TYPE IC; USH1C	USHER SYNDROME, TYPE I, ACADIAN VARIETY	
Number Sign	276950	VACTERL ASSOCIATION WITH HYDROCEPHALUS	VACTERL-H	VATER ASSOCIATION WITH HYDROCEPHALUS, INCLUDED;; VATER ASSOCIATION WITH MACROCEPHALY AND VENTRICULOMEGALY, INCLUDED
Percent	277000	MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME	MRKH SYNDROME;; MULLERIAN APLASIA/DYSGENESIS;; VON MAYER-ROKITANSKY-KUSTER ANOMALY;; MRKH ANOMALY;; MRK ANOMALY;; UTERUS BIPARTITUS SOLIDUS RUDIMENTARIUS CUM VAGINA SOLIDA;; CONGENITAL ABSENCE OF UTERUS AND VAGINA; CAUV	UROGENITAL ADYSPLASIA, INCLUDED
Percent	277100	VALINEMIA	VALINE TRANSAMINASE DEFICIENCY;; HYPERVALINEMIA	
Percent	277150	VAN BOGAERT-HOZAY SYNDROME		
Number Sign	277170	OROFACIODIGITAL SYNDROME VI; OFD6	ORAL-FACIAL-DIGITAL SYNDROME, TYPE VI;; OFDS VI;; VARADI-PAPP SYNDROME;; VARADI SYNDROME;; POLYDACTYLY, CLEFT LIP/PALATE OR LINGUAL LUMP, AND PSYCHOMOTOR RETARDATION	
NULL	277175	VASCULAR HYALINOSIS		
Number Sign	277180	VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD	CAVD	
NULL	277200	RIGHT VENTRICULAR HYPOPLASIA, ISOLATED	IRVH	
Number Sign	277300	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE; SCDO1	VERTEBRAL ANOMALIES;; JARCHO-LEVIN SYNDROME;; SPONDYLOTHORACIC DYSPLASIA;; COSTOVERTEBRAL DYSPLASIA;; SPONDYLOTHORACIC DYSOSTOSIS	
Percent	277320	VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	INTESTINAL PSEUDOOBSTRUCTION WITH EXTERNAL OPHTHALMOPLEGIA;; MUSCULAR DYSTROPHY, OCULOGASTROINTESTINAL	
Percent	277350	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL RECESSIVE		
Number Sign	277380	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE	METHYLMALONIC ACIDEMIA AND HOMOCYSTINURIA, cblF TYPE;; METHYLMALONIC ACIDURIA DUE TO VITAMIN B12-RELEASE DEFECT;; VITAMIN B12 LYSOSOMAL RELEASE DEFECT;; COBALAMIN, DEFECT IN LYSOSOMAL RELEASE OF;; VITAMIN B12 STORAGE DISEASE;; COBALAMIN F DISEASE; cblF	
Number Sign	277400	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE	METHYLMALONIC ACIDEMIA AND HOMOCYSTINURIA, cblC TYPE;; METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, VITAMIN B12-RESPONSIVE;; VITAMIN B12 METABOLIC DEFECT WITH COMBINED DEFICIENCY OF METHYLMALONYL-CoA MUTASE AND HOMOCYSTEINE:METHYLTETRAHYDROFOLATE METHYLTRANSFERASE	
Number Sign	277410	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE	METHYLMALONIC ACIDEMIA AND HOMOCYSTINURIA, cblD TYPE METHYLMALONIC ACIDURIA, cblH TYPE, FORMERLY;; METHYLMALONIC ACIDEMIA, cblH TYPE, FORMERLY	HOMOCYSTINURIA, cblD TYPE, VARIANT 1, INCLUDED;; METHYLMALONIC ACIDURIA, cblD TYPE, VARIANT 2, INCLUDED
Number Sign	277440	VITAMIN D-DEPENDENT RICKETS, TYPE 2A; VDDR2A	VITAMIN D-DEPENDENT RICKETS, TYPE 2A, WITH OR WITHOUT ALOPECIA;; RICKETS, HEREDITARY VITAMIN D-RESISTANT; HVDRR;; GENERALIZED RESISTANCE TO 1,25-DIHYDROXYVITAMIN D;; VITAMIN D-RESISTANT RICKETS WITH END-ORGAN UNRESPONSIVENESS TO 1,25-DIHYDROXYCHOLECALCIFEROL;; PSEUDOVITAMIN D-DEFICIENCY, TYPE IIA;; PDDR IIA;; HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS;; RICKETS-ALOPECIA SYNDROME	
Number Sign	277450	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1	VKCFD;; VITAMIN K-DEPENDENT COAGULATION DEFECT;; FAMILIAL MULTIPLE COAGULATION FACTOR DEFICIENCY III;; FMFD III;; MULTIPLE COAGULATION FACTOR DEFICIENCY III; MCFD3;; FACTORS II, VII, IX, AND X, COMBINED DEFICIENCY OF;; GLUTAMIC ACID, DEFICIENT GAMMA-CARBOXYLATION OF	
Number Sign	277460	VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF; VED	ATAXIA, FRIEDREICH-LIKE, WITH SELECTIVE VITAMIN E DEFICIENCY; AVED;; FRIEDREICH-LIKE ATAXIA	
NULL	277465	VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION		
Number Sign	277470	PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	PCH2;; PONTOCEREBELLAR HYPOPLASIA WITH PROGRESSIVE CEREBRAL ATROPHY;; VOLENDAM NEURODEGENERATIVE DISEASE	
Number Sign	277480	VON WILLEBRAND DISEASE, TYPE 3; VWD3	VON WILLEBRAND DISEASE, TYPE III;; VWD, TYPE 3	
Number Sign	277580	WAARDENBURG SYNDROME, TYPE 4A; WS4A	WAARDENBURG SYNDROME, TYPE IVA;; WAARDENBURG SYNDROME WITH HIRSCHSPRUNG DISEASE, TYPE 4A;; WAARDENBURG-SHAH SYNDROME;; SHAH-WAARDENBURG SYNDROME;; WS4	
Number Sign	277590	WEAVER SYNDROME; WVS	WEAVER-SMITH SYNDROME; WSS	WEAVER-LIKE SYNDROME, INCLUDED
Number Sign	277600	WEILL-MARCHESANI SYNDROME 1; WMS1	WEILL-MARCHESANI SYNDROME, AUTOSOMAL RECESSIVE;; SPHEROPHAKIA-BRACHYMORPHIA SYNDROME;; MESODERMAL DYSMORPHODYSTROPHY, CONGENITAL	
Number Sign	277700	WERNER SYNDROME; WRN		
Percent	277720	WHISTLING FACE SYNDROME, RECESSIVE FORM		
Percent	277730	WERNICKE-KORSAKOFF SYNDROME	TRANSKETOLASE DEFECT;; ALCOHOL-INDUCED ENCEPHALOPATHY	
NULL	277740	WHITE FORELOCK WITH MALFORMATIONS		
Number Sign	277900	WILSON DISEASE	WND; WD;; HEPATOLENTICULAR DEGENERATION	
Number Sign	277950	WINCHESTER SYNDROME; WNCHRS		
NULL	277970	WISKOTT-ALDRICH SYNDROME		
NULL	277990	WOLFF MENTAL RETARDATION SYNDROME		
Number Sign	278000	LYSOSOMAL ACID LIPASE DEFICIENCY	CHOLESTERYL ESTER STORAGE DISEASE; CESD;; LIPA DEFICIENCY;; LAL DEFICIENCY;; CHOLESTEROL ESTER HYDROLASE DEFICIENCY	WOLMAN DISEASE, INCLUDED
NULL	278100	WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS		
Number Sign	278150	HYPOTRICHOSIS 8; HYPT8	HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE 3; LAH3	WOOLLY HAIR, AUTOSOMAL RECESSIVE 1, WITH OR WITHOUT HYPOTRICHOSIS, INCLUDED; ARWH1, INCLUDED
NULL	278200	WOOLLY HAIR, HYPOTRICHOSIS, EVERTED LOWER LIP, AND OUTSTANDING EARS	SALAMON SYNDROME	
Number Sign	278250	WRINKLY SKIN SYNDROME; WSS		
Number Sign	278300	XANTHINURIA, TYPE I; XAN1	XANTHINE DEHYDROGENASE DEFICIENCY;; XDH DEFICIENCY;; XANTHINE OXIDASE DEFICIENCY	
Number Sign	278700	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	XP, GROUP A;; XERODERMA PIGMENTOSUM I; XP1	
Number Sign	278720	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC	XPCC;; XP, GROUP C;; XERODERMA PIGMENTOSUM III; XP3	
Number Sign	278730	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	XP, GROUP D; XPDC;; XERODERMA PIGMENTOSUM IV;; XP4 XERODERMA PIGMENTOSUM VIII, FORMERLY; XP8, FORMERLY;; XP, GROUP H, FORMERLY; XPH, FORMERLY	
Number Sign	278740	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	XPE;; XP, GROUP E;; XERODERMA PIGMENTOSUM V; XP5	
Number Sign	278750	XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV	XERODERMA PIGMENTOSUM WITH NORMAL DNA REPAIR RATES;; PHOTOSENSITIVITY WITH DEFECTIVE DNA SYNTHESIS	
Number Sign	278760	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	XP, GROUP F;; XERODERMA PIGMENTOSUM VI; XP6	XERODERMA PIGMENTOSUM, TYPE F/COCKAYNE SYNDROME, INCLUDED; XPF/CS, INCLUDED
Number Sign	278780	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	XP, GROUP G; XPGC;; XERODERMA PIGMENTOSUM VII; XP7	XERODERMA PIGMENTOSUM, TYPE G/COCKAYNE SYNDROME, INCLUDED; XPG/CS, INCLUDED
Number Sign	278800	DE SANCTIS-CACCHIONE SYNDROME		
Number Sign	278850	46,XX SEX REVERSAL 2; SRXX2	CHROMOSOME 17q24 DUPLICATION SYNDROME	
NULL	278900	XYLOSIDASE DEFICIENCY		
Percent	279000	YOUNG SYNDROME	AZOOSPERMIA, OBSTRUCTIVE, AND CHRONIC SINOPULMONARY INFECTIONS;; SINUSITIS-INFERTILITY SYNDROME;; BARRY-PERKINS-YOUNG SYNDROME	
Number Sign	280000	COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME; CHIME	CHIME SYNDROME;; ZUNICH NEUROECTODERMAL SYNDROME;; GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 5; GPIBD5	
Number Sign	300000	OPITZ GBBB SYNDROME, TYPE I; GBBB1	OPITZ GBBB SYNDROME, X-LINKED;; OPITZ SYNDROME; OS;; OPITZ SYNDROME, X-LINKED; OSX;; OPITZ-G SYNDROME, TYPE I; OGS1;; OPITZ BBBG SYNDROME, TYPE I; BBBG1;; HYPERTELORISM WITH ESOPHAGEAL ABNORMALITY AND HYPOSPADIAS;; HYPERTELORISM-HYPOSPADIAS SYNDROME;; TELECANTHUS-HYPOSPADIAS SYNDROME	
Percent	300001	ICHTHYOSIS, X-LINKED, WITHOUT STEROID SULFATASE DEFICIENCY		
Number Sign	300004	CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA	ACC WITH ABNORMAL GENITALIA;; PROUD SYNDROME	
Number Sign	300009	DENT DISEASE 1	NEPHROLITHIASIS, HYPERCALCIURIC, X-LINKED;; UROLITHIASIS, HYPERCALCIURIC, X-LINKED;; NEPHROLITHIASIS 2; NPHL2	
Number Sign	300018	46,XY SEX REVERSAL 2; SRXY2	46,XY SEX REVERSAL, DAX1-RELATED;; DOSAGE-SENSITIVE SEX REVERSAL; DSS	
Number Sign	300029	RETINITIS PIGMENTOSA 3; RP3	RETINITIS PIGMENTOSA 15; RP15;; CONE-ROD DEGENERATION, X-LINKED;; CHOROIDORETINAL DEGENERATION WITH RETINAL REFLEX IN HETEROZYGOUS WOMEN	
Percent	300030	DEAFNESS, X-LINKED 3; DFNX3	DEAFNESS, X-LINKED 4, CONGENITAL SENSORINEURAL; DFN4	
NULL	300042	ALOPECIA, CONGENITAL; ALPC		
Percent	300046	MENTAL RETARDATION, X-LINKED 23; MRX23		
Percent	300047	MENTAL RETARDATION, X-LINKED 20; MRX20		
Number Sign	300048	INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	IPOX;; CONGENITAL IDIOPATHIC INTESTINAL PSEUDOOBSTRUCTION; CIIP;; CIIP, X-LINKED; CIIPX;; INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT	CONGENITAL SHORT BOWEL SYNDROME, X-LINKED, INCLUDED
Number Sign	300049	PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1	HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;; HETEROTOPIA, FAMILIAL NODULAR;; NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNH;; HETEROTOPIA, PERIVENTRICULAR, EHLERS-DANLOS VARIANT;; PERIVENTRICULAR NODULAR HETEROTOPIA 4, FORMERLY; PVNH4, FORMERLY	HETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA, INCLUDED
NULL	300054	BODY LENGTH, MOUSE, HUMAN HOMOLOG		
Number Sign	300055	MENTAL RETARDATION, X-LINKED, SYNDROMIC 13; MRXS13	MENTAL RETARDATION, X-LINKED 79; MRX79;; MENTAL RETARDATION, X-LINKED 16; MRX16;; MENTAL RETARDATION, X-LINKED, WITH SPASTICITY;; MENTAL RETARDATION WITH PSYCHOSIS, PYRAMIDAL SIGNS, AND MACROORCHIDISM; PPMX	
Percent	300062	MENTAL RETARDATION, X-LINKED 14; MRX14		
NULL	300064	MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM	MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	
Number Sign	300066	DEAFNESS, X-LINKED 4; DFNX4	DEAFNESS, X-LINKED 6, PROGRESSIVE; DFN6;; DEAFNESS, NONSYNDROMIC SENSORINEURAL PROGRESSIVE 6	
Number Sign	300067	LISSENCEPHALY, X-LINKED, 1; LISX1	XLIS;; LISSENCEPHALY AND AGENESIS OF CORPUS CALLOSUM	SUBCORTICAL LAMINAR HETEROTOPIA, X-LINKED, INCLUDED; SCLH, INCLUDED;; SUBCORTICAL BAND HETEROTOPIA, X-LINKED, INCLUDED; SBH, INCLUDED;; DOUBLE CORTEX SYNDROME, INCLUDED;; DC SYNDROME, INCLUDED
Number Sign	300068	ANDROGEN INSENSITIVITY SYNDROME; AIS	TESTICULAR FEMINIZATION SYNDROME; TFM;; ANDROGEN RECEPTOR DEFICIENCY;; AR DEFICIENCY;; DIHYDROTESTOSTERONE RECEPTOR DEFICIENCY;; DHTR DEFICIENCY	
Number Sign	300071	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A	CSNB, INCOMPLETE, X-LINKED;; NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2; CSNB2	
NULL	300073	FETAL AKINESIA SYNDROME, X-LINKED		
Percent	300076	IMMUNONEUROLOGIC DISORDER, X-LINKED	WOODS-BLACK-NORBURY SYNDROME	
Percent	300082	COGNITIVE FUNCTION 1, SOCIAL; CGF1	SOCIAL COGNITION	
Percent	300085	CONE-ROD DYSTROPHY, X-LINKED, 2; CORDX2	CONE DYSTROPHY 2, X-LINKED; COD2	
Number Sign	300087	X INACTIVATION, FAMILIAL SKEWED, 1; SXI1		
Number Sign	300088	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	EPILEPSY, FEMALE-RESTRICTED, WITH MENTAL RETARDATION; EFMR;; JUBERG-HELLMAN SYNDROME	
Number Sign	300100	ADRENOLEUKODYSTROPHY; ALD	ADDISON DISEASE AND CEREBRAL SCLEROSIS;; SIEMERLING-CREUTZFELDT DISEASE;; BRONZE SCHILDER DISEASE;; MELANODERMIC LEUKODYSTROPHY	ADRENOMYELONEUROPATHY, INCLUDED; AMN, INCLUDED
Number Sign	300106	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED; SEMDX	SEMD, X-LINKED	
NULL	300113	X-LINKED B CELL SURFACE ANTIGEN, MOUSE, HOMOLOG-LIKE 1; XLRL		
Number Sign	300114	MENTAL RETARDATION, X-LINKED 49; MRX49	MENTAL RETARDATION, X-LINKED 15; MRX15	
Percent	300115	MENTAL RETARDATION, X-LINKED 50; MRX50		
Number Sign	300123	MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISM		MENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY, INCLUDED; MRGH, INCLUDED
Percent	300125	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 2	MGR2;; MFTS	
NULL	300129	HEMATOPOIETIC STEM CELL KINETICS, CONTROL OF		
Percent	300136	DIABETES MELLITUS, INSULIN-DEPENDENT, X-LINKED, SUSCEPTIBILITY TO	IDDMX;; INSULIN-DEPENDENT DIABETES MELLITUS, X-LINKED, SUSCEPTIBILITY TO	
Number Sign	300143	MENTAL RETARDATION, X-LINKED 21; MRX21	MENTAL RETARDATION, X-LINKED 34; MRX34	
Percent	300147	PROSTATE CANCER, HEREDITARY, X-LINKED 1; HPCX1	PROSTATE CANCER SUSCEPTIBILITY, X-LINKED; PCSX	
Percent	300148	MENTAL RETARDATION, EPILEPTIC SEIZURES, HYPOGONADISM AND HYPOGENITALISM, MICROCEPHALY, AND OBESITY; MEHMO	MENTAL RETARDATION, X-LINKED, SYNDROMIC 20; MRXS20;; MENTAL RETARDATION, X-LINKED, SYNDROMIC 25; MRXS25	
Percent	300155	RETINITIS PIGMENTOSA 24; RP24		
Percent	300158	ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX	ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	
Number Sign	300166	MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	OCULOFACIOCARDIODENTAL SYNDROME;; OFCD SYNDROME;; MICROPHTHALMIA, CATARACTS, RADICULOMEGALY, AND SEPTAL HEART DEFECTS;; ANOP2, FORMERLY;; MAA2, FORMERLY	
Percent	300179	X INACTIVATION, FAMILIAL SKEWED, 2; SXI2		
NULL	300184	HYPOTONIA, CONGENITAL NYSTAGMUS, ATAXIA, AND ABNORMAL AUDITORY BRAINSTEM RESPONSES		
Number Sign	300194	AMME COMPLEX	ALPORT SYNDROME, MENTAL RETARDATION, MIDFACE HYPOPLASIA, AND ELLIPTOCYTOSIS;; ATS-MR;; CHROMOSOME Xq22.3 TELOMERIC DELETION SYNDROME	
Number Sign	300200	ADRENAL HYPOPLASIA, CONGENITAL; AHC	ADRENAL HYPOPLASIA, CONGENITAL, WITH HYPOGONADOTROPIC HYPOGONADISM; AHCH;; ADDISON DISEASE, X-LINKED; AHX;; AHC WITH HHG;; CYTOMEGALIC ADRENOCORTICAL HYPOPLASIA;; AHC WITH ISOLATED GONADOTROPIN DEFICIENCY	
Number Sign	300209	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2		
Number Sign	300210	MENTAL RETARDATION, X-LINKED 58; MRX58		
Percent	300211	EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX		
Number Sign	300215	LISSENCEPHALY, X-LINKED, 2; LISX2	LISSENCEPHALY, X-LINKED, WITH AMBIGUOUS GENITALIA; XLAG;; XLISG	HYDRANENCEPHALY AND ABNORMAL GENITALIA, INCLUDED
NULL	300216	COATS DISEASE	RETINAL TELANGIECTASIS	
Percent	300218	MENTAL RETARDATION, X-LINKED, SYNDROMIC 7; MRXS7	AHMAD X-LINKED MENTAL RETARDATION SYNDROME	
Number Sign	300219	MYOTUBULAR MYOPATHY WITH ABNORMAL GENITAL DEVELOPMENT		
Percent	300221	LYMPHOMA, HODGKIN, X-LINKED PSEUDOAUTOSOMAL	HODGKIN DISEASE, X-LINKED PSEUDOAUTOSOMAL	
Percent	300228	TESTICULAR GERM CELL TUMOR 1; TGCT1		
NULL	300232	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION	SEMD, X-LINKED, WITH MENTAL DETERIORATION	
NULL	300233	RADIOULNAR SYNOSTOSIS, RADIAL RAY ABNORMALITIES, AND SEVERE MALFORMATIONS IN THE MALE		
Number Sign	300238	MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	SHASHI X-LINKED MENTAL RETARDATION SYNDROME; SMRXS;; MENTAL RETARDATION, X-LINKED, SHASHI TYPE	
Number Sign	300243	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE; MRXSCH	ANGELMAN-LIKE SYNDROME, X-LINKED;; MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND ATAXIA SYNDROME	
Number Sign	300244	TERMINAL OSSEOUS DYSPLASIA; TOD	TERMINAL OSSEOUS DYSPLASIA AND PIGMENTARY DEFECTS; TODPD;; ODPD;; OSSEOUS DYSPLASIA, DIGITAL, WITH FACIAL PIGMENTARY DEFECTS AND MULTIPLE FRENULA; ODPF;; ODPF SYNDROME	
Percent	300245	PTOSIS, HEREDITARY CONGENITAL 2	PTOS2;; PTOSIS, X-LINKED; PTOSX	
Number Sign	300257	DANON DISEASE	VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;; PSEUDOGLYCOGENOSIS II;; ANTOPOL DISEASE;; LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY, FORMERLY;; GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;; GSD IIb, FORMERLY	
NULL	300259	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, X-LINKED	MTBSX	
Number Sign	300260	LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	MECP2 DUPLICATION SYNDROME;; MENTAL RETARDATION, X-LINKED, SYNDROMIC, LUBS TYPE;; MENTAL RETARDATION, X-LINKED, WITH RECURRENT RESPIRATORY INFECTIONS	
Percent	300261	ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA	MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	
Percent	300262	ABIDI X-LINKED MENTAL RETARDATION SYNDROME; MRXSAB	MENTAL RETARDATION, X-LINKED, SYNDROMIC, ABIDI TYPE	
Number Sign	300263	SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	MENTAL RETARDATION, X-LINKED, SYNDROMIC, SIDERIUS TYPE;; SIDERIUS-HAMEL SYNDROME	
Percent	300266	SPASTIC PARAPLEGIA 16, X-LINKED; SPG16		
NULL	300270	ADRENOMYODYSTROPHY		
Number Sign	300271	MENTAL RETARDATION, X-LINKED 72; MRX72		
Percent	300273	GOITER, MULTINODULAR 2; MNG2		
NULL	300280	URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME	FCMS;; FACIOCARDIOMUSCULOSKELETAL SYNDROME, URUGUAY TYPE	
Number Sign	300291	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY	HED-ID	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNE DEFICIENCY, INCLUDED;; EDA-ID, INCLUDED;; HYPER-IgM IMMUNODEFICIENCY, X-LINKED, WITH HYPOHIDROTIC ECTODERMAL DYSPLASIA, INCLUDED;; XHM-ED, INCLUDED
Number Sign	300299	NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX	XLN	
Number Sign	300301	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY, OSTEOPETROSIS, AND LYMPHEDEMA; OLEDAID		
Percent	300306	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 11; BMIQ11	OBESITY, SUSCEPTIBILITY TO	
Percent	300310	AGAMMAGLOBULINEMIA, X-LINKED, TYPE 2; AGMX2	XLA2	
Number Sign	300321	FG SYNDROME 2; FGS2		
Number Sign	300322	LESCH-NYHAN SYNDROME; LNS	HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1 DEFICIENCY;; HPRT1 DEFICIENCY;; HPRT DEFICIENCY;; HPRT DEFICIENCY, COMPLETE	HPRT DEFICIENCY, NEUROLOGIC VARIANT, INCLUDED;; LESCH-NYHAN SYNDROME, NEUROLOGIC VARIANT, INCLUDED
Number Sign	300323	KELLEY-SEEGMILLER SYNDROME	GOUT, HPRT-RELATED;; HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1 DEFICIENCY, PARTIAL;; HPRT DEFICIENCY, PARTIAL;; HPRT1 DEFICIENCY, PARTIAL	
Percent	300324	MENTAL RETARDATION, X-LINKED 53; MRX53		
Percent	300331	THROMBOCYTHEMIA, X-LINKED; THCYTX	THROMBOCYTOSIS, X-LINKED	
Number Sign	300337	HYPOMELANOSIS OF ITO; HMI	INCONTINENTIA PIGMENTI ACHROMIANS; IPA;; ITO HYPOMELANOSIS; ITO;; INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	
Percent	300345	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 1; MCOPCB1	MICROPHTHALMIA, COLOBOMATOUS, ISOLATED 1	
Percent	300351	GRAVES DISEASE, SUSCEPTIBILITY TO, X-LINKED 1	GRDX1	GRAVES DISEASE, SUSCEPTIBILITY TO, X-LINKED 2, INCLUDED; GRDX2, INCLUDED
Number Sign	300352	CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1	CREATINE DEFICIENCY SYNDROME, X-LINKED;; CREATINE TRANSPORTER DEFECT;; MENTAL RETARDATION, X-LINKED, WITH SEIZURES, SHORT STATURE, AND MIDFACE HYPOPLASIA;; MENTAL RETARDATION, X-LINKED, WITH CREATINE TRANSPORT DEFICIENCY	
Number Sign	300354	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	CABEZAS SYNDROME;; MENTAL RETARDATION, X-LINKED, SYNDROMIC 15; MRXS15;; MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND ABNORMAL GAIT;; MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE; MRSS	
Percent	300355	MENTAL RETARDATION, X-LINKED 73; MRX73		
Number Sign	300367	THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA		
Percent	300372	MENTAL RETARDATION, X-LINKED 42; MRX42		
Number Sign	300373	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS; OSCS	HYPEROSTOSIS GENERALISATA WITH STRIATIONS	
Number Sign	300376	MUSCULAR DYSTROPHY, BECKER TYPE; BMD	BECKER MUSCULAR DYSTROPHY;; MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, BECKER TYPE	
Percent	300378	RADIAL RAY DEFICIENCY, X-LINKED	RRDX	
Number Sign	300387	MENTAL RETARDATION, X-LINKED 63; MRX63	MENTAL RETARDATION, X-LINKED 68; MRX68	
Percent	300388	POLYMICROGYRIA, BILATERAL PERISYLVIAN, X-LINKED; BPPX	PMGX;; BPP;; PERISYLVIAN SYNDROME, CONGENITAL BILATERAL; CBPS	
Number Sign	300400	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED; SCIDX1	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE;; SCIDX; XSCID;; SCID, X-LINKED;; IMMUNODEFICIENCY 4; IMD4	
Percent	300406	FG SYNDROME 3; FGS3		
Number Sign	300419	MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED; MRXARX	MENTAL RETARDATION, X-LINKED 29; MRX29;; MENTAL RETARDATION, X-LINKED 32; MRX32;; MENTAL RETARDATION, X-LINKED 33; MRX33;; MENTAL RETARDATION, X-LINKED 38; MRX38;; MENTAL RETARDATION, X-LINKED 43; MRX43;; MENTAL RETARDATION, X-LINKED 54; MRX54;; MENTAL RETARDATION, X-LINKED 76; MRX76;; MENTAL RETARDATION, X-LINKED 87; MRX87	
Number Sign	300422	FG SYNDROME 4; FGS4		MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED
Number Sign	300423	MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	MENTAL RETARDATION, X-LINKED, WITH EPILEPSY; MRXE	
Number Sign	300424	RETINITIS PIGMENTOSA 23; RP23		
Number Sign	300425	AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1		
Percent	300428	MENTAL RETARDATION, X-LINKED 2; MRX2		
NULL	300431	ATKIN-FLAITZ SYNDROME	ATKIN SYNDROME	
Percent	300433	MENTAL RETARDATION, X-LINKED 81; MRX81		
Number Sign	300434	STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	MENTAL RETARDATION, X-LINKED, STOCCO DOS SANTOS TYPE	
Number Sign	300436	MENTAL RETARDATION, X-LINKED 46; MRX46		
Number Sign	300438	HSD10 MITOCHONDRIAL DISEASE; HSD10MD	HSD17B10 DEFICIENCY;; 17-BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY;; 3-HYDROXYACYL-CoA DEHYDROGENASE II DEFICIENCY;; 2-METHYL-3-HYDROXYBUTYRYL-CoA DEHYDROGENASE DEFICIENCY;; MHBD DEFICIENCY;; MENTAL RETARDATION, X-LINKED, SYNDROMIC 10; MRXS10;; CHORIOATHETOSIS WITH MENTAL RETARDATION AND ABNORMAL BEHAVIOR; CAMR;; MENTAL RETARDATION WITH CHORIOATHETOSIS AND ABNORMAL BEHAVIOR	
Number Sign	300448	ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS	HEMOGLOBIN H DISEASE, ACQUIRED	
Percent	300454	MENTAL RETARDATION, X-LINKED 77; MRX77		
Number Sign	300455	RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH OR WITHOUT DEAFNESS		
Percent	300464	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 3	CHDS3	
Percent	300471	CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES		
Number Sign	300472	CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA, AND MICROGNATHIA	MENTAL RETARDATION, X-LINKED, SYNDROMIC 28; MRXS28	
Number Sign	300475	DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH		CONTIGUOUS ABCD1/DXS1375E DELETION SYNDROME, INCLUDED; CADDS, INCLUDED
Number Sign	300476	CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3		
Percent	300484	OROFACIODIGITAL SYNDROME VIII; OFD8	OFDS VIII;; ORAL-FACIAL-DIGITAL SYNDROME, TYPE VIII;; ORAL-FACIAL-DIGITAL SYNDROME WITH HYPOPLASTIC EPIGLOTTIS;; EDWARDS SYNDROME	
Number Sign	300486	MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	MENTAL RETARDATION, X-LINKED 60, FORMERLY; MRX60, FORMERLY	
Percent	300488	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENOQ1		
Number Sign	300489	SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3; SMAX3	SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED RECESSIVE;; DSMAX	
Number Sign	300491	EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS		
Number Sign	300494	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1		
Number Sign	300495	AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2		MENTAL RETARDATION, X-LINKED, INCLUDED
Number Sign	300496	AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3		
Number Sign	300497	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2		
Percent	300498	MENTAL RETARDATION, X-LINKED 45; MRX45		
Number Sign	300500	ALBINISM, OCULAR, TYPE I; OA1	NETTLESHIP-FALLS TYPE OCULAR ALBINISM	
Percent	300504	MENTAL RETARDATION, X-LINKED 52; MRX52		
Percent	300505	MENTAL RETARDATION, X-LINKED 84; MRX84		
Percent	300509	DYSLEXIA, SUSCEPTIBILITY TO, 9; DYX9		
Number Sign	300510	OVARIAN DYSGENESIS 2; ODG2	OVARIAN DYSGENESIS, HYPERGONADOTROPIC, X-LINKED;; OVARIAN FAILURE, HYPERGONADOTROPIC, DUE TO OVARIAN DYSGENESIS	PREMATURE OVARIAN FAILURE 4, INCLUDED; POF4, INCLUDED
Number Sign	300511	PREMATURE OVARIAN FAILURE 2A; POF2A		
Number Sign	300514	FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	FACB;; FANCONI PANCYTOPENIA, TYPE 2; FA2	
Percent	300518	MENTAL RETARDATION, X-LINKED 82; MRX82		
Percent	300519	MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE; MRXSMP	MARTIN-PROBST DEAFNESS-MENTAL RETARDATION SYNDROME	
Number Sign	300523	ALLAN-HERNDON-DUDLEY SYNDROME; AHDS	ALLAN-HERNDON SYNDROME;; MONOCARBOXYLATE TRANSPORTER 8 DEFICIENCY;; TRIIODOTHYRONINE RESISTANCE;; T3 RESISTANCE;; MENTAL RETARDATION, X-LINKED, WITH HYPOTONIA;; MENTAL RETARDATION AND MUSCULAR ATROPHY	
Number Sign	300534	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ	MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	
Percent	300536	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 4; BMND4		
Number Sign	300539	NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD		
Number Sign	300554	HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE		
Number Sign	300555	DENT DISEASE 2		
Percent	300557	PARKINSON DISEASE 12; PARK12	PARKINSON DISEASE, X-LINKED	
Number Sign	300558	MENTAL RETARDATION, X-LINKED 30; MRX30	MENTAL RETARDATION, X-LINKED 47; MRX47	
Number Sign	300559	GLYCOGEN STORAGE DISEASE, TYPE IXd; GSD9D	GSD IXd;; MUSCLE PHOSPHORYLASE KINASE DEFICIENCY;; MUSCLE GLYCOGENOSIS, X-LINKED	
Number Sign	300577	MENTAL RETARDATION, X-LINKED 91; MRX91		
Number Sign	300578	CHROMOSOME Xp11.3 DELETION SYNDROME	MENTAL RETARDATION, X-LINKED, WITH RETINITIS PIGMENTOSA	
Percent	300580	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX		
Percent	300581	FG SYNDROME 5; FGS5		
Number Sign	300582	SHORT STATURE, IDIOPATHIC, X-LINKED; ISS		
Number Sign	300584	IMMUNODEFICIENCY WITHOUT ANHIDROTIC ECTODERMAL DYSPLASIA	IMMUNODEFICIENCY, ISOLATED;; IMMUNODEFICIENCY, PURE	
Percent	300589	NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5		
Number Sign	300590	CORNELIA DE LANGE SYNDROME 2; CDLS2	CORNELIA DE LANGE SYNDROME, X-LINKED;; CDLS, X-LINKED	
Percent	300591	STATURE QUANTITATIVE TRAIT LOCUS 6; STQTL6		
Number Sign	300600	ALAND ISLAND EYE DISEASE; AIED	FORSIUS-ERIKSSON TYPE OCULAR ALBINISM	
NULL	300602	CLARK-BARAITSER SYNDROME	BARAITSER SYNDROME	
Number Sign	300604	PREMATURE OVARIAN FAILURE 2B; POF2B		
Percent	300605	RETINITIS PIGMENTOSA 34; RP34		
Number Sign	300607	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8	HYPEREKPLEXIA AND EPILEPSY	
Percent	300612	BROOKS-WISNIEWSKI-BROWN SYNDROME	MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE; MRXSBWB	
Percent	300613	MYOPIA 13, X-LINKED; MYP13		
Number Sign	300614	DEAFNESS, X-LINKED 5; DFNX5	AUDITORY NEUROPATHY, X-LINKED, 1, WITH PERIPHERAL SENSORY NEUROPATHY; AUNX1	
Number Sign	300615	BRUNNER SYNDROME; BRNRS		ANTISOCIAL BEHAVIOR, SUSCEPTIBILITY TO, INCLUDED
Percent	300619	CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	CASM SYNDROME	
Number Sign	300622	TN POLYAGGLUTINATION SYNDROME; TNPS	GALACTOSYLTRANSFERASE DEFICIENCY	
Number Sign	300623	FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS		
Number Sign	300624	FRAGILE X SYNDROME; FXS	FRAGILE X MENTAL RETARDATION SYNDROME;; MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28;; X-LINKED MENTAL RETARDATION AND MACROORCHIDISM;; MARKER X SYNDROME;; MARTIN-BELL SYNDROME	
Number Sign	300633	HYPOSPADIAS 1, X-LINKED; HYSP1		
Number Sign	300635	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	XIAP DEFICIENCY	
Number Sign	300636	IMMUNODEFICIENCY 33; IMD33	IMMUNODEFICIENCY 33, MYCOBACTERIOSIS, X-LINKED;; ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 1; AMCBX1	
Number Sign	300640	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2; IPD2		
Number Sign	300643	ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED; RESDX		
Number Sign	300645	IMMUNODEFICIENCY 34; IMD34	IMMUNODEFICIENCY 34, MYCOBACTERIOSIS, X-LINKED;; ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 2; AMCBX2	
NULL	300650	ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS; OASD	OCULAR ALBINISM WITH SENSORINEURAL DEAFNESS;; DEAFNESS AND OCULAR ALBINISM	
Percent	300652	ANGIOMA SERPIGINOSUM, X-LINKED		
Number Sign	300653	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	PGK1 DEFICIENCY	
Number Sign	300659	MENTAL RETARDATION, X-LINKED 93; MRX93	MENTAL RETARDATION, X-LINKED, WITH MACROCEPHALY	
Percent	300660	LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD		
Number Sign	300661	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	PRPS1 SUPERACTIVITY	GOUT, PRPS-RELATED, INCLUDED
Number Sign	300672	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2	INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	
Number Sign	300673	ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS		
Number Sign	300676	MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14		
Number Sign	300679	CHROMOSOME Xp21 DELETION SYNDROME	COMPLEX GLYCEROL KINASE DEFICIENCY	
Number Sign	300695	SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM	SCAPULOPERONEAL MYOPATHY, FHL1-RELATED	
Number Sign	300696	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMA		EMERY-DREIFUSS MUSCULAR DYSTROPHY 6, X-LINKED, INCLUDED; EDMD6, INCLUDED
Number Sign	300699	MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	MENTAL RETARDATION, X-LINKED 94; MRX94;; MENTAL RETARDATION, X-LINKED, SYNDROMIC 29; MRXS29	
Percent	300700	ALBINISM-DEAFNESS SYNDROME; ADFN	ALDS	
Percent	300703	SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5		
Percent	300704	PROSTATE CANCER, HEREDITARY, X-LINKED 2; HPCX2		
Number Sign	300705	CHROMOSOME Xp11.22 DUPLICATION SYNDROME	MENTAL RETARDATION, X-LINKED 17; MRX17;; MENTAL RETARDATION, X-LINKED 31; MRX31	
Number Sign	300706	MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	MENTAL RETARDATION AND MACROCEPHALY SYNDROME	
Number Sign	300707	TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	STAR SYNDROME;; SYNDACTYLY WITH RENAL AND ANOGENITAL MALFORMATIONS	
Percent	300709	MENTAL RETARDATION, X-LINKED, SYNDROMIC 9; MRXS9		
Percent	300710	ALOPECIA, ANDROGENETIC, 2; AGA2		
Percent	300711	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 4; IHPS4		
Percent	300712	CRANIOFACIOSKELETAL SYNDROME		
Percent	300716	MENTAL RETARDATION, X-LINKED 95; MRX95		
Number Sign	300717	REDUCING BODY MYOPATHY, X-LINKED 1A, SEVERE, WITH INFANTILE OR EARLY CHILDHOOD ONSET; RBMX1A		
Number Sign	300718	REDUCING BODY MYOPATHY, X-LINKED 1B, WITH LATE CHILDHOOD OR ADULT ONSET; RBMX1B		
Percent	300719	DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES		
Number Sign	300749	MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	MICPCH SYNDROME;; MENTAL RETARDATION, X-LINKED, SYNDROMIC, NAJM TYPE; MRXSNA	
Percent	300750	SPASTIC PARAPLEGIA 34, X-LINKED; SPG34		
Number Sign	300751	ANEMIA, SIDEROBLASTIC, 1; SIDBA1	ANEMIA, SIDEROBLASTIC, X-LINKED; XLSA;; ANEMIA, HYPOCHROMIC; ANH1;; ANEMIA, HEREDITARY SIDEROBLASTIC;; HEREDITARY IRON-LOADING ANEMIA	
Number Sign	300752	PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP	PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED DOMINANT; XLDPP;; ERYTHROHEPATIC PROTOPORPHYRIA, X-LINKED	
Number Sign	300755	AGAMMAGLOBULINEMIA, X-LINKED; XLA	BRUTON-TYPE AGAMMAGLOBULINEMIA;; AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;; IMMUNODEFICIENCY 1; IMD1	HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED
Percent	300756	ALZHEIMER DISEASE 16; AD16		
Number Sign	300758	HYPOSPADIAS 2, X-LINKED; HYSP2		
Number Sign	300770	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4	PULMONARY ALVEOLAR PROTEINOSIS, CONGENITAL, 4;; PAP DUE TO CSF2RA DEFICIENCY;; CSF2RA DEFICIENCY	
Percent	300778	CORNEAL DYSTROPHY, LISCH EPITHELIAL; LECD	LISCH EPITHELIAL CORNEAL DYSTROPHY;; BAND-SHAPED AND WHORLED MICROCYSTIC CORNEAL EPITHELIAL DYSTROPHY	
Percent	300779	CORNEAL DYSTROPHY, ENDOTHELIAL, X-LINKED; XECD	ENDOTHELIAL CORNEAL DYSTROPHY, X-LINKED	
Number Sign	300799	MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR		
Number Sign	300801	CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME		
Number Sign	300802	MENTAL RETARDATION, X-LINKED 96; MRX96		
Number Sign	300803	MENTAL RETARDATION, X-LINKED 97; MRX97	MENTAL RETARDATION, X-LINKED 65; MRX65;; MRXZ	
Number Sign	300804	JOUBERT SYNDROME 10; JBTS10		
Number Sign	300807	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; THPH8		DEEP VENOUS THROMBOSIS, PROTECTION AGAINST, INCLUDED
Percent	300809	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 15; SLEB15		
NULL	300813	SARCOMA, SYNOVIAL		
Number Sign	300814	NYSTAGMUS 6, CONGENITAL, X-LINKED; NYS6		
Number Sign	300815	CHROMOSOME Xq28 DUPLICATION SYNDROME		
Number Sign	300816	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	ENCEPHALOMYOPATHY, MITOCHONDRIAL, X-LINKED	
Number Sign	300818	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1; PNH1		
Percent	300829	CARDIOMYOPATHY, FATAL FETAL, DUE TO MYOCARDIAL CALCIFICATION		
Number Sign	300830	AUTISM, SUSCEPTIBILITY TO, X-LINKED 4; AUTSX4	CHROMOSOME Xp22 DELETION SYNDROME	
Number Sign	300831	CK SYNDROME	MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICAL MALFORMATION	
Number Sign	300833	46,XX SEX REVERSAL 3; SRXX3	CHROMOSOME Xq26 DUPLICATION SYNDROME;; 46,XX SEX REVERSAL, SOX3-RELATED	CHROMOSOME Xq26 DELETION SYNDROME, INCLUDED
Number Sign	300834	MACULAR DEGENERATION, X-LINKED ATROPHIC		
Number Sign	300835	ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP		
Number Sign	300842	MCLEOD SYNDROME; MCLDS	MCLEOD PHENOTYPE;; NEUROACANTHOCYTOSIS, MCLEOD TYPE	MCLEOD SYNDROME WITH CHRONIC GRANULOMATOUS DISEASE, INCLUDED
Percent	300843	BORNHOLM EYE DISEASE; BED	MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	
Number Sign	300844	MENTAL RETARDATION, X-LINKED 19; MRX19		
Number Sign	300845	MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM, AND FACIAL DYSMORPHISM; MYMY4	CHROMOSOME Xq28 DELETION SYNDROME, 3.4-KB;; SYNDROMIC MOYAMOYA DISEASE	
Number Sign	300847	AUTISM, SUSCEPTIBILITY TO, X-LINKED 5; AUTSX5		
Percent	300848	MENTAL RETARDATION, X-LINKED 89; MRX89		
Number Sign	300849	MENTAL RETARDATION, X-LINKED 41; MRX41	MENTAL RETARDATION, X-LINKED 48; MRX48	
Number Sign	300850	MENTAL RETARDATION, X-LINKED 90; MRX90		
Percent	300851	MENTAL RETARDATION, X-LINKED 92; MRX92		
Percent	300852	MENTAL RETARDATION, X-LINKED 88; MRX88		
Number Sign	300853	IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN		
Number Sign	300854	RENAL CELL CARCINOMA, Xp11-ASSOCIATED; RCCX1		
Number Sign	300855	OGDEN SYNDROME; OGDNS	N-TERMINAL ACETYLTRANSFERASE DEFICIENCY; NATD	
Percent	300856	HYPOSPADIAS 4, X-LINKED, SUSCEPTIBILITY TO; HYSP4		
Number Sign	300857	AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15		
Percent	300858	MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17	MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	
Number Sign	300860	MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN	MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	
Percent	300861	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS	MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA, AND GAIT DISTURBANCE	
Number Sign	300863	CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA		
NULL	300864	CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED		
Number Sign	300867	KABUKI SYNDROME 2; KABUK2		
Number Sign	300868	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 20; EIEE20;; GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 4; GPIBD4	
Number Sign	300869	CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME		
Percent	300870	ANEURYSM, INTRACRANIAL BERRY, 5; ANIB5		
Number Sign	300872	AUTISM, SUSCEPTIBILITY TO, X-LINKED 6; AUTSX6	EPSILON-TRIMETHYLLYSINE HYDROXYLASE DEFICIENCY; TMLHED	
Percent	300881	BARATELA-SCOTT SYNDROME		
Number Sign	300882	CORNELIA DE LANGE SYNDROME 5; CDLS5		
Number Sign	300884	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36		CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Is, INCLUDED; CDG1S, INCLUDED;; CDG Is, INCLUDED; CDGIs, INCLUDED
Number Sign	300886	MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32		
Number Sign	300887	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	APLASIA CUTIS CONGENITA, RETICULOLINEAR, WITH MICROCEPHALY, FACIAL DYSMORPHISM, AND OTHER CONGENITAL ANOMALIES; APLCC	
Number Sign	300888	HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT; CHTE		
Number Sign	300894	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5	BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;; STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD; SENDA	
Number Sign	300895	OHDO SYNDROME, X-LINKED; OHDOX	BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNER TYPE	
Number Sign	300896	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	CDG IIm; CDGIIm;; EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 22; EIEE22	
Number Sign	300905	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED DOMINANT, 6	
Number Sign	300908	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY		
Number Sign	300909	ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO; AEACEI		
Number Sign	300910	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18; BMND18	OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES, SUSCEPTIBILITY TO	
Number Sign	300911	PARKINSONISM WITH SPASTICITY, X-LINKED; XPDS		
Number Sign	300912	MENTAL RETARDATION, X-LINKED 98; MRX98		
Number Sign	300914	DEAFNESS, X-LINKED 6; DFNX6		
Number Sign	300915	MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	MAINE MICROPHTHALMOS;; COLOBOMATOUS MICROPHTHALMIA WITH MICROCEPHALY, SHORT STATURE, AND PSYCHOMOTOR RETARDATION	
Number Sign	300918	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES, X-LINKED	OLMSTED SYNDROME, X-LINKED; OLMSX	
Number Sign	300919	MENTAL RETARDATION, X-LINKED 99; MRX99		
Number Sign	300923	MENTAL RETARDATION, X-LINKED 100; MRX100		
Number Sign	300928	MENTAL RETARDATION, X-LINKED 101; MRX101		
Number Sign	300932	THYROXINE-BINDING GLOBULIN QUANTITATIVE TRAIT LOCUS; TBGQTL		
Number Sign	300934	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	CDG IY; CDGIy	
Number Sign	300942	CHROMOSOME Xq26.3 DUPLICATION SYNDROME	CHROMOSOME Xq26 MICRODUPLICATION SYNDROME;; X-LINKED ACROGIGANTISM; XLAG	
Number Sign	300943	PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA2	ACROMEGALY DUE TO PITUITARY ADENOMA 2;; ACROMEGALY, X-LINKED	
Number Sign	300946	DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14		
Number Sign	300952	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	LINEAR SKIN DEFECTS WITH CARDIOMYOPATHY AND OTHER CONGENITAL ANOMALIES	
Number Sign	300953	TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE; TTD5		
Number Sign	300957	MENTAL RETARDATION, X-LINKED 12; MRX12	MENTAL RETARDATION, X-LINKED 35; MRX35	
Number Sign	300958	MENTAL RETARDATION, X-LINKED 102; MRX102		
Number Sign	300960	MEND SYNDROME; MEND	MALE EBP DISORDER WITH NEUROLOGIC DEFECTS	
Number Sign	300963	RITSCHER-SCHINZEL SYNDROME 2; RTSC2		
Number Sign	300966	MENTAL RETARDATION, X-LINKED, SYNDROMIC 33; MRXS33		
Number Sign	300967	MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	MENTAL RETARDATION, X-LINKED, SYNDROMIC, MIRCSOF-LANGOUET TYPE; MRXSML	
Number Sign	300968	MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED; MRXS99F		
Number Sign	300971	BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT; BARTS5		
Number Sign	300972	IMMUNODEFICIENCY 47; IMD47	IMMUNODEFICIENCY AND HEPATOPATHY WITH OR WITHOUT NEUROLOGIC FEATURES	
Percent	300977	SCHOLTE SYNDROME; SHLTS	EARLY BALDING, PATELLA LUXATION, ACROMICRIA, AND HYPOGONADISM	
Number Sign	300978	MENTAL RETARDATION, X-LINKED 61; MRX61		
Number Sign	300979	Xq25 DUPLICATION SYNDROME		Xq25 TRIPLICATION SYNDROME, INCLUDED
Number Sign	300982	MENTAL RETARDATION, X-LINKED 103; MRX103		
Number Sign	300983	MENTAL RETARDATION, X-LINKED 104; MRX104		
Number Sign	300984	MENTAL RETARDATION, X-LINKED 105; MRX105		
Number Sign	300985	VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF, X-LINKED; CBAVDX		
Number Sign	300986	MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB		
Number Sign	300987	MENTAL RETARDATION, X-LINKED, SYNDROMIC, BORCK TYPE; MRXSBRK		
Number Sign	300988	IMMUNODEFICIENCY 50; IMD50	IMMUNODEFICIENCY 50, X-LINKED RECESSIVE	
Number Sign	300989	MEESTER-LOEYS SYNDROME; MRLS		
Number Sign	300990	MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN		
Number Sign	300991	CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED; CILD36	CILIARY DYSKINESIA, PRIMARY, 36, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	300997	MENTAL RETARDATION, X-LINKED 106; MRX106		
Number Sign	300998	MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35		
Number Sign	301000	WISKOTT-ALDRICH SYNDROME; WAS	WISKOTT-ALDRICH SYNDROME 1; WAS1;; ALDRICH SYNDROME;; ECZEMA-THROMBOCYTOPENIA-IMMUNODEFICIENCY SYNDROME;; IMMUNODEFICIENCY 2; IMD2	
Number Sign	301040	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE;; ATR-X SYNDROME;; ATR, NONDELETION TYPE	
Number Sign	301050	ALPORT SYNDROME, X-LINKED; ATS	NEPHROPATHY AND DEAFNESS, X-LINKED	
Number Sign	301200	AMELOGENESIS IMPERFECTA, TYPE IE; AI1E	AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;; AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;; AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;; ENAMEL HYPOPLASIA, X-LINKED	
Percent	301201	AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 2	AMELOGENESIS IMPERFECTA 3, HYPOPLASTIC TYPE, FORMERLY; AIH3, FORMERLY;; ENAMEL HYPOPLASIA, X-LINKED	
Number Sign	301220	PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR	XLPDR	
Number Sign	301310	ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA; ASAT		
NULL	301410	NEURAL TUBE DEFECTS, X-LINKED		SPINA BIFIDA, X-LINKED, INCLUDED
Number Sign	301500	FABRY DISEASE	ANGIOKERATOMA CORPORIS DIFFUSUM;; ANDERSON-FABRY DISEASE;; HEREDITARY DYSTOPIC LIPIDOSIS;; ALPHA-GALACTOSIDASE A DEFICIENCY;; GLA DEFICIENCY;; CERAMIDE TRIHEXOSIDASE DEFICIENCY	FABRY DISEASE, CARDIAC VARIANT, INCLUDED
Percent	301590	MICROPHTHALMIA, SYNDROMIC 4; MCOPS4	MICROPHTHALMIA WITH ANKYLOBLEPHARON AND MENTAL RETARDATION;; ANOP1, FORMERLY	
NULL	301700	ANOSMIA		
NULL	301790	SPINOCEREBELLAR ATAXIA, X-LINKED 3	SCAX3;; ATAXIA-DEAFNESS SYNDROME, X-LINKED	
NULL	301800	ANUS, IMPERFORATE		
NULL	301815	ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY		
Number Sign	301830	SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2	SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;; SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;; ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;; AMC, DISTAL, X-LINKED;; ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	
Number Sign	301835	ARTS SYNDROME; ARTS	MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;; ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;; MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	
NULL	301840	SPINOCEREBELLAR ATAXIA, X-LINKED 4	SCAX4;; ATAXIA-DEMENTIA SYNDROME, X-LINKED	
Percent	301845	BAZEX SYNDROME; BZX	BAZEX-DUPRE-CHRISTOL SYNDROME; BDCS;; FOLLICULAR ATROPHODERMA AND BASAL CELL CARCINOMAS	
NULL	301850	TUBULIN, BETA		
Number Sign	301900	BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	MENTAL RETARDATION, X-LINKED, SYNDROMIC, BORJESON-FORSSMAN-LEHMANN TYPE; MRXSBFL;; BORJESON SYNDROME; BORJ;; MENTAL RETARDATION, EPILEPSY, AND ENDOCRINE DISORDERS	
NULL	301940	BRACHYDACTYLY, MONONEN TYPE	THUMBS AND GREAT TOES, SHORT AND ABDUCTED	
NULL	301950	BRANCHIAL ARCH SYNDROME, X-LINKED	MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	
Percent	302000	BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	EPIDERMOLYSIS BULLOSA, MACULAR TYPE; EBM	
NULL	302030	CALVARIAL HYPEROSTOSIS		
Number Sign	302045	CARDIOMYOPATHY, DILATED, 3B; CMD3B	CARDIOMYOPATHY, DILATED, X-LINKED; XLCM	
Number Sign	302060	BARTH SYNDROME; BTHS	CARDIOSKELETAL MYOPATHY WITH NEUTROPENIA AND ABNORMAL MITOCHONDRIA;; 3-METHYLGLUTACONIC ACIDURIA, TYPE II; MGCA2;; MGA, TYPE II; MGA2	
Number Sign	302200	CATARACT 40; CTRCT40	CATARACT 40 WITH OR WITHOUT MICROCORNEA;; CATARACT, CONGENITAL, X-LINKED; CXN;; CATARACT, CONGENITAL TOTAL, WITH POSTERIOR SUTURAL OPACITIES IN HETEROZYGOTES; CCT	
Number Sign	302350	NANCE-HORAN SYNDROME; NHS	CATARACT-DENTAL SYNDROME;; CATARACT, X-LINKED, WITH HUTCHINSONIAN TEETH;; MESIODENS-CATARACT SYNDROME	
NULL	302400	CENTRAL INCISORS, ABSENCE OF		
Number Sign	302500	SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	OLIVOPONTOCEREBELLAR ATROPHY, X-LINKED;; OPCA, X-LINKED; OPCAX	
NULL	302600	SPINOCEREBELLAR ATAXIA, X-LINKED 2	SCAX2;; CEREBELLAR ATAXIA WITH EXTRAPYRAMIDAL INVOLVEMENT, EARLY-ONSET	
NULL	302700	CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE		
Number Sign	302800	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1	CMTX;; CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;; HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;; HMSN, X-LINKED;; CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;; CMT2, FORMERLY	
Percent	302801	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2; CMTX2	CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED RECESSIVE, 2	
Percent	302802	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED RECESSIVE, 3	
NULL	302803	CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED, WITH APLASIA CUTIS CONGENITA		
NULL	302900	CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA, COMBINED		
Number Sign	302905	ABRUZZO-ERICKSON SYNDROME; ABERS	CHARGE-LIKE SYNDROME, X-LINKED	
Number Sign	302950	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1	CPXR;; CHONDRODYSPLASIA PUNCTATA, BRACHYTELEPHALANGIC	
Number Sign	302960	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	CDPXD; CPXD;; CONRADI-HUNERMANN SYNDROME;; HAPPLE SYNDROME;; CONRADI-HUNERMANN-HAPPLE SYNDROME	
Number Sign	303100	CHOROIDEREMIA; CHM	TAPETOCHOROIDAL DYSTROPHY, PROGRESSIVE; TCD	CHOROIDAL SCLEROSIS, INCLUDED
Number Sign	303110	CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION	CHROMOSOME Xq21 DELETION SYNDROME	
Number Sign	303350	MASA SYNDROME	MENTAL RETARDATION, APHASIA, SHUFFLING GAIT, AND ADDUCTED THUMBS;; SPASTIC PARAPLEGIA 1, X-LINKED; SPG1;; CLASPED THUMB AND MENTAL RETARDATION;; THUMB, CONGENITAL CLASPED, WITH MENTAL RETARDATION;; ADDUCTED THUMB WITH MENTAL RETARDATION;; GAREIS-MASON SYNDROME;; CRASH SYNDROME	
Number Sign	303400	CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED; CPX		
Number Sign	303600	COFFIN-LOWRY SYNDROME; CLS		
NULL	303650	COLONIC ATRESIA		
Number Sign	303700	BLUE CONE MONOCHROMACY; BCM	BLUE CONE MONOCHROMATISM;; COLORBLINDNESS, BLUE-MONO-CONE-MONOCHROMATIC TYPE; CBBM	CONE DYSTROPHY 5, X-LINKED, INCLUDED; COD5, INCLUDED
Number Sign	303800	COLORBLINDNESS, PARTIAL, DEUTAN SERIES; CBD	DEUTAN COLORBLINDNESS; DCB;; DEUTERANOPIA;; GREEN COLORBLINDNESS	DEUTERANOMALY, INCLUDED
Number Sign	303900	COLORBLINDNESS, PARTIAL, PROTAN SERIES; CBP	PROTANOPIA;; RED COLORBLINDNESS	PROTANOMALY, INCLUDED
Number Sign	304020	CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	CONE DYSTROPHY 1, X-LINKED; COD1	
NULL	304030	CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN		
Percent	304050	AICARDI SYNDROME; AIC	CORPUS CALLOSUM, AGENESIS OF, WITH CHORIORETINAL ABNORMALITY	
Number Sign	304100	CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED		
Number Sign	304110	CRANIOFRONTONASAL SYNDROME; CFNS	CRANIOFRONTONASAL DYSPLASIA; CFND;; CRANIOFRONTONASAL DYSOSTOSIS	
Number Sign	304120	OTOPALATODIGITAL SYNDROME, TYPE II; OPD2	OPD II SYNDROME;; OPD SYNDROME 2;; CRANIOORODIGITAL SYNDROME;; FACIOPALATOOSSEOUS SYNDROME; FPO	
Number Sign	304150	OCCIPITAL HORN SYNDROME; OHS	CUTIS LAXA, X-LINKED, FORMERLY;; EHLERS-DANLOS SYNDROME, OCCIPITAL HORN TYPE, FORMERLY;; EDS IX, FORMERLY;; EDS9, FORMERLY	
NULL	304200	CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION		
NULL	304300	CYANIDE, INABILITY TO SMELL		
Number Sign	304340	PETTIGREW SYNDROME; PGS	MENTAL RETARDATION, X-LINKED, SYNDROMIC 5; MRXS5;; MENTAL RETARDATION, X-LINKED, WITH DANDY-WALKER MALFORMATION, BASAL GANGLIA DISEASE, AND SEIZURES;; MENTAL RETARDATION, X-LINKED, SYNDROMIC, FRIED TYPE; MRXSF;; MENTAL RETARDATION, X-LINKED 59; MRX59;; MENTAL RETARDATION, X-LINKED, SYNDROMIC 21; MRXS21	
NULL	304350	DEAFNESS-HYPOGONADISM SYNDROME	DHS	
Number Sign	304400	DEAFNESS, X-LINKED 2; DFNX2	DEAFNESS, CONDUCTIVE, WITH STAPES FIXATION;; DEAFNESS 3, CONDUCTIVE, WITH STAPES FIXATION; DFN3;; PERILYMPHATIC GUSHER-DEAFNESS SYNDROME;; DEAFNESS, MIXED, WITH PERILYMPHATIC GUSHER;; NANCE DEAFNESS;; SENSORINEURAL DEAFNESS, PROFOUND, WITH OR WITHOUT A CONDUCTIVE COMPONENT, ASSOCIATED WITH A UNIQUE DEVELOPMENTAL ABNORMALITY OF THE EAR	
Number Sign	304500	DEAFNESS, X-LINKED 1; DFNX1	DEAFNESS, X-LINKED 2, SENSORINEURAL CONGENITAL; DFN2	
Number Sign	304700	MOHR-TRANEBJAERG SYNDROME; MTS	DYSTONIA-DEAFNESS SYNDROME; DDS;; DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;; DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES, AND MENTAL DEFICIENCY;; OPTICOACOUSTIC NERVE ATROPHY WITH DEMENTIA;; JENSEN SYNDROME	
Percent	304730	DERMOIDS OF CORNEA; CND		
Number Sign	304790	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	X-LINKED AUTOIMMUNITY-ALLERGIC DYSREGULATION SYNDROME; XLAAD;; IDDM-SECRETORY DIARRHEA SYNDROME; DMSD;; AUTOIMMUNITY-IMMUNODEFICIENCY SYNDROME, X-LINKED;; DIARRHEA, POLYENDOCRINOPATHY, FATAL INFECTION SYNDROME, X-LINKED;; ENTEROPATHY, AUTOIMMUNE, WITH HEMOLYTIC ANEMIA AND POLYENDOCRINOPATHY;; POLYENDOCRINOPATHY, IMMUNE DYSFUNCTION, AND DIARRHEA, X-LINKED; XPID;; DIABETES MELLITUS, CONGENITAL INSULIN-DEPENDENT, WITH FATAL SECRETORY DIARRHEA;; IMMUNODEFICIENCY, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED, FORMERLY	ISLETS OF LANGERHANS, ABSENCE OF, INCLUDED
Number Sign	304800	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	NDI;; DIABETES INSIPIDUS, NEPHROGENIC, TYPE I	
NULL	304900	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE		
NULL	304950	DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED		
Number Sign	305000	DYSKERATOSIS CONGENITA, X-LINKED; DKCX	ZINSSER-COLE-ENGMAN SYNDROME	HOYERAAL-HREIDARSSON SYNDROME, INCLUDED; HHS, INCLUDED;; CEREBELLAR HYPOPLASIA WITH PANCYTOPENIA, INCLUDED;; GROWTH RETARDATION, PRENATAL, WITH PROGRESSIVE PANCYTOPENIA AND CEREBELLAR HYPOPLASIA, INCLUDED
Number Sign	305100	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC/HAIR/TOOTH TYPE, X-LINKED; ECTD1;; XLHED;; ECTODERMAL DYSPLASIA, ANHIDROTIC, X-LINKED; EDA;; EDA1;; ECTODERMAL DYSPLASIA, HYPOHIDROTIC, 1; HED1;; ECTODERMAL DYSPLASIA 1; ED1;; CHRIST-SIEMENS-TOURAINE SYNDROME;; CST SYNDROME	
Percent	305200	EHLERS-DANLOS SYNDROME, TYPE V	EDS5;; EDS V	
NULL	305350	EPIDERMODYSPLASIA VERRUCIFORMIS, X-LINKED; EDVX; EDV2		
Number Sign	305390	EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2	EXUDATIVE VITREORETINOPATHY, FAMILIAL, 2;; EVRX;; FEVR, X-LINKED; FEVRX	
Number Sign	305400	AARSKOG-SCOTT SYNDROME; AAS	FACIOGENITAL DYSPLASIA; FGDY;; FACIODIGITOGENITAL SYNDROME;; AARSKOG SYNDROME, X-LINKED	FACIOGENITAL DYSPLASIA WITH ATTENTION DEFICIT-HYPERACTIVITY DISORDER, INCLUDED;; MENTAL RETARDATION, X-LINKED, SYNDROMIC 16, INCLUDED; MRXS16, INCLUDED
Percent	305435	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HBFQTL3	F-CELL PRODUCTION, X-LINKED; FCPX;; HETEROCELLULAR HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, SWISS TYPE;; HPFH, SWISS TYPE	
Number Sign	305450	OPITZ-KAVEGGIA SYNDROME; OKS	FG SYNDROME 1; FGS1;; FG SYNDROME; FGS;; MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA, AND PARTIAL AGENESIS OF CORPUS CALLOSUM;; KELLER SYNDROME	
NULL	305550	FINGERPRINT BODY MYOPATHY		
Number Sign	305600	FOCAL DERMAL HYPOPLASIA; FDH	FODH; DHOF;; GOLTZ SYNDROME;; GOLTZ-GORLIN SYNDROME	
Number Sign	305620	FRONTOMETAPHYSEAL DYSPLASIA 1; FMD1	FMD	
NULL	305690	GENITOURINARY TRACT ANOMALIES		
NULL	305700	SPERMATOGENIC FAILURE, X-LINKED, 1; SPGFX1	SERTOLI CELL-ONLY SYNDROME;; GERMINAL CELL APLASIA;; DEL CASTILLO SYNDROME	
NULL	305800	MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	MESANGIOCAPILLARY GLOMERULONEPHRITIS, X-LINKED	
NULL	305920	GLUTAMYL RIBOSE-5-PHOSPHATE STORAGE DISEASE	ADP-RIBOSE PROTEIN HYDROLASE DEFICIENCY	
Number Sign	306000	GLYCOGEN STORAGE DISEASE IXa1; GSD9A1	LIVER GLYCOGENOSIS, X-LINKED, TYPE I; XLG1;; GLYCOGEN STORAGE DISEASE VIII, FORMERLY;; GSD VIII, FORMERLY; GSD8, FORMERLY	GLYCOGEN STORAGE DISEASE IXa2, INCLUDED; GSD9A2, INCLUDED;; GSD IXa2, INCLUDED;; LIVER GLYCOGENOSIS, X-LINKED, TYPE II, INCLUDED; XLG2, INCLUDED
NULL	306300	GRANULOMAS, CONGENITAL CEREBRAL		
Number Sign	306400	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	CGD;; CYTOCHROME b-NEGATIVE GRANULOMATOUS DISEASE, CHRONIC, X-LINKED;; CHRONIC GRANULOMATOUS DISEASE, X-LINKED	CYTOCHROME b-POSITIVE GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, INCLUDED;; GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, VARIANT, INCLUDED;; CHRONIC GRANULOMATOUS DISEASE, ATYPICAL, INCLUDED
Number Sign	306700	HEMOPHILIA A; HEMA	HEMOPHILIA, CLASSIC	
NULL	306800	HEMOPHILIA A WITH VASCULAR ABNORMALITY		
Number Sign	306900	HEMOPHILIA B; HEMB	CHRISTMAS DISEASE;; FACTOR IX DEFICIENCY;; F9 DEFICIENCY;; PLASMA THROMBOPLASTIN COMPONENT DEFICIENCY	HEMOPHILIA B(M), INCLUDED;; HEMOPHILIA B LEYDEN, INCLUDED
NULL	306930	HEMOPOIETIC PROLIFERATION		
NULL	306950	HERNIA, ANTERIOR DIAPHRAGMATIC		
Number Sign	306955	HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	DEXTROCARDIA WITH OTHER CARDIAC MALFORMATIONS;; LATERALITY, X-LINKED;; SITUS INVERSUS, COMPLEX CARDIAC DEFECTS, AND SPLENIC DEFECTS, X-LINKED	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 1, X-LINKED, INCLUDED; CHTD1, INCLUDED
Percent	306960	HHHH SYNDROME	HEREDITARY HEMIHYPOTROPHY HEMIPARESIS HEMIATHETOSIS SYNDROME	
NULL	306980	HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY		
NULL	306990	HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE		
NULL	306995	HOMOSEXUALITY 1; HMS1	SEXUAL ORIENTATION, MALE	
Number Sign	307000	HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS; HSAS	HSAS1;; HYDROCEPHALUS, X-LINKED; HYCX;; AQUEDUCTAL STENOSIS, X-LINKED; XLAS	HYDROCEPHALUS, X-LINKED, WITH CONGENITAL IDIOPATHIC INTESTINAL PSEUDOOBSTRUCTION, INCLUDED
NULL	307010	HYDROCEPHALUS WITH CEREBELLAR AGENESIS		
Number Sign	307030	GLYCEROL KINASE DEFICIENCY; GKD	GK DEFICIENCY;; GK1 DEFICIENCY;; HYPERGLYCEROLEMIA	
Number Sign	307150	HYPERTRICHOSIS, CONGENITAL GENERALIZED; HTC2	CHROMOSOME Xq27.1 INTERCHROMOSOMAL INSERTION SYNDROME;; CGH;; HCG	
Number Sign	307200	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3	IGHD III;; GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;; HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;; AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;; FLEISHER SYNDROME	
NULL	307500	HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES		
Percent	307700	HYPOPARATHYROIDISM, X-LINKED; HYPX	PARATHYROID GLANDS, AGENESIS OF	
Number Sign	307800	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR	HYPOPHOSPHATEMIA, X-LINKED; XLH;; HYP;; VITAMIN D-RESISTANT RICKETS, X-LINKED;; HYPOPHOSPHATEMIC VITAMIN D-RESISTANT RICKETS; HPDR	
NULL	307830	HYPOURICEMIA, FAMILIAL RENAL, DUE TO TUBULAR HYPERSECRETION		
Number Sign	308050	CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	CHILD SYNDROME;; ICHTHYOSIFORM ERYTHRODERMA, UNILATERAL, WITH IPSILATERAL MALFORMATIONS, ESPECIALLY ABSENCE DEFORMITY OF LIMBS	
Number Sign	308100	ICHTHYOSIS, X-LINKED; XLI	STEROID SULFATASE DEFICIENCY;; STS DEFICIENCY;; PLACENTAL STEROID SULFATASE DEFICIENCY;; STEROID SULFATASE DEFICIENCY DISEASE; SSDD	ICHTHYOSIS, X-LINKED, COMPLICATED, INCLUDED
NULL	308200	ICHTHYOSIS AND MALE HYPOGONADISM		RUD SYNDROME, INCLUDED;; RUDS, INCLUDED
Number Sign	308205	IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	ICHTHYOSIS FOLLICULARIS, ATRICHIA, AND PHOTOPHOBIA WITH OR WITHOUT BRAIN ANOMALIES, RETARDATION, ECTODERMAL DYSPLASIA, SKELETAL MALFORMATIONS, HIRSCHSPRUNG DISEASE, EAR/EYE ANOMALIES, CLEFT PALATE/CRYPTORCHIDISM, AND KIDNEY DYSPLASIA/HYPOPLASIA	
NULL	308220	IMMUNODEFICIENCY, X-LINKED, WITH DEFICIENCY OF 115,000 DALTON SURFACE GLYCOPROTEIN	GPL115 DEFICIENCY	
Number Sign	308230	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1; HIGM1	HYPER-IgM IMMUNODEFICIENCY, X-LINKED; XHIM;; HYPER-IgM SYNDROME 1;; HYPER-IgM SYNDROME; HIGM; IHIS;; IMMUNODEFICIENCY 3; IMD3	
Number Sign	308240	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	XLP;; LYMPHOPROLIFERATIVE DISEASE, X-LINKED; XLPD;; LYP;; DUNCAN DISEASE;; EPSTEIN-BARR VIRUS INFECTION, FAMILIAL FATAL;; EBV INFECTION, SEVERE, SUSCEPTIBILITY TO; EBVS;; INFECTIOUS MONONUCLEOSIS, SEVERE, SUSCEPTIBILITY TO;; IMMUNODEFICIENCY, X-LINKED PROGRESSIVE COMBINED VARIABLE;; IMMUNODEFICIENCY 5; IMD5;; PURTILO SYNDROME	
Percent	308250	IMMUNOGLOBULIN M, LEVEL OF		
Percent	308280	IMPACTED TEETH, MULTIPLE		
NULL	308290	IMPRINTING GENE RELATED TO RETINOBLASTOMA		
Number Sign	308300	INCONTINENTIA PIGMENTI; IP	INCONTINENTIA PIGMENTI, FAMILIAL MALE-LETHAL TYPE;; BLOCH-SULZBERGER SYNDROME;; INCONTINENTIA PIGMENTI, TYPE II, FORMERLY; IP2, FORMERLY	
Number Sign	308350	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	INFANTILE SPASM SYNDROME, X-LINKED 1; ISSX1;; WEST SYNDROME, X-LINKED;; OHTAHARA SYNDROME, X-LINKED;; INFANTILE EPILEPTIC-DYSKINETIC ENCEPHALOPATHY;; XMESID	
NULL	308500	IRIS HYPOPLASIA WITH GLAUCOMA; IHG		
NULL	308600	JAUNDICE, FAMILIAL OBSTRUCTIVE, OF INFANCY		
Number Sign	308700	HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	KALLMANN SYNDROME 1; KAL1;; KMS;; HYPOGONADOTROPIC HYPOGONADISM AND ANOSMIA; HHA;; DYSPLASIA OLFACTOGENITALIS OF DE MORSIER;; ANOSMIC HYPOGONADISM	
NULL	308750	KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	SPASTIC PARAPLEGIA-KALLMANN SYNDROME	
Number Sign	308800	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS CUM OPHIASI	
NULL	308830	KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY		
NULL	308850	LARYNGEAL ABDUCTOR PARALYSIS	VOCAL CORD DYSFUNCTION, FAMILIAL;; PLOTT SYNDROME	
Percent	308905	LEBER OPTIC ATROPHY, SUSCEPTIBILITY TO	LOAS;; LEBER HEREDITARY OPTIC NEUROPATHY, MODIFIER OF;; LHON, MODIFIER OF	
Number Sign	308940	LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS	LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;; ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;; CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	
NULL	308950	LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT		
NULL	308960	LEUKEMIA, ACUTE, ?X-LINKED		
Number Sign	308990	PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS		
Number Sign	309000	LOWE OCULOCEREBRORENAL SYNDROME; OCRL	OCRL1;; LOWE SYNDROME;; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 5-PHOSPHATASE DEFICIENCY	
NULL	309050	LUTHERAN SUPPRESSOR, X-LINKED; XS	LUXS	
Percent	309100	MACULAR DYSTROPHY, X-LINKED		
Number Sign	309120	SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	MALE INFERTILITY FROM DEFECT IN MEIOSIS	
Percent	309200	MAJOR AFFECTIVE DISORDER 2; MAFD2	MANIC-DEPRESSIVE ILLNESS; MDI;; MANIC-DEPRESSIVE PSYCHOSIS, X-LINKED; MDX;; BIPOLAR AFFECTIVE DISORDER; BPAD	
Number Sign	309300	MEGALOCORNEA; MGC1	MGCN	
Number Sign	309350	MELNICK-NEEDLES SYNDROME; MNS	MELNICK-NEEDLES OSTEODYSPLASTY;; OSTEODYSPLASTY OF MELNICK AND NEEDLES	
Number Sign	309400	MENKES DISEASE	MK; MNK;; MENKES SYNDROME;; KINKY HAIR DISEASE;; STEELY HAIR DISEASE;; COPPER TRANSPORT DISEASE	
NULL	309480	MENTAL RETARDATION AND PSORIASIS		
Number Sign	309500	RENPENNING SYNDROME 1; RENS1	MENTAL RETARDATION, X-LINKED, RENPENNING TYPE;; SUTHERLAND-HAAN X-LINKED MENTAL RETARDATION SYNDROME; SHS;; GOLABI-ITO-HALL SYNDROME;; MENTAL RETARDATION, X-LINKED, WITH SPASTIC DIPLEGIA;; MENTAL RETARDATION, X-LINKED, SYNDROMIC 3; MRXS3;; MENTAL RETARDATION, X-LINKED, SYNDROMIC 8; MRXS8;; MENTAL RETARDATION, X-LINKED 55; MRX55	
Number Sign	309510	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS	PARTINGTON SYNDROME;; MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;; MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, AND SEIZURES;; MENTAL RETARDATION, X-LINKED 36; MRX36	
Number Sign	309520	LUJAN-FRYNS SYNDROME	MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	
Number Sign	309530	MENTAL RETARDATION, X-LINKED 1; MRX1	MRX;; MENTAL RETARDATION, X-LINKED 18; MRX18;; MENTAL RETARDATION, X-LINKED 78; MRX78	
Number Sign	309541	METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	MENTAL RETARDATION, X-LINKED 3; MRX3	
Percent	309545	MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12		
Number Sign	309548	MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE	FRAXE MENTAL RETARDATION SYNDROME	
Number Sign	309549	MENTAL RETARDATION, X-LINKED 9; MRX9	MENTAL RETARDATION, X-LINKED 44; MRX44	
Percent	309555	MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	GUSTAVSON SYNDROME; GUST	
Percent	309560	MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS		
Number Sign	309580	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	SMITH-FINEMAN-MYERS SYNDROME 1; SFM1;; SFMS;; XLMR-HYPOTONIC FACIES SYNDROME;; CARPENTER-WAZIRI SYNDROME;; CHUDLEY-LOWRY SYNDROME;; JUBERG-MARSIDI SYNDROME; JMS;; HOLMES-GANG SYNDROME;; MENTAL RETARDATION, X-LINKED, WITH GROWTH RETARDATION, DEAFNESS, AND MICROGENITALISM	
Number Sign	309583	MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE; MRXSSR	SNYDER-ROBINSON MENTAL RETARDATION SYNDROME; SRS	
Number Sign	309585	WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	MENTAL RETARDATION, X-LINKED, SYNDROMIC 6; MRXS6;; MENTAL RETARDATION, X-LINKED, WITH GYNECOMASTIA AND OBESITY	
Percent	309610	PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	MENTAL RETARDATION, X-LINKED, SYNDROMIC 2; MRXS2;; MENTAL RETARDATION, X-LINKED, WITH DYSMORPHISM AND CEREBRAL ATROPHY	
Percent	309620	MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD	CHRISTIAN SYNDROME; CHRS	
Number Sign	309630	METACARPAL 4-5 FUSION; MF4		
NULL	309640	MENTAL RETARDATION WITH SPASTIC PARAPLEGIA		
Number Sign	309800	MICROPHTHALMIA, SYNDROMIC 1; MCOPS1	LENZ MICROPHTHALMIA SYNDROME;; LENZ DYSPLASIA;; MAA, FORMERLY	
Number Sign	309801	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1; LSDMCA1	MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;; MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;; MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;; MIDAS SYNDROME	
NULL	309840	MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	TOURETTE SYNDROME, MODIFIER OF	
Number Sign	309900	MUCOPOLYSACCHARIDOSIS, TYPE II; MPS2	MPS II;; HUNTER SYNDROME;; IDURONATE 2-SULFATASE DEFICIENCY;; IDS DEFICIENCY;; SULFOIDURONATE SULFATASE DEFICIENCY;; SIDS DEFICIENCY	
NULL	309930	MUSCULAR DYSTROPHY, CARDIAC TYPE		
NULL	309950	MUSCULAR DYSTROPHY, HEMIZYGOUS LETHAL TYPE		
NULL	310000	MUSCULAR DYSTROPHY, MABRY TYPE		
NULL	310095	MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL	MUSCULAR DYSTROPHY, PROGRESSIVE, INVOLVING SHOULDER GIRDLE AND BACK	
Number Sign	310200	MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	DUCHENNE MUSCULAR DYSTROPHY;; MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE TYPE	
Number Sign	310300	EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	EMD1;; MUSCULAR DYSTROPHY, TARDIVE, DREIFUSS-EMERY TYPE, WITH CONTRACTURES;; SCAPULOPERONEAL SYNDROME, X-LINKED, FORMERLY;; HUMEROPERONEAL NEUROMUSCULAR DISEASE, FORMERLY	
NULL	310350	MYELOLYMPHATIC INSUFFICIENCY	PELGER-LIKE ANOMALY WITH LEUKOPENIA AND SUSCEPTIBILITY TO INFECTIONS	
NULL	310370	MYOCLONIC EPILEPSY, PROGRESSIVE		
Number Sign	310400	MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	MYOTUBULAR MYOPATHY, X-LINKED; MTMX; XLMTM;; MYOTUBULAR MYOPATHY 1; MTM1	
Number Sign	310440	MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX	XMEA	
Percent	310460	MYOPIA 1, X-LINKED; MYP1		
NULL	310465	N SYNDROME; NSX		
Number Sign	310468	NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN	NEPHROLITHIASIS, X-LINKED RECESSIVE, TYPE 1;; UROLITHIASIS, X-LINKED RECESSIVE, TYPE 1;; NEPHROLITHIASIS 1; NPHL1	
NULL	310470	NEUROPATHY, HEREDITARY SENSORY, X-LINKED		
Number Sign	310490	COWCHOCK SYNDROME; COWCK	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 4; CMTX4;; CHARCOT-MARIE-TOOTH DISEASE WITH DEAFNESS AND MENTAL RETARDATION;; NEUROPATHY, AXONAL MOTOR-SENSORY, WITH DEAFNESS AND MENTAL RETARDATION; NAMSD;; NADMR	
Number Sign	310500	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A	CSNB, COMPLETE, X-LINKED;; NIGHT BLINDNESS, CONGENITAL STATIONARY, WITH MYOPIA;; HEMERALOPIA-MYOPIA;; MYOPIA-NIGHT BLINDNESS; NBM1	NYCTALOPIA, INCLUDED
Number Sign	310600	NORRIE DISEASE; ND	ATROPHIA BULBORUM HEREDITARIA;; EPISKOPI BLINDNESS	
NULL	310650	NUCLEAR RIBONUCLEIC ACID; nRNA		
Number Sign	310700	NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	NYSTAGMUS, CONGENITAL MOTOR, 1;; NYSTAGMUS 1, INFANTILE, X-LINKED;; NYSTAGMUS, INFANTILE IDIOPATHIC, FORMERLY; IIN, FORMERLY	NYSTAGMUS, INFANTILE PERIODIC ALTERNATING, X-LINKED, INCLUDED; XIPAN, INCLUDED;; XLPAN, INCLUDED
NULL	310800	NYSTAGMUS, MYOCLONIC		
NULL	310900	OCCIPITAL HAIR, WHITE LOCK OF		
NULL	310980	OMPHALOCELE, X-LINKED		
Percent	311000	OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA; OPEM	MYOPIA-OPHTHALMOPLEGIA SYNDROME	
Percent	311050	OPTIC ATROPHY 2; OPA2	OPTIC ATROPHY, X-LINKED;; OPTIC ATROPHY, NON-LEBER TYPE, WITH EARLY ONSET	
Number Sign	311070	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5; CMTX5	OPTIC ATROPHY, POLYNEUROPATHY, AND DEAFNESS;; ROSENBERG-CHUTORIAN SYNDROME;; CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED RECESSIVE, 5	
NULL	311100	OPTIC ATROPHY--SPASTIC PARAPLEGIA SYNDROME		
Number Sign	311200	OROFACIODIGITAL SYNDROME I; OFD1	ORAL-FACIAL-DIGITAL SYNDROME, TYPE I;; OFDS I;; PAPILLON-LEAGE AND PSAUME SYNDROME	
Number Sign	311250	ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO	ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;; OTC DEFICIENCY	VALPROATE SENSITIVITY, INCLUDED
Number Sign	311300	OTOPALATODIGITAL SYNDROME, TYPE I; OPD1	OPD I SYNDROME;; OPD SYNDROME 1	OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;; FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED
NULL	311350	OUABAIN RESISTANCE; OUBR		
Number Sign	311360	PREMATURE OVARIAN FAILURE 1; POF1	PREMATURE OVARIAN FAILURE, X-LINKED; POFX;; HYPERGONADOTROPIC OVARIAN FAILURE, X-LINKED;; OVARIAN FAILURE, PREMATURE; POF;; PRIMARY OVARIAN INSUFFICIENCY, FRAGILE X-ASSOCIATED;; FRAGILE X PREMATURE OVARIAN FAILURE	
NULL	311400	PAINE SYNDROME	MICROCEPHALY WITH SPASTIC DIPLEGIA	SEEMANOVA SYNDROME I, INCLUDED
NULL	311450	PALLISTER W SYNDROME	W SYNDROME	
Number Sign	311510	WAISMAN SYNDROME; WSMN	PARKINSONISM, EARLY-ONSET, WITH MENTAL RETARDATION;; BASAL GANGLION DISORDER WITH MENTAL RETARDATION; BGMR;; WSN	
NULL	311895	PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES		
Number Sign	311900	TARP SYNDROME; TARPS	TALIPES EQUINOVARUS, ATRIAL SEPTAL DEFECT, ROBIN SEQUENCE, AND PERSISTENCE OF LEFT SUPERIOR VENA CAVA;; PIERRE ROBIN SYNDROME WITH CONGENITAL HEART MALFORMATION AND CLUBFOOT	
Number Sign	312000	PANHYPOPITUITARISM, X-LINKED; PHPX	PITUITARY DWARFISM IV, FORMERLY	
Number Sign	312060	PROPERDIN DEFICIENCY, X-LINKED; CFPD	PROPERDIN P FACTOR DEFICIENCY; PFD;; COMPLEMENT FACTOR PROPERDIN DEFICIENCY;; PROPERDIN DEFICIENCY, TYPE I	PROPERDIN DEFICIENCY, TYPE II, INCLUDED;; PROPERDIN DEFICIENCY, TYPE III, INCLUDED
Number Sign	312080	PELIZAEUS-MERZBACHER DISEASE; PMD	LEUKODYSTROPHY, HYPOMYELINATING, 1; HLD1	
Percent	312150	MULTIPLE PTERYGIUM SYNDROME, X-LINKED	PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	
Number Sign	312170	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY;; PYRUVATE DECARBOXYLASE DEFICIENCY;; ATAXIA, INTERMITTENT, WITH ABNORMAL PYRUVATE METABOLISM;; PDH DEFICIENCY;; ATAXIA, INTERMITTENT, WITH PYRUVATE DEHYDROGENASE DEFICIENCY;; ATAXIA WITH LACTIC ACIDOSIS I	LACTIC ACIDEMIA, THIAMINE-RESPONSIVE, INCLUDED
NULL	312190	RADIAL APLASIA, X-LINKED	RADIAL APLASIA AND ANOGENITAL ANOMALIES	
NULL	312200	RADIAL LOOP, PLAIN, ON RIGHT INDEX FINGER		
NULL	312210	RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	X-RAY NK SENSITIVITY; XNKS	
Number Sign	312300	ANDROGEN INSENSITIVITY, PARTIAL; PAIS	REIFENSTEIN SYNDROME;; ANDROGEN INSENSITIVITY, PARTIAL, WITH OR WITHOUT BREAST CANCER;; FAMILIAL INCOMPLETE MALE PSEUDOHERMAPHRODITISM, TYPE 1	
Percent	312500	RETICULOENDOTHELIOSIS, X-LINKED		
NULL	312550	RETINAL DYSPLASIA, PRIMARY; PRD		
Number Sign	312600	RETINITIS PIGMENTOSA 2; RP2		
Percent	312612	RETINITIS PIGMENTOSA 6; RP6	RETINITIS PIGMENTOSA, X-LINKED RECESSIVE, 6	
Number Sign	312700	RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	XLRS1;; RS	
Number Sign	312750	RETT SYNDROME; RTT	RTS;; AUTISM, DEMENTIA, ATAXIA, AND LOSS OF PURPOSEFUL HAND USE	RETT SYNDROME, ZAPPELLA VARIANT, INCLUDED;; RETT SYNDROME, PRESERVED SPEECH VARIANT, INCLUDED;; RETT SYNDROME, ATYPICAL, INCLUDED
NULL	312780	RUSSELL-SILVER SYNDROME, X-LINKED	RUSSELL-SILVER-LIKE SYNDROME WITH SKIN PIGMENTATION;; PARTINGTON SYNDROME	
NULL	312830	SCARF SYNDROME	SKELETAL ABNORMALITIES, CUTIS LAXA, CRANIOSTENOSIS, AMBIGUOUS GENITALIA, RETARDATION, AND FACIAL ABNORMALITIES	
NULL	312840	SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	CHOREOATHETOSIS WITH MENTAL RETARDATION, X-LINKED	
Number Sign	312863	COMBINED IMMUNODEFICIENCY, X-LINKED; CIDX	XCID;; IMMUNODEFICIENCY 6; IMD6	
Number Sign	312870	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; SGBS1	SGBS;; BULLDOG SYNDROME;; DYSPLASIA GIGANTISM SYNDROME, X-LINKED; DGSX;; GOLABI-ROSEN SYNDROME;; SIMPSON DYSMORPHIA SYNDROME; SDYS	
NULL	312910	SPASTIC PARAPARESIS AND DEAFNESS		
Number Sign	312920	SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	SPPX2	
Percent	313000	SPATIAL VISUALIZATION, APTITUDE FOR	VISUOSPATIAL/PERCEPTUAL ABILITIES; VSPA	TURNER SYNDROME-ASSOCIATED NEUROCOGNITIVE PHENOTYPE, INCLUDED
Number Sign	313200	SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1; SMAX1	SPINAL AND BULBAR MUSCULAR ATROPHY; SBMA;; KENNEDY DISEASE; KD;; KENNEDY SPINAL AND BULBAR MUSCULAR ATROPHY;; BULBOSPINAL MUSCULAR ATROPHY, X-LINKED;; BULBOSPINAL NEURONOPATHY, X-LINKED RECESSIVE; XBSN	
Percent	313350	SPLIT-HAND/FOOT MALFORMATION 2; SHFM2	SPLIT-HAND/SPLIT-FOOT ANOMALY, X-LINKED;; SPLIT-HAND/FOOT DEFORMITY 2; SHFD2;; SHSF2	
Number Sign	313400	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT	SED TARDA, X-LINKED;; SPONDYLOEPIPHYSEAL DYSPLASIA, LATE	
Percent	313420	SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	SPONDYLOMETAPHYSEAL DYSPLASIA, RICHMOND TYPE	
NULL	313480	TaqI POLYMORPHISM; TAQ1		
NULL	313490	TAURODONTISM, MICRODONTIA, AND DENS INVAGINATUS		
Number Sign	313500	TOOTH AGENESIS, SELECTIVE, X-LINKED, 1; STHAGX1	HYPODONTIA/OLIGODONTIA, X-LINKED, 1	
Percent	313850	THORACOABDOMINAL SYNDROME; THAS	TAS	MIDLINE DEFECTS, X-LINKED, INCLUDED;; PENTALOGY OF CANTRELL, INCLUDED
Number Sign	313900	THROMBOCYTOPENIA 1; THC1	THC;; THROMBOCYTOPENIA, X-LINKED; XLT;; THROMBOCYTOPENIA, X-LINKED, 1	THROMBOCYTOPENIA, X-LINKED, INTERMITTENT, INCLUDED
NULL	314000	THROMBOCYTOPENIA WITH ELEVATED SERUM IgA AND RENAL DISEASE		
Number Sign	314050	THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT	THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCED GLOBIN SYNTHESIS	
NULL	314100	THUMBS, CONGENITAL CLASPED	ADDUCTED THUMBS SYNDROME	
NULL	314240	TOOTH SIZE		
Number Sign	314250	DYSTONIA 3, TORSION, X-LINKED; DYT3	DYSTONIA-PARKINSONISM, X-LINKED; XDP;; TORSION DYSTONIA-PARKINSONISM, FILIPINO TYPE	
Percent	314300	TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	TKC;; TKCR SYNDROME;; GOEMINNE SYNDROME	
NULL	314320	TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY		
NULL	314360	ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET		
Percent	314380	UNIQUE GREEN PHENOMENON		
Number Sign	314390	VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	VACTERL-H, X-LINKED	
Number Sign	314400	CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	VALVULAR HEART DISEASE, CONGENITAL;; MYXOMATOUS VALVULAR DYSTROPHY, X-LINKED; XMVD	
Percent	314500	VAN DEN BOSCH SYNDROME		
NULL	314550	VESICOURETERAL REFLUX, X-LINKED; VURX		
NULL	314560	VON WILLEBRAND DISEASE, X-LINKED FORM		
NULL	314570	WIDOW'S PEAK SYNDROME	WIDOW'S PEAK, PTOSIS, AND SKELETAL ANOMALIES	
Number Sign	314580	WIEACKER-WOLFF SYNDROME; WRWF	WIEACKER SYNDROME;; CONTRACTURES OF FEET, MUSCLE ATROPHY, AND OCULOMOTOR APRAXIA;; APRAXIA, OCULOMOTOR, WITH CONGENITAL CONTRACTURES AND MUSCLE ATROPHY;; MILES-CARPENTER X-LINKED MENTAL RETARDATION SYNDROME; MCS;; MENTAL RETARDATION, X-LINKED, SYNDROMIC 4; MRXS4;; MENTAL RETARDATION, X-LINKED, WITH CONGENITAL CONTRACTURES AND LOW FINGERTIP ARCHES	
Percent	314600	WILDERVANCK SYNDROME	CERVICOOCULOACOUSTIC SYNDROME	
NULL	314700	BLOOD GROUP, XG SYSTEM; XG	XG BLOOD GROUP SYSTEM	
Percent	314705	XG REGULATOR; XGR	XG AND MIC2 EXPRESSION ON ERYTHROCYTES	
NULL	314800	XH ANTIGEN		
Percent	314900	XM SYSTEM		
Percent	400004	RETINITIS PIGMENTOSA, Y-LINKED; RPY		
Percent	400021	LYMPHOMA, HODGKIN, Y-LINKED PSEUDOAUTOSOMAL	HODGKIN DISEASE, Y-LINKED PSEUDOAUTOSOMAL	
Number Sign	400042	SPERMATOGENIC FAILURE, Y-LINKED, 1; SPGFY1	SERTOLI CELL-ONLY SYNDROME, Y-LINKED;; SERTOLI CELL-ONLY SYNDROME, TYPE I	SERTOLI CELL-ONLY SYNDROME, TYPE II, INCLUDED;; HYPOSPERMATOGENESIS, INCLUDED;; INCOMPLETE SERTOLI CELL-ONLY SYNDROME, INCLUDED
Percent	400043	DEAFNESS, Y-LINKED 1; DFNY1		
Number Sign	400044	46,XY SEX REVERSAL 1; SRXY1	46,XY SEX REVERSAL, SRY-RELATED;; 46,XY GONADAL DYSGENESIS, COMPLETE, SRY-RELATED	46,XY TRUE HERMAPHRODITISM, SRY-RELATED, INCLUDED;; TESTIS-DETERMINING FACTOR, X-CHROMOSOMAL, FORMERLY, INCLUDED; TDFX, FORMERLY, INCLUDED;; SEX-REVERSING LOCUS ON X, FORMERLY, INCLUDED; SRVX, FORMERLY, INCLUDED
Number Sign	400045	46,XX SEX REVERSAL 1; SRXX1	46,XX SEX REVERSAL, SRY-POSITIVE;; XX MALE, SRY-POSITIVE;; 46,XX TESTICULAR DISORDER OF SEX DEVELOPMENT;; 46,XX GONADAL DYSGENESIS, COMPLETE, SRY-POSITIVE	46,XX TRUE HERMAPHRODITISM, SRY-POSITIVE, INCLUDED;; OVOTESTICULAR DISORDER OF SEX DEVELOPMENT, INCLUDED;; OVOTESTICULAR DSD, INCLUDED
Number Sign	415000	SPERMATOGENIC FAILURE, Y-LINKED, 2; SPGFY2	SPERMATOGENIC FAILURE, NONOBSTRUCTIVE, Y-LINKED;; AZOOSPERMIA, NONOBSTRUCTIVE, Y-LINKED;; OLIGOZOOSPERMIA, NONOBSTRUCTIVE, Y-LINKED;; OLIGOSPERMIA, NONOBSTRUCTIVE, Y-LINKED;; SPERMATOGENIC ARREST, Y-LINKED	AZOOSPERMIA FACTOR REGIONS, INCLUDED;; AZF REGIONS, INCLUDED
Percent	424500	GONADOBLASTOMA; GBY		
NULL	425500	HAIRY EARS, Y-LINKED	HYPERTRICHOSIS PINNAE AURIS, Y-LINKED	
Percent	475000	GROWTH CONTROL, Y-CHROMOSOME INFLUENCED; GCY	STATURE; STA;; TOOTH SIZE; TS; TSY	
NULL	489000	UBIQUITIN-ACTIVATING ENZYME, Y-LINKED	UBE1Y	
Number Sign	500000	CARDIOMYOPATHY, INFANTILE HISTIOCYTOID	CARDIOMYOPATHY, INFANTILE XANTHOMATOUS;; CARDIOMYOPATHY, FOCAL LIPID;; CARDIOMYOPATHY, ONCOCYTIC;; FOAMY MYOCARDIAL TRANSFORMATION OF INFANCY	
Number Sign	500001	LEBER OPTIC ATROPHY AND DYSTONIA	LEBER HEREDITARY OPTIC NEUROPATHY WITH DYSTONIA; LDYT;; DYSTONIA, FAMILIAL, WITH VISUAL FAILURE AND STRIATAL LUCENCIES;; MARSDEN SYNDROME	
Number Sign	500002	MITOCHONDRIAL MYOPATHY WITH DIABETES	MITOCHONDRIAL MYOPATHY, LIPID TYPE	
Number Sign	500003	STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	BILATERAL STRIATAL NECROSIS, INFANTILE, MITOCHONDRIAL;; INFANTILE BILATERAL STRIATAL NECROSIS, MITOCHONDRIAL	
Number Sign	500004	RETINITIS PIGMENTOSA-DEAFNESS SYNDROME	RETINITIS PIGMENTOSA 8, FORMERLY; RP8, FORMERLY;; RETINITIS PIGMENTOSA 21, FORMERLY; RP21, FORMERLY	
Number Sign	500005	HYPOMAGNESEMIA, HYPERTENSION, AND HYPERCHOLESTEROLEMIA, MITOCHONDRIAL		
Number Sign	500006	CARDIOMYOPATHY, INFANTILE HYPERTROPHIC		
Number Sign	500007	CYCLIC VOMITING SYNDROME; CVS		CYCLIC VOMITING SYNDROME WITH NEUROMUSCULAR DISEASE, INCLUDED;; CYCLIC VOMITING SYNDROME-PLUS, INCLUDED;; CVS-PLUS, INCLUDED
Number Sign	500008	DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL		
Number Sign	500009	MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT	MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAIN DEFICIENCY;; COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;; RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	
Number Sign	500010	ATAXIA AND POLYNEUROPATHY, ADULT-ONSET		
Number Sign	500011	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 3; MLASA3		
Number Sign	502000	AGING		
Number Sign	502500	ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL		
Number Sign	515000	CHLORAMPHENICOL TOXICITY	ANEMIA, CHLORAMPHENICOL-INDUCED	CHLORAMPHENICOL RESISTANCE, INCLUDED
Number Sign	520000	DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD	DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;; BALLINGER-WALLACE SYNDROME;; DIABETES MELLITUS, TYPE II, WITH DEAFNESS;; NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;; NIDDM WITH DEAFNESS	
Number Sign	520100	DIARRHEA, CHRONIC, WITH VILLOUS ATROPHY		
Number Sign	530000	KEARNS-SAYRE SYNDROME; KSS	OPHTHALMOPLEGIA, PIGMENTARY DEGENERATION OF RETINA, AND CARDIOMYOPATHY;; OCULOCRANIOSOMATIC SYNDROME;; OPHTHALMOPLEGIA-PLUS SYNDROME;; MITOCHONDRIAL CYTOPATHY;; OPHTHALMOPLEGIA, PROGRESSIVE EXTERNAL, WITH RAGGED-RED FIBERS;; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MYOPATHY;; CPEO WITH MYOPATHY;; CPEO WITH RAGGED-RED FIBERS	
Number Sign	535000	LEBER OPTIC ATROPHY	LEBER HEREDITARY OPTIC NEUROPATHY; LHON	
Number Sign	540000	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	MELAS SYNDROME	
Number Sign	545000	MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS; MERRF	MERRF SYNDROME	
Number Sign	550500	MYOGLOBINURIA, RECURRENT		
Number Sign	551000	MITOCHONDRIAL MYOPATHY, LETHAL, INFANTILE; LIMM		
Number Sign	551200	NEPHROPATHY, CHRONIC TUBULOINTERSTITIAL		
Number Sign	551500	NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	NARP SYNDROME	
Number Sign	553000	ONCOCYTOMA		
Number Sign	556500	PARKINSON DISEASE, MITOCHONDRIAL		
Number Sign	557000	PEARSON MARROW-PANCREAS SYNDROME	SIDEROBLASTIC ANEMIA WITH MARROW CELL VACUOLIZATION AND EXOCRINE PANCREATIC DYSFUNCTION	
Number Sign	560000	RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA		
Number Sign	580000	DEAFNESS, AMINOGLYCOSIDE-INDUCED	DEAFNESS, STREPTOMYCIN-INDUCED;; STREPTOMYCIN OTOTOXICITY	
Number Sign	598500	WOLFRAM SYNDROME, MITOCHONDRIAL FORM	DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS, MITOCHONDRIAL FORM;; DIDMOAD SYNDROME, MITOCHONDRIAL FORM	
NULL	600000	SPONDYLOCAMPTODACTYLY	CAMPTODACTYLY WITH CERVICAL PLATYSPONDYLY	
Number Sign	600001	HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	PANCREATIC HYPOPLASIA, CONGENITAL, WITH DIABETES MELLITUS AND CONGENITAL HEART DISEASE;; PANCREATIC AGENESIS AND CONGENITAL HEART DEFECTS; PACHD	
Number Sign	600002	EIKEN SYNDROME	EIKEN SKELETAL DYSPLASIA;; BONE MODELING DEFECT OF HANDS AND FEET	
Percent	600048	BREAST CANCER, 11-22 TRANSLOCATION-ASSOCIATED; BRCATA		
Percent	600057	EXSTROPHY OF BLADDER		BLADDER EXSTROPHY AND EPISPADIAS COMPLEX, INCLUDED; BEEC, INCLUDED
Number Sign	600059	RETINITIS PIGMENTOSA 13; RP13		
Number Sign	600060	DEAFNESS, AUTOSOMAL RECESSIVE 2; DFNB2	NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 2; NSRD2	
Number Sign	600072	FATAL FAMILIAL INSOMNIA; FFI	INSOMNIA, FATAL FAMILIAL	
NULL	600080	MYELOCYTIC LEUKEMIA-LIKE SYNDROME, FAMILIAL, CHRONIC	CML-LIKE SYNDROME, FAMILIAL	
Number Sign	600081	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B; VDDR1B	VITAMIN D-DEPENDENT RICKETS, TYPE 1B;; 25-HYDROXYVITAMIN D3 DEFICIENCY, SELECTIVE;; PSEUDOVITAMIN D3 DEFICIENCY RICKETS DUE TO 25-HYDROXYLASE DEFICIENCY	
Percent	600082	PROSTATIC HYPERPLASIA, BENIGN; BPH		
NULL	600084	MACROCYTOSIS, FAMILIAL		
NULL	600089	PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS		
NULL	600092	CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME		
NULL	600093	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES		
NULL	600096	PUERTO RICAN INFANT HYPOTONIA SYNDROME		
Number Sign	600101	DEAFNESS, AUTOSOMAL DOMINANT 2A; DFNA2A		
Number Sign	600105	RETINITIS PIGMENTOSA 12; RP12	RETINITIS PIGMENTOSA WITH OR WITHOUT PARAARTERIOLAR PRESERVATION OF RETINAL PIGMENT EPITHELIUM;; RP WITH OR WITHOUT PRESERVED PARAARTERIOLE RETINAL PIGMENT EPITHELIUM;; RP WITH OR WITHOUT PPRPE	
Number Sign	600110	STARGARDT DISEASE 3; STGD3	MACULAR DYSTROPHY WITH FLECKS, TYPE 3;; STARGARDT-LIKE MACULAR DYSTROPHY, AUTOSOMAL DOMINANT	
Number Sign	600116	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2	PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ;; PARKINSONISM, EARLY-ONSET, WITH DIURNAL FLUCTUATION; EPDF	
NULL	600117	DYSPHASIA, FAMILIAL DEVELOPMENTAL		
Number Sign	600118	WARBURG MICRO SYNDROME 1; WARBM1	MICRO SYNDROME	
Number Sign	600121	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3	ALKYLDIHYDROXYACETONEPHOSPHATE SYNTHASE DEFICIENCY;; ALKYLGLYCERONE-PHOSPHATE SYNTHASE DEFICIENCY;; AGPS DEFICIENCY	
NULL	600122	MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	VERLOES SYNDROME	
NULL	600123	ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL AND RADIAL DEFECTS		
Percent	600131	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1		
Number Sign	600132	RETINITIS PIGMENTOSA 14; RP14		
Number Sign	600138	RETINITIS PIGMENTOSA 11; RP11		
Number Sign	600142	CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	MAEDA SYNDROME;; SUBCORTICAL VASCULAR ENCEPHALOPATHY, PROGRESSIVE;; CEREBROVASCULAR DISEASE WITH THIN SKIN, ALOPECIA, AND DISC DISEASE	
Number Sign	600143	CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8		
Number Sign	600145	SACRAL DEFECT WITH ANTERIOR MENINGOCELE	SDAM	CAUDAL DYSGENESIS SYNDROME, INCLUDED;; CAUDAL REGRESSION SYNDROME, INCLUDED;; SACRAL AGENESIS, INCLUDED;; SIRENOMELIA, INCLUDED
NULL	600148	GLYCEROL KINASE 2; GK2	GLYCEROL KINASE, TESTICULAR, TYPE A; GKTA;; GLYCEROL KINASE PSEUDOGENE 2; GKP2	
NULL	600149	GLYCEROL KINASE 3 PSEUDOGENE; GK3P	GLYCEROL KINASE, TESTICULAR, TYPE B; GKTB;; GKP3	
Number Sign	600151	BARDET-BIEDL SYNDROME 3; BBS3		
Number Sign	600155	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2; HSCR2		
Percent	600156	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 5; HSCR5		
NULL	600159	PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES		
Percent	600165	NANOPHTHALMOS 1; NNO1	NANOPHTHALMIA 1;; NANOPHTHALMOS, AUTOSOMAL DOMINANT;; NANOPHTHALMOS WITH HIGH HYPEROPIA AND ANGLE-CLOSURE GLAUCOMA;; MICROPHTHALMOS, SIMPLE, AUTOSOMAL DOMINANT	
NULL	600166	HYPERPARATHYROIDISM, PRIMARY, CAUSED BY WATER CLEAR CELL HYPERPLASIA		
NULL	600171	GONADAL AGENESIS		
Number Sign	600175	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIII; HMN8	NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIII; DHMN8;; SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;; SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	
Percent	600176	PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS	PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	
Percent	600193	WAARDENBURG SYNDROME, TYPE 2B; WS2B	WAARDENBURG SYNDROME, TYPE IIB	
Number Sign	600195	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL; VMCM	VMCM1	
Percent	600202	DYSLEXIA, SUSCEPTIBILITY TO, 2; DYX2	READING DISABILITY, SPECIFIC, 2	
Number Sign	600204	EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2		
Number Sign	600208	MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS		
Percent	600209	EXOSTOSES, MULTIPLE, TYPE III; EXT3		
Percent	600223	SPINOCEREBELLAR ATAXIA 4; SCA4	SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	
Number Sign	600224	SPINOCEREBELLAR ATAXIA 5; SCA5		
Number Sign	600231	PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB		
Number Sign	600251	FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	OCULOMAXILLOFACIAL DYSPLASIA WITH OBLIQUE FACIAL CLEFTS	
NULL	600252	LOWRY-MACLEAN SYNDROME		
Number Sign	600257	CHROMOSOME 8q12.1-q21.2 DELETION SYNDROME	BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	
Number Sign	600263	HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO		
Percent	600268	OCULOECTODERMAL SYNDROME; OES	APLASIA CUTIS CONGENITA WITH EPIBULBAR DERMOIDS	
NULL	600269	SHORT TARSUS WITH ABSENCE OF LOWER EYELASHES; STALE		
Number Sign	600273	POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS; PKDTS	CHROMOSOME 16p13.3 DELETION SYNDROME, DISTAL;; TUBEROUS SCLEROSIS/POLYCYSTIC KIDNEY DISEASE CONTIGUOUS GENE SYNDROME	
Number Sign	600274	FRONTOTEMPORAL DEMENTIA; FTD	FRONTOTEMPORAL LOBAR DEGENERATION WITH TAU INCLUSIONS;; FTLD WITH TAU INCLUSIONS;; DEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM;; FRONTOTEMPORAL DEMENTIA WITH PARKINSONISM;; FRONTOTEMPORAL LOBE DEMENTIA; FLDEM;; FTDP17;; MULTIPLE SYSTEM TAUOPATHY WITH PRESENILE DEMENTIA; MSTD;; DISINHIBITION-DEMENTIA-PARKINSONISM-AMYOTROPHY COMPLEX; DDPAC;; WILHELMSEN-LYNCH DISEASE; WLD;; PALLIDOPONTONIGRAL DEGENERATION; PPND	PICK COMPLEX, INCLUDED
NULL	600302	FRYNS MACROCEPHALY	MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIAL APPEARANCE	
Number Sign	600309	ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3		
Number Sign	600316	DEAFNESS, AUTOSOMAL RECESSIVE 3; DFNB3	NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 3; NSRD3	
Percent	600318	DIABETES MELLITUS, INSULIN-DEPENDENT, 3; IDDM3	INSULIN-DEPENDENT DIABETES MELLITUS 3	
Percent	600319	DIABETES MELLITUS, INSULIN-DEPENDENT, 4; IDDM4	INSULIN-DEPENDENT DIABETES MELLITUS 4	
Number Sign	600320	DIABETES MELLITUS, INSULIN-DEPENDENT, 5; IDDM5	INSULIN-DEPENDENT DIABETES MELLITUS 5	
Percent	600321	DIABETES MELLITUS, INSULIN-DEPENDENT, 7; IDDM7	INSULIN-DEPENDENT DIABETES MELLITUS 7	
Percent	600325	AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA	PSEUDOAMINOPTERIN SYNDROME	
NULL	600329	OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY		
NULL	600331	PARC SYNDROME	POIKILODERMA, ALOPECIA, RETROGNATHISM, AND CLEFT PALATE	
Percent	600332	RIPPLING MUSCLE DISEASE 1; RMD1		
NULL	600333	MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA		
Number Sign	600334	TIBIAL MUSCULAR DYSTROPHY, TARDIVE; TMD	TARDIVE TIBIAL MUSCULAR DYSTROPHY;; UDD MYOPATHY	
NULL	600335	SUCCINIC ACIDEMIA		
Percent	600343	PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP		
NULL	600347	BREVICAN; BCAN		
Number Sign	600348	BAND HETEROTOPIA; BH		
NULL	600351	ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY		
NULL	600356	PACHYDERMODACTYLY, FAMILIAL		
Percent	600360	APLASIA CUTIS CONGENITA OF LIMBS, AUTOSOMAL RECESSIVE		
Percent	600361	HEREDITARY MOTOR AND SENSORY NEUROPATHY V	HMSN V;; HMSN5;; PERONEAL MUSCULAR ATROPHY WITH PYRAMIDAL FEATURES, AUTOSOMAL DOMINANT;; CHARCOT-MARIE-TOOTH DISEASE WITH PYRAMIDAL FEATURES, AUTOSOMAL DOMINANT;; CHARCOT-MARIE-TOOTH NEUROPATHY WITH PYRAMIDAL FEATURES, AUTOSOMAL DOMINANT;; CMT WITH PYRAMIDAL FEATURES	
Number Sign	600363	SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT; SPG6	FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 3; FSP3	
Number Sign	600373	CODAS SYNDROME	CEREBRAL, OCULAR, DENTAL, AURICULAR, AND SKELETAL ANOMALIES SYNDROME	
Number Sign	600376	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2		PULMONARY ARTERIAL HYPERTENSION, HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED, INCLUDED
Number Sign	600383	MESOMELIA-SYNOSTOSES SYNDROME	CHROMOSOME 8q13 DELETION SYNDROME;; MESOMELIC DYSPLASIA WITH ACRAL SYNOSTOSES, VERLOES-DAVID-PFEIFFER TYPE;; MESOMELIC DYSPLASIA, SYNDROMIC	
Percent	600384	APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSAL IV		
Percent	600399	PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS		
NULL	600416	MUSCULAR DYSTROPHY, SCAPULOHUMERAL		
NULL	600419	ANGIOKERATOMA CORPORIS DIFFUSUM WITH ARTERIOVENOUS FISTULAS		
Number Sign	600430	CHROMOSOME 2q37 DELETION SYNDROME	ALBRIGHT HEREDITARY OSTEODYSTROPHY-LIKE SYNDROME;; BRACHYDACTYLY-MENTAL RETARDATION SYNDROME; BDMR	
NULL	600457	HYPERTRICHOSIS, ANTERIOR CERVICAL		
NULL	600458	ADENOMYOSIS		
NULL	600459	ARTERIAL DISSECTION WITH LENTIGINOSIS		
NULL	600460	CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY	CCGE;; ACROCARDIOFACIAL SYNDROME; ACFS	
NULL	600461	HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES		
Number Sign	600462	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	
Percent	600467	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	MHS4	
Number Sign	600496	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3	MODY, TYPE 3	
Number Sign	600501	ABCD SYNDROME; ABCDS	ALBINISM, BLACK LOCK, CELL MIGRATION DISORDER OF THE NEUROCYTES OF THE GUT, AND DEAFNESS	
Percent	600510	GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	GLAUCOMA, PIGMENT-DISPERSION TYPE;; PIGMENT DISPERSION SYNDROME; PDS	
Percent	600511	SCHIZOPHRENIA 3; SCZD3	SCHIZOPHRENIA 3 WITH OR WITHOUT AN AFFECTIVE DISORDER;; SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	
Number Sign	600512	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1	EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT; ADLTE;; EPILEPSY, PARTIAL, WITH AUDITORY FEATURES; ADPEAF	
Number Sign	600513	EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1		
NULL	600546	INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY		
NULL	600559	HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	HEC SYNDROME	
NULL	600561	SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY		
Percent	600593	CRANIOSYNOSTOSIS, ADELAIDE TYPE; CRSA		
NULL	600598	SETTING-SUN PHENOMENON, FAMILIAL BENIGN		
Percent	600624	CONE-ROD DYSTROPHY 1; CORD1	CRD1	
Number Sign	600625	OROFACIAL CLEFT 11; OFC11	CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 11	CLEFT LIP, CONGENITAL HEALED, INCLUDED;; CONGENITAL HEALED CLEFT LIP, INCLUDED; CHCL, INCLUDED
Number Sign	600627	HYPERTRYPTOPHANEMIA; HYPTRP	HYPERTRYPTOPHANEMIA, FAMILIAL	
NULL	600628	LOOSE ANAGEN HAIR SYNDROME		
Number Sign	600630	UV-SENSITIVE SYNDROME 1; UVSS1		
Percent	600631	ENURESIS, NOCTURNAL, 1; ENUR1	BEDWETTING	
Number Sign	600634	PITUITARY ADENOMA, PROLACTIN-SECRETING	PROLACTINOMA, FAMILIAL	
Number Sign	600638	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A	FEOM3 LOCUS	
NULL	600643	CAROLI DISEASE, ISOLATED		
Number Sign	600649	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY WITH HYPOKETOTIC HYPOGLYCEMIA;; CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, HEPATOCARDIOMUSCULAR;; CPT II DEFICIENCY, HEPATIC;; CPT2 DEFICIENCY, INFANTILE	
Number Sign	600651	FRAGILE SITE 11B; FRA11B		
Number Sign	600652	DEAFNESS, AUTOSOMAL DOMINANT 4A; DFNA4A	DEAFNESS, AUTOSOMAL DOMINANT 4; DFNA4	
Number Sign	600666	POLYCYSTIC KIDNEY DISEASE 3; PKD3	POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE III; APKD3	
Percent	600668	CHONDROCALCINOSIS 1; CCAL1	CHONDROCALCINOSIS WITH EARLY-ONSET OSTEOARTHRITIS	
Percent	600669	EPILEPSY, IDIOPATHIC GENERALIZED; EIG	IDIOPATHIC GENERALIZED EPILEPSY; IGE	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 1, INCLUDED; EIG1, INCLUDED;; EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, LOCUS ON CHROMOSOME 8, INCLUDED
NULL	600670	VARICELLA, SEVERE RECURRENT		
Percent	600674	MICROTIA-ANOTIA		
NULL	600679	DERMOID CYSTS, FAMILIAL FRONTONASAL		
NULL	600705	SATOYOSHI SYNDROME	KOMURAGAERI DISEASE;; MUSCLE SPASMS, INTERMITTENT, WITH ALOPECIA, DIARRHEA, AND SKELETAL ABNORMALITIES	
NULL	600706	PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA		
Number Sign	600721	D-2-HYDROXYGLUTARIC ACIDURIA 1; D2HGA1	D2HGA	
NULL	600736	VELOFACIOSKELETAL SYNDROME		
Number Sign	600740	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III; HHC3	FAMILIAL BENIGN HYPERCALCEMIA, TYPE III; FBH3;; HYPERCALCEMIA, FAMILIAL BENIGN, TYPE III;; HYPERCALCEMIA, FAMILIAL BENIGN, OKLAHOMA TYPE	
Percent	600757	OROFACIAL CLEFT 3; OFC3	CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 3	
Percent	600771	DWARFISM, FAMILIAL, WITH MUSCLE SPASMS		
Number Sign	600775	CRANIOSYNOSTOSIS 4; CRS4		
NULL	600776	FRYNS MICROPHTHALMIA SYNDROME	MICROPHTHALMIA WITH FACIAL CLEFTING;; ANOPHTHALMIA-PLUS SYNDROME	
Percent	600785	VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR; VDDR2B		
Percent	600790	CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	CRAPB;; PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY; PBCRA	
Number Sign	600791	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4	NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 4; NSRD4;; DILATED VESTIBULAR AQUEDUCT; DVA	
Percent	600792	DEAFNESS, AUTOSOMAL RECESSIVE 5; DFNB5	NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 5; NSRD5	
Number Sign	600794	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	HMN VA;; NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V; HMN5;; NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; DHMN5A;; DHMN VA;; SPINAL MUSCULAR ATROPHY, DISTAL, TYPE VA; DSMAVA;; SPINAL MUSCULAR ATROPHY, DISTAL, TYPE V; DSMAV;; SPINAL MUSCULAR ATROPHY, DISTAL, WITH UPPER LIMB PREDOMINANCE	
Number Sign	600795	FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	DMT1; DEM;; DEMENTIA, FAMILIAL NONSPECIFIC	
NULL	600801	ISOPROTERENOL-MEDIATED VASODILATATION		
Number Sign	600802	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	
Number Sign	600803	GALLBLADDER DISEASE 1; GBD1	CHOLELITHIASIS, LOW PHOSPHOLIPID-ASSOCIATED; LPAC	
Number Sign	600807	ASTHMA, SUSCEPTIBILITY TO	ASTHMA, BRONCHIAL;; ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO	ASTHMA, PROTECTION AGAINST, INCLUDED;; ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN, INCLUDED
Percent	600808	ENURESIS, NOCTURNAL, 2; ENUR2		
NULL	600841	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 ALPHA-1-LIKE 14; EEF1A1L14	PROSTATIC CARCINOMA TUMOR-INDUCING GENE 1; PTI1	
Number Sign	600850	SCHIZOPHRENIA 4; SCZD4	SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 22q11-RELATED	
NULL	600851	MITOCHONDRIAL IMPORT-STIMULATING FACTOR	MSF	
Number Sign	600852	RETINITIS PIGMENTOSA 17; RP17		
Number Sign	600858	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6; CMH6		
Number Sign	600880	BUDD-CHIARI SYNDROME; BDCHS		MEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED; MOVC, INCLUDED
Number Sign	600881	CATARACT 10, MULTIPLE TYPES; CTRCT10	CATARACT, CONGENITAL ZONULAR, WITH SUTURAL OPACITIES; CCZS	
Number Sign	600882	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL DOMINANT, TYPE 2B;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2B;; HEREDITARY MOTOR AND SENSORY NEUROPATHY IIB; HMSN IIB;; HMSN2B	
Percent	600883	DIABETES MELLITUS, INSULIN-DEPENDENT, 8; IDDM8	INSULIN-DEPENDENT DIABETES MELLITUS 8	
Percent	600884	CARDIOMYOPATHY, DILATED, 1B; CMD1B	CARDIOMYOPATHY, FAMILIAL DILATED, 1; CMPD1;; CARDIOMYOPATHY, FAMILIAL DILATED; FDC	
Number Sign	600886	HYPERFERRITINEMIA WITH OR WITHOUT CATARACT; HRFTC	HYPERFERRITINEMIA-CATARACT SYNDROME;; HYPERFERRITINEMIA, HEREDITARY, WITH CONGENITAL CATARACTS; HHCS	
Number Sign	600901	FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	FACE	
NULL	600903	WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM		
NULL	600906	ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY		
NULL	600907	ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS		
NULL	600908	KENNERKNECHT SYNDROME	AGONADISM, 46,XY, WITH MENTAL RETARDATION, SHORT STATURE, RETARDED BONE AGE, AND MULTIPLE EXTRAGENITAL MALFORMATIONS	
Number Sign	600919	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED	ANKYRIN-B SYNDROME	LONG QT SYNDROME 4, INCLUDED; LQT4, INCLUDED
Number Sign	600920	VAN DEN ENDE-GUPTA SYNDROME; VDEGS	MARDEN-WALKER-LIKE SYNDROME WITHOUT PSYCHOMOTOR RETARDATION;; BLEPHAROPHIMOSIS, ARACHNODACTYLY, AND CONGENITAL CONTRACTURES	
NULL	600931	PROTOCADHERIN 3	PCDH3	
NULL	600952	TRANSSEXUALITY		
Number Sign	600955	PROPROTEIN CONVERTASE 1/3 DEFICIENCY	OBESITY AND ENDOCRINOPATHY DUE TO IMPAIRED PROCESSING OF PROHORMONES	
Number Sign	600962	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC; NEPPK	PPKNE;; NONEPIDERMOLYTIC PALMOPLANTAR KERATODERMA;; KERATODERMA, NONEPIDERMOLYTIC PALMOPLANTAR;; TYLOSIS	
Number Sign	600965	DEAFNESS, AUTOSOMAL DOMINANT 6; DFNA6	DEAFNESS, AUTOSOMAL DOMINANT 14; DFNA14;; DEAFNESS, AUTOSOMAL DOMINANT 38; DFNA38	
Number Sign	600969	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3		EPIPHYSEAL DYSPLASIA, MULTIPLE, 3, WITH MYOPATHY, INCLUDED
Number Sign	600971	DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6	NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 6; NSRD6	
Number Sign	600972	ACHONDROGENESIS, TYPE IB; ACG1B	ACHONDROGENESIS, FRACCARO TYPE	
Number Sign	600974	DEAFNESS, AUTOSOMAL RECESSIVE 7; DFNB7	DEAFNESS, AUTOSOMAL RECESSIVE 11; DFNB11	
Percent	600975	GLAUCOMA 3, PRIMARY INFANTILE, B; GLC3B	GLAUCOMA, PRIMARY CONGENITAL, TYPE B;; GLC3, TYPE B	
Number Sign	600977	CONE-ROD DYSTROPHY 5; CORD5		
Number Sign	600987	CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	CARDIAC MALFORMATION, CLEFT LIP/PALATE, MICROCEPHALY, AND DIGITAL ANOMALIES	
NULL	600989	INFUNDIBULOPELVIC DYSGENESIS		
NULL	600991	HYDROCEPHALUS, SPRENGEL ANOMALY, AND COSTOVERTEBRAL DYSPLASIA		
Number Sign	600994	DEAFNESS, AUTOSOMAL DOMINANT 5; DFNA5		
Number Sign	600995	NEPHROTIC SYNDROME, TYPE 2; NPHS2	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE; SRN1	
Number Sign	600996	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2	ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 2; ARVC2	
Number Sign	601001	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 1; EBSB1		
Number Sign	601003	BRODY MYOPATHY		
NULL	601004	PORTAL VEIN, CAVERNOUS TRANSFORMATION OF		
Number Sign	601005	TIMOTHY SYNDROME; TS	LONG QT SYNDROME WITH SYNDACTYLY;; LONG QT SYNDROME 8; LQT8	
NULL	601016	MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM	DINCSOY SYNDROME	
NULL	601027	TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES		
NULL	601039	ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN		
Number Sign	601042	DYSTONIA 9; DYT9	CHOREOATHETOSIS/SPASTICITY, EPISODIC;; CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA;; CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY	
Number Sign	601067	USHER SYNDROME, TYPE ID; USH1D		USHER SYNDROME, TYPE ID/F, CDH23/PCDH15, DIGENIC, INCLUDED;; USH1D/F, CDH23/PCDH15, DIGENIC, INCLUDED
Percent	601068	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 1; BAFME1;; CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 1; FCMTE1	
Number Sign	601071	DEAFNESS, AUTOSOMAL RECESSIVE 9; DFNB9	NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 9; NSRD9	AUDITORY NEUROPATHY, AUTOSOMAL RECESSIVE, 1, INCLUDED; AUNB1, INCLUDED;; AUDITORY NEUROPATHY, NONSYNDROMIC RECESSIVE, INCLUDED; NSRAN, INCLUDED
Number Sign	601072	DEAFNESS, AUTOSOMAL RECESSIVE 8; DFNB8	DEAFNESS, AUTOSOMAL RECESSIVE 10; DFNB10;; DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8; DFNB8;; NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 8; NSRD8	
NULL	601075	APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION		
Percent	601076	MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACIC SOMITE ANOMALIES; MURCS	MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME, TYPE II;; MRKH, TYPE II;; KLIPPEL-FEIL DEFORMITY, CONDUCTIVE DEAFNESS, AND ABSENT VAGINA	
NULL	601083	CD4/CD8 T-CELL RATIO		
Percent	601086	LATERALITY DEFECTS, AUTOSOMAL DOMINANT		
Number Sign	601088	AYME-GRIPP SYNDROME; AYGRP	CATARACTS, CONGENITAL, WITH SENSORINEURAL DEAFNESS, DOWN SYNDROME-LIKE FACIAL APPEARANCE, SHORT STATURE, AND MENTAL RETARDATION	
NULL	601095	HARROD SYNDROME		
NULL	601096	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	SEMD, MICROMELIC;; DWARFISM, MICROMELIC, WITH CONE EPIPHYSES, METAPHYSEAL DYSPLASIA, AND VERTEBRAL SEGMENTATION DEFECTS	
Number Sign	601098	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C	CMT, SLOW NERVE CONDUCTION TYPE C;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 1C;; NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE IC; HMSN1C;; HMSN IC	
Percent	601101	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 3; HHT3		
Number Sign	601104	SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	PSP;; STEELE-RICHARDSON-OLSZEWSKI SYNDROME	
Number Sign	601110	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	CDG Id; CDGId;; CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE IV, FORMERLY; CDGS4, FORMERLY;; CDGS, TYPE IV, FORMERLY	
NULL	601127	FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION		
NULL	601136	TRANSSUPPRESSOR OF EXPRESSION 2	TSE2;; ALBUMIN EXTINGUISHER	
NULL	601138	GUANYLATE CYCLASE 2E, PSEUDOGENE; GUCY2EP	GUCY2E;; GUANYLYL CYCLASE, MEMBRANE, TYPE E;; GC-E;; GUCY2D, MOUSE, HOMOLOG OF	
Number Sign	601144	BRUGADA SYNDROME 1; BRGDA1	RIGHT BUNDLE BRANCH BLOCK, ST SEGMENT ELEVATION, AND SUDDEN DEATH SYNDROME;; SUDDEN UNEXPLAINED NOCTURNAL DEATH SYNDROME; SUNDS	CARDIAC CONDUCTION DEFECT, NONSPECIFIC, INCLUDED
Number Sign	601152	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA; HMSN6A	HMSN VIA;; NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VI; HMSN6;; PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;; CHARCOT-MARIE-TOOTH DISEASE, TYPE 6A; CMT6A;; CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	
Number Sign	601154	CARDIOMYOPATHY, DILATED, 1E; CMD1E	CARDIOMYOPATHY, DILATED, WITH CONDUCTION DISORDER AND ARRHYTHMIA;; CARDIOMYOPATHY, DILATED, WITH CONDUCTION DEFECT 2; CDCD2	
NULL	601160	LISSENCEPHALY TYPE III AND BONE DYSPLASIA		
NULL	601161	TRISOMY 18-LIKE SYNDROME		
Number Sign	601162	SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	CATARACTS WITH MOTOR NEURONOPATHY, SHORT STATURE, AND SKELETAL ABNORMALITIES;; SPASTIC PARAPARESIS WITH AMYOTROPHY, CATARACTS, AND GASTROESOPHAGEAL REFLUX	
Percent	601163	DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	FROSTER SYNDROME	
NULL	601165	CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION, AND LETHAL CONGENITAL HEART DISEASE		
NULL	601170	MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS		
Number Sign	601186	MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	ANOPHTHALMIA, CLINICAL, WITH MILD FACIAL DYSMORPHISM AND VARIABLE MALFORMATIONS OF THE LUNG, HEART, AND DIAPHRAGM;; ANOPHTHALMIA/MICROPHTHALMIA AND PULMONARY HYPOPLASIA;; SPEAR SYNDROME;; MATTHEW-WOOD SYNDROME;; PULMONARY AGENESIS, MICROPHTHALMIA, AND DIAPHRAGMATIC DEFECT; PMD	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 8, INCLUDED; MCOPCB8, INCLUDED
NULL	601187	GURRIERI SYNDROME		
NULL	601188	SUPPRESSION OF TUMORIGENICITY 12; ST12	PROSTATE ADENOCARCINOMA 1; PAC1	
NULL	601195	IRON OVERLOAD IN AFRICA	AFRICAN IRON OVERLOAD;; BANTU SIDEROSIS	
Number Sign	601198	HYPOCALCEMIA, AUTOSOMAL DOMINANT 1; HYPOC1	HYPERCALCIURIC HYPOCALCEMIA;; HYPOCALCEMIA, FAMILIAL	HYPOCALCEMIA, AUTOSOMAL DOMINANT 1, WITH BARTTER SYNDROME, INCLUDED
Number Sign	601200	PLEUROPULMONARY BLASTOMA; PPB	PPB FAMILIAL TUMOR AND DYSPLASIA SYNDROME; PPBFTDS	
Percent	601202	CATARACT 24; CTRCT24	CATARACT 24, ANTERIOR POLAR;; CATARACT, ANTERIOR POLAR, 2; CTAA2	
Percent	601208	DIABETES MELLITUS, INSULIN-DEPENDENT, 11; IDDM11	INSULIN-DEPENDENT DIABETES MELLITUS 11	
Number Sign	601214	NAXOS DISEASE; NXD	CARDIOMYOPATHY, ARRHYTHMOGENIC RIGHT VENTRICULAR, WITH SKIN, HAIR, AND NAIL ABNORMALITIES;; MAL DE NAXOS;; KERATOSIS PALMOPLANTARIS WITH ARRHYTHMOGENIC CARDIOMYOPATHY;; WOOLLY HAIR, PALMOPLANTAR KERATODERMA, AND CARDIAC ABNORMALITIES;; PALMOPLANTAR KERATODERMA WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY AND WOOLLY HAIR	
Number Sign	601216	DENTAL ANOMALIES AND SHORT STATURE; DASS	PLATYSPONDYLY WITH AMELOGENESIS IMPERFECTA;; TOOTH AGENESIS, SELECTIVE, 6, FORMERLY; STHAG6, FORMERLY	
NULL	601217	ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPIC HYPOGONADISM		
NULL	601220	OSTEOPOROSIS AND OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME; OOCH		
NULL	601221	TISSUE-SPECIFIC EXTINGUISHER 3	TSE3	
NULL	601223	NEURONAL INTESTINAL DYSPLASIA, TYPE B	NID B	
Number Sign	601224	POTOCKI-SHAFFER SYNDROME	PSS;; CHROMOSOME 11p11.2 DELETION SYNDROME;; PROXIMAL 11p DELETION SYNDROME; P11pDS;; DEFECT11 SYNDROME	
Number Sign	601228	POLYPOSIS SYNDROME, HEREDITARY MIXED, 1; HMPS1	CHROMOSOME 15q13-q14 DUPLICATION SYNDROME, 40-KB;; COLORECTAL ADENOMA AND CARCINOMA 1; CRAC1	COLORECTAL CANCER, SUSCEPTIBILITY TO, 4, INCLUDED; CRCS4, INCLUDED;; COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 15, INCLUDED
NULL	601230	DERMATITIS HERPETIFORMIS, FAMILIAL	DH	
Number Sign	601238	CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY		
Number Sign	601277	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A	ICHTHYOSIS CONGENITA IIB; ICR2B;; ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	
Number Sign	601283	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1; NIDDM1	NONINSULIN-DEPENDENT DIABETES MELLITUS 1	
Number Sign	601287	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F; LGMD2F		
Percent	601308	MYELOID TUMOR SUPPRESSOR	MYELOID LEUKEMIA-RELATED LOCUS; MLRL	
NULL	601315	EPITHELIAL BASOLATERAL CHLORIDE CONDUCTANCE REGULATOR, RABBIT, HOMOLOG OF	EBCR	
Number Sign	601316	DEAFNESS, AUTOSOMAL DOMINANT 10; DFNA10		
Number Sign	601317	DEAFNESS, AUTOSOMAL DOMINANT 11; DFNA11		
Percent	601318	DIABETES MELLITUS, INSULIN-DEPENDENT, 13; IDDM13	INSULIN-DEPENDENT DIABETES MELLITUS 13	
NULL	601319	ODONTOMICRONYCHIAL DYSPLASIA	ECTODERMAL DYSPLASIA, NAIL/TOOTH TYPE	
Number Sign	601321	NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	NOONAN-NEUROFIBROMATOSIS SYNDROME;; NEUROFIBROMATOSIS WITH NOONAN PHENOTYPE	
NULL	601322	PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS		
Number Sign	601331	RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO; CYSRD		
Number Sign	601338	CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS		
NULL	601341	ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL; AMVC	VARIOLIFORM MACULAR ATROPHY OF THE SKIN	
NULL	601344	SPINAL DYSPLASIA, ANHALT TYPE		
NULL	601345	ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	ECTODERMAL DYSPLASIA, HAIR/TOOTH TYPE	
Percent	601346	MARTINEZ-FRIAS SYNDROME	PANCREATIC HYPOPLASIA, INTESTINAL ATRESIA, AND GALLBLADDER APLASIA OR HYPOPLASIA, WITH OR WITHOUT TRACHEOESOPHAGEAL FISTULA	
NULL	601347	MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE, AND PSYCHOMOTOR DELAY		
NULL	601348	ECTRODACTYLY OF LOWER LIMBS, CONGENITAL HEART DEFECT, AND MICROGNATHIA		
Percent	601349	MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	MICROCEPHALY, MICROPHTHALMIA, ECTRODACTYLY OF LOWER LIMBS, AND PROGNATHISM; MMEP	
NULL	601350	SHORT STATURE SYNDROME, BRUSSELS TYPE		
NULL	601351	GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION		
NULL	601352	MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE		
Percent	601353	BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	FINE-LUBINSKY SYNDROME	
NULL	601355	MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS, AND HYPOSEGMENTED LUNGS		
Percent	601356	LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE		
Percent	601357	BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	BRACHIAL AMELIA, FOREBRAIN DEFECTS, AND FACIAL CLEFTS	
Number Sign	601358	NICOLAIDES-BARAITSER SYNDROME; NCBRS	SPARSE HAIR AND MENTAL RETARDATION;; NBS	
NULL	601360	AMELIA, AUTOSOMAL RECESSIVE		
Percent	601362	DIGEORGE SYNDROME/VELOCARDIOFACIAL SYNDROME COMPLEX 2	DGS2	
Percent	601363	WILMS TUMOR 4; WT4	FAMILIAL WILMS TUMOR 1; FWT1	
Number Sign	601367	STROKE, ISCHEMIC	CEREBROVASCULAR ACCIDENT;; CEREBRAL INFARCTION	
Number Sign	601369	DEAFNESS, AUTOSOMAL DOMINANT 9; DFNA9		
NULL	601370	HOLOPROSENCEPHALY, SEMILOBAR, WITH CRANIOSYNOSTOSIS	GENOA SYNDROME	
NULL	601371	CATARACT, AGE-RELATED NUCLEAR	NUCLEAR SCLEROSIS OF THE LENS	
NULL	601372	CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT		
NULL	601374	APROSENCEPHALY AND CEREBELLAR DYSGENESIS		
NULL	601375	ECTODERMAL DYSPLASIA, HIDROTIC, CHRISTIANSON-FOURIE TYPE		
NULL	601376	CHONDRODYSPLASIA, LETHAL, WITH LONG BONE ANGULATION AND MIXED BONE DENSITY		
NULL	601379	HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME		
Number Sign	601382	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL RECESSIVE, WITH FOCALLY FOLDED MYELIN SHEATHS, AUTOSOMAL RECESSIVE, TYPE 4B1;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4B1;; CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B; CMT4B	
Number Sign	601386	DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12		
Number Sign	601388	DIABETES MELLITUS, INSULIN-DEPENDENT, 12; IDDM12	INSULIN-DEPENDENT DIABETES MELLITUS 12	
NULL	601389	CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION		
Number Sign	601390	VAN MALDERGEM SYNDROME 1; VMLDS1	CEREBROFACIOARTICULAR SYNDROME	
Number Sign	601399	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY; FPDMM	PLATELET DISORDER, ASPIRIN-LIKE;; THROMBOCYTOPENIA, FAMILIAL, WITH PROPENSITY TO ACUTE MYELOGENOUS LEUKEMIA; FPD/AML	
Percent	601407	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2; NIDDM2	NONINSULIN-DEPENDENT DIABETES MELLITUS 2	
Number Sign	601410	DIABETES MELLITUS, TRANSIENT NEONATAL, 1	TNDM1;; TNDM;; DMTN	
Percent	601412	DEAFNESS, AUTOSOMAL DOMINANT 7; DFNA7		
Number Sign	601414	RETINITIS PIGMENTOSA 18; RP18		
Number Sign	601419	MYOPATHY, MYOFIBRILLAR, 1; MFM1	MYOPATHY, MYOFIBRILLAR, DESMIN-RELATED;; DESMINOPATHY, PRIMARY;; DESMIN-RELATED MYOPATHY; DRM;; MYOFIBRILLAR MYOPATHY WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;; DESMIN-RELATED MYOPATHY WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 7, FORMERLY; ARVD7, FORMERLY;; ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 7, FORMERLY; ARVC7, FORMERLY;; INCLUSION BODY MYOPATHY 1, AUTOSOMAL DOMINANT, FORMERLY; IBM1, FORMERLY;; CARDIOMYOPATHY, DILATED, 1F AND LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1D, FORMERLY;; CMD1F AND LGMD1D, FORMERLY;; CARDIOMYOPATHY, DILATED, WITH CONDUCTION DEFECT AND MUSCULAR DYSTROPHY; CDCD3, FORMERLY	
NULL	601420	MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE		
NULL	601427	ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS		
NULL	601438	RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE		
NULL	601449	DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION		
NULL	601450	DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERS AND FACIAL DYSMORPHISM	HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERS AND FACIAL DYSMORPHISM	
Percent	601452	OCULOAURICULOFRONTONASAL SYNDROME; OAFNS	OCULOAURICULOFRONTONASAL DYSPLASIA	
NULL	601453	TRICHODENTAL DYSPLASIA		
Percent	601454	PSORIASIS 3, SUSCEPTIBILITY TO; PSORS3		
Number Sign	601455	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;; CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4D;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;; HMSN4D	
Number Sign	601457	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	SCID, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	
Percent	601458	INFLAMMATORY BOWEL DISEASE 2; IBD2		
Number Sign	601462	MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A	MYASTHENIC SYNDROME, CONGENITAL, TYPE IIa, FORMERLY; CMS2A, FORMERLY;; CMS IIa, FORMERLY	
NULL	601466	PATENT DUCTUS VENOSUS; PDV	PORTOSYSTEMIC VENOUS SHUNT, CONGENITAL; PSVS	
Percent	601471	FACIAL PARESIS, HEREDITARY CONGENITAL, 1; HCFP1	FACIAL PALSY, CONGENITAL, UNILATERAL OR BILATERAL;; MOEBIUS SYNDROME 2, FORMERLY; MBS2, FORMERLY;; MOBIUS SYNDROME 2, FORMERLY	
Number Sign	601472	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2D;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2D	
NULL	601477	RIBBING DISEASE	DIAPHYSEAL SCLEROSIS, MULTIPLE	
Number Sign	601492	MUCOPOLYSACCHARIDOSIS, TYPE IX; MPS9	MPS IX;; HYALURONIDASE DEFICIENCY	
Number Sign	601493	CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1C		LEFT VENTRICULAR NONCOMPACTION 3, INCLUDED; LVNC3, INCLUDED;; CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 24, INCLUDED; CMH24, INCLUDED
Number Sign	601494	CARDIOMYOPATHY, DILATED, 1D; CMD1D	LEFT VENTRICULAR NONCOMPACTION 6, INCLUDED; LVNC6, INCLUDED	
Number Sign	601495	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE; AGM1	AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO IGHM DEFECT	
Percent	601499	AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2	RIEGER SYNDROME, TYPE 2	
Number Sign	601518	PROSTATE CANCER, HEREDITARY, 1; HPC1	PRCA1	
Number Sign	601536	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS	NAVAJO BRAINSTEM SYNDROME	BOSLEY-SALIH-ALORAINY SYNDROME, INCLUDED; BSAS, INCLUDED
Percent	601537	MICROCEPHALY, RETINITIS PIGMENTOSA, AND SUTURAL CATARACT		
Number Sign	601539	PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	PEROXISOME BIOGENESIS DISORDER (NEONATAL ADRENOLEUKODYSTROPHY/INFANTILE REFSUM DISEASE);; PEROXISOME BIOGENESIS DISORDER (NALD/IRD);; ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL;; REFSUM DISEASE, INFANTILE;; INFANTILE PHYTANIC ACID STORAGE DISEASE	
Number Sign	601543	DEAFNESS, AUTOSOMAL DOMINANT 12; DFNA12	DEAFNESS, AUTOSOMAL DOMINANT 8; DFNA8	
Number Sign	601544	DEAFNESS, AUTOSOMAL DOMINANT 3A; DFNA3A		
Number Sign	601547	CATARACT 3, MULTIPLE TYPES; CTRCT3	CATARACT 3, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;; CATARACT, CONGENITAL, CERULEAN TYPE, 2; CCA2	
Percent	601549	ALACRIMA, CONGENITAL, AUTOSOMAL RECESSIVE		
Number Sign	601550	BLOOD GROUP--SWANN SYSTEM; SW	SWANN BLOOD GROUP	
Number Sign	601551	BLOOD GROUP--FROESE	FR;; FROESE BLOOD GROUP ANTIGEN	
Number Sign	601552	FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	TRABOULSI SYNDROME;; ECTOPIA LENTIS, SPONTANEOUS FILTERING BLEBS, AND CRANIOFACIAL DYSMORPHISM	
Number Sign	601553	HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD	HYPOTRICHOSIS WITH CONE-ROD DYSTROPHY	
Number Sign	601559	STUVE-WIEDEMANN SYNDROME	STWS; SWS;; SCHWARTZ-JAMPEL SYNDROME, TYPE 2; SJS2;; SCHWARTZ-JAMPEL SYNDROME, NEONATAL;; STUVE-WIEDEMANN/SCHWARTZ-JAMPEL TYPE 2 SYNDROME	
NULL	601560	MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH ROBIN PHENOTYPE	
NULL	601561	DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA		
NULL	601563	HORNS IN SHEEP	HO	
Number Sign	601583	WILMS TUMOR 5; WT5	WILMS TUMOR, SUSCEPTIBILITY TO; WTSL	
Number Sign	601596	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4C;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4C	
Number Sign	601606	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1	MFT1;; EPITHELIOMA ADENOIDES CYSTICUM OF BROOKE; EAC;; EPITHELIOMA, HEREDITARY MULTIPLE BENIGN CYSTIC;; BROOKE-FORDYCE TRICHOEPITHELIOMAS	
NULL	601608	SPASTIC PARAPLEGIA AND EVANS SYNDROME		
Percent	601612	LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME; LACHT	MARDINI-NYHAN ASSOCIATION	
Percent	601616	IRIS PIGMENT EPITHELIUM ANOMALIES	RUFFLES AND CYSTS OF IRIS PIGMENT EPITHELIUM;; CYSTS OF IRIS PIGMENT EPITHELIUM	
Number Sign	601626	LEUKEMIA, ACUTE MYELOID; AML	LEUKEMIA, ACUTE MYELOGENOUS	LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED
Number Sign	601631	ANTERIOR SEGMENT DYSGENESIS 3; ASGD3	IRIDOGONIODYSGENESIS, TYPE 1; IRID1;; IRIDOGONIODYSGENESIS ANOMALY, AUTOSOMAL DOMINANT; IGDA;; IRIS HYPOPLASIA WITH GLAUCOMA;; GLAUCOMA IRIDOGONIODYSPLASIA, FAMILIAL	
Number Sign	601634	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS	NTD, FOLATE-SENSITIVE	SPINA BIFIDA, FOLATE-SENSITIVE, INCLUDED
Number Sign	601650	PARAGANGLIOMAS 2; PGL2	GLOMUS TUMORS, FAMILIAL, 2	
Number Sign	601665	OBESITY		LEANNESS, INCLUDED
Percent	601666	DIABETES MELLITUS, INSULIN-DEPENDENT, 15; IDDM15	INSULIN-DEPENDENT DIABETES MELLITUS 15	
NULL	601668	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD		
Number Sign	601675	TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	TRICHOTHIODYSTROPHY, PHOTOSENSITIVE; TTDP;; ICHTHYOSIFORM ERYTHRODERMA WITH HAIR ABNORMALITY AND MENTAL AND GROWTH RETARDATION;; TAY SYNDROME;; TRICHOTHIODYSTROPHY WITH CONGENITAL ICHTHYOSIS; ICHTHYOSIS, CONGENITAL, WITH TRICHOTHIODYSTROPHY;; PIBIDS SYNDROME	
Percent	601676	ACUTE INSULIN RESPONSE	AIR	
Number Sign	601678	BARTTER SYNDROME, TYPE 1, ANTENATAL; BARTS1	HYPOKALEMIC ALKALOSIS WITH HYPERCALCIURIA 1, ANTENATAL;; HYPERPROSTAGLANDIN E SYNDROME 1	
Number Sign	601680	ARTHROGRYPOSIS, DISTAL, TYPE 2B; DA2B	ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE 2B;; SHELDON-HALL SYNDROME; SHS;; FREEMAN-SHELDON SYNDROME VARIANT; FSSV;; ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE II, WITH CRANIOFACIAL ABNORMALITIES	
Percent	601682	GLAUCOMA 1, PRIMARY OPEN ANGLE, C; GLC1C		
Percent	601694	LEPTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; LEPQTL1	LSL	
NULL	601696	NOVELTY SEEKING PERSONALITY TRAIT		RISK-TAKING BEHAVIOR, INCLUDED
Percent	601700	SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE		
NULL	601701	ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	TRICHOOCULODERMOVERTEBRAL SYNDROME;; TODV SYNDROME;; ALVES SYNDROME	
Number Sign	601705	T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY		
NULL	601706	YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME		
Number Sign	601707	CURRY-JONES SYNDROME; CRJS	CRANIOFACIAL MALFORMATIONS, ASYMMETRIC, WITH POLYSYNDACTYLY AND ABNORMAL SKIN AND GUT DEVELOPMENT	
NULL	601708	SUPERIOR TRANSVERSE SCAPULAR LIGAMENT, CALCIFICATION OF, FAMILIAL		
Number Sign	601709	QUEBEC PLATELET DISORDER; QPD	BLEEDING DISORDER, PLATELET-TYPE, 5; BDPLT5;; FACTOR V QUEBEC	
Number Sign	601718	RETINITIS PIGMENTOSA 19; RP19		
Number Sign	601744	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1; SLEB1		SYSTEMIC LUPUS ERYTHEMATOSUS, RESISTANCE TO, 1, INCLUDED
NULL	601759	PREAXIAL HALLUCAL POLYDACTYLY		
Percent	601764	SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	CONVULSIONS, BENIGN FAMILIAL INFANTILE, 1; BFIC1	
NULL	601775	FOLATE LEVEL IN ERYTHROCYTES		
Number Sign	601776	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	EDSMC;; ADDUCTED THUMB, CLUBFOOT, AND PROGRESSIVE JOINT AND SKIN LAXITY SYNDROME;; EHLERS-DANLOS SYNDROME, TYPE VIB, FORMERLY; EDS6B, FORMERLY;; ADDUCTED THUMB-CLUBFOOT SYNDROME; ATCS;; DUNDAR SYNDROME;; ARTHROGRYPOSIS, DISTAL, WITH PECULIAR FACIES AND HYDRONEPHROSIS	
Number Sign	601777	CONE-ROD DYSTROPHY 6; CORD6	RETINAL CONE DYSTROPHY 2; RCD2	
Number Sign	601780	CEROID LIPOFUSCINOSIS, NEURONAL, 6; CLN6	CEROID LIPOFUSCINOSIS, NEURONAL, 6, VARIABLE AGE AT ONSET	NEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, VARIANT, INCLUDED; vLINCL, INCLUDED
Percent	601794	COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME		
Number Sign	601800	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3; SHEP3	SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN;; SKIN/HAIR/EYE PIGMENTATION 3, FRECKLING;; SKIN/HAIR/EYE PIGMENTATION 3, BLUE/GREEN EYE COLOR;; EYE COLOR 1; EYCL1;; EYE COLOR, GREEN/BLUE; GEY	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8, INCLUDED
Number Sign	601803	PALLISTER-KILLIAN SYNDROME; PKS	TETRASOMY 12p, MOSAIC;; ISOCHROMOSOME 12p SYNDROME	HEXASOMY 12p, MOSAIC, INCLUDED
Number Sign	601808	CHROMOSOME 18q DELETION SYNDROME	CHROMOSOME 18q- SYNDROME;; 18q- SYNDROME	
NULL	601809	SPONDYLOSPINAL THORACIC DYSOSTOSIS		
NULL	601811	PREMATURE AGING SYNDROME, OKAMOTO TYPE		
Number Sign	601812	PREMATURE AGING SYNDROME, PENTTINEN TYPE; PENTT		
Number Sign	601813	EXUDATIVE VITREORETINOPATHY 4; EVR4		
Number Sign	601815	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY; PHGDHD	PHGDH DEFICIENCY	
Number Sign	601816	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1		
Number Sign	601820	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;; HYPERINSULINEMIC HYPOGLYCEMIA, PERSISTENT;; HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;; HYPERINSULINISM, NEONATAL;; HYPERINSULINISM, CONGENITAL;; HYPERINSULINISM, FAMILIAL;; NESIDIOBLASTOSIS	
NULL	601829	ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE		
Percent	601846	VACUOLAR NEUROMYOPATHY	MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	
Number Sign	601847	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2		
Percent	601853	GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	CEREBELLOTRIGEMINAL DERMAL DYSPLASIA CEREBELLO-TRIGEMINAL-DERMAL DYSPLASIA	
Number Sign	601859	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPS	CANALE-SMITH SYNDROME;; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE I, AUTOSOMAL DOMINANT	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA, INCLUDED; ALPS1A, INCLUDED;; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IB, INCLUDED; ALPS1B, INCLUDED;; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE I, AUTOSOMAL RECESSIVE, INCLUDED
Number Sign	601868	DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13		
Number Sign	601869	DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15	DEAFNESS, AUTOSOMAL RECESSIVE 72; DFNB72;; DEAFNESS, AUTOSOMAL RECESSIVE 95; DFNB95	
NULL	601876	SPERM-SPECIFIC ANTIGEN 1; SSFA1	FERTILIZATION ANTIGEN 1; FA1	
Number Sign	601884	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1; BMND1		HIGH BONE MASS, INCLUDED; HBM, INCLUDED;; OSTEOPOROSIS, SUSCEPTIBILITY TO, INCLUDED
Number Sign	601885	CATARACT 14, MULTIPLE TYPES; CTRCT14	CATARACT, ZONULAR PULVERULENT 3; CZP3;; CAE3	
Number Sign	601887	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	MHS5	
Percent	601888	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 6	MHS6	
Number Sign	601894	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2	GLOMERULAR NEPHRITIS, FAMILIAL, WITH FIBRONECTIN DEPOSITS;; FIBRONECTIN GLOMERULOPATHY	
Percent	601927	LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES	IRONS-BIANCHI SYNDROME;; LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	
Percent	601941	DIABETES MELLITUS, INSULIN-DEPENDENT, 6; IDDM6	INSULIN-DEPENDENT DIABETES MELLITUS 6	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 5, INCLUDED; AITD5, INCLUDED
Number Sign	601942	DIABETES MELLITUS, INSULIN-DEPENDENT, 10; IDDM10	INSULIN-DEPENDENT DIABETES MELLITUS 10	
Number Sign	601952	KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA; KLICK	KLICK SYNDROME	
Number Sign	601954	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G; LGMD2G		
NULL	601957	ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME	OTUDP SYNDROME	
NULL	601976	OTOFACIOOSSEOUS-GONADAL SYNDROME		
Number Sign	601977	THROMBOCYTHEMIA 2; THCYT2		
NULL	601979	HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION		
Percent	601992	FRIEDREICH ATAXIA 2; FRDA2		
Number Sign	602014	HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	HOMG;; HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA; HSH;; HYPOMAGNESEMIC TETANY;; HYPOMAGNESEMIA, INTESTINAL, WITH SECONDARY HYPOCALCEMIA	
Number Sign	602025	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9	OBESITY, SUSCEPTIBILITY TO	
Number Sign	602032	ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE; ECTD4	ECTODERMAL DYSPLASIA, 'PURE' HAIR/NAIL TYPE	
Number Sign	602066	CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS; ICCA	INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;; ICCA SYNDROME;; PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	
NULL	602068	LEISHMANIASIS, TEGUMENTARY, SUSCEPTIBILITY TO		
Percent	602071	BROAD TERMINAL PHALANGES, FAMILIAL		
Number Sign	602078	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	FEOM2 LOCUS;; FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, AUTOSOMAL RECESSIVE	
Number Sign	602079	TRIMETHYLAMINURIA; TMAU	FISH-ODOR SYNDROME	
Number Sign	602080	PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2		
Number Sign	602081	SPEECH-LANGUAGE DISORDER 1; SPCH1	CHILDHOOD APRAXIA OF SPEECH; CAS;; DEVELOPMENTAL VERBAL DYSPRAXIA; DVD;; SPEECH AND LANGUAGE DISORDER WITH OROFACIAL DYSPRAXIA	
Number Sign	602082	CORNEAL DYSTROPHY, THIEL-BEHNKE TYPE; CDTB	THIEL-BEHNKE CORNEAL DYSTROPHY; TBCD;; CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II; CDB2;; CORNEAL DYSTROPHY, HONEYCOMB-SHAPED	
Number Sign	602083	USHER SYNDROME, TYPE IF; USH1F		
Percent	602085	POLYDACTYLY, POSTAXIAL, TYPE A2; PAPA2	POSTAXIAL POLYDACTYLY, TYPE A2	
Percent	602086	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 3; ARVD3	ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 3; ARVC3	
Percent	602087	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 4; ARVD4	ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 4; ARVC4	
Number Sign	602088	NEPHRONOPHTHISIS 2; NPHP2	NPH2	
Number Sign	602089	HEMANGIOMA, CAPILLARY INFANTILE	HCI;; HEMANGIOMA, HEREDITARY CAPILLARY	
Number Sign	602092	DEAFNESS, AUTOSOMAL RECESSIVE 18A; DFNB18A	DEAFNESS, AUTOSOMAL RECESSIVE 18; DFNB18	
Number Sign	602093	CONE DYSTROPHY 3; COD3	RETINAL CONE DYSTROPHY	CONE-ROD DYSTROPHY 14, INCLUDED; CORD14, INCLUDED
Percent	602096	ALZHEIMER DISEASE 5	AD5;; ALZHEIMER DISEASE, FAMILIAL, 5	
Percent	602097	USHER SYNDROME, TYPE IE; USH1E		
Number Sign	602099	AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5		
NULL	602107	NEUROPATHY, HEREDITARY THERMOSENSITIVE		
Number Sign	602111	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	SEMD, MISSOURI TYPE	METAPHYSEAL ANADYSPLASIA 1, INCLUDED; MANDP1, INCLUDED
NULL	602114	NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVER DISEASE		
Percent	602124	DYSTONIA 7, TORSION; DYT7	TORSION DYSTONIA, FOCAL ADULT-ONSET	CERVICAL DYSTONIA, PRIMARY, INCLUDED
Percent	602134	TREMOR, HEREDITARY ESSENTIAL, 2; ETM2		
NULL	602152	RHYNS SYNDROME	RETINITIS PIGMENTOSA SYNDROME;; RETINITIS PIGMENTOSA, HYPOPITUITARISM, NEPHRONOPHTHISIS, AND MILD SKELETAL DYSPLASIA	
Percent	602196	PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	SKELETAL DYSPLASIA RELATED TO CAMPOMELIC DYSPLASIA;; CAMPOMELIC DYSPLASIA, MILD	
NULL	602197	CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 3	CDR3	
Percent	602199	MEDIUM CHAIN 3-KETOACYL-CoA THIOLASE DEFICIENCY	MCKAT DEFICIENCY	
Percent	602200	VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY		
Percent	602247	XANTHOMATOSIS, SUSCEPTIBILITY TO		
Percent	602248	MALIGNANT ATROPHIC PAPULOSIS	DEGOS DISEASE;; PAPULOSIS, MALIGNANT ATROPHIC	
NULL	602249	PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES		
NULL	602252	MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TIM12, YEAST, HOMOLOG OF		
Number Sign	602271	SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	SMD, AXIAL;; AXIAL SMD	
NULL	602340	SENSORINEURAL HEARING LOSS, RETINAL PIGMENT EPITHELIUM LESIONS, DISCOLORED TEETH		
Number Sign	602342	PIERPONT SYNDROME; PRPTS	PLANTAR LIPOMATOSIS, UNUSUAL FACIES, AND DEVELOPMENTAL DELAY	
Number Sign	602347	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	MDR3 DEFICIENCY;; CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, WITH ELEVATED SERUM GAMMA-GLUTAMYLTRANSFERASE	
Number Sign	602361	GRACILE BONE DYSPLASIA; GCLEB	SKELETAL DYSPLASIA, LETHAL, WITH GRACILE BONES;; OSTEOCRANIOSPLENIC SYNDROME;; OSTEOCRANIOSTENOSIS;; HABRODYSPLASIA	
Number Sign	602390	HEMOCHROMATOSIS, TYPE 2A; HFE2A		HEMOCHROMATOSIS, TYPE 2, INCLUDED; HFE2, INCLUDED;; HEMOCHROMATOSIS, JUVENILE, INCLUDED; JH, INCLUDED
Number Sign	602398	DESMOSTEROLOSIS		
Number Sign	602400	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	ICHTHYOSIS WITH HYPOTRICHOSIS, AUTOSOMAL RECESSIVE; ARIH;; ICHTHYOSIS AND FOLLICULAR ATROPHODERMA WITH HYPOTRICHOSIS AND HYPOHIDROSIS; IFAH	
Percent	602401	ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE; ECTD8		
Percent	602404	PARKINSON DISEASE 3, AUTOSOMAL DOMINANT; PARK3	PARKINSON DISEASE 3, AUTOSOMAL DOMINANT LEWY BODY	
NULL	602418	WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME		
Percent	602429	GLAUCOMA 1, OPEN ANGLE, D; GLC1D	GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET	
Number Sign	602433	AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4	NEURONOPATHY, DISTAL HEREDITARY MOTOR, WITH PYRAMIDAL FEATURES	
Percent	602440	AMYOTROPHY, MONOMELIC	HIRAYAMA DISEASE;; SPINAL MUSCULAR ATROPHY, JUVENILE, NONPROGRESSIVE	
Number Sign	602450	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	RS-SCID;; SCID, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE, WITH SENSITIVITY TO IONIZING RADIATION	SEVERE COMBINED IMMUNODEFICIENCY, ATHABASKAN-TYPE, INCLUDED; SCIDA, INCLUDED;; ATHABASKAN SEVERE COMBINED IMMUNODEFICIENCY, INCLUDED;; SEVERE COMBINED IMMUNODEFICIENCY, PARTIAL, INCLUDED
Number Sign	602459	DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15		
Number Sign	602471	SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, AND SKELETAL ABNORMALITIES; SAMS		
NULL	602472	CREASES, INFRA-AURICULAR CUTANEOUS, WITH TALL STATURE AND ADVANCED BONE AGE		
Number Sign	602473	ENCEPHALOPATHY, ETHYLMALONIC; EE		
Percent	602475	OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL		
Percent	602477	FEBRILE SEIZURES, FAMILIAL, 2; FEB2	CONVULSIONS, FAMILIAL FEBRILE, 2	
Number Sign	602481	MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	MHP2	MIGRAINE, FAMILIAL BASILAR, INCLUDED
Number Sign	602482	AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3	AXENFELD-RIEGER ANOMALY WITH CARDIAC DEFECTS AND/OR SENSORINEURAL HEARING LOSS;; ANTERIOR CHAMBER CLEAVAGE SYNDROME;; RIEGER SYNDROME, TYPE 3	
Number Sign	602483	AURICULOCONDYLAR SYNDROME 1; ARCND1	QUESTION MARK EARS SYNDROME	
NULL	602484	PELVIC HYPOPLASIA WITH LOWER-LIMB ARTHROGRYPOSIS		
Number Sign	602485	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3		
Number Sign	602491	HYPERLIPIDEMIA, COMBINED, 1	HYPLIP1;; HYPERLIPIDEMIA, FAMILIAL COMBINED, 1; FCHL1	
NULL	602497	CHONDRODYSPLASIA PUNCTATA, BRACHYTELEPHALANGIC, AUTOSOMAL	BRACHYTELEPHALANGIC CHONDRODYSPLASIA PUNCTATA; BCDP	
Percent	602499	MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM		
Number Sign	602501	MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP	MACROCEPHALY-CAPILLARY MALFORMATION; MCM;; MEGALENCEPHALY-CAPILLARY MALFORMATION SYNDROME;; MACROCEPHALY-CUTIS MARMORATA TELANGIECTATICA CONGENITA; MCMTC;; MEGALENCEPHALY-CUTIS MARMORATA TELANGIECTATICA CONGENITA	
NULL	602511	PSEUDOACROMEGALY WITH SEVERE INSULIN RESISTANCE		
Number Sign	602522	BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4A	BARTTER SYNDROME, NEONATAL, WITH SENSORINEURAL DEAFNESS; BSND	SENSORINEURAL DEAFNESS WITH MILD RENAL DYSFUNCTION, INCLUDED
Number Sign	602531	GRANGE SYNDROME; GRNG	ARTERIAL OCCLUSIVE DISEASE, PROGRESSIVE, WITH HYPERTENSION, HEART DEFECTS, BONE FRAGILITY, AND BRACHYSYNDACTYLY;; GRANGE OCCLUSIVE ARTERIAL SYNDROME	
Number Sign	602535	MARSHALL-SMITH SYNDROME; MRSHSS		
Number Sign	602540	ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS	HID SYNDROME	
Number Sign	602541	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC	MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	
NULL	602551	JEJUNAL ATRESIA WITH RENAL ADYSPLASIA		
NULL	602553	ANAL ATRESIA, HYPOSPADIAS, AND PENOSCROTAL INVERSION		
NULL	602554	TORSION DYSTONIA WITH ONSET IN INFANCY		
NULL	602555	MICROCEPHALY, MACROTIA, AND MENTAL RETARDATION		
NULL	602556	FACIAL DYSMORPHISM, CLEFT PALATE, HEARING LOSS, AND CAMPTODACTYLY		
NULL	602557	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	SEMD, SHOHAT TYPE	
NULL	602558	CRANIOMICROMELIC SYNDROME		
NULL	602561	BRACHYDACTYLY, INTRAVENTRICULAR SEPTAL DEFECT, AND DEAFNESS		
NULL	602562	MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	VERLOES-LESENFANTS SYNDROME;; MACROBLEPHARON, ECTROPION, HYPERTELORISM, AND MACROSTOMIA; MEHM	
NULL	602564	EMPHYSEMA, CONGENITAL, WITH DEAFNESS, PENOSCROTAL WEB, AND MENTAL RETARDATION		
Number Sign	602579	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	CDG Ib; CDGIb;; CDG, GASTROINTESTINAL TYPE;; MANNOSEPHOSPHATE ISOMERASE DEFICIENCY;; MPI DEFICIENCY;; PROTEIN-LOSING ENTEROPATHY-HEPATIC FIBROSIS SYNDROME;; SAGUENAY-LAC SAINT-JEAN SYNDROME;; SLSJ SYNDROME	
Number Sign	602588	BRANCHIOOTIC SYNDROME 1; BOS1	BO SYNDROME 1;; BRANCHIOOTIC DYSPLASIA	ANTERIOR SEGMENT ANOMALIES WITH OR WITHOUT CATARACT, INCLUDED
Percent	602594	RETINITIS PIGMENTOSA 22; RP22		
NULL	602596	PANCREATIC LYMPHOMA, FAMILIAL		
NULL	602611	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CORONAL CRANIOSYNOSTOSIS, CATARACTS, CLEFT PALATE, AND MENTAL RETARDATION		
NULL	602612	CAMPTODACTYLY, MYOPIA, AND FIBROSIS OF THE MEDIAL RECTUS MUSCLE OF EYE		
NULL	602613	SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL		
Number Sign	602629	DYSTONIA 6, TORSION; DYT6	TORSION DYSTONIA, ADULT-ONSET, MIXED TYPE	
Percent	602639	TOOTH AGENESIS, SELECTIVE, 2; STHAG2	HYPODONTIA/OLIGODONTIA 2; HYD2	
Number Sign	602668	MYOTONIC DYSTROPHY 2; DM2	DYSTROPHIA MYOTONICA 2;; PROXIMAL MYOTONIC MYOPATHY; PROMM;; MYOTONIC MYOPATHY, PROXIMAL;; RICKER SYNDROME	
Percent	602685	MENTAL RETARDATION, SEVERE, WITH SPASTICITY AND PIGMENTARY TAPETORETINAL DEGENERATION	MRST	
Number Sign	602722	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR	RTA, DISTAL, AUTOSOMAL RECESSIVE;; RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARING	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSET SENSORINEURAL HEARING LOSS, INCLUDED
Number Sign	602723	PSORIASIS 2; PSORS2		
Percent	602759	PROSTATE CANCER, HEREDITARY, 8	HPC8;; PREDISPOSING FOR PROSTATE CANCER; PCAP	
Number Sign	602771	RIGID SPINE MUSCULAR DYSTROPHY 1; RSMD1	RIGID SPINE SYNDROME; RSS;; MYOPATHY, SEPN1-RELATED;; MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE, WITH EARLY SPINE RIGIDITY; MDRS1;; MULTICORE MYOPATHY, SEVERE CLASSIC FORM;; MINICORE MYOPATHY, SEVERE CLASSIC FORM;; MULTIMINICORE DISEASE, SEVERE CLASSIC FORM;; DESMIN-RELATED MYOPATHY WITH MALLORY BODIES;; MUSCULAR DYSTROPHY, CONGENITAL, EICHSFELD TYPE	
Number Sign	602772	RETINITIS PIGMENTOSA 25; RP25		
Number Sign	602782	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	HISTIOCYTOSIS AND LYMPHADENOPATHY WITH OR WITHOUT CUTANEOUS, CARDIAC, AND/OR ENDOCRINE FEATURES, JOINT CONTRACTURES, AND/OR DEAFNESS;; HYPERPIGMENTATION, CUTANEOUS, WITH HYPERTRICHOSIS, HEPATOSPLENOMEGALY, HEART ANOMALIES, AND HYPOGONADISM WITH OR WITHOUT HEARING LOSS;; H SYNDROME;; PIGMENTED HYPERTRICHOSIS WITH INSULIN-DEPENDENT DIABETES MELLITUS; PHID;; HISTIOCYTOSIS WITH JOINT CONTRACTURES AND SENSORINEURAL DEAFNESS; HJCD;; FAISALABAD HISTIOCYTOSIS;; ROSAI-DORFMAN DISEASE, FAMILIAL;; SINUS HISTIOCYTOSIS AND MASSIVE LYMPHADENOPATHY; SHML	
Number Sign	602849	MUENKE SYNDROME; MNKES	MUENKE NONSYNDROMIC CORONAL CRANIOSYNOSTOSIS	
Number Sign	602875	ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDM	ST. HELENA DYSPLASIA	
Percent	602966	OROFACIAL CLEFT 2; OFC2	CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 2	
NULL	602994	LEUKOREGULIN		
Percent	603003	BILE DUCT CYSTS	CHOLEDOCHAL CYSTS;; CHOLEDOCHOCELE	
Percent	603010	DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17		
Percent	603013	SCHIZOPHRENIA 6; SCZD6	SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 8p-RELATED	
Number Sign	603034	MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY; EAD;; ENGEL CONGENITAL MYASTHENIC SYNDROME;; MYASTHENIC SYNDROME, CONGENITAL, ENGEL TYPE;; CONGENITAL MYASTHENIC SYNDROME TYPE Ic, FORMERLY; CMS1C, FORMERLY;; CMS Ic, FORMERLY	
Percent	603040	TUMOR SUPPRESSOR GENE ON CHROMOSOME 11	TSG11;; NONSMALL CELL LUNG CANCER SUPPRESSOR	
Number Sign	603041	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME, TYMP-RELATED;; MNGIE, TYMP-RELATED;; MYONEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME;; POLYNEUROPATHY, OPHTHALMOPLEGIA, LEUKOENCEPHALOPATHY, AND INTESTINAL PSEUDOOBSTRUCTION;; POLIP SYNDROME	
Percent	603047	ASTIGMATISM		
Number Sign	603075	MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	MACULOPATHY, AGE-RELATED, 1	
Percent	603098	DEAFNESS, AUTOSOMAL RECESSIVE 13; DFNB13		
Percent	603116	CDAGS SYNDROME	CRANIOSYNOSTOSIS, ANAL ANOMALIES, AND POROKERATOSIS;; CAP SYNDROME	
NULL	603117	SPASTIC PARAPLEGIA, OPTIC ATROPHY, MICROCEPHALY, AND XY SEX REVERSAL		
NULL	603119	APRAXIA OF EYELID OPENING		
NULL	603133	DISLOCATED ELBOWS, BOWED TIBIAS, SCOLIOSIS, DEAFNESS, CATARACT, MICROCEPHALY, AND MENTAL RETARDATION		
Number Sign	603147	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	CDG Ic; CDGIc;; CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE I, WITH DEFICIENT GLYCOSYLATION OF DOLICHOL-LINKED OLIGOSACCHARIDE, FORMERLY;; CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE V, FORMERLY; CDGS5, FORMERLY	
Percent	603165	DERMATITIS, ATOPIC	ATOD;; ECZEMA, ATOPIC	DERMATITIS, ATOPIC, 1, INCLUDED; ATOD1, INCLUDED
NULL	603174	HOMOCYSTEINEMIA	HYPERHOMOCYSTEINEMIA	
Percent	603175	SCHIZOPHRENIA 5; SCZD5	SCHIZOPHRENIA 5 WITH OR WITHOUT AN AFFECTIVE DISORDER;; SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6q-RELATED	
Percent	603176	SCHIZOPHRENIA 7; SCZD7	SCHIZOPHRENIA 7 WITH OR WITHOUT AN AFFECTIVE DISORDER;; SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 13q-RELATED	
Percent	603188	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 8; BMIQ8	OBESITY, SUSCEPTIBILITY TO	
Number Sign	603194	MECKEL SYNDROME, TYPE 2; MKS2	MECKEL-GRUBER SYNDROME, TYPE 2	
Percent	603204	EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2		
Percent	603206	SCHIZOPHRENIA 8; SCZD8	SCHIZOPHRENIA 8 WITH OR WITHOUT AN AFFECTIVE DISORDER;; SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 18-RELATED	
NULL	603209	CYTIDINE MONOPHOSPHO-N-ACETYLNEURAMINIC ACID HYDROXYLASE, PSEUDOGENE; CMAHP	CMAH;; CMP-NeuAc HYDROXYLASE;; CMP-Neu5Ac HYDROXYLASE;; CMP-SIALIC ACID HYDROXYLASE; CSAH	
Number Sign	603218	HUNTINGTON DISEASE-LIKE 1; HDL1	HUNTINGTON-LIKE NEURODEGENERATIVE DISORDER 1; HLN1;; HUNTINGTON-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL DOMINANT;; PRION DISEASE, EARLY-ONSET, WITH PROMINENT PSYCHIATRIC FEATURES	
Percent	603221	MYOPIA 3, AUTOSOMAL DOMINANT; MYP3		
Number Sign	603233	PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B	PHP IB	
Percent	603266	DIABETES MELLITUS, INSULIN-DEPENDENT, 17; IDDM17	INSULIN-DEPENDENT DIABETES MELLITUS 17	
Number Sign	603278	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1; FSGS1	GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 1	
NULL	603282	ZINC FINGER PROTEIN 204; ZNF204		ZINC FINGER PROTEIN 204 PSEUDOGENE, INCLUDED;; ZNF204 PSEUDOGENE, INCLUDED
Number Sign	603284	CEREBRAL CAVERNOUS MALFORMATIONS 2; CCM2		
Number Sign	603285	CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3		
NULL	603323	MUSCULAR DYSTROPHY, CONGENITAL, WITH CEREBELLAR ATROPHY		
Percent	603342	SCHIZOPHRENIA 2; SCZD2	SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 11q-RELATED	
Number Sign	603358	GRACILE SYNDROME	GROWTH RETARDATION, AMINO ACIDURIA, CHOLESTASIS, IRON OVERLOAD, LACTIC ACIDOSIS, AND EARLY DEATH;; FINNISH LETHAL NEONATAL METABOLIC SYNDROME; FLNMS;; LACTIC ACIDOSIS, FINNISH, WITH HEPATIC HEMOSIDEROSIS;; FELLMAN SYNDROME	
Number Sign	603373	HYPERTHYROIDISM, FAMILIAL GESTATIONAL		
NULL	603376	LONG CHAIN FATTY ACIDS, DEFECT IN TRANSPORT OF		
Number Sign	603383	GLAUCOMA 1, OPEN ANGLE, F; GLC1F	GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET	
Percent	603386	THYROID CARCINOMA, NONMEDULLARY, WITH OR WITHOUT CELL OXYPHILIA	TCO;; TCO1	
Number Sign	603387	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1; MPPH1	MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME; MPPH;; MEG-PMG-MEGACC SYNDROME;; MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	
Percent	603388	GRAVES DISEASE, SUSCEPTIBILITY TO, 2	GRD2	
NULL	603389	OSEBOLD SKELETAL DYSPLASIA/OSTEOLYSIS SYNDROME		
NULL	603393	OSTEOSCLEROTIC CHONDRODYSPLASIA, LETHAL, WITH INTRACELLULAR INCLUSIONS		
NULL	603394	MICROCEPHALY, SEVERE, WITH SKELETAL ANOMALIES INCLUDING POSTERIOR RIB-GAP DEFECTS		
NULL	603396	TONOKI SYNDROME		
NULL	603416	RIBOSOMAL PROTEIN L21 PSEUDOGENE 1; RPL21P1		
NULL	603438	RADIOULNAR SYNOSTOSIS WITH MICROCEPHALY, SHORT STATURE, SCOLIOSIS, AND MENTAL RETARDATION	TSUKAHARA SYNDROME;; GIUFFRE-TSUKAHARA SYNDROME	
NULL	603439	EXPANSILE BONE LESIONS		
NULL	603446	OROACRAL SYNDROME, VERLOES-KOULISCHER TYPE		
Number Sign	603457	BOSMA ARHINIA MICROPHTHALMIA SYNDROME; BAMS	ARHINIA, CHOANAL ATRESIA, MICROPHTHALMIA, AND HYPOGONADOTROPIC HYPOGONADISM	
NULL	603463	HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARING LOSS		
Number Sign	603467	FANCONI ANEMIA, COMPLEMENTATION GROUP F; FANCF		
Number Sign	603471	CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2	CITRIN DEFICIENCY	
NULL	603472	NEURONAL INTRANUCLEAR INCLUSION DISEASE	NIID	
Number Sign	603511	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E; LGMD1E	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1D, FORMERLY; LGMD1D, FORMERLY	
Number Sign	603513	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 1; CPSQ1		
Number Sign	603516	SPINOCEREBELLAR ATAXIA 10; SCA10		
NULL	603523	CHYLOTHORAX, CONGENITAL	HYDROTHORAX, CONGENITAL	
NULL	603529	DYSERYTHROPOIESIS, CONGENITAL, WITH ULTRASTRUCTURALLY NORMAL ERYTHROBLAST HETEROCHROMATIN		
NULL	603530	LIGHT FIXATION SEIZURE SYNDROME	LFSS;; M SYNDROME	
Number Sign	603543	LIMB-MAMMARY SYNDROME; LMS		
Number Sign	603546	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2; SEMDJL2	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, HALL TYPE;; SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, LEPTODACTYLIC TYPE;; SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS, HALL TYPE	
Number Sign	603552	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4	HPLH4;; HLH4	
Number Sign	603553	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2	HPLH2;; HLH2	
Number Sign	603554	OMENN SYNDROME	RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;; SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	
Number Sign	603563	SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8		
NULL	603569	TRACHEOBRONCHIAL STENOSIS, CONGENITAL		
NULL	603572	MICROCEPHALY, FACIAL ABNORMALITIES, MICROMELIA, AND MENTAL RETARDATION		
Number Sign	603585	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	CDG IIf; CDGIIf	
NULL	603587	FOLLICULAR ATROPHODERMA, PERIORAL PIGMENTED, WITH MILIA AND EPIDERMOID CYSTS		
NULL	603588	PAROTITIS, JUVENILE RECURRENT		
NULL	603589	FACIAL DYSMORPHISM, SELECTIVE TOOTH AGENESIS, AND CHOROID CALCIFICATION		
Number Sign	603592	XANTHINURIA, TYPE II; XAN2	XANTHINE DEHYDROGENASE AND ALDEHYDE OXIDASE, COMBINED DEFICIENCY OF	
NULL	603595	CRANIOSYNOSTOSIS WITH ECTOPIA LENTIS		
Number Sign	603596	POLYDACTYLY		
NULL	603600	OSTEOMA OF CRANIAL VAULT, FAMILIAL		
Number Sign	603622	DEAFNESS, AUTOSOMAL DOMINANT 17; DFNA17		COCHLEOSACCULAR DEGENERATION, INCLUDED
Number Sign	603629	DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21		
NULL	603641	NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA		
NULL	603642	ATRIAL SEPTAL DEFECT, SECUNDUM, WITH VARIOUS CARDIAC AND NONCARDIAC DEFECTS		
NULL	603643	SITUS INVERSUS TOTALIS WITH CYSTIC DYSPLASIA OF KIDNEYS AND PANCREAS		
Number Sign	603649	CONE-ROD DYSTROPHY 7; CORD7		
NULL	603656	EXOSTOSIS, DUPUYTREN SUBUNGUAL		
Percent	603663	MENTAL HEALTH WELLNESS 1	MHW1	
NULL	603664	MENTAL HEALTH WELLNESS 2	MHW2	
NULL	603669	ECCRINE SYRINGOFIBROADENOMATOSIS WITH EYELID ABNORMALITIES		
NULL	603670	BLUE NEVI, FAMILIAL MULTIPLE		
Number Sign	603671	ACROMELIC FRONTONASAL DYSOSTOSIS; AFND		
Percent	603678	DEAFNESS, AUTOSOMAL RECESSIVE 14; DFNB14		
Number Sign	603688	PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY	PCBC;; CAPB	
Number Sign	603689	HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE; HMERF	MYOPATHY, PROXIMAL, WITH EARLY RESPIRATORY MUSCLE INVOLVEMENT; MPRM;; EDSTROM MYOPATHY	
Percent	603694	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 3	NIDDM3;; NONINSULIN-DEPENDENT DIABETES MELLITUS 3	
Number Sign	603720	DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16		
Number Sign	603736	OHDO SYNDROME, SBBYS VARIANT; SBBYSS	SAY-BARBER-BIESECKER-YOUNG-SIMPSON SYNDROME;; YOUNG-SIMPSON SYNDROME; YSS	
NULL	603737	OVARIAN GERM CELL CANCER		
NULL	603740	ACRODYSPLASIA WITH OSSIFICATION ABNORMALITIES, SHORT STATURE, AND FIBULAR HYPOPLASIA		
NULL	603744	PAPILLARY THYROID MICROCARCINOMA		
Number Sign	603776	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3	FH3	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1, INCLUDED; LDLCQ1, INCLUDED
Percent	603783	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1	INTLQ1;; COGNITIVE ABILITY, GENERAL	SELF-PERCEIVED ABILITY, INCLUDED
Number Sign	603786	STARGARDT DISEASE 4; STGD4		
NULL	603794	HYDROA VACCINIFORME, FAMILIAL		
Percent	603802	MICROCEPHALY WITH SIMPLIFIED GYRAL PATTERN		
NULL	603806	URINARY TRACT INFECTIONS, RECURRENT, SUSCEPTIBILITY TO		
Number Sign	603813	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE, 1, FORMERLY; ARH1, FORMERLY;; FHCB1, FORMERLY;; HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE, 2, FORMERLY; ARH2, FORMERLY;; FHCB2, FORMERLY	
NULL	603828	BRITTLE BONE DISORDER		
Number Sign	603829	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1	VF;; IVF	VENTRICULAR FIBRILLATION DURING MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, INCLUDED
Number Sign	603830	LONG QT SYNDROME 3; LQT3		LONG QT SYNDROME 3, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;; LONG QT SYNDROME 2/3, DIGENIC, INCLUDED; LQT2/3, DIGENIC, INCLUDED;; LONG QT SYNDROME 3/6, DIGENIC, INCLUDED; LQT3/6, DIGENIC, INCLUDED
Percent	603855	CYSTIC FIBROSIS, MODIFIER OF, 1; CFM1		MECONIUM ILEUS IN CYSTIC FIBROSIS, SUSCEPTIBILITY TO, INCLUDED
Number Sign	603860	MEDULLARY CYSTIC KIDNEY DISEASE 2; MCKD2	MEDULLARY CYSTIC KIDNEY DISEASE 2, AUTOSOMAL DOMINANT; ADMCKD2	
Number Sign	603896	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	CHILDHOOD ATAXIA WITH CENTRAL NERVOUS SYSTEM HYPOMYELINIZATION; CACH;; VANISHING WHITE MATTER LEUKODYSTROPHY;; CREE LEUKOENCEPHALOPATHY; CLE	VANISHING WHITE MATTER LEUKODYSTROPHY WITH OVARIAN FAILURE, INCLUDED;; OVARIOLEUKODYSTROPHY, INCLUDED
Number Sign	603902	BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE	DYSERYTHROPOIETIC ANEMIA, CONGENITAL, IRISH OR WEATHERALL TYPE	
Number Sign	603903	SICKLE CELL ANEMIA		
Number Sign	603909	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA; ALPS2A	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE II; ALPS2	
Percent	603918	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 1	HYT1	
Number Sign	603932	INTERVERTEBRAL DISC DISEASE; IDD		LUMBAR DISC DISEASE, INCLUDED; LDD, INCLUDED;; LUMBAR DISC HERNIATION, SUSCEPTIBILITY TO, INCLUDED;; LUMBAR DISC DEGENERATION, SUSCEPTIBILITY TO, INCLUDED
Number Sign	603933	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1; MVCD1	PROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO;; NONPROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, INCLUDED;; MICROVASCULAR COMPLICATIONS OF DIABETES, PROTECTION AGAINST, INCLUDED;; NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO, INCLUDED;; END-STAGE RENAL DISEASE, DIABETIC, SUSCEPTIBILITY TO, INCLUDED;; PROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO, INCLUDED;; NONPROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO, INCLUDED;; NEUROPATHY, DIABETIC, SUSCEPTIBILITY TO, INCLUDED
Percent	603935	PSORIASIS 4, SUSCEPTIBILITY TO; PSORS4		
Number Sign	603956	CERVICAL CANCER		
Percent	603964	DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16		
Number Sign	603965	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 2	
Number Sign	604004	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1	VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;; LVM;; VL;; LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;; VAN DER KNAAP DISEASE	
Percent	604060	DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20		
Number Sign	604091	HYPOALPHALIPOPROTEINEMIA, PRIMARY	HYPOALPHALIPOPROTEINEMIA, FAMILIAL; FHA;; HIGH DENSITY LIPOPROTEIN DEFICIENCY; HDLD;; FAMILIAL HDL DEFICIENCY; FHD;; HDL CHOLESTEROL, LOW SERUM; HDLC	
Number Sign	604093	KERATOSIS PILARIS ATROPHICANS; KPA		
Number Sign	604116	CONE-ROD DYSTROPHY 3; CORD3		
Number Sign	604117	VOHWINKEL SYNDROME, VARIANT FORM	VOHWINKEL SYNDROME WITH ICHTHYOSIS;; MUTILATING KERATODERMA WITH ICHTHYOSIS;; LORICRIN KERATODERMA	
Number Sign	604121	CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN		
Number Sign	604129	EPIDERMOLYSIS BULLOSA PRURIGINOSA	DYSTROPHIC EPIDERMOLYSIS BULLOSA PRURIGINOSA;; DEB, PRURIGINOSA	
Number Sign	604131	ALPHA-THALASSEMIA		
Number Sign	604145	CARDIOMYOPATHY, DILATED, 1G; CMD1G		
NULL	604154	ALZHEIMER DISEASE WITHOUT NEUROFIBRILLARY TANGLES		
Number Sign	604168	CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	CATARACT, CONGENITAL, WITH FACIAL DYSMORPHISM AND NEUROPATHY	
Number Sign	604169	LEFT VENTRICULAR NONCOMPACTION 1; LVNC1	LEFT VENTRICULAR NONCOMPACTION 1 WITH OR WITHOUT CONGENITAL HEART DEFECTS	
NULL	604172	CARONTE	CAR	
Number Sign	604173	POIKILODERMA WITH NEUTROPENIA; PN	POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	
NULL	604183	CHOLESTEATOMA, CONGENITAL		
Percent	604185	FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	MOEBIUS SYNDROME 3, FORMERLY; MBS3, FORMERLY;; MOBIUS SYNDROME 3, FORMERLY	
Number Sign	604187	SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10	SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	
Percent	604201	HEPATIC FIBROSIS, SEVERE, SUSCEPTIBILITY TO, DUE TO SCHISTOSOMA MANSONI INFECTION	SM2	HEPATIC FIBROSIS, SEVERE, SUSCEPTIBILITY TO, DUE TO SCHISTOSOMA JAPONICUM INFECTION, INCLUDED
NULL	604211	HIRSCHSPRUNG DISEASE WITH HEART DEFECTS, LARYNGEAL ANOMALIES, AND PREAXIAL POLYDACTYLY		
Number Sign	604213	CHUDLEY-MCCULLOUGH SYNDROME; CMCS	DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUM AND ARACHNOID CYSTS;; DEAFNESS, AUTOSOMAL RECESSIVE 82, FORMERLY; DFNB82, FORMERLY	
Number Sign	604218	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	ENCEPHALOPATHY, FAMILIAL, WITH COLLINS BODIES	
Number Sign	604219	CATARACT 9, MULTIPLE TYPES; CTRCT9	CATARACT 9, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;; CATARACT, AUTOSOMAL DOMINANT;; CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 1; CATC1	
Number Sign	604229	ANTERIOR SEGMENT DYSGENESIS 5; ASGD5		
Number Sign	604232	LEBER CONGENITAL AMAUROSIS 3; LCA3		RETINITIS PIGMENTOSA, JUVENILE, SPATA7-RELATED, INCLUDED
Number Sign	604233	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1	GEFS+, TYPE 1; GEFS+1	
Number Sign	604250	HEMOCHROMATOSIS, TYPE 3; HFE3	HEMOCHROMATOSIS DUE TO DEFECT IN TRANSFERRIN RECEPTOR 2	
Percent	604254	DYSLEXIA, SUSCEPTIBILITY TO, 3; DYX3		
NULL	604257	CAMERA-MARUGO-COHEN SYNDROME		
Number Sign	604271	GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP		
Number Sign	604273	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATPAF2 TYPE	
Number Sign	604278	RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION	RTA, PROXIMAL, AUTOSOMAL RECESSIVE	
Number Sign	604286	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E; LGMD2E		
NULL	604287	CARNEY TRIAD	GASTRIC LEIOMYOSARCOMA, PULMONARY CHONDROMA, AND EXTRAADRENAL PARAGANGLIOMA	
Percent	604288	CARDIOMYOPATHY, DILATED, 1H; CMD1H	CARDIOMYOPATHY, DILATED, WITH CONDUCTION DEFECT	
Number Sign	604290	ACERULOPLASMINEMIA		HYPOCERULOPLASMINEMIA, INCLUDED;; CERULOPLASMIN DEFICIENCY, INCLUDED;; HEMOSIDEROSIS, SYSTEMIC, DUE TO ACERULOPLASMINEMIA, INCLUDED
NULL	604291	ASCARIS LUMBRICOIDES INFECTION, SUSCEPTIBILITY TO	ASCARIASIS, SUSCEPTIBILITY TO	
Number Sign	604292	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	EEC SYNDROME 3	
Number Sign	604302	RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE	SYSTEMIC JUVENILE RHEUMATOID ARTHRITIS	
Number Sign	604307	CATARACT 2, MULTIPLE TYPES; CTRCT2	CATARACT 2, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;; CATARACT, COPPOCK-LIKE; CCL	
Number Sign	604308	MASS SYNDROME	MASS PHENOTYPE;; OVERLAP CONNECTIVE TISSUE DISEASE; OCTD	
Percent	604314	BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, VERLOES TYPE	
NULL	604315	ANEMIA, CONGENITAL HYPOPLASTIC, WITH MULTIPLE CONGENITAL ANOMALIES/MENTAL RETARDATION SYNDROME		
Percent	604316	PSORIASIS 5, SUSCEPTIBILITY TO; PSORS5		
Number Sign	604317	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS; MCPH2		
Number Sign	604320	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	SPINAL MUSCULAR ATROPHY WITH RESPIRATORY DISTRESS 1; SMARD1;; NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VI; DHMN6;; HMN6;; HMN VI;; SEVERE INFANTILE AXONAL NEUROPATHY WITH RESPIRATORY FAILURE; SIANRF;; NEURONOPATHY, SEVERE INFANTILE AXONAL, WITH RESPIRATORY FAILURE;; SPINAL MUSCULAR ATROPHY, DIAPHRAGMATIC	
Number Sign	604321	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4		
NULL	604324	ACNE, ADULT		
Number Sign	604326	SPINOCEREBELLAR ATAXIA 12; SCA12		
Percent	604329	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 2	HYT2	
NULL	604335	REFLEX SYMPATHETIC DYSTROPHY		
Number Sign	604348	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1		
Number Sign	604352	FEBRILE SEIZURES, FAMILIAL, 4; FEB4	CONVULSIONS, FAMILIAL FEBRILE, 4	
Number Sign	604356	DUANE RETRACTION SYNDROME 2; DURS2		
Number Sign	604360	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11	SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT AND THIN CORPUS CALLOSUM;; SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUS CALLOSUM;; HSP-TCC	
NULL	604363	MYOCLONIC EPILEPSY, CONGENITAL DEAFNESS, MACULAR DYSTROPHY, AND PSYCHIATRIC DISORDERS		
Number Sign	604364	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 1; FFEVF1	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;; EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	
Number Sign	604367	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3	LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	
Number Sign	604369	SALLA DISEASE; SD	SIALURIA, FINNISH TYPE	
Number Sign	604370	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1		BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1, INCLUDED;; OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1, INCLUDED
Number Sign	604377	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	CYTOCHROME c OXIDASE DEFICIENCY, FATAL INFANTILE, WITH CARDIOENCEPHALOMYOPATHY	
Number Sign	604379	HYPOTRICHOSIS 7; HYPT7	HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE 2; LAH2;; HYPOTRICHOSIS, AUTOSOMAL RECESSIVE; AH;; HYPOTRICHOSIS, TOTAL, MARI TYPE	WOOLLY HAIR, AUTOSOMAL RECESSIVE 2, WITH OR WITHOUT HYPOTRICHOSIS, INCLUDED; ARWH2, INCLUDED;; WH/HT, INCLUDED
NULL	604380	ULNAR RAY DYSGENESIS WITH POSTAXIAL POLYDACTYLY AND RENAL CYSTIC DYSPLASIA		
NULL	604381	PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES		
NULL	604382	LISSENCEPHALY, FAMILIAL, WITH CLEFT PALATE AND CEREBELLAR HYPOPLASIA		
Number Sign	604387	NEPHRONOPHTHISIS 3; NPHP3	NPH3	
Number Sign	604391	ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	ATLD	
Number Sign	604393	LEBER CONGENITAL AMAUROSIS 4; LCA4		RETINITIS PIGMENTOSA, JUVENILE, AIPL1-RELATED, INCLUDED;; CONE-ROD DYSTROPHY, AIPL1-RELATED, INCLUDED
Number Sign	604400	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5	ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 5; ARVC5	
Percent	604401	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 6; ARVD6	ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 6; ARVC6	
Number Sign	604403	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2	GEFS+, TYPE 2; GEFS+2	FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED
Number Sign	604416	PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE	PAPA SYNDROME; PAPAS;; FAMILIAL RECURRENT ARTHRITIS; FRA	
Percent	604431	POLYNEUROPATHY, LETHAL NEONATAL, AXONAL SENSORIMOTOR, AUTOSOMAL RECESSIVE		
Number Sign	604432	SPINOCEREBELLAR ATAXIA 11; SCA11		
NULL	604451	BASAL CELL CARCINOMA, INFUNDIBULOCYSTIC	BASAL CELL CARCINOMA WITH FOLLICULAR DIFFERENTIATION	
Number Sign	604454	WELANDER DISTAL MYOPATHY; WDM	MUSCULAR DYSTROPHY, DISTAL, LATE-ONSET, AUTOSOMAL DOMINANT;; MYOPATHY, DISTAL, SWEDISH	
NULL	604474	HUMAN HERPESVIRUS TYPE 6, INTEGRATED		
Number Sign	604484	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	HEREDITARY MOTOR AND SENSORY NEUROPATHY, PROXIMAL TYPE, FORMERLY; HMSNP, FORMERLY	
Number Sign	604498	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL; CAMT		
Percent	604499	HYPERLIPIDEMIA, COMBINED, 2	HYPLIP2;; HYPERLIPIDEMIA, FAMILIAL COMBINED, 2; FCHL2	
Percent	604519	INFLAMMATORY BOWEL DISEASE 3; IBD3		
Number Sign	604536	ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME	MCGRATH SYNDROME	
Number Sign	604537	LEBER CONGENITAL AMAUROSIS 5; LCA5		
Percent	604547	VAN DER WOUDE SYNDROME 1, MODIFIER OF	VWSM	
Number Sign	604559	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB; PFHB1B	PFHBIB	
Number Sign	604563	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	CHARCOT-MARIE-TOOTH DISEASE, WITH FOCALLY FOLDED MYELIN SHEATHS, AUTOSOMAL RECESSIVE, TYPE 4B2;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4B2	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2, WITH EARLY-ONSET GLAUCOMA, INCLUDED;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4B2, WITH EARLY-ONSET GLAUCOMA, INCLUDED
Number Sign	604571	BARE LYMPHOCYTE SYNDROME, TYPE I	BLS, TYPE I;; HLA CLASS I DEFICIENCY	
Percent	604595	CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1	CLQTL1;; CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 13;; CHOLESTEROL-LOWERING FACTOR; CLF	
Number Sign	604625	TOOTH AGENESIS, SELECTIVE, 3; STHAG3	HYPODONTIA/OLIGODONTIA 3	
NULL	604690	GROWTH AND DEVELOPMENTAL RETARDATION, OCULAR PTOSIS, CARDIAC DEFECT, AND ANAL ATRESIA	ROCA SYNDROME;; ROCA-WEIDEMANN SYNDROME	
Number Sign	604715	ORTHOSTATIC INTOLERANCE	NEUROCIRCULATORY ASTHENIA;; MITRAL VALVE PROLAPSE SYNDROME;; IRRITABLE HEART;; SOLDIERS HEART	
Number Sign	604717	DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20	DFNA26	
Number Sign	604757	CRANIOSYNOSTOSIS 2; CRS2	CRANIOSYNOSTOSIS, BOSTON-TYPE; CSB	
Number Sign	604765	CARDIOMYOPATHY, DILATED, 1I; CMD1I		
NULL	604771	POLYCYSTIC BONE DISEASE	PCBD	
Number Sign	604772	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC; VTSIP	
Number Sign	604777	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5	ICHTHYOSIS, NONLAMELLAR AND NONERYTHRODERMIC, CONGENITAL, AUTOSOMAL RECESSIVE; NNCI;; ICHTHYOSIS CONGENITA III;; ICHTHYOSIS, LAMELLAR, 3, FORMERLY; LI3, FORMERLY	
Percent	604801	MUSCULAR DYSTROPHY, CONGENITAL, 1B; MDC1B		
Percent	604802	HUNTINGTON DISEASE-LIKE 3; HDL3	HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	
Number Sign	604804	MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3		
Number Sign	604805	SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT; SPG12		
Percent	604809	PANBRONCHIOLITIS, DIFFUSE	DPB;; PBLT	
Percent	604827	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 7; EIG7		MYOCLONIC EPILEPSY, JUVENILE, 2, INCLUDED; EJM2, INCLUDED
NULL	604830	MANDIBULOFACIAL DYSOSTOSIS SYNDROME, BAURU TYPE		
Number Sign	604841	STICKLER SYNDROME, TYPE II; STL2	STICKLER SYNDROME, VITREOUS TYPE 2;; STICKLER SYNDROME, BEADED VITREOUS TYPE	
NULL	604855	HYALURONAN METABOLISM, DEFECT IN		
NULL	604856	LANGERHANS CELL HISTIOCYTOSIS	LCH	
Number Sign	604864	OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA; OSCDP	NAMAQUALAND HIP DYSPLASIA; NHD	
Percent	604901	NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS; NAIC		
Number Sign	604906	SCHIZOPHRENIA 9; SCZD9	SCHIZOPHRENIA 9 WITH OR WITHOUT AN AFFECTIVE DISORDER;; SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 1q42-RELATED	
NULL	604916	HYDRONEPHROSIS, CONGENITAL, WITH CLEFT PALATE, CHARACTERISTIC FACIES, HYPOTONIA, AND MENTAL RETARDATION	OKAMOTO SYNDROME	
NULL	604919	BECKER NEVUS SYNDROME		
NULL	604922	CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA		
Number Sign	604928	WOLFRAM SYNDROME 2; WFS2		
Number Sign	604931	CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1		
Number Sign	604966	PROTOCADHERIN-ALPHA GENE CLUSTER; PCDHA@	PCDH-ALPHA GENE CLUSTER; PCDHA	
Number Sign	604967	PROTOCADHERIN-BETA GENE CLUSTER; PCDHB@	PCDH-BETA GENE CLUSTER; PCDHB	
Number Sign	604968	PROTOCADHERIN-GAMMA GENE CLUSTER; PCDHG@	PCDH-GAMMA GENE CLUSTER; PCDHG	
Number Sign	605013	MICROHYDRANENCEPHALY; MHAC	HYDRANENCEPHALY AND MICROCEPHALY	
Number Sign	605019	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2; FHBL2	HYPOLIPIDEMIA, FAMILIAL, COMBINED	
Number Sign	605021	MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME	EIM	
NULL	605026	DIABETES MELLITUS, CONGENITAL AUTOIMMUNE		
Number Sign	605027	LYMPHOMA, NON-HODGKIN, FAMILIAL	NON-HODGKIN LYMPHOMA; NHL	
NULL	605028	LOW DENSITY LIPOPROTEIN CHOLESTEROL, MILD ELEVATION OF	LDLC, MILD ELEVATION OF	
Number Sign	605039	BOHRING-OPITZ SYNDROME; BOPS	C-LIKE SYNDROME;; OPITZ TRIGONOCEPHALY-LIKE SYNDROME;; BOHRING SYNDROME	
NULL	605040	CLAVICULAR HYPOPLASIA, ZYGOMATIC ARCH HYPOPLASIA, AND MICROGNATHIA	CHZAM	
Number Sign	605041	BROOKE-SPIEGLER SYNDROME; BRSS	BSS;; SPIEGLER-BROOKE SYNDROME; SBS	
Percent	605055	ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY		
NULL	605067	TRICUSPID ATRESIA		
Number Sign	605074	RENAL CELL CARCINOMA, PAPILLARY, 1; RCCP1		
NULL	605105	EARLY RESPONSE TO NEURAL INDUCTION GENE	ERNI	
Number Sign	605115	HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY		
Number Sign	605130	WIEDEMANN-STEINER SYNDROME; WDSTS	HAIRY ELBOWS, SHORT STATURE, FACIAL DYSMORPHISM, AND DEVELOPMENTAL DELAY	
Number Sign	605192	DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23		
Percent	605201	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 14; HDLCQ14		
Number Sign	605218	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2; SLEB2		
Percent	605225	INFLAMMATORY BOWEL DISEASE 7; IBD7		
Percent	605229	SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE; SPG14		
Number Sign	605231	BARDET-BIEDL SYNDROME 6; BBS6		
Percent	605233	DIANZANI AUTOIMMUNE LYMPHOPROLIFERATIVE DISEASE	DALD	
Percent	605244	CARNEY COMPLEX, TYPE 2; CNC2	CARNEY MYXOMA-ENDOCRINE COMPLEX, TYPE 2	
Number Sign	605249	SEBASTIAN SYNDROME; SBS	SEBASTIAN PLATELET SYNDROME;; MACROTHROMBOCYTOPENIA WITH DISPERSED LEUKOCYTIC INCLUSIONS	
Number Sign	605253	NEUROPATHY, CONGENITAL HYPOMYELINATING OR AMYELINATING, AUTOSOMAL RECESSIVE; CHN	HYPOMYELINATION, SEVERE CONGENITAL;; CHARCOT-MARIE-TOOTH DISEASE, TYPE 4E; CMT4E;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4E	NEUROPATHY, CONGENITAL HYPOMYELINATING, AUTOSOMAL DOMINANT, INCLUDED
Number Sign	605258	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2; HIGM2	HYPER-IgM SYNDROME 2	
Number Sign	605259	SPINOCEREBELLAR ATAXIA 13; SCA13		
NULL	605274	MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	MESOMELIC DYSPLASIA WITH ABSENT FIBULAS AND TRIANGULAR TIBIAS	
NULL	605275	NOONAN SYNDROME 2; NS2	NOONAN SYNDROME, AUTOSOMAL RECESSIVE	
Number Sign	605280	SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT; SPG13		
Number Sign	605282	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME; TPBS	PREAXIAL BRACHYDACTYLY SYNDROME, TEMTAMY TYPE	
Number Sign	605285	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4G; CMT4G;; CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL RECESSIVE, TYPE 4G;; HEREDITARY MOTOR AND SENSORY NEUROPATHY, RUSSE TYPE;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4G	
Number Sign	605289	SPLIT-HAND/FOOT MALFORMATION 4; SHFM4		
Percent	605293	OPTIC ATROPHY 4; OPA4		
Number Sign	605309	MACROCEPHALY/AUTISM SYNDROME		
NULL	605321	FRONTOOCULAR SYNDROME		
Number Sign	605355	NEMALINE MYOPATHY 5; NEM5	NEMALINE MYOPATHY, AMISH TYPE; ANM;; AMISH NEMALINE MYOPATHY	
Number Sign	605361	SPINOCEREBELLAR ATAXIA 14; SCA14		
Number Sign	605362	CARDIOMYOPATHY, DILATED, 1J; CMD1J	CARDIOMYOPATHY, DILATED, WITH SENSORINEURAL HEARING LOSS, AUTOSOMAL DOMINANT	
Percent	605364	PSORIASIS 6, SUSCEPTIBILITY TO; PSORS6		
Percent	605365	BREAST CANCER 3; BRCA3	BRCAX	
Number Sign	605373	PARAGANGLIOMAS 3; PGL3	GLOMUS TUMORS, FAMILIAL, 3	
Number Sign	605375	EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3		
Number Sign	605376	HETEROTAXY, VISCERAL, 2, AUTOSOMAL; HTX2	HTX	
Number Sign	605387	CATARACT 31, MULTIPLE TYPES; CTRCT31	CATARACT, POSTERIOR POLAR, 3; CTPP3; CPP3	
Percent	605388	CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	ACP;; ATAXIC CEREBRAL PALSY	
Number Sign	605389	HYPOTRICHOSIS 1; HYPT1	HYPOTRICHOSIS SIMPLEX, GENERALIZED, HEREDITARY; HHS;; HTS	
NULL	605400	FIBROMATOSIS, GINGIVAL, WITH HYPERTRICHOSIS AND MENTAL RETARDATION		
Number Sign	605407	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;; DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;; DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;; TYROSINE HYDROXYLASE DEFICIENCY	
Percent	605419	SCHIZOPHRENIA 10; SCZD10	SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 15q15-RELATED;; CATATONIA, PERIODIC	
Percent	605428	DEAFNESS, AUTOSOMAL RECESSIVE 26; DFNB26		
Percent	605429	DEAFNESS, NONSYNDROMIC, MODIFIER 1; DFNM1		
Number Sign	605432	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 1; RUSAT1	RUSAT;; THROMBOCYTOPENIA, CONGENITAL, WITH RADIOULNAR SYNOSTOSIS; CTRUS	
Percent	605462	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1		BASAL CELL CARCINOMA, NONSYNDROMIC, INCLUDED;; BASAL CELL CARCINOMA, MULTIPLE, INCLUDED
NULL	605463	RADIATION SENSITIVITY/CHROMOSOME INSTABILITY SYNDROME, AUTOSOMAL DOMINANT		
Number Sign	605472	USHER SYNDROME, TYPE IIC; USH2C		USHER SYNDROME, TYPE IIC, GPR98/PDZD7, DIGENIC, INCLUDED;; USHER SYNDROME, TYPE IIB, FORMERLY, INCLUDED; USH2B, FORMERLY, INCLUDED
Number Sign	605479	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2		
Percent	605480	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 3; SLEB3		
Percent	605526	ALZHEIMER DISEASE 6	AD6;; ALZHEIMER DISEASE 6, LATE-ONSET	PLASMA BETA-AMYLOID-42 LEVEL QUANTITATIVE TRAIT LOCUS, INCLUDED
Number Sign	605543	PARKINSON DISEASE 4, AUTOSOMAL DOMINANT; PARK4	PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	
Percent	605544	FIBROMATOSIS, GINGIVAL, 2; GINGF2	GGF2;; FIBROMATOSIS, GINGIVAL, HEREDITARY, 2; HGF2	
Percent	605549	CONE-ROD DYSTROPHY 8; CORD8		
Percent	605552	ABDOMINAL OBESITY-METABOLIC SYNDROME 1; AOMS1	METABOLIC SYNDROME X	ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 1, INCLUDED;; METABOLIC SYNDROME, PROTECTION AGAINST, INCLUDED
Percent	605572	ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	AOMS2	
Percent	605582	CARDIOMYOPATHY, DILATED, 1K; CMD1K		
Number Sign	605583	DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25		
Number Sign	605588	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2B1;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2B1;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2B1	
Number Sign	605589	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2; CMT2B2	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2B2;; CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2B2;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2B2;; ARCMT2B	
Number Sign	605594	DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	DFNA39/DENTINOGENESIS IMPERFECTA 1 SYNDROME;; DFNA39/DGI1 SYNDROME;; DGI1/DFNA39 SYNDROME	
Percent	605598	DIABETES MELLITUS, INSULIN-DEPENDENT, 18; IDDM18	INSULIN-DEPENDENT DIABETES MELLITUS 18	
Percent	605606	PSORIASIS 7, SUSCEPTIBILITY TO; PSORS7		
NULL	605618	TETRALOGY OF FALLOT SYNDROME, AUTOSOMAL RECESSIVE		
Percent	605627	CEREBROOCULONASAL SYNDROME		
Percent	605635	HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	FH II	
Number Sign	605637	MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA; MYPOP	MYOPATHY WITH CONGENITAL JOINT CONTRACTURES, OPHTHALMOPLEGIA, AND RIMMED VACUOLES;; INCLUSION BODY MYOPATHY 3, AUTOSOMAL DOMINANT, FORMERLY; IBM3, FORMERLY	
Percent	605642	THYROID CARCINOMA, PAPILLARY, WITH PAPILLARY RENAL NEOPLASIA	PTCPRN;; PRN1	
Number Sign	605670	LATE-ONSET RETINAL DEGENERATION; LORD	RETINAL DEGENERATION, LATE-ONSET, AUTOSOMAL DOMINANT	
NULL	605672	CEREBELLAR ATAXIA AND HYPERGONADOTROPIC HYPOGONADISM		
Number Sign	605676	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK	CARVAJAL SYNDROME;; PALMOPLANTAR KERATODERMA WITH LEFT VENTRICULAR CARDIOMYOPATHY AND WOOLLY HAIR	
Number Sign	605711	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	MMDS	
Number Sign	605714	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED	AMYLOIDOSIS, CEREBROARTERIAL, APP-RELATED;; AMYLOIDOSIS, HEREDITARY, WITH CEREBRAL HEMORRHAGE, DUTCH VARIANT; HCHWAD;; CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, DUTCH VARIANT;; CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT;; CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT;; CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT;; CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT	
Number Sign	605724	FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1	FAD1	
Number Sign	605726	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2; DSMA2	NEURONOPATHY, DISTAL HEREDITARY MOTOR, JERASH TYPE;; NEUROPATHY, DISTAL HEREDITARY MOTOR, JERASH TYPE; HMNJ;; SPINAL MUSCULAR ATROPHY, JERASH TYPE	
Percent	605727	OTOSCLEROSIS 2; OTSC2		
Percent	605728	CATARACT 25; CTRCT25	CATARACT, CENTRAL SACCULAR, WITH SUTURAL OPACITIES; CCSSO;; CATARACT, CENTRAL POUCH-LIKE, WITH SUTURAL OPACITIES	
Percent	605735	BLEEDING DISORDER, PLATELET-TYPE, 12; BDPLT12	PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1 DEFICIENCY, PLATELET;; PGHS1 DEFICIENCY;; PLATELET CYCLOOXYGENASE 1 DEFICIENCY;; PLATELET COX1 DEFICIENCY	
Percent	605738	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 2; MCOPCB2	MICROPHTHALMIA, COLOBOMATOUS, ISOLATED 2; MCOPCB2	
Percent	605746	ANISOMASTIA		
Percent	605749	CATARACT 26, MULTIPLE TYPES; CTRCT26	CATARACT, AUTOSOMAL RECESSIVE, EARLY-ONSET, PULVERULENT; CAAR	
Percent	605750	EXUDATIVE VITREORETINOPATHY 3; EVR3		
Number Sign	605751	SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2	CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	
NULL	605756	OVARIAN DYSGENESIS, HYPERGONADOTROPIC, WITH SHORT STATURE AND RECURRENT METABOLIC ACIDOSIS	GONADAL DYSGENESIS, HYPERGONADOTROPIC, XX TYPE, WITH SHORT STATURE AND RECURRENT METABOLIC ACIDOSIS	
Percent	605779	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 7; NDNC7	ONYCHODYSPLASIA, ISOLATED CONGENITAL	
Number Sign	605803	DERMATITIS, ATOPIC, 2; ATOD2		
Percent	605804	DERMATITIS, ATOPIC, 3; ATOD3	DERMATITIS, ATOPIC, WITH ASTHMA	
Percent	605805	DERMATITIS, ATOPIC, 4; ATOD4		
NULL	605808	BIRDSHOT CHORIORETINOPATHY	BSCR	
Number Sign	605809	MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	CONGENITAL MYASTHENIC SYNDROME TYPE Ia1, FORMERLY; CMS1A1, FORMERLY;; CMS Ia1, FORMERLY	
Number Sign	605814	CITRULLINEMIA, TYPE II, NEONATAL-ONSET	CITRULLINEMIA, TYPE II, NEONATAL-ONSET, WITH OR WITHOUT FAILURE TO THRIVE AND DYSLIPIDEMIA;; CHOLESTASIS, NEONATAL INTRAHEPATIC, CAUSED BY CITRIN DEFICIENCY; NICCD	
Percent	605818	DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27		
Number Sign	605820	NONAKA MYOPATHY; NM	NONAKA DISTAL MYOPATHY;; MYOPATHY, DISTAL, WITH OR WITHOUT RIMMED VACUOLES;; INCLUSION BODY MYOPATHY, HEREDITARY, AUTOSOMAL RECESSIVE; HIBM;; INCLUSION BODY MYOPATHY, QUADRICEPS-SPARING; QSM;; GNE MYOPATHY;; INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE, FORMERLY; IBM2, FORMERLY	
Number Sign	605822	SPONDYLOOCULAR SYNDROME; SOS		
Percent	605827	BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT; GBFHS		
Percent	605833	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 2; BMND2		
NULL	605838	BABY RATTLE PELVIS DYSPLASIA		
Percent	605841	NARCOLEPSY 2, SUSCEPTIBILITY TO; NRCLP2		
Percent	605844	DERMATITIS, ATOPIC, 5; ATOD5		
Percent	605845	DERMATITIS, ATOPIC, 6; ATOD6		
Number Sign	605850	DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY; DMGDHD	DMGDH DEFICIENCY	
Percent	605856	SHORT STATURE, MENTAL RETARDATION, CALLOSAL AGENESIS, HEMINASAL HYPOPLASIA, MICROPHTHALMIA, AND ATYPICAL CLEFTING		
Number Sign	605899	GLYCINE ENCEPHALOPATHY; GCE	HYPERGLYCINEMIA, NONKETOTIC; NKH	HYPERGLYCINEMIA, TRANSIENT NEONATAL, INCLUDED; TNH, INCLUDED
Number Sign	605909	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK6	PARKINSON DISEASE 6, EARLY-ONSET; PARK6	PARKINSON DISEASE 6, LATE-ONSET, SUSCEPTIBILITY TO, INCLUDED;; PARKINSON DISEASE, AUTOSOMAL RECESSIVE EARLY-ONSET, DIGENIC, PINK1/DJ1, INCLUDED
Number Sign	605911	3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE-2 DEFICIENCY; HMGCS2D	MITOCHONDRIAL HMG-CoA SYNTHASE DEFICIENCY;; HMGCS2 DEFICIENCY	
Percent	605913	BLEEDING DISORDER, EAST TEXAS TYPE	BDET	
Percent	605934	HOLOPROSENCEPHALY 6; HPE6		
NULL	605935	ARTHROPATHY, EROSIVE		
NULL	605944	LIVER FIBROCYSTIC DISEASE AND POLYDACTYLY		
NULL	605945	CRUMPLED HELICES AND SMALL MOUTH		
Percent	605946	METAPHYSEAL DYSPLASIA, BRAUN-TINSCHERT TYPE		
Percent	605967	ACROPECTORAL SYNDROME; ACRPS	ACRP SYNDROME;; DUNDAR ACROPECTORAL SYNDROME;; SYNDACTYLY, PREAXIAL POLYDACTYLY, AND STERNAL DEFORMITY	
Number Sign	605990	NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO	UAN;; UROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO	
Number Sign	606002	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	ATAXIA-OCULOMOTOR APRAXIA 2; AOA2;; ATAXIA-OCULAR APRAXIA 2	
Number Sign	606003	TRANSALDOLASE DEFICIENCY	EYAID SYNDROME;; TALDO DEFICIENCY	
Percent	606012	DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18		
Percent	606035	FASTING INSULIN LEVEL QUANTITATIVE TRAIT LOCUS 1; FIQTL1		
Percent	606049	ACROMEGALOID FEATURES, OVERGROWTH, CLEFT PALATE, AND HERNIA	AOCH	
Percent	606053	AUTISM, SUSCEPTIBILITY TO, 5; AUTS5	PHRASE SPEECH DELAY, AUTISM-RELATED;; AUTISM-RELATED SPEECH DELAY	
Number Sign	606054	PROPIONIC ACIDEMIA	PROPIONYL-CoA CARBOXYLASE DEFICIENCY;; PCC DEFICIENCY;; GLYCINEMIA, KETOTIC;; HYPERGLYCINEMIA WITH KETOACIDOSIS AND LEUKOPENIA;; KETOTIC HYPERGLYCINEMIA	
Number Sign	606056	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb; CDG2B	CDG IIb; CDGIIb;; GLUCOSIDASE I DEFICIENCY	
Number Sign	606068	RETINITIS PIGMENTOSA 28; RP28		
Number Sign	606069	HEMOCHROMATOSIS, TYPE 4; HFE4	HEMOCHROMATOSIS, AUTOSOMAL DOMINANT;; HEMOCHROMATOSIS DUE TO DEFECT IN FERROPORTIN	
Number Sign	606070	AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21	MYOPATHY, DISTAL, 2, FORMERLY; MPD2, FORMERLY;; VOCAL CORD AND PHARYNGEAL DYSFUNCTION WITH DISTAL MYOPATHY, FORMERLY; VCPDM, FORMERLY	
Number Sign	606071	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	HMSN IIC;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2C; CMT2C;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2C	
Number Sign	606072	RIPPLING MUSCLE DISEASE 2; RMD2	RIPPLING MUSCLE DISEASE; RMD	
Percent	606082	GOITER, MULTINODULAR 3; MNG3		
Percent	606129	DIAMOND-BLACKFAN ANEMIA 2; DBA2		
NULL	606156	SENER SYNDROME	FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	
Number Sign	606159	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	NEUROFERRITINOPATHY;; BASAL GANGLIA DISEASE, ADULT-ONSET	
Number Sign	606164	DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15		
Number Sign	606170	GENITOPATELLAR SYNDROME; GTPTS	ABSENT PATELLAE, SCROTAL HYPOPLASIA, RENAL ANOMALIES, FACIAL DYSMORPHISM, AND MENTAL RETARDATION	
NULL	606174	BACULUM, CONGENITAL ABSENCE OF	OS PENIS, CONGENITAL ABSENCE OF	
NULL	606175	CARNITINE ACETYLTRANSFERASE DEFICIENCY		
Number Sign	606176	DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	DIABETES MELLITUS, PERMANENT, OF INFANCY; PDMI	DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES, INCLUDED;; DEVELOPMENTAL DELAY, EPILEPSY, AND NEONATAL DIABETES, INCLUDED; DEND, INCLUDED
NULL	606177	PARS PLANITIS		
NULL	606179	ANEURYSMAL BONE CYSTS		
NULL	606183	LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY		
Percent	606187	ALZHEIMER DISEASE 7	ALZHEIMER DISEASE, FAMILIAL, 7;; AD7	
NULL	606190	MENINGIOMA, RADIATION-INDUCED	MNRI	
Percent	606215	ATRIOVENTRICULAR SEPTAL DEFECT; AVSD	ATRIOVENTRICULAR CANAL DEFECT; AVCD;; AVC DEFECT;; ENDOCARDIAL CUSHION DEFECT; ECD	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 1, INCLUDED; AVSD1, INCLUDED
Number Sign	606217	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2; AVSD2		ATRIOVENTRICULAR SEPTAL DEFECT, PARTIAL, WITH HETEROTAXY SYNDROME, INCLUDED
NULL	606220	MENTAL RETARDATION, SHORT STATURE, FACIAL ANOMALIES, AND JOINT DISLOCATIONS		
Number Sign	606232	PHELAN-MCDERMID SYNDROME; PHMDS	CHROMOSOME 22q13.3 DELETION SYNDROME;; TELOMERIC 22q13 MONOSOMY SYNDROME	
Percent	606240	THYROID CANCER, NONMEDULLARY, 3; NMTC3	THYROID CANCER, NONMEDULLARY, 1, FORMERLY; NMTC1, FORMERLY	
Percent	606242	MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES, AND FACIAL DYSMORPHISM	KONDOH SYNDROME	
Number Sign	606243	ALVEOLAR SOFT PART SARCOMA; ASPS		
Percent	606255	STATURE AS A QUANTITATIVE TRAIT		STATURE QUANTITATIVE TRAIT LOCUS 1, INCLUDED; STQTL1, INCLUDED
Percent	606256	STATURE QUANTITATIVE TRAIT LOCUS 2; STQTL2		
Percent	606257	STATURE QUANTITATIVE TRAIT LOCUS 3; STQTL3		
Percent	606258	STATURE QUANTITATIVE TRAIT LOCUS 4; STQTL4		
Percent	606263	PAGET DISEASE OF BONE 4; PDB4		
Percent	606282	DEAFNESS, AUTOSOMAL DOMINANT 24; DFNA24		
Number Sign	606324	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7		
Percent	606325	HETEROTAXY, VISCERAL, 3, AUTOSOMAL; HTX3		
Number Sign	606346	DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22		DEAFNESS, AUTOSOMAL DOMINANT 22, WITH HYPERTROPHIC CARDIOMYOPATHY, INCLUDED
Percent	606348	INFLAMMATORY BOWEL DISEASE 5; IBD5		
NULL	606349	GAMBLING, PATHOLOGIC		
Number Sign	606353	PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	PLS, JUVENILE	
Number Sign	606367	IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41	INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;; IL2RA DEFICIENCY;; CD25 DEFICIENCY	
NULL	606369	MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY		
Number Sign	606391	MATURITY-ONSET DIABETES OF THE YOUNG; MODY	MASON-TYPE DIABETES	
Number Sign	606392	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4; MODY4	MODY, TYPE 4	
Number Sign	606394	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6; MODY6	MODY, TYPE 6	
Number Sign	606407	HYPOTONIA-CYSTINURIA SYNDROME	CYSTINURIA WITH MITOCHONDRIAL DISEASE;; HOMOZYGOUS 2p16 DELETION SYNDROME, FORMERLY	HOMOZYGOUS 2p21 DELETION SYNDROME, INCLUDED
Number Sign	606408	EHLERS-DANLOS SYNDROME DUE TO TENASCIN-X DEFICIENCY	EDS DUE TO TNX DEFICIENCY;; TNX DEFICIENCY	
Number Sign	606438	HUNTINGTON DISEASE-LIKE 2; HDL2		
NULL	606445	PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL		
Percent	606451	DEAFNESS, AUTOSOMAL DOMINANT 30; DFNA30		
Percent	606460	LONGEVITY 2	LGV2	
Number Sign	606482	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB	CHARCOT-MARIE-TOOTH NEUROPATHY, DOMINANT INTERMEDIATE B;; DI-CMTB;; CMTDI1	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2M, INCLUDED; CMT2M, INCLUDED;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2M, INCLUDED;; CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, TYPE 2M, INCLUDED;; CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B, WITH NEUTROPENIA, INCLUDED;; CHARCOT-MARIE-TOOTH NEUROPATHY, DOMINANT INTERMEDIATE B, WITH NEUTROPENIA, INCLUDED
Percent	606483	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	CHARCOT-MARIE-TOOTH NEUROPATHY, DOMINANT INTERMEDIATE A;; DI-CMTA	
NULL	606519	PHACE ASSOCIATION	PHACES ASSOCIATION;; AORTIC ANEURYSM, GIANT CONGENITAL	
NULL	606527	MEGARBANE SYNDROME		
Number Sign	606528	HOMOZYGOUS 11p15-p14 DELETION SYNDROME	HYPERINSULINISM, INFANTILE, WITH ENTEROPATHY AND DEAFNESS	
NULL	606529	CRANIOSYNOSTOSIS SYNDROME, AUTOSOMAL RECESSIVE		
Number Sign	606545	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3; ARCI3	COLLODION BABY, SELF-HEALING;; ICHTHYOSIS, LAMELLAR, 5, FORMERLY; LI5, FORMERLY	
Percent	606552	EPISODIC ATAXIA, TYPE 4; EA4	PERIODIC VESTIBULOCEREBELLAR ATAXIA; PATX;; ATAXIA, PERIODIC VESTIBULOCEREBELLAR	
Percent	606554	EPISODIC ATAXIA, TYPE 3; EA3	ATAXIA, EPISODIC, WITH VERTIGO AND TINNITUS	
Number Sign	606574	ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4	OCULOCUTANEOUS ALBINISM, TYPE IV	
Number Sign	606579	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1; VAMAS1	VITILIGO; VTLG;; SYSTEMIC LUPUS ERYTHEMATOSUS, VITILIGO-RELATED; SLEV1	
Number Sign	606581	POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO; PSAB	DRUG ADDICTION, SUSCEPTIBILITY TO	
Number Sign	606593	LIG4 SYNDROME		
Number Sign	606595	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2F;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2F	
Number Sign	606612	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT MENTAL RETARDATION), TYPE B, 5; MDDGB5	MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;; MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	
Percent	606613	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1; HDLCQ1	HDLC1	
Percent	606616	DYSLEXIA, SUSCEPTIBILITY TO, 6; DYX6		
Percent	606631	CAMURATI-ENGELMANN DISEASE, TYPE 2	CAEND2	
NULL	606632	ODOR, MALE, WOMEN'S CHOICE OF		
Percent	606640	AMYOTROPHIC LATERAL SCLEROSIS 3; ALS3		
Percent	606641	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 1; BMIQ1	BODY MASS INDEX; BMI	
Percent	606643	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 2; BMIQ2		
Percent	606656	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 2; IBGC2		
Number Sign	606657	GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO	NTG;; GLAUCOMA, NORMAL PRESSURE, SUSCEPTIBILITY TO; NPG	
Number Sign	606658	SPINOCEREBELLAR ATAXIA 15; SCA15	SPINOCEREBELLAR ATAXIA 16, FORMERLY; SCA16, FORMERLY	
Percent	606660	MELANOMA, UVEAL, SUSCEPTIBILITY TO, 1	UVM1	
Percent	606661	MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2	UVM2	
Percent	606662	WAARDENBURG SYNDROME, TYPE 2C; WS2C	WAARDENBURG SYNDROME, TYPE IIC	
Number Sign	606664	GLYCINE N-METHYLTRANSFERASE DEFICIENCY	GNMT DEFICIENCY	
Percent	606668	INFLAMMATORY BOWEL DISEASE 8; IBD8		
Percent	606674	INFLAMMATORY BOWEL DISEASE 6; IBD6		
Percent	606675	INFLAMMATORY BOWEL DISEASE 4; IBD4		
Number Sign	606685	CARDIOMYOPATHY, DILATED, 1L; CMD1L		
Number Sign	606688	SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES		
Percent	606689	GLAUCOMA 1, OPEN ANGLE, B; GLC1B		
Number Sign	606690	LYMPHANGIOLEIOMYOMATOSIS; LAM	LYMPHANGIOMYOMATOSIS	
Number Sign	606693	KUFOR-RAKEB SYNDROME; KRS	PARKINSON DISEASE 9, AUTOSOMAL RECESSIVE, JUVENILE-ONSET; PARK9;; PALLIDOPYRAMIDAL DEGENERATION WITH SUPRANUCLEAR UPGAZE PARESIS AND DEMENTIA; KRPPD	
Number Sign	606703	DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM		
Number Sign	606705	DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36		
Percent	606708	SPLIT-HAND/FOOT MALFORMATION 5; SHFM5		
Percent	606711	SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	SPECIFIC LANGUAGE IMPAIRMENT QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 16	
Percent	606712	SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	SPECIFIC LANGUAGE IMPAIRMENT QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 19	
Number Sign	606713	VAN DER WOUDE SYNDROME 2; VWS2		
Number Sign	606719	MELANOMA-PANCREATIC CANCER SYNDROME	FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA-PANCREATIC CARCINOMA SYNDROME; FAMMMPC	
Number Sign	606721	PARTIAL LIPODYSTROPHY, CONGENITAL CATARACTS, AND NEURODEGENERATION SYNDROME; LCCNS	LIPODYSTROPHY, PARTIAL, WITH CONGENITAL CATARACTS AND NEURODEGENERATION	
Number Sign	606744	SECKEL SYNDROME 2; SCKL2	SECKEL-TYPE DWARFISM 2;; MICROCEPHALIC PRIMORDIAL DWARFISM 2	
NULL	606752	ACUTE HEMORRHAGIC LEUKOENCEPHALITIS	AHL	
Number Sign	606762	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	
Number Sign	606763	CILIARY DYSKINESIA, PRIMARY, 2; CILD2	CILIARY DYSKINESIA, PRIMARY, 2, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	606764	GASTROINTESTINAL STROMAL TUMOR; GIST		
Number Sign	606766	SPERMATOGENIC FAILURE 3; SPGF3		
Number Sign	606768	MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT		
Percent	606770	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2; ADIPQTL2	CIRCULATING ADIPONECTIN QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 5; CAQ5	
Percent	606771	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3; ADIPQTL3	CIRCULATING ADIPONECTIN QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 14; CAQ14	
Percent	606772	MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKIN ANOMALIES	MOMES SYNDROME	
NULL	606773	HEMIFACIAL MYOHYPERPLASIA; HMH		
Number Sign	606777	GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1	GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIER	GLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED
Number Sign	606785	CRIGLER-NAJJAR SYNDROME, TYPE II	HYPERBILIRUBINEMIA, CRIGLER-NAJJAR TYPE II; HBLRCN2	
Percent	606787	PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1	PAOD1	
Percent	606788	ANOREXIA NERVOSA, SUSCEPTIBILITY TO, 1; ANON1	AN	
Percent	606789	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 4; HBFQTL4		
Number Sign	606798	BLEPHAROSPASM, BENIGN ESSENTIAL		
Percent	606799	STROKE, SUSCEPTIBILITY TO, 1	STRK1	
Number Sign	606812	FUMARASE DEFICIENCY; FMRD	FUMARIC ACIDURIA	
Number Sign	606824	GLUCOSE/GALACTOSE MALABSORPTION; GGM	MONOSACCHARIDE MALABSORPTION; GM	
Number Sign	606835	DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB		
Percent	606840	PARASOMNIA, SLEEP BRUXISM TYPE; PSMNSB	FACIOMANDIBULAR MYOCLONUS, NOCTURNAL	PARASOMNIA, SLEEPTALKING TYPE, INCLUDED; PSMNST, INCLUDED
Percent	606842	CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS		
Number Sign	606843	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3; HIGM3	HYPER-IgM SYNDROME 3	
NULL	606851	CREE MENTAL RETARDATION SYNDROME		
Percent	606852	PARKINSON DISEASE 10; PARK10	PARKINSON DISEASE, AGE AT ONSET OF; AAOPD	
Number Sign	606854	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL; BFPP	CEREBELLAR ATAXIA WITH NEURONAL MIGRATION DEFECT	
Number Sign	606856	PANCREATIC CANCER, SUSCEPTIBILITY TO, 1	PNCA1	
Number Sign	606864	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	CARNEY-STRATAKIS SYNDROME;; PARAGANGLIOMA AND GASTROINTESTINAL STROMAL TUMOR; GIST	
Percent	606874	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 6; HSCR6		
Percent	606875	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 7; HSCR7		
Number Sign	606889	ALZHEIMER DISEASE 4	AD4;; ALZHEIMER DISEASE, FAMILIAL, 4	
Number Sign	606893	VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	VASCULAR MALFORMATION OSSEOUS; VMOS;; HEMANGIOMA, INTRAOSSEOUS	
NULL	606894	DUODENOJEJUNAL ATRESIA WITH VOLVULUS, ABSENT DORSAL MESENTERY, AND ABSENT SUPERIOR MESENTERIC ARTERY		
NULL	606895	SYMPHALANGISM, DISTAL, WITH MICRODONTIA, DENTAL PULP STONES, AND NARROWED ZYGOMATIC ARCH		
Percent	606896	DYSLEXIA, SUSCEPTIBILITY TO, 5; DYX5		
Percent	606928	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 3; BMND3	BONE MINERAL DENSITY, LOW, SUSCEPTIBILITY TO	
Number Sign	606943	USHER SYNDROME, TYPE IG; USH1G		
Number Sign	606952	ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B	OCULOCUTANEOUS ALBINISM, TYPE IB;; ALBINISM, YELLOW MUTANT TYPE;; YELLOW ALBINISM	ALBINISM, OCULOCUTANEOUS, TYPE I, TEMPERATURE-SENSITIVE, INCLUDED;; OCA1-TS, INCLUDED
Percent	606960	INSULINOMA TUMOR SUPPRESSOR GENE LOCUS		
Percent	606963	PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD		PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, SEVERE EARLY-ONSET, INCLUDED;; COPD, SEVERE EARLY-ONSET, INCLUDED;; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, RATE OF DECLINE OF LUNG FUNCTION IN, INCLUDED
Number Sign	606966	NEPHRONOPHTHISIS 4; NPHP4	NEPHRONOPHTHISIS 4, JUVENILE	
Percent	606972	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 2; EIG2	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, LOCUS ON CHROMOSOME 14	
Percent	606984	HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 2	FHHA2	
Percent	606995	SENIOR-LOKEN SYNDROME 3; SLSN3		
Number Sign	606996	SENIOR-LOKEN SYNDROME 4; SLSN4		
Percent	607004	BRACHYDACTYLY, TYPE A1, B; BDA1B		
Number Sign	607014	HURLER SYNDROME	MUCOPOLYSACCHARIDOSIS TYPE IH; MPS1-H	
Number Sign	607015	HURLER-SCHEIE SYNDROME	MUCOPOLYSACCHARIDOSIS TYPE IH/S; MPS1-HS	
Number Sign	607016	SCHEIE SYNDROME	MUCOPOLYSACCHARIDOSIS TYPE IS; MPS1-S;; MUCOPOLYSACCHARIDOSIS TYPE V, FORMERLY;; MPS V, FORMERLY; MPS5, FORMERLY	
Percent	607017	DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21		
Number Sign	607039	DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22		
NULL	607044	T-BOX 24	TBX24	
Percent	607053	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2; HDLCQ2		
Number Sign	607060	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8		
Number Sign	607078	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5	MULTIPLE EPIPHYSEAL DYSPLASIA, MATN3-RELATED;; MICROEPIPHYSEAL DYSPLASIA, BILATERAL HEREDITARY; BHMED	
Number Sign	607080	46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY		
Number Sign	607084	DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31	WHIRLER, MOUSE, HOMOLOG OF	
Percent	607085	MYASTHENIA GRAVIS WITH THYMUS HYPERPLASIA	MYAS1	
Percent	607086	AORTIC ANEURYSM, FAMILIAL THORACIC 1; AAT1	FAA1;; ANNULOAORTIC ECTASIA;; AORTIC DISSECTION, FAMILIAL;; AORTIC ANEURYSM, FAMILIAL THORACIC;; ANEURYSM, THORACIC AORTIC	ERDHEIM CYSTIC MEDIAL NECROSIS OF AORTA, INCLUDED
Percent	607087	AORTIC ANEURYSM, FAMILIAL THORACIC 2; AAT2	FAA2	
Percent	607088	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 3; DSMA3	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IV; HMN4;; DHMN4;; NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IV;; HMN IV;; NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE III; HMN3;; DHMN3;; HMN III	
Number Sign	607091	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId; CDG2D	CDG IId; CDGIId	
Number Sign	607095	ANAUXETIC DYSPLASIA 1; ANXD1	ANAUXETIC DYSPLASIA; ANXD; SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;; SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE	
Number Sign	607101	DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30		
Percent	607107	NASOPHARYNGEAL CARCINOMA	NPCA;; NPC;; NASOPHARYNGEAL CANCER	NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 1, INCLUDED; NPCA1, INCLUDED
Number Sign	607115	CINCA SYNDROME; CINCA	CHRONIC NEUROLOGIC CUTANEOUS AND ARTICULAR SYNDROME;; MULTISYSTEM INFLAMMATORY DISEASE, NEONATAL-ONSET; NOMID;; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 3; CAPS3	
Percent	607116	ALZHEIMER DISEASE 8	ALZHEIMER DISEASE, FAMILIAL, 8;; AD8	
Number Sign	607131	AL-GAZALI-BAKALINOVA SYNDROME; AGBK	MACROCEPHALY WITH MULTIPLE EPIPHYSEAL DYSPLASIA AND DISTINCTIVE FACIES; MMEDF	
NULL	607132	LARYNGEAL ATRESIA, ENCEPHALOCELE, AND LIMB DEFORMITIES	LEL	
Percent	607134	SPECIFIC LANGUAGE IMPAIRMENT 3; SLI3	SPECIFIC LANGUAGE IMPAIRMENT QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 13	
Percent	607135	CREATININE CLEARANCE QUANTITATIVE TRAIT LOCUS	CRCL	
Number Sign	607136	SPINOCEREBELLAR ATAXIA 17; SCA17	HUNTINGTON DISEASE-LIKE 4; HDL4	
Number Sign	607140	ANGIOID STREAKS		
Number Sign	607143	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	CDG Ig; CDGIg	
Number Sign	607151	MOYAMOYA DISEASE 2; MYMY2		
Percent	607152	SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT; SPG19		
Number Sign	607154	ALLERGIC RHINITIS	ALRH	
Number Sign	607155	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2I; LGMD2I;; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, FRKP-RELATED	
NULL	607161	MULTIPLE CONGENITAL ANOMALIES SYNDROME WITH CLOVERLEAF SKULL		
Number Sign	607174	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO		
Number Sign	607196	MICROCEPHALY, AMISH TYPE; MCPHA	AMISH LETHAL MICROCEPHALY;; THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	
NULL	607197	DEAFNESS, AUTOSOMAL RECESSIVE		
Number Sign	607200	THYROID DYSHORMONOGENESIS 6; TDH6	THYROID HORMONOGENESIS, GENETIC DEFECT IN, 6;; HYPOTHYROIDISM, CONGENITAL, DUE TO DYSHORMONOGENESIS, 6	
Percent	607202	CELIAC DISEASE, SUSCEPTIBILITY TO, 5; CELIAC5	GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 5;; GSES	
Number Sign	607208	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6	DRAVET SYNDROME;; SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	
NULL	607214	ANONYCHIA, TOTAL, WITH MICROCEPHALY		
Percent	607221	EPILEPSY, PARTIAL, WITH PERICENTRAL SPIKES; PEPS	EPPS	
Number Sign	607225	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP		
Number Sign	607236	HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA, AND PALLIDAL DEGENERATION	HARP SYNDROME	
Percent	607239	DEAFNESS, AUTOSOMAL RECESSIVE 33; DFNB33		
Percent	607248	GLIOMA SUSCEPTIBILITY 4; GLM4		
Number Sign	607250	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY; SCAN1		
Percent	607258	HYPERCALCIURIA, ABSORPTIVE, 1	HCA1	
Number Sign	607259	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7		
Number Sign	607271	CASPASE 8 DEFICIENCY	CEDS;; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIB; ALPS2B	
Number Sign	607276	RESTING HEART RATE, VARIATION IN	RHR	
Number Sign	607277	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1	ASRT1;; AS1	
Number Sign	607278	OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO; OSFD	OFD;; TIBIA, BOWING OF, WITH PSEUDARTHROSIS AND PECTUS EXCAVATUM	
Percent	607279	SYSTEMIC LUPUS ERYTHEMATOSUS WITH HEMOLYTIC ANEMIA, SUSCEPTIBILITY TO, 1; SLEH1	SYSTEMIC LUPUS ERYTHEMATOSUS, HEMOLYTIC ANEMIA-RELATED	
Percent	607304	CATARACT 27; CTRCT27	CATARACT 27, NUCLEAR PROGRESSIVE;; CCNP	
Percent	607308	MAMMOGRAPHIC DENSITY		
Number Sign	607313	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1; HGPPS1	HGPPS	OPHTHALMOPLEGIA, PROGRESSIVE EXTERNAL, AND SCOLIOSIS, INCLUDED
Percent	607317	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	SPINOCEREBELLAR ATAXIA WITH SACCADIC INTRUSIONS; SCASI;; SPINOCEREBELLAR ATAXIA 24, FORMERLY; SCA24, FORMERLY	
Number Sign	607323	DUANE-RADIAL RAY SYNDROME; DRRS	OKIHIRO SYNDROME;; DUANE ANOMALY WITH RADIAL RAY ABNORMALITIES AND DEAFNESS;; DR SYNDROME;; ACRORENOOCULAR SYNDROME	
Percent	607324	POLYDACTYLY, POSTAXIAL, TYPE A3; PAPA3	POSTAXIAL POLYDACTYLY, TYPE A3	
Number Sign	607326	SMITH-MCCORT DYSPLASIA 1; SMC1	SMC	
Percent	607329	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 3	HYT3	
Number Sign	607330	LATHOSTEROLOSIS	STEROL C5-DESATURASE DEFICIENCY;; SC5D DEFICIENCY	
Percent	607339	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 1	CHDS1	
Number Sign	607341	FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2	CORTICAL DYSPLASIA OF TAYLOR; CDT;; FOCAL CORTICAL DYSPLASIA OF TAYLOR; FCDT;; FCD2	FOCAL CORTICAL DYSPLASIA, TYPE IIA, INCLUDED; FCORD2A, INCLUDED;; FCD IIA, INCLUDED;; CORTICAL DYSPLASIA OF TAYLOR WITHOUT BALLOON CELLS, INCLUDED;; CORTICAL DYSPLASIA OF TAYLOR, DYSPLASIA ONLY, INCLUDED; CDTD, INCLUDED;; FOCAL CORTICAL DYSPLASIA, TYPE IIB, INCLUDED; FCORD2B, INCLUDED;; FCD IIB, INCLUDED;; CORTICAL DYSPLASIA OF TAYLOR WITH BALLOON CELLS, INCLUDED; CDTBC, INCLUDED
Number Sign	607346	SPINOCEREBELLAR ATAXIA 19; SCA19	SPINOCEREBELLAR ATAXIA 22; SCA22	
Percent	607354	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 2; IS2		
Number Sign	607361	MECKEL SYNDROME, TYPE 3; MKS3	MECKEL-GRUBER SYNDROME, TYPE 3	
Number Sign	607364	BARTTER SYNDROME, TYPE 3; BARTS3	BARTTER SYNDROME, CLASSIC	BARTTER SYNDROME, TYPE 3, WITH HYPOCALCIURIA, INCLUDED
Number Sign	607371	DYSTONIA, JUVENILE-ONSET; DJO		
Percent	607373	AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	AUTS2, FORMERLY	
NULL	607395	STREPTOCOCCUS, GROUP A, SEVERITY OF INFECTION BY		
Number Sign	607398	GLUCOCORTICOID DEFICIENCY 2; GCCD2	FAMILIAL GLUCOCORTICOID DEFICIENCY 2; FGD2	
Percent	607411	PATENT DUCTUS ARTERIOSUS 1; PDA1	PDA	
NULL	607413	ALZHEIMER DISEASE NEURONAL THREAD PROTEIN	AD7CNTP	
Number Sign	607417	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2A; MRT2A	
Number Sign	607426	COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	CoQ10 DEFICIENCY, PRIMARY, 1;; UBIQUINONE DEFICIENCY 1;; COENZYME Q DEFICIENCY 1;; CoQ DEFICIENCY 1	
Number Sign	607432	LISSENCEPHALY 1; LIS1	LISSENCEPHALY SEQUENCE, ISOLATED; ILS;; LISSENCEPHALY, CLASSIC	SUBCORTICAL LAMINAR HETEROTOPIA, INCLUDED; SCLH, INCLUDED;; SUBCORTICAL BAND HETEROTOPIA, INCLUDED; SBH, INCLUDED
Percent	607446	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 3; BMIQ3		
Number Sign	607447	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4; BMIQ4	OBESITY, SUSCEPTIBILITY TO	
Number Sign	607450	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8	ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 8; ARVC8	
Number Sign	607453	DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44		
Number Sign	607454	SPINOCEREBELLAR ATAXIA 21; SCA21		
Number Sign	607457	GIL BLOOD GROUP		
Percent	607458	SPINOCEREBELLAR ATAXIA 18; SCA18	SENSORIMOTOR NEUROPATHY WITH ATAXIA, AUTOSOMAL DOMINANT; SMNA	
Number Sign	607459	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	SENSORY ATAXIC NEUROPATHY WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE	SPINOCEREBELLAR ATAXIA WITH EPILEPSY, INCLUDED; SCAE, INCLUDED;; EPILEPSY, PROGRESSIVE MYOCLONIC, WITH SENSORY ATAXIC NEUROPATHY, INCLUDED;; EPILEPSY, PROGRESSIVE MYOCLONIC, 5, FORMERLY; EPM5, FORMERLY
Number Sign	607464	THYROID CARCINOMA, HURTHLE CELL	HURTHLE CELL THYROID NEOPLASIA	
Number Sign	607473	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2; VKCFD2		
Number Sign	607475	BOTHNIA RETINAL DYSTROPHY	VASTERBOTTEN DYSTROPHY	
Number Sign	607476	NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD		
Number Sign	607482	CARDIOMYOPATHY, DILATED, 1M; CMD1M		
Number Sign	607483	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	BASAL GANGLIA DISEASE, BIOTIN-RESPONSIVE; BBGD;; ENCEPHALOPATHY, THIAMINE-RESPONSIVE	
Number Sign	607485	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	FTLD-TDP, GRN-RELATED;; FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, GRN-RELATED;; FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS; FTLDU;; FRONTOTEMPORAL DEMENTIA, UBIQUITIN-POSITIVE; FTDU;; DEMENTIA, HEREDITARY DYSPHASIC DISINHIBITION; HDDD	APHASIA, PRIMARY PROGRESSIVE, INCLUDED; PPA, INCLUDED
Number Sign	607486	KNOPS BLOOD GROUP SYSTEM; KN		
Number Sign	607487	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25; CMH25		
Percent	607488	DYSTONIA 15, MYOCLONIC; DYT15		
Percent	607498	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	MGR3	
Percent	607499	BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1; BULN1	BN	
Percent	607501	MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	MGR4;; MGOA	
NULL	607504	HEADACHE ASSOCIATED WITH SEXUAL ACTIVITY; HSA	BENIGN SEXUAL HEADACHE; BSH	
Number Sign	607507	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO		PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO, 1, INCLUDED; PSORAS1, INCLUDED
Percent	607508	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	MGR5	
Number Sign	607514	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10; BMIQ10	OBESITY, SUSCEPTIBILITY TO	
Percent	607516	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	MGR6	MIGRAINE, FAMILIAL HEMIPLEGIC, 4, INCLUDED; FHM4, INCLUDED
Number Sign	607523	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8	TOENAIL DYSTROPHY, ISOLATED	
Number Sign	607539	CAMPTOSYNPOLYDACTYLY, COMPLEX; CCSPD	CAMPTOPOLYDACTYLY, DISORGANIZATION TYPE	
NULL	607540	SECRETORY DIARRHEA, MYOPATHY, AND DEAFNESS		
Number Sign	607541	CORNEAL DYSTROPHY, AVELLINO TYPE; CDA	ACD;; AVELLINO CORNEAL DYSTROPHY;; COMBINED GRANULAR-LATTICE CORNEAL DYSTROPHY;; GRANULAR CORNEAL DYSTROPHY, TYPE II; CGD2	
NULL	607543	SPONDYLOMETAPHYSEAL DYSPLASIA WITH BOWED FOREARMS AND FACIAL DYSMORPHISM	SMD WITH BOWED FOREARMS AND FACIAL DYSMORPHISM	
Number Sign	607554	ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3		
NULL	607565	SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	SPAR	
NULL	607569	MYOPATHY, DISTAL, WITH EARLY RESPIRATORY FAILURE, AUTOSOMAL DOMINANT		
Percent	607572	LEPROSY, SUSCEPTIBILITY TO, 2; LPRS2		
NULL	607578	BREATH-HOLDING SPELLS	BHS	
Percent	607584	SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE; SPG24		
Percent	607592	PROSTATE CANCER AGGRESSIVENESS QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 19	HPCQTL19	
Number Sign	607594	IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1	ANTIBODY DEFICIENCY DUE TO ICOS DEFECT	IMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED
Number Sign	607595	BRAIN SMALL VESSEL DISEASE WITH OR WITHOUT OCULAR ANOMALIES; BSVD	BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE;; INFANTILE HEMIPARESIS;; RETINAL ARTERIOLAR TORTUOSITY, INFANTILE HEMIPARESIS, AND LEUKOENCEPHALOPATHY, AUTOSOMAL DOMINANT;; BRAIN SMALL VESSEL DISEASE WITH AXENFELD-RIEGER ANOMALY;; LEUKOENCEPHALOPATHY WITH AXENFELD-RIEGER ANOMALY	
Number Sign	607596	PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	PCH1;; PONTOCEREBELLAR HYPOPLASIA WITH INFANTILE SPINAL MUSCULAR ATROPHY;; PONTOCEREBELLAR HYPOPLASIA WITH ANTERIOR HORN CELL DISEASE	
NULL	607597	MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES		
Number Sign	607598	LETHAL CONGENITAL CONTRACTURE SYNDROME 2; LCCS2	MULTIPLE CONTRACTURE SYNDROME, ISRAELI BEDOUIN TYPE A	
Percent	607600	EPIDERMOLYSIS BULLOSA SIMPLEX SUPERFICIALIS; EBSS		
Number Sign	607602	ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS	CIEHK;; EPIDERMOLYTIC ICHTHYOSIS, ANNULAR; AEI	
Number Sign	607616	NIEMANN-PICK DISEASE, TYPE B		NIEMANN-PICK DISEASE, TYPE E, INCLUDED;; NIEMANN-PICK DISEASE, TYPE F, INCLUDED;; NIEMANN-PICK DISEASE, INTERMEDIATE, WITH VISCERAL INVOLVEMENT AND RAPID PROGRESSION, INCLUDED
Number Sign	607624	GRISCELLI SYNDROME, TYPE 2; GS2	GRISCELLI SYNDROME WITH HEMOPHAGOCYTIC SYNDROME;; PARTIAL ALBINISM AND IMMUNODEFICIENCY SYNDROME;; PAID SYNDROME	
Number Sign	607625	NIEMANN-PICK DISEASE, TYPE C2; NPC2		
Number Sign	607626	ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME;; NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME;; NISCH SYNDROME	
Number Sign	607628	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11; EIG11		EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 8, INCLUDED; EJM8, INCLUDED;; EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 2, INCLUDED; EJA2, INCLUDED
Number Sign	607631	EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1; EJA1	JAE1	
Number Sign	607634	OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	OSTEOPETROSIS, AUTOSOMAL DOMINANT, TYPE I	
Number Sign	607636	VAN BUCHEM DISEASE, TYPE 2	VBCH2	
Number Sign	607641	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B	HMN VIIB;; NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB;; DHMN7B;; NEUROPATHY, DISTAL HEREDITARY MOTOR, WITH VOCAL CORD PARALYSIS, TYPE VIIB;; LOWER MOTOR NEURON DISEASE, DYNACTIN TYPE	
Percent	607644	CANDIDIASIS, FAMILIAL, 3; CANDF3	CANDIDIASIS, FAMILIAL CHRONIC NAIL, WITH ICAM1 DEFICIENCY; CANDN1;; FCNC	
Number Sign	607654	KERATOSIS PALMOPLANTARIS STRIATA III; PPKS3	STRIATE PALMOPLANTAR KERATODERMA III; SPPK3;; KERATODERMA, PALMOPLANTAR, STRIATE FORM III; KPPS3	
Number Sign	607655	SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS		
Percent	607656	CURLY HAIR-ACRAL KERATODERMA-CARIES SYNDROME	CHACS	
Percent	607658	HYPOTRICHOSIS-OSTEOLYSIS-PERIODONTITIS-PALMOPLANTAR KERATODERMA SYNDROME	HOPP SYNDROME	
NULL	607665	TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU		ACUTE TUBULOINTERSTITIAL NEPHRITIS, INCLUDED; ATIN, INCLUDED
Percent	607671	DYSTONIA 13, TORSION, AUTOSOMAL DOMINANT; DYT13		
Percent	607674	CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY		
Number Sign	607676	IRAK4 DEFICIENCY	IRAK4D	
Number Sign	607677	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I; CMT2I	CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2I	
Number Sign	607678	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	HEREDITARY MOTOR AND SENSORY NEUROPATHY 1D;; HMSN ID;; HMSN1D;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 1D	
Number Sign	607681	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2; ECA2		
Number Sign	607682	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9		EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6, INCLUDED
Percent	607683	DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52	DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	
Number Sign	607684	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2E	
Number Sign	607685	HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC; HES		
Percent	607687	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 3	HDLCQ3	
Number Sign	607688	PARKINSON DISEASE 11, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK11		
Number Sign	607694	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7	LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;; ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;; LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPIC HYPOGONADISM;; 4H SYNDROME	
Number Sign	607706	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE	CMT2 WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE;; CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A, AXONAL FORM;; CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE	
Number Sign	607721	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	NSLH;; TOSTI SYNDROME	
Percent	607728	POROKERATOSIS 4, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK4	POROKERATOSIS, DISSEMINATED SUPERFICIAL ACTINIC, 2; DSAP2	
Percent	607731	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH PYRAMIDAL FEATURES, AUTOSOMAL RECESSIVE;; CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, WITH PYRAMIDAL FEATURES, AUTOSOMAL RECESSIVE	
Number Sign	607734	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 1F	
Number Sign	607736	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J; CMT2J	CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2J;; CHARCOT-MARIE-TOOTH DISEASE, TYPE 2, WITH HEARING LOSS AND PUPILLARY ABNORMALITIES	
Number Sign	607745	SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	CONVULSIONS, BENIGN FAMILIAL INFANTILE, 3; BFIC3;; SEIZURES, BENIGN FAMILIAL NEONATAL-INFANTILE; BFNIS	
Number Sign	607748	HYPERCHOLANEMIA, FAMILIAL; FHCA		
Number Sign	607765	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	3-BETA-HYDROXY-DELTA-5-C27-STEROID OXIDOREDUCTASE DEFICIENCY	
Number Sign	607778	ACROCAPITOFEMORAL DYSPLASIA; ACFD		
Number Sign	607785	JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML	LEUKEMIA, JUVENILE MYELOMONOCYTIC	LEUKEMIA, CHRONIC MYELOMONOCYTIC, INCLUDED; CMML, INCLUDED
Number Sign	607791	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D; CMTDID	CHARCOT-MARIE-TOOTH NEUROPATHY, DOMINANT INTERMEDIATE D;; DI-CMTD	
Number Sign	607801	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C; LGMD1C		
Number Sign	607812	CRANIOLENTICULOSUTURAL DYSPLASIA; CLSD	BOYADJIEV-JABS SYNDROME	
Number Sign	607821	DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37		
Number Sign	607822	ALZHEIMER DISEASE 3; AD	ALZHEIMER DISEASE 3, EARLY-ONSET;; ALZHEIMER DISEASE, FAMILIAL, 3	ALZHEIMER DISEASE, FAMILIAL, 3, WITH SPASTIC PARAPARESIS AND UNUSUAL PLAQUES, INCLUDED;; ALZHEIMER DISEASE, FAMILIAL, 3, WITH SPASTIC PARAPARESIS AND APRAXIA, INCLUDED
Number Sign	607823	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS		
Number Sign	607829	MITRAL VALVE PROLAPSE 2; MVP2	MITRAL VALVE PROLAPSE, MYXOMATOUS 2; MMVP2;; MYXOMATOUS MITRAL VALVE PROLAPSE 2	
Number Sign	607831	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2K;; CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, TYPE 2K	CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL DOMINANT, TYPE 2K, INCLUDED
Number Sign	607832	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3	GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 3, SUSCEPTIBILITY TO	
Percent	607834	ANXIETY		HARM AVOIDANCE, INCLUDED
Number Sign	607836	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 2; VAMAS2;; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 1p-RELATED	
Percent	607841	DEAFNESS, AUTOSOMAL DOMINANT 48; DFNA48		
Number Sign	607842	AURAL ATRESIA, CONGENITAL; CAA	AURAL ATRESIA, CONGENITAL, WITH HYPOSMIA	
Number Sign	607847	NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS	NONIMMUNE CHRONIC IDIOPATHIC NEUTROPENIA OF ADULTS;; NI-CINA	
Number Sign	607850	OSTEOARTHRITIS SUSCEPTIBILITY 3; OS3	OSTEOARTHRITIS OF KNEE/HIP	
Percent	607853	PANIC DISORDER 2	PAND2;; PANIC DISORDER SUSCEPTIBILITY LOCUS, CHROMOSOME 9q-RELATED	
Number Sign	607855	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO PARTIAL LAMA2 DEFICIENCY, INCLUDED
Percent	607857	PSORIASIS 9, SUSCEPTIBILITY TO; PSORS9		
NULL	607859	ANGIOMA, TUFTED	TUFTED ANGIOMA	
Number Sign	607864	CAUDAL DUPLICATION ANOMALY		
Number Sign	607872	CHROMOSOME 1p36 DELETION SYNDROME	MONOSOMY 1p36 SYNDROME	
Number Sign	607876	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2	BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;; CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;; CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	
Percent	607893	OVARIAN CANCER, SUSCEPTIBILITY TO, 1; OVCAS1		
Number Sign	607903	HYPOTRICHOSIS 6; HYPT6	HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE 1; LAH1;; HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE; LAH;; HTL;; MONILETHRIX-LIKE HYPOTRICHOSIS	
Number Sign	607906	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	CDG Ii; CDGIi	
Number Sign	607907	DERMATOFIBROSARCOMA PROTUBERANS; DFSP	GIANT CELL FIBROBLASTOMA	
Number Sign	607921	RETINITIS PIGMENTOSA 30; RP30		MACULAR DEGENERATION, INCLUDED
Number Sign	607932	MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	MICROPHTHALMIA AND PITUITARY ANOMALIES;; MICROPHTHALMIA WITH BRAIN AND DIGIT DEVELOPMENTAL ANOMALIES;; ANOPHTHALMIA, CLINICAL, WITH MICROGNATHIA, MALFORMED EARS, DIGITAL ANOMALIES, AND ABNORMAL EXTERNAL GENITALIA	
Number Sign	607936	PEELING SKIN SYNDROME 4; PSS4	ICHTHYOSIS BULLOSA OF SIEMENS-LIKE;; ICHTHYOSIS, EXFOLIATIVE, AUTOSOMAL RECESSIVE; AREI	
Number Sign	607941	ATRIAL SEPTAL DEFECT 2; ASD2		
Number Sign	607944	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	SPENCD;; COMBINED IMMUNODEFICIENCY WITH AUTOIMMUNITY AND SPONDYLOMETAPHYSEAL DYSPLASIA;; ROIFMAN IMMUNOSKELETAL SYNDROME	
Number Sign	607948	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO		MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST, INCLUDED
Percent	607949	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 1	MTBS1	
Percent	607965	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 1; SLEN1		
Percent	607966	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 2; SLEN2		
Percent	607967	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 3; SLEN3		
Number Sign	608013	GAUCHER DISEASE, PERINATAL LETHAL	GAUCHER DISEASE, COLLODION TYPE	
Number Sign	608022	DIAPHANOSPONDYLODYSOSTOSIS	VERTEBRAL OSSIFICATION, DEFECT IN, WITH NEPHROGENIC RESTS	
Percent	608026	HYPERTENSIVE NEPHROPATHY; HNP1		
Number Sign	608027	PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3	CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;; PCH WITH OPTIC ATROPHY	
NULL	608028	THAI SYMPHALANGISM SYNDROME		
Percent	608029	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6; SCAR6	CEREBELLAR ATAXIA, INFANTILE NONPROGRESSIVE, AUTOSOMAL RECESSIVE;; NORWEGIAN INFANTILE ONSET ATAXIA	
Number Sign	608030	AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS6		
Percent	608031	AMYOTROPHIC LATERAL SCLEROSIS 7; ALS7		
Number Sign	608033	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3	ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	
Percent	608035	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 4; CMM4		
Percent	608036	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 4	NIDDM4;; NONINSULIN-DEPENDENT DIABETES MELLITUS 4	
Percent	608045	REPRESSOR OF TELOMERASE EXPRESSION 1	RTE1	
Percent	608049	AUTISM, SUSCEPTIBILITY TO, 3; AUTS3		
Number Sign	608051	MACULAR DYSTROPHY, RETINAL, 2; MCDR2		
NULL	608063	BILE AND PANCREATIC DUCTS, COMPLETE ABSENCE OF		
Percent	608068	NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE	AFND;; SWEET SYNDROME; SS;; GOMM-BUTTON DISEASE	
Percent	608078	SCHIZOPHRENIA 11	SCZD11;; SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 10q-RELATED	
Percent	608088	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IB; HSAN1B;; NEUROPATHY, HEREDITARY SENSORY, TYPE IB; HSN1B	
Number Sign	608089	ENDOMETRIAL CANCER		
Number Sign	608091	JOUBERT SYNDROME 2; JBTS2	CEREBELLOOCULORENAL SYNDROME 2; CORS2	
Number Sign	608093	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	CDG Ij; CDGIj	
Percent	608096	EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	FTLE	
Number Sign	608097	PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	PERIVENTRICULAR NODULAR HETEROTOPIA 2; PVNH2;; HETEROTOPIA, PERIVENTRICULAR, AUTOSOMAL RECESSIVE	
Percent	608098	HETEROTOPIA, PERIVENTRICULAR, ASSOCIATED WITH CHROMOSOME 5p ANOMALIES	PERIVENTRICULAR NODULAR HETEROTOPIA 3; PVNH3	
Number Sign	608099	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D	DUCHENNE-LIKE AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, TYPE 2; DMDA2;; ADHALINOPATHY, PRIMARY	
Number Sign	608104	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	CDG Ih; CDGIh	
Percent	608105	EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	RE-PED-WC	
Number Sign	608106	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5; HIGM5	HYPER-IgM SYNDROME 5	
Number Sign	608115	OVARIAN HYPERSTIMULATION SYNDROME; OHSS	OVARIAN HYPERSTIMULATION SYNDROME, FAMILIAL GESTATIONAL SPONTANEOUS	
Number Sign	608118	ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	ZINC DEFICIENCY, NEONATAL, DUE TO LOW BREAST MILK ZINC	ZINC IN BREAST MILK, REDUCED, INCLUDED
Number Sign	608133	RETINITIS PIGMENTOSA 7; RP7		RETINITIS PIGMENTOSA 7, DIGENIC, INCLUDED;; LEBER CONGENITAL AMAUROSIS 18, INCLUDED; LCA18, INCLUDED
Number Sign	608149	KAGAMI-OGATA SYNDROME	UNIPARENTAL DISOMY, PATERNAL, CHROMOSOME 14	
Percent	608154	LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES		
Number Sign	608156	NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	CHROMOSOME 8q22.1 DELETION SYNDROME	
Percent	608158	CoQ-RESPONSIVE OXPHOS DEFICIENCY		
Number Sign	608161	MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	VITELLIFORM MACULAR DYSTROPHY, ADULT-ONSET; AVMD;; FOVEOMACULAR DYSTROPHY, ADULT-ONSET; AOFMD;; FOVEOMACULAR DYSTROPHY, ADULT-ONSET, WITH OR WITHOUT CHOROIDAL NEOVASCULARIZATION	
Percent	608173	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 1	AITD1	
Percent	608174	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 2	AITD2	
Number Sign	608175	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3		
Percent	608176	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 4	AITD4	
Number Sign	608180	SYNPOLYDACTYLY 2; SPD2	SYNPOLYDACTYLY, 3/3-PRIME/4, ASSOCIATED WITH METACARPAL AND METATARSAL SYNOSTOSES	
NULL	608184	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 4; HIGM4	HYPER-IgM SYNDROME 4	
Number Sign	608189	TROPICAL CALCIFIC PANCREATITIS	TCP	
Number Sign	608194	CONE-ROD DYSTROPHY 13; CORD13		
Number Sign	608203	NEUTROPHIL IMMUNODEFICIENCY SYNDROME		
Percent	608207	KALA-AZAR, SUSCEPTIBILITY TO, 1; KAZA1	LEISHMANIASIS, VISCERAL, SUSCEPTIBILITY TO, 1	
Percent	608217	SEIZURES, BENIGN FAMILIAL NEONATAL, 3; BFNS3	CONVULSIONS, BENIGN FAMILIAL NEONATAL, 3; BFNC3	
Percent	608219	DEAFNESS, AUTOSOMAL RECESSIVE 38; DFNB38		
Percent	608220	SPASTIC PARAPLEGIA 25, AUTOSOMAL RECESSIVE; SPG25	DISC HERNIATION WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	
NULL	608223	ASPIRIN RESISTANCE	ASPIRIN, RESISTANCE TO ANTITHROMBOTIC EFFECT OF;; ASPIRIN, RESISTANCE TO CARDIOPROTECTIVE EFFECT OF	
Number Sign	608224	DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41		
NULL	608227	CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRAL NEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION		
Number Sign	608232	LEUKEMIA, CHRONIC MYELOID; CML	LEUKEMIA, CHRONIC MYELOGENOUS	LEUKEMIA, CHRONIC MYELOID, ATYPICAL, INCLUDED; ACML, INCLUDED
Number Sign	608233	HERMANSKY-PUDLAK SYNDROME 2; HPS2		
Number Sign	608236	SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT; SNCV		
Percent	608244	OTOSCLEROSIS 3; OTSC3		
Percent	608251	PHOBIA, SPECIFIC	PHOBIA, SIMPLE	
NULL	608257	MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT		
Percent	608264	DEAFNESS, AUTOSOMAL RECESSIVE 40; DFNB40		
Number Sign	608265	DEAFNESS, AUTOSOMAL RECESSIVE 39; DFNB39		
Number Sign	608266	PARATHYROID CARCINOMA	PRTC	
NULL	608278	GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGE JOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLAR ATROPHY		
NULL	608279	CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS		
NULL	608281	SCIMITAR ANOMALY, MULTIPLE CARDIAC MALFORMATIONS, AND CRANIOFACIAL AND CENTRAL NERVOUS SYSTEM ABNORMALITIES	ANOMALOUS PULMONARY VENOUS RETURN, MULTIPLE CARDIAC MALFORMATIONS, AND CRANIOFACIAL AND CENTRAL NERVOUS SYSTEM ABNORMALITIES	
Percent	608290	LELIS SYNDROME	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH ACANTHOSIS NIGRICANS	
Percent	608316	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 2	CHDS2	
Percent	608318	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 4	CHDS4	
Number Sign	608320	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	CORONARY ARTERY DISEASE WITH MYOCARDIAL INFARCTION	
Number Sign	608323	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	CHARCOT-MARIE-TOOTH NEUROPATHY, DOMINANT INTERMEDIATE C;; DI-CMTC	
Number Sign	608328	WEILL-MARCHESANI SYNDROME 2; WMS2	WEILL-MARCHESANI SYNDROME, AUTOSOMAL DOMINANT;; SPHEROPHAKIA-BRACHYMORPHIA SYNDROME;; MESODERMAL DYSMORPHODYSTROPHY, CONGENITAL;; GLAUCOMA-LENS ECTOPIA-MICROSPHEROPHAKIA-STIFFNESS-SHORTNESS SYNDROME; GEMSS	
Number Sign	608340	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA	CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE A;; RI-CMTA	
Percent	608345	NYSTAGMUS 3, CONGENITAL, AUTOSOMAL DOMINANT; NYS3		
Number Sign	608354	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM		CAPILLARY MALFORMATION WITHOUT ARTERIOVENOUS MALFORMATION, INCLUDED
Number Sign	608355	PARKES WEBER SYNDROME	PKWS	
Number Sign	608358	MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA	MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT;; MYOPATHY WITH LYSIS OF TYPE I MYOFIBRILS	
Number Sign	608361	SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE; SEDK		
Number Sign	608363	CHROMOSOME 22q11.2 DUPLICATION SYNDROME	CHROMOSOME 22q11.2 MICRODUPLICATION SYNDROME	
Percent	608367	MYOPIA 17, AUTOSOMAL DOMINANT; MYP17	MYOPIA 4, FORMERLY; MYP4, FORMERLY	
Percent	608371	OROFACIAL CLEFT 4; OFC4	CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 4	
Percent	608372	DEAFNESS, AUTOSOMAL DOMINANT 49; DFNA49		
Number Sign	608380	RETINITIS PIGMENTOSA 26; RP26		
Number Sign	608389	BRANCHIOOTIC SYNDROME 3; BOS3	BO SYNDROME 3	
Number Sign	608390	MYOTONIA, POTASSIUM-AGGRAVATED	MYOTONIA FLUCTUANS;; MYOTONIA PERMANENS;; SODIUM CHANNEL MUSCLE DISEASE;; MYOTONIA CONGENITA, ACETAZOLAMIDE-RESPONSIVE;; MYOTONIA CONGENITA, ATYPICAL	LARYNGOSPASM, SEVERE NEONATAL EPISODIC, INCLUDED; SNEL, INCLUDED
Percent	608391	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 2; AIS2	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 3; VAMAS3;; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 7-RELATED	
Percent	608392	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 3; AIS3	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 4; VAMAS4;; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 8-RELATED	
Number Sign	608393	MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE; MCPH6		
Percent	608394	DEAFNESS, AUTOSOMAL DOMINANT 43; DFNA43		
Number Sign	608404	PLATELET GLYCOPROTEIN IV DEFICIENCY	BLEEDING DISORDER, PLATELET-TYPE, 10; BDPLT10;; CD36 DEFICIENCY	
NULL	608406	VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY		
Percent	608410	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 7; BMIQ7	OBESITY, SUSCEPTIBILITY TO	
Number Sign	608415	PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION; PERRS	BRADYOPSIA	
Number Sign	608423	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1F; LGMD1F		
NULL	608432	CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM		
Percent	608437	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 4; SLEB4		
Number Sign	608443	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3		
Percent	608445	SPEECH-SOUND DISORDER	SSD	
Number Sign	608446	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO		MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1, INCLUDED; MCI1, INCLUDED;; MYOCARDIAL INFARCTION, PROTECTION AGAINST, INCLUDED
Percent	608447	CAROTID INTIMAL MEDIAL THICKNESS 2	CIMT2;; CAROTID INTIMAL MEDIAL THICKNESS QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 12	
Percent	608448	INFLAMMATORY BOWEL DISEASE 9; IBD9		
Number Sign	608456	FAMILIAL ADENOMATOUS POLYPOSIS 2; FAP2	COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE;; ADENOMAS, MULTIPLE COLORECTAL, AUTOSOMAL RECESSIVE	
Percent	608462	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 8; HSCR8		
Number Sign	608470	CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB	REIS-BUCKLERS CORNEAL DYSTROPHY; RBCD;; CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I; CDB1;; CORNEAL DYSTROPHY, GEOGRAPHIC;; GRANULAR CORNEAL DYSTROPHY, TYPE III	
Number Sign	608471	CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A	LATTICE CORNEAL DYSTROPHY, TYPE IIIA	
Percent	608474	MYOPIA 5, AUTOSOMAL DOMINANT; MYP5		
NULL	608484	CONGENITAL CORNEAL OPACITIES, CORNEA GUTTATA, AND CORECTOPIA	CORNEAL OPACITIES, CONGENITAL, WITH CORNEA GUTTATA AND CORECTOPIA	
NULL	608509	ALOPECIA UNIVERSALIS CONGENITA, XY GONADAL DYSGENESIS, AND LARYNGOMALACIA		
Number Sign	608516	MAJOR DEPRESSIVE DISORDER; MDD	UNIPOLAR DEPRESSION	SEASONAL AFFECTIVE DISORDER, INCLUDED; SAD, INCLUDED
NULL	608518	OROFACIODIGITAL SYNDROME VII; OFD7	OFDS VII;; ORAL-FACIAL-DIGITAL SYNDROME, TYPE VII;; WHELAN SYNDROME	
Percent	608520	MAJOR DEPRESSIVE DISORDER 1	MDD1;; UNIPOLAR DEPRESSION 1	
Percent	608526	PERIODONTITIS, AGGRESSIVE, 2		
Number Sign	608540	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	CDG Ik; CDGIk	
Percent	608542	ANEURYSM, INTRACRANIAL BERRY, 2; ANIB2		
Percent	608543	SCHIZOPHRENIA 12	SCZD12;; SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 1p-RELATED	
Percent	608545	LARSEN-LIKE SYNDROME	LRSL	
Number Sign	608553	LEBER CONGENITAL AMAUROSIS 9; LCA9		
Number Sign	608556	LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO		
Percent	608557	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 2	MCI2	
Percent	608558	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 5; BMIQ5		
Percent	608559	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 6; BMIQ6		
Percent	608562	POLYDACTYLY, POSTAXIAL, TYPE A4	PAPA4;; POSTAXIAL POLYDACTYLY, TYPE A4	
Number Sign	608565	DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35		
Number Sign	608567	SICK SINUS SYNDROME 1; SSS1	SINUS RHYTHM, CONGENITAL ABSENCE OF;; SINUS NODE DISEASE, FAMILIAL, AUTOSOMAL RECESSIVE;; SICK SINUS SYNDROME, CONGENITAL;; SINUS BRADYCARDIA SYNDROME, FAMILIAL	
Number Sign	608569	CARDIOMYOPATHY, DILATED, 1O; CMD1O	CARDIOMYOPATHY, DILATED, WITH VENTRICULAR TACHYCARDIA	
NULL	608571	ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY		
Number Sign	608572	BURN-MCKEOWN SYNDROME; BMKS	OCULOOTOFACIAL DYSPLASIA; OOFD	
Number Sign	608579	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO		TOXIC EPIDERMAL NECROLYSIS, SUSCEPTIBILITY TO, INCLUDED;; STEVENS-JOHNSON SYNDROME, SUSCEPTIBILITY TO, INCLUDED;; HYPERSENSITIVITY SYNDROME, CARBAMAZEPINE-INDUCED, SUSCEPTIBILITY TO, INCLUDED
NULL	608580	MYOSIN, HEAVY CHAIN 16, SKELETAL MUSCLE, PSEUDOGENE; MYH16		
Percent	608583	ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	ATRIAL FIBRILLATION, AUTOSOMAL DOMINANT	
Number Sign	608584	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2	ASRT2	
Percent	608585	BRACHIAL PALSY, FAMILIAL CONGENITAL		
Percent	608586	KERATOCONUS 3; KTCN3		
Number Sign	608594	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1	BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY, TYPE 1; BSCL1;; LIPODYSTROPHY, BERARDINELLI-SEIP CONGENITAL, TYPE 1;; BRUNZELL SYNDROME, AGPAT2-RELATED	
Percent	608600	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1; FPLD1	LIPODYSTROPHY, FAMILIAL PARTIAL, KOBBERLING TYPE	
Number Sign	608611	RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY		
Number Sign	608612	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	LIPODYSTROPHY, TYPE B, ASSOCIATED WITH MANDIBULOACRAL DYSPLASIA	
Number Sign	608615	OLIGODONTIA-COLORECTAL CANCER SYNDROME; ODCRCS	TOOTH AGENESIS-COLORECTAL CANCER SYNDROME	
Number Sign	608622	HYPERTENSION, DIASTOLIC, RESISTANCE TO		
NULL	608624	MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA		
Number Sign	608627	AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8		
Number Sign	608629	JOUBERT SYNDROME 3; JBTS3		
Percent	608631	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2		
Number Sign	608634	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	HMN IIB;; NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; DHMN2B	
Number Sign	608636	CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	DUPLICATION 15q11-q13 SYNDROME	AUTISM, SUSCEPTIBILITY TO, 4, INCLUDED; AUTS4, INCLUDED;; CHROMOSOME 15q11.2 DUPLICATION SYNDROME, INCLUDED
Percent	608638	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1		
Number Sign	608641	DEAFNESS, AUTOSOMAL DOMINANT 28; DFNA28		
Number Sign	608643	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	AADC DEFICIENCY;; DOPA DECARBOXYLASE DEFICIENCY;; DDC DEFICIENCY	
Number Sign	608644	CILIARY DYSKINESIA, PRIMARY, 3; CILD3	CILIARY DYSKINESIA, PRIMARY, 3, WITH OR WITHOUT SITUS INVERSUS	
Percent	608645	DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31		
Percent	608646	CILIARY DYSKINESIA, PRIMARY, 4; CILD4	CILIARY DYSKINESIA, PRIMARY, 4, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	608647	CILIARY DYSKINESIA, PRIMARY, 5; CILD5	CILIARY DYSKINESIA, PRIMARY, 5, WITHOUT SITUS INVERSUS	
Number Sign	608649	ICHTHYOSIS PREMATURITY SYNDROME; IPS	ICHTHYOSIS CONGENITA IV	
Percent	608652	DEAFNESS, AUTOSOMAL DOMINANT 47; DFNA47		
Percent	608653	DEAFNESS, AUTOSOMAL RECESSIVE 32; DFNB32		
Number Sign	608654	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V; HSAN5	HSAN V;; INSENSITIVITY TO PAIN, CONGENITAL	
Percent	608656	PROSTATE CANCER, HEREDITARY, 3	HPC3	
Percent	608658	PROSTATE CANCER, HEREDITARY, 4	HPC4;; PROSTATE CANCER, HEREDITARY, ON CHROMOSOME 7	
NULL	608670	ROBIN SEQUENCE WITH DISTINCTIVE FACIAL APPEARANCE AND BRACHYDACTYLY		
Number Sign	608673	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, TYPE 2L;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2L	
Number Sign	608681	SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2		
Number Sign	608687	SPINOCEREBELLAR ATAXIA 20; SCA20	CHROMOSOME 11q12 DUPLICATION SYNDROME, 260-KB;; SPINOCEREBELLAR ATAXIA WITH DYSPHONIA;; SPINOCEREBELLAR ATAXIA WITH SPASMODIC COUGH	
Number Sign	608688	AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	ATIC DEFICIENCY;; AICA-RIBOSURIA DUE TO ATIC DEFICIENCY	
Percent	608691	MAJOR DEPRESSIVE DISORDER 2	MDD2;; UNIPOLAR DEPRESSION 2	
Percent	608695	GLAUCOMA 1, OPEN ANGLE, J; GLC1J	GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET, 2; JOAG2	
Percent	608696	GLAUCOMA 1, OPEN ANGLE, K; GLC1K	GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET, 3; JOAG3	
Percent	608703	SPINOCEREBELLAR ATAXIA 25; SCA25		
Number Sign	608709	LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD	APLD, SUSCEPTIBILITY TO;; BARRAQUER-SIMONS SYNDROME;; LIPODYSTROPHY, CEPHALOTHORACIC TYPE;; LIPODYSTROPHY, PARTIAL, PROGRESSIVE	
Percent	608710	WEGENER GRANULOMATOSIS	WG;; GRANULOMATOSIS WITH POLYANGIITIS	
Number Sign	608716	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5		
NULL	608720	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA		
Number Sign	608728	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED	SEMD, MATN3-RELATED	
Percent	608742	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 4	HYT4	
Number Sign	608747	INSULIN-LIKE GROWTH FACTOR I DEFICIENCY	IGF1 DEFICIENCY;; GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	
Number Sign	608751	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8; CMH8	CARDIOMYOPATHY, HYPERTROPHIC, MID-LEFT VENTRICULAR CHAMBER TYPE, 1	
Number Sign	608758	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10	CARDIOMYOPATHY, HYPERTROPHIC, MID-LEFT VENTRICULAR CHAMBER TYPE, 2	
Percent	608762	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, LOCUS ON CHROMOSOME 9	
NULL	608763	EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	EHLERS-DANLOS SYNDROME WITH MENTAL RETARDATION, DEAFNESS, AND CATARACT	
Percent	608765	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3; IS3		
Number Sign	608768	SPINOCEREBELLAR ATAXIA 8; SCA8		
Number Sign	608776	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	CDG Il; CDGIl	
Number Sign	608779	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	CDG IIe; CDGIIe	
Percent	608781	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 3; ASPG3		
Number Sign	608782	PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDHPD	LACTIC ACIDEMIA WITH PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	
Percent	608787	OTOSCLEROSIS 5; OTSC5		
Percent	608796	MOYAMOYA DISEASE 3; MYMY3		
Number Sign	608799	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie; CDG1E	CDG Ie; CDGIe	
Number Sign	608800	SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME; SIDDT		
Number Sign	608804	LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2	PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	
Number Sign	608805	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 1; ANFH1	FEMORAL HEAD, AVASCULAR NECROSIS OF; ANFH;; FEMORAL HEAD, ASEPTIC NECROSIS OF;; ISCHEMIC NECROSIS OF FEMORAL HEAD;; OSTEONECROSIS OF FEMORAL HEAD	
Number Sign	608807	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J; LGMD2J		
Number Sign	608808	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 1; DTGA1	D-TGA	
NULL	608809	LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA; LACH		
Number Sign	608810	MYOPATHY, MYOFIBRILLAR, 2; MFM2	MYOPATHY, MYOFIBRILLAR, ALPHA-B CRYSTALLIN-RELATED;; MYOPATHY, DESMIN-RELATED, ASSOCIATED WITH MUTATION IN THE CRYAB GENE;; ALPHA-B CRYSTALLINOPATHY;; MYOPATHY, MYOFIBRILLAR, WITH OR WITHOUT CATARACT AND/OR CARDIOMYOPATHY	
NULL	608811	METAPHYSEAL UNDERMODELING, SPONDYLAR DYSPLASIA, AND OVERGROWTH		
Number Sign	608812	COLORECTAL CANCER, SUSCEPTIBILITY TO, 1; CRCS1	COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 9;; COLORECTAL ADENOMA AND CANCER, SUSCEPTIBILITY TO	
NULL	608814	LATERAL SEMICIRCULAR CANAL MALFORMATION, FAMILIAL, WITH EXTERNAL AND MIDDLE EAR ABNORMALITIES		
Percent	608816	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 3; EJM3		
Percent	608831	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 2; RLS2		
Number Sign	608836	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;; CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;; CPT II DEFICIENCY, LETHAL NEONATAL;; CPT2 DEFICIENCY, LETHAL NEONATAL	
Number Sign	608837	CARNEY COMPLEX VARIANT		
Number Sign	608840	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6; MDDGB6	MUSCULAR DYSTROPHY, CONGENITAL, LARGE-RELATED;; MUSCULAR DYSTROPHY, CONGENITAL, TYPE 1D; MDC1D	
Percent	608850	MACULAR DYSTROPHY, RETINAL, 3; MCDR3		
Percent	608852	PULMONARY FUNCTION	PLF;; LUNG FUNCTION, ACCELERATED RATE OF DECLINE IN, SMOKING-RELATED	
Number Sign	608864	OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6	CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 6	
Number Sign	608874	OROFACIAL CLEFT 5; OFC5	CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 5	
Percent	608875	GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 14	GEVQ1	
Percent	608878	GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 20	GEVQ2	
Number Sign	608885	STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	GLUT1 DEFICIENCY SYNDROME WITH PSEUDOHYPERKALEMIA AND HEMOLYSIS;; CRYOHYDROCYTOSIS, STOMATIN-DEFICIENT, WITH MENTAL RETARDATION, SEIZURES, CATARACTS, AND MASSIVE HEPATOSPLENOMEGALY	
Number Sign	608890	WAARDENBURG SYNDROME, TYPE 2D; WS2D	WAARDENBURG SYNDROME, TYPE IID	
Number Sign	608895	NEUROPATHY, HEREDITARY, WITH OR WITHOUT AGE-RELATED MACULAR DEGENERATION; HNARMD		MACULAR DEGENERATION, AGE-RELATED, 3, INCLUDED; ARMD3, INCLUDED
Number Sign	608898	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3	HPLH3;; HLH3	
Number Sign	608901	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5	CHDS5;; CORONARY ARTERY DISEASE, EARLY-ONSET	
Number Sign	608902	DRUG METABOLISM, POOR, CYP2D6-RELATED		DRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED;; DEBRISOQUINE, POOR METABOLISM OF, INCLUDED;; DEBRISOQUINE, ULTRARAPID METABOLISM OF, INCLUDED;; SPARTEINE, POOR METABOLISM OF, INCLUDED;; NORTRIPTYLINE, POOR METABOLISM OF, INCLUDED;; CODEINE, ULTRARAPID METABOLISM OF, INCLUDED
Percent	608903	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 1	ADHD1	
Percent	608904	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 2	ADHD2	
Percent	608905	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 3	ADHD3	
Percent	608906	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 4	ADHD4	
Number Sign	608907	ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	ALZHEIMER DISEASE 9, LATE-ONSET	
Number Sign	608908	MYOPIA 6; MYP6		
Percent	608911	CHOANAL ATRESIA, POSTERIOR; PCA		
Number Sign	608930	MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B		
Number Sign	608931	MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C	MYASTHENIC SYNDROME, CONGENITAL, TYPE Id; CMS1D, FORMERLY;; CMS Id, FORMERLY;; MYASTHENIA, FAMILIAL INFANTILE, 1, FORMERLY; FIM1, FORMERLY	
Percent	608932	KERATOCONUS 2; KTCN2		
Percent	608935	LUNG CANCER SUSCEPTIBILITY 1; LNCR1		
Number Sign	608940	SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD		
Number Sign	608957	CD8 DEFICIENCY, FAMILIAL		
Number Sign	608970	MACULAR DYSTROPHY, PATTERNED, 2; MDPT2	MACULAR DYSTROPHY, BUTTERFLY-SHAPED PIGMENTARY, 2	
Number Sign	608971	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	SCID, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	
Number Sign	608978	MEACHAM SYNDROME		
Number Sign	608980	BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR		
Percent	608982	STATURE QUANTITATIVE TRAIT LOCUS 5; STQTL5		
Number Sign	608984	ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT; SNAX1	ADSA	
Percent	608988	ATRIAL FIBRILLATION, FAMILIAL, 2; ATFB2		
Percent	608995	DYSLEXIA, SUSCEPTIBILITY TO, 8; DYX8		
Number Sign	608996	PREMATURE OVARIAN FAILURE 3; POF3		
Number Sign	609006	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT; DFNB36		DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT, INCLUDED
NULL	609008	MARFANOID HABITUS WITH SITUS INVERSUS		
Number Sign	609015	MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	TRIFUNCTIONAL PROTEIN DEFICIENCY	TRIFUNCTIONAL PROTEIN DEFICIENCY WITH MYOPATHY AND NEUROPATHY, INCLUDED
Number Sign	609016	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	LCHAD DEFICIENCY	
Percent	609021	PERIPHERAL CONE DYSTROPHY		
Percent	609026	CATARACT 28; CTRCT28	CATARACT, AGE-RELATED CORTICAL, 1; ARCC1	
Number Sign	609027	BLOOD GROUP, INDIAN SYSTEM; IN	INDIAN BLOOD GROUP SYSTEM; IN	
Number Sign	609029	EMANUEL SYNDROME	SUPERNUMERARY DER(22)t(11;22) SYNDROME	
Number Sign	609033	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	PCARP	
NULL	609037	MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE		
Percent	609039	NARCOLEPSY 3; NRCLP3		
Number Sign	609040	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9; ARVD9	ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 9; ARVC9	
Percent	609041	SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE; SPG27		
NULL	609047	SKELETAL DYSPLASIA, RHIZOMELIC, WITH RETINITIS PIGMENTOSA		
Number Sign	609048	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3; CMM3		
Number Sign	609049	PIERSON SYNDROME	MICROCORIA-CONGENITAL NEPHROTIC SYNDROME	
Percent	609052	SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4		
Number Sign	609053	FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI		
Number Sign	609054	FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ		
Percent	609055	CEROID LIPOFUSCINOSIS, NEURONAL, 9; CLN9		
Number Sign	609056	SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	AMISH INFANTILE EPILEPSY SYNDROME;; EPILEPSY SYNDROME, INFANTILE-ONSET SYMPTOMATIC;; GM3 SYNTHASE DEFICIENCY;; SALT AND PEPPER MENTAL RETARDATION SYNDROME	
Number Sign	609057	NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS		
Number Sign	609060	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1	HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	
Number Sign	609069	PANCREATIC AND CEREBELLAR AGENESIS; PACA	DIABETES MELLITUS, PERMANENT NEONATAL, WITH CEREBELLAR AGENESIS	
Number Sign	609070	HEMOGLOBIN, HIGH ALTITUDE ADAPTATION; HALAH	HEMOGLOBIN, HIGH OXYGEN SATURATION OF	
Percent	609113	TELOMERE LENGTH, MEAN LEUKOCYTE; LTL	TELM	
Number Sign	609115	LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G		
Percent	609116	RESPIRATORY RHYTHMICITY IN SLEEP	RRIS	
Percent	609122	ANEURYSM, INTRACRANIAL BERRY, 3; ANIB3		
Percent	609128	ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	ARTHROGRYPOSIS WITH SEVERE SCOLIOSIS;; ARTHROGRYPOSIS, DISTAL, TYPE IID; DAIID	
Number Sign	609129	AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1; AUNA1	AUDITORY NEUROPATHY, NONSYNDROMIC DOMINANT; NSDAN	
Number Sign	609135	APLASTIC ANEMIA		APLASTIC ANEMIA, SUSCEPTIBILITY TO, INCLUDED
Number Sign	609136	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	WAARDENBURG-SHAH SYNDROME, NEUROLOGIC VARIANT	
Number Sign	609140	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2; PPCD2		
Number Sign	609141	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3; PPCD3		
Number Sign	609148	MALARIA, MILD, SUSCEPTIBILITY TO	MALS	
Number Sign	609152	HYPERTHYROIDISM, NONAUTOIMMUNE	HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;; HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;; TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	
Number Sign	609153	PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK; PSHK2	PSEUDOHYPERKALEMIA LILLE;; PSEUDOHYPERKALEMIA FALKIRK;; PSEUDOHYPERKALEMIA CHISWICK;; PSEUDOHYPERKALEMIA CARDIFF;; PSEUDOHYPERKALEMIA EAST LONDON;; CRYOHYDROCYTOSIS, MILD	
Number Sign	609161	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 1; ADSD1		
Number Sign	609162	CZECH DYSPLASIA	CZECH DYSPLASIA, METATARSAL TYPE;; PSEUDORHEUMATOID DYSPLASIA, PROGRESSIVE, WITH HYPOPLASTIC TOES;; SPONDYLOEPIPHYSEAL DYSPLASIA WITH PRECOCIOUS OSTEOARTHRITIS	
Percent	609164	UMBILICUS, FAMILIAL FLAT	FLAT UMBILICUS, AUTOSOMAL DOMINANT	
Number Sign	609165	ERYTHRODERMA, ICHTHYOSIFORM, CONGENITAL RETICULAR; CRIE	ICHTHYOSIS WITH CONFETTI; IWC;; ICHTHYOSIS VARIEGATA	ERYTHROKERATODERMA, RETICULAR, INCLUDED;; AARAU DISEASE, INCLUDED
Percent	609166	BRANCHIOGENIC-DEAFNESS SYNDROME		
Percent	609179	MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 7	MGR7	
Number Sign	609180	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If; CDG1F	CDG If; CDGIf	
Number Sign	609192	LOEYS-DIETZ SYNDROME 1; LDS1	FURLONG SYNDROME;; LOEYS-DIETZ AORTIC ANEURYSM SYNDROME;; AORTIC ANEURYSM, FAMILIAL THORACIC 5; AAT5	
Number Sign	609195	SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26		
Percent	609197	GLUCOCORTICOID DEFICIENCY 3; GCCD3	FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3;; GLUCOCORTICOID DEFICIENCY 2, FORMERLY; GCCD2, FORMERLY	
Number Sign	609200	MYOPATHY, MYOFIBRILLAR, 3; MFM3	MYOTILINOPATHY;; MYOPATHY, MYOFIBRILLAR, MYOTILIN-RELATED	
Number Sign	609218	FOVEAL HYPOPLASIA 2; FVH2	FOVEAL HYPOPLASIA 2 WITH OR WITHOUT OPTIC NERVE MISROUTING AND/OR ANTERIOR SEGMENT DYSGENESIS;; FOVEAL HYPOPLASIA 2 WITH OPTIC NERVE DECUSSATION DEFECTS AND ANTERIOR SEGMENT DYSGENESIS WITHOUT ALBINISM; FHONDA	
Number Sign	609220	BRUCK SYNDROME 2; BRKS2	OSTEOGENESIS IMPERFECTA WITH CONGENITAL JOINT CONTRACTURES	
Percent	609222	DANDY-WALKER MALFORMATION WITH OCCIPITAL CEPHALOCELE, AUTOSOMAL DOMINANT; ADDWOC		
Percent	609223	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGER TYPE		
Number Sign	609227	GRISCELLI SYNDROME, TYPE 3; GS3		
Number Sign	609241	SCHINDLER DISEASE, TYPE I	NEUROAXONAL DYSTROPHY, SCHINDLER TYPE;; ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE I;; NAGA DEFICIENCY, TYPE I	ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE III, INCLUDED;; NAGA DEFICIENCY, TYPE III, INCLUDED;; SCHINDLER DISEASE, TYPE III, INCLUDED
Number Sign	609242	KANZAKI DISEASE	ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;; ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;; NAGA DEFICIENCY, TYPE II;; SCHINDLER DISEASE, TYPE II	
NULL	609250	HYPOTRICHOSIS, PROGRESSIVE PATTERNED SCALP, WITH WIRY HAIR, ONYCHOLYSIS, AND CLEFT LIP/PALATE	MARIE UNNA-LIKE SCALP HYPOTRICHOSIS	
Percent	609253	FEBRILE SEIZURES, FAMILIAL, 6; FEB6	CONVULSIONS, FAMILIAL FEBRILE, 6	
Number Sign	609254	SENIOR-LOKEN SYNDROME 5; SLSN5		
Percent	609255	FEBRILE SEIZURES, FAMILIAL, 5; FEB5	CONVULSIONS, FAMILIAL FEBRILE, 5	
Percent	609256	MYOPIA 7; MYP7		
Percent	609257	MYOPIA 8; MYP8		
Percent	609258	MYOPIA 9; MYP9		
Percent	609259	MYOPIA 10; MYP10		
Number Sign	609260	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A; CMT2A2A	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2;; CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2A2;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2A2;; HEREDITARY MOTOR AND SENSORY NEUROPATHY IIA2; HMSN2A2;; HMSN IIA2	
Percent	609261	STUTTERING, FAMILIAL PERSISTENT, 2; STUT2		
Number Sign	609265	LI-FRAUMENI SYNDROME 2; LFS2		
Percent	609266	LI-FRAUMENI SYNDROME 3; LFS3		
Number Sign	609270	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7		
Percent	609271	KERATOCONUS 4; KTCN4		
Number Sign	609273	NEMALINE MYOPATHY 6; NEM6		
Number Sign	609283	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 2	
Number Sign	609284	NEMALINE MYOPATHY 1; NEM1		CAP MYOPATHY 1, INCLUDED; CAPM1, INCLUDED
Number Sign	609285	NEMALINE MYOPATHY 4; NEM4		CAP MYOPATHY 2, INCLUDED; CAPM2, INCLUDED
Number Sign	609286	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 3	
Percent	609289	SYNCOPE, FAMILIAL VASOVAGAL; VVS	SYNCOPE, FAMILIAL NEUROCARDIOGENIC	
Percent	609296	B-CELL IMMUNODEFICIENCY, DISTAL LIMB ANOMALIES, AND UROGENITAL MALFORMATIONS	BILU SYNDROME;; HOFFMAN SYNDROME	
Percent	609299	PROSTATE CANCER, HEREDITARY, 5	HPC5	
Number Sign	609304	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3		
Number Sign	609306	SPINOCEREBELLAR ATAXIA 26; SCA26		
Number Sign	609307	SPINOCEREBELLAR ATAXIA 27; SCA27	CEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, FGF14-RELATED	
Number Sign	609308	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	
Number Sign	609310	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2; HNPCC2	COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2; FCC2;; COCA2	
Number Sign	609311	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL RECESSIVE, TYPE 4H;; CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4H;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4H	
Number Sign	609313	MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA; MEDNIK	ERYTHROKERATODERMIA VARIABILIS 3; EKV3;; ERYTHROKERATODERMIA VARIABILIS, KAMOURASKA TYPE	
Percent	609319	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HCHGQ1	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 6	
Percent	609320	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HCHGQ2	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 9	
Number Sign	609322	RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1	BRAIN TUMOR, POSTERIOR FOSSA, OF INFANCY, FAMILIAL	MALIGNANT RHABDOID TUMOR, SOMATIC, INCLUDED;; RHABDOID TUMOR, INCLUDED; RDT, INCLUDED;; TERATOID TUMOR, ATYPICAL, INCLUDED;; AT/RT, INCLUDED
Percent	609324	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA		
Percent	609325	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES		
Number Sign	609334	CHROMOSOME 18 PERICENTRIC INVERSION		
Number Sign	609338	CAROTID INTIMAL MEDIAL THICKNESS 1	CIMT1;; INTIMAL MEDIAL THICKNESS OF INTERNAL CAROTID ARTERY	
Number Sign	609340	SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28		
NULL	609345	CEREBRORENODIGITAL SYNDROME WITH LIMB MALFORMATIONS AND TRIRADIATE ACETABULA		
Number Sign	609352	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA		
Percent	609354	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 5; BMND5		
NULL	609363	COLLOID CYSTS OF THIRD VENTRICLE	NEUROEPITHELIAL CYSTS OF THIRD VENTRICLE	
Percent	609376	CATARACT 35; CTRCT35	CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 1; CATCN1	
Percent	609378	AUTISM, SUSCEPTIBILITY TO, 6; AUTS6		
Percent	609384	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3C; CFEOM3C	FEOM4 LOCUS	
Percent	609400	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 4; AIS4	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 5; VAMAS5;; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 4-RELATED	
Percent	609402	PREECLAMPSIA/ECLAMPSIA 2; PEE2		
Percent	609403	PREECLAMPSIA/ECLAMPSIA 3; PEE3		
Number Sign	609404	PREECLAMPSIA/ECLAMPSIA 4; PEE4		
Percent	609408	HOLOPROSENCEPHALY 8; HPE8		
Number Sign	609423	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO	HIV-1, SUSCEPTIBILITY TO	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RESISTANCE TO, INCLUDED;; HIV-1, RESISTANCE TO, INCLUDED;; ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO, INCLUDED;; AIDS, PROGRESSION TO, INCLUDED
Number Sign	609425	CHROMOSOME 3q29 DELETION SYNDROME	MICRODELETION 3q29 SYNDROME	
Percent	609428	TUKEL SYNDROME	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH ULNAR HAND ANOMALIES;; CFEOM-U;; FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 4; CFEOM4	
Number Sign	609432	SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION; MSSD	SYNDACTYLY, MALIK-PERCIN TYPE;; SYNDACTYLY, TYPE IX	
NULL	609438	MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIAL BLOCK		
Number Sign	609439	DEAFNESS, AUTOSOMAL RECESSIVE 48; DFNB48		
Number Sign	609441	ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	CHONDRODYSPLASIA, ACROMESOMELIC, WITH OR WITHOUT GENITAL ANOMALIES	
NULL	609442	VALPROATE EMBRYOPATHY, SUSCEPTIBILITY TO	FETAL VALPROATE SYNDROME; FVS	
Number Sign	609446	PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	GENERALIZED EPILEPSY AND PAROXYSMAL DYSKINESIA; GEPD	
Number Sign	609452	MYOPATHY, MYOFIBRILLAR, 4; MFM4		
Percent	609454	SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2		
Percent	609456	MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE		
Number Sign	609460	GOLDBERG-SHPRINTZEN SYNDROME; GOSHS	GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	
NULL	609465	AL-GAZALI SYNDROME		
NULL	609466	CLEFT PALATE, MIDFACIAL HYPOPLASIA, TRIANGULAR FACIES, AND SENSORINEURAL HEARING LOSS		
Percent	609469	NEPHROPATHY, PROGRESSIVE, WITH DEAFNESS	NEDE;; ALPORT/FOCAL SEGMENTAL GLOMERULOSCLEROSIS-LIKE SYNDROME	
Percent	609470	LEFT VENTRICULAR NONCOMPACTION 2; LVNC2		
Percent	609500	MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET		
Number Sign	609508	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR	STICKLER SYNDROME, TYPE I, PREDOMINANTLY OCULAR;; STICKLER SYNDROME, ATYPICAL	RHEGMATOGENOUS RETINAL DETACHMENT, AUTOSOMAL DOMINANT, INCLUDED; DRRD, INCLUDED
NULL	609515	IRIDOGONIODYSGENESIS AND SKELETAL ANOMALIES		
Number Sign	609524	MYOPATHY, MYOFIBRILLAR, 5; MFM5	MYOPATHY, MYOFIBRILLAR, FILAMIN C-RELATED;; FILAMINOPATHY, AUTOSOMAL DOMINANT	
Number Sign	609528	CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME	CEDNIK SYNDROME	
Number Sign	609529	IMMUNOGLOBULIN A DEFICIENCY 2; IGAD2	IMMUNOGLOBULIN A, SELECTIVE DEFICIENCY OF, TACI-RELATED;; IgA, SELECTIVE DEFICIENCY OF, TACI-RELATED	
Number Sign	609532	HEPATITIS C VIRUS, SUSCEPTIBILITY TO	HCV, SUSCEPTIBILITY TO	HEPATITIS C VIRUS, RESISTANCE TO, INCLUDED;; HCV, RESISTANCE TO, INCLUDED;; HEPATITIS C VIRUS INFECTION, RESPONSE TO THERAPY OF, INCLUDED
Number Sign	609533	DEAFNESS, AUTOSOMAL RECESSIVE 23; DFNB23		
Number Sign	609535	DRUG METABOLISM, POOR, CYP2C19-RELATED		MEPHENYTOIN, POOR METABOLISM OF, INCLUDED;; OMEPRAZOLE, POOR METABOLISM OF, INCLUDED;; PROGUANIL, POOR METABOLISM OF, INCLUDED;; CLOPIDOGREL, POOR METABOLISM OF, INCLUDED
Number Sign	609536	COMPLEMENT COMPONENT 5 DEFICIENCY; C5D	C5 DEFICIENCY	
NULL	609537	LIPOMYELOMENINGOCELE		
Number Sign	609541	SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN		
NULL	609545	OMPHALOCELE, DIAPHRAGMATIC HERNIA, AND RADIAL RAY DEFECTS	GERSHONI-BARUCH SYNDROME	
Number Sign	609549	NANOPHTHALMOS 2; NNO2	NANOPHTHALMIA 2;; NANOPHTHALMOS, AUTOSOMAL RECESSIVE	
Percent	609558	PROSTATE CANCER, HEREDITARY, 6	HPC6	
Number Sign	609560	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); MTDPS2	MITOCHONDRIAL DNA DEPLETION MYOPATHY, TK2-RELATED	
Percent	609566	PARIETAL FORAMINA 3; PFM3		
Percent	609570	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 8	MGR8	
Percent	609572	PHOTOPAROXYSMAL RESPONSE 2; PPR2	PHOTOPAROXYSMAL RESPONSE WITH OR WITHOUT IDIOPATHIC GENERALIZED EPILEPSY	
Percent	609573	PHOTOPAROXYSMAL RESPONSE 3; PPR3	PHOTOPAROXYSMAL RESPONSE WITH OR WITHOUT MYOCLONIC EPILEPSY	
Percent	609578	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 2; RCM2		
Number Sign	609579	SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION		
Number Sign	609583	JOUBERT SYNDROME 4; JBTS4		
Number Sign	609597	PARIETAL FORAMINA 2; PFM2		
NULL	609612	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE	CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;; EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCE	EXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, AND OCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED
NULL	609616	SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATE CALCIFICATIONS, AND DEAFNESS		
Number Sign	609620	SHORT QT SYNDROME 1; SQT1		
Number Sign	609621	SHORT QT SYNDROME 2; SQT2		
Number Sign	609622	SHORT QT SYNDROME 3; SQT3		
Number Sign	609625	CHROMOSOME 10q26 DELETION SYNDROME	TERMINAL CHROMOSOME 10q26 DELETION SYNDROME	
Number Sign	609628	MAJEED SYNDROME; MJDS	CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS, CONGENITAL DYSERYTHROPOIETIC ANEMIA, AND NEUTROPHILIC DERMATOSIS	
Percent	609629	VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL DOMINANT	ENTERIC NEUROPATHY, FAMILIAL;; PSEUDOOBSTRUCTION, CHRONIC INTESTINAL, NEUROPATHIC;; PSEUDOOBSTRUCTION, IDIOPATHIC INTESTINAL	
Percent	609630	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 1	CLLS1	
Percent	609633	MAJOR AFFECTIVE DISORDER 3; MAFD3	BIPOLAR AFFECTIVE DISORDER, EARLY-ONSET; BPEO	
Number Sign	609634	MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3		
Percent	609636	ALZHEIMER DISEASE 10	ALZHEIMER DISEASE, FAMILIAL, 10;; AD10	
Number Sign	609637	HOLOPROSENCEPHALY 5; HPE5		
Number Sign	609638	EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	LETHAL ACANTHOLYTIC EPIDERMOLYSIS BULLOSA; LAEB	
Number Sign	609640	FRIAS SYNDROME	CHROMOSOME 14q22 DELETION SYNDROME;; GROWTH DEFICIENCY, FACIAL ANOMALIES, AND BRACHYDACTYLY	
Percent	609643	NGUYEN SYNDROME	MCA/MR WITH HYPOCHOLESTEROLEMIA DUE TO FAMILIAL HYPOBETALIPOPROTEINEMIA	
Number Sign	609646	DEAFNESS, AUTOSOMAL RECESSIVE 42; DFNB42		
Percent	609647	DEAFNESS, AUTOSOMAL RECESSIVE 46; DFNB46		
Percent	609649	TRICHILEMMAL CYST 1; TRICY1	TRICHOLEMMAL CYST;; PILAR CYST	
NULL	609654	SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS		
NULL	609655	TALO-PATELLO-SCAPHOID OSTEOLYSIS, SYNOVITIS, AND SHORT FOURTH METACARPALS		
Percent	609656	BONE SIZE QUANTITATIVE TRAIT LOCUS 1	BSZQTL1	
Percent	609657	BONE SIZE QUANTITATIVE TRAIT LOCUS 2	BSZQTL2	
Percent	609670	MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 9	MGR9	
Number Sign	609698	THYROID HORMONE METABOLISM, ABNORMAL		
Number Sign	609706	DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53		
Percent	609727	SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT; SPG29		
Number Sign	609734	PROOPIOMELANOCORTIN DEFICIENCY	OBESITY, EARLY-ONSET, ADRENAL INSUFFICIENCY, AND RED HAIR	
Number Sign	609741	CATARACT 22, MULTIPLE TYPES; CTRCT22	CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 2; CATCN2	
Percent	609745	GLAUCOMA 1, OPEN ANGLE, I; GLC1I		
Percent	609750	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 4; EIG4	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, LOCUS ON CHROMOSOME 10	
Number Sign	609753	CELIAC DISEASE, SUSCEPTIBILITY TO, 4; CELIAC4	GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 4	
Percent	609754	CELIAC DISEASE, SUSCEPTIBILITY TO, 2; CELIAC2	GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 2	
Number Sign	609755	CELIAC DISEASE, SUSCEPTIBILITY TO, 3; CELIAC3	GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 3	
Number Sign	609757	WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	WBS DUPLICATION SYNDROME;; CHROMOSOME 7q11.23 DUPLICATION SYNDROME;; SOMERVILLE-VAN DER AA SYNDROME	WBS TRIPLICATION SYNDROME, INCLUDED;; CHROMOSOME 7q11.23 TRIPLICATION SYNDROME, INCLUDED
Percent	609782	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 2; AAA2		
Percent	609790	ALZHEIMER DISEASE 11	ALZHEIMER DISEASE, FAMILIAL, 11;; AD11	
Number Sign	609796	PEELING SKIN SYNDROME 2; PSS2	ACRAL PEELING SKIN SYNDROME; APSS;; PEELING SKIN SYNDROME, ACRAL TYPE	
Percent	609800	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	GEFS+, TYPE 4; GEFS+4	
NULL	609808	HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	PCFH	
Number Sign	609812	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8	DIABETES AND PANCREATIC EXOCRINE DYSFUNCTION; DPED;; DIABETES-PANCREATIC EXOCRINE DYSFUNCTION SYNDROME	
Number Sign	609813	SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3		
Number Sign	609814	COMPLEMENT FACTOR H DEFICIENCY; CFHD	FACTOR H DEFICIENCY;; CFH DEFICIENCY	
Percent	609815	ZYGODACTYLY 1	ZD1	
Percent	609817	VASCULITIS, LYMPHOCYTIC, CUTANEOUS SMALL VESSEL		
Number Sign	609820	ERYTHROCYTOSIS, FAMILIAL, 3; ECYT3		
Number Sign	609821	BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8	BLEEDING DISORDER DUE TO P2RY12 DEFECT	
Percent	609822	STATURE QUANTITATIVE TRAIT LOCUS 7; STQTL7		
Number Sign	609823	DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28		
Percent	609876	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 6; BMND6		
Number Sign	609886	GLOMERULOCYSTIC KIDNEY DISEASE WITH HYPERURICEMIA AND ISOSTHENURIA		
Number Sign	609887	GLAUCOMA 1, OPEN ANGLE, G; GLC1G		
Percent	609888	LEPROSY, SUSCEPTIBILITY TO, 1; LPRS1	LEPROSY, PAUCIBACILLARY TYPE, SUSCEPTIBILITY TO, 1	
Number Sign	609889	ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY		
Percent	609893	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 3; CHNG3	RESISTANCE TO THYROTROPIN; RTSH;; THYROTROPIN RESISTANCE	
Percent	609903	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 5; SLEB5		
Number Sign	609909	CARDIOMYOPATHY, DILATED, 1P; CMD1P		
Percent	609913	RETINITIS PIGMENTOSA 32; RP32		
Percent	609915	CARDIOMYOPATHY, DILATED, 1Q; CMD1Q		
Percent	609918	GALLBLADDER DISEASE 2; GBD2		
Percent	609919	GALLBLADDER DISEASE 3; GBD3		
Number Sign	609923	RETINITIS PIGMENTOSA 31; RP31		
Number Sign	609924	AMINOACYLASE 1 DEFICIENCY; ACY1D		
Percent	609939	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6		
Percent	609941	DEAFNESS, AUTOSOMAL RECESSIVE 51; DFNB51		
Number Sign	609942	NOONAN SYNDROME 3; NS3		
NULL	609943	HYPERTRICHOSIS, HYPERKERATOSIS, MENTAL RETARDATION, AND DISTINCTIVE FACIAL FEATURES		
NULL	609944	ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES		
NULL	609945	BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA		
Percent	609946	DEAFNESS, AUTOSOMAL RECESSIVE 47; DFNB47		
Percent	609952	DEAFNESS, AUTOSOMAL RECESSIVE 55; DFNB55		
Percent	609954	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 4; ASPG4		
Percent	609955	FIBROMATOSIS, GINGIVAL, 3; GINGF3	GGF3;; FIBROMATOSIS, GINGIVAL, HEREDITARY, 3; HGF3	
Percent	609958	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 3	ASRT3	
Percent	609965	DEAFNESS, AUTOSOMAL DOMINANT 53; DFNA53		
Number Sign	609968	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5		
Number Sign	609975	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4		
Number Sign	609981	NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT; NKGCD	NATURAL KILLER CELL DEFICIENCY, FAMILIAL ISOLATED; NKCD	
Percent	609985	PANIC DISORDER 3	PAND3;; PANIC DISORDER SUSCEPTIBILITY LOCUS, CHROMOSOME 4q-RELATED	
Percent	609989	METAPHYSEAL CHONDRODYSPLASIA WITH CONE-SHAPED EPIPHYSES, NORMAL HAIR, AND NORMAL HANDS	CUPPED METAPHYSES AND CONE-SHAPED EPIPHYSES WITHOUT ALOPECIA OR BRACHYDACTYLY	
Percent	609990	TRICHOSCYPHODYSPLASIA	METAPHYSEAL CHONDRODYSPLASIA WITH CONE-SHAPED EPIPHYSES AND ALOPECIA;; METAPHYSEAL CHONDRODYSPLASIA WITH ECTODERMAL DYSPLASIA;; CUPPED METAPHYSES AND CONE-SHAPED EPIPHYSES WITH ALOPECIA	
Percent	609993	OSTEOSCLEROSIS WITH ICHTHYOSIS AND PREMATURE OVARIAN FAILURE	SCLEROSING DYSPLASIA OF BONE WITH ICHTHYOSIS AND PREMATURE OVARIAN FAILURE	
Percent	609994	MYOPIA 11, AUTOSOMAL DOMINANT; MYP11		
Percent	609995	MYOPIA 12, AUTOSOMAL DOMINANT; MYP12		
NULL	610001	ARTHROGRYPOSIS MULTIPLEX WITH DEAFNESS, INGUINAL HERNIAS, AND EARLY DEATH		
Number Sign	610003	CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	NORTHERN EPILEPSY;; EPILEPSY, PROGRESSIVE, WITH MENTAL RETARDATION; EPMR	
Number Sign	610006	2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	2-METHYLBUTYRYL GLYCINURIA;; SHORT/BRANCHED-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY; SBCADD	
Number Sign	610015	GLUTAMINE DEFICIENCY, CONGENITAL	GLUTAMINE SYNTHASE DEFICIENCY, CONGENITAL SYSTEMIC	
Number Sign	610017	MULTIPLE SYNOSTOSES SYNDROME 2; SYNS2		
Number Sign	610019	CATARACT 18; CTRCT18	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 2; CATC2	
Number Sign	610021	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	HYPERINSULINEMIC HYPOGLYCEMIA, EXERCISE-INDUCED	
NULL	610023	BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS		
Number Sign	610024	RETINAL CONE DYSTROPHY 3A; RCD3A	CONE DYSTROPHY WITH NIGHT BLINDNESS AND SUPERNORMAL ROD RESPONSES, PDE6H-RELATED	ACHROMATOPSIA 6, INCLUDED; ACHM6, INCLUDED
Number Sign	610031	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7	POLYMICROGYRIA, SYMMETRIC OR ASYMMETRIC; PMGYSA	
Number Sign	610042	PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	CORTICAL DYSPLASIA-FOCAL EPILEPSY SYNDROME; CDFES	
Number Sign	610048	CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD	CONGENITAL STROMAL CORNEAL DYSTROPHY	
Percent	610064	OPIOID DEPENDENCE, SUSCEPTIBILITY TO, 1	ODS1	
Percent	610065	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 7; SLEB7		
Percent	610066	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 8; SLEB8		
Number Sign	610069	POLYPOSIS SYNDROME, HEREDITARY MIXED, 2; HMPS2		
Percent	610071	HYPERPARATHYROIDISM 3; HRPT3	HYPERPARATHYROIDISM, FAMILIAL ISOLATED	
Number Sign	610090	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD	PNPO DEFICIENCY;; SEIZURES, PYRIDOXINE-RESISTANT, PLP-SENSITIVE;; EPILEPTIC ENCEPHALOPATHY, NEONATAL, PNPO-RELATED	
Number Sign	610092	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3; MCOPCB3	MICROPHTHALMIA, COLOBOMATOUS, ISOLATED 3	MICROPHTHALMIA, CATARACTS, AND IRIS ABNORMALITIES, INCLUDED
Number Sign	610093	MICROPHTHALMIA, ISOLATED 2; MCOP2	ANOPHTHALMIA, CLINICAL, ISOLATED	
Percent	610099	MYOPATHY, DISTAL, 3; MPD3		
Number Sign	610100	GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT; GAN2		
Number Sign	610102	COMPLEMENT COMPONENT 7 DEFICIENCY; C7D	C7 DEFICIENCY	
Percent	610114	STATURE QUANTITATIVE TRAIT LOCUS 8; STQTL8		
Number Sign	610125	MICROPHTHALMIA, SYNDROMIC 5; MCOPS5		RETINAL DYSTROPHY, EARLY-ONSET, WITH OR WITHOUT PITUITARY DYSFUNCTION, INCLUDED
Number Sign	610127	CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10	CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;; NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCY	NEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED
Number Sign	610131	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 4	
NULL	610136	DEVRIENDT SYNDROME		
Number Sign	610140	HEART-HAND SYNDROME, SLOVENIAN TYPE		
Percent	610141	QT INTERVAL, VARIATION IN		
Percent	610143	DEAFNESS, AUTOSOMAL RECESSIVE 62; DFNB62		
Number Sign	610149	MACULAR DEGENERATION, AGE-RELATED, 7; ARMD7		MACULAR DEGENERATION, AGE-RELATED, NEOVASCULAR TYPE, SUSCEPTIBILITY TO, INCLUDED;; MACULAR DEGENERATION, AGE-RELATED, WET TYPE, SUSCEPTIBILITY TO, INCLUDED
Number Sign	610153	DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49		
Number Sign	610154	DEAFNESS, AUTOSOMAL RECESSIVE 44; DFNB44		
Percent	610155	DIABETES MELLITUS, INSULIN-DEPENDENT, 19; IDDM19		
Number Sign	610156	MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	MORM SYNDROME	
NULL	610157	HEAT-SHOCK RNA 1	HSR1	
Percent	610158	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2	FCD1 LOCUS;; CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	
Number Sign	610163	IMMUNODEFICIENCY 25; IMD25	IMMUNODEFICIENCY DUE TO DEFECT IN CD3-ZETA	
Number Sign	610168	LOEYS-DIETZ SYNDROME 2; LDS2	AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;; MARFAN SYNDROME, TYPE II, FORMERLY	
Percent	610170	KYPHOSCOLIOSIS 1; KYPSC1		
Number Sign	610181	AICARDI-GOUTIERES SYNDROME 2; AGS2		
Number Sign	610185	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2	CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL LOCOMOTION 2	
Number Sign	610187	DIAPHRAGMATIC HERNIA 3; DIH3		
Number Sign	610188	JOUBERT SYNDROME 5; JBTS5		
Number Sign	610189	SENIOR-LOKEN SYNDROME 6; SLSN6		
Number Sign	610193	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10; ARVD10	ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 10; ARVC10	
Number Sign	610198	3-METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5	CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;; MGA, TYPE V; MGA5	
Number Sign	610199	DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	NDH SYNDROME	
Number Sign	610202	CATARACT 21, MULTIPLE TYPES; CTRCT21	CATARACT 21, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;; CATARACT, CONGENITAL, CERULEAN TYPE, 4; CCA4;; CATARACT, PULVERULENT, JUVENILE-ONSET	
Number Sign	610204	PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	OLIVOPONTOCEREBELLAR HYPOPLASIA, FETAL-ONSET	
Number Sign	610205	ALAGILLE SYNDROME 2; ALGS2		
Percent	610208	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	MGR10;; MIGRAINE WITH PULSATION	
Percent	610209	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	MGR11	
Number Sign	610212	DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66		
Percent	610213	ANEURYSM, INTRACRANIAL BERRY, 4; ANIB4		
Number Sign	610217	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION, PLA2G6-RELATED;; NEUROAXONAL DYSTROPHY, ATYPICAL	KARAK SYNDROME, INCLUDED
Number Sign	610220	DEAFNESS, AUTOSOMAL RECESSIVE 59; DFNB59		
Number Sign	610227	SEBORRHEA-LIKE DERMATITIS WITH PSORIASIFORM ELEMENTS		
Percent	610234	SYNPOLYDACTYLY 3; SPD3		
Percent	610239	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 4	HDLCQ4	
Number Sign	610244	SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT; SPG33		
Number Sign	610245	SPINOCEREBELLAR ATAXIA 23; SCA23		
Number Sign	610246	SPINOCEREBELLAR ATAXIA 28; SCA28		
Percent	610247	ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	ESOPHAGITIS, EOSINOPHILIC; EE	
Percent	610248	DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65		
Number Sign	610250	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31		
Number Sign	610251	ALCOHOL SENSITIVITY, ACUTE		HANGOVER, SUSCEPTIBILITY TO, INCLUDED
Number Sign	610253	KLEEFSTRA SYNDROME	CHROMOSOME 9q34.3 DELETION SYNDROME;; 9q- SYNDROME;; 9q SUBTELOMERIC DELETION SYNDROME	
Number Sign	610256	ANTERIOR SEGMENT DYSGENESIS 2; ASGD2	APHAKIA, CONGENITAL PRIMARY; CPAK;; CPA	
Percent	610260	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 2; IHPS2		
Percent	610261	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 5	HYT5;; HYPERTENSION, ESSENTIAL, BODY MASS-RELATED	
Percent	610262	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 6	HYT6;; HYPERTENSION, ESSENTIAL, KIDNEY FUNCTION-RELATED	
Number Sign	610265	DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67		
Number Sign	610269	BULIMIA NERVOSA, SUSCEPTIBILITY TO, 2; BULN2		ANOREXIA NERVOSA, SUSCEPTIBILITY TO, 2, INCLUDED; ANON2, INCLUDED
Percent	610279	PACHYGYRIA, FRONTOTEMPORAL		
Number Sign	610282	RETINITIS PIGMENTOSA 35; RP35		
Number Sign	610283	CONE-ROD DYSTROPHY 10; CORD10		
Number Sign	610293	GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY; GPID	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 1; GPIBD1	
Percent	610294	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 2	INTLQ2	
Percent	610295	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 3	INTLQ3	
Number Sign	610297	PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK13		
Number Sign	610313	COLD-INDUCED SWEATING SYNDROME 2; CISS2		
NULL	610319	RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA		
Percent	610320	MYOPIA 14; MYP14		
Percent	610321	PROSTATE CANCER, HEREDITARY, 7; HPC7	PROSTATE CANCER AGGRESSIVENESS	
Number Sign	610329	AICARDI-GOUTIERES SYNDROME 3; AGS3		
Number Sign	610333	AICARDI-GOUTIERES SYNDROME 4; AGS4		
NULL	610338	RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, WITH VENTRICULAR SEPTAL DEFECT, PATENT FORAMEN OVALE, AND PATENT DUCTUS ARTERIOSUS;; ARPA, FAMILIAL	
Number Sign	610353	EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	EPILEPSY, FAMILIAL, WITH NOCTURNAL WANDERING AND ICTAL FEAR	
Number Sign	610356	RETINAL CONE DYSTROPHY 3B; RCD3B	CONE DYSTROPHY WITH SUPERNORMAL ROD RESPONSES; CDSRR;; CONE DYSTROPHY WITH NIGHT BLINDNESS AND SUPERNORMAL ROD RESPONSES, KCNV2-RELATED	
Number Sign	610357	SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE; SPG30		
Number Sign	610359	RETINITIS PIGMENTOSA 33; RP33		
Percent	610361	OROFACIAL CLEFT 9; OFC9	CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 9	
Number Sign	610370	DIARRHEA 4, MALABSORPTIVE, CONGENITAL; DIAR4	ENTERIC ANENDOCRINOSIS	
Number Sign	610374	DIABETES MELLITUS, TRANSIENT NEONATAL, 2	TNDM2	
Number Sign	610377	MEVALONIC ACIDURIA; MEVA		
Number Sign	610379	WEST NILE VIRUS, SUSCEPTIBILITY TO	WNV, SUSCEPTIBILITY TO	
Number Sign	610381	CONE-ROD DYSTROPHY 11; CORD11		
Percent	610382	PROSOPAGNOSIA, HEREDITARY	FACE BLINDNESS;; PROSOPAGNOSIA, DEVELOPMENTAL;; PROSOPAGNOSIA, CONGENITAL	
Number Sign	610419	DEAFNESS, AUTOSOMAL RECESSIVE 68; DFNB68		
Percent	610420	PREAURICULAR TAG, ISOLATED, AUTOSOMAL DOMINANT, 1		
Percent	610422	ALOPECIA-MENTAL RETARDATION SYNDROME 2; APMR2		
Number Sign	610424	HEPATITIS B VIRUS, SUSCEPTIBILITY TO	HBV, SUSCEPTIBILITY TO	HEPATITIS B VIRUS, RESISTANCE TO, INCLUDED;; HBV, RESISTANCE TO, INCLUDED
Number Sign	610425	CATARACT 23, MULTIPLE TYPES; CTRCT23	CATARACT 23, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA	
Number Sign	610427	CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B, FORMERLY; CSNB2B, FORMERLY;; NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE, FORMERLY	
Percent	610430	MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 2; WM2		
Percent	610438	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 3; RLS3		
Percent	610439	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 4; RLS4		
Percent	610441	TESTICULAR MICROLITHIASIS		
Number Sign	610442	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	SEMD, GENEVIEVE TYPE;; NANS DEFICIENCY	
Number Sign	610443	KOOLEN-DE VRIES SYNDROME; KDVS	CHROMOSOME 17q21.31 DELETION SYNDROME;; MICRODELETION 17q21.31 SYNDROME	
Number Sign	610444	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3	NIGHT BLINDNESS, CONGENITAL STATIONARY, NOUGARET TYPE	
Number Sign	610445	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1	NIGHT BLINDNESS, CONGENITAL STATIONARY, RHODOPSIN-RELATED	
Number Sign	610446	BURULI ULCER, SUSCEPTIBILITY TO	MYCOBACTERIUM ULCERANS, SUSCEPTIBILITY TO	
Number Sign	610448	CHILBLAIN LUPUS 1; CHBL1		
Percent	610452	MUTAGEN SENSITIVITY		
Number Sign	610455	TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL; NFTC	CALCINOSIS, TUMORAL, WITH NORMOPHOSPHATEMIA	
Number Sign	610460	THIOPURINES, POOR METABOLISM OF, 1; THPM1	THIOPURINE S-METHYLTRANSFERASE DEFICIENCY; TPMTD;; TPMT DEFICIENCY	
Number Sign	610474	CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME; CATSHLS	CATSHL SYNDROME	
Number Sign	610475	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2	PIGMENTED MICRONODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2;; CUSHING SYNDROME, ADRENAL, DUE TO PPNAD2	
Number Sign	610476	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11	ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 11; ARVC11	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11, AND MILD PALMOPLANTAR KERATODERMA WITH OR WITHOUT WOOLLY HAIR, INCLUDED
Number Sign	610478	RETINAL CONE DYSTROPHY 4; RCD4		
Percent	610483	AGAMMAGLOBULINEMIA, MICROCEPHALY, AND SEVERE DERMATITIS		
Number Sign	610489	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1	PIGMENTED MICRONODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1;; CUSHING SYNDROME, ADRENAL, DUE TO PPNAD1;; ADRENOCORTICAL NODULAR DYSPLASIA, PRIMARY	
Number Sign	610498	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	CORPUS CALLOSUM, AGENESIS OF, WITH DYSMORPHISM AND FATAL LACTIC ACIDOSIS	
Number Sign	610504	PRETERM PREMATURE RUPTURE OF THE MEMBRANES; PPROM		
Number Sign	610505	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3	ENCEPHALOMYOPATHY, RESPIRATORY FAILURE, AND LACTIC ACIDOSIS;; CONCENTRIC CARDIOMYOPATHY, HYPOTONIA, AND LACTIC ACIDOSIS	
Number Sign	610508	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7; MODY7		
Number Sign	610532	LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	HYPOMYELINATION AND CONGENITAL CATARACT: HCC	
Percent	610535	GLAUCOMA 1, OPEN ANGLE, M; GLC1M		
Number Sign	610536	MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	MANDIBULOFACIAL DYSOSTOSIS WITH MICROCEPHALY; MFDM;; GROWTH AND MENTAL RETARDATION, MANDIBULOFACIAL DYSOSTOSIS, MICROCEPHALY, AND CLEFT PALATE	
Number Sign	610539	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY		
Number Sign	610542	MYASTHENIC SYNDROME, CONGENITAL, 12; CMS12	MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 1; CMSTA1	
Number Sign	610543	CHROMOSOME 16p13.3 DELETION SYNDROME, PROXIMAL	RUBINSTEIN-TAYBI DELETION SYNDROME;; RSTS DELETION SYNDROME	
Number Sign	610549	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	INSULIN RECEPTOR, DEFECT IN, WITH INSULIN-RESISTANT DIABETES MELLITUS AND ACANTHOSIS NIGRICANS;; DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS, TYPE A;; IRAN, TYPE A	
Number Sign	610551	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 1	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 1; IIAE1	
Number Sign	610582	DIABETES MELLITUS, TRANSIENT NEONATAL, 3	TNDM3	DIABETES MELLITUS, TYPE II, AUTOSOMAL DOMINANT, INCLUDED
Number Sign	610599	RETINITIS PIGMENTOSA 36; RP36		
Number Sign	610600	CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY	CMO II DEFICIENCY;; ALDOSTERONE DEFICIENCY II;; HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1B;; ALDOSTERONE DEFICIENCY DUE TO DEFICIENCY OF STEROID 18-OXIDASE;; STEROID 18-OXIDASE DEFICIENCY;; 18-OXIDASE DEFICIENCY	
Number Sign	610612	LEBER CONGENITAL AMAUROSIS 12; LCA12		
Number Sign	610618	ANGIOEDEMA, HEREDITARY, TYPE III; HAE3	HAE III;; ESTROGEN-RELATED HAE;; ESTROGEN-SENSITIVE HAE;; ANGIONEUROTIC EDEMA, HEREDITARY, WITH NORMAL C1 INHIBITOR CONCENTRATION AND FUNCTION;; HAE WITH NORMAL C1 INHIBITOR CONCENTRATION AND FUNCTION;; HEREDITARY ANGIOEDEMA WITH NORMAL C1 INHIBITOR ACTIVITY	
Number Sign	610623	CATARACT 11, MULTIPLE TYPES; CTRCT11	CATARACT, POSTERIOR POLAR, 4; CTPP4;; CPP4	CATARACT 11 WITH MICROPHTHALMIA AND NEURODEVELOPMENTAL ABNORMALITIES, INCLUDED
Number Sign	610628	HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4		
Number Sign	610629	DIAMOND-BLACKFAN ANEMIA 3; DBA3		
Number Sign	610644	PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL		PALMOPLANTAR HYPERKERATOSIS AND TRUE HERMAPHRODITISM, INCLUDED
Percent	610649	BONE SIZE QUANTITATIVE TRAIT LOCUS 3	BSZQTL3	
Number Sign	610651	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB	XP, GROUP B; XPBC	XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME, INCLUDED;; XPB/CS, INCLUDED
Percent	610655	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4		
Percent	610676	AUTISM, SUSCEPTIBILITY TO, 7; AUTS7		
Number Sign	610678	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4		
NULL	610680	HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS		
Number Sign	610682	OSTEOGENESIS IMPERFECTA, TYPE VII; OI7	OI, TYPE VII;; OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY	
Percent	610685	SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 2; SHFLD2		
Number Sign	610687	NEMALINE MYOPATHY 7; NEM7		
Number Sign	610688	JOUBERT SYNDROME 6; JBTS6		
Number Sign	610698	MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4		
Number Sign	610706	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA	DEAFNESS, CONGENITAL, WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA;; DEAFNESS WITH LAMM	
Percent	610707	PSORIASIS 8, SUSCEPTIBILITY TO; PSORS8		
Percent	610708	OPTIC ATROPHY 5; OPA5		
Number Sign	610713	BRACHYDACTYLY-SYNDACTYLY SYNDROME; BDSD		BRACHYDACTYLY-SYNDACTYLY-OLIGODACTYLY SYNDROME, INCLUDED; BDSDO, INCLUDED
Number Sign	610717	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	NEUTRAL LIPID STORAGE DISEASE WITHOUT ICHTHYOSIS	
Number Sign	610725	NEPHROTIC SYNDROME, TYPE 3; NPHS3	NEPHROTIC SYNDROME, EARLY-ONSET, TYPE 3	
Number Sign	610733	NOONAN SYNDROME 4; NS4		
Number Sign	610738	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	KOSTMANN DISEASE;; AGRANULOCYTOSIS, INFANTILE	
Number Sign	610743	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	ATAXIA, RECESSIVE, OF BEAUCE;; CEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, TYPE 1; ARCA1	
Percent	610744	IRIS PATTERN		
Percent	610753	ALOPECIA AREATA 2; AA2		
Number Sign	610755	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4		
Number Sign	610756	CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2		
Number Sign	610758	CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4		
Number Sign	610759	CORNELIA DE LANGE SYNDROME 3; CDLS3		
Percent	610760	CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2	CLQTL2	
Percent	610761	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 5	HDLCQ5	
Number Sign	610762	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6		
Number Sign	610768	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M	CDG Im; CDGIm;; DOLICHOL KINASE DEFICIENCY;; DK1 DEFICIENCY	
Number Sign	610773	MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY	MPCD	
NULL	610797	EPIPHYSEAL DYSPLASIA, BAUMANN TYPE		
Number Sign	610798	IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN		
Number Sign	610799	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 1; IPD1		INVASIVE PNEUMOCOCCAL DISEASE, PROTECTION AGAINST, INCLUDED
Number Sign	610805	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 1, SUSCEPTIBILITY TO; CAKUT1	RENAL HYPODYSPLASIA, NONSYNDROMIC, 1; RHDNS1	
Number Sign	610828	HOLOPROSENCEPHALY 7; HPE7		
Number Sign	610829	HOLOPROSENCEPHALY 9; HPE9	PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;; HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	
NULL	610830	POLYOSTEOLYSIS-HYPEROSTOSIS SYNDROME		
Number Sign	610832	FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN		
Percent	610836	AUTISM, SUSCEPTIBILITY TO, 11; AUTS11		
Percent	610838	AUTISM, SUSCEPTIBILITY TO, 12; AUTS12		
Percent	610839	OSTEOARTHRITIS SUSCEPTIBILITY 4; OS4	OSTEOARTHRITIS, GENERALIZED, WITHOUT DYSPLASIA; GOA1	
Percent	610840	MITRAL VALVE PROLAPSE 3; MVP3	MITRAL VALVE PROLAPSE, MYXOMATOUS 3; MMVP3;; MYXOMATOUS MITRAL VALVE PROLAPSE 3	
Number Sign	610842	PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	PXE-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	
Number Sign	610852	CILIARY DYSKINESIA, PRIMARY, 6; CILD6		
NULL	610871	SAKODA COMPLEX	SPHENOETHMOIDAL ENCEPHALOMENINGOCELE, AGENESIS OF THE CORPUS CALLOSUM, AND CLEFT LIP/PALATE	SAKODA SPECTRUM, INCLUDED
Percent	610873	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENAQ1		
Number Sign	610878	VESICOURETERAL REFLUX 2; VUR2		
Number Sign	610883	POTOCKI-LUPSKI SYNDROME; PTLS	CHROMOSOME 17p11.2 DUPLICATION SYNDROME	
Number Sign	610896	BRANCHIOOTORENAL SYNDROME 2; BOR2		
Percent	610898	SUPRANUCLEAR PALSY, PROGRESSIVE, 3; PSNP3		
Percent	610906	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 4	ASRT4;; ASTHMA AND ALLERGIC RHINITIS, SUSCEPTIBILITY TO	
Percent	610908	AUTISM, SUSCEPTIBILITY TO, 13; AUTS13		
Percent	610910	PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	PAP, ACQUIRED;; PULMONARY ALVEOLAR LIPOPROTEINOSIS, ACQUIRED;; PULMONARY ALVEOLAR PROTEINOSIS, AUTOIMMUNE	
Number Sign	610913	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2	INTERSTITIAL LUNG DISEASE DUE TO SURFACTANT PROTEIN C DEFICIENCY;; DESQUAMATIVE INTERSTITIAL PNEUMONITIS DUE TO SURFACTANT PROTEIN C DEFICIENCY;; PULMONARY ALVEOLAR PROTEINOSIS, CONGENITAL, 2	
Number Sign	610915	OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8	OI, TYPE VIII	
Number Sign	610921	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3	PULMONARY ALVEOLAR PROTEINOSIS, CONGENITAL, 3;; INTERSTITIAL LUNG DISEASE DUE TO ABCA3 DEFICIENCY	
Percent	610926	TOOTH AGENESIS, SELECTIVE, 5; STHAG5	HYPODONTIA/OLIGODONTIA 5;; HE-ZHAO DEFICIENCY	
Number Sign	610927	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9; SLEB9		
Number Sign	610938	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7		
Number Sign	610947	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2		
Percent	610948	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 7	HYT7	
Number Sign	610951	CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7		
Number Sign	610954	PITT-HOPKINS SYNDROME; PTHS	ENCEPHALOPATHY, SEVERE EPILEPTIC, WITH AUTONOMIC DYSFUNCTION;; MENTAL RETARDATION, SYNDROMAL, WITH INTERMITTENT HYPERVENTILATION	
Number Sign	610965	XFE PROGEROID SYNDROME; XFEPS	XPF-ERCC1 PROGEROID SYNDROME	
Number Sign	610967	OSTEOGENESIS IMPERFECTA, TYPE V; OI5	OI, TYPE V	
Number Sign	610968	OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	OI, TYPE XI	
Number Sign	610978	CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION; CAHTP	BRAIN-LUNG-THYROID SYNDROME	
Number Sign	610984	COMPLEMENT FACTOR I DEFICIENCY; CFID	COMPLEMENT COMPONENT 3 INACTIVATOR DEFICIENCY;; C3 INACTIVATOR DEFICIENCY	
Number Sign	610988	LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4		LEPROSY, EARLY-ONSET, SUSCEPTIBILITY TO, INCLUDED
Number Sign	610992	PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	PSAT DEFICIENCY	
Percent	610997	PROSTATE CANCER, HEREDITARY, 9	HPC9	
Percent	611003	SMOKING AS A QUANTITATIVE TRAIT LOCUS 1; SQTL1		
Percent	611004	SMOKING AS A QUANTITATIVE TRAIT LOCUS 2; SQTL2		
Percent	611010	FIBROMATOSIS, GINGIVAL, 4; GINGF4	GGF4;; FIBROMATOSIS, GINGIVAL, HEREDITARY, 4; HGF4	
Percent	611014	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 8; HYT8		
Percent	611015	AUTISM, SUSCEPTIBILITY TO, 9; AUTS9		
Percent	611016	AUTISM, SUSCEPTIBILITY TO, 10; AUTS10		
Number Sign	611022	DEAFNESS, AUTOSOMAL RECESSIVE 24; DFNB24		
Percent	611031	EPISODIC KINESIGENIC DYSKINESIA 2; EKD2	DYSTONIA 19; DYT19	
Number Sign	611038	MICROPHTHALMIA, ISOLATED 3; MCOP3		
Number Sign	611040	MICROPHTHALMIA, ISOLATED 5; MCOP5	MICROPHTHALMIA, POSTERIOR, WITH RETINITIS PIGMENTOSA, FOVEOSCHISIS, AND OPTIC DISC DRUSEN	
Percent	611046	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 2	MTBS2	
Number Sign	611064	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5	ASRT5	
Number Sign	611067	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4; DSMA4		
Percent	611073	ALZHEIMER DISEASE 12	AD12;; ALZHEIMER DISEASE, FAMILIAL, 12	
Number Sign	611081	INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 10; IBD10		
Number Sign	611087	POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	PMSE SYNDROME	
Number Sign	611090	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12; MRT12		
Number Sign	611091	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5; MRT5		
Number Sign	611092	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6		
Number Sign	611093	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7; MRT7	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 22; MRT22	
Percent	611095	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 26; MRT26	
Percent	611096	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10; MRT10	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 20; MRT20	
Percent	611097	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 11; MRT11		
Percent	611100	PROSTATE CANCER, HEREDITARY, 10; HPC10		
Number Sign	611102	DEAFNESS-INFERTILITY SYNDROME; DIS	DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY;; CHROMOSOME 15q15.3 DELETION SYNDROME	
Number Sign	611105	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	MITOCHONDRIAL ASPARTYL-tRNA SYNTHETASE DEFICIENCY	
Percent	611107	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4; MRT4		
Percent	611109	CINNAMON ODOR, PLEASANTNESS OF	CINN	
Number Sign	611126	MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	ACYL-CoA DEHYDROGENASE 9 DEFICIENCY;; ACAD9 DEFICIENCY	
Number Sign	611131	RETINITIS PIGMENTOSA 37; RP37		
Number Sign	611134	MECKEL SYNDROME, TYPE 4; MKS4	MECKEL-GRUBER SYNDROME, TYPE 4	MECKEL-LIKE CEREBRORENODIGITAL SYNDROME, INCLUDED
Number Sign	611136	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13; EIG13		EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 5, INCLUDED; EJM5, INCLUDED;; EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 4, INCLUDED; ECA4, INCLUDED
Percent	611139	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 8; CHDS8		
Percent	611147	PAROXYSMAL NONKINESIGENIC DYSKINESIA 2; PNKD2	DYSTONIA 20; DYT20	
Percent	611152	ALZHEIMER DISEASE 13; AD13		
Percent	611154	ALZHEIMER DISEASE 14; AD14		
Percent	611155	ALZHEIMER DISEASE 15; AD15		
Number Sign	611162	MALARIA, SUSCEPTIBILITY TO		MALARIA, RESISTANCE TO, INCLUDED;; MALARIA, SEVERE, SUSCEPTIBILITY TO, INCLUDED;; MALARIA, SEVERE, RESISTANCE TO, INCLUDED;; MALARIA, CEREBRAL, SUSCEPTIBILITY TO, INCLUDED;; MALARIA, CEREBRAL, RESISTANCE TO, INCLUDED
Number Sign	611174	HAMAMY SYNDROME; HMMS	HYPERTELORISM, SEVERE, WITH MIDFACE PROMINENCE, MYOPIA, MENTAL RETARDATION, AND BONE FRAGILITY	
Number Sign	611182	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh; CDG2H	CDG IIh; CDGIIh	
Percent	611185	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 6; RLS6	PERIODIC LIMB MOVEMENTS IN SLEEP	
Number Sign	611209	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	CDG IIg; CDGIIg;; CDGII/COG1 CEREBROCOSTOMANDIBULAR-LIKE SYNDROME	
Percent	611222	MICROPHTHALMIA, SYNDROMIC 10; MCOPS10	MICROPHTHALMIA AND BRAIN ATROPHY; MOBA	
Number Sign	611225	SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	INTELLECTUAL DISABILITY, MOTOR DYSFUNCTION, AND JOINT CONTRACTURES; IDMDC	
Number Sign	611228	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J; CMT4J	CHARCOT-MARIE-TOOTH DISEASE, AUTOSOMAL RECESSIVE, TYPE 4J	
Percent	611242	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 5; RLS5		
Percent	611247	MAJOR AFFECTIVE DISORDER 4; MAFD4	BIPOLAR AFFECTIVE DISORDER; BPAD	
Percent	611252	SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32		
Number Sign	611263	SHORT-RIB THORACIC DYSPLASIA 2 WITH OR WITHOUT POLYDACTYLY; SRTD2	ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	
Percent	611274	GLAUCOMA 1, OPEN ANGLE, N; GLC1N		
Percent	611276	GLAUCOMA 1, OPEN ANGLE, H; GLC1H		
Number Sign	611277	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3; GEFSP3	GEFS+, TYPE 3; GEFS+3	FEBRILE SEIZURES, FAMILIAL, 8, INCLUDED; FEB8, INCLUDED
Number Sign	611283	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	IBD DEFICIENCY;; ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 8, DEFICIENCY OF;; ACAD8 DEFICIENCY	
Percent	611284	DYSTONIA, FOCAL, TASK-SPECIFIC; FTSD		MUSICIAN'S DYSTONIA, INCLUDED
Number Sign	611291	SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION	SCID, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE, WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION;; NHEJ1 SYNDROME	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION DUE TO NHEJ1 DEFICIENCY, INCLUDED;; SCID, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE, AND SENSITIVITY TO IONIZING RADIATION DUE TO NHEJ1 DEFICIENCY, INCLUDED
Number Sign	611302	SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2		
Number Sign	611307	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L		
Percent	611308	PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL DOMINANT; PHPVAD		
Number Sign	611363	ATRIAL SEPTAL DEFECT 4; ASD4		
Percent	611364	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4		
Number Sign	611369	LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3	MULTIPLE CONTRACTURE SYNDROME, ISRAELI BEDOUIN TYPE B	
Percent	611376	MUNGAN SYNDROME; MGS	VISCERAL NEUROMYOPATHY, FAMILIAL, WITH PSEUDOOBSTRUCTION, MEGADUODENUM, BARRETT ESOPHAGUS, AND CARDIAC ABNORMALITIES;; PSEUDOOBSTRUCTION, CHRONIC IDIOPATHIC INTESTINAL, WITH BARRETT ESOPHAGUS AND CARDIAC ABNORMALITIES	
Number Sign	611377	BRACHYDACTYLY, TYPE B2; BDB2		
Number Sign	611378	MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9		
Percent	611381	KALA-AZAR, SUSCEPTIBILITY TO, 2; KAZA2	LEISHMANIASIS, VISCERAL, SUSCEPTIBILITY TO, 2	
Percent	611382	KALA-AZAR, SUSCEPTIBILITY TO, 3; KAZA3	LEISHMANIASIS, VISCERAL, SUSCEPTIBILITY TO, 3	
Number Sign	611383	USHER SYNDROME, TYPE IID; USH2D		
Percent	611384	PLASMODIUM FALCIPARUM FEVER EPISODES QUANTITATIVE TRAIT LOCUS 1	PFFE1;; MALARIA FEVER EPISODES QUANTITATIVE TRAIT LOCUS 1	
Number Sign	611390	SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3	AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	
Number Sign	611391	CATARACT 33, MULTIPLE TYPES; CTRCT33		
Percent	611403	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 6	ASRT6	
Number Sign	611407	CARDIOMYOPATHY, DILATED, 1W; CMD1W		
NULL	611426	TENTED EYEBROWS		
Number Sign	611431	LEGIUS SYNDROME	NEUROFIBROMATOSIS TYPE 1-LIKE SYNDROME; NFLS	
Number Sign	611451	DEAFNESS, AUTOSOMAL RECESSIVE 63; DFNB63		
Percent	611456	TREMOR, HEREDITARY ESSENTIAL, 3; ETM3		
Number Sign	611465	GALLBLADDER DISEASE 4; GBD4		
Percent	611469	COLORECTAL CANCER, SUSCEPTIBILITY TO, 2; CRCS2	COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 8q24	
Percent	611488	MACULAR DEGENERATION, AGE-RELATED, 10; ARMD10		
Number Sign	611489	CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	CBG DEFICIENCY;; TRANSCORTIN DEFICIENCY	CORTICOSTEROID-BINDING GLOBULIN, ELEVATED, INCLUDED
Number Sign	611490	OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	OSTEOPETROSIS, INFANTILE MALIGNANT 2	
Number Sign	611493	ATRIAL FIBRILLATION, FAMILIAL, 4; ATFB4		
Percent	611494	ATRIAL FIBRILLATION, FAMILIAL, 5; ATFB5		
Number Sign	611497	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6	OSTEOPETROSIS, AUTOSOMAL RECESSIVE, INTERMEDIATE FORM	
Number Sign	611498	NEPHRONOPHTHISIS 7; NPHP7		
Percent	611515	FEBRILE SEIZURES, FAMILIAL, 7; FEB7	FEBRILE CONVULSIONS, FAMILIAL, 7; FEB7	
Number Sign	611521	IMMUNODEFICIENCY 35; IMD35	TYROSINE KINASE 2 DEFICIENCY;; TYK2 DEFICIENCY;; HYPER-IgE SYNDROME WITH ATYPICAL MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE;; HIES WITH ATYPICAL MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE	
Percent	611522	INTRAOCULAR PRESSURE QUANTITATIVE TRAIT LOCUS; IOPQTL	GLAUCOMA, SUSCEPTIBILITY TO	
Number Sign	611523	PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6	ENCEPHALOPATHY, FATAL INFANTILE, WITH MITOCHONDRIAL RESPIRATORY CHAIN DEFECTS	
Number Sign	611528	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12; ARVD12	ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 12; ARVC12	
Percent	611535	MAJOR AFFECTIVE DISORDER 5; MAFD5	BIPOLAR AFFECTIVE DISORDER; BPAD	
Percent	611536	MAJOR AFFECTIVE DISORDER 6; MAFD6	BIPOLAR AFFECTIVE DISORDER; BPAD	
Number Sign	611543	CAVITARY OPTIC DISC ANOMALIES; CODA		
Number Sign	611544	CATARACT 17, MULTIPLE TYPES; CTRCT17	CATARACT 17, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;; CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 3; CATCN3	
Percent	611547	STATURE QUANTITATIVE TRAIT LOCUS 9; STQTL9		
Number Sign	611548	PREMATURE OVARIAN FAILURE 5; POF5		
Number Sign	611553	NOONAN SYNDROME 5; NS5		
Number Sign	611554	LEOPARD SYNDROME 2; LPRD2		
NULL	611555	RENAL TUBULAR ACIDOSIS, DISTAL, WITH NEPHROCALCINOSIS, SHORT STATURE, MENTAL RETARDATION, AND DISTINCTIVE FACIES		
Number Sign	611556	GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	GSD 0b;; MUSCLE GLYCOGEN STORAGE DISEASE 0;; MUSCLE GLYCOGEN SYNTHASE DEFICIENCY	
Number Sign	611560	JOUBERT SYNDROME 7; JBTS7		
Number Sign	611561	MECKEL SYNDROME, TYPE 5; MKS5		
Percent	611571	OTOSCLEROSIS 4; OTSC4		
Percent	611572	OTOSCLEROSIS 7; OTSC7		
Number Sign	611584	WAARDENBURG SYNDROME, TYPE 2E; WS2E	HYPOGONADOTROPIC HYPOGONADISM WITH ANOSMIA AND DEAFNESS, WITH OR WITHOUT HYPOPIGMENTATION;; WAARDENBURG SYNDROME, TYPE 2E, WITH OR WITHOUT NEUROLOGIC INVOLVEMENT;; WS2E, WITH OR WITHOUT NEUROLOGIC INVOLVEMENT;; WAARDENBURG SYNDROME, TYPE IIE	
Number Sign	611588	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2M; LGMD2M	
Number Sign	611590	RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	RTA, DISTAL, AUTOSOMAL RECESSIVE, WITH HEMOLYTIC ANEMIA	RENAL TUBULAR ACIDOSIS, DISTAL, WITH NORMAL RED CELL MORPHOLOGY, INCLUDED
Number Sign	611597	CATARACT 12, MULTIPLE TYPES; CTRCT12		
Percent	611598	CELIAC DISEASE, SUSCEPTIBILITY TO, 6; CELIAC6	GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 6	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 5, INCLUDED; AIS5, INCLUDED
Number Sign	611603	LISSENCEPHALY 3; LIS3		
Number Sign	611615	CARDIOMYOPATHY, DILATED, 1X; CMD1X	CARDIOMYOPATHY, DILATED, WITH MILD OR NO PROXIMAL MUSCLE WEAKNESS	
Percent	611630	EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	EPILEPSY, FAMILIAL MESIAL TEMPORAL LOBE; FMTLE	
Percent	611631	EPILEPSY, FAMILIAL TEMPORAL LOBE, 4; ETL4	EPILEPSY, OCCIPITOTEMPORAL LOBE, AND MIGRAINE WITH AURA; EPOLM	
Percent	611634	FEBRILE SEIZURES, FAMILIAL, 9; FEB9	FEBRILE CONVULSIONS, FAMILIAL, 9; FEB9	
Percent	611637	PRIMARY LATERAL SCLEROSIS, ADULT, 1; PLSA1	PLS, ADULT; PLSA	
Number Sign	611638	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5; MCOPCB5		
Percent	611644	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 9; HSCR9		
NULL	611650	PERIPAPILLARY ATROPHY, BETA TYPE; PPAB	BETA-PPA;; PERIPAPILLARY CHORIORETINAL ATROPHY, BETA TYPE	
Number Sign	611664	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 7; SHEP7	SKIN/HAIR/EYE PIGMENTATION 7, BLOND/BROWN HAIR;; SKIN/HAIR/EYE PIGMENTATION 7, DARK/LIGHT SKIN	
Percent	611694	DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA		
NULL	611702	SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE		
Number Sign	611705	SALIH MYOPATHY; SALMY	MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY; EOMFC	
Percent	611706	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12		
Percent	611717	SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	SED-BDS;; FANTASY ISLAND SYNDROME;; TATOO DYSPLASIA	
Number Sign	611718	HYPOMAGNESEMIA 4, RENAL; HOMG4	HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	
Number Sign	611719	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5		
Number Sign	611721	COMBINED SAPOSIN DEFICIENCY	PROSAPOSIN DEFICIENCY; PSAPD;; COMBINED SAP DEFICIENCY	
Number Sign	611722	KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY	SAPOSIN A DEFICIENCY	
Number Sign	611724	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 8; SHEP8	SKIN/HAIR/EYE PIGMENTATION 8, BROWN HAIR;; SKIN/HAIR/EYE PIGMENTATION 8, FAIR SKIN;; SKIN/HAIR/EYE PIGMENTATION 8, BLUE/LIGHT EYE COLOR;; SKIN/HAIR/EYE PIGMENTATION 8, FRECKLING/SUNBURN	
Number Sign	611726	EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3	CEROID LIPOFUSCINOSIS, NEURONAL, 14; CLN14	
NULL	611733	DAUWERSE-PETERS SYNDROME	SHORT STATURE, FACIAL DYSMORPHISM, SEVERE BRACHYDACTYLY, AND SYNDACTYLY	
Percent	611738	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 7; BMND7		
Percent	611739	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 8; BMND8	OSTEOPOROSIS, SUSCEPTIBILITY TO	
Number Sign	611742	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 9; SHEP9	SKIN/HAIR/EYE PIGMENTATION 9, DARK/LIGHT HAIR;; SKIN/HAIR/EYE PIGMENTATION 9, BROWN/NONBROWN EYES;; SKIN/HAIR/EYE PIGMENTATION 9, RED/NONRED HAIR;; SKIN/HAIR/EYE PIGMENTATION 9, FRECKLING/SUNBURN	
Number Sign	611755	LEBER CONGENITAL AMAUROSIS 10; LCA10		
Number Sign	611762	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2		
Number Sign	611771	LIPOPROTEIN GLOMERULOPATHY; LPG		
Number Sign	611773	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS; HANAC		
Number Sign	611775	KAWASAKI DISEASE	KD;; MUCOCUTANEOUS LYMPH NODE SYNDROME;; INFANTILE POLYARTERITIS	
Number Sign	611777	BRUGADA SYNDROME 2; BRGDA2		
Number Sign	611783	ERYTHROCYTOSIS, FAMILIAL, 4; ECYT4		
Number Sign	611788	AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6	FAMILIAL THORACIC AORTIC ANEURYSM WITH LIVEDO RETICULARIS AND IRIS FLOCCULI	
Number Sign	611804	ELLIPTOCYTOSIS 1; EL1	ELLIPTOCYTOSIS, RHESUS-LINKED TYPE;; PROTEIN 4.1 OF ERYTHROCYTE MEMBRANE, DEFECT OF;; 4.1-MINUS TRAIT;; 4.1- TRAIT	
NULL	611808	TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS; ETINPH		
Number Sign	611809	BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB		
Number Sign	611812	46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	SERKAL SYNDROME	
Number Sign	611816	TEMPLE-BARAITSER SYNDROME; TMBTS	MENTAL RETARDATION, SEVERE, AND ABSENT NAILS OF HALLUX AND POLLEX	
Number Sign	611818	LONG QT SYNDROME 9; LQT9	LONG QT SYNDROME 9, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;; LONG QT SYNDROME 2/9, DIGENIC, INCLUDED; LQT2/9, DIGENIC, INCLUDED	
Number Sign	611819	LONG QT SYNDROME 10; LQT10		ATRIAL FIBRILLATION, FAMILIAL, 17, INCLUDED; ATFB17, INCLUDED
Number Sign	611820	LONG QT SYNDROME 11; LQT11		
Number Sign	611862	WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1; WBCQ1		
Percent	611863	MICROTIA WITH NASOLACRIMAL DUCT IMPERFORATION AND EYE COLOBOMA		
Number Sign	611867	CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	DISTAL CHROMOSOME 22q11.2 DELETION SYNDROME	
Number Sign	611868	PROSTATE CANCER, HEREDITARY, 12; HPC12		
Number Sign	611875	BRUGADA SYNDROME 3; BRGDA3		
Number Sign	611876	BRUGADA SYNDROME 4; BRGDA4		
Number Sign	611878	CARDIOMYOPATHY, DILATED, 1Y; CMD1Y		LEFT VENTRICULAR NONCOMPACTION 9, INCLUDED; LVNC9, INCLUDED
Number Sign	611879	CARDIOMYOPATHY, DILATED, 1Z; CMD1Z		
Number Sign	611880	CARDIOMYOPATHY, DILATED, 2A; CMD2A	CARDIOMYOPATHY, DILATED, AUTOSOMAL RECESSIVE;; CARDIOMYOPATHY, CONGESTIVE, AUTOSOMAL RECESSIVE	
Number Sign	611881	GLYCOGEN STORAGE DISEASE XII; GSD12	GSD XII;; ALDOLASE A DEFICIENCY;; ALDOA DEFICIENCY;; ALDOLASE DEFICIENCY, RED CELL;; RED CELL ALDOLASE DEFICIENCY	
Number Sign	611884	CILIARY DYSKINESIA, PRIMARY, 7; CILD7	CILIARY DYSKINESIA, PRIMARY, 7, WITH OR WITHOUT SITUS INVERSUS	
NULL	611886	MESOMELIC DYSPLASIA, CAMERA TYPE		
Number Sign	611890	LETHAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; LAAHD		
Percent	611891	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 3; AAA3		
Percent	611892	ANEURYSM, INTRACRANIAL BERRY, 6; ANIB6		
Number Sign	611895	AMYOTROPHIC LATERAL SCLEROSIS 9; ALS9		
Percent	611897	NANOPHTHALMOS 3; NNO3	NANOPHTHALMIA 3	
Percent	611907	EPISODIC ATAXIA, TYPE 7; EA7		
Number Sign	611913	CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB		AUTISM, SUSCEPTIBILITY TO, 14A, INCLUDED; AUTS14A, INCLUDED
Percent	611920	C-REACTIVE PROTEIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; CRPQTL1		
Percent	611926	IMMUNODEFICIENCY, OVARIAN DYSGENESIS, AND PULMONARY FIBROSIS		
Number Sign	611928	PROSTATE CANCER, HEREDITARY, 13; HPC13		
Percent	611929	CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III		
Percent	611934	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 5; EIG5	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, LOCUS ON CHROMOSOME 10	
Number Sign	611936	CHROMOSOME 3q29 DUPLICATION SYNDROME	MICRODUPLICATION 3q29 SYNDROME	
Number Sign	611938	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC; VTSIP	
Number Sign	611942	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6; ECA6		EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 6, INCLUDED; EIG6, INCLUDED
Number Sign	611943	RIDDLE SYNDROME	RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNING DIFFICULTIES	
Percent	611944	LYMPHEDEMA, HEREDITARY, IB; LMPH1B		
Percent	611945	SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37		
Number Sign	611953	MACULAR DEGENERATION, AGE-RELATED, 11; ARMD11		
Percent	611955	PROSTATE CANCER, HEREDITARY, 11; HPC11		
Percent	611958	PROSTATE CANCER, HEREDITARY, 14; HPC14		
Percent	611959	PROSTATE CANCER, HEREDITARY, 15; HPC15		
Number Sign	611960	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7		
NULL	611961	STEVENSON-CAREY SYNDROME		
Percent	611962	HUNTER-MACDONALD SYNDROME		
Number Sign	612001	CHROMOSOME 15q13.3 DELETION SYNDROME	CHROMOSOME 15q13.3 MICRODELETION SYNDROME	
Number Sign	612004	THROMBOCYTOPENIA 4; THC4	THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 4	
Percent	612005	CELIAC DISEASE, SUSCEPTIBILITY TO, 7; CELIAC7	GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 7	
Percent	612006	CELIAC DISEASE, SUSCEPTIBILITY TO, 8; CELIAC8	GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 8	
Percent	612007	CELIAC DISEASE, SUSCEPTIBILITY TO, 9; CELIAC9	GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 9	
Percent	612008	CELIAC DISEASE, SUSCEPTIBILITY TO, 10; CELIAC10	GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 10	
Percent	612009	CELIAC DISEASE, SUSCEPTIBILITY TO, 11; CELIAC11	GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 11	
Percent	612010	CELIAC DISEASE, SUSCEPTIBILITY TO, 12; CELIAC12	GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 12	
Percent	612011	CELIAC DISEASE, SUSCEPTIBILITY TO, 13; CELIAC13	GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 13	
Number Sign	612015	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In; CDG1N	CDG In; CDGIn	
Number Sign	612016	COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 9; SCAR9	
Percent	612017	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 3; IHPS3		
Number Sign	612018	CATARACT 47; CTRCT47	CATARACT, JUVENILE, WITH MICROCORNEA;; CATARACT, JUVENILE, WITH MICROCORNEA AND GLUCOSURIA, FORMERLY; CJMG, FORMERLY	
Number Sign	612020	SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39	NTE-RELATED MOTOR NEURON DISORDER; NTEMND	
Percent	612030	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 9; CHDS9		
Number Sign	612042	RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1; RRQTL1		
Number Sign	612052	SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3	NICOTINE DEPENDENCE, SUSCEPTIBILITY TO	LUNG CANCER SUSCEPTIBILITY 2, INCLUDED; LNCR2, INCLUDED
Number Sign	612067	DYSTONIA 16; DYT16		
Number Sign	612069	AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10		FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED, INCLUDED;; FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED, INCLUDED;; FTLD-TDP, TARDBP-RELATED, INCLUDED
Number Sign	612073	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM, WITH OR WITHOUT METHYLMALONIC ACIDURIA, AUTOSOMAL RECESSIVE, SUCLA2-RELATED	
Number Sign	612075	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY); MTDPS8A	MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC, WITH RENAL TUBULOPATHY, AUTOSOMAL RECESSIVE	MITOCHONDRIAL DNA DEPLETION SYNDROME 8B (MNGIE TYPE), INCLUDED; MTDPS8B, INCLUDED;; MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME, RRM2B-RELATED, INCLUDED;; MNGIE, RRM2B-RELATED, INCLUDED
Number Sign	612076	HYPOURICEMIA, RENAL, 2; RHUC2		URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 2, INCLUDED; UAQTL2, INCLUDED;; GOUT SUSCEPTIBILITY 2, INCLUDED; GOUT2, INCLUDED
Number Sign	612079	ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	ANE SYNDROME	
Percent	612083	MUSCLE STRENGTH QUANTITATIVE TRAIT LOCUS 1	MUSTQTL1	
Percent	612089	HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM		
Number Sign	612095	RETINITIS PIGMENTOSA 41; RP41	RETINAL DEGENERATION, AUTOSOMAL RECESSIVE, PROMININ-RELATED	
Percent	612096	OTOSCLEROSIS 8; OTSC8		
Percent	612097	DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS		
Number Sign	612098	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11		
Percent	612099	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 2	MFT2	
Number Sign	612100	AUTISM, SUSCEPTIBILITY TO, 15; AUTS15		
Percent	612108	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 1; FGQTL1		
Number Sign	612109	OCULOAURICULAR SYNDROME; OCACS	MICROPHTHALMIA, MICROCORNEA, ANTERIOR SEGMENT DYSGENESIS, CATARACT, OCULAR COLOBOMA, RETINAL PIGMENT EPITHELIUM ABNORMALITIES, ROD-CONE DYSTROPHY, AND ANOMALIES OF THE EXTERNAL EAR;; SCHORDERET-MUNIER-FRANCESCHETTI SYNDROME	
Percent	612110	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 9; BMND9		
Percent	612113	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 10; BMND10		
Percent	612114	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 11; BMND11		
Percent	612119	TREHALASE DEFICIENCY	TREHALOSE INTOLERANCE	
Number Sign	612124	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12; CMH12		
Number Sign	612126	GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	PAROXYSMAL EXERCISE-INDUCED DYSKINESIA WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA;; PED WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA;; PAROXYSMAL EXERTION-INDUCED DYSTONIA WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA;; DYSTONIA 18; DYT18	
Number Sign	612132	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT		
Number Sign	612138	EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA; EBSPA	EBS WITH PYLORIC ATRESIA	
Number Sign	612158	CARDIOMYOPATHY, DILATED, 1AA, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1AA		CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 23, WITH OR WITHOUT VENTRICULAR NONCOMPACTION, INCLUDED; CMH23, INCLUDED
Number Sign	612160	HISTIOCYTOMA, ANGIOMATOID FIBROUS		
Percent	612161	ANEURYSM, INTRACRANIAL BERRY, 7; ANIB7		
Percent	612162	ANEURYSM, INTRACRANIAL BERRY, 8; ANIB8		
Number Sign	612164	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4; EIEE4		
Percent	612165	RETINITIS PIGMENTOSA 29; RP29		
Percent	612198	DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA		
Number Sign	612199	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 1; CRMCC1	CRMCC;; COATS PLUS SYNDROME	
Number Sign	612201	ATRIAL FIBRILLATION, FAMILIAL, 6; ATFB6		
Number Sign	612219	EWING SARCOMA; ES		NEUROEPITHELIOMA, PERIPHERAL, INCLUDED; PNE, INCLUDED;; ASKIN TUMOR, INCLUDED
Percent	612221	STATURE QUANTITATIVE TRAIT LOCUS 10; STQTL10		
Percent	612223	STATURE QUANTITATIVE TRAIT LOCUS 11; STQTL11		
Percent	612224	STATURE QUANTITATIVE TRAIT LOCUS 12; STQTL12		
Number Sign	612225	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9; MODY9		
Percent	612226	STATURE QUANTITATIVE TRAIT LOCUS 13; STQTL13		
Number Sign	612227	DIABETES MELLITUS, KETOSIS-PRONE; KPD		
Percent	612228	STATURE QUANTITATIVE TRAIT LOCUS 14; STQTL14		
Number Sign	612229	COLORECTAL CANCER, SUSCEPTIBILITY TO, 3; CRCS3	COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 18	
Percent	612230	COLORECTAL CANCER, SUSCEPTIBILITY TO, 5; CRCS5	COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 10	
Percent	612231	COLORECTAL CANCER, SUSCEPTIBILITY TO, 6; CRCS6	COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 8q23	
Percent	612232	COLORECTAL CANCER, SUSCEPTIBILITY TO, 7; CRCS7	COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 11	
Number Sign	612233	LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4	MITOCHONDRIAL HSP60 CHAPERONOPATHY;; MITCHAP60 DISEASE	
Number Sign	612237	CHONDROSARCOMA, EXTRASKELETAL MYXOID	EMC	
Percent	612238	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 4; IS4		
Percent	612239	SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 5; IS5		
Number Sign	612240	ATRIAL FIBRILLATION, FAMILIAL, 7; ATFB7		
Percent	612241	INFLAMMATORY BOWEL DISEASE 12; IBD12		
Number Sign	612242	CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME		JUVENILE POLYPOSIS OF INFANCY, INCLUDED;; JUVENILE POLYPOSIS, INFANTILE, INCLUDED
Number Sign	612244	INFLAMMATORY BOWEL DISEASE 13; IBD13		
Number Sign	612245	INFLAMMATORY BOWEL DISEASE 14; IBD14		
Number Sign	612247	CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS; CAN	CROUZONODERMOSKELETAL SYNDROME	
Number Sign	612251	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10; SLEB10		
Number Sign	612253	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11; SLEB11		
Percent	612254	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 12; SLEB12		
Percent	612255	INFLAMMATORY BOWEL DISEASE 15; IBD15		
Percent	612259	INFLAMMATORY BOWEL DISEASE 16; IBD16		
Number Sign	612260	MYD88 DEFICIENCY; MYD88D	PYOGENIC BACTERIAL INFECTIONS, RECURRENT, DUE TO MYD88 DEFICIENCY;; RECURRENT PYOGENIC BACTERIAL INFECTIONS DUE TO MYD88 DEFICIENCY	
Number Sign	612261	INFLAMMATORY BOWEL DISEASE 17; IBD17		
Percent	612262	INFLAMMATORY BOWEL DISEASE 18; IBD18		
Percent	612263	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 7; CMM7		
Number Sign	612267	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10; SHEP10	SKIN/HAIR/EYE PIGMENTATION 10, BLOND/BROWN HAIR	
Number Sign	612269	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5		
Number Sign	612271	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 11; SHEP11	MELANESIAN BLOND HAIR;; SKIN/HAIR/EYE PIGMENTATION 11, BLUE/NONBLUE EYES	
Percent	612274	CILIARY DYSKINESIA, PRIMARY, 8; CILD8	CILIARY DYSKINESIA, PRIMARY, 8, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	612278	INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 19; IBD19		
Percent	612279	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 6; GEFSP6	GEFS+, TYPE 6; GEFS+6	
Number Sign	612281	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6; ARCI6	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE, NIPAL4-RELATED	
Number Sign	612284	MECKEL SYNDROME, TYPE 6; MKS6		
Number Sign	612285	JOUBERT SYNDROME 9; JBTS9		JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED
Number Sign	612286	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1; NPHLOP1		
Number Sign	612287	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2; NPHLOP2		
Percent	612288	INFLAMMATORY BOWEL DISEASE 20; IBD20		
NULL	612289	PROGEROID SYNDROME, CONGENITAL, PETTY TYPE		
Number Sign	612290	MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE		MICROTIA WITH OR WITHOUT HEARING IMPAIRMENT, INCLUDED
Number Sign	612291	JOUBERT SYNDROME 8; JBTS8		
Number Sign	612292	BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME	BIRK-BAREL SYNDROME;; MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	
Percent	612293	POROKERATOSIS 5, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK5	POROKERATOSIS, DISSEMINATED SUPERFICIAL ACTINIC, 3; DSAP3	
Number Sign	612300	HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	CD59 DEFICIENCY	
Number Sign	612301	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	OSTEOPETROSIS, OSTEOCLAST-POOR, WITH HYPOGAMMAGLOBULINEMIA	
Number Sign	612304	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE;; PROC DEFICIENCY, AUTOSOMAL RECESSIVE	
Percent	612306	THYROID-STIMULATING HORMONE LEVEL QUANTITATIVE TRAIT LOCUS 1; TSHQTL1	THYROTROPIN QUANTITATIVE TRAIT LOCUS 1	
Number Sign	612310	PREMATURE OVARIAN FAILURE 6; POF6		
Percent	612311	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 5	ADHD5;; MOTOR TIMING QUANTITATIVE TRAIT LOCUS	
Percent	612312	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 6	ADHD6;; DIGIT SPAN QUANTITATIVE TRAIT LOCUS	
Number Sign	612313	GLASS SYNDROME; GLASS	CHROMOSOME 2q32-q33 DELETION SYNDROME	
Number Sign	612318	PSEUDOFOLLICULITIS BARBAE	PFB;; PILI INCARNATI;; INGROWN HAIRS	
Number Sign	612319	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE; SPG35	FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION; FAHN;; LEUKODYSTROPHY, DYSMYELINATING, AND SPASTIC PARAPARESIS WITH OR WITHOUT DYSTONIA	
Percent	612335	SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38		
Number Sign	612336	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT; THPH5		
Number Sign	612337	MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22		CHROMOSOME 1q43-q44 DELETION SYNDROME, INCLUDED;; CHROMOSOME 1qter DELETION SYNDROME, INCLUDED
Percent	612343	MUSICAL APTITUDE QUANTITATIVE TRAIT LOCUS		
Number Sign	612345	CHROMOSOME 2q31.2 DELETION SYNDROME		
Number Sign	612347	JERVELL AND LANGE-NIELSEN SYNDROME 2; JLNS2		
Percent	612348	THROMBOPHILIA, FAMILIAL, DUE TO DECREASED RELEASE OF TISSUE PLASMINOGEN ACTIVATOR; THPH9		HYPERFIBRINOLYSIS, FAMILIAL, DUE TO INCREASED RELEASE OF TISSUE PLASMINOGEN ACTIVATOR, INCLUDED
Number Sign	612350	SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	SCD-EDS	
Percent	612353	POROKERATOSIS 6, MULTIPLE TYPES; POROK6	POROKERATOSIS 6, DISSEMINATED SUPERFICIAL;; POROKERATOSIS, DISSEMINATED SUPERFICIAL ACTINIC, 4; DSAP4	
Percent	612354	INFLAMMATORY BOWEL DISEASE 21; IBD21		
Number Sign	612356	HEPARIN COFACTOR II DEFICIENCY	THROMBOPHILIA DUE TO HEPARIN COFACTOR II DEFICIENCY; THPH10;; HCF II DEFICIENCY;; HCF2 DEFICIENCY	
Percent	612357	MAJOR AFFECTIVE DISORDER 8; MAFD8	BIPOLAR AFFECTIVE DISORDER	
Number Sign	612359	COWDEN SYNDROME 2; CWS2		
Percent	612361	SCHIZOPHRENIA 14	SCZD14;; SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 2q32-RELATED	
Number Sign	612362	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12; BMIQ12	OBESITY, SUSCEPTIBILITY TO	
Percent	612363	ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1	ALTQTL1	
Percent	612364	ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2	ALTQTL2	
Percent	612365	GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1	GGTQTL1	
Percent	612366	GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2	GGTQTL2	
Percent	612367	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2	ALPQTL2	
Percent	612368	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 3	ALPQTL3	
Percent	612369	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 4	ALPQTL4	
Number Sign	612370	HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA; HH5		
Number Sign	612371	MAJOR AFFECTIVE DISORDER 7; MAFD7	BIPOLAR AFFECTIVE DISORDER	
Percent	612372	MAJOR AFFECTIVE DISORDER 9; MAFD9	BIPOLAR AFFECTIVE DISORDER	
Number Sign	612376	ACUTE PROMYELOCYTIC LEUKEMIA; APL	LEUKEMIA, ACUTE PROMYELOCYTIC	
Percent	612378	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 13; SLEB13		
Number Sign	612379	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq; CDG1Q	COLOBOMA, OCULAR, WITH ICHTHYOSIS, BRAIN MALFORMATIONS, AND ENDOCRINE ABNORMALITIES;; CDG Iq; CDGIq	
Percent	612380	INFLAMMATORY BOWEL DISEASE 22; IBD22		
Percent	612381	INFLAMMATORY BOWEL DISEASE 23; IBD23		
Number Sign	612387	SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2		
Percent	612388	SARCOIDOSIS, SUSCEPTIBILITY TO, 3; SS3		
Number Sign	612389	PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B		
Number Sign	612390	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C		
Number Sign	612394	BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	LYSYL HYDROXYLASE 3 DEFICIENCY;; LH3 DEFICIENCY	
NULL	612396	ALLANTOICASE; ALLC		
Number Sign	612400	OSTEOARTHRITIS SUSCEPTIBILITY 5; OS5	OSTEOARTHRITIS OF HIP	
Percent	612401	OSTEOARTHRITIS SUSCEPTIBILITY 6; OS6	OSTEOARTHRITIS OF KNEE	
Percent	612406	DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17		
Percent	612410	PSORIASIS 10, SUSCEPTIBILITY TO; PSORS10		
Number Sign	612416	FACTOR XI DEFICIENCY	F11 DEFICIENCY;; PLASMA THROMBOPLASTIN ANTECEDENT DEFICIENCY;; PTA DEFICIENCY;; ROSENTHAL SYNDROME	
Percent	612417	NARCOLEPSY 4, SUSCEPTIBILITY TO; NRCLP4		
Percent	612421	ALOPECIA, ANDROGENETIC, 3; AGA3		
Number Sign	612422	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3; RCM3		
Number Sign	612423	PREKALLIKREIN DEFICIENCY	PKK DEFICIENCY;; FLETCHER FACTOR DEFICIENCY	
Percent	612431	DEAFNESS, AUTOSOMAL DOMINANT 27; DFNA27		
Percent	612433	DEAFNESS, AUTOSOMAL RECESSIVE 45; DFNB45		
Number Sign	612437	EPILEPSY, PROGRESSIVE MYOCLONIC, 1B; EPM1B		
Number Sign	612438	LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6	LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIA AND CEREBELLUM; HABC	
Number Sign	612444	CILIARY DYSKINESIA, PRIMARY, 9; CILD9	CILIARY DYSKINESIA, PRIMARY, 9, WITH OR WITHOUT SITUS INVERSUS	
NULL	612445	SCOLIOSIS, ARACHNODACTYLY, AND BLINDNESS		
Number Sign	612446	COMPLEMENT COMPONENT 6 DEFICIENCY; C6D	C6 DEFICIENCY	COMPLEMENT COMPONENT 6 DEFICIENCY, SUBTOTAL, INCLUDED;; C6 DEFICIENCY, SUBTOTAL, INCLUDED
Number Sign	612447	SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION		
Percent	612448	AGE-RELATED HEARING IMPAIRMENT 1; ARHI1	PRESBYCUSIS 1	
Percent	612459	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 13; BMIQ13		
Number Sign	612460	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14; BMIQ14	OBESITY, SUSCEPTIBILITY TO	
Number Sign	612462	PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C	PHP IC	
Number Sign	612463	PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP	ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	
Number Sign	612469	WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, MENTAL RETARDATION, AND OBESITY SYNDROME; WAGRO	WAGRO SYNDROME;; WAGR SYNDROME WITH OBESITY;; CHROMOSOME 11p13-p12 DELETION SYNDROME	
Number Sign	612474	CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB		
Number Sign	612475	CHROMOSOME 1q21.1 DUPLICATION SYNDROME		
Number Sign	612513	CHROMOSOME 2p16.1-p15 DELETION SYNDROME		
Percent	612514	SPECIFIC LANGUAGE IMPAIRMENT 4; SLI4		
Number Sign	612518	CILIARY DYSKINESIA, PRIMARY, 10; CILD10	CILIARY DYSKINESIA, PRIMARY, 10, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	612520	DIABETES MELLITUS, INSULIN-DEPENDENT, 20; IDDM20		
Percent	612521	DIABETES MELLITUS, INSULIN-DEPENDENT, 21; IDDM21		
Number Sign	612522	DIABETES MELLITUS, INSULIN-DEPENDENT, 22; IDDM22		
Percent	612525	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 5; IHPS5		
Number Sign	612526	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY, TYPE 3; BSCL3;; LIPODYSTROPHY, BERARDINELLI-SEIP CONGENITAL, TYPE 3	
Number Sign	612527	DIAMOND-BLACKFAN ANEMIA 4; DBA4		
Number Sign	612528	DIAMOND-BLACKFAN ANEMIA 5; DBA5		
Number Sign	612529	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2; AI2A2	AMELOGENESIS IMPERFECTA, PIGMENTED HYPOMATURATION TYPE, 2	
Number Sign	612530	CHROMOSOME 1q41-q42 DELETION SYNDROME	HOLOPROSENCEPHALY 10, INCLUDED; HPE10, INCLUDED	
Number Sign	612539	SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42		
Number Sign	612540	MYOPATHY, CONGENITAL, COMPTON-NORTH; MYPCN		
Number Sign	612541	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4		DURSUN SYNDROME, INCLUDED;; PULMONARY ARTERIAL HYPERTENSION, LEUKOPENIA, AND ATRIAL SEPTAL DEFECT, INCLUDED
Number Sign	612542	VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B12QTL1		
Number Sign	612551	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4	END-STAGE RENAL DISEASE, NONDIABETIC, SUSCEPTIBILITY TO, INCLUDED	
Percent	612554	MYOPIA 16, AUTOSOMAL DOMINANT; MYP16		
Number Sign	612555	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2		BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2, INCLUDED;; OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2, INCLUDED
Number Sign	612556	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; ADIPQTL1		ADIPONECTIN DEFICIENCY, INCLUDED;; HYPOADIPONECTINEMIA, INCLUDED
Percent	612557	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 3	CLLS3	
Percent	612558	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 4	CLLS4	
Percent	612559	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 5	CLLS5	
Number Sign	612560	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12		
Number Sign	612561	DIAMOND-BLACKFAN ANEMIA 6; DBA6	AASE-SMITH SYNDROME II	
Number Sign	612562	DIAMOND-BLACKFAN ANEMIA 7; DBA7		
Number Sign	612563	DIAMOND-BLACKFAN ANEMIA 8; DBA8		
Percent	612566	INFLAMMATORY BOWEL DISEASE 24; IBD24		
Number Sign	612567	INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE; IBD25	INFLAMMATORY BOWEL DISEASE, EARLY-ONSET, AUTOSOMAL RECESSIVE	
Percent	612571	LUNG CANCER SUSCEPTIBILITY 3; LNCR3	ADENOCARCINOMA OF LUNG, SUSCEPTIBILITY TO	
Number Sign	612572	RETINITIS PIGMENTOSA 46; RP46	RETINITIS PIGMENTOSA, AUTOSOMAL RECESSIVE, IDH3B-RELATED	
Percent	612573	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 1; MPVQTL1		
Percent	612574	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 2; MPVQTL2	PLATELET COUNT QUANTITATIVE TRAIT LOCUS 1	
Percent	612575	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 3; MPVQTL3		
Number Sign	612576	CHROMOSOME 17p13.3, TELOMERIC, DUPLICATION SYNDROME	SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 3; SHFLD3	
Number Sign	612577	AMYOTROPHIC LATERAL SCLEROSIS 11; ALS11		
Percent	612578	STATURE QUANTITATIVE TRAIT LOCUS 15; STQTL15		
Percent	612579	STATURE QUANTITATIVE TRAIT LOCUS 16; STQTL16		
Number Sign	612580	MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3		
Number Sign	612581	MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4		
Number Sign	612582	CHROMOSOME 6pter-p24 DELETION SYNDROME		
Percent	612586	ANEURYSM, INTRACRANIAL BERRY, 9; ANIB9		
Percent	612587	ANEURYSM, INTRACRANIAL BERRY, 10; ANIB10		
Percent	612589	COLORECTAL CANCER, SUSCEPTIBILITY TO, 8; CRCS8	COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 14q	
Percent	612590	COLORECTAL CANCER, SUSCEPTIBILITY TO, 9; CRCS9	COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 16q	
Number Sign	612591	COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10	COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 19q	
Percent	612592	COLORECTAL CANCER, SUSCEPTIBILITY TO, 11; CRCS11	COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 20p	
Percent	612593	LUNG CANCER SUSCEPTIBILITY 4; LNCR4		
Percent	612594	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 2; MS2		
Percent	612595	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3; MS3		
Percent	612596	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 4; MS4		
Percent	612599	PSORIASIS 11, SUSCEPTIBILITY TO; PSORS11		
Number Sign	612621	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5; MRD5		
Percent	612622	DIABETES MELLITUS, INSULIN-DEPENDENT, 23; IDDM23		
Number Sign	612623	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2; MVCD2	PROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO;; END-STAGE RENAL DISEASE, DIABETIC, SUSCEPTIBILITY TO	
Number Sign	612624	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3	NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO;; END-STAGE RENAL DISEASE, DIABETIC, SUSCEPTIBILITY TO	
Number Sign	612626	CHROMOSOME 15q26-qter DELETION SYNDROME	DRAYER SYNDROME	
Percent	612627	SEIZURES, BENIGN FAMILIAL INFANTILE, 4; BFIS4	CONVULSIONS, BENIGN FAMILIAL INFANTILE, 4; BFIC4	
Number Sign	612628	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4; MVCD4	NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO	
Percent	612629	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 4; ADIPQTL4		
Number Sign	612630	HAIR MORPHOLOGY 1; HRM1	HAIR THICKNESS, VARIATION IN	
Number Sign	612631	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO		
Percent	612632	USHER SYNDROME, TYPE IH; USH1H		
Number Sign	612633	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5; MVCD5	RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO	
Number Sign	612634	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6	NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO	
Number Sign	612635	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7; MVCD7	PROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO;; NONPROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO;; NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO	
Percent	612637	FEBRILE SEIZURES, FAMILIAL, 10; FEB10	CONVULSIONS, FAMILIAL FEBRILE, 10	
Percent	612639	INFLAMMATORY BOWEL DISEASE 26; IBD26		
Percent	612642	DEAFNESS, AUTOSOMAL DOMINANT 59; DFNA59		
Number Sign	612643	DEAFNESS, AUTOSOMAL DOMINANT 3B; DFNA3B		
Number Sign	612644	DEAFNESS, AUTOSOMAL DOMINANT 2B; DFNA2B		
Number Sign	612645	DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B		
Number Sign	612649	CILIARY DYSKINESIA, PRIMARY, 11; CILD11	CILIARY DYSKINESIA, PRIMARY, 11, WITHOUT SITUS INVERSUS	
Number Sign	612650	CILIARY DYSKINESIA, PRIMARY, 12; CILD12	CILIARY DYSKINESIA, PRIMARY, 12, WITHOUT SITUS INVERSUS	
Number Sign	612651	ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO		
Number Sign	612653	SPHEROCYTOSIS, TYPE 4; SPH4	SPHEROCYTOSIS, HEREDITARY, 4; HS4	
Number Sign	612656	EPISODIC ATAXIA, TYPE 6; EA6		
Number Sign	612657	CONE-ROD DYSTROPHY 12; CORD12		
Number Sign	612671	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4	GOUT SUSCEPTIBILITY 4; GOUT4	
Number Sign	612674	POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT; PHARC		
Number Sign	612690	SPHEROCYTOSIS, TYPE 5; SPH5	SPHEROCYTOSIS, HEREDITARY, 5; HS5	
Number Sign	612691	POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP		
Number Sign	612692	AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE; AGM6	AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO CD79B DEFECT	
Number Sign	612702	HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6		
Number Sign	612703	MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE; MCPH7		
Number Sign	612712	LEBER CONGENITAL AMAUROSIS 13; LCA13		RETINITIS PIGMENTOSA 53, INCLUDED; RP53, INCLUDED
Number Sign	612713	KAHRIZI SYNDROME; KHRZ	MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	
Number Sign	612714	EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS		
Percent	612715	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 2; DUH2		
Number Sign	612716	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	SEPIAPTERIN REDUCTASE DEFICIENCY; SRD;; SPR DEFICIENCY	
Percent	612717	MYOPIA 15, AUTOSOMAL DOMINANT; MYP15		
Number Sign	612718	CEREBRAL CREATINE DEFICIENCY SYNDROME 3; CCDS3	ARGININE:GLYCINE AMIDINOTRANSFERASE DEFICIENCY;; AGAT DEFICIENCY;; GATM DEFICIENCY;; CREATINE DEFICIENCY SYNDROME DUE TO AGAT DEFICIENCY	
Percent	612726	HARDIKAR SYNDROME		
Percent	612727	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 13; BMND13		
Percent	612728	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 14; BMND14		
Percent	612729	LEAN BODY MASS QUANTITATIVE TRAIT LOCUS 1; LBMQTL1		
Percent	612731	FACIOCARDIOMELIC SYNDROME		
Number Sign	612736	CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2	GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY;; GAMT DEFICIENCY;; CREATINE DEFICIENCY SYNDROME DUE TO GAMT DEFICIENCY	
Percent	612737	STATURE QUANTITATIVE TRAIT LOCUS 17; STQTL17		
Number Sign	612740	PORPHYRIA, ACUTE HEPATIC	DELTA-AMINOLEVULINATE DEHYDRATASE DEFICIENCY;; ALAD DEFICIENCY;; PORPHYRIA, ALAD;; PORPHOBILINOGEN SYNTHASE DEFICIENCY;; DOSS PORPHYRIA	LEAD POISONING, SUSCEPTIBILITY TO, INCLUDED
Percent	612759	SYNESTHESIA	SYNSTH	
Number Sign	612775	CONE-ROD DYSTROPHY 9; CORD9		
Percent	612776	HYPOGLOSSIA WITH SITUS INVERSUS		HYPOGLOSSIA, ISOLATED, INCLUDED
NULL	612777	HYPOTONIA, SEIZURES, AND PRECOCIOUS PUBERTY		
Number Sign	612780	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE; SESAMES	SESAME SYNDROME;; EPILEPSY, ATAXIA, SENSORINEURAL DEAFNESS, AND TUBULOPATHY;; EAST SYNDROME	
Number Sign	612781	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B	IGHD IB;; DWARFISM OF SINDH	
Number Sign	612782	IMMUNODEFICIENCY 9; IMD9	IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 1	
Number Sign	612783	IMMUNODEFICIENCY 10; IMD10	IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 2;; STIM1 DEFICIENCY	
NULL	612785	MEGARBANE-JALKH SYNDROME	DEVELOPMENTAL DELAY, DYSMORPHIC FEATURES, NEONATAL SPONTANEOUS FRACTURES, WRINKLED SKIN, AND HEPATIC FAILURE	
Percent	612789	DEAFNESS, AUTOSOMAL RECESSIVE 71; DFNB71		
Number Sign	612794	ATRIAL SEPTAL DEFECT 5; ASD5		
Percent	612795	POLYUNSATURATED FATTY ACIDS PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; PUFAQTL1		
Percent	612796	INFLAMMATORY BOWEL DISEASE 27; IBD27		
Number Sign	612797	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12		
Number Sign	612798	QUESTION MARK EARS, ISOLATED; QME	EARS, PROMINENT AND CONSTRICTED;; COSMAN DEFORMITY OF THE AURICLE;; AURICULAR CLEFT, CONGENITAL	
Number Sign	612813	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	SEMD, AGGRECAN TYPE	
Number Sign	612838	BRUGADA SYNDROME 5; BRGDA5		CARDIAC CONDUCTION DEFECT, NONSPECIFIC, INCLUDED
Number Sign	612840	LEUKOCYTE ADHESION DEFICIENCY, TYPE III; LAD3	LEUKOCYTE ADHESION DEFICIENCY 3;; LEUKOCYTE ADHESION DEFICIENCY 1 VARIANT; LAD1V;; INTEGRIN ACTIVATION DEFICIENCY DISEASE; IADD	
Percent	612841	HYPOTRICHOSIS 5; HYPT5	MARIE UNNA HEREDITARY HYPOTRICHOSIS 2; MUHH2	
Percent	612843	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD		
Number Sign	612847	BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, PAKISTANI TYPE;; SEMD, PAKISTANI TYPE;; SPONDYLODYSPLASIA AND PREMATURE PUBARCHE	
Percent	612851	NARCOLEPSY 5, SUSCEPTIBILITY TO; NRCLP5		
Number Sign	612852	OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	INTERLEUKIN 1 RECEPTOR ANTAGONIST DEFICIENCY; DIRA	
Percent	612853	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 7; RLS7		
Percent	612858	OROFACIAL CLEFT 12; OFC12	CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 12	
Percent	612862	PULMONARY HYPERTENSION, CHRONIC THROMBOEMBOLIC, WITHOUT DEEP VEIN THROMBOSIS, SUSCEPTIBILITY TO	CTEPH, DVT-NEGATIVE, SUSCEPTIBILITY TO	
Number Sign	612863	CHROMOSOME 6q24-q25 DELETION SYNDROME		
NULL	612867	CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD	SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	
Number Sign	612868	CORNEAL DYSTROPHY, POSTERIOR AMORPHOUS; PACD	CHROMOSOME 12q21.33 DELETION SYNDROME;; POSTERIOR AMORPHOUS CORNEAL DYSTROPHY	
Number Sign	612874	ERYTHROCYTE AMP DEAMINASE DEFICIENCY		
NULL	612875	GONADOTROPIN-RELEASING HORMONE RECEPTOR 2; GNRHR2		
Percent	612876	SPINOCEREBELLAR ATAXIA 9; SCA9		
Number Sign	612877	CARDIOMYOPATHY, DILATED, 1BB; CMD1BB		
Number Sign	612881	CHROMOSOME 5q14.3 DELETION SYNDROME, DISTAL	HETEROTOPIA, PERIVENTRICULAR, ASSOCIATED WITH CHROMOSOME 5q DELETION;; PERIVENTRICULAR NODULAR HETEROTOPIA 5; PVNH5	
Percent	612882	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENAQ2		
Percent	612883	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 3; MENAQ3		
Percent	612884	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENOQ2		
Number Sign	612885	PREMATURE OVARIAN FAILURE 10; POF10		MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 3, INCLUDED; MENOQ3, INCLUDED
Percent	612886	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 4; MENOQ4		
Percent	612892	STATURE QUANTITATIVE TRAIT LOCUS 18; STQTL18		
Percent	612893	STATURE QUANTITATIVE TRAIT LOCUS 19; STQTL19		
Percent	612894	STATURE QUANTITATIVE TRAIT LOCUS 20; STQTL20		
Number Sign	612899	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8; EIG8		
Number Sign	612900	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2		
Number Sign	612908	KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2	KERATODERMA, PALMOPLANTAR, STRIATE FORM II; KPPS2;; STRIATE PALMOPLANTAR KERATODERMA II; SPPK2	
Percent	612913	OROFACIODIGITAL SYNDROME XI; OFD11	OFDS XI;; ORAL-FACIAL-DIGITAL SYNDROME, TYPE XI;; ORAL-FACIAL-DIGITAL SYNDROME WITH SKELETAL ANOMALIES;; GABRIELLI SYNDROME	
NULL	612916	ZECHI-CEIDE SYNDROME	OCCIPITAL ATRETIC CEPHALOCELE, UNUSUAL FACIES, AND LARGE FEET	
NULL	612917	GIACHETI SYNDROME	MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	
Number Sign	612918	CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	CLOVE SYNDROME;; CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, EPIDERMAL NEVI, AND SKELETAL/SPINAL ABNORMALITIES;; CLOVES SYNDROME	
Number Sign	612921	THREE M SYNDROME 2; 3M2	3M SYNDROME 2	
Number Sign	612922	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2	AHUS, SUSCEPTIBILITY TO, 2	
Number Sign	612923	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3	AHUS, SUSCEPTIBILITY TO, 3	
Number Sign	612924	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4	AHUS, SUSCEPTIBILITY TO, 4	
Number Sign	612925	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5	AHUS, SUSCEPTIBILITY TO, 5	
Number Sign	612926	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6	AHUS, SUSCEPTIBILITY TO, 6	
Percent	612929	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 3	MTBS3	
Number Sign	612932	GLYCOGEN STORAGE DISEASE XIII; GSD13	GSD XIII;; ENOLASE 3 DEFICIENCY;; ENOLASE-BETA DEFICIENCY	
Number Sign	612933	GLYCOGEN STORAGE DISEASE XI; GSD11	GSD XI;; LACTATE DEHYDROGENASE A DEFICIENCY	
Number Sign	612936	SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	
Number Sign	612937	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Io; CDG1O	CDG Io; CDGIo;; CDG1(DPM3)	
Number Sign	612938	GROWTH RETARDATION, DEVELOPMENTAL DELAY, AND FACIAL DYSMORPHISM; GDFD		
Number Sign	612940	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	CUTIS LAXA WITH PROGEROID FEATURES	
Number Sign	612943	RETINITIS PIGMENTOSA 42; RP42		
Percent	612946	HADZISELIMOVIC SYNDROME	MICROCEPHALY-FACIOCARDIOSKELETAL SYNDROME	
NULL	612947	MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE		
NULL	612948	STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, MENTAL RETARDATION, AND DYSMORPHIC FEATURES		
Number Sign	612949	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39; EIEE39	HYPOMYELINATION, GLOBAL CEREBRAL;; ASPARTATE-GLUTAMATE CARRIER 1 DEFICIENCY;; AGC1 DEFICIENCY	
Percent	612950	PSORIASIS 12, SUSCEPTIBILITY TO; PSORS12		
Number Sign	612951	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY		
Number Sign	612952	AICARDI-GOUTIERES SYNDROME 5; AGS5		
Number Sign	612953	PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	DYSTONIA-PARKINSONISM, ADULT-ONSET	
Number Sign	612954	MYOPATHY, MYOFIBRILLAR, 6; MFM6		
Number Sign	612955	LONG QT SYNDROME 12; LQT12		
Number Sign	612956	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2; VF2		
Percent	612957	VITAMIN B6 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B6QTL1		
Number Sign	612961	MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3		
Number Sign	612964	PREMATURE OVARIAN FAILURE 7; POF7		ADRENAL INSUFFICIENCY, NR5A1-RELATED, INCLUDED
Number Sign	612965	46,XY SEX REVERSAL 3; SRXY3	46,XY SEX REVERSAL, PARTIAL OR COMPLETE, NR5A1-RELATED;; 46,XY GONADAL DYSGENESIS, PARTIAL OR COMPLETE, WITH OR WITHOUT ADRENAL FAILURE;; SEX REVERSAL, XY, WITH OR WITHOUT ADRENAL FAILURE;; DISORDER OF SEX DEVELOPMENT, 46,XY, NR5A1-RELATED	
Percent	612967	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 15; BMIQ15		
Number Sign	612968	CATARACT 34, MULTIPLE TYPES; CTRCT34	CATARACT 34, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;; CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 3; CATC3	
NULL	612970	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 17, PSEUDOGENE; NBPF17P	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 23, PSEUDOGENE; NBPF23P; NBPF23	
Number Sign	612975	SHORT SLEEPER	SHORT SLEEP PHENOTYPE	
Percent	612976	AGE-RELATED HEARING IMPAIRMENT 2; ARHI2	PRESBYCUSIS 2	
Number Sign	612989	OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7		
Number Sign	612997	SPERMATOGENIC FAILURE 7; SPGF7	MALE INFERTILITY, NONSYNDROMIC, AUTOSOMAL RECESSIVE; MIAR	
Number Sign	612998	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT; EDMD4	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4 WITH VARIABLE FEATURES	
Number Sign	612999	EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT; EDMD5		
Number Sign	613000	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 1; FNEPPK1	PPKFNE;; FOCAL NONEPIDERMOLYTIC PALMOPLANTAR KERATODERMA;; KERATODERMA, FOCAL NONEPIDERMOLYTIC PALMOPLANTAR	
Number Sign	613001	ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL		
Number Sign	613002	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 2; IIAE2	
Number Sign	613003	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7	ADHD7	
NULL	613005	SANTOS SYNDROME	FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAIL HYPOPLASIA SYNDROME	
Percent	613006	DIABETES MELLITUS, INSULIN-DEPENDENT, 24; IDDM24		
Percent	613007	BILIARY CIRRHOSIS, PRIMARY, 2; PBC2		
Percent	613008	BILIARY CIRRHOSIS, PRIMARY, 3; PBC3		
Number Sign	613011	LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1		
Number Sign	613013	NEUROBLASTOMA, SUSCEPTIBILITY TO, 2; NBLST2		NEUROBLASTOMA WITH HIRSCHSPRUNG DISEASE, INCLUDED
Number Sign	613014	NEUROBLASTOMA, SUSCEPTIBILITY TO, 3; NBLST3		
Percent	613015	NEUROBLASTOMA, SUSCEPTIBILITY TO, 4; NBLST4		
Percent	613016	NEUROBLASTOMA, SUSCEPTIBILITY TO, 5; NBLST5		
Percent	613017	NEUROBLASTOMA, SUSCEPTIBILITY TO, 6; NBLST6		
Number Sign	613021	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2	CYSTIC FIBROSIS-LIKE SYNDROME	
Percent	613024	FOLLICULAR LYMPHOMA, SUSCEPTIBILITY TO, 1; FL1		
Percent	613025	SCHIZOPHRENIA 13; SCZD13	SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 15q13-q14-RELATED	
Number Sign	613026	CHROMOSOME 19q13.11 DELETION SYNDROME, DISTAL		
Number Sign	613027	GLYCOGEN STORAGE DISEASE IXc; GSD9C	GSD IXc	
Number Sign	613028	GLIOMA SUSCEPTIBILITY 2; GLM2		
Number Sign	613029	GLIOMA SUSCEPTIBILITY 3; GLM3		
Percent	613030	GLIOMA SUSCEPTIBILITY 5; GLM5		
Percent	613031	GLIOMA SUSCEPTIBILITY 6; GLM6		
Percent	613032	GLIOMA SUSCEPTIBILITY 7; GLM7		
Percent	613033	GLIOMA SUSCEPTIBILITY 8; GLM8		
Percent	613035	HEARING LOSS, NOISE-INDUCED, SUSCEPTIBILITY TO; NIHL		
Number Sign	613038	PITUITARY HORMONE DEFICIENCY, COMBINED, 1; CPHD1		
Percent	613055	ATRIAL FIBRILLATION, FAMILIAL, 8; ATFB8		
Percent	613058	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 2; BCC2		
Percent	613059	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 3; BCC3		
Number Sign	613060	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10		GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITY TO, INCLUDED; GEFS5, INCLUDED;; GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;; GEFS+5, SUSCEPTIBILITY TO, INCLUDED;; GEFSP5, SUSCEPTIBILITY TO, INCLUDED;; EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7, INCLUDED
Percent	613061	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 4; BCC4		
Percent	613062	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 5; BCC5		
Percent	613063	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 6; BCC6		
Percent	613064	DERMATITIS, ATOPIC, 7; ATOD7		
Percent	613065	LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL		LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1, INCLUDED;; ALL1, INCLUDED;; LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1, INCLUDED;; LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;; LEUKEMIA, T-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;; LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO, INCLUDED
Percent	613067	LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 2; ALL2	LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 2	
Number Sign	613068	NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY		
Number Sign	613070	LIVER FAILURE, INFANTILE, TRANSIENT; LFIT		
Number Sign	613071	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3	CYSTIC FIBROSIS-LIKE SYNDROME	
Number Sign	613073	METAPHYSEAL ANADYSPLASIA 2; MANDP2		
Number Sign	613074	DEAFNESS, AUTOSOMAL DOMINANT 50; DFNA50		
Number Sign	613075	MACS SYNDROME	MACROCEPHALY, ALOPECIA, CUTIS LAXA, AND SCOLIOSIS;; TALL FOREHEAD, SPARSE HAIR, SKIN HYPEREXTENSIBILITY, AND SCOLIOSIS	
Number Sign	613076	MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARING LOSS, AND DEVELOPMENTAL DELAY	MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;; MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	
Number Sign	613077	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 5	
Number Sign	613078	NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD	NBS-LIKE DISORDER;; RAD50 DEFICIENCY;; MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	
Number Sign	613079	DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77		
Number Sign	613080	46,XY SEX REVERSAL 5; SRXY5	46,XY SEX REVERSAL, CBX2-RELATED;; 46,XY GONADAL DYSGENESIS, COMPLETE, CBX2-RELATED;; SEX REVERSAL, XY, CBX2-RELATED;; DISORDER OF SEX DEVELOPMENT, 46,XY, CBX2-RELATED	
Percent	613085	GLAUCOMA 3, PRIMARY CONGENITAL, C; GLC3C		
Number Sign	613086	GLAUCOMA 3, PRIMARY CONGENITAL, D; GLC3D		
Number Sign	613087	ATRIAL SEPTAL DEFECT 6; ASD6		
Percent	613088	PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO, 2	PVOP2	
NULL	613089	CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH	CLAPO;; LOPEZ-GUTIERREZ SYNDROME	
Number Sign	613090	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4B		
Number Sign	613091	SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY; SRTD3	ASPHYXIATING THORACIC DYSTROPHY 3; ATD3;; SHORT RIB-POLYDACTYLY SYNDROME, TYPE I; SRPS1;; SALDINO-NOONAN SYNDROME;; POLYDACTYLY WITH NEONATAL CHONDRODYSTROPHY, TYPE I;; SHORT RIB-POLYDACTYLY SYNDROME, TYPE III; SRPS3;; VERMA-NAUMOFF SYNDROME;; POLYDACTYLY WITH NEONATAL CHONDRODYSTROPHY, TYPE III;; SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIB; SRPS2B	
Number Sign	613092	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2; HNFJ2	EARLY-ONSET HYPERURICEMIA, ANEMIA, AND PROGRESSIVE KIDNEY FAILURE	
Number Sign	613093	CONE DYSTROPHY 4; COD4		ACHROMATOPSIA 5, INCLUDED; ACHM5, INCLUDED
Number Sign	613094	MICROPHTHALMIA, ISOLATED 4; MCOP4		
Number Sign	613095	POLYCYSTIC KIDNEY DISEASE 2; PKD2	POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE II; APKD2	
Percent	613096	SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36		
Number Sign	613098	INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC		
Number Sign	613099	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5; CMM5		
Number Sign	613100	GLAUCOMA 1, OPEN ANGLE, O; GLC1O		
Number Sign	613101	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5		
Number Sign	613102	HYPOTRICHOSIS AND RECURRENT SKIN VESICLES		
Number Sign	613105	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2	MACULAR DYSTROPHY, PROGRESSIVE	
Percent	613106	VERTIGO, BENIGN RECURRENT, 2; BRV2		
Number Sign	613107	NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT; SCN2		
Number Sign	613108	CANDIDIASIS, FAMILIAL, 4; CANDF4	CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS	
Number Sign	613112	MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED		
Number Sign	613115	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B		
Number Sign	613116	THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY; THPH11		THROMBOPHILIA DUE TO ELEVATED HISTIDINE-RICH GLYCOPROTEIN, INCLUDED
Number Sign	613118	ANTITHROMBIN III DEFICIENCY; AT3D	THROMBOPHILIA DUE TO ANTITHROMBIN III DEFICIENCY; THPH7	
Number Sign	613119	BRUGADA SYNDROME 6; BRGDA6		
Number Sign	613120	BRUGADA SYNDROME 7; BRGDA7		ATRIAL FIBRILLATION, FAMILIAL, 16, INCLUDED; ATFB16, INCLUDED
Number Sign	613122	CARDIOMYOPATHY, DILATED, 1CC; CMD1CC		
Number Sign	613123	BRUGADA SYNDROME 8; BRGDA8		
NULL	613124	HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHIC FEATURES		
Number Sign	613135	PARKINSONISM-DYSTONIA, INFANTILE; PKDYS	DOPAMINE TRANSPORTER DEFICIENCY SYNDROME; DTDS	
Percent	613144	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 3; CACD3	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, WITH OR WITHOUT DRUSEN	
Percent	613145	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 14; SLEB14		
Number Sign	613148	INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE; IBD28	INFLAMMATORY BOWEL DISEASE, EARLY-ONSET, AUTOSOMAL RECESSIVE	
Number Sign	613150	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; MDDGA2	WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	
Number Sign	613151	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3; MDDGB3	MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	
Number Sign	613152	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4; MDDGB4	MUSCULAR DYSTROPHY, CONGENITAL, FKTN-RELATED	
Number Sign	613153	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, FKRP-RELATED	
Number Sign	613154	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6	WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, LARGE-RELATED	
Number Sign	613155	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	MUSCULAR DYSTROPHY, CONGENITAL, POMT1-RELATED	
Number Sign	613156	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2; MDDGB2	MUSCULAR DYSTROPHY, CONGENITAL, POMT2-RELATED	
Number Sign	613157	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2O; LGMD2O;; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMGNT1-RELATED	
Number Sign	613158	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2N; LGMD2N;; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMT2-RELATED	
Number Sign	613159	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1		
Number Sign	613161	BETA-UREIDOPROPIONASE DEFICIENCY; UPB1D		
Number Sign	613162	SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45		
Number Sign	613163	GABA-TRANSAMINASE DEFICIENCY		
Percent	613164	PARKINSON DISEASE 16; PARK16		
Number Sign	613172	CARDIOMYOPATHY, DILATED, 1DD; CMD1DD		
Number Sign	613174	CHROMOSOME 5p13 DUPLICATION SYNDROME		
Number Sign	613177	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	CUTIS LAXA WITH SEVERE PULMONARY, GASTROINTESTINAL, AND URINARY ABNORMALITIES;; URBAN-RIFKIN-DAVIS SYNDROME; URDS	
Number Sign	613179	PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	
Number Sign	613180	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 8; CDCBM8	POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	
Number Sign	613192	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13		
Number Sign	613193	CILIARY DYSKINESIA, PRIMARY, 13; CILD13	CILIARY DYSKINESIA, PRIMARY, 13, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	613194	RETINITIS PIGMENTOSA 50; RP50		RETINITIS PIGMENTOSA, CONCENTRIC, INCLUDED
Number Sign	613195	WEILL-MARCHESANI-LIKE SYNDROME		
Number Sign	613204	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	MYOPATHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	
Number Sign	613205	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED	MDCL	
Number Sign	613206	SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44		
Percent	613207	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 8; ASRT8		RHINOCONJUNCTIVITIS, SUSCEPTIBILITY TO, INCLUDED
Number Sign	613211	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3; AI2A3		
Number Sign	613215	CHROMOSOME 17p13.3, CENTROMERIC, DUPLICATION SYNDROME		
Number Sign	613216	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C	CSNB, COMPLETE, AUTOSOMAL RECESSIVE	
Number Sign	613217	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL; DIAR5	ENTEROPATHY, CONGENITAL TUFTING; CTE;; INTESTINAL EPITHELIAL CELL DYSPLASIA	
Percent	613219	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 2; FGQTL2		BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 1, INCLUDED; BWQTL1, INCLUDED
Number Sign	613223	LEPROSY, SUSCEPTIBILITY TO, 5; LPRS5		LEPROSY, PROTECTION AGAINST, INCLUDED
Number Sign	613224	NOONAN SYNDROME 6; NS6		
Number Sign	613225	FACTOR XIII, A SUBUNIT, DEFICIENCY OF		
Number Sign	613227	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 3; CAMRQ3	CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL LOCOMOTION 3	
Number Sign	613229	TRICHOTILLOMANIA; TTM		
Percent	613233	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 3; FGQTL3		
Number Sign	613235	FACTOR XIII, B SUBUNIT, DEFICIENCY OF		
Number Sign	613237	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5	GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 5	
Percent	613238	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 3; SPDA3		
Number Sign	613239	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2		
NULL	613241	PSEUDOPILI ANNULATI		
Number Sign	613243	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13		
Number Sign	613244	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8; HNPCC8		
Number Sign	613251	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14; CMH14		
Number Sign	613252	CARDIOMYOPATHY, DILATED, 1EE; CMD1EE		
Number Sign	613254	TUBEROUS SCLEROSIS 2; TSC2		TSC2 ANGIOMYOLIPOMAS, RENAL, MODIFIER OF, INCLUDED
Number Sign	613255	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15; CMH15		
Number Sign	613265	WAARDENBURG SYNDROME, TYPE 4B; WS4B	WAARDENBURG SYNDROME, TYPE 4B, WITH HIRSCHSPRUNG DISEASE;; WAARDENBURG SYNDROME, TYPE IVB	
Number Sign	613266	WAARDENBURG SYNDROME, TYPE 4C; WS4C	WAARDENBURG SYNDROME WITH HIRSCHSPRUNG DISEASE, TYPE 4C;; WAARDENBURG SYNDROME, TYPE IVC	
Number Sign	613267	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3	FCD2 LOCUS;; CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	
Number Sign	613268	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	
Percent	613269	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 5; FECD5	FCD3 LOCUS;; CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	
Number Sign	613270	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6; FECD6	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	
Percent	613271	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 7; FECD7	FCD4 LOCUS;; CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	
Number Sign	613280	HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	HYPERMANGANESEMIA WITH DYSTONIA, POLYCYTHEMIA, AND CIRRHOSIS; HMDPC	
Percent	613282	FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1		LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1, INCLUDED
Percent	613284	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HCHGQ3	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 22	
Number Sign	613285	DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25		
Number Sign	613286	CARDIOMYOPATHY, DILATED, 1FF; CMD1FF		
Number Sign	613287	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N; CMT2N	CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, TYPE 2N;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2N	
Percent	613290	HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO; CIHL		
Number Sign	613291	BILE ACID MALABSORPTION, PRIMARY; PBAM		
Number Sign	613307	DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79		
Number Sign	613308	DIAMOND-BLACKFAN ANEMIA 9; DBA9		
Number Sign	613309	DIAMOND-BLACKFAN ANEMIA 10; DBA10		
Number Sign	613310	EXUDATIVE VITREORETINOPATHY 5; EVR5		
Number Sign	613312	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2		
Number Sign	613313	HEMOCHROMATOSIS, TYPE 2B; HFE2B		
Percent	613318	MIYOSHI MUSCULAR DYSTROPHY 2; MMD2	MIYOSHI MYOPATHY 2	
Number Sign	613319	MIYOSHI MUSCULAR DYSTROPHY 3; MMD3	MIYOSHI MYOPATHY 3	
Number Sign	613320	SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	CHONDRODYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE	
Number Sign	613325	RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2		
Number Sign	613327	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY, TYPE 4, WITH MUSCULAR DYSTROPHY;; LIPODYSTROPHY, BERARDINELLI-SEIP CONGENITAL, TYPE 4, WITH MUSCULAR DYSTROPHY	
NULL	613328	ROIFMAN-CHITAYAT SYNDROME	COMBINED IMMUNODEFICIENCY, FACIAL DYSMORPHISM, OPTIC NERVE ATROPHY, SKELETAL ANOMALIES, AND DEVELOPMENTAL DELAY	
Number Sign	613329	PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY	HYPERFIBRINOLYSIS DUE TO PAI1 DEFICIENCY	
Number Sign	613330	SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD		
Percent	613339	EPILEPSY, HOT WATER, 1; HWE1	BATHING EPILEPSY;; WATER IMMERSION EPILEPSY	
Percent	613340	EPILEPSY, HOT WATER, 2; HWE2		
Number Sign	613341	LEBER CONGENITAL AMAUROSIS 14; LCA14		RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED, INCLUDED;; RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED, INCLUDED
NULL	613342	MSELENI JOINT DISEASE		
Percent	613343	HANDIGODU JOINT DISEASE	HJD;; SPONDYLOEPIMETAPHYSEAL DYSPLASIA, HANDIGODU TYPE	
Number Sign	613345	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2		
Number Sign	613347	PANCREATIC CANCER, SUSCEPTIBILITY TO, 2	PNCA2	
Number Sign	613348	PANCREATIC CANCER, SUSCEPTIBILITY TO, 3	PNCA3	
Number Sign	613353	MONONEUROPATHY OF THE MEDIAN NERVE, MILD; MNMN	CARPAL TUNNEL SYNDROME, SUSCEPTIBILITY TO	
Number Sign	613355	CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME		
Percent	613364	SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41		
Number Sign	613370	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10		
Percent	613371	SPINOCEREBELLAR ATAXIA 30; SCA30		
Number Sign	613375	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11; MODY11		
Number Sign	613376	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C	HMN IIC;; NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; DHMN2C	
Number Sign	613382	BRACHYDACTYLY, TYPE E2; BDE2		
Number Sign	613385	AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD		
Percent	613387	FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2; NAFLD2		
Number Sign	613388	FANCONI RENOTUBULAR SYNDROME 2; FRTS2		
Number Sign	613390	FANCONI ANEMIA, COMPLEMENTATION GROUP O; FANCO		
Number Sign	613391	DEAFNESS, AUTOSOMAL RECESSIVE 84A; DFNB84A	DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84;; DEAFNESS, AUTOSOMAL RECESSIVE 84A, WITH VESTIBULAR DYSFUNCTION	
Percent	613392	DEAFNESS, AUTOSOMAL RECESSIVE 85; DFNB85		
Number Sign	613393	BIRBECK GRANULE DEFICIENCY	BIRBECK GRANULES, ABSENCE OF	
Number Sign	613398	WARSAW BREAKAGE SYNDROME; WABS		
Number Sign	613399	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3; BROVCA3		BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3, INCLUDED;; OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3, INCLUDED
Number Sign	613402	MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY; MCSZ	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 10; EIEE10	
Number Sign	613404	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2; ARCS2		
Number Sign	613406	WITTEVEEN-KOLK SYNDROME; WITKOS		CHROMOSOME 15q24 DELETION SYNDROME, INCLUDED;; CHROMOSOME 15q24 DUPLICATION SYNDROME, INCLUDED
Percent	613407	LEPROSY, SUSCEPTIBILITY TO, 6; LPRS6		
Number Sign	613410	AUTISM, SUSCEPTIBILITY TO, 16; AUTS16	AUTISM WITH OR WITHOUT SEIZURES	
Number Sign	613411	OGUCHI DISEASE 2	NIGHT BLINDNESS, CONGENITAL STATIONARY, OGUCHI TYPE 2; CSNBO2	
Percent	613412	ESOPHAGITIS, EOSINOPHILIC, 2; EOE2		
Number Sign	613418	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15; BMND15	OSTEOPOROSIS, SUSCEPTIBILITY TO;; METAPHYSEAL FRACTURE, SUSCEPTIBILITY TO;; COMPRESSION FRACTURE, SUSCEPTIBILITY TO	
Number Sign	613424	CARDIOMYOPATHY, DILATED, 1R; CMD1R		LEFT VENTRICULAR NONCOMPACTION 4, INCLUDED; LVNC4, INCLUDED
Number Sign	613426	CARDIOMYOPATHY, DILATED, 1S; CMD1S		LEFT VENTRICULAR NONCOMPACTION 5, INCLUDED; LVNC5, INCLUDED
Number Sign	613428	RETINITIS PIGMENTOSA 54; RP54		
Number Sign	613435	AMYOTROPHIC LATERAL SCLEROSIS 12; ALS12		
Number Sign	613436	AUTISM, SUSCEPTIBILITY TO, 17; AUTS17		
Percent	613440	STATURE QUANTITATIVE TRAIT LOCUS 21; STQTL21		
Number Sign	613443	MENTAL RETARDATION, AUTOSOMAL DOMINANT 20; MRD20	MENTAL RETARDATION, STEREOTYPIC MOVEMENTS, EPILEPSY, AND/OR CEREBRAL MALFORMATIONS	CHROMOSOME 5q14.3 DELETION SYNDROME, PROXIMAL, INCLUDED
Number Sign	613444	CHROMOSOME 16p11.2 DELETION SYNDROME, 220-KB		BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 16, INCLUDED; BMIQ16, INCLUDED;; OBESITY, SUSCEPTIBILITY TO, INCLUDED
Number Sign	613451	FRONTONASAL DYSPLASIA 2; FND2		
Number Sign	613453	DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91		
Number Sign	613454	RETT SYNDROME, CONGENITAL VARIANT		
Number Sign	613456	FRONTONASAL DYSPLASIA 3; FND3		
Number Sign	613457	CHROMOSOME 14q11-q22 DELETION SYNDROME		
Number Sign	613458	CHROMOSOME 16p13.3 DUPLICATION SYNDROME		
Percent	613459	BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 2; BWQTL2		
Percent	613460	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 6; FGQTL6		BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 3, INCLUDED; BWQTL3, INCLUDED;; PLASMA GLUCOSE, 2-HOUR, QUANTITATIVE TRAIT LOCUS 1, INCLUDED; PGQTL1, INCLUDED
Percent	613462	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 4; FGQTL4		
Number Sign	613463	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5; FGQTL5		
Number Sign	613464	RETINITIS PIGMENTOSA 51; RP51		
Number Sign	613470	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY		
Number Sign	613471	REYNOLDS SYNDROME	PRIMARY BILIARY CIRRHOSIS, SCLERODERMA, RAYNAUD DISEASE, AND TELANGIECTASIA	
Number Sign	613477	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5; EIEE5		
Number Sign	613480	LYMPHEDEMA, HEREDITARY, IC; LMPH1C		
Number Sign	613485	LONG QT SYNDROME 13; LQT13		
Number Sign	613488	MYXOID LIPOSARCOMA		
Number Sign	613489	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	CDG IIj; CDGIIj	
Number Sign	613490	ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD		
Number Sign	613493	IMMUNODEFICIENCY, COMMON VARIABLE, 3; CVID3	ANTIBODY DEFICIENCY DUE TO CD19 DEFECT	
Number Sign	613494	IMMUNODEFICIENCY, COMMON VARIABLE, 4; CVID4	ANTIBODY DEFICIENCY DUE TO BAFFR DEFECT	
Number Sign	613495	IMMUNODEFICIENCY, COMMON VARIABLE, 5; CVID5	ANTIBODY DEFICIENCY DUE TO CD20 DEFECT	
Number Sign	613496	IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	ANTIBODY DEFICIENCY DUE TO CD81 DEFECT	
Percent	613498	SEX HORMONE-BINDING GLOBULIN CIRCULATING LEVEL QUANTITATIVE TRAIT LOCUS; SXGQTL1	TESTOSTERONE CIRCULATING LEVEL QUANTITATIVE TRAIT LOCUS, DUE TO SEX HORMONE-BINDING GLOBULIN	
Number Sign	613500	AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE; AGM2	AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO IGLL1 DEFECT	
Number Sign	613501	AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE; AGM3	AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO CD79A DEFECT	
Number Sign	613502	AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE; AGM4	AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO BLNK DEFECT	
Number Sign	613506	AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5	AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	
Number Sign	613507	GLYCOGEN STORAGE DISEASE XV; GSD15	GSD XV;; GLYCOGENIN DEFICIENCY;; GYG1 DEFICIENCY	
Number Sign	613508	SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1; SSQTL1		HYPONATREMIA, INCLUDED
Number Sign	613509	CHROMOSOME 4q21 DELETION SYNDROME		
Number Sign	613517	MICROPHTHALMIA, ISOLATED 6; MCOP6	MICROPHTHALMIA, POSTERIOR NONSYNDROMIC	
Percent	613518	DERMATITIS, ATOPIC, 8; ATOD8	DERMATITIS, ATOPIC, SEVERITY OF	
Percent	613519	DERMATITIS, ATOPIC, 9; ATOD9		
Number Sign	613523	CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME	STEM CELL LEUKEMIA/LYMPHOMA; SCLL	
Percent	613530	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H		
Number Sign	613533	CHROMOSOME 17q21.31 DUPLICATION SYNDROME		
Number Sign	613544	CHROMOSOME 6q11-q14 DELETION SYNDROME		CHROMOSOME 6q13-q14 DELETION SYNDROME, INCLUDED
Percent	613545	MACROSTOMIA, ISOLATED	LATERAL CLEFT, ISOLATED;; COMMISSURAL CLEFT, ISOLATED;; TRANSVERSE CLEFT, ISOLATED	
Number Sign	613546	AROMATASE DEFICIENCY	PSEUDOHERMAPHRODITISM, FEMALE, DUE TO PLACENTAL AROMATASE DEFICIENCY	
Percent	613547	STATURE QUANTITATIVE TRAIT LOCUS 22; STQTL22		
Percent	613548	STATURE QUANTITATIVE TRAIT LOCUS 23; STQTL23		
Percent	613549	STATURE QUANTITATIVE TRAIT LOCUS 24; STQTL24		
Number Sign	613550	NEPHRONOPHTHISIS 11; NPHP11		
Number Sign	613551	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6; AIS6		
Number Sign	613554	VON WILLEBRAND DISEASE, TYPE 2; VWD2	VON WILLEBRAND DISEASE, TYPE II;; VWD, TYPE 2	VON WILLEBRAND DISEASE, TYPE 2A, INCLUDED; VWD2A, INCLUDED;; VON WILLEBRAND DISEASE, TYPE 2B, INCLUDED; VWD2B, INCLUDED;; VON WILLEBRAND DISEASE, TYPE 2M, INCLUDED; VWD2M, INCLUDED;; VON WILLEBRAND DISEASE, TYPE 2N, INCLUDED; VWD2N, INCLUDED
Number Sign	613558	DEAFNESS, AUTOSOMAL DOMINANT 51; DFNA51	CHROMOSOME 9q21.11 DUPLICATION SYNDROME	
Number Sign	613559	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7		
Number Sign	613561	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2		
Number Sign	613563	NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA; NSLL	CBL SYNDROME;; CBL MUTATION-ASSOCIATED SYNDROME	
Number Sign	613564	CHROMOSOME 2p12-p11.2 DELETION SYNDROME		
Number Sign	613566	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6; HBFQTL6	HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, KLF1-RELATED	
Number Sign	613571	DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY;; DISORDERED STEROIDOGENESIS DUE TO POR DEFICIENCY	
Number Sign	613573	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1; EDSS1		
Number Sign	613575	RETINITIS PIGMENTOSA 55; RP55		
Percent	613576	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2		
Number Sign	613581	RETINITIS PIGMENTOSA 56; RP56		
Number Sign	613582	RETINITIS PIGMENTOSA 57; RP57		
Number Sign	613587	OCCULT MACULAR DYSTROPHY; OCMD	OMD	
Number Sign	613589	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; LDLCQ6		
NULL	613600	TORSADE DE POINTES, SHORT-COUPLED VARIANT		
NULL	613601	EARLY REPOLARIZATION ASSOCIATED WITH VENTRICULAR FIBRILLATION	EARLY REPOLARIZATION SYNDROME	
Number Sign	613603	CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME		
Number Sign	613604	CHROMOSOME 16p12.2-p11.2 DELETION SYNDROME, 7.1- TO 8.7-MB		
Percent	613606	FORSYTHE-WAKELING SYNDROME; FWS	MICROCEPHALY AND GROWTH RETARDATION WITH CHILDHOOD-ONSET NEPHROTIC SYNDROME AND THROMBOCYTOPENIA	
Percent	613608	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3	CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	
Number Sign	613610	CRANIOECTODERMAL DYSPLASIA 2; CED2		
Number Sign	613611	CHOANAL ATRESIA AND LYMPHEDEMA		
Number Sign	613612	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I	CDG IIi; CDGIIi	
Number Sign	613615	SENIOR-LOKEN SYNDROME 7; SLSN7		
Number Sign	613616	HYPEROXALURIA, PRIMARY, TYPE III; HP3		
Number Sign	613617	RETINITIS PIGMENTOSA 58; RP58		
Number Sign	613618	CHROMOSOME 17q23.1-q23.2 DUPLICATION SYNDROME		
NULL	613623	AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA		
Number Sign	613625	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2; F5F8D2		
NULL	613627	BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY, PTOSIS, HEARING LOSS, AND MENTAL RETARDATION	TSUKAHARA SYNDROME	
Percent	613628	ODONTOID HYPOPLASIA		
Number Sign	613630	COCOON SYNDROME	FETAL ENCASEMENT SYNDROME	
Percent	613636	TUBERCULIN SKIN TEST REACTIVITY, ABSENCE OF	TST REACTIVITY, ABSENCE OF;; TST1	
Percent	613637	TUBERCULIN SKIN TEST REACTIVITY QUANTITATIVE TRAIT LOCUS	TST REACTIVITY QUANTITATIVE TRAIT LOCUS;; TST2	
Number Sign	613638	CHROMOSOME 19p13.13 DELETION SYNDROME		CHROMOSOME 19p13.13 DUPLICATION SYNDROME, INCLUDED
Number Sign	613640	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	HSAN IC;; NEUROPATHY, HEREDITARY SENSORY, TYPE IC; HSN1C;; HSN IC	
Number Sign	613641	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB	CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	
Number Sign	613642	CARDIOMYOPATHY, DILATED, 1GG; CMD1GG		
Number Sign	613643	PARKINSON DISEASE 5, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK5		
Number Sign	613646	METHYLMALONIC ACIDURIA, TRANSIENT, DUE TO TRANSCOBALAMIN RECEPTOR DEFECT	METHYLMALONIC ACIDEMIA, TCblR TYPE	
Number Sign	613647	SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48		
Number Sign	613652	C1q DEFICIENCY; C1QD		
Number Sign	613656	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13		
Number Sign	613657	D-2-HYDROXYGLUTARIC ACIDURIA 2; D2HGA2		
Percent	613658	RAJAB SYNDROME	DEVELOPMENTAL DELAY, SMALL STATURE, MICROCEPHALY, AND BRAIN CALCIFICATIONS	
Number Sign	613659	GASTRIC CANCER		GASTRIC CANCER, INTESTINAL, INCLUDED
Number Sign	613660	CONE-ROD DYSTROPHY 15; CORD15		RETINITIS PIGMENTOSA 65, INCLUDED; RP65, INCLUDED
Number Sign	613661	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P		
Number Sign	613662	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME, POLG-RELATED;; MNGIE, POLG-RELATED	
Number Sign	613668	MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY		
Number Sign	613670	MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES		
Number Sign	613671	MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS		
Number Sign	613672	SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4		
Number Sign	613673	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IV; CDAN4	CDA, TYPE IV	
Number Sign	613674	VESICOURETERAL REFLUX 3; VUR3		
Number Sign	613675	CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB	NEUROFIBROMATOSIS 1 MICRODELETION SYNDROME;; NF1 MICRODELETION SYNDROME;; VAN ASPEREN SYNDROME	NF1 MICRODUPLICATION SYNDROME, INCLUDED
Number Sign	613676	SECKEL SYNDROME 4; SCKL4		
Number Sign	613677	HYPERALDOSTERONISM, FAMILIAL, TYPE III; HALD3	FH III	
Percent	613678	BRACHYOLMIA TYPE 2; BCYM2	BRACHYOLMIA, MAROTEAUX TYPE	
Number Sign	613679	PROTHROMBIN DEFICIENCY, CONGENITAL	HYPOPROTHROMBINEMIA	DYSPROTHROMBINEMIA, INCLUDED
Number Sign	613680	BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	MICROCEPHALY, MENTAL RETARDATION, AND DISTINCTIVE FACIES, WITH CARDIAC AND GENITOURINARY MALFORMATIONS	
Number Sign	613681	CHROMOSOME 2q31.1 DUPLICATION SYNDROME	MESOMELIC DYSPLASIA, 2q31.1 DUPLICATION-RELATED	
Number Sign	613684	RUBINSTEIN-TAYBI SYNDROME 2; RSTS2		
Percent	613685	DEAFNESS, AUTOSOMAL RECESSIVE 83; DFNB83		
Number Sign	613686	SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4		
Number Sign	613688	LONG QT SYNDROME 2; LQT2		LONG QT SYNDROME 2, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;; LONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;; LONG QT SYNDROME 2/3, DIGENIC, INCLUDED; LQT2/3, DIGENIC, INCLUDED;; LONG QT SYNDROME 2/5, DIGENIC, INCLUDED; LQT2/5, DIGENIC, INCLUDED;; LONG QT SYNDROME 2/9, DIGENIC, INCLUDED; LQT2/9, DIGENIC, INCLUDED
Percent	613689	MAMMARY-DIGITAL-NAIL SYNDROME; MDNS		
Number Sign	613690	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7		
Number Sign	613693	LONG QT SYNDROME 6; LQT6		LONG QT SYNDROME 6, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;; LONG QT SYNDROME 3/6, DIGENIC, INCLUDED; LQT3/6, DIGENIC, INCLUDED
Number Sign	613694	CARDIOMYOPATHY, DILATED, 1U; CMD1U		
Number Sign	613695	LONG QT SYNDROME 5; LQT5		LONG QT SYNDROME 5, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED;; LONG QT SYNDROME 2/5, DIGENIC, INCLUDED; LQT2/5, DIGENIC, INCLUDED
Number Sign	613697	CARDIOMYOPATHY, DILATED, 1V; CMD1V		
Number Sign	613700	SUPERNUMERARY DER(22)t(8;22) SYNDROME		
Number Sign	613702	KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT; KFS3		
Number Sign	613703	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB6		
Number Sign	613704	MICROPHTHALMIA, ISOLATED 7; MCOP7		
Number Sign	613705	OROFACIAL CLEFT 10; OFC10	CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 10	
Number Sign	613706	NOONAN SYNDROME 7; NS7		
Number Sign	613707	LEOPARD SYNDROME 3; LPRD3		
Number Sign	613708	NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D		
Number Sign	613710	THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4	BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY;; STRIATAL NECROSIS, BILATERAL, AND PROGRESSIVE POLYNEUROPATHY	
Number Sign	613711	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3; HSCR3		
Number Sign	613712	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4; HSCR4		
Number Sign	613717	TREACHER COLLINS SYNDROME 2; TCS2		
Number Sign	613718	DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74		
Number Sign	613720	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7; EIEE7		
Number Sign	613721	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11		
Number Sign	613722	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12		
Number Sign	613723	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q; LGMD2Q		
Number Sign	613724	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY; LKDMN	STEROL CARRIER PROTEIN 2 DEFICIENCY	
Number Sign	613728	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10		
Number Sign	613729	CHROMOSOME 7q11.23 DELETION SYNDROME, DISTAL, 1.2-MB	DISTAL CHROMOSOME 7q11.23 DELETION SYNDROME	
Number Sign	613730	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS; HDBSCC		
Number Sign	613731	RETINITIS PIGMENTOSA 4; RP4	RETINITIS PIGMENTOSA, RHODOPSIN-RELATED	
Number Sign	613735	BRAIN MALFORMATIONS AND URINARY TRACT DEFECTS; BRMUTD		CHROMOSOME 1p32-p31 DELETION SYNDROME, INCLUDED
Number Sign	613736	ACNE INVERSA, FAMILIAL, 2; ACNINV2		
Number Sign	613737	ACNE INVERSA, FAMILIAL, 3; ACNINV3		
Number Sign	613743	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	P450scc DEFICIENCY	
Number Sign	613744	SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	
Number Sign	613750	RETINITIS PIGMENTOSA 27; RP27		RETINAL DEGENERATION, AUTOSOMAL RECESSIVE, CLUMPED PIGMENT TYPE, INCLUDED
Number Sign	613751	HETEROTAXY, VISCERAL, 4, AUTOSOMAL; HTX4		
Number Sign	613752	HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY		
Number Sign	613756	RETINITIS PIGMENTOSA 49; RP49		
Number Sign	613757	MACULAR DEGENERATION, AGE-RELATED, 6; ARMD6		
Number Sign	613758	RETINITIS PIGMENTOSA 47; RP47		
Number Sign	613759	INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	FADD DEFICIENCY	
Number Sign	613761	MACULAR DEGENERATION, AGE-RELATED, 5; ARMD5		
Number Sign	613762	46,XY SEX REVERSAL 6; SRXY6	46,XY SEX REVERSAL, PARTIAL OR COMPLETE, MAP3K1-RELATED;; 46,XY GONADAL DYSGENESIS, PARTIAL OR COMPLETE, MAP3K1-RELATED	
Number Sign	613763	CATARACT 16, MULTIPLE TYPES; CTRCT16	CATARACT, POSTERIOR POLAR, 2; CTPP2;; CATARACT, CONGENITAL LAMELLAR	
Number Sign	613765	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9; CMH9		
Number Sign	613767	RETINITIS PIGMENTOSA 45; RP45		
Number Sign	613769	RETINITIS PIGMENTOSA 44; RP44		
Number Sign	613776	CHROMOSOME 17p13.1 DELETION SYNDROME		
Number Sign	613778	MACULAR DEGENERATION, AGE-RELATED, 8; ARMD8		
Number Sign	613779	COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	C3 DEFICIENCY, AUTOSOMAL RECESSIVE	
Number Sign	613780	AORTIC ANEURYSM, FAMILIAL THORACIC 7; AAT7	AORTIC DISSECTION, FAMILIAL, WITH OR WITHOUT AORTIC ANEURYSM	
Number Sign	613783	COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD	C1s DEFICIENCY	
Number Sign	613784	MACULAR DEGENERATION, AGE-RELATED, 12; ARMD12		
Number Sign	613789	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II; C8D2	C8 DEFICIENCY, TYPE II;; COMPLEMENT COMPONENT 8B DEFICIENCY;; C8 BETA DEFICIENCY;; C8B DEFICIENCY	
Number Sign	613790	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I; C8D1	C8 DEFICIENCY, TYPE I;; C8 ALPHA-GAMMA DEFICIENCY;; C8AG DEFICIENCY	
Number Sign	613791	MASP2 DEFICIENCY	LECTIN COMPLEMENT ACTIVATION PATHWAY, DEFECT IN, 2; LCAPD2	
Number Sign	613792	CHROMOSOME 3pter-p25 DELETION SYNDROME	3p- SYNDROME	
Number Sign	613793	BLOOD GROUP, CROMER SYSTEM; CROM	CROMER BLOOD GROUP SYSTEM	
Number Sign	613794	RETINITIS PIGMENTOSA 20; RP20		
Number Sign	613795	LOEYS-DIETZ SYNDROME 3; LDS3	ANEURYSMS-OSTEOARTHRITIS SYNDROME;; LOEYS-DIETZ SYNDROME WITH OSTEOARTHRITIS;; LOEYS-DIETZ SYNDROME, TYPE 1C, FORMERLY; LDS1C, FORMERLY	
Number Sign	613796	IMMUNODEFICIENCY 31B; IMD31B	IMMUNODEFICIENCY 31B, MYCOBACTERIAL AND VIRAL INFECTIONS, AUTOSOMAL RECESSIVE;; STAT1 DEFICIENCY, AUTOSOMAL RECESSIVE	
Number Sign	613800	MEIER-GORLIN SYNDROME 2; MGORS2		
Number Sign	613801	RETINITIS PIGMENTOSA 40; RP40		
Number Sign	613803	MEIER-GORLIN SYNDROME 3; MGORS3		
Number Sign	613804	MEIER-GORLIN SYNDROME 4; MGORS4		
Number Sign	613805	MEIER-GORLIN SYNDROME 5; MGORS5		
Percent	613806	CHOLANGITIS, PRIMARY SCLEROSING; PSC		
Number Sign	613807	CILIARY DYSKINESIA, PRIMARY, 14; CILD14	CILIARY DYSKINESIA, PRIMARY, 14, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	613808	CILIARY DYSKINESIA, PRIMARY, 15; CILD15	CILIARY DYSKINESIA, PRIMARY, 15, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	613809	RETINITIS PIGMENTOSA 39; RP39		
Number Sign	613810	RETINITIS PIGMENTOSA 43; RP43		
Number Sign	613811	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D	CEREBELLOCEREBRAL ATROPHY, PROGRESSIVE; PCCA	
Number Sign	613812	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3		
Number Sign	613818	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2P; LGMD2P;; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, DAG1-RELATED	
Number Sign	613819	SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	ASPHYXIATING THORACIC DYSTROPHY 4; ATD4	
Number Sign	613820	NEPHRONOPHTHISIS 12; NPHP12		JOUBERT SYNDROME 11, INCLUDED; JBTS11, INCLUDED
Number Sign	613823	SECKEL SYNDROME 5; SCKL5		
Number Sign	613824	NEPHRONOPHTHISIS 9; NPHP9		
Number Sign	613825	COMPLEMENT COMPONENT 9 DEFICIENCY; C9D	C9 DEFICIENCY	
Number Sign	613826	LEBER CONGENITAL AMAUROSIS 6; LCA6		
Number Sign	613827	RETINITIS PIGMENTOSA 48; RP48		
Percent	613828	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 8; GEFSP8	GEFS+, TYPE 8; GEFS+8	
Number Sign	613829	LEBER CONGENITAL AMAUROSIS 7; LCA7		
Number Sign	613830	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D	CSNB, COMPLETE, AUTOSOMAL RECESSIVE	
Number Sign	613834	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	MYDRIASIS, CONGENITAL, WITH PATENT DUCTUS ARTERIOSUS, THORACIC AORTIC ANEURYSM, AND VASCULOPATHY	
Number Sign	613835	LEBER CONGENITAL AMAUROSIS 8; LCA8		
Percent	613836	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 5; ADIPQTL5		
Number Sign	613837	LEBER CONGENITAL AMAUROSIS 11; LCA11		
Number Sign	613838	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16; CMH16		
Number Sign	613839	MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	DHFR DEFICIENCY	
Number Sign	613843	LEBER CONGENITAL AMAUROSIS 15; LCA15		RETINITIS PIGMENTOSA, JUVENILE, TULP1-RELATED, INCLUDED
Number Sign	613845	HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME; HUPRAS	HUPRA SYNDROME	
Number Sign	613848	OSTEOGENESIS IMPERFECTA, TYPE X; OI10	OI, TYPE X	
Number Sign	613849	OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	OI, TYPE XII	
Number Sign	613850	INOSINE TRIPHOSPHATASE DEFICIENCY	INOSINE TRIPHOSPHATE PYROPHOSPHOHYDROLASE DEFICIENCY	
Number Sign	613852	FUCOSYLTRANSFERASE 6 DEFICIENCY		
Number Sign	613854	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 3; DTGA3		
Number Sign	613855	EPISODIC ATAXIA, TYPE 5; EA5		
Number Sign	613856	ACHROMATOPSIA 4; ACHM4		
Percent	613857	OROFACIAL CLEFT 13; OFC13		
Number Sign	613860	FICOLIN 3 DEFICIENCY	FCN3 DEFICIENCY;; LECTIN COMPLEMENT ACTIVATION PATHWAY, DEFECT IN, 3; LCAPD3	
Number Sign	613861	RETINITIS PIGMENTOSA 59; RP59		
Number Sign	613862	RETINITIS PIGMENTOSA 38; RP38	ROD-CONE DYSTROPHY, CHILDHOOD-ONSET	
Number Sign	613863	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7	GEFS+, TYPE 7; GEFS+7	FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED
Number Sign	613865	DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61		
Number Sign	613869	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	MFM, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	
Number Sign	613870	HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD		
Number Sign	613873	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17; CMH17		
Number Sign	613874	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18		
Number Sign	613875	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 19; CMH19		
Number Sign	613876	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20; CMH20		
Number Sign	613877	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4	LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PLIN1 MUTATIONS	
Number Sign	613881	CARDIOMYOPATHY, DILATED, 1HH; CMD1HH		
Number Sign	613882	HYPOMAGNESEMIA 6, RENAL; HOMG6		
Number Sign	613884	CHROMOSOME 13q14 DELETION SYNDROME	CHROMOSOME 13q DELETION SYNDROME	
Number Sign	613885	MECKEL SYNDROME, TYPE 8; MKS8		
Number Sign	613886	OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD		
Number Sign	613887	CATARACT 36; CTRCT36	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 4; CATC4	
Number Sign	613908	SPINOCEREBELLAR ATAXIA 35; SCA35		
Percent	613909	SPINOCEREBELLAR ATAXIA 32; SCA32		
Number Sign	613912	COMPLEMENT FACTOR D DEFICIENCY; CFDD	FACTOR D DEFICIENCY	
Percent	613913	LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	LIPODYSTROPHY, PARTIAL, ACQUIRED, ASSOCIATED WITH C3 NEPHRITIC FACTOR	
Number Sign	613916	DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89		
Number Sign	613925	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A		
Number Sign	613926	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B		
Percent	613930	ALOPECIA-MENTAL RETARDATION SYNDROME 3; APMR3		
Percent	613933	ACETYL-CoA CARBOXYLASE DEFICIENCY; ACACAD	ACACA DEFICIENCY;; ACC1 DEFICIENCY	
Percent	613938	PARASOMNIA, SLEEPWALKING TYPE; PSMNSW		PARASOMNIA, SLEEP TERRORS TYPE, INCLUDED; PSMNST, INCLUDED
Number Sign	613943	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8	LAMELLAR ICHTHYOSIS, LATE-ONSET;; ICHTHYOSIS, LAMELLAR, 4, FORMERLY; LI4, FORMERLY	
Percent	613944	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2		
Number Sign	613949	OKT4 EPITOPE DEFICIENCY	T4 EPITOPE DEFICIENCY	
Number Sign	613950	SCHIZOPHRENIA 15; SCZD15	SCHIZOPHRENIA 15 WITH OR WITHOUT AN AFFECTIVE DISORDER;; SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 22q13-RELATED	
Number Sign	613951	FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP		
Number Sign	613953	IMMUNODEFICIENCY 51; IMD51	CANDIDIASIS, FAMILIAL, 5, FORMERLY; CANDF5, FORMERLY	
Number Sign	613954	AMYOTROPHIC LATERAL SCLEROSIS 14 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS14		
Number Sign	613955	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2; PLCA2		
Number Sign	613956	CANDIDIASIS, FAMILIAL, 6; CANDF6	CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	
Number Sign	613957	SPERMATOGENIC FAILURE 8; SPGF8		
Number Sign	613958	SPERMATOGENIC FAILURE 9; SPGF9	GLOBOZOOSPERMIA, COMPLETE;; GLOBOZOOSPERMIA, TOTAL	
Number Sign	613959	SCHIZOPHRENIA 16; SCZD16	SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 7q36.3-RELATED;; CHROMOSOME 7q36.3 DUPLICATION SYNDROME, 362-KB	
Number Sign	613960	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III; CDG3	CGD, AUTOSOMAL RECESSIVE CYTOCHROME b-POSITIVE, TYPE III;; GRANULOMATOUS DISEASE, CHRONIC, DUE TO NCF4 DEFICIENCY	
Percent	613969	MYOPIA 19, AUTOSOMAL DOMINANT; MYP19		
Number Sign	613970	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6		
Number Sign	613972	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6; CMM6		
Number Sign	613977	CYANOSIS, TRANSIENT NEONATAL; TNCY		
Number Sign	613978	HEMOGLOBIN H DISEASE; HBH	ALPHA-THALASSEMIA, HEMOGLOBIN H TYPE;; HEMOGLOBIN H DISEASE, DELETIONAL	HEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED
Number Sign	613980	ATRIAL FIBRILLATION, FAMILIAL, 9; ATFB9		
Number Sign	613981	HYPOTRICHOSIS 3; HYPT3	HYPOTRICHOSIS SIMPLEX OF THE SCALP 2; HTSS2	
Number Sign	613982	OSTEOGENESIS IMPERFECTA, TYPE VI; OI6		
Number Sign	613983	RETINITIS PIGMENTOSA 60; RP60		
Number Sign	613985	BETA-THALASSEMIA		
Number Sign	613986	PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6		
Number Sign	613987	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2; DKCB2		
Number Sign	613988	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 3; DKCB3		
Number Sign	613989	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2		DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 4, INCLUDED; DKCB4, INCLUDED
Number Sign	613990	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3		
Number Sign	614008	NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	PROGERIA SYNDROME, CHILDHOOD-ONSET, WITH OSTEOLYSIS; PSCOO	
Number Sign	614009	BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13	BLEEDING DISORDER, SUSCEPTIBILITY TO, DUE TO DEFECTIVE PLATELET THROMBOXANE A2 RECEPTOR	
Number Sign	614017	CILIARY DYSKINESIA, PRIMARY, 16; CILD16	CILIARY DYSKINESIA, PRIMARY, 16, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	614018	EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6		
Number Sign	614019	LISSENCEPHALY 4; LIS4	LISSENCEPHALY 4 WITH MICROCEPHALY	
Number Sign	614020	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14; MRT14		
Number Sign	614021	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3; CPVT3		
Number Sign	614022	ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10		
Number Sign	614023	PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD		
Number Sign	614024	PROTEIN Z DEFICIENCY		
Number Sign	614025	HEPATIC LIPASE DEFICIENCY	LIPC DEFICIENCY;; HL DEFICIENCY	
Number Sign	614028	APOLIPOPROTEIN C-III DEFICIENCY	HYPERALPHALIPOPROTEINEMIA 2; HALP2	
NULL	614033	HYDROXYACYL GLUTATHIONE HYDROLASE DEFICIENCY	GLYOXALASE II DEFICIENCY	
Number Sign	614034	HEME OXYGENASE 1 DEFICIENCY; HMOX1D		
Number Sign	614035	DEAFNESS, AUTOSOMAL RECESSIVE 29; DFNB29		
NULL	614036	ALPHA-2-MACROGLOBULIN DEFICIENCY; A2MD		
NULL	614037	LEUKOTRIENE C4 SYNTHASE DEFICIENCY	LTC4 SYNTHASE DEFICIENCY	
Number Sign	614038	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	EMBERGER SYNDROME	
Number Sign	614039	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1; CDCBM1		
Number Sign	614042	MOYAMOYA DISEASE 5; MYMY5		
NULL	614044	TRYPSINOGEN DEFICIENCY		
Number Sign	614049	ATRIAL FIBRILLATION, FAMILIAL, 11; ATFB11		
Number Sign	614050	ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12		
Number Sign	614052	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, TMEM70 TYPE;; ENCEPHALOCARDIOMYOPATHY, MITOCHONDRIAL, NEONATAL, DUE TO ATP SYNTHASE DEFICIENCY	
Number Sign	614053	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3; MC5DN3	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5E TYPE	
NULL	614055	ACETYL-CoA ACETYLTRANSFERASE-2 DEFICIENCY; ACAT2D	ACAT2 DEFICIENCY	
Number Sign	614063	N-ACETYLASPARTATE DEFICIENCY; NACED	NAA DEFICIENCY;; HYPOACETYLASPARTIA	
Number Sign	614065	MYOPATHY, DISTAL, 4; MPD4	WILLIAMS DISTAL MYOPATHY	
Number Sign	614066	SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 5, FORMERLY; CPSQ5, FORMERLY	
Number Sign	614067	SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE; SPG52	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 6, FORMERLY; CPSQ6, FORMERLY	
Number Sign	614069	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2; ICF2		
Number Sign	614070	PSORIASIS 13, SUSCEPTIBILITY TO; PSORS13		
Number Sign	614072	HERMANSKY-PUDLAK SYNDROME 3; HPS3		
Number Sign	614073	HERMANSKY-PUDLAK SYNDROME 4; HPS4		
Number Sign	614074	HERMANSKY-PUDLAK SYNDROME 5; HPS5		
Number Sign	614075	HERMANSKY-PUDLAK SYNDROME 6; HPS6		
Number Sign	614076	HERMANSKY-PUDLAK SYNDROME 7; HPS7		
Number Sign	614077	HERMANSKY-PUDLAK SYNDROME 8; HPS8		
Number Sign	614078	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	GPAPP DEFICIENCY	
Number Sign	614079	ASPERGILLOSIS, SUSCEPTIBILITY TO		
Number Sign	614080	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 3; GPIBD3	
Number Sign	614081	ANHAPTOGLOBINEMIA; AHP	AHAPTOGLOBINEMIA	HYPOHAPTOGLOBINEMIA, INCLUDED
Number Sign	614082	FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG		
Number Sign	614083	FANCONI ANEMIA, COMPLEMENTATION GROUP L; FANCL		
Number Sign	614089	ATRIAL SEPTAL DEFECT 3; ASD3		
Number Sign	614090	SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO; SSS3		
Number Sign	614091	SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	SHORT RIB-POLYDACTYLY SYNDROME, TYPE V; SRPS5	
Number Sign	614096	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8	CARDIOMYOPATHY, HYPERTROPHIC MITOCHONDRIAL, FATAL INFANTILE	
Number Sign	614097	ACATALASEMIA	ACATALASIA;; CATALASE DEFICIENCY	
Number Sign	614098	KEPPEN-LUBINSKY SYNDROME; KPLBS		
Number Sign	614099	CRANIOECTODERMAL DYSPLASIA 3; CED3		
Percent	614100	CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE	CUTIS LAXA-MARFANOID SYNDROME	
Percent	614101	PLASMA FIBRONECTIN DEFICIENCY		
Number Sign	614102	IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY; IGKCD	KAPPA CHAIN DEFICIENCY	
Percent	614103	LIPEDEMA		
Number Sign	614104	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7; MRD7		
Number Sign	614105	METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; MMSDHD	MMSDH DEFICIENCY	
Number Sign	614111	PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD		
Number Sign	614113	MENTAL RETARDATION, AUTOSOMAL DOMINANT 2; MRD2		
Number Sign	614114	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2		
Number Sign	614115	CORTICAL MALFORMATIONS, OCCIPITAL; OCCM		
Number Sign	614116	NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	HSN IE;; NEUROPATHY, HEREDITARY SENSORY, WITH HEARING LOSS AND DEMENTIA	
Number Sign	614120	HYDROLETHALUS SYNDROME 2; HLS2		
Number Sign	614122	CHITOTRIOSIDASE DEFICIENCY; CHITD		
Number Sign	614128	LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD		
Number Sign	614129	PERRAULT SYNDROME 3; PRLTS3	DEAFNESS, AUTOSOMAL RECESSIVE 81, FORMERLY; DFNB81, FORMERLY	
Number Sign	614131	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6	GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 6	
Number Sign	614134	STICKLER SYNDROME, TYPE IV; STL4		
Number Sign	614135	EPIPHYSEAL DYSPLASIA, MULTIPLE, 6; EDM6		
Percent	614149	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 9; NDNC9	ANONYCHIA-ONYCHOLYSIS, ISOLATED;; ONYCHODYSTROPHY;; NAIL DYSPLASIA	
Number Sign	614152	DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64		
Number Sign	614153	SPINOCEREBELLAR ATAXIA 36; SCA36		
Number Sign	614156	HYPERBILIVERDINEMIA; HBLVD	GREEN JAUNDICE	
Number Sign	614157	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10; NDNC10	CLAW-SHAPED NAILS;; ONYCHAUXIS, HYPONYCHIA, AND ONYCHOLYSIS	
NULL	614158	BLEEDING DISORDER, PLATELET-TYPE, 14; BDPLT14	THROMBOXANE SYNTHETASE DEFICIENCY	
Number Sign	614160	MUSCLE HYPERTROPHY; MSLHP		
Number Sign	614162	IMMUNODEFICIENCY 31C; IMD31C	CANDIDIASIS, FAMILIAL, 7; CANDF7;; CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	
Number Sign	614163	DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO; DSPD		
Percent	614164	GLUTATHIONE PEROXIDASE DEFICIENCY; GPXD		
Number Sign	614165	PARAGANGLIOMAS 5; PGL5		
Percent	614166	MYOPIA 20, AUTOSOMAL DOMINANT; MYP20		
Number Sign	614167	MYOPIA 21, AUTOSOMAL DOMINANT; MYP21		
Number Sign	614170	BRITTLE CORNEA SYNDROME 2; BCS2		
Number Sign	614171	HERMANSKY-PUDLAK SYNDROME 9; HPS9		
Number Sign	614172	IMMUNODEFICIENCY 21; IMD21	DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE DEFICIENCY; DCML;; MONOCYTOPENIA AND MYCOBACTERIAL INFECTION SYNDROME; MONOMAC;; MONOCYTOPENIA WITH SUSCEPTIBILITY TO MYCOBACTERIAL, FUNGAL, AND PAPILLOMAVIRUS INFECTIONS AND MYELODYSPLASIA;; COMBINED IMMUNODEFICIENCY WITH SUSCEPTIBILITY TO MYCOBACTERIAL, VIRAL, AND FUNGAL INFECTIONS;; GATA2 DEFICIENCY	
Number Sign	614173	JOUBERT SYNDROME 13; JBTS13		
Number Sign	614175	MECKEL SYNDROME, TYPE 10; MKS10		
Number Sign	614180	RETINITIS PIGMENTOSA 61; RP61		
Number Sign	614181	RETINITIS PIGMENTOSA 62; RP62		
Number Sign	614185	GELEOPHYSIC DYSPLASIA 2; GPHYSD2		
Number Sign	614186	LEBER CONGENITAL AMAUROSIS 16; LCA16		
Percent	614187	HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD		
Number Sign	614188	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	KREIBORG-PAKISTANI SYNDROME	
Number Sign	614190	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3; PPNAD3	CUSHING SYNDROME, ADRENAL, DUE TO PPNAD3	
Number Sign	614192	MACROCEPHALY, MACROSOMIA, AND FACIAL DYSMORPHISM SYNDROME; MMFD		
Number Sign	614193	TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2; TFQTL2		
Number Sign	614195	CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS		
Number Sign	614196	NEPHROTIC SYNDROME, TYPE 6; NPHS6		
Number Sign	614198	MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	MYASTHENIC SYNDROME, CONGENITAL, ACETAZOLAMIDE-RESPONSIVE	
Number Sign	614199	NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES; NPHS5		
Percent	614200	BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9	GLYCOPROTEIN Ia DEFICIENCY;; GP Ia DEFICIENCY;; COLLAGEN PLATELET RECEPTOR DEFICIENCY	
Number Sign	614201	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11	GLYCOPROTEIN VI DEFICIENCY;; GP VI DEFICIENCY	
Number Sign	614202	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15		
Number Sign	614203	PARKINSON DISEASE 17; PARK17		
Number Sign	614204	PSORIASIS 14, PUSTULAR; PSORS14	INTERLEUKIN 36 RECEPTOR ANTAGONIST DEFICIENCY; DITRA;; GENERALIZED PUSTULAR PSORIASIS; GPP;; PSORP;; ACRODERMATITIS CONTINUA OF HALLOPEAU;; PALMOPLANTAR PUSTULOSIS	
Number Sign	614205	THREE M SYNDROME 3; 3M3	3M SYNDROME 3	
Number Sign	614207	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 17; MRT17;; MENTAL RETARDATION, AUTOSOMAL RECESSIVE 21; MRT21;; GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 8; GPIBD8	
Percent	614208	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16; MRT16		
Number Sign	614209	MECKEL SYNDROME, TYPE 9; MKS9		
Percent	614210	LUNG CANCER SUSCEPTIBILITY 5; LNCR5		
Percent	614211	DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33		
Number Sign	614212	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4		
Number Sign	614213	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C		
Number Sign	614219	ADAMS-OLIVER SYNDROME 2; AOS2		
Percent	614220	BILIARY CIRRHOSIS, PRIMARY, 4; PBC4		
Percent	614221	BILIARY CIRRHOSIS, PRIMARY, 5; PBC5		
Number Sign	614222	WARBURG MICRO SYNDROME 3; WARBM3	MICRO SYNDROME 3	
Percent	614223	NARCOLEPSY 6, SUSCEPTIBILITY TO; NRCLP6		
Number Sign	614224	RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS; RAMSVPS		
Number Sign	614225	WARBURG MICRO SYNDROME 2; WARBM2	MICRO SYNDROME 2	
Number Sign	614226	HOLOPROSENCEPHALY 11; HPE11		
Percent	614227	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3; HNFJ3		
Number Sign	614228	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, TYPE 2O;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2O	
Number Sign	614229	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11		
Number Sign	614230	CHROMOSOME 8q21.11 DELETION SYNDROME		
Number Sign	614231	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME; MEDS		
Percent	614233	HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 1; FPH1	FPH	
Percent	614237	HYPOTRICHOSIS 9; HYPT9		
Percent	614238	HYPOTRICHOSIS 10; HYPT10		
Number Sign	614249	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18; MRT18		
Number Sign	614250	NARCOLEPSY 7; NRCLP7		
Number Sign	614251	PARKINSON DISEASE 18, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK18		
Percent	614252	ANEURYSM, INTRACRANIAL BERRY, 11; ANIB11		
Number Sign	614254	MENTAL RETARDATION, AUTOSOMAL DOMINANT 8; MRD8		
Number Sign	614255	MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9		
Number Sign	614256	MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10		
Number Sign	614257	MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11		
Number Sign	614261	MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME; MICCAP		
Number Sign	614262	ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG		
Number Sign	614265	COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA		
Number Sign	614266	BARRETT ESOPHAGUS	BARRETT METAPLASIA	ADENOCARCINOMA OF ESOPHAGUS, INCLUDED
Number Sign	614278	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY; PAFAD		
Number Sign	614279	46,XY SEX REVERSAL 8; SRXY8	MALE PSEUDOHERMAPHRODITISM DUE TO DEFICIENCY OF TESTICULAR 17,20-DESMOLASE; TDD	
Percent	614280	EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9		
Number Sign	614284	STICKLER SYNDROME, TYPE V; STL5		
Number Sign	614286	MYELODYSPLASTIC SYNDROME; MDS	MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO, INCLUDED	
Number Sign	614290	TETRASOMY 18p	ISOCHROMOSOME 18p SYNDROME	
Number Sign	614291	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4; BROVCA4		
Number Sign	614292	MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION; MCVD		
Number Sign	614293	HYDATIDIFORM MOLE, RECURRENT, 2; HYDM2	HYDATIDIFORM MOLE, COMPLETE	
Number Sign	614294	CHROMOSOME 15q25 DELETION SYNDROME		
Number Sign	614296	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	HEARING LOSS, PROGRESSIVE, WITH OPTIC ATROPHY AND/OR IMPAIRED GLUCOSE REGULATION	
Number Sign	614298	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	MITOCHONDRIAL PROTEIN-ASSOCIATED NEURODEGENERATION; MPAN	
Number Sign	614299	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2		
Number Sign	614300	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 8, FORMERLY; MRT8, FORMERLY	
Number Sign	614302	EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT; EDMD7		
Number Sign	614303	EDICT SYNDROME; EDICT	ENDOTHELIAL DYSTROPHY, IRIS HYPOPLASIA, CONGENITAL CATARACT, AND STROMAL THINNING SYNDROME;; KERATOCONUS WITH CATARACT; KTCNCT;; KERATOCONUS, FAMILIAL, WITH EARLY-ONSET ANTERIOR POLAR CATARACT	
Number Sign	614305	SCLEROSTEOSIS 2; SOST2		
Number Sign	614306	COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT		
Number Sign	614307	ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	AMACR DEFICIENCY	
Percent	614317	VESICOURETERAL REFLUX 4; VUR4		
Percent	614318	VESICOURETERAL REFLUX 5; VUR5		
Percent	614319	VESICOURETERAL REFLUX 6; VUR6		
Number Sign	614320	PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4		
Number Sign	614321	MYOPATHY, DISTAL, TATEYAMA TYPE; MPDT		
Number Sign	614322	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12	SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	
Percent	614323	NEVOID HYPERMELANOSIS, LINEAR AND WHORLED; LWNH		HYPERPIGMENTATION, PROGRESSIVE CRIBRIFORM AND ZOSTERIFORM, INCLUDED; PCZH, INCLUDED
Number Sign	614324	OVARIAN DYSGENESIS 3; ODG3		
Number Sign	614325	PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2		
Number Sign	614326	FEINGOLD SYNDROME 2; FGLDS2	BRACHYDACTYLY WITH SHORT STATURE AND MICROCEPHALY	
Number Sign	614327	TUMOR PREDISPOSITION SYNDROME; TPDS		
Number Sign	614328	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1		
Percent	614329	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31		
Number Sign	614331	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6; HNPCC6	COLON CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6	
Number Sign	614332	CHROMOSOME 2p16.3 DELETION SYNDROME		SCHIZOPHRENIA 17, INCLUDED; SCZD17, INCLUDED
Percent	614333	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29; MRT29		
Number Sign	614335	ARTHROGRYPOSIS, DISTAL, TYPE 1B; DA1B		
Number Sign	614337	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4		
Number Sign	614338	PANCREATIC LIPASE DEFICIENCY; PNLIPD	LIPASE, CONGENITAL ABSENCE OF PANCREATIC;; PL DEFICIENCY	PANCREATIC COLIPASE DEFICIENCY, INCLUDED;; COLIPASE, CONGENITAL ABSENCE OF PANCREATIC, INCLUDED;; LIPASE AND COLIPASE, DEFICIENCY OF, INCLUDED;; LIPASE AND COLIPASE, CONGENITAL ABSENCE OF PANCREATIC, INCLUDED
Number Sign	614340	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27; MRT27		
Percent	614341	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33; MRT33		
Percent	614342	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30; MRT30		
Percent	614343	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19; MRT19		
Percent	614344	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23; MRT23		
Percent	614345	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24; MRT24		
Percent	614346	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25; MRT25		
Percent	614347	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28; MRT28		
Number Sign	614350	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5; HNPCC5		
Number Sign	614369	PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH		
Number Sign	614370	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5; SMDP5	PULMONARY ALVEOLAR PROTEINOSIS 5;; PAP DUE TO CSF2RB DEFICIENCY;; CSF2RB DEFICIENCY	
Number Sign	614371	DENGUE VIRUS, SUSCEPTIBILITY TO		DENGUE FEVER, SUSCEPTIBILITY TO, INCLUDED;; DENGUE FEVER, PROTECTION AGAINST, INCLUDED;; DENGUE HEMORRHAGIC FEVER, SUSCEPTIBILITY TO, INCLUDED;; DENGUE SHOCK SYNDROME, SUSCEPTIBILITY TO, INCLUDED
Number Sign	614372	MANNOSE-BINDING LECTIN DEFICIENCY; MBLD	LECTIN COMPLEMENT ACTIVATION PATHWAY, DEFECT IN, 1; LCAPD1;; MBL DEFICIENCY;; MANNOSE-BINDING PROTEIN DEFICIENCY;; MBP DEFICIENCY;; MBL2 DEFICIENCY	
Number Sign	614373	AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16		
Number Sign	614374	BLOOD GROUP, CHIDO/RODGERS SYSTEM	CHIDO/RODGERS BLOOD GROUP SYSTEM	
Percent	614375	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 4; AAA4		
Number Sign	614376	SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	ASPHYXIATING THORACIC DYSTROPHY 5; ATD5	
Number Sign	614377	NEPHRONOPHTHISIS 13; NPHP13		
Number Sign	614378	CRANIOECTODERMAL DYSPLASIA 4; CED4		
Number Sign	614379	COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD	C4B DEFICIENCY	
Number Sign	614380	COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD	C4A DEFICIENCY	
Number Sign	614381	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8		
Number Sign	614382	BACTEREMIA, SUSCEPTIBILITY TO, 1; BACTS1		BACTEREMIA, RESISTANCE TO, INCLUDED
Number Sign	614383	BACTEREMIA, SUSCEPTIBILITY TO, 2; BACTS2		
Number Sign	614385	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7; HNPCC7		
Number Sign	614388	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1; EMPF1	EMPF	
Number Sign	614389	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1; RPRGL1	RPRGL;; RPL;; ABORTION, SPONTANEOUS, RECURRENT;; FETAL LOSS, RECURRENT, SUSCEPTIBILITY TO;; MISCARRIAGE, RECURRENT;; EMBRYONIC LOSS, RECURRENT;; STILLBIRTH, RECURRENT	
Number Sign	614390	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2; RPRGL2		
Number Sign	614391	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3; RPRGL3		
Number Sign	614395	GRAFT-VERSUS-HOST DISEASE, SUSCEPTIBILITY TO; GVHDS		GRAFT-VERSUS-HOST DISEASE, RESISTANCE TO, INCLUDED
Number Sign	614399	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET; EMARDD		MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET, MILD VARIANT, INCLUDED
Number Sign	614400	GLUCOCORTICOID THERAPY, RESPONSE TO; GCTR		
Number Sign	614401	ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO; ACTFS		
Number Sign	614402	MICROPHTHALMIA, SYNDROMIC 11; MCOPS11		
Percent	614407	MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	ZAKI-GLEESON SYNDROME	
Number Sign	614408	MYOPATHY, CENTRONUCLEAR, 3; CNM3		
Number Sign	614409	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46		
Number Sign	614411	GLYCEROL QUANTITATIVE TRAIT LOCUS; GLYCQTL	GLYCEROL RELEASE DURING EXERCISE, DEFECTIVE	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 17, INCLUDED; BMIQ17, INCLUDED
Percent	614414	DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96		
Number Sign	614415	CHILBLAIN LUPUS 2; CHBL2		
Number Sign	614416	RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES; RHFCA		
Number Sign	614417	EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5		
Number Sign	614418	FEBRILE SEIZURES, FAMILIAL, 11; FEB11	CONVULSIONS, FAMILIAL FEBRILE, 11	
Number Sign	614419	ASPARTATE AMINOTRANSFERASE, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1	ASTQTL1	
Number Sign	614420	SYSTEMIC LUPUS ERYTHEMATOSUS 16; SLEB16		
Percent	614422	CATARACT 37; CTRCT37	CATARACT, CONGENITAL, CERULEAN TYPE, 5; CCA5	
Number Sign	614424	JOUBERT SYNDROME 14; JBTS14		
Number Sign	614429	VENTRICULAR SEPTAL DEFECT 1; VSD1		
Number Sign	614430	ATRIOVENTRICULAR SEPTAL DEFECT 4; AVSD4		
Number Sign	614431	VENTRICULAR SEPTAL DEFECT 2; VSD2		
Number Sign	614432	VENTRICULAR SEPTAL DEFECT 3; VSD3		
Number Sign	614433	ATRIAL SEPTAL DEFECT 8; ASD8		
Number Sign	614434	CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2		
Number Sign	614435	HYPOPLASTIC LEFT HEART SYNDROME 2; HLHS2		
Number Sign	614436	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2P;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2G, FORMERLY; CMT2G, FORMERLY	
Number Sign	614437	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB; ARCL1B		
Number Sign	614438	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B	DE BARSY SYNDROME B	
Number Sign	614441	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2	PACHYDERMOPERIOSTOSIS, AUTOSOMAL RECESSIVE;; PDP, AUTOSOMAL RECESSIVE	
Number Sign	614450	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6		
Number Sign	614455	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE	CHARCOT-MARIE-TOOTH NEUROPATHY WITH FOCAL SEGMENTAL GLOMERULONEPHRITIS	
Number Sign	614456	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8; CMM8	MELANOMA AND RENAL CELL CARCINOMA, SUSCEPTIBILITY TO	
Number Sign	614457	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR		
Number Sign	614458	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5	ENCEPHALOPATHY, EPISODIC, DUE TO THIAMINE PYROPHOSPHOKINASE DEFICIENCY	
Number Sign	614462	HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES; HGCLAS	PYRUVATE DEHYDROGENASE LIPOIC ACID SYNTHETASE DEFICIENCY; PDHLD	
Number Sign	614464	JOUBERT SYNDROME 15; JBTS15		JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED;; JOUBERT SYNDROME 12/15, DIGENIC, INCLUDED
Number Sign	614465	JOUBERT SYNDROME 16; JBTS16		
Number Sign	614466	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6; CHDS6		
Number Sign	614468	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	ANTIBODY DEFICIENCY AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED; PLAID;; FAMILIAL ATYPICAL COLD URTICARIA; FACU	
Number Sign	614470	RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IV; ALPS4	
Number Sign	614473	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2		
Number Sign	614474	ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5		
Number Sign	614475	ATRIAL SEPTAL DEFECT 9; ASD9		
Number Sign	614480	HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI		
Number Sign	614482	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND		
Number Sign	614483	PORENCEPHALY 2; POREN2		
Number Sign	614485	TRIGONOCEPHALY 2; TRIGNO2	CRANIOSYNOSTOSIS, METOPIC	
Number Sign	614486	THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT; THPH12		
Number Sign	614487	SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5		
Number Sign	614490	BLOOD GROUP, JUNIOR SYSTEM; JR		
Number Sign	614491	PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B		
Number Sign	614492	PSEUDOHYPOALDOSTERONISM, TYPE IIC; PHA2C		
Number Sign	614493	WISKOTT-ALDRICH SYNDROME 2; WAS2	WIPF1 DEFICIENCY	
Percent	614494	RETINITIS PIGMENTOSA 63; RP63		
Number Sign	614495	PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D	FAMILIAL HYPERKALEMIC HYPERTENSION; FHHT	
Number Sign	614496	PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E		
Number Sign	614497	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7; MCOPCB7		
Number Sign	614498	RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL		
Number Sign	614499	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34		
Number Sign	614500	CONE-ROD DYSTROPHY 16; CORD16	RETINAL DYSTROPHY WITH EARLY MACULAR INVOLVEMENT	RETINITIS PIGMENTOSA 64, INCLUDED; RP64, INCLUDED
Number Sign	614501	PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM; PMRED		
Number Sign	614504	USHER SYNDROME, TYPE IIIB; USH3B		
Number Sign	614507	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir; CDG1R		
Number Sign	614508	MIRROR MOVEMENTS 2; MRMV2		
Number Sign	614514	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6		
Number Sign	614519	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH	STROKE, HEMORRHAGIC, SUSCEPTIBILITY TO	
NULL	614520	ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY		
Number Sign	614521	THROMBOCYTHEMIA 3; THCYT3	THROMBOCYTOSIS 3	
Number Sign	614524	FIBROCHONDROGENESIS 2; FBCG2		
Number Sign	614526	CHROMOSOME 17q12 DUPLICATION SYNDROME		
Number Sign	614527	CHROMOSOME 17q12 DELETION SYNDROME		
Number Sign	614541	CHROMOSOME 16q22 DELETION SYNDROME		
Number Sign	614546	EFAVIRENZ, POOR METABOLISM OF		EFAVIRENZ CENTRAL NERVOUS SYSTEM TOXICITY, SUSCEPTIBILITY TO, INCLUDED
Number Sign	614557	EHLERS-DANLOS SYNDROME WITH PROGRESSIVE KYPHOSCOLIOSIS, MYOPATHY, AND HEARING LOSS; EDSKMH		
Number Sign	614558	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13; EIEE13		
Number Sign	614559	INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD		
Number Sign	614561	LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS; LCC	LABRUNE SYNDROME	
Number Sign	614563	MENTAL RETARDATION, AUTOSOMAL DOMINANT 13; MRD13	MENTAL RETARDATION, AUTOSOMAL DOMINANT, 13, WITH NEURONAL MIGRATION DEFECTS	
Number Sign	614564	CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL; FCTCS	TELANGIECTASIA, CUTANEOUS, AND CANCER SYNDROME, FAMILIAL	
Number Sign	614565	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E; CSNB1E	CSNB, COMPLETE, AUTOSOMAL RECESSIVE	
Percent	614569	MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE	MAFFUCCI SYNDROME	
Percent	614575	CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS		
Number Sign	614576	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	CDG IIl; CDGIIl	
Number Sign	614582	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9		
Number Sign	614583	BARAITSER-WINTER SYNDROME 2; BRWS2		
Percent	614588	DYSTONIA 21; DYT21		
Percent	614590	PODOCONIOSIS, SUSCEPTIBILITY TO; PDCOS	NONFILARIAL ELEPHANTIASIS OF LOWER LEGS, SUSCEPTIBILITY TO;; ENDEMIC NONFILARIAL ELEPHANTIASIS, SUSCEPTIBILITY TO;; LYMPHOSTATIC VERRUCOSIS, SUSCEPTIBILITY TO	
Number Sign	614592	BENT BONE DYSPLASIA SYNDROME; BBDS		
Number Sign	614594	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES	OLMSTED SYNDROME; OLMS	
Number Sign	614595	PREECLAMPSIA/ECLAMPSIA 5; PEE5		
Number Sign	614602	TRICHOHEPATOENTERIC SYNDROME 2; THES2		
Number Sign	614607	COFFIN-SIRIS SYNDROME 2; CSS2	MENTAL RETARDATION, AUTOSOMAL DOMINANT 14; MRD14	
Number Sign	614608	COFFIN-SIRIS SYNDROME 3; CSS3	MENTAL RETARDATION, AUTOSOMAL DOMINANT 15; MRD15	
Number Sign	614609	COFFIN-SIRIS SYNDROME 4; CSS4	MENTAL RETARDATION, AUTOSOMAL DOMINANT 16; MRD16	
Number Sign	614613	ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS2		
Number Sign	614614	DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B		
Number Sign	614615	JOUBERT SYNDROME 17; JBTS17		
Number Sign	614616	DIARRHEA 6; DIAR6		
Number Sign	614617	DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86		
Number Sign	614618	HYPEREKPLEXIA 3; HKPX3		
Number Sign	614619	HYPEREKPLEXIA 2; HKPX2		
Number Sign	614621	UV-SENSITIVE SYNDROME 2; UVSS2		
Percent	614622	KERATOCONUS 5; KTCN5		
Percent	614623	KERATOCONUS 6; KTCN6		
Percent	614628	KERATOCONUS 8; KTCN8		
Percent	614629	KERATOCONUS 7; KTCN7		
Number Sign	614640	UV-SENSITIVE SYNDROME 3; UVSS3		
Number Sign	614643	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, ISPD-RELATED	
Percent	614644	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 4; MPVQTL4		
Percent	614645	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 5; MPVQTL5		
Percent	614646	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 6; MPVQTL6		
Number Sign	614650	COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6		
Number Sign	614651	COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2		
Number Sign	614652	COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3		
Number Sign	614653	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6	HSAN VI	
Number Sign	614654	COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5		
Percent	614655	STUTTERING, FAMILIAL PERSISTENT, 3; STUT3		
Number Sign	614662	CORTISONE REDUCTASE DEFICIENCY 2; CORTRD2		
Number Sign	614665	MECONIUM ILEUS		
Percent	614668	STUTTERING, FAMILIAL PERSISTENT, 4; STUT4		
Number Sign	614669	AURICULOCONDYLAR SYNDROME 2; ARCND2		
Percent	614670	PERIPARTUM CARDIOMYOPATHY, SUSCEPTIBILITY TO	PPCM, SUSCEPTIBILITY TO	
Number Sign	614671	CHROMOSOME 16p11.2 DUPLICATION SYNDROME		AUTISM, SUSCEPTIBILITY TO, 14B, INCLUDED; AUTS14B, INCLUDED
Number Sign	614672	CARDIOMYOPATHY, DILATED, 2B; CMD2B		
Number Sign	614673	MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8		
Number Sign	614674	PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT		
Number Sign	614675	BONE MARROW FAILURE SYNDROME 1; BMFS1		
Percent	614676	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 21; CMH21		
Number Sign	614678	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B; PCH1B		
Number Sign	614679	CILIARY DYSKINESIA, PRIMARY, 17; CILD17	CILIARY DYSKINESIA, PRIMARY, 17, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	614680	INFLUENZA, SEVERE, SUSCEPTIBILITY TO		
Percent	614684	HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES		
NULL	614687	ALAR CLEFT, ISOLATED		
NULL	614688	PONTINE TEGMENTAL CAP DYSPLASIA; PTCD		
Number Sign	614689	SOLUBLE INTERLEUKIN-6 RECEPTOR, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS	SOLUBLE IL6R, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS	
Number Sign	614691	CATARACT 38; CTRCT38	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 5; CATC5	
Percent	614692	MEMBRANOUS NEPHROPATHY, SUSCEPTIBILITY TO; MBNP		
Number Sign	614696	AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17	AMYOTROPHIC LATERAL SCLEROSIS, CHMP2B-RELATED	
Number Sign	614699	IMMUNODEFICIENCY, COMMON VARIABLE, 7; CVID7		
Number Sign	614700	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8		
Number Sign	614701	CORNELIA DE LANGE SYNDROME 4; CDLS4		
Number Sign	614702	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10; COXPD10	CARDIOMYOPATHY, INFANTILE HYPERTROPHIC MITOCHONDRIAL, AND LACTIC ACIDOSIS	
Number Sign	614706	CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11		
Number Sign	614707	BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2		
Number Sign	614714	POROKERATOSIS 7, MULTIPLE TYPES; POROK7		
Number Sign	614723	ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY; APRTD	APRT DEFICIENCY;; UROLITHIASIS, 2,8-DIHYDROXYADENINE;; UROLITHIASIS, DHA;; NEPHROLITHIASIS, DHA	
Number Sign	614727	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk; CDG2K	CDG IIk; CDGIIk	
Number Sign	614728	SECKEL SYNDROME 6; SCKL6		
Number Sign	614731	PROSTATE CANCER, HEREDITARY, 2; HPC2		
Number Sign	614732	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES	IMAGE SYNDROME	
Number Sign	614736	GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4		
Number Sign	614739	3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	3-METHYLGLUTACONIC ACIDURIA, TYPE VI; MGCA6	
Number Sign	614740	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7; BCC7		
Number Sign	614741	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY; MPYCD		
Number Sign	614742	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1		
Number Sign	614743	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2		
Number Sign	614744	FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3		
Number Sign	614745	BLOOD GROUP, JOHN MILTON HAGEN SYSTEM; JMH	JOHN MILTON HAGEN BLOOD GROUP SYSTEM;; JMH BLOOD GROUP SYSTEM	
Percent	614746	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 5; UAQTL5		
Percent	614747	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 6; UAQTL6		
Number Sign	614748	INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB		
Number Sign	614749	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 6; GPIBD6	
Number Sign	614750	MYASTHENIC SYNDROME, CONGENITAL, 13; CMS13	MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 2; CMSTA2	
Number Sign	614751	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB; HMN5B	HMN VB;; NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VB; DHMN5B;; DHMN VB;; SPINAL MUSCULAR ATROPHY, DISTAL, TYPE VB; DSMAVB	
Number Sign	614752	INTERLEUKIN 6, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS	IL6, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS	
Number Sign	614753	SOTOS SYNDROME 2; SOTOS2	MALAN SYNDROME	
Number Sign	614756	CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR		
Number Sign	614779	HETEROTAXY, VISCERAL, 6, AUTOSOMAL; HTX6		
Number Sign	614782	TREMOR, HEREDITARY ESSENTIAL, 4; ETM4		
Number Sign	614800	SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH		
Number Sign	614807	MYOPATHY, CENTRONUCLEAR, 4; CNM4		
Number Sign	614808	AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18		
Number Sign	614809	CFHR5 DEFICIENCY		
Number Sign	614810	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 5; MS5		
Number Sign	614813	SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS; SOFT	SOFT SYNDROME	
Number Sign	614814	ADAMS-OLIVER SYNDROME 3; AOS3		
Number Sign	614815	JOUBERT SYNDROME 18; JBTS18		
Number Sign	614816	LOEYS-DIETZ SYNDROME 4; LDS4	ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETAL MANIFESTATIONS	
Number Sign	614817	INTERSTITIAL NEPHRITIS, KARYOMEGALIC; KMIN		
Number Sign	614819	WEILL-MARCHESANI SYNDROME 3; WMS3		
Number Sign	614820	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2		
Number Sign	614822	SPERMATOGENIC FAILURE 10; SPGF10	SPERMATOGENIC FAILURE WITH DEFECTIVE SPERM ANNULUS	
Number Sign	614823	AORTIC VALVE DISEASE 2; AOVD2	BICUSPID AORTIC VALVE;; AORTIC VALVE STENOSIS	
Percent	614826	NYSTAGMUS 7, CONGENITAL, AUTOSOMAL DOMINANT; NYS7		
Number Sign	614830	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8; MDDGA8	WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, GTDC2-RELATED	
Number Sign	614831	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13		
Number Sign	614832	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4; AI2A4		
Number Sign	614833	MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	POLYMICROGYRIA WITH SEIZURES; PMGYS	
Percent	614834	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 3; TTPP3		
Percent	614836	HUMAN HERPESVIRUS 8, SUSCEPTIBILITY TO; HHV8S	HHV-8, SUSCEPTIBILITY TO	
Number Sign	614837	HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8		
Number Sign	614838	HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9		
Number Sign	614839	HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA; HH10		
Number Sign	614840	HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA; HH11		
Number Sign	614841	HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA; HH12	EUNUCHOIDISM, FAMILIAL HYPOGONADOTROPIC;; GONADOTROPIN DEFICIENCY, FAMILIAL IDIOPATHIC; FIGD	
Number Sign	614842	HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA; HH13		
Number Sign	614844	NEPHRONOPHTHISIS 14; NPHP14		JOUBERT SYNDROME 19, INCLUDED; JBTS19, INCLUDED
Number Sign	614845	NEPHRONOPHTHISIS 15; NPHP15		
Number Sign	614846	TETRASOMY 15q26	LEVY-SHANSKE SYNDROME	
Number Sign	614847	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12		
Number Sign	614849	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 3	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 5; IIAE5	
Number Sign	614850	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 4	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 6; IIAE6	
Number Sign	614851	SECKEL SYNDROME 7; SCKL7		
Number Sign	614852	MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9		
Number Sign	614856	OSTEOGENESIS IMPERFECTA, TYPE XIII; OI13	OI, TYPE XIII	
Number Sign	614857	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ		
Number Sign	614858	HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14		
Number Sign	614859	PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A		PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 3, INCLUDED; CG3, INCLUDED
Number Sign	614860	DYSTONIA 23; DYT23		
Number Sign	614861	DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98		
Number Sign	614862	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER); PBD4A		PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 4, INCLUDED; CG4, INCLUDED;; PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 6, INCLUDED; CG6, INCLUDED;; PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP C, INCLUDED; CGC, INCLUDED
Number Sign	614863	PEROXISOME BIOGENESIS DISORDER 4B; PBD4B		
Number Sign	614866	PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER); PBD5A		PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 5, INCLUDED; CG5, INCLUDED;; PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 10, INCLUDED; CG10, INCLUDED;; PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP F, INCLUDED; CGF, INCLUDED
Number Sign	614867	PEROXISOME BIOGENESIS DISORDER 5B; PBD5B		
Number Sign	614868	T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH OR WITHOUT CARDIAC MALFORMATIONS; TIIAC	STK4 DEFICIENCY;; MST1 DEFICIENCY	
Number Sign	614869	USHER SYNDROME, TYPE IJ; USH1J		
Number Sign	614870	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A		PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 7, INCLUDED; CG7, INCLUDED;; PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP B, INCLUDED; CGB, INCLUDED
Number Sign	614871	PEROXISOME BIOGENESIS DISORDER 6B; PBD6B		
Number Sign	614872	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A		PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 8, INCLUDED; CG8, INCLUDED;; PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP A, INCLUDED; CGA, INCLUDED
Number Sign	614873	PEROXISOME BIOGENESIS DISORDER 7B; PBD7B		
Number Sign	614874	CILIARY DYSKINESIA, PRIMARY, 18; CILD18	CILIARY DYSKINESIA, PRIMARY, 18, WITH OR WITHOUT SITUS INVERSUS	
Percent	614875	METAPHYSEAL ENCHONDROMATOSIS WITH D-2-HYDROXYGLUTARIC ACIDURIA	SPONDYLOENCHONDROMATOSIS WITH D-2-HYDROXYGLUTARIC ACIDURIA;; METAPHYSEAL ENCHONDRODYSPLASIA WITH 2-HYDROXYGLUTARIC ACIDURIA;; METAPHYSEAL CHONDROMATOSIS WITH D-2-HYDROXYGLUTARIC ACIDURIA	
Number Sign	614876	PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A		PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 9, INCLUDED; CG9, INCLUDED;; PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP D, INCLUDED; CGD, INCLUDED
Number Sign	614877	PEROXISOME BIOGENESIS DISORDER 8B; PBD8B		
Number Sign	614878	AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED; APLAID		
Number Sign	614879	PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	REFSUM DISEASE, ADULT, 2;; PEROXISOME BIOGENESIS DISORDER, PEX7-RELATED, ATYPICAL	PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 11, INCLUDED; CG11, INCLUDED;; PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP R, INCLUDED; CGR, INCLUDED
Number Sign	614880	HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA; HH15		
Number Sign	614881	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5; DSMA5		
Number Sign	614882	PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A		PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 12, INCLUDED; CG12, INCLUDED;; PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP G, INCLUDED; CGG, INCLUDED
Number Sign	614883	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A		PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 13, INCLUDED; CG13, INCLUDED;; PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP H, INCLUDED; CGH, INCLUDED
Number Sign	614885	PEROXISOME BIOGENESIS DISORDER 11B; PBD11B		
Number Sign	614886	PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12A		PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP 14, INCLUDED;; CG14, INCLUDED;; PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP J, INCLUDED;; CGJ, INCLUDED
Number Sign	614887	PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER); PBD13A		PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP K, INCLUDED; CGK, INCLUDED
Number Sign	614889	IMMUNODEFICIENCY 28; IMD28	IMMUNODEFICIENCY 28, MYCOBACTERIOSIS;; IFNGR2 DEFICIENCY	
Number Sign	614890	IMMUNODEFICIENCY 29; IMD29	IL12B DEFICIENCY	
Number Sign	614891	IMMUNODEFICIENCY 30; IMD30	IL12RB1 DEFICIENCY	
Number Sign	614892	IMMUNODEFICIENCY 31A; IMD31A	IMMUNODEFICIENCY 31A, MYCOBACTERIOSIS, AUTOSOMAL DOMINANT;; STAT1 DEFICIENCY, AUTOSOMAL DOMINANT	
Number Sign	614893	IMMUNODEFICIENCY 32A; IMD32A	IMMUNODEFICIENCY 32A, MYCOBACTERIOSIS, AUTOSOMAL DOMINANT;; IRF8 DEFICIENCY, AUTOSOMAL DOMINANT;; CD11C-POSITIVE/CD1C-POSITIVE DENDRITIC CELL DEFICIENCY, AUTOSOMAL DOMINANT	
Number Sign	614894	IMMUNODEFICIENCY 32B; IMD32B	IMMUNODEFICIENCY 32B, MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE;; IRF8 DEFICIENCY, AUTOSOMAL RECESSIVE;; MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	
Number Sign	614895	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F		
Number Sign	614896	SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD		
Number Sign	614897	HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16		
Number Sign	614898	SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE; SPG53		
Number Sign	614899	DEAFNESS, AUTOSOMAL RECESSIVE 93; DFNB93		
Number Sign	614900	DIAMOND-BLACKFAN ANEMIA 11; DBA11		
Number Sign	614915	LETHAL CONGENITAL CONTRACTURE SYNDROME 4; LCCS4		
Number Sign	614916	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4; CPVT4		
Number Sign	614920	PEROXISOME BIOGENESIS DISORDER 14B; PEX14B		
Number Sign	614921	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T	CDG It; CDGIt;; PHOSPHOGLUCOMUTASE 1 DEFICIENCY;; PGM1 DEFICIENCY;; GLYCOGEN STORAGE DISEASE XIV; GSD14;; GSD XIV	
Number Sign	614922	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	ENCEPHALONEUROMYOPATHY, INFANTILE, DUE TO MITOCHONDRIAL TRANSLATION DEFECT	
Number Sign	614923	BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD	BCKDK DEFICIENCY	
Number Sign	614924	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	LEUKOENCEPHALOPATHY WITH THALAMUS AND BRAINSTEM INVOLVEMENT AND HIGH LACTATE; LTBL	
Number Sign	614926	PERRAULT SYNDROME 2; PRLTS2		
Percent	614927	ECTODERMAL DYSPLASIA 5, HAIR/NAIL TYPE; ECTD5		
Percent	614928	ECTODERMAL DYSPLASIA 6, HAIR/NAIL TYPE; ECTD6		
Number Sign	614929	ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7		
Number Sign	614931	ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE; ECTD9		
Number Sign	614932	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13		
Number Sign	614934	DEAFNESS, AUTOSOMAL RECESSIVE 70; DFNB70		
Number Sign	614935	CILIARY DYSKINESIA, PRIMARY, 19; CILD19	CILIARY DYSKINESIA, PRIMARY, 19, WITH OR WITHOUT SITUS INVERSUS	
Percent	614936	PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IB; PPKP1B		
Number Sign	614937	MYOCLONUS, FAMILIAL CORTICAL; FCM		
Number Sign	614940	ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT; HED	
Number Sign	614941	ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	ECTODERMAL DYSPLASIA, HYPOHIDROTIC; HED;; ECTODERMAL DYSPLASIA, ANHIDROTIC; EDA	
Number Sign	614944	DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B		
Number Sign	614945	DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B		
Number Sign	614946	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14		
Number Sign	614947	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15		
Percent	614954	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, WITH CARDIAC RHYTHM AND CONDUCTION DISTURBANCES	
Number Sign	614959	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14		
Number Sign	614961	PONTOCEREBELLAR HYPOPLASIA, TYPE 8; PCH8		
Number Sign	614962	LEPTIN DEFICIENCY OR DYSFUNCTION; LEPD	OBESITY, MORBID, NONSYNDROMIC 1	
Number Sign	614963	LEPTIN RECEPTOR DEFICIENCY	OBESITY, MORBID, NONSYNDROMIC 2	
Number Sign	614969	PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7		
Number Sign	614970	JOUBERT SYNDROME 20; JBTS20		
Number Sign	614972	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3; ICP3		
Percent	614973	FOCAL FACIAL DERMAL DYSPLASIA 2, BRAUER-SETLEIS TYPE; FFDD2	BRAUER-SETLEIS SYNDROME	
Number Sign	614974	FOCAL FACIAL DERMAL DYSPLASIA 4; FFDD4		
Number Sign	614976	CARPENTER SYNDROME 2; CRPT2		
Percent	614979	SPLENOMEGALY, CYTOPENIA, AND VISION LOSS		
Number Sign	614980	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2		
Percent	614990	USHER SYNDROME, TYPE IK; USH1K		
Number Sign	615005	EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5		
Number Sign	615006	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15		
Number Sign	615007	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4		
Number Sign	615008	NEPHROTIC SYNDROME, TYPE 7; NPHS7	NEPHROTIC SYNDROME, TYPE 7, WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 7, INCLUDED; AHUS7, INCLUDED;; AHUS, SUSCEPTIBILITY TO, 7, INCLUDED
Number Sign	615009	SCHUURS-HOEIJMAKERS SYNDROME; SHMS	MENTAL RETARDATION, AUTOSOMAL DOMINANT 17; MRD17	
Number Sign	615010	AICARDI-GOUTIERES SYNDROME 6; AGS6		
Number Sign	615011	PHOSPHOHYDROXYLYSINURIA; PHLU		
Number Sign	615021	BLOOD GROUP, GLOBOSIDE SYSTEM; GLOB		
Percent	615022	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 7; ARCI7		
Number Sign	615023	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9; ARCI9		
Number Sign	615024	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10; ARCI10		
Number Sign	615025	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q	CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2Q;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2Q	
Number Sign	615026	RIBOFLAVIN DEFICIENCY; RBFVD		
Number Sign	615028	EPIDERMOLYSIS BULLOSA, NONSPECIFIC, AUTOSOMAL RECESSIVE; EBNS		
Number Sign	615030	SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56		
Number Sign	615031	SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE; SPG49		
Number Sign	615032	AUTISM, SUSCEPTIBILITY TO, 18; AUTS18		
Number Sign	615033	SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54		
Number Sign	615034	DYSTONIA 24; DYT24		
Number Sign	615035	SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55		
Number Sign	615040	EPISODIC PAIN SYNDROME, FAMILIAL, 1; FEPS1		
Number Sign	615041	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10; MDDGA10	WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, TMEM5-RELATED	
Number Sign	615042	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	CDG Iu; CDGIu	
Number Sign	615043	SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43		
Number Sign	615048	SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ		
Number Sign	615058	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F; CSNB1F		
Number Sign	615059	HYPOTRICHOSIS 11; HYPT11		
Number Sign	615065	ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D		
Number Sign	615066	OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14	OI, TYPE XIV	
Number Sign	615067	CILIARY DYSKINESIA, PRIMARY, 20; CILD20	CILIARY DYSKINESIA, PRIMARY, 20, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	615071	ALAZAMI SYNDROME; ALAZS	FACIAL DYSMORPHISM, INTELLECTUAL DISABILITY, AND PRIMORDIAL DWARFISM	
Number Sign	615072	BRACHYDACTYLY, TYPE A1, C; BDA1C		
Number Sign	615073	DYSTONIA 25; DYT25		
Number Sign	615074	MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18		
Number Sign	615075	MENTAL RETARDATION, AUTOSOMAL DOMINANT 19; MRD19		
Percent	615080	ALZHEIMER DISEASE 17; AD17	ALZHEIMER DISEASE 17, LATE-ONSET	
Number Sign	615081	SPERMATOGENIC FAILURE 11; SPGF11		
Number Sign	615082	C3HEX, ABILITY TO SMELL		
Number Sign	615083	COLORECTAL CANCER, SUSCEPTIBILITY TO, 12; CRCS12	COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 12q24	
Number Sign	615084	MITOCHONDRIAL DNA DEPLETION SYNDROME 11; MTDPS11		
Number Sign	615085	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8		
Number Sign	615091	AUTISM, SUSCEPTIBILITY TO, 19; AUTS19		
Number Sign	615092	LEFT VENTRICULAR NONCOMPACTION 7; LVNC7		
Number Sign	615095	MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10		
Percent	615102	TYSHCHENKO SYNDROME		
Number Sign	615106	COWDEN SYNDROME 3; CWS3		
Number Sign	615107	COWDEN SYNDROME 4; CWS4		
Number Sign	615108	COWDEN SYNDROME 5; CWS5		
Number Sign	615109	COWDEN SYNDROME 6; CWS6		
Number Sign	615112	UROFACIAL SYNDROME 2; UFS2		
Number Sign	615113	MICROPHTHALMIA, ISOLATED 8; MCOP8		
Number Sign	615119	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2		
Number Sign	615120	MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	MYASTHENIC SYNDROME, CONGENITAL, WITH PRE- AND POSTSYNAPTIC DEFECTS; CMSPPD;; MYASTHENIC SYNDROME, CONGENITAL, DUE TO AGRIN DEFICIENCY	
Percent	615121	STOMATIN-LIKE PROTEIN-2, HYPERPHOSPHORYLATION OF	HYPERPHOSPHORYLATED PARATARG-7	
Number Sign	615122	LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	CD27 DEFICIENCY	
Percent	615127	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 4; FCMTE4	
Number Sign	615134	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9; CMM9		
Number Sign	615135	MAPLE SYRUP URINE DISEASE, MILD VARIANT; MSUDMV		
Number Sign	615139	FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS		
Number Sign	615145	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9		
Number Sign	615147	RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME; RDCCAS		
Number Sign	615155	STEEL SYNDROME; STLS	DISLOCATED HIPS AND RADIAL HEADS, CARPAL COALITION, SCOLIOSIS, AND SHORT STATURE	
Number Sign	615156	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6; PEOA6	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 6	
Number Sign	615157	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2		
Number Sign	615158	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3		
Number Sign	615159	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4		
Number Sign	615160	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5		
Percent	615162	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35; MRT35		
Percent	615163	CONE-ROD DYSTROPHY 17; CORD17		
Percent	615170	WAHAB SYNDROME	CAMPTODACTYLY, CLINODACTYLY, SYNDACTYLY, AND BIFID TOE SYNDROME	
NULL	615174	L-THREONINE DEHYDROGENASE, PSEUDOGENE; TDH		
Number Sign	615179	ALBINISM, OCULOCUTANEOUS, TYPE VII; OCA7		
Number Sign	615181	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, B3GALNT2-RELATED	
Number Sign	615182	COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD		
Number Sign	615184	CARDIOMYOPATHY, DILATED, 1II; CMD1II		
Number Sign	615185	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F; CMTDIF		
Number Sign	615188	CATARACT 39, MULTIPLE TYPES; CTRCT39		
Number Sign	615190	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5		DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 4, INCLUDED; DKCA4, INCLUDED
Number Sign	615191	LISSENCEPHALY 5; LIS5		
Percent	615192	BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 4; BWQTL4		
Number Sign	615193	BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, ACTN1-RELATED	
Percent	615197	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 8; RLS8		
Percent	615198	OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA; OSMD		
Number Sign	615206	IMMUNODEFICIENCY 11; IMD11A	IMMUNODEFICIENCY 11; IMD11;; CARD11 IMMUNODEFICIENCY	
Number Sign	615207	IL21R IMMUNODEFICIENCY		
Number Sign	615214	AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE; AGM7	AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO PIK3R1 DEFECT	
Number Sign	615217	ATAXIA-OCULOMOTOR APRAXIA 3; AOA3		
Number Sign	615219	HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 2; HYC2		
Number Sign	615220	OSTEOGENESIS IMPERFECTA, TYPE XV; OI15	OI, TYPE XV	
Number Sign	615221	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 16; BMND16	OSTEOPOROSIS, EARLY-ONSET, SUSCEPTIBILITY TO	
Number Sign	615222	SMITH-MCCORT DYSPLASIA 2; SMC2		
Number Sign	615224	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2		
Number Sign	615225	PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING; MSPC	CORNEAL INTRAEPITHELIAL DYSKERATOSIS AND ECTODERMAL DYSPLASIA, FORMERLY; CIDED, FORMERLY	
Number Sign	615226	POLYDACTYLY, POSTAXIAL, TYPE A6; PAPA6		
Number Sign	615228	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5A1 TYPE	
Number Sign	615232	SCHIZOPHRENIA 18; SCZD18	SCHIZOPHRENIA 18 WITH OR WITHOUT AN AFFECTIVE DISORDER	
Number Sign	615233	RETINITIS PIGMENTOSA 66; RP66		
Number Sign	615234	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2		
Number Sign	615235	CARDIOMYOPATHY, DILATED, 1JJ; CMD1JJ		
NULL	615236	WOODS SYNDROME		
Number Sign	615237	CONGENITAL SHORT BOWEL SYNDROME; CSBS		
Number Sign	615238	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5	LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH CIDEC MUTATIONS	
Number Sign	615244	NEPHROTIC SYNDROME, TYPE 8; NPHS8		
Number Sign	615248	CARDIOMYOPATHY, DILATED, 1KK; CMD1KK		CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 22, INCLUDED; CMH22, INCLUDED;; CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 4, INCLUDED; RCM4, INCLUDED
Number Sign	615249	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMK-RELATED	
Number Sign	615264	BLOOD GROUP, VEL SYSTEM; VEL		VEL-NULL PHENOTYPE, INCLUDED
Number Sign	615266	HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17		
Number Sign	615267	HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18		
Number Sign	615268	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4; CAMRQ4	CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL LOCOMOTION 4	
Number Sign	615269	HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19		
Number Sign	615270	HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20		
Number Sign	615271	HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21		
Number Sign	615272	FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ		
Number Sign	615273	CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iv, FORMERLY; CDG1V, FORMERLY	
Number Sign	615274	CATARACT 15, MULTIPLE TYPES; CTRCT15		
Number Sign	615277	CATARACT 19, MULTIPLE TYPES; CTRCT19		
Number Sign	615278	CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2		
Number Sign	615279	CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3		
Number Sign	615280	CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4		
Number Sign	615281	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY; HBSL	ASPARTYL-tRNA SYNTHETASE DEFICIENCY	
Number Sign	615282	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2		
Number Sign	615284	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3		
Number Sign	615285	NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5		
Number Sign	615286	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36		
Number Sign	615287	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, B3GNT1-RELATED	
Number Sign	615290	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMAL DOMINANT; SMALED2		
Number Sign	615293	MYOFIBROMATOSIS, INFANTILE, 2; IMF2		
Number Sign	615294	CILIARY DYSKINESIA, PRIMARY, 21; CILD21	CILIARY DYSKINESIA, PRIMARY, 21, WITHOUT SITUS INVERSUS	
Number Sign	615297	ADAMS-OLIVER SYNDROME 4; AOS4		
Number Sign	615298	SYMPHALANGISM, PROXIMAL, 1B; SYM1B		
Number Sign	615300	PERRAULT SYNDROME 4; PRLTS4		
Number Sign	615311	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17; BMND17	BONE MINERAL DENSITY, LOW, SUSCEPTIBILITY TO	
Percent	615312	ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5		
Number Sign	615314	CRANIOSYNOSTOSIS 3; CRS3		
Number Sign	615325	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2R; LGMD2R		
Number Sign	615327	DOWLING-DEGOS DISEASE 2; DDD2		
Number Sign	615328	SHAHEEN SYNDROME; SHNS		
Number Sign	615330	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3		
Number Sign	615338	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16		
Number Sign	615342	PULMONARY HYPERTENSION, PRIMARY, 2; PPH2		
Number Sign	615343	PULMONARY HYPERTENSION, PRIMARY, 3; PPH3		
Number Sign	615344	PULMONARY HYPERTENSION, PRIMARY, 4; PPH4		
Number Sign	615346	PRECOCIOUS PUBERTY, CENTRAL, 2; CPPB2		
Number Sign	615348	NEMALINE MYOPATHY 8; NEM8		
Number Sign	615349	EHLERS-DANLOS SYNDROME, PROGEROID TYPE, 2; EDSP2		
Number Sign	615350	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, GMPPB-RELATED	
Number Sign	615351	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	MUSCULAR DYSTROPHY, CONGENITAL, GMPPB-RELATED	
Number Sign	615352	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, GMPPB-RELATED;; MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2T; LGMD2T	
Number Sign	615355	NOONAN SYNDROME 8; NS8		
Number Sign	615356	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2S; LGMD2S		
Number Sign	615360	LEBER CONGENITAL AMAUROSIS 17; LCA17		
Number Sign	615361	HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2		
Number Sign	615362	CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	CEROID LIPOFUSCINOSIS, NEURONAL, 13, KUFS TYPE	
Number Sign	615363	ESTROGEN RESISTANCE; ESTRR	ESTROGEN INSENSITIVITY	
Number Sign	615368	LETHAL CONGENITAL CONTRACTURE SYNDROME 5; LCCS5	MYOPATHY, CENTRONUCLEAR, LETHAL, AUTOSOMAL RECESSIVE	
Number Sign	615369	EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC		
Number Sign	615371	PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO; PHN		
Number Sign	615373	LEFT VENTRICULAR NONCOMPACTION 8; LVNC8		CARDIOMYOPATHY, DILATED, 1LL, INCLUDED; CMD1LL, INCLUDED
Number Sign	615374	CONE-ROD DYSTROPHY 18; CORD18		
Number Sign	615376	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C; CMTRIC	CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE C; RI-CMTC	
Number Sign	615377	ATRIAL FIBRILLATION, FAMILIAL, 13; ATFB13		
Number Sign	615378	ATRIAL FIBRILLATION, FAMILIAL, 14; ATFB14		
Number Sign	615381	MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL		
Number Sign	615382	NEPHRONOPHTHISIS 16; NPHP16		
Number Sign	615386	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14; SCAR14	CEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, SPECTRIN-ASSOCIATED, 1; SPARCA1	
Number Sign	615387	T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	TCR-ALPHA/BETA DEFICIENCY;; IMMUNODEFICIENCY 7; IMD7	
Percent	615390	VESICOURETERAL REFLUX 7; VUR7		
Number Sign	615395	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16		
Number Sign	615396	LEFT VENTRICULAR NONCOMPACTION 10; LVNC10		CARDIOMYOPATHY, DILATED, 1MM, INCLUDED; CMD1MM, INCLUDED
Number Sign	615397	MECKEL SYNDROME, TYPE 11; MKS11		
Number Sign	615398	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 7; GPIBD7	
Number Sign	615399	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2		
Number Sign	615400	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 5; FCMTE5	
Number Sign	615401	IMMUNODEFICIENCY 8; IMD8		
Number Sign	615402	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3; DUH3		
Number Sign	615411	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3		
Number Sign	615412	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4		
Number Sign	615413	SPERMATOGENIC FAILURE 12; SPGF12		
Number Sign	615414	MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11		
Number Sign	615415	RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2		
Number Sign	615418	MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE; MTDPS12B		
Number Sign	615419	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	IHPRF	
Number Sign	615420	MYOPIA 22, AUTOSOMAL DOMINANT; MYP22		
Number Sign	615422	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2	MULTISYSTEM PROTEINOPATHY 2; MSP2	
Number Sign	615424	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3	MULTISYSTEM PROTEINOPATHY 3; MSP3	
Number Sign	615425	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 2; EBSB2		
Number Sign	615426	AMYOTROPHIC LATERAL SCLEROSIS 20; ALS20		
Number Sign	615429	DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88		
Number Sign	615431	MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23		
Number Sign	615432	SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5		
Number Sign	615433	CHROMOSOME 3q13.31 DELETION SYNDROME		
Number Sign	615434	RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS		
Number Sign	615436	AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8		
Number Sign	615438	INFANTILE LIVER FAILURE SYNDROME 1; ILFS1		
Number Sign	615439	MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13		
Number Sign	615440	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17; COXPD17		
Number Sign	615441	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS; CPVT5		
Number Sign	615444	CILIARY DYSKINESIA, PRIMARY, 22; CILD22	CILIARY DYSKINESIA, PRIMARY, 22, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	615451	CILIARY DYSKINESIA, PRIMARY, 23; CILD23	CILIARY DYSKINESIA, PRIMARY, 23, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	615453	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6		
Number Sign	615457	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 18; BMIQ18	OBESITY, SUSCEPTIBILITY TO	
Number Sign	615458	MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT		
Number Sign	615465	HARTSFIELD SYNDROME; HRTFDS	HOLOPROSENCEPHALY, ECTRODACTYLY, AND BILATERAL CLEFT LIP/PALATE	
Number Sign	615468	IMMUNODEFICIENCY 12; IMD12		
Number Sign	615471	MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13		
Number Sign	615473	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17		
Number Sign	615474	PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES; PASNA		
Number Sign	615476	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18; EIEE18		
Number Sign	615481	CILIARY DYSKINESIA, PRIMARY, 24; CILD24	CILIARY DYSKINESIA, PRIMARY, 24, WITHOUT SITUS INVERSUS	
Number Sign	615482	CILIARY DYSKINESIA, PRIMARY, 25; CILD25	CILIARY DYSKINESIA, PRIMARY, 25, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	615483	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5		
Number Sign	615485	BAINBRIDGE-ROPERS SYNDROME; BRPS		
Number Sign	615486	INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	PULMONARY ALVEOLAR PROTEINOSIS, REUNION ISLAND;; INFANTILE LIVER FAILURE SYNDROME 2, FORMERLY; ILFS2, FORMERLY	
Number Sign	615489	MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14		MACULAR DEGENERATION, AGE-RELATED, REDUCED RISK OF, INCLUDED
Number Sign	615490	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2R;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2R	
Number Sign	615491	SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	NEURODEGENERATION WITH OPTIC ATROPHY, CHILDHOOD-ONSET; NDGOA	
Number Sign	615493	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37; MRT37		
Number Sign	615500	CILIARY DYSKINESIA, PRIMARY, 26; CILD26	CILIARY DYSKINESIA, PRIMARY, 26, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	615501	MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC		
Number Sign	615502	MENTAL RETARDATION, AUTOSOMAL DOMINANT 21; MRD21		
Number Sign	615503	SHORT-RIB THORACIC DYSPLASIA 8 WITH OR WITHOUT POLYDACTYLY; SRTD8	SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6	
Number Sign	615504	CILIARY DYSKINESIA, PRIMARY, 27; CILD27	CILIARY DYSKINESIA, PRIMARY, 27, WITHOUT SITUS INVERSUS	
Number Sign	615505	CILIARY DYSKINESIA, PRIMARY, 28; CILD28	CILIARY DYSKINESIA, PRIMARY, 28, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	615506	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5		
Number Sign	615508	ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE; EPKHE	SEVERE DERMATITIS, MULTIPLE ALLERGIES, AND METABOLIC WASTING SYNDROME;; SAM SYNDROME	
Number Sign	615510	ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME; AAMR		
Number Sign	615511	MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY; MMDD	ADENOSINE MONOPHOSPHATE DEAMINASE-1 DEFICIENCY, MYOPATHY DUE TO;; AMPD1 DEFICIENCY;; MYOADENYLATE DEAMINASE DEFICIENCY, MYOPATHY DUE TO	
Number Sign	615512	TRIOSEPHOSPHATE ISOMERASE DEFICIENCY; TPID		
Number Sign	615513	IMMUNODEFICIENCY 14; IMD14	ACTIVATED PI3K-DELTA SYNDROME; APDS;; p110-DELTA-ACTIVATING MUTATION CAUSING SENESCENT T CELLS, LYMPHADENOPATHY, AND IMMUNODEFICIENCY; PASLI	
Number Sign	615515	AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19		
Number Sign	615516	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38		
Number Sign	615517	HEMOCHROMATOSIS, TYPE 5; HFE5	IRON OVERLOAD, AUTOSOMAL DOMINANT	
Number Sign	615518	IMMUNODEFICIENCY 13; IMD13	IDIOPATHIC CD4 LYMPHOPENIA; ICL	
Number Sign	615522	COLE DISEASE; COLED	GUTTATE HYPOPIGMENTATION AND PUNCTATE PALMOPLANTAR KERATODERMA WITH OR WITHOUT ECTOPIC CALCIFICATION	
Number Sign	615523	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8; FECD8		
Number Sign	615524	MICROPHTHALMIA, SYNDROMIC 12; MCOPS12	MICROPHTHALMIA WITH OR WITHOUT PULMONARY HYPOPLASIA, DIAPHRAGMATIC HERNIA, AND/OR CARDIAC DEFECTS	
Number Sign	615527	CANDIDIASIS, FAMILIAL, 8; CANDF8	CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	
Number Sign	615528	PARKINSON DISEASE 19A, JUVENILE-ONSET; PARK19A	PARK19, FORMERLY	PARKINSON DISEASE 19B, EARLY-ONSET, INCLUDED; PARK19B, INCLUDED
Number Sign	615529	CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO; CRS5		
Number Sign	615530	PARKINSON DISEASE 20, EARLY-ONSET; PARK20		
Number Sign	615537	RETICULATE ACROPIGMENTATION OF KITAMURA; RAK	ACROPIGMENTATIO RETICULARIS;; RETICULATE PIGMENTATION OF KITAMURA; RPK;; KITAMURA RETICULATE ACROPIGMENTATION	
Number Sign	615538	CHROMOSOME 22q13 DUPLICATION SYNDROME		
Number Sign	615539	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2		
Number Sign	615540	DEAFNESS, AUTOSOMAL RECESSIVE 76; DFNB76		
Number Sign	615541	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39		
Number Sign	615542	TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE; TACHD		
Number Sign	615544	PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6		
Number Sign	615545	LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3; ALL3		
Number Sign	615546	VAN MALDERGEM SYNDROME 2; VMLDS2		
Number Sign	615547	SCHAAF-YANG SYNDROME; SHFYNG	PRADER-WILLI-LIKE SYNDROME; PWLS	
Number Sign	615548	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	HSAN VII;; INSENSITIVITY TO PAIN, CONGENITAL, WITH GASTROINTESTINAL DYSFUNCTION AND HYPERHIDROSIS	
Number Sign	615550	DIAMOND-BLACKFAN ANEMIA 12; DBA12		
Number Sign	615551	EPISODIC PAIN SYNDROME, FAMILIAL, 2; FEPS2		
Number Sign	615552	EPISODIC PAIN SYNDROME, FAMILIAL, 3; FEPS3		
Number Sign	615553	ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES; AMRS		
Number Sign	615554	MULTIPLE FIBROADENOMAS OF THE BREAST; MFAB		
Number Sign	615555	HYPERPROLACTINEMIA; HPRL		
Number Sign	615557	MELIOIDOSIS, SUSCEPTIBILITY TO		MELIOIDOSIS, RESISTANCE TO, INCLUDED
Number Sign	615558	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1	HYPOBETALIPOPROTEINEMIA, FAMILIAL; FHBL;; ACANTHOCYTOSIS WITH HYPOBETALIPOPROTEINEMIA;; HYPOBETALIPOPROTEINEMIA, NORMOTRIGLYCERIDEMIC	
Number Sign	615559	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	IMMUNODEFICIENCY, COMMON VARIABLE, 9, FORMERLY; CVID9, FORMERLY	
Number Sign	615560	OTOFACIOCERVICAL SYNDROME 2; OTFCS2	OFC2	
Number Sign	615561	COMPLEMENT FACTOR B DEFICIENCY; CFBD		
Number Sign	615565	RETINITIS PIGMENTOSA 67; RP67		
Number Sign	615573	NEPHROTIC SYNDROME, TYPE 9; NPHS9		
Number Sign	615574	ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	ASNS DEFICIENCY	
Number Sign	615575	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; HMN2D	HMN IID;; NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; DHMN2D;; SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL DOMINANT, CALF-PREDOMINANT	
Number Sign	615577	IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	IMMUNODEFICIENCY, COMMON VARIABLE, WITH CENTRAL ADRENAL INSUFFICIENCY;; DEFICIT IN ANTERIOR PITUITARY FUNCTION AND VARIABLE IMMUNODEFICIENCY; DAVID	
Number Sign	615578	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18; COXPD18		
Number Sign	615582	LOEYS-DIETZ SYNDROME 5; LDS5	RIENHOFF SYNDROME; RNHF	
Number Sign	615583	VERHEIJ SYNDROME; VRJS	CHROMOSOME 8q24.3 DELETION SYNDROME	
Percent	615589	OTOSCLEROSIS 10; OTSC10		
Number Sign	615590	ALZHEIMER DISEASE 18; AD18	ALZHEIMER DISEASE 18, LATE-ONSET	
Number Sign	615591	MACULAR DEGENERATION, AGE-RELATED, 15; ARMD15		
Number Sign	615592	IMMUNODEFICIENCY 15; IMD15		
Number Sign	615593	IMMUNODEFICIENCY 16; IMD16	OX40 DEFICIENCY	
Number Sign	615595	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19		
Number Sign	615596	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	CDG Iw; CDGIw	
Number Sign	615597	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	CDG Ix; CDGIx	
Number Sign	615598	PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE; PPKN		
Number Sign	615599	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40		
Number Sign	615602	MEMORY QUANTITATIVE TRAIT LOCUS; MEMRYQTL		
Number Sign	615604	L-FERRITIN DEFICIENCY; LFTD		
Number Sign	615605	FANCONI RENOTUBULAR SYNDROME 3; FRTS3		
Number Sign	615607	IMMUNODEFICIENCY 17; IMD17	CD3-GAMMA DEFICIENCY;; SCID-LIKE IMMUNODEFICIENCY, T CELL-PARTIAL, B CELL-POSITIVE, NK CELL-POSITIVE	
Percent	615612	DEVELOPMENTAL DYSPLASIA OF THE HIP 2; DDH2		
Number Sign	615615	IMMUNODEFICIENCY 18; IMD18	CD3-EPSILON DEFICIENCY	IMMUNODEFICIENCY 18, SEVERE COMBINED IMMUNODEFICIENCY VARIANT, INCLUDED;; IMMUNODEFICIENCY 18, SCID VARIANT, INCLUDED
Number Sign	615616	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13; ARVD13	ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 13; ARVC13	
Number Sign	615617	IMMUNODEFICIENCY 19; IMD19	CD3-DELTA DEFICIENCY;; SEVERE COMBINED IMMUNODEFICIENCY, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE;; SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	
NULL	615619	CHOLANGIOCARCINOMA, SUSCEPTIBILITY TO	CHLC, SUSCEPTIBILITY TO	
Number Sign	615625	SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE; SPG72		SPASTIC PARAPLEGIA 72, AUTOSOMAL DOMINANT, INCLUDED
Number Sign	615629	DEAFNESS, AUTOSOMAL DOMINANT 56; DFNA56		
Number Sign	615630	SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10		
Number Sign	615631	ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B	CDA, TYPE Ib	
Number Sign	615632	NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F	HSN IF	
Number Sign	615633	SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11		
Number Sign	615636	JOUBERT SYNDROME 21; JBTS21		
Number Sign	615637	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41		
Number Sign	615643	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6		
Percent	615649	DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54		
Number Sign	615651	LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT		
Percent	615654	DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58		
Number Sign	615656	CHROMOSOME 15q11.2 DELETION SYNDROME		
Number Sign	615658	SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57		
Number Sign	615663	WARBURG MICRO SYNDROME 4; WARBM4		
Number Sign	615665	JOUBERT SYNDROME 22; JBTS22		
Number Sign	615668	CHROMOSOME 5q12 DELETION SYNDROME		
Number Sign	615670	SCHWANNOMATOSIS 2; SWNTS2		
Number Sign	615673	MYOPATHY WITH EXTRAPYRAMIDAL SIGNS; MPXPS		
Percent	615674	DOWLING-DEGOS DISEASE 3; DDD3		
Number Sign	615681	SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE; SPG62		
Number Sign	615683	SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64		
Number Sign	615685	SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61		
Number Sign	615686	SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63		
Number Sign	615688	POLYARTERITIS NODOSA, CHILDHOOD-ONSET; PAN	ADA2 DEFICIENCY	
Number Sign	615696	DOWLING-DEGOS DISEASE 4; DDD4		
Percent	615697	EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6		
Number Sign	615703	MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF		
Number Sign	615704	POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	POIKILODERMA, HEREDITARY SCLEROSING, WITH TENDON AND PULMONARY INVOLVEMENT	
Number Sign	615705	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15	SALIH ATAXIA	
Number Sign	615706	AURICULOCONDYLAR SYNDROME 3; ARCND3		
Number Sign	615707	IMMUNODEFICIENCY 20; IMD20		
Number Sign	615709	SACRAL AGENESIS WITH VERTEBRAL ANOMALIES; SAVA		
Number Sign	615710	MITCHELL-RILEY SYNDROME; MTCHRS	DIABETES, NEONATAL, WITH PANCREATIC HYPOPLASIA, INTESTINAL ATRESIA, AND GALLBLADDER APLASIA OR HYPOPLASIA	
NULL	615711	ALZHEIMER DISEASE 19; AD19	ALZHEIMER DISEASE 19, LATE-ONSET	
Number Sign	615715	BONE MARROW FAILURE SYNDROME 2; BMFS2		
Number Sign	615716	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4; HPMRS4	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 10; GPIBD10	
Number Sign	615721	RENAL HYPODYSPLASIA/APLASIA 2; RHDA2		
Number Sign	615722	BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS		
Number Sign	615723	PREMATURE OVARIAN FAILURE 8; POF8		
Number Sign	615724	PREMATURE OVARIAN FAILURE 9; POF9		
Number Sign	615725	RETINITIS PIGMENTOSA 68; RP68		
Number Sign	615726	PACHYONYCHIA CONGENITA 3; PC3		
Number Sign	615728	PACHYONYCHIA CONGENITA 4; PC4		
Number Sign	615731	NEMALINE MYOPATHY 9; NEM9		
Number Sign	615735	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE; PPKNEFD		
Number Sign	615744	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19		
Number Sign	615745	ATRIAL STANDSTILL 2; ATRST2	ATRIAL DILATION AND STANDSTILL;; CARDIOMYOPATHY, ATRIAL DILATED, WITH ATRIAL STANDSTILL	
Number Sign	615749	ECULIZUMAB, POOR RESPONSE TO		
Number Sign	615750	MOYAMOYA DISEASE 6 WITH ACHALASIA; MYMY6		
Number Sign	615751	CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD		
Number Sign	615752	POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR	PMGR	
Number Sign	615758	IMMUNODEFICIENCY 22; IMD22		
Number Sign	615760	MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY; MSCCA		
Number Sign	615761	MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23		
Number Sign	615763	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5		
Number Sign	615767	IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	IL21 DEFICIENCY	
Number Sign	615768	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16		
Number Sign	615770	ATRIAL FIBRILLATION, FAMILIAL, 15; ATFB15		
Number Sign	615771	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6		
Number Sign	615774	OOCYTE MATURATION DEFECT 1; OOMD1	OOMD	
Number Sign	615777	DESBUQUOIS DYSPLASIA 2; DBQD2		
Number Sign	615779	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4; CHTD4		
Number Sign	615780	RETINITIS PIGMENTOSA 69; RP69		
Number Sign	615785	WHITE SPONGE NEVUS 2; WSN2		
Number Sign	615789	SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES		
Number Sign	615802	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 9; GPIBD9	
Number Sign	615803	PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10		
Number Sign	615807	SECKEL SYNDROME 8; SCKL8		
Number Sign	615809	PONTOCEREBELLAR HYPOPLASIA, TYPE 9; PCH9		
Number Sign	615812	ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	CENTRAL OBESITY, TYPE 2 DIABETES, HYPERTENSION, AND EARLY-ONSET CORONARY ARTERY DISEASE	
Number Sign	615816	IMMUNODEFICIENCY 23; IMD23	IMMUNODEFICIENCY WITH HYPER IgE AND COGNITIVE IMPAIRMENT;; IMMUNODEFICIENCY-VASCULITIS-MYOCLONUS SYNDROME; IVMS	
Number Sign	615817	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43		
Number Sign	615821	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA		
Number Sign	615824	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7		
Number Sign	615828	MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24		
Number Sign	615829	XIA-GIBBS SYNDROME	MENTAL RETARDATION, AUTOSOMAL DOMINANT 25; MRD25	
Number Sign	615830	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4; PPNAD4	CUSHING SYNDROME, ADRENAL, DUE TO PPNAD4;; CHROMOSOME 19p13 DUPLICATION SYNDROME	ACTH-INDEPENDENT ADRENAL CUSHING SYNDROME, SOMATIC, INCLUDED
Number Sign	615833	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21		
Number Sign	615834	MENTAL RETARDATION, AUTOSOMAL DOMINANT 26; MRD26		
Number Sign	615835	CHROMOSOME 16 INVERSION, 0.45-MB		
Number Sign	615837	DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101		
Number Sign	615838	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8		
Number Sign	615841	SPERMATOGENIC FAILURE 13; SPGF13		
Number Sign	615842	SPERMATOGENIC FAILURE 14; SPGF14		
Number Sign	615846	AICARDI-GOUTIERES SYNDROME 7; AGS7		
Number Sign	615848	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10; CMM10		
Number Sign	615849	CULLER-JONES SYNDROME; CJS	PALLISTER-HALL SYNDROME 2, FORMERLY; PHS2, FORMERLY	
Number Sign	615851	PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E		
Number Sign	615859	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23		
Number Sign	615860	CONE-ROD DYSTROPHY 19; CORD19		
Number Sign	615861	NEPHROTIC SYNDROME, TYPE 10; NPHS10		
Number Sign	615862	NEPHRONOPHTHISIS 18; NPHP18		
Number Sign	615863	DIARRHEA 7; DIAR7		
Number Sign	615866	MENTAL RETARDATION, AUTOSOMAL DOMINANT 27; MRD27		
Number Sign	615871	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24		
Number Sign	615872	CILIARY DYSKINESIA, PRIMARY, 29; CILD29	CILIARY DYSKINESIA, PRIMARY, 29, WITHOUT SITUS INVERSUS	
Number Sign	615873	HELSMOORTEL-VAN DER AA SYNDROME; HVDAS	MENTAL RETARDATION, AUTOSOMAL DOMINANT 28; MRD28	
Number Sign	615877	MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	MICROPHTHALMIA OR COLOBOMA WITH OR WITHOUT RHIZOMELIC SKELETAL DYSPLASIA;; MICROPHTHALMIA, SYNDROMIC 14; MCOPS14	
Number Sign	615878	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4; PFIC4		
Number Sign	615879	TATTON-BROWN-RAHMAN SYNDROME; TBRS		
Number Sign	615881	PLASMA TRIGLYCERIDE LEVEL QUANTITATIVE TRAIT LOCUS; TGQTL		
Number Sign	615883	MYOPATHY, TUBULAR AGGREGATE, 2; TAM2		
Number Sign	615885	HYPOTRICHOSIS 12; HYPT12		
Number Sign	615887	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5; AI2A5		
Number Sign	615888	BLEEDING DISORDER, PLATELET-TYPE, 18; BDPLT18		
Number Sign	615889	LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP		
Percent	615892	OROFACIAL CLEFT 14; OFC14		
Number Sign	615895	POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	POLYGLUCOSAN BODY MYOPATHY, EARLY-ONSET, WITH OR WITHOUT IMMUNODEFICIENCY; PBMEI	
Number Sign	615896	HYPOTRICHOSIS 13; HYPT13	HYPOTRICHOSIS WITH WOOLLY HAIR	
Number Sign	615897	IMMUNODEFICIENCY 24; IMD24		
Number Sign	615905	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25; EIEE25		
Number Sign	615907	LYMPHEDEMA, HEREDITARY, ID; LMPH1D		
Number Sign	615909	DIAMOND-BLACKFAN ANEMIA 13; DBA13		
Number Sign	615911	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2		
Number Sign	615916	CARDIOMYOPATHY, DILATED, 1NN; CMD1NN		
Number Sign	615917	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20		
Number Sign	615918	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21; COXPD21		
Number Sign	615919	ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2		
Number Sign	615922	RETINITIS PIGMENTOSA 70; RP70		
Number Sign	615923	EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM		
Number Sign	615924	ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD		
Number Sign	615925	GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP		
Number Sign	615926	WEBB-DATTANI SYNDROME; WEDAS	HYPOTHALAMO-PITUITARY-FRONTOTEMPORAL HYPOPLASIA WITH VISUAL AND RENAL ANOMALIES	
Number Sign	615934	STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI		
Number Sign	615935	PANCREATIC AGENESIS 2; PAGEN2	PANCREATIC HYPOPLASIA, CONGENITAL 2	
Number Sign	615937	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2; MPPH2		
Number Sign	615938	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3		
Number Sign	615942	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44; MRT44		
Number Sign	615945	SPINOCEREBELLAR ATAXIA 37; SCA37		
Number Sign	615946	MYOPIA 24, AUTOSOMAL DOMINANT; MYP24		
Number Sign	615947	HYPERLIPOPROTEINEMIA, TYPE ID		
Number Sign	615948	OROFACIODIGITAL SYNDROME XIV; OFD14		
Number Sign	615952	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1		
Number Sign	615953	KALLIKREIN, DECREASED URINARY ACTIVITY OF		
Number Sign	615954	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	PRIMARY MACRONODULAR ADRENAL HYPERPLASIA	
Number Sign	615957	SPINOCEREBELLAR ATAXIA 38; SCA38		
Number Sign	615959	MYOPATHY, CENTRONUCLEAR, 5; CNM5		
Number Sign	615960	PORETTI-BOLTSHAUSER SYNDROME; PTBHS		
Number Sign	615961	ACID-LABILE SUBUNIT DEFICIENCY; ACLSD		
Number Sign	615962	GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	GLUCOCORTICOID RECEPTOR DEFICIENCY;; GCCR DEFICIENCY;; GCR DEFICIENCY;; GRL DEFICIENCY;; CORTISOL RESISTANCE FROM GLUCOCORTICOID RECEPTOR DEFECT	
Number Sign	615963	VESICOURETERAL REFLUX 8; VUR8		
Number Sign	615966	IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26		
Number Sign	615969	ALPHA-FETOPROTEIN DEFICIENCY; AFPD		
Number Sign	615970	ALPHA-FETOPROTEIN, HEREDITARY PERSISTENCE OF; HPAFP		
Number Sign	615972	NANOPHTHALMOS 4; NNO4	NANOPHTHALMIA 4	
Number Sign	615973	CONE-ROD DYSTROPHY 20; CORD20		
Number Sign	615974	DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102		
Number Sign	615978	IMMUNODEFICIENCY 27B; IMD27B	IMMUNODEFICIENCY 27B, MYCOBACTERIOSIS, AUTOSOMAL DOMINANT;; IFNGR1 DEFICIENCY, AUTOSOMAL DOMINANT	
Number Sign	615979	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45		
Number Sign	615980	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH LIPE MUTATIONS	
Number Sign	615981	BARDET-BIEDL SYNDROME 2; BBS2		
Number Sign	615982	BARDET-BIEDL SYNDROME 4; BBS4		
Number Sign	615983	BARDET-BIEDL SYNDROME 5; BBS5		
Number Sign	615984	BARDET-BIEDL SYNDROME 7; BBS7		
Number Sign	615985	BARDET-BIEDL SYNDROME 8; BBS8		
Number Sign	615986	BARDET-BIEDL SYNDROME 9; BBS9		
Number Sign	615987	BARDET-BIEDL SYNDROME 10; BBS10		
Number Sign	615988	BARDET-BIEDL SYNDROME 11; BBS11		
Number Sign	615989	BARDET-BIEDL SYNDROME 12; BBS12		
Number Sign	615990	BARDET-BIEDL SYNDROME 13; BBS13		
Number Sign	615991	BARDET-BIEDL SYNDROME 14; BBS14		
Number Sign	615992	BARDET-BIEDL SYNDROME 15; BBS15		
Number Sign	615993	BARDET-BIEDL SYNDROME 16; BBS16		
Number Sign	615994	BARDET-BIEDL SYNDROME 17; BBS17		
Number Sign	615995	BARDET-BIEDL SYNDROME 18; BBS18		
Number Sign	615996	BARDET-BIEDL SYNDROME 19; BBS19		
Number Sign	615999	HYPERTHYROXINEMIA, FAMILIAL DYSALBUMINEMIC; FDAH	FDH;; EUTHYROID HYPERTHYROXINEMIA 1	
Number Sign	616000	ANALBUMINEMIA; ANALBA		
Number Sign	616001	BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2		
Number Sign	616002	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7; FSGS7	GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 7	
Number Sign	616004	DYSFIBRINOGENEMIA, CONGENITAL		HYPODYSFIBRINOGENEMIA, CONGENITAL, INCLUDED
Number Sign	616005	IMMUNODEFICIENCY 36; IMD36		
Number Sign	616006	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2		
Number Sign	616007	CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS		
Number Sign	616022	NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6		
Number Sign	616025	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 5; HPMRS5	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	
Number Sign	616026	FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	FRTS4 WITH MODY	
Number Sign	616028	ADAMS-OLIVER SYNDROME 5; AOS5		
Number Sign	616029	ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME; ECTDS		
Number Sign	616030	HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA; HH22		
Number Sign	616032	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8; FSGS8	GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 8	
Number Sign	616033	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	MSSGM	
Number Sign	616034	2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD		
Number Sign	616037	CILIARY DYSKINESIA, PRIMARY, 30; CILD30	CILIARY DYSKINESIA, PRIMARY, 30, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	616038	NEU-LAXOVA SYNDROME 2; NLS2		
Number Sign	616039	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID		
Number Sign	616040	MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	MYASTHENIC SYNDROME, PRESYNAPTIC, CONGENITAL, WITH OR WITHOUT MOTOR NEUROPATHY; MYSPC	
Number Sign	616042	DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103		
Number Sign	616044	DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65		
Number Sign	616045	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22; COXPD22		
Number Sign	616050	AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC		
Number Sign	616051	MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13		
Number Sign	616052	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2U; LGMD2U	
Number Sign	616053	SPINOCEREBELLAR ATAXIA 40; SCA40		
Percent	616055	EPISODIC ATAXIA, TYPE 8; EA8		
Number Sign	616056	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26		
Number Sign	616059	MIRROR MOVEMENTS 3; MRMV3		
Number Sign	616060	BLOOD GROUP, DOMBROCK SYSTEM; DO	DOMBROCK BLOOD GROUP SYSTEM	
Number Sign	616063	POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK8		
Number Sign	616067	46,XY SEX REVERSAL 9; SRXY9	46,XY SEX REVERSAL, ZFPM2-RELATED	
Number Sign	616069	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2		
Number Sign	616078	MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29		
Number Sign	616079	RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA		
Number Sign	616080	MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12		
Number Sign	616081	PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	HYPOMYELINATION WITH SPINAL MUSCULAR ATROPHY AND CEREBELLAR HYPOPLASIA	
Number Sign	616083	MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30		
Number Sign	616084	SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD		
Number Sign	616087	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 5; NIDDM5		
Number Sign	616089	BLOOD GROUP, GERBICH SYSTEM; GE	GERBICH BLOOD GROUP SYSTEM	
Number Sign	616093	BLOOD GROUP, ABO SYSTEM	ABO BLOOD GROUP SYSTEM	
Number Sign	616094	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMK-RELATED	
Number Sign	616095	MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D		
Number Sign	616098	IMMUNODEFICIENCY 37; IMD37		
Number Sign	616099	PALMOPLANTAR KERATODERMA AND WOOLLY HAIR; PPKWH		
Number Sign	616100	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	CTLA4 HAPLOINSUFFICIENCY WITH AUTOIMMUNE INFILTRATION; CHAI	
Number Sign	616106	PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO; PSORS15		
Number Sign	616108	RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS		
Number Sign	616111	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9; MC3DN9		
Number Sign	616113	POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS		
Number Sign	616115	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4		
Number Sign	616116	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46; MRT46		
Number Sign	616117	CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY; CCDD		
Number Sign	616118	MACULAR DEGENERATION, EARLY-ONSET; EOMD		
NULL	616121	GTPase, VERY LARGE INTERFERON-INDUCIBLE, PSEUDOGENE 1; GVINP1	VERY LARGE INDUCIBLE GTPase 1; VLIG1	
Number Sign	616126	IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	IMMUNODEFICIENCY 38, MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE;; ISG15 DEFICIENCY, AUTOSOMAL RECESSIVE	
Number Sign	616127	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17		
Number Sign	616138	PERRAULT SYNDROME 5; PRLTS5		
Number Sign	616139	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27		
Number Sign	616140	LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9		
Number Sign	616145	CATEL-MANZKE SYNDROME; CATMANS	HYPERPHALANGY-CLINODACTYLY OF INDEX FINGER WITH PIERRE ROBIN SYNDROME;; PIERRE ROBIN SYNDROME WITH HYPERPHALANGY AND CLINODACTYLY;; INDEX FINGER ANOMALY WITH PIERRE ROBIN SYNDROME;; PALATODIGITAL SYNDROME, CATEL-MANZKE TYPE;; MICROGNATHIA DIGITAL SYNDROME	
Number Sign	616151	MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4		
Number Sign	616152	MACULAR DYSTROPHY, VITELLIFORM, 5; VMD5		
Number Sign	616154	PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD		
Number Sign	616155	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2S;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2S	
Number Sign	616158	MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31		
Number Sign	616165	NEMALINE MYOPATHY 10; NEM10		
Number Sign	616166	AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	AORTIC ANEURYSM, THORACIC, WITH OR WITHOUT AORTIC DISSECTION	
Number Sign	616170	MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD		
Number Sign	616171	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2		
Number Sign	616172	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	GEFS+, TYPE 9; GEFS+9	
Number Sign	616176	BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19		
Percent	616182	CHRONIC MOUNTAIN SICKNESS, SUSCEPTIBILITY TO	MONGE DISEASE	
Number Sign	616185	OVARIAN DYSGENESIS 4; ODG4		
Number Sign	616187	EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7		
Number Sign	616188	RETINAL DYSTROPHY AND OBESITY; RDOB		
Number Sign	616192	ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD		
Number Sign	616193	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47; MRT47		
Number Sign	616198	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23; COXPD23		
Number Sign	616199	POLYGLUCOSAN BODY MYOPATHY 2; PGBM2		
Number Sign	616200	RUIJS-AALFS SYNDROME; RJALS		
Number Sign	616201	CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID		
Number Sign	616202	CEREBELLOFACIODENTAL SYNDROME; CFDS	CEREBELLAR-FACIAL-DENTAL SYNDROME	
Number Sign	616204	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18		
Number Sign	616208	AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22		
Number Sign	616209	MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD		
Number Sign	616211	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28		
Number Sign	616212	LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6		
Number Sign	616214	HYPERPROINSULINEMIA		
Number Sign	616216	THROMBOCYTOPENIA 5; THC5	THROMBOCYTOPENIA 5 WITH INCREASED SUSCEPTIBILITY TO MALIGNANCY;; THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 5	
Number Sign	616217	NEPHRONOPHTHISIS 19; NPHP19		
Number Sign	616219	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5; CFEOM5		
Number Sign	616220	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9; FSGS9	GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 9	
Number Sign	616221	AMELOGENESIS IMPERFECTA, TYPE IH; AI1H		
Number Sign	616222	TEMPLE SYNDROME	UNIPARENTAL DISOMY, MATERNAL, CHROMOSOME 14	
Number Sign	616224	MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	PREPL DEFICIENCY	
Number Sign	616227	MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	MYASTHENIC SYNDROME, CONGENITAL, WITHOUT TUBULAR AGGREGATES; CMSWTA	
Number Sign	616228	MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 3; CMSTA3	
Number Sign	616229	OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	OI, TYPE XVI;; CHROMOSOME 11p11.2 DELETION SYNDROME, 91.3-KB	
Number Sign	616230	EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8		
Number Sign	616231	MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES; VMCQA		
Number Sign	616239	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24		
Number Sign	616247	LONG QT SYNDROME 14; LQT14		
Number Sign	616248	LETHAL CONGENITAL CONTRACTURE SYNDROME 6; LCCS6		
Number Sign	616249	LONG QT SYNDROME 15; LQT15		
Number Sign	616255	SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES; SNSK		
Number Sign	616258	MECKEL SYNDROME 12; MKS12		
Number Sign	616260	TENORIO SYNDROME; TNORS	OVERGROWTH, MACROCEPHALY, AND INTELLECTUAL DISABILITY SYNDROME	
Number Sign	616263	NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD		
Number Sign	616265	PEELING SKIN SYNDROME 3; PSS3		
Number Sign	616266	CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY; CLIFAHDD		
Number Sign	616267	ATAXIA-OCULOMOTOR APRAXIA 4; AOA4		
Number Sign	616268	MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32		
Number Sign	616269	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48		
Number Sign	616270	AMELOGENESIS IMPERFECTA, TYPE IF; AI1F	AMELOGENESIS IMPERFECTA, HYPOPLASTIC TYPE IF; AI1F	
Number Sign	616271	3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	3-METHYLGLUTACONIC ACIDURIA, TYPE VII; MGCA7	
Number Sign	616276	COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7		
Number Sign	616277	MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D		
Number Sign	616278	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5		
Number Sign	616279	CATARACT 43; CTRCT43		
Number Sign	616280	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2U;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2U	
Number Sign	616281	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49		
Number Sign	616282	SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73		
Number Sign	616286	LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7		
Number Sign	616287	LETHAL CONGENITAL CONTRACTURE SYNDROME 8; LCCS8		
Number Sign	616289	OPTIC ATROPHY 9; OPA9		
Number Sign	616291	LICHTENSTEIN-KNORR SYNDROME; LIKNS	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 19; SCAR19	
Number Sign	616294	COLE-CARPENTER SYNDROME 2; CLCRP2		
Number Sign	616295	PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS; PLACK		
Number Sign	616298	SINGLETON-MERTEN SYNDROME 2; SGMRT2		
Number Sign	616299	LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D		
Number Sign	616300	SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13		
Number Sign	616304	MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17		
Number Sign	616307	SENIOR-LOKEN SYNDROME 8; SLSN8		
Number Sign	616311	MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33		
Number Sign	616313	MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A		
Number Sign	616314	MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C		
Number Sign	616321	MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A		
Number Sign	616322	MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B		
Number Sign	616323	MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C		
Number Sign	616324	MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B		
Number Sign	616325	MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9		
Number Sign	616326	MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	MYASTHENIC SYNDROME, CONGENITAL, Ie, FORMERLY; CMS1E, FORMERLY;; CMS Ie, FORMERLY	
Number Sign	616329	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13; MODY13	MODY, TYPE 13	
Number Sign	616330	MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	MYASTHENIC SYNDROME, CONGENITAL, 18, WITH INTELLECTUAL DISABILITY AND ATAXIA	
Number Sign	616331	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2		
Number Sign	616335	MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3		
Number Sign	616339	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29		
Number Sign	616340	DEAFNESS, AUTOSOMAL DOMINANT 67; DFNA67		
Number Sign	616341	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30		
Number Sign	616342	LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7		
Number Sign	616345	IMMUNODEFICIENCY 39; IMD39		
Number Sign	616346	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31		
Number Sign	616351	MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34		
Number Sign	616353	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6; DKCB6		
Number Sign	616354	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20		
Number Sign	616355	MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35		
Number Sign	616357	DEAFNESS, AUTOSOMAL DOMINANT 40; DFNA40		
Percent	616361	PARKINSON DISEASE 21; PARK21		
Number Sign	616362	MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36		
Number Sign	616364	WHITE-SUTTON SYNDROME; WHSUS	MENTAL RETARDATION, AUTOSOMAL DOMINANT 37; MRD37	
Number Sign	616366	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32		
Number Sign	616367	MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA		
Number Sign	616368	CHOPS SYNDROME; CHOPS	COGNITIVE IMPAIRMENT, COARSE FACIES, HEART DEFECTS, OBESITY, PULMONARY INVOLVEMENT, SHORT STATURE, AND SKELETAL DYSPLASIA	
Number Sign	616370	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4		
Number Sign	616371	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4; PFBMFT4		
Number Sign	616373	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3; PFBMFT3		
Number Sign	616389	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G		
Number Sign	616390	TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE; TTD2		
NULL	616392	SKINT1-LIKE PSEUDOGENE; SKINTL	SKINT1L;; SKINTP	
Number Sign	616393	MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	PSYCHOMOTOR RETARDATION, EPILEPSY, AND LANGUAGE DISABILITY SYNDROME; PRELDS	
Number Sign	616394	RETINITIS PIGMENTOSA 71; RP71		
Number Sign	616395	TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3	TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	
Number Sign	616398	DYSTONIA 26, MYOCLONIC; DYT26		
Number Sign	616399	BRUGADA SYNDROME 9; BRGDA9		
Number Sign	616400	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 2; FNEPPK2		
Number Sign	616402	MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14		
Percent	616407	BROWN SYNDROME; BRWNS		
Number Sign	616409	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33		
Number Sign	616410	SPINOCEREBELLAR ATAXIA 41; SCA41		
Number Sign	616411	DYSTONIA 27; DYT27		
Number Sign	616413	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6		
Number Sign	616414	AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK		
Number Sign	616415	FAMILIAL ADENOMATOUS POLYPOSIS 3; FAP3		
Number Sign	616418	HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR		
Number Sign	616420	LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10		
Number Sign	616421	MYOCLONIC-ATONIC EPILEPSY; MAE		
Number Sign	616425	46,XY SEX REVERSAL 10; SRXY10	CHROMOSOME 17q24 DELETION SYNDROME	
Number Sign	616428	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10; MCOPCB10		
Number Sign	616430	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25		
Number Sign	616433	IMMUNODEFICIENCY 40; IMD40		
Number Sign	616435	FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT		
Number Sign	616436	EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7		
Number Sign	616437	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3		
Number Sign	616439	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4		
Number Sign	616445	CANDIDIASIS, FAMILIAL, 9; CANDF9		
Number Sign	616449	BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS		
Number Sign	616451	SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74		
Number Sign	616452	B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA		
Number Sign	616455	ZIMMERMANN-LABAND SYNDROME 2; ZLS2		
Number Sign	616457	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iz, FORMERLY; CDG1Z, FORMERLY	
Number Sign	616459	AL-RAQAD SYNDROME; ARS		
Number Sign	616460	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50		
Number Sign	616461	EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8		
Number Sign	616462	ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN		
Number Sign	616468	EXUDATIVE VITREORETINOPATHY 6; EVR6		
Number Sign	616469	RETINITIS PIGMENTOSA 72; RP72		
Number Sign	616470	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2		
Number Sign	616471	BETHLEM MYOPATHY 2; BTHLM2		
Number Sign	616479	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE 2	
Number Sign	616481	CILIARY DYSKINESIA, PRIMARY, 32; CILD32	CILIARY DYSKINESIA, PRIMARY, 32, WITHOUT SITUS INVERSUS	
Number Sign	616482	ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	SADDAN DYSPLASIA	
Number Sign	616483	INFANTILE LIVER FAILURE SYNDROME 2; ILFS2		
Number Sign	616486	MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE; MCPH15		
Number Sign	616487	EPIDERMOLYSIS BULLOSA SIMPLEX WITH NAIL DYSTROPHY; EBSND		
Number Sign	616488	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8	HSAN VIII	
Number Sign	616489	GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF		
Number Sign	616490	JOUBERT SYNDROME 23; JBTS23		
Number Sign	616491	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V; CMT2V	CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2V;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2V	
Number Sign	616494	LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11		
Number Sign	616500	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 3; CEMCOX3		
Number Sign	616501	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 4; CEMCOX4		
Number Sign	616502	CONE-ROD DYSTROPHY 21; CORD21	RETINAL DYSTROPHY WITH EARLY MACULAR INVOLVEMENT	
Number Sign	616503	LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9		
Number Sign	616505	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	HMSN VIB;; CHARCOT-MARIE-TOOTH DISEASE, TYPE 6B; CMT6B	
Number Sign	616507	OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17		
Number Sign	616509	CATARACT 44; CTRCT44		
Number Sign	616511	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14		
Number Sign	616515	DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104		
Number Sign	616516	EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3		
Number Sign	616517	ACHROMATOPSIA 7; ACHM7		
Number Sign	616521	MENTAL RETARDATION, AUTOSOMAL DOMINANT 39; MRD39		CHROMOSOME 2p25.3 DELETION SYNDROME, INCLUDED;; CHROMOSOME 2p25.3 DUPLICATION SYNDROME, INCLUDED
Number Sign	616531	POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA		
Number Sign	616532	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 7	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 7; IIAE7	
Number Sign	616534	THYROID CANCER, NONMEDULLARY, 4; NMTC4		
Number Sign	616535	THYROID CANCER, NONMEDULLARY, 5; NMTC5		
Number Sign	616538	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	WALKER-WARBURG SYNDROME OR MUSCLE-EYE BRAIN DISEASE, DAG1-RELATED	
Number Sign	616539	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26		
Number Sign	616540	EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9		
Number Sign	616541	SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED		
Number Sign	616544	RETINITIS PIGMENTOSA 73; RP73		
Number Sign	616546	SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY; SRTD14		
Number Sign	616549	KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4		
Number Sign	616553	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6		DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 7, INCLUDED; DKCB7, INCLUDED
Number Sign	616559	NOONAN SYNDROME 9; NS9		
Number Sign	616562	RETINITIS PIGMENTOSA 74; RP74		
Number Sign	616564	NOONAN SYNDROME 10; NS10		
Number Sign	616566	SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6		
Number Sign	616568	GLIOMA SUSCEPTIBILITY 9; GLM9		
Number Sign	616570	CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3		
Number Sign	616576	IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	NFKB1 DEFICIENCY	
Number Sign	616577	EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS		
Number Sign	616579	MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40		
Number Sign	616580	AU-KLINE SYNDROME; AUKS		
Number Sign	616583	SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE; SEDSTN	SED, STANESCU TYPE	
Number Sign	616586	SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B		
Number Sign	616589	ADAMS-OLIVER SYNDROME 6; AOS6		
Number Sign	616592	KOSAKI OVERGROWTH SYNDROME; KOGS	SKELETAL OVERGROWTH WITH FACIAL DYSMORPHISM, HYPERELASTIC SKIN, WHITE MATTER LESIONS, AND NEUROLOGIC DETERIORATION	
Number Sign	616602	CRANIOSYNOSTOSIS 6; CRS6		
Number Sign	616603	CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3		
Number Sign	616604	CHROMOSOME 14q32 DUPLICATION SYNDROME, 700-KB	MYELOPROLIFERATIVE NEOPLASMS, FAMILIAL, SUSCEPTIBILITY TO	
Number Sign	616606	RING CHROMOSOME 14 SYNDROME		
Number Sign	616617	HEIMLER SYNDROME 2; HMLR2	PEROXISOME BIOGENESIS DISORDER 4C; PBD4C	
Number Sign	616622	IMMUNODEFICIENCY 42; IMD42		
Number Sign	616625	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W; CMT2W	CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2W;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2W	
Number Sign	616629	SENIOR-LOKEN SYNDROME 9; SLSN9		
Number Sign	616631	POROKERATOSIS 9, MULTIPLE TYPES; POROK9		
Number Sign	616632	SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME; SCBMS		
Number Sign	616636	IMMUNODEFICIENCY 44; IMD44		
Number Sign	616638	SMITH-KINGSMORE SYNDROME; SKS	MACROCEPHALY, SEIZURES, MENTAL RETARDATION, UMBILICAL HERNIA, AND FACIAL DYSMORPHISM	
Number Sign	616640	EPILEPSY, PROGRESSIVE MYOCLONIC, 10; EPM10		
Number Sign	616645	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34		
Number Sign	616647	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35; EIEE35		
Percent	616648	OPTIC ATROPHY 8; OPA8		
Number Sign	616649	SPHEROCYTOSIS, TYPE 2; SPH2	SPHEROCYTOSIS, HEREDITARY, 2; HS2	
Number Sign	616651	ROIFMAN SYNDROME; RFMN	SPONDYLOEPIPHYSEAL DYSPLASIA, RETINAL DYSTROPHY, AND ANTIBODY DEFICIENCY	
Number Sign	616652	YUAN-HAREL-LUPSKI SYNDROME; YUHAL		
Number Sign	616654	JOUBERT SYNDROME 24; JBTS24		
Number Sign	616657	SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM		
Number Sign	616668	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2X;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2X	
Number Sign	616669	IMMUNODEFICIENCY 45; IMD45		
Number Sign	616672	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27		
Number Sign	616680	SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE; SPG75		
Number Sign	616681	MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE; MCPH16		
Number Sign	616682	SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME; SSMS		
Number Sign	616683	LEUKODYSTROPHY, HYPOMYELINATING, 12; HLD12		
Number Sign	616684	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4K;; CHARCOT-MARIE-TOOTH NEUROPATHY, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4K	
Number Sign	616685	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14; EIG14		
Number Sign	616687	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2Y;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2Y	
Number Sign	616688	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2Z;; CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2Z	
Number Sign	616689	DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	XEROCYTOSIS GARDOS;; DESICCYTOSIS GARDOS	
Number Sign	616697	DEAFNESS, AUTOSOMAL DOMINANT 69; DFNA69	DEAFNESS, CONGENITAL, UNILATERAL OR ASYMMETRIC; DCUA	
Number Sign	616705	DEAFNESS, AUTOSOMAL RECESSIVE 97; DFNB97		
Number Sign	616707	DEAFNESS, AUTOSOMAL DOMINANT 68; DFNA68		
Number Sign	616708	DESANTO-SHINAWI SYNDROME; DESSH	DEVELOPMENTAL DELAY, BEHAVIORAL ABNORMALITIES, FACIAL DYSMORPHISM, AND OCULAR ABNORMALITIES	CHROMOSOME 10p12-p11 DELETION SYNDROME, INCLUDED
Number Sign	616710	PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22		
Number Sign	616716	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5		
Number Sign	616719	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21; SCAR21	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21, WITH HEPATOPATHY	
Number Sign	616720	MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19		
Number Sign	616721	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn; CDG2N	CDG IIn; CDGIIn	
Number Sign	616722	RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT; RDICC		
Number Sign	616723	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, PROGRESSIVE, WITH SHORT STATURE, FACIAL DYSMORPHISM, SHORT FOURTH METATARSALS, AND MENTAL RETARDATION, WITH OR WITHOUT CRANIOSYNOSTOSIS	
Number Sign	616724	TOOTH AGENESIS, SELECTIVE, 7; STHAG7		
Number Sign	616726	CILIARY DYSKINESIA, PRIMARY, 33; CILD33	CILIARY DYSKINESIA, PRIMARY, 33, WITHOUT SITUS INVERSUS	
Number Sign	616728	CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES; CPRF		
Number Sign	616730	NEPHROTIC SYNDROME, TYPE 11; NPHS11		
Number Sign	616732	OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES; OPA10		
Number Sign	616733	COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8		
Number Sign	616734	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2		
Number Sign	616736	TREMOR, HEREDITARY ESSENTIAL, 5; ETM5		
Number Sign	616737	TAKENOUCHI-KOSAKI SYNDROME; TKS	MACROTHROMBOCYTOPENIA AND MENTAL RETARDATION SYNDROME	
Number Sign	616738	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2; RUSAT2		
Number Sign	616739	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51; MRT51		
Number Sign	616740	IMMUNODEFICIENCY 46; IMD46		
Number Sign	616744	AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE; AISBL		
Number Sign	616749	HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7		
Number Sign	616754	BOMBAY PHENOTYPE		PARA-BOMBAY PHENOTYPE, INCLUDED;; REUNION VARIANT, INCLUDED
Number Sign	616756	SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES; SPPRS		
Number Sign	616760	WOOLLY HAIR, AUTOSOMAL RECESSIVE 3; ARWH3	WOOLLY HAIR, AUTOSOMAL RECESSIVE 3, WITH HYPOTRICHOSIS	
Number Sign	616763	LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD		
Number Sign	616777	SECKEL SYNDROME 9; SCKL9		
Number Sign	616779	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2		
Number Sign	616780	OOCYTE MATURATION DEFECT 2; OOMD2		
Number Sign	616781	JOUBERT SYNDROME 25; JBTS25		
Number Sign	616784	JOUBERT SYNDROME 26; JBTS26		
Number Sign	616788	OROFACIAL CLEFT 15; OFC15		
Number Sign	616789	MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD		
Percent	616792	NEUROBLASTOMA, SUSCEPTIBILITY TO, 7; NBLST7		
Number Sign	616794	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28; COXPD28		
Number Sign	616795	SPINOCEREBELLAR ATAXIA 42; SCA42		
Number Sign	616801	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2		
Number Sign	616803	LAMB-SHAFFER SYNDROME; LAMSHF		
Number Sign	616806	WILMS TUMOR 6; WT6	WILMS TUMOR, SUSCEPTIBILITY TO	
Number Sign	616809	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6; HPMRS6	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 12; GPIBD12	
Number Sign	616811	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29		
Number Sign	616812	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2X; LGMD2X		
Number Sign	616814	PREIMPLANTATION EMBRYONIC LETHALITY 1; PREMBL1	PREMBL	
Number Sign	616816	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR		
Number Sign	616817	MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2; MSSGM2		
Number Sign	616818	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 3; IGAN3		
Number Sign	616819	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	BIRK-FLUSSER SYNDROME	
Number Sign	616827	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W		
Number Sign	616828	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo; CDG2O	CDG IIo; CDGIIo	
Number Sign	616829	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp; CDG2P	CDG IIp; CDGIIp	
Number Sign	616831	LUSCAN-LUMISH SYNDROME; LLS		
Number Sign	616833	PAGET DISEASE OF BONE 6; PDB6		
Number Sign	616834	MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS; MCCPD	SC4MOL DEFICIENCY	
Number Sign	616835	MEIER-GORLIN SYNDROME 6; MGORS6		
Number Sign	616839	EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE; RREI		
Number Sign	616840	PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK23		
Number Sign	616843	LYMPHEDEMA, HEREDITARY, III; LMPH3	GENERALIZED LYMPHATIC DYSPLASIA OF FOTIOU	
Number Sign	616849	BRACHYDACTYLY, TYPE A1, D; BDA1D		
Number Sign	616851	CATARACT 45; CTRCT45		
Number Sign	616852	MYOPATHY, SCAPULOHUMEROPERONEAL; SHPM		
Number Sign	616854	EVEN-PLUS SYNDROME; EVPLS	EPIPHYSEAL AND VERTEBRAL DYSPLASIA, MICROTIA, AND FLAT NOSE, PLUS ASSOCIATED MALFORMATIONS	
Number Sign	616858	COWDEN SYNDROME 7; CWS7		
Number Sign	616859	SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA; SPAHGC		
Number Sign	616860	ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3		
Number Sign	616863	CHROMOSOME 16p13.2 DELETION SYNDROME		
Number Sign	616866	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1		
Number Sign	616867	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2; SMABF2		
Number Sign	616868	DIARRHEA 8, SECRETORY SODIUM, CONGENITAL; DIAR8	DIARRHEA, CONGENITAL SODIUM; CSD	
Number Sign	616871	MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF		
Number Sign	616873	IMMUNODEFICIENCY, COMMON VARIABLE, 13; CVID13		
Number Sign	616875	CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR		
Number Sign	616878	METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN		
Number Sign	616881	LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13		
Number Sign	616882	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3		
Number Sign	616887	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52; MRT52		
Number Sign	616890	SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP		
Number Sign	616892	NEPHROTIC SYNDROME, TYPE 12; NPHS12		
Number Sign	616893	NEPHROTIC SYNDROME, TYPE 13; NPHS13		
Number Sign	616894	ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3		
Number Sign	616896	MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE); MTDPS14		
Number Sign	616897	OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE; OCLSBG		
Number Sign	616898	CHROMOSOME 15q14 DELETION SYNDROME		
Number Sign	616900	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3		
Number Sign	616901	DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR; DEDSSH	LOUCKS-INNES SYNDROME	
Number Sign	616902	CHROMOSOME 11p13 DELETION SYNDROME, DISTAL		
Number Sign	616903	THIOPURINES, POOR METABOLISM OF, 2; THPM2	NUDT15 DEFICIENCY	
Number Sign	616907	SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE; SPG76		
Number Sign	616910	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3		
Number Sign	616911	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4		
Number Sign	616913	BLEEDING DISORDER, PLATELET-TYPE, 20; BDPLT20		
Number Sign	616914	MARFAN LIPODYSTROPHY SYNDROME; MFLS	MARFANOID-PROGEROID SYNDROME;; MARFAN-PROGEROID-LIPODYSTROPHY SYNDROME	
Number Sign	616917	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 13; GPIBD13	
Number Sign	616920	HEART AND BRAIN MALFORMATION SYNDROME; HBMS		
Number Sign	616921	DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD		
Number Sign	616922	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2; ADSD2		
Number Sign	616924	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2CC	
Number Sign	616937	THROMBOCYTOPENIA 6; THC6	THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 6	
Number Sign	616938	COFFIN-SIRIS SYNDROME 5; CSS5		
Number Sign	616939	CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION; COCPMR		
Number Sign	616941	AGAMMAGLOBULINEMIA 8, AUTOSOMAL DOMINANT; AGM8	AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO TCF3 DEFECT	
Number Sign	616943	TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6		
Number Sign	616944	MENTAL RETARDATION, AUTOSOMAL DOMINANT 41; MRD41		
Number Sign	616946	PREMATURE OVARIAN FAILURE 11; POF11		
Number Sign	616947	PREMATURE OVARIAN FAILURE 12; POF12		
Number Sign	616948	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22; SCAR22		
Number Sign	616949	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23		
Number Sign	616950	SPERMATOGENIC FAILURE 15; SPGF15		
Number Sign	616954	YOU-HOOVER-FONG SYNDROME; YHFS		
Number Sign	616958	DEAFNESS, AUTOSOMAL RECESSIVE 105; DFNB105		
Number Sign	616959	RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM		
Number Sign	616963	HYPERCALCEMIA, INFANTILE, 2; HCINF2		
Number Sign	616968	DEAFNESS, AUTOSOMAL DOMINANT 70; DFNA70		
Number Sign	616969	DEAFNESS, AUTOSOMAL DOMINANT 66; DFNA66		
Number Sign	616973	MENTAL RETARDATION, AUTOSOMAL DOMINANT 42; MRD42		
Number Sign	616974	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30; COXPD30		
Number Sign	616975	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH		
Number Sign	616977	MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43		
Number Sign	616981	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37		
Number Sign	617004	POLYCYSTIC LIVER DISEASE 2; PCLD2		
Number Sign	617006	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2		
Number Sign	617008	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3		
Number Sign	617011	MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR		
Number Sign	617013	HYPERMANGANESEMIA WITH DYSTONIA 2; HMNDYT2		
Number Sign	617014	NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE; SCN7		
Number Sign	617017	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2T;; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2T	
Number Sign	617018	SPINOCEREBELLAR ATAXIA 43; SCA43		
Number Sign	617020	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38		
Number Sign	617021	HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA		
Number Sign	617022	LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10		
Number Sign	617023	RETINITIS PIGMENTOSA 75; RP75		
Number Sign	617024	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H		
Number Sign	617025	NEVUS COMEDONICUS; NC		
Number Sign	617026	PONTOCEREBELLAR HYPOPLASIA, TYPE 2F; PCH2F		
Number Sign	617027	HYPERALDOSTERONISM, FAMILIAL, TYPE IV; HALD4	FH IV;; ALDOSTERONISM, PRIMARY, AND HYPERTENSION	
Number Sign	617028	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54; MRT54		
Number Sign	617030	MYOPATHY, DISTAL, 5; MPD5		
Number Sign	617035	PATENT DUCTUS ARTERIOSUS 2; PDA2		
Number Sign	617039	PATENT DUCTUS ARTERIOSUS 3; PDA3		
Number Sign	617041	DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS; DURS3		
Number Sign	617044	SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS; SDDHD		
Number Sign	617046	SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE; SPG77		
Number Sign	617047	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26; CMH26		CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 5, INCLUDED; RCM5, INCLUDED
Number Sign	617049	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5; PFIC5		
Number Sign	617050	HERMANSKY-PUDLAK SYNDROME 10; HPS10		
Number Sign	617051	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55; MRT55		
Number Sign	617052	BONE MARROW FAILURE SYNDROME 3; BMFS3		
Number Sign	617053	MIRAGE SYNDROME; MIRAGE	MYELODYSPLASIA, INFECTION, RESTRICTION OF GROWTH, ADRENAL HYPOPLASIA, GENITAL PHENOTYPES, AND ENTEROPATHY	
Number Sign	617054	STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET; SNDC	LENK-PLOSKI SYNDROME	
Number Sign	617055	COLD-INDUCED SWEATING SYNDROME 3; CISS3		
Number Sign	617056	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4		
Number Sign	617061	MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44		
Number Sign	617062	OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS		
Number Sign	617063	MEIER-GORLIN SYNDROME 7; MGORS7		
Number Sign	617065	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40; EIEE40		
Number Sign	617066	MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC		
Number Sign	617068	PORTAL HYPERTENSION, NONCIRRHOTIC; NCPH		
Number Sign	617069	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3; PEOB3	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE 3	
Number Sign	617070	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4; PEOB4	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE 4	
Number Sign	617072	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y		
Number Sign	617073	TOOTH AGENESIS, SELECTIVE, 8; STHAG8		
Number Sign	617075	NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 3; NPCA3		
Number Sign	617080	SEIZURES, BENIGN FAMILIAL INFANTILE, 5; BFIS5	CONVULSIONS, BENIGN FAMILIAL INFANTILE, 5; BFIC5	
Number Sign	617082	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa; CDG1AA		
Number Sign	617086	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2; EMPF2		
Number Sign	617087	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B		
Number Sign	617088	SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15		
Number Sign	617090	MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17		
Number Sign	617091	CILIARY DYSKINESIA, PRIMARY, 34; CILD34	CILIARY DYSKINESIA, PRIMARY, 34, WITHOUT SITUS INVERSUS	
Number Sign	617092	CILIARY DYSKINESIA, PRIMARY, 35; CILD35	CILIARY DYSKINESIA, PRIMARY, 35, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	617093	GROWTH RETARDATION, INTELLECTUAL DEVELOPMENTAL DISORDER, HYPOTONIA, AND HEPATOPATHY; GRIDHH		
Number Sign	617099	AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	OTULIN-RELATED AUTOINFLAMMATORY SYNDROME; ORAS;; OTULIPENIA	
Number Sign	617100	FAMILIAL ADENOMATOUS POLYPOSIS 4; FAP4		
Number Sign	617101	INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	INTELLECTUAL DEVELOPMENTAL DISORDER WITH HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN	
Number Sign	617102	SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16		
Number Sign	617105	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41		
Number Sign	617106	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42		
Number Sign	617107	THAUVIN-ROBINET-FAIVRE SYNDROME; TROFAS		
Number Sign	617108	SESSILE SERRATED POLYPOSIS CANCER SYNDROME; SSPCS		
Number Sign	617111	MACULAR DYSTROPHY, PATTERNED, 3; MDPT3	MARTINIQUE CRINKLED RETINAL PIGMENT EPITHELIOPATHY	
Number Sign	617113	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43; EIEE43		
Number Sign	617114	MYOPATHY, MYOFIBRILLAR, 7; MFM7		
Number Sign	617115	PEELING SKIN SYNDROME 5; PSS5		
Number Sign	617116	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2		
Number Sign	617118	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3		
Number Sign	617119	BARDET-BIEDL SYNDROME 20; BBS20		
Number Sign	617120	JOUBERT SYNDROME 27; JBTS27		
Number Sign	617121	JOUBERT SYNDROME 28; JBTS28		
Number Sign	617123	RETINITIS PIGMENTOSA 76; RP76		
Number Sign	617125	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56; MRT56		
Number Sign	617126	ALAZAMI-YUAN SYNDROME; ALYUS		
Number Sign	617127	OROFACIODIGITAL SYNDROME XV; OFD15	OFDS XV;; ORAL-FACIAL-DIGITAL SYNDROME, TYPE XV	
Number Sign	617132	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44; EIEE44		
Number Sign	617133	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24		
Number Sign	617137	FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2		
Number Sign	617140	ZTTK SYNDROME; ZTTKS	ZHU-TOKITA-TAKENOUCHI-KIM SYNDROME;; ZTTK MULTIPLE CONGENITAL ANOMALIES-MENTAL RETARDATION SYNDROME	
Number Sign	617141	ANIRIDIA 2; AN2		
Number Sign	617142	ANIRIDIA 3; AN3		
Number Sign	617143	MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20		
Number Sign	617145	NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET; NADGP		
Number Sign	617146	ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT		
Number Sign	617153	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45; EIEE45		
Number Sign	617156	MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15		
Number Sign	617157	SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS		
Number Sign	617158	MYOPATHY, DISTAL, WITH RIMMED VACUOLES; DMRV		
Number Sign	617159	SIFRIM-HITZ-WEISS SYNDROME; SIHIWES	SIFRIM-HITZ-WEISS MULTIPLE CONGENITAL ANOMALIES-MENTAL RETARDATION SYNDROME	
Number Sign	617162	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46		
Number Sign	617164	SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD		
Number Sign	617166	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47; EIEE47		
Number Sign	617168	AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	AORTIC ANEURYSM, THORACIC, WITH OR WITHOUT AORTIC DISSECTION	
Number Sign	617169	SOTOS SYNDROME 3; SOTOS3		
Number Sign	617171	DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; DYSEIDD		
Number Sign	617173	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA; IDDCA		
Number Sign	617174	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2		
Number Sign	617175	RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES; RDEOA		
Number Sign	617180	CHITAYAT SYNDROME; CHYTS		
Number Sign	617182	LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI		
Number Sign	617183	HAREL-YOON SYNDROME; HAYOS		
Number Sign	617184	MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A		
Number Sign	617186	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY; PEBEL		
Number Sign	617187	SPERMATOGENIC FAILURE 16; SPGF16	ACEPHALIC SPERMATOZOA SYNDROME	
Number Sign	617188	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57		
Number Sign	617190	SHASHI-PENA SYNDROME; SHAPNS		
Number Sign	617193	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT		
Number Sign	617194	LETHAL CONGENITAL CONTRACTURE SYNDROME 11; LCCS11		
Number Sign	617201	PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7		
Number Sign	617205	HETEROTAXY, VISCERAL, 8, AUTOSOMAL; HTX8		
Number Sign	617207	ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO		
Number Sign	617213	SEDOHEPTULOKINASE DEFICIENCY; SHPKD		
Number Sign	617214	SPERMATOGENIC FAILURE 17; SPGF17	MALE INFERTILITY DUE TO OOCYTE ACTIVATION FAILURE	
Number Sign	617217	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA6; AI2A6		
Number Sign	617219	CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL		
Number Sign	617222	SUDDEN CARDIAC FAILURE, INFANTILE; SCFI		
Number Sign	617223	SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED; SCFAI		
Number Sign	617225	SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE; SPG78		
Number Sign	617228	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31; COXPD31		
Number Sign	617232	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Z; LGMD2Z		
Number Sign	617234	PREIMPLANTATION EMBRYONIC LETHALITY 2; PREMBL2		
Number Sign	617235	MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY		
Number Sign	617236	CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL		
Number Sign	617237	IMMUNODEFICIENCY 49; IMD49	SEVERE COMBINED IMMUNODEFICIENCY, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE, WITH INTELLECTUAL DISABILITY, SPASTICITY, AND CRANIOFACIAL ABNORMALITIES;; SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE, WITH INTELLECTUAL DISABILITY, SPASTICITY, AND CRANIOFACIAL ABNORMALITIES	
Number Sign	617238	MYOPIA 25, AUTOSOMAL DOMINANT; MYP25		
Number Sign	617239	MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC; CMS21		
Number Sign	617241	LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS		
Number Sign	617243	FANCONI ANEMIA, COMPLEMENTATION GROUP V; FANCV		
Number Sign	617244	FANCONI ANEMIA, COMPLEMENTATION GROUP R; FANCR		
Number Sign	617247	FANCONI ANEMIA, COMPLEMENTATION GROUP U; FANCU		
Number Sign	617248	3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8		
Number Sign	617251	UNCOMBABLE HAIR SYNDROME 2; UHS2		
Number Sign	617252	UNCOMBABLE HAIR SYNDROME 3; UHS3		
Number Sign	617253	SECKEL SYNDROME 10; SCKL10		
Number Sign	617255	LISSENCEPHALY 8; LIS8		
Number Sign	617258	MYOPATHY, MYOFIBRILLAR, 8; MFM8		
Number Sign	617260	GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF		
Number Sign	617268	NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL		
Number Sign	617270	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58		
Number Sign	617271	NEPHRONOPHTHISIS 20; NPHP20		
Number Sign	617272	GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E		
Number Sign	617275	TOOTH AGENESIS, SELECTIVE, 9; STHAG9		
Number Sign	617276	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48; EIEE48		
Number Sign	617280	ATRIAL FIBRILLATION, FAMILIAL, 18; ATFB18		
Number Sign	617281	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49		
Number Sign	617282	DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	DYSTONIA 29, CHILDHOOD-ONSET; DYT29	
Number Sign	617284	DYSTONIA 28, CHILDHOOD-ONSET; DYT28		
Number Sign	617290	EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D		
Number Sign	617294	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED, WITH SCARRING AND HAIR LOSS; EBSSH		
Number Sign	617296	SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO		
Number Sign	617297	AMELOGENESIS IMPERFECTA, TYPE IJ; AI1J		
Number Sign	617300	HYDROPS FETALIS, NONIMMUNE, AND/OR ATRIAL SEPTAL DEFECT, SUSCEPTIBILITY TO; HFASD		
Number Sign	617301	GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE		
Number Sign	617302	OPTIC ATROPHY 11; OPA11		
Number Sign	617303	MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS		
Number Sign	617304	RETINITIS PIGMENTOSA 77; RP77		
Number Sign	617306	COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD		
Number Sign	617308	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6		
Number Sign	617315	ANTERIOR SEGMENT DYSGENESIS 6; ASGD6		
Number Sign	617319	ANTERIOR SEGMENT DYSGENESIS 8; ASGD8		
Number Sign	617320	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 12; ARCI12		
Number Sign	617321	YAO SYNDROME; YAOS		
Number Sign	617323	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59; MRT59		
Number Sign	617330	HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS		
Number Sign	617333	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP		
Number Sign	617336	NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11		
Number Sign	617337	ECTODERMAL DYSPLASIA 12, HYPOHIDROTIC/HAIR/TOOTH/NAIL TYPE; ECTD12		
Number Sign	617339	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51		
Number Sign	617341	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2; CRMCC2		
Number Sign	617343	HYPERPARATHYROIDISM 4; HRPT4		
Number Sign	617347	HYPERLIPOPROTEINEMIA, TYPE III	APOLIPOPROTEIN E, DEFICIENCY OR DEFECT OF;; DYSBETALIPOPROTEINEMIA DUE TO DEFECT IN APOLIPOPROTEIN E-d;; FAMILIAL HYPERBETA- AND PREBETALIPOPROTEINEMIA;; FAMILIAL HYPERCHOLESTEROLEMIA WITH HYPERLIPEMIA;; HYPERLIPEMIA WITH FAMILIAL HYPERCHOLESTEROLEMIC XANTHOMATOSIS;; BROAD-BETALIPOPROTEINEMIA;; FLOATING-BETALIPOPROTEINEMIA	CORONARY ARTERY DISEASE, SEVERE, SUSCEPTIBILITY TO, INCLUDED;; LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 5, INCLUDED; LDLCQ5, INCLUDED
Number Sign	617349	AORTIC ANEURYSM, FAMILIAL THORACIC 11, SUSCEPTIBILITY TO; AAT11		
Number Sign	617350	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52		
Number Sign	617352	MULCHANDANI-BHOJ-CONLIN SYNDROME; MBCS	UNIPARENTAL DISOMY, MATERNAL, CHROMOSOME 20	
Number Sign	617360	CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD		
Number Sign	617364	CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA; CHDED		
Number Sign	617370	PEROXISOME BIOGENESIS DISORDER 10B; PBD10B		
Number Sign	617383	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2; ANFH2		
Number Sign	617384	HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4		
NULL	617386	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 5, PSEUDOGENE; NR1H5P	FARNESOID X-ACTIVATED RECEPTOR, BETA, PSEUDOGENE; FXRB	
Number Sign	617388	AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK		
Number Sign	617389	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53		
Number Sign	617391	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54		
Number Sign	617392	ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13		
Number Sign	617393	NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION; NECFM		
Number Sign	617394	SCLEROSING CHOLANGITIS, NEONATAL; NSC		
Number Sign	617395	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	CDG IIq; CDGIIq	
Number Sign	617396	ANAUXETIC DYSPLASIA 2; ANXD2		
Number Sign	617397	PSEUDO-TORCH SYNDROME 2; PTORCH2		
Number Sign	617402	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C		
Number Sign	617403	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D		
Number Sign	617404	MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY; MDCCAID		
Number Sign	617405	SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17		
Number Sign	617406	BARDET-BIEDL SYNDROME 21; BBS21		
Number Sign	617408	DIAMOND-BLACKFAN ANEMIA 16; DBA16		
Number Sign	617409	DIAMOND-BLACKFAN ANEMIA 17; DBA17		
Number Sign	617412	BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	MACINNES SYNDROME; MCINS	
Number Sign	617425	IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA		
Number Sign	617432	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60; MRT60		
Number Sign	617433	RETINITIS PIGMENTOSA 78; RP78		
Number Sign	617435	LOPES-MACIEL-RODAN SYNDROME; LOMARS		
Number Sign	617439	CRANIOSYNOSTOSIS 7; CRS7	CRANIOSYNOSTOSIS 7, DIGENIC;; CRS7, DIGENIC	
Number Sign	617441	THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY		
Number Sign	617442	PREMATURE OVARIAN FAILURE 13; POF13		
Number Sign	617443	BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21		
Number Sign	617450	INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD; IDDGIP		
Number Sign	617452	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES; IDDFSDA		
Number Sign	617460	RETINITIS PIGMENTOSA 79; RP79		
Number Sign	617466	TOWNES-BROCKS SYNDROME 2; TBS2		
Number Sign	617468	ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT; AMCNMY		
Number Sign	617475	SPECIFIC GRANULE DEFICIENCY 2; SGD2		
Number Sign	617478	STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME; SHDRA		
Number Sign	617480	46,XX SEX REVERSAL 4; SRXX4	46,XX SEX REVERSAL, SRY-NEGATIVE	
Number Sign	617481	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA		
Number Sign	617493	NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM		
Number Sign	617506	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2		
Number Sign	617507	PEHO-LIKE SYNDROME; PEHOL	PROGRESSIVE ENCEPHALOPATHY WITH EDEMA, HYPSARRHYTHMIA, AND OPTIC ATROPHY-LIKE SYNDROME	
Number Sign	617514	IMMUNODEFICIENCY 52; IMD52		
Number Sign	617516	STANKIEWICZ-ISIDOR SYNDROME; STISS		
Number Sign	617519	MYOPATHY, CONGENITAL, WITH NEUROPATHY AND DEAFNESS; CMND		
Number Sign	617520	MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18		
Number Sign	617523	NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM		
Number Sign	617524	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 2; EKVP2		
Number Sign	617525	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 3; EKVP3		
Number Sign	617526	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4; EKVP4		
Number Sign	617527	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA		
Number Sign	617532	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF		
Number Sign	617537	RAHMAN SYNDROME; RMNS		
Number Sign	617540	PITUITARY ADENOMA 5, MULTIPLE TYPES; PITA5		
Number Sign	617542	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 2; HGPPS2		
Number Sign	617547	RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS		
Number Sign	617557	GABRIELE-DE VRIES SYNDROME; GADEVS		
Number Sign	617560	SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8		
Number Sign	617561	COHEN-GIBSON SYNDROME; COGIS		
Number Sign	617562	MECKEL SYNDROME 13; MKS13		JOUBERT SYNDROME 29, INCLUDED; JBTS29, INCLUDED
Number Sign	617563	OROFACIODIGITAL SYNDROME XVI; OFD16	OFDS XVI;; ORAL-FACIAL-DIGITAL SYNDROME, TYPE XVI	
Number Sign	617564	MEIER-GORLIN SYNDROME 8; MGORS8		
Number Sign	617565	PERRAULT SYNDROME 6; PRLTS6		
Number Sign	617571	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14; ARCI14		
Number Sign	617572	EXUDATIVE VITREORETINOPATHY 7; EVR7		
Number Sign	617574	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13; ARCI13		
Number Sign	617575	NEPHROTIC SYNDROME 14; NPHS14		
Number Sign	617576	SPERMATOGENIC FAILURE 18; SPGF18		
Number Sign	617577	CILIARY DYSKINESIA, PRIMARY, 37; CILD37	CILIARY DYSKINESIA, PRIMARY, 37, WITH OR WITHOUT SITUS INVERSUS	
Number Sign	617584	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25		
Number Sign	617585	IMMUNODEFICIENCY 53; IMD53		
Number Sign	617592	SPERMATOGENIC FAILURE 19; SPGF19		
Number Sign	617593	SPERMATOGENIC FAILURE 20; SPGF20		
Number Sign	617595	BIRK-LANDAU-PEREZ SYNDROME; BILAPES		
Number Sign	617596	MALEYLACETOACETATE ISOMERASE DEFICIENCY; MAAID	MAAI DEFICIENCY;; HYPERSUCCINYLACETONEMIA, MILD; MHSA;; BENIGN HYPERSUCCINYLACETONEMIA; BHSA	
Number Sign	617598	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3		
Number Sign	617599	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 14; GPIBD14	
Number Sign	617600	MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45		
Number Sign	617601	MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46		
Number Sign	617602	CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM		
Number Sign	617604	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA		
Number Sign	617605	DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71		
Number Sign	617606	DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72		
Number Sign	617607	AMELOGENESIS IMPERFECTA, TYPE IIIB; AI3B		
Number Sign	617609	NEPHROTIC SYNDROME 15; NPHS15		
Number Sign	617610	POLYCYSTIC KIDNEY DISEASE 5; PKD5		
Number Sign	617613	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5		
Number Sign	617616	SKRABAN-DEARDORFF SYNDROME; SKDEAS	INTELLECTUAL DISABILITY WITH SEIZURES, ABNORMAL GAIT, AND DISTINCTIVE FACIAL FEATURES	
Number Sign	617622	JOUBERT SYNDROME 30; JBTS30		
Number Sign	617626	FIBROMATOSIS, GINGIVAL, 5; GINGF5	GGF5;; FIBROMATOSIS, GINGIVAL, HEREDITARY, 5; HGF5	
Number Sign	617629	SCHIZOPHRENIA 19; SCZD19	SCHIZOPHRENIA 19 WITH OR WITHOUT AN AFFECTIVE DISORDER	
Number Sign	617633	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26		
Number Sign	617635	MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47		
Number Sign	617637	DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106		
Number Sign	617638	IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	ATOPIC DERMATITIS, ELEVATED IgE, AND EOSINOPHILIA	
Number Sign	617639	DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107		
Number Sign	617641	CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED		
Number Sign	617642	POLYDACTYLY, POSTAXIAL, TYPE A7; PAPA7		
Number Sign	617643	CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS		
Number Sign	617644	SPERMATOGENIC FAILURE 21; SPGF21		
Number Sign	617654	DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108		
Number Sign	617660	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	CONGENITAL NAD DEFICIENCY DISORDER 1;; 3-HYDROXYANTHRANILIC ACIDEMIA	
Number Sign	617661	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	CONGENITAL NAD DEFICIENCY DISORDER 2;; KYNURENINASE DEFICIENCY, COMPLETE	
Number Sign	617662	JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM		
Number Sign	617663	DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73		
Number Sign	617664	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32		
Number Sign	617665	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56		
Number Sign	617666	FRASER SYNDROME 2; FRASRS2		
Number Sign	617667	FRASER SYNDROME 3; FRASRS3		
Number Sign	617668	ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	LIPOYLTRANSFERASE 2 DEFICIENCY; LIPT2D	
Number Sign	617669	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS		
Number Sign	617671	HELIX SYNDROME; HELIX	HYPOHIDROSIS, ELECTROLYTE IMBALANCE, LACRIMAL GLAND DYSFUNCTION, ICHTHYOSIS, AND XEROSTOMIA	
Number Sign	617672	NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA		
Number Sign	617675	MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT		
Number Sign	617681	BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2		
Number Sign	617682	PILAROWSKI-BJORNSSON SYNDROME; PILBOS	DEVELOPMENTAL DELAY AND SPEECH APRAXIA WITH OR WITHOUT SEIZURES	
Number Sign	617686	PITUITARY ADENOMA 3, MULTIPLE TYPES; PITA3		
Number Sign	617690	OVARIAN DYSGENESIS 5; ODG5		
Number Sign	617691	SPINOCEREBELLAR ATAXIA 44; SCA44		
Number Sign	617694	AL KAISSI SYNDROME; ALKAS	GROWTH RETARDATION, SPINE MALFORMATION, DYSMORPHIC FACIES, AND DEVELOPMENTAL DELAY	
Number Sign	617695	PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11		
Number Sign	617698	3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9		
Number Sign	617706	SPERMATOGENIC FAILURE 22; SPGF22		
Number Sign	617707	SPERMATOGENIC FAILURE 23; SPGF23		
Number Sign	617709	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS		
Number Sign	617710	NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS		
Number Sign	617712	OOCYTE MATURATION DEFECT 3; OOMD3		
Number Sign	617713	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33		
Number Sign	617717	AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA		
Number Sign	617719	EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7		
